Citrus Sinensis ID: 001678
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1033 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.184 | 0.204 | 0.384 | 5e-30 | |
| P18160 | 2410 | Dual specificity protein | yes | no | 0.193 | 0.082 | 0.385 | 1e-27 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.183 | 0.231 | 0.377 | 2e-27 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.176 | 0.141 | 0.376 | 3e-25 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.193 | 0.150 | 0.325 | 8e-25 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.188 | 0.212 | 0.350 | 8e-25 | |
| Q7TQP6 | 835 | Serine/threonine-protein | yes | no | 0.206 | 0.255 | 0.334 | 1e-23 | |
| Q5GIG6 | 834 | Serine/threonine-protein | yes | no | 0.206 | 0.255 | 0.334 | 2e-23 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.217 | 0.576 | 0.309 | 3e-23 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.211 | 0.134 | 0.323 | 4e-23 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 134 bits (336), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 80/208 (38%), Positives = 113/208 (54%), Gaps = 17/208 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+DL +G G+YG VYH W G++VA+K+ F+G +A+F E ++
Sbjct: 667 NDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA------LAEFRSEVRIMRR 720
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNVV F G V P+ L+ VTEF+ GSL + L + ID R+R+ +A+D A GM
Sbjct: 721 LRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGM 778
Query: 920 EYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWM 976
LH IVH DLK NLLV+ K+GD GLS++K T +S GT WM
Sbjct: 779 NCLHTSTPTIVHRDLKTPNLLVD----NNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQL 1004
APE+L ++ EK ++S ++L
Sbjct: 835 APEVL--RNEPSNEKCDVYSFGVILWEL 860
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 125 bits (315), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 86/223 (38%), Positives = 120/223 (53%), Gaps = 23/223 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I ++LE + +G G +G V G WR +DVAIK I F K S + F E +
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK--RLIIAMD 914
LS L HPNVV F G G + VTE+M GSL+QFL +++ RL +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 915 AAFGMEYLHGKN--IVHFDLKCENLLVNMR-DPQRPV--------CKIGDLGLSKVK--Q 961
A GM YLHG I+H DL N+L++ DP+ PV CKI D GLS++K Q
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ ++ V G +P+MAPE+ G S+ +EK ++S F+L
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN--SEKSDVYSYGMVLFEL 2324
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 79/209 (37%), Positives = 118/209 (56%), Gaps = 19/209 (9%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
DL ++G+G++G+V+ +W GSDVA+K + F +ER + +F +E ++ L
Sbjct: 550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH---AER---VNEFLREVAIMKRL 603
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFG 918
HPN+V F G V P+ L+ VTE++ GSL + L K +D R+RL +A D A G
Sbjct: 604 RHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 919 MEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPW 975
M YLH +N IVH DLK NLLV+ ++ K+ D GLS++K T +S GT W
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 717
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
MAPE+L + EK ++S ++L
Sbjct: 718 MAPEVL--RDEPSNEKSDVYSFGVILWEL 744
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 118 bits (295), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 75/199 (37%), Positives = 107/199 (53%), Gaps = 17/199 (8%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
+G G YG V+ G WRG++VA+K + K LI+D KE LL L HPN+V
Sbjct: 857 IGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLK------LISDLRKEVDLLCKLRHPNIVL 910
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN- 926
F G + S VTE++ GSL L + +D RL + D A GM YLH +N
Sbjct: 911 FMGACTEP--SSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 927 -IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985
I+H DLK +NLLV+ D + K+ D GL+ VK T + + GT W+APE+L+ +
Sbjct: 969 IIIHRDLKTDNLLVD--DSWQ--VKVADFGLATVKSHTF-AKTMCGTTGWVAPEVLAEEG 1023
Query: 986 HMVTEKVTLFSLKFCCFQL 1004
+ TEK ++S ++L
Sbjct: 1024 Y--TEKADVYSYAIVLWEL 1040
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 116 bits (291), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 72/221 (32%), Positives = 119/221 (53%), Gaps = 21/221 (9%)
Query: 790 IARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD 849
I+ + I D++ +E+G G + V G W+G DVA+K++ ++ K RE +I +
Sbjct: 1061 ISSSVTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSN----KDKAREEMIQE 1116
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL------QKKDRTI 903
F E LL SL HPN+V+ YG + + V EF+ +G+L + + Q++ +
Sbjct: 1117 FKAEVELLGSLQHPNLVTCYGYSLN----PMCIVMEFLPSGNLFELIHSKPSEQQQSIKL 1172
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
D L IA D A GM++LH +NI+H DLK NLL++ + KI DLG+++ T
Sbjct: 1173 DSTLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMD----KHFNIKIADLGIARETSFT 1228
Query: 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ GT+ W APE+L +S+ +K ++S ++L
Sbjct: 1229 QTMTTI-GTVAWTAPEILRHESY--NQKADVYSYAIVLYEL 1266
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 116 bits (291), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 73/208 (35%), Positives = 112/208 (53%), Gaps = 13/208 (6%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I +L+ +LG GT+G VY G WRGS VAIK+IK + +++ +F KE +
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS L HPN+V P+ L +TE++ GSL L K ++ + +A+ A
Sbjct: 712 LSRLRHPNIVLLMAACTAPPN--LCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
GM YLH ++H D+K NLL++ + KI D GLSK+K ++ G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLD----EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+PELL G+ + TEKV +++ ++L
Sbjct: 826 SPELLMGEDY--TEKVDVYAFGIILWEL 851
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TQP6|TNI3K_RAT Serine/threonine-protein kinase TNNI3K OS=Rattus norvegicus GN=Tnni3k PE=2 SV=3 | Back alignment and function description |
|---|
Score = 112 bits (281), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 17/230 (7%)
Query: 779 KIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAG 838
K + + AE +R + + E+ +GSG++G VY G+ R VAIKR +A+ +
Sbjct: 442 KADVLLLRAELPSRFHLQLSEIEFHEI--IGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 499
Query: 839 KPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK 898
K + F +E +L L+HP VV F G D P A VT+++ GSL L +
Sbjct: 500 KSD-----VDMFCREVSILCQLNHPCVVQFVGACLDDPS-QFAIVTQYISGGSLFSLLHE 553
Query: 899 KDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
+ R +D + +LIIA+D A GMEYLH I+H DL N+L + + V + D G
Sbjct: 554 QKRILDLQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNIL--LYEDGHAV--VADFGE 609
Query: 957 SKVKQQTLVSGGVR--GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
S+ Q + G L WMAPE+ + + T K +FS C ++L
Sbjct: 610 SRFLQSLDEDNMTKQPGNLRWMAPEVFT-QCTRYTIKADVFSYSLCLWEL 658
|
May play a role in cardiac physiology. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5GIG6|TNI3K_MOUSE Serine/threonine-protein kinase TNNI3K OS=Mus musculus GN=Tnni3k PE=2 SV=4 | Back alignment and function description |
|---|
Score = 112 bits (280), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 17/230 (7%)
Query: 779 KIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAG 838
K + + AE +R + + E+ +GSG++G VY G+ R VAIKR +A+ +
Sbjct: 441 KADVLLLRAELPSRFHLQLSEIEFHEI--IGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 498
Query: 839 KPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK 898
K + F +E +L L+HP VV F G D P A VT+++ GSL L +
Sbjct: 499 KSD-----VDMFCREVSILCQLNHPCVVQFVGACLDDPS-QFAIVTQYISGGSLFSLLHE 552
Query: 899 KDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
+ R +D + +LIIA+D A GMEYLH I+H DL N+L + + V + D G
Sbjct: 553 QKRILDLQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNIL--LYEDGHAV--VADFGE 608
Query: 957 SKVKQQTLVSGGVR--GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
S+ Q + G L WMAPE+ + + T K +FS C ++L
Sbjct: 609 SRFLQSLDEDNMTKQPGNLRWMAPEVFT-QCTRYTIKADVFSYALCLWEL 657
|
May play a role in cardiac physiology. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 111 bits (277), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 74/239 (30%), Positives = 121/239 (50%), Gaps = 14/239 (5%)
Query: 770 YDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEV---RELGSGTYGSVYHGKWRGSDV 826
+D+ ++ +E E ++G + DL ++ + SG + +Y G ++ V
Sbjct: 51 FDSMESWSMILESENVETWEASKGEREEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAV 110
Query: 827 AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEF 886
A+K ++ K R +L F E LLS L HPN+V F + P +TE+
Sbjct: 111 AVKMVRIP--THKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP--VYCIITEY 166
Query: 887 MVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945
M G+L+ +L KK+ ++ L +A+D + GMEYLH + ++H DLK NLL+N D
Sbjct: 167 MSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN--DEM 224
Query: 946 RPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
R K+ D G S ++ Q + G GT WMAPE++ K + T KV ++S ++L
Sbjct: 225 R--VKVADFGTSCLETQCREAKGNMGTYRWMAPEMIKEKPY--TRKVDVYSFGIVLWEL 279
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 110 bits (276), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 78/241 (32%), Positives = 125/241 (51%), Gaps = 23/241 (9%)
Query: 766 IEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD 825
I++DY D K E + + + R + I D++ +++G G+YG V++GKW+G D
Sbjct: 1334 IDIDYMADIDK----EDSFLTSANMCRWI--INYDEISIGKQIGLGSYGIVFNGKWKGVD 1387
Query: 826 VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885
VA+K+ K SE + L +F E LS L H N+V+F G P+ + VTE
Sbjct: 1388 VAVKKFVKQ----KLSETQLL--EFRAEMAFLSELKHSNIVTFIGACIKKPN--ICIVTE 1439
Query: 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRD 943
+M G+L+ L+ D I +L + AA G++YLH N IVH D+K N+LV+
Sbjct: 1440 YMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHSSNPMIVHRDIKPANILVD--- 1496
Query: 944 PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQ 1003
+ KI D G +++K+ GT W APE++ G+ + EK +FS ++
Sbjct: 1497 -EHFNVKIADFGFARIKEDNTTMTRC-GTPCWTAPEVIRGEKY--CEKADVFSFGVVMWE 1552
Query: 1004 L 1004
+
Sbjct: 1553 V 1553
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1033 | ||||||
| 225446134 | 1217 | PREDICTED: uncharacterized protein LOC10 | 0.956 | 0.811 | 0.632 | 0.0 | |
| 255570521 | 1090 | serine/threonine protein kinase, putativ | 0.946 | 0.897 | 0.633 | 0.0 | |
| 297735348 | 978 | unnamed protein product [Vitis vinifera] | 0.860 | 0.908 | 0.597 | 0.0 | |
| 449462731 | 1102 | PREDICTED: uncharacterized protein LOC10 | 0.951 | 0.892 | 0.560 | 0.0 | |
| 449525772 | 1102 | PREDICTED: uncharacterized protein LOC10 | 0.951 | 0.892 | 0.559 | 0.0 | |
| 356550754 | 1087 | PREDICTED: uncharacterized protein LOC10 | 0.939 | 0.892 | 0.571 | 0.0 | |
| 357479749 | 1113 | Protein kinase-like protein [Medicago tr | 0.934 | 0.867 | 0.565 | 0.0 | |
| 356564856 | 1073 | PREDICTED: uncharacterized protein LOC10 | 0.912 | 0.878 | 0.559 | 0.0 | |
| 297793271 | 1045 | kinase family protein [Arabidopsis lyrat | 0.905 | 0.894 | 0.554 | 0.0 | |
| 147856633 | 4128 | hypothetical protein VITISV_010028 [Viti | 0.804 | 0.201 | 0.587 | 0.0 |
| >gi|225446134|ref|XP_002270697.1| PREDICTED: uncharacterized protein LOC100266729 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1287 bits (3330), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/1058 (63%), Positives = 798/1058 (75%), Gaps = 70/1058 (6%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSPS S GSND+ PRVKFLCSF G ILPRPQDGKLRYVGGETRIVS+PRD+
Sbjct: 105 MDSPSAT---PSSAHGSNDENPRVKFLCSFSGSILPRPQDGKLRYVGGETRIVSVPRDIG 161
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +M+EL++ A VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 162 YEELMGKMKELFDMAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 221
Query: 121 FLFSHSDQDG-SNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMA 179
FLFSH DQDG S+H+VD DD +ERRYVDALNN+ND +DFRK Q +SP +S+IDDIH+A
Sbjct: 222 FLFSHPDQDGGSSHFVDVDD--TERRYVDALNNLNDASDFRKQQVGESPTMSAIDDIHLA 279
Query: 180 ERFFNTMSLEGGIHNQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAY 232
E+FFN++SLEGG+HNQ Q+NLH LT+PHM SGQ Q PV+QRYNEME W+PAY
Sbjct: 280 EQFFNSISLEGGLHNQRNCEMPMSQFNLHHLTIPHMGSGQHQ-PVAQRYNEMESQWNPAY 338
Query: 233 YSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQ 286
+SPRH+GHHD RPL E+PSSPSSARFRMPFGE +R+PEEY+RQ VN Y+ Q
Sbjct: 339 FSPRHHGHHDA-RPLAEYPSSPSSARFRMPFGELPDKCIDRLPEEYSRQPVNPQAPYDHQ 397
Query: 287 PQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN 346
PQ S+N++W+P G +S +K+GFPG++ HG NVF+GN +CEHCR+T+HR HL+QPN+GN
Sbjct: 398 PQASDNVVWLPTGAISSEKAGFPGSMLHGPNVFEGNSICEHCRMTFHR---HLEQPNMGN 454
Query: 347 GLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLN 404
GLP V CAEC RE+ +LN +AK+ G+YPK+ ND RS+YNE+H HERGW+LQHQLN
Sbjct: 455 GLPPVANPCAECPPGRESFLLNTDAKMQHGIYPKEHNDPRSLYNETHNHERGWILQHQLN 514
Query: 405 PRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHH------RTGPE 458
PR E+AR +SGAGRLND Y+VDG G+N P HGNL+D HHVS N+ HH RTGPE
Sbjct: 515 PRAEDARAQISGAGRLNDPYIVDGSGVNFPVAHGNLLDNHHVSSNYVHHEDPRYIRTGPE 574
Query: 459 MGNELFHDPAAAVVPHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNLWRNVQN 516
+GN +FHD AAA P ++ P EER VRYGN +PYGAD +Y VSHGH A LWRNVQN
Sbjct: 575 LGNGVFHDQAAAAGPAINVPPLEERAVRYGNLPYPYGADNLYQVSHGHVPAHALWRNVQN 634
Query: 517 PIHVTP-LEASGPVI--NGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTA 573
P+H P EAS +GS+ P +RG EG+PR VG+D+ N W + SQ++ GF G+A
Sbjct: 635 PMHGAPSYEASTSTCQASGSVNPGPIRGTREGSPRFCVGLDNQNPWGESSQKILGFDGSA 694
Query: 574 TPPEYYYSQTQKMNPQSYNQQNQLP-------------------DPVHQSDSFSALVQDK 614
P +Y Y K+NP ++ Q+ Q P +P+H ++S L+ DK
Sbjct: 695 LP-DYSYGHATKLNPNTHGQEGQHPFTPGPVPSPSDMLKFAAPMEPLHFTNSSPTLMDDK 753
Query: 615 LVSSTTDCNLGLRV-----NNVSEAVRTDENCNLGQEKAANHVVKVEETDVKRSCL-EQN 668
V+S NL NNV++ V + + K H+ KVE+ D+ + L E+N
Sbjct: 754 FVASA---NLSYNPESRNDNNVNQTVIMEAKQAFREGKEEIHMEKVEDNDMPVTSLPEKN 810
Query: 669 MIPEKPIGSTSL--LAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAAL 726
+K SL + + N+ KP + ED+KL NLS LPELIASVKRAAL
Sbjct: 811 NNADKKCEVASLEPVNLPAEDNVFKPVVNDCAPLEEDAKLDVSNLSFLPELIASVKRAAL 870
Query: 727 EGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAE 786
E AEEVKAKV+E+ D+V ++TKEA +NE E N G++E+D DND V T KIEPT AE
Sbjct: 871 ESAEEVKAKVQENADAVHA-SSTKEA-SNELETANALGDLELDSDNDNVNTFKIEPTKAE 928
Query: 787 AEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERL 846
EA++RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSERERL
Sbjct: 929 EEALSRGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERERL 988
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
IADFWKEAL+LSSLHHPNVVSFYGIVRDGP GSLATVTEFMVNGSLKQFLQKKDRTIDRR
Sbjct: 989 IADFWKEALILSSLHHPNVVSFYGIVRDGPGGSLATVTEFMVNGSLKQFLQKKDRTIDRR 1048
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
KR IIAMDA+FGMEYLHGKNIVHFDLKCENLLVNMRDP RPVCKIGDLGLSKVKQ TLVS
Sbjct: 1049 KRRIIAMDASFGMEYLHGKNIVHFDLKCENLLVNMRDPHRPVCKIGDLGLSKVKQHTLVS 1108
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
GGVRGTLPWMAPELLSGK++MVTEK+ ++S ++L
Sbjct: 1109 GGVRGTLPWMAPELLSGKTNMVTEKIDVYSFGIVMWEL 1146
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570521|ref|XP_002526218.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223534457|gb|EEF36159.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1283 bits (3320), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 653/1030 (63%), Positives = 778/1030 (75%), Gaps = 52/1030 (5%)
Query: 15 AGSNDD-VPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE 73
AGS+D+ PRVK LCSFLG I+PRPQDGKLRYVGGETRIVSLPRD+++EELM++MRELYE
Sbjct: 18 AGSHDENTPRVKLLCSFLGSIMPRPQDGKLRYVGGETRIVSLPRDISFEELMNKMRELYE 77
Query: 74 GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSHSDQDGSNH 133
GA VLKYQQPDEDLDALVSVVNDDDV NMMEEYEKL SGDGFTRLRIFLFSH DQDGS+H
Sbjct: 78 GASVLKYQQPDEDLDALVSVVNDDDVTNMMEEYEKLDSGDGFTRLRIFLFSHPDQDGSSH 137
Query: 134 YVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMAERFFNTMSLEGGIH 193
YVDGD+RESERRYVDALNN+NDG DFR+ Q DSP+I I+D+H+ E FF+ M+L+ G+H
Sbjct: 138 YVDGDERESERRYVDALNNLNDGADFRR-QQADSPLIGPIEDVHLHEHFFSPMNLDSGLH 196
Query: 194 NQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYGHHDPPRP 246
NQ PQYNLH + +P QRYNEMEGPWSPA+YSPRH+GHHDP RP
Sbjct: 197 NQRSGEMLIPQYNLHHVAIP------------QRYNEMEGPWSPAFYSPRHHGHHDP-RP 243
Query: 247 LPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENLIWMPPGN 300
L EFP+SP S+R+R FGE +RV EEYAR +NHHP Y+ QP + +N++WMPPG
Sbjct: 244 LTEFPNSPPSSRYRTQFGEFPDRGMDRVSEEYARSQLNHHPAYDHQPPYPDNVVWMPPGT 303
Query: 301 VSGD-KSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGNGLPQVPLSCAECR 359
+SGD K+GFPGNL HG V +G+ CEHCR+ + RNQLHL+QPN+GN + QV SC EC
Sbjct: 304 ISGDNKAGFPGNLLHGPTVVEGSSTCEHCRVAFQRNQLHLEQPNVGNPVHQVANSCTECH 363
Query: 360 QNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLNPRIEEARTHMSGA 417
NRE+ +LNA+ K+ MYPKD ND RS+YNE+H HERGW LQHQL+P +EARTH+SGA
Sbjct: 364 PNREHFMLNADTKVHHAMYPKDQNDPRSIYNEAHSHERGWSLQHQLSPHADEARTHISGA 423
Query: 418 GRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNELFHDPAAAVVPHLHT 477
GR+N+HY+VDGPG+N P GH NL DG H S NH+HHR G E+GN++FHD A A + HLH
Sbjct: 424 GRINEHYIVDGPGINYPLGHSNLADGQHASSNHSHHRAGHELGNDVFHDQAVAAMHHLHI 483
Query: 478 PSAEERVVRYGNFPYGADTI--YPVSHGHATAQNLWRNVQNPIHVTPLEASGPV--INGS 533
P +EER VRYGNF YG T YP+SHGH Q LWRNVQNP+H TP + S +NG+
Sbjct: 484 PPSEERAVRYGNFAYGYGTENPYPISHGHLHPQTLWRNVQNPVHGTPYDTSSATSQVNGT 543
Query: 534 ITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQKMNPQSYNQ 593
+ PA LRG +EG+ R +D+ +S ++ +Q++ GF GT T PEY Y + K+ P Y
Sbjct: 544 VNPALLRGTLEGSQRTGNDLDNMHSRLESAQKILGFDGT-TAPEYSYGHSLKLTPNHYGP 602
Query: 594 QN-QLPDPVHQSDSFSALVQDK-LVSSTTDCNLGLRVNNVSEAVRTDENCNLGQEKAANH 651
+N QL P ++ +S T+ N L +N+ E + ++ LG EK A +
Sbjct: 603 ENKQLFTPETVRPPLPREIRSSSAISGTSGYNPELSSSNIMEVTKMEKPV-LGMEKEAIY 661
Query: 652 VVKVEETDVKRS-CLEQNMIPE--------KPIGSTSLLAMEVSGNIEKPGEKSPSDRPE 702
++E DV+ EQ+M+ + + S S E +G+I K GE PS E
Sbjct: 662 AEQIENLDVQNLLSTEQDMVARGNGDAALLETLHSNSSRHTEGAGDIVKGGETDPSAVME 721
Query: 703 DSKLLAHNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNI 762
SKL LS LPELIASVK+AALE AEEVKA V E++ S + +KEA +E+E VN
Sbjct: 722 TSKLSLDRLSFLPELIASVKKAALEEAEEVKAVVNENEHS----SASKEATPSESEAVNA 777
Query: 763 HGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR 822
H E E+D ++D + T +IEPT AE EAI RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+
Sbjct: 778 HEEPELDSESDNINTNEIEPTKAEEEAIERGLQTIKNDDLEEIRELGSGTYGAVYHGKWK 837
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
GSDVAIKRIKASCFAG+PSERERLIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLAT
Sbjct: 838 GSDVAIKRIKASCFAGRPSERERLIADFWKEALILSSLHHPNVVSFYGIVRDGPDGSLAT 897
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD AFGMEYLHGKNIVHFD+KCENLLVNMR
Sbjct: 898 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDMKCENLLVNMR 957
Query: 943 DPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCF 1002
DPQRPVCKIGDLGLSKVKQ TLVSGGVRGTLPWMAPELLSGKSHMVTEK+ ++S +
Sbjct: 958 DPQRPVCKIGDLGLSKVKQHTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMW 1017
Query: 1003 QLKWSYDCYS 1012
+L + Y+
Sbjct: 1018 ELLTGEEPYA 1027
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735348|emb|CBI17788.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1145 bits (2962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 611/1022 (59%), Positives = 727/1022 (71%), Gaps = 133/1022 (13%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSPS S GSND+ PRVKFLCSF G ILPRPQDGKLRYVGGETRIVS+PRD+
Sbjct: 1 MDSPSAT---PSSAHGSNDENPRVKFLCSFSGSILPRPQDGKLRYVGGETRIVSVPRDIG 57
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +M+EL++ A VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 58 YEELMGKMKELFDMAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 117
Query: 121 FLFSHSDQDG-SNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMA 179
FLFSH DQDG S+H+VD DD +ERRYVDALNN+ND +DFRK Q P S
Sbjct: 118 FLFSHPDQDGGSSHFVDVDD--TERRYVDALNNLNDASDFRKQQMPMS------------ 163
Query: 180 ERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYG 239
Q+NLH LT+PHM SGQ Q PV+QRYNEME W+PAY+SPRH+G
Sbjct: 164 -----------------QFNLHHLTIPHMGSGQHQ-PVAQRYNEMESQWNPAYFSPRHHG 205
Query: 240 HHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENL 293
HHD RPL E+PSSPSSARFRMPFGE +R+PEEY+RQ VN Y+ QPQ S+N+
Sbjct: 206 HHDA-RPLAEYPSSPSSARFRMPFGELPDKCIDRLPEEYSRQPVNPQAPYDHQPQASDNV 264
Query: 294 IWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGNGLPQVPL 353
+W+P G +S +K+GFPG++ HG NVF+GN +CEHCR+T+HR HL+QPN+GNGLP V
Sbjct: 265 VWLPTGAISSEKAGFPGSMLHGPNVFEGNSICEHCRMTFHR---HLEQPNMGNGLPPVAN 321
Query: 354 SCAECRQNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLNPRIEEAR 411
CAEC RE+ +LN +AK+ G+YPK+ ND RS+YNE+H HERGW+LQHQLNPR E+AR
Sbjct: 322 PCAECPPGRESFLLNTDAKMQHGIYPKEHNDPRSLYNETHNHERGWILQHQLNPRAEDAR 381
Query: 412 THMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHH------RTGPEMGNELFH 465
+SGAGRLND Y+VDG G+N P HGNL+D HHVS N+ HH RTGPE+GN +FH
Sbjct: 382 AQISGAGRLNDPYIVDGSGVNFPVAHGNLLDNHHVSSNYVHHEDPRYIRTGPELGNGVFH 441
Query: 466 DPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYPVSHGHATAQNLWRNVQNPIHVTPLEA 525
D AAA P ++ P EE +T Q
Sbjct: 442 DQAAAAGPAINVPPLEEPST-------------------STCQ----------------- 465
Query: 526 SGPVINGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQK 585
+GS+ P +RG EG+PR VG+D+ N W + SQ++ GF G+A P+Y Y K
Sbjct: 466 ----ASGSVNPGPIRGTREGSPRFCVGLDNQNPWGESSQKILGFDGSAL-PDYSYGHATK 520
Query: 586 MNPQSYNQQNQLPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSEAVRTDENCNLGQ 645
+NP ++ Q+ Q P F+ ++ + +A R G+
Sbjct: 521 LNPNTHGQEGQHP--------FTPVIME-----------------AKQAFRE------GK 549
Query: 646 EKAANHVVKVEETDVKRSCL-EQNMIPEKPIGSTSL--LAMEVSGNIEKPGEKSPSDRPE 702
E+ H+ KVE+ D+ + L E+N +K SL + + N+ KP + E
Sbjct: 550 EEI--HMEKVEDNDMPVTSLPEKNNNADKKCEVASLEPVNLPAEDNVFKPVVNDCAPLEE 607
Query: 703 DSKLLAHNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNI 762
D+KL NLS LPELIASVKRAALE AEEVKAKV+E+ D+V ++TKEA +NE E N
Sbjct: 608 DAKLDVSNLSFLPELIASVKRAALESAEEVKAKVQENADAVHA-SSTKEA-SNELETANA 665
Query: 763 HGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR 822
G++E+D DND V T KIEPT AE EA++RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+
Sbjct: 666 LGDLELDSDNDNVNTFKIEPTKAEEEALSRGLQTIKNDDLEEIRELGSGTYGAVYHGKWK 725
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
GSDVAIKRIKASCFAG+PSERERLIADFWKEAL+LSSLHHPNVVSFYGIVRDGP GSLAT
Sbjct: 726 GSDVAIKRIKASCFAGRPSERERLIADFWKEALILSSLHHPNVVSFYGIVRDGPGGSLAT 785
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
VTEFMVNGSLKQFLQKKDRTIDRRKR IIAMDA+FGMEYLHGKNIVHFDLKCENLLVNMR
Sbjct: 786 VTEFMVNGSLKQFLQKKDRTIDRRKRRIIAMDASFGMEYLHGKNIVHFDLKCENLLVNMR 845
Query: 943 DPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCF 1002
DP RPVCKIGDLGLSKVKQ TLVSGGVRGTLPWMAPELLSGK++MVTEK+ ++S +
Sbjct: 846 DPHRPVCKIGDLGLSKVKQHTLVSGGVRGTLPWMAPELLSGKTNMVTEKIDVYSFGIVMW 905
Query: 1003 QL 1004
+L
Sbjct: 906 EL 907
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462731|ref|XP_004149094.1| PREDICTED: uncharacterized protein LOC101215475 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1090 bits (2818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/1068 (56%), Positives = 736/1068 (68%), Gaps = 85/1068 (7%)
Query: 1 MDSP--SPNVPGSG--STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP + P S S GS+D+ PRVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+P
Sbjct: 1 MDSPLTRSSTPNSSPISNPGSHDENPRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVP 60
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+TYEELM +MRELY+GA VLKYQQPDED DALVSVVNDDDVINMMEEY+K+GSGDGFT
Sbjct: 61 RDITYEELMVKMRELYDGAAVLKYQQPDEDPDALVSVVNDDDVINMMEEYDKVGSGDGFT 120
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFSH +QD S +VDGD+R++ERRYVDALNN ND NDF + Q +SP +S IDD+
Sbjct: 121 RLRIFLFSHPEQDASLPFVDGDERDTERRYVDALNNSNDMNDFVRQQQQNSPALSGIDDM 180
Query: 177 HMAERFFNTMSLEGGIHNQ------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
H E F N M++EG +H Q QY+LHQLT+PH+ SG QQQ V+QRY+EME PWSP
Sbjct: 181 HGTEHFLNPMNIEGSLHTQRSCEPLSQYHLHQLTIPHVGSGGQQQSVAQRYSEMEAPWSP 240
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
A SPRH+G +D RP+ ++PSSP AR+RMPF + ER+PE+Y RQ +NH YE
Sbjct: 241 ALLSPRHHGPYDS-RPMGDYPSSPF-ARYRMPFPDLPDKYLERMPEDYVRQQMNHQHMYE 298
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ++EN++W+P G ++ ++SGFPGN+ HGH V DGN CEHCR +HR Q H++Q N
Sbjct: 299 HQPQYNENIVWLPNGTIN-EESGFPGNILHGHGVPDGNSSCEHCRANFHRYQAHMEQVNT 357
Query: 345 GNGLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD---NDSRSVYNESHCHERGWVLQ 400
NGLP E QNRE L+ A+ K G++P + ND RS YNE+ HE+GW++Q
Sbjct: 358 LNGLP------LEYTQNREALMQKADTKFHHGIFPNEQNINDHRSAYNETPPHEKGWIMQ 411
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
HQ++ R ++ RTH+SG GRL DHY+VDG G N+P N+ DG+H S N
Sbjct: 412 HQMSVRGDDTRTHVSGTGRLTDHYIVDGSGSNLPSTQSNVADGYHASTN---------FH 462
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP-VSHGHATAQNLWRNVQNPIH 519
+E+F D H+ P E+R V Y + YG + YP ++ H WRNVQNP+H
Sbjct: 463 DEVFRDQVVPSGQHMCVPPPEDRGVGYMPYGYGGEPHYPPMAQRHMPGNASWRNVQNPLH 522
Query: 520 VTP-LEAS--GPVINGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPP 576
V P EAS N SI P Y++ +G+PRI +GVD N W + SQ+V G G AT
Sbjct: 523 VAPPYEASVFHQQGNASINPGYIKAMQDGSPRIHMGVDHQNPWHESSQKVLGVDG-ATGT 581
Query: 577 EYYYSQTQKMNPQSYNQQNQ-----------------LPDPVHQSDSFSALVQDKLVSST 619
E+ + K N + NQ + P+ +SDS SA +Q+K+V+
Sbjct: 582 EHLPAHVLKTNSTTVGHDNQQFTSLEHIQPHLDKINLVASPMQRSDSSSAFIQEKMVAPF 641
Query: 620 TDC-NLGLR-VNNVSEAVRTDENCNLGQEKAANHVVK------VEETDVKRSCLEQN--- 668
N LR V+ V+EA+ + G+ H++K + E + N
Sbjct: 642 HPSQNPQLRAVSAVNEAMMMERKVVHGE--GNGHMIKDMGKPDISEAHTASHPGQNNTDD 699
Query: 669 ----MIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRA 724
+ P + + ST + +G+ KP ++ E KL LS LPELIASVKRA
Sbjct: 700 TYSKVAPLELLNSTCTNSAVENGDGLKPSVETL----EKPKLSVSRLSFLPELIASVKRA 755
Query: 725 ALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTI 784
ALE +EE VEE+ +PD+ K+ NE N H E E++ +++ ++ +IEPT
Sbjct: 756 ALEVSEETM--VEETALR-RPDSIEKKETTNEQHSSNNHVEPELETESEN-QSSRIEPTK 811
Query: 785 AEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERE 844
AE EAI+RGLQTIKNDDLEE+RELGSGTYG+VYHGKWRGSDVAIKRIKASCFAG+PSERE
Sbjct: 812 AEEEAISRGLQTIKNDDLEEIRELGSGTYGAVYHGKWRGSDVAIKRIKASCFAGRPSERE 871
Query: 845 RLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
RLIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRTID
Sbjct: 872 RLIADFWKEALILSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTID 931
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV+Q TL
Sbjct: 932 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVRQHTL 991
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
VSGGVRGTLPWMAPELLSGKS+MVTEK+ ++S ++L + YS
Sbjct: 992 VSGGVRGTLPWMAPELLSGKSNMVTEKIDVYSFGIVMWELLTGDEPYS 1039
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525772|ref|XP_004169890.1| PREDICTED: uncharacterized protein LOC101228819 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1089 bits (2816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 598/1068 (55%), Positives = 735/1068 (68%), Gaps = 85/1068 (7%)
Query: 1 MDSP--SPNVPGSG--STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP + P S S GS+D+ PRVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+P
Sbjct: 1 MDSPLTRSSTPNSSPISNPGSHDENPRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVP 60
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+TYEELM +MRELY+GA VLKYQQPDED DALVSVVNDDDVINMMEEY+K+GSGDGFT
Sbjct: 61 RDITYEELMVKMRELYDGAAVLKYQQPDEDPDALVSVVNDDDVINMMEEYDKVGSGDGFT 120
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFSH +QD S +VDGD+R++ERRYVDALNN ND NDF + Q +SP +S IDD+
Sbjct: 121 RLRIFLFSHPEQDASLPFVDGDERDTERRYVDALNNSNDMNDFVRQQQQNSPALSGIDDM 180
Query: 177 HMAERFFNTMSLEGGIHNQ------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
H E F N M++EG +H Q QY+LHQLT+PH+ SG QQQ V+QRY+EME PWSP
Sbjct: 181 HGTEHFLNPMNIEGSLHTQRSCEPLSQYHLHQLTIPHVGSGGQQQSVAQRYSEMEAPWSP 240
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
A SPRH+G +D RP+ ++PSSP AR+RMPF + ER+PE+Y RQ +NH YE
Sbjct: 241 ALLSPRHHGPYDS-RPMGDYPSSPF-ARYRMPFPDLPDKYLERMPEDYVRQQMNHQHMYE 298
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ++EN++W+P G ++ ++SGFPGN+ HGH V DGN CEHCR +HR Q H++Q N
Sbjct: 299 HQPQYNENIVWLPNGTIN-EESGFPGNILHGHGVPDGNSSCEHCRANFHRYQAHMEQVNT 357
Query: 345 GNGLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD---NDSRSVYNESHCHERGWVLQ 400
NGLP E QNRE L+ A+ K G++P + ND RS YNE+ HE+GW++Q
Sbjct: 358 LNGLP------LEYTQNREALMQKADTKFHHGIFPNEQNINDHRSAYNETPPHEKGWIMQ 411
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
HQ++ R ++ RTH+SG GRL DHY+VDG G N+P N+ DG+H S N
Sbjct: 412 HQMSVRGDDTRTHVSGTGRLTDHYIVDGSGSNLPSTQSNVADGYHASTN---------FH 462
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP-VSHGHATAQNLWRNVQNPIH 519
+E+F D H+ P E+R V Y + YG + YP ++ H WRNVQNP+H
Sbjct: 463 DEVFRDQVVPSGQHMCVPPPEDRGVGYMPYGYGGEPHYPPMAQRHMPGNASWRNVQNPLH 522
Query: 520 VTP-LEAS--GPVINGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPP 576
V P EAS N SI P Y++ +G+PRI +GVD N W + SQ+ G G AT
Sbjct: 523 VAPPYEASVFHQQGNASINPGYIKAMQDGSPRIHIGVDHQNPWHESSQKALGVDG-ATGT 581
Query: 577 EYYYSQTQKMNPQSYNQQNQ-----------------LPDPVHQSDSFSALVQDKLVSST 619
E+ + K N + NQ + P+ +SDS SA +Q+K+V+
Sbjct: 582 EHLPAHVLKTNSTTVGHDNQQFTSLEHIQPHLDKINLVASPMQRSDSSSAFIQEKMVAPF 641
Query: 620 TDC-NLGLR-VNNVSEAVRTDENCNLGQEKAANHVVK------VEETDVKRSCLEQN--- 668
N LR V+ V+EA+ + G+ H++K + E + N
Sbjct: 642 HPSQNPQLRAVSAVNEAMMMERKVVHGE--GNGHMIKDMGKPDISEAHTASHPGQNNTDD 699
Query: 669 ----MIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRA 724
+ P + + ST + +G+ KP ++ E KL LS LPELIASVKRA
Sbjct: 700 TYSKVAPLELLNSTCTNSAVENGDGLKPSVETL----EKPKLSVSRLSFLPELIASVKRA 755
Query: 725 ALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTI 784
ALE +EE VEE+ +PD+ K+ NE N H E E++ +++ ++ +IEPT
Sbjct: 756 ALEVSEETM--VEETALR-RPDSIEKKETTNEQHSSNNHVEPELETESEN-QSSRIEPTK 811
Query: 785 AEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERE 844
AE EAI+RGLQTIKNDDLEE+RELGSGTYG+VYHGKWRGSDVAIKRIKASCFAG+PSERE
Sbjct: 812 AEEEAISRGLQTIKNDDLEEIRELGSGTYGAVYHGKWRGSDVAIKRIKASCFAGRPSERE 871
Query: 845 RLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
RLIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRTID
Sbjct: 872 RLIADFWKEALILSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTID 931
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV+Q TL
Sbjct: 932 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVRQHTL 991
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
VSGGVRGTLPWMAPELLSGKS+MVTEK+ ++S ++L + YS
Sbjct: 992 VSGGVRGTLPWMAPELLSGKSNMVTEKIDVYSFGIVMWELLTGDEPYS 1039
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550754|ref|XP_003543749.1| PREDICTED: uncharacterized protein LOC100779077 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1085 bits (2805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 600/1050 (57%), Positives = 736/1050 (70%), Gaps = 80/1050 (7%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSP P +GS +GS +D RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+ RD++
Sbjct: 1 MDSPI-RSPATGSGSGSGEDNRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVHRDIS 59
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +MRELY+GA VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFTRLRI
Sbjct: 60 YEELMGKMRELYDGAAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFTRLRI 119
Query: 121 FLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHM-A 179
FLFS S+QDGS+H++DGDD SERRYVDALN++NDG+DFR+LQ + P++S ++DIH+ A
Sbjct: 120 FLFSQSEQDGSSHFIDGDD--SERRYVDALNSLNDGSDFRRLQQGEFPMMSPVEDIHVVA 177
Query: 180 ERFFNTMSLEGGIHNQPQ-------YNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAY 232
++F++ +S+E GIH+Q YN+H LTV H S + QRYNEM+ PW+PAY
Sbjct: 178 DQFYSPISVESGIHSQRSGDLSMSPYNMHHLTVQHPKS------MGQRYNEMDAPWNPAY 231
Query: 233 YSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQ 286
YSPRH+G H EFPSSPS R+R+PF E +RV EEY R HVNHHP Y+ Q
Sbjct: 232 YSPRHHGLH-------EFPSSPSGTRYRVPFPELPDKCIDRVSEEYVRHHVNHHPVYDNQ 284
Query: 287 PQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN 346
Q+SEN++W+P G G+KS FPGN+ H +V DGN +CE CR+ +HR Q H++ NI N
Sbjct: 285 LQYSENVMWVPTGAAHGEKSAFPGNILHSPHVVDGNSICEQCRMGFHRGQPHMEHSNISN 344
Query: 347 GLPQVPLSCAECRQ-NRENLVLNAEAKL-PGMYPKD--NDSRSVYNESHCHERGWVLQHQ 402
GLPQ CAEC NR+ +NA+AKL P +YP + ND RSVYN++ HERGW LQH
Sbjct: 345 GLPQAANPCAECPPPNRDTFTVNADAKLHPAIYPNEPNNDHRSVYNDTQNHERGWGLQHP 404
Query: 403 LNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNE 462
R+EE+R H+SG+GR+ D P N GHG++ DGH++S N+ H + GPE+G E
Sbjct: 405 -TARVEESRVHVSGSGRM-----FDVPVANFSLGHGSVTDGHNLSSNYVHQQAGPELGPE 458
Query: 463 LFHDPAAAVVPHLHTPSAEERVVRYGNFP--YGADTIYPVSHGHATAQNLWRNVQNPIHV 520
LF D +P + P EE V+YGN P YG D Y V GH WRN P+H+
Sbjct: 459 LFPDQTVTSIPPIQIPPLEECNVQYGNSPSPYGLDCNYAVPRGHPPG--FWRNTPVPVHI 516
Query: 521 TPL--EASGPV-INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPE 577
P A+ P +N + +RG EG+ +G DS N W+D SQ++ G GTA P E
Sbjct: 517 GPSYEAATSPQPLNSMMNVGLIRG--EGSTGFFIGPDSQNHWVDSSQKLTGHDGTAIP-E 573
Query: 578 YYYSQTQKMNPQSYNQQNQLPD------PVHQSDSFSALVQDKLVSSTTDCNLGLRV--- 628
Y Y+ +NP Q+NQ PD P ++ + L +L S+ + +V
Sbjct: 574 YPYAHA--LNPVPLGQENQHPDIVDTIHPPQDMNAGTCLEPLQLPKSSFNMVQNQQVLRD 631
Query: 629 -NNVSEAVRTDENCNLGQEKAANHVVKVEET-----DVKRSCLEQNMIPE------KPIG 676
+++EA + N LG+ V+K+E+ S EQN I E +
Sbjct: 632 DTHLTEAKSFESNSLLGE----GIVIKIEDNVENPGAQTISSSEQNKIAEHACEAAASVE 687
Query: 677 STSLLAMEVSG--NIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAALEGAEEVKA 734
S +L + + ++EK +K PS PEDSK L S LPELIASVK+AALE AEE+KA
Sbjct: 688 SNNLKSKPEADCVHVEKLADKDPS-VPEDSKHLVDQFSFLPELIASVKKAALEDAEELKA 746
Query: 735 KVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGL 794
+E +S ++ TK+ NE E N HG++E+D +ND V T KIE T AE EA A GL
Sbjct: 747 AADEPANSQNHNSDTKDETTNEVEPTNAHGDLELDSENDHVDTNKIESTRAEEEAFANGL 806
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
QTI NDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSER RLI DFWKEA
Sbjct: 807 QTINNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERARLITDFWKEA 866
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFM+NGSLKQFL KKDRTIDRRKRLIIAMD
Sbjct: 867 LMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMINGSLKQFLHKKDRTIDRRKRLIIAMD 926
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+CKIGDLGLSKVKQ TLVSGGVRGTLP
Sbjct: 927 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQHTLVSGGVRGTLP 986
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
WMAPELLSGKS+MV+EK+ ++S ++L
Sbjct: 987 WMAPELLSGKSNMVSEKIDVYSFGIVMWEL 1016
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479749|ref|XP_003610160.1| Protein kinase-like protein [Medicago truncatula] gi|355511215|gb|AES92357.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1079 bits (2791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/1055 (56%), Positives = 732/1055 (69%), Gaps = 90/1055 (8%)
Query: 1 MDSP----SPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP SP GSG GSNDD RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+
Sbjct: 27 MDSPTAIRSPATTGSG--PGSNDDGRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVS 84
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+++EELM +MRELYEG VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFT
Sbjct: 85 RDISFEELMGKMRELYEGVAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFT 144
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFS S+QDGS H++DGDD ERRYVDALN++ND ++ R+LQ + P+I +++DI
Sbjct: 145 RLRIFLFSQSEQDGSAHFIDGDD--PERRYVDALNSLNDASELRRLQQMEFPLIGTVEDI 202
Query: 177 HMAERFFNTMSLEGGIHNQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWS 229
H+ +++ + + +E GI +Q QY LH + + Q QQP+ QRYNE++ PW+
Sbjct: 203 HVGDQYISPVGMENGILSQRSGELAMSQYGLHHMPI------QHQQPMGQRYNEIDAPWN 256
Query: 230 PAYYSPRHYG--HHDPPRPLPEFPSSPSSARFRMPF------GEERVPEEYARQHVNHHP 281
YYSPRH+G HHD L E+PSSPS R+RMPF G +RV +EYAR H+NHHP
Sbjct: 257 SGYYSPRHHGQCHHDSRTSLVEYPSSPSGPRYRMPFPEMPDKGIDRVSDEYARHHINHHP 316
Query: 282 TYEPQPQFSENLIWMPPGNV-SGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLD 340
Y+ QP + EN++W+P G GDKSGFPGN+ HG + DGN +CEHCR+++ R Q HL+
Sbjct: 317 VYDNQPPYPENVVWLPTGPAHGGDKSGFPGNVLHGSHALDGNNICEHCRMSFQRPQPHLE 376
Query: 341 QPNIGNGLPQVPLSCAECRQNRENLVLNAEAKL-PGMYPKDNDSRSVYNESHCHERGWVL 399
PN+ LP V + C EC +R+ L++NA+AKL P MYP N++ HERG L
Sbjct: 377 HPNM---LPSVAIPCPECPSSRDALIVNADAKLQPPMYP---------NDTQNHERGCGL 424
Query: 400 QHQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEM 459
QHQ +GR+ DHY+ D P ++ PGHG+++DGH + NH H GPE+
Sbjct: 425 QHQ-------------NSGRVGDHYVGDVPIISFSPGHGSMIDGHALPSNHVHQPVGPEL 471
Query: 460 GNELFHDPAAAVVPHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNLWRNVQNP 517
G ELF D A +PHL P EE V+YGN PYG D Y + G A LWRN P
Sbjct: 472 GVELFPDQTMANIPHLKIPPLEESSVQYGNPPSPYGVDKNYAMPRGQAPGYTLWRNGPTP 531
Query: 518 IHVTPLEASGPV---INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT 574
+H+ P + + ++G I +RG EG+P VG DS + W+D SQ+ G G+AT
Sbjct: 532 VHIGPPHEATTLPQPVDGVINAGIIRG--EGSPGFFVGPDSQSLWVDSSQKFSGHDGSAT 589
Query: 575 PPEYYYSQTQKMNPQSYNQQNQLP---DPVHQSDSFSAL-----VQDKLVSSTTDCNLGL 626
P EY ++ K+NP + Q+N P D +H +A VQ + S N G+
Sbjct: 590 P-EYPHTNAPKLNPMAIGQENPHPIIVDAIHPPQDVNASIYMEPVQLQKSSFHMVHNNGV 648
Query: 627 RVNN--VSEAVRTDENCNLGQEKAANHVVKVEETDVKR-SCLEQNMIPEKPIGSTSLLAM 683
N+ ++E V LG+ + A VE+++V+ S EQN I E + +T+
Sbjct: 649 LKNDAHLTEGVSLQSISLLGERQEAKKEDAVEKSNVQSISFPEQNQIVED-VSNTAASVA 707
Query: 684 EVSGNIEKP------GEK---SPSDRPEDSKLLAHNLSILPELIASVKRAALEGAEEVKA 734
E + + KP GEK PEDSK L +ILPELIASVK+AALE +EVK
Sbjct: 708 ECNDSFLKPASGCEHGEKVADKDCSAPEDSKGLVDQFNILPELIASVKKAALECHDEVKP 767
Query: 735 KVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGL 794
+E+ + ++ TKE ANE E VN+HG++E+D +ND V T KIEPT AEAEAIARGL
Sbjct: 768 TGKENANCQMDNSNTKEEKANEVEPVNVHGDLELDSENDRVDTSKIEPTKAEAEAIARGL 827
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
QTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSER RLIADFWKEA
Sbjct: 828 QTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERARLIADFWKEA 887
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRTIDRRKRLIIAMD
Sbjct: 888 LMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTIDRRKRLIIAMD 947
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK-----IGDLGLSKVKQQTLVSGGV 969
AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK IGDLGLSKVKQ TLVSGGV
Sbjct: 948 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKVLASIIGDLGLSKVKQHTLVSGGV 1007
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
RGTLPWMAPELLSGKS+MV+EK+ ++S ++L
Sbjct: 1008 RGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWEL 1042
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564856|ref|XP_003550663.1| PREDICTED: uncharacterized protein LOC100782903 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1042 bits (2695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/1063 (55%), Positives = 725/1063 (68%), Gaps = 120/1063 (11%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSP P +GS +GS +D RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+PRD++
Sbjct: 1 MDSPI-RSPATGSGSGSGEDNRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVPRDIS 59
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM RMRELY+GA VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFTRLRI
Sbjct: 60 YEELMGRMRELYDGAAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFTRLRI 119
Query: 121 FLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGN--DFRKLQHPDSPVISSIDDIHM 178
FLFS S+QDGS+H++DGDD SERRYVDALN++NDG+ DFR+LQ + ++S ++DIH+
Sbjct: 120 FLFSQSEQDGSSHFIDGDD--SERRYVDALNSLNDGSNSDFRRLQQGEFSMMSPVEDIHV 177
Query: 179 A-ERFFNTMSLEGGIHNQPQ-------YNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
A ++F+N +++E GIH+Q YN+H LTV Q Q + QRYNEM+ PW+P
Sbjct: 178 AADQFYNPINVESGIHSQRSGDLSMSPYNMHHLTV------QHPQALGQRYNEMDAPWNP 231
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
AYYSPRH+G HD FPSSPS R+R+PF E +RVPEEYAR HVNHHP Y+
Sbjct: 232 AYYSPRHHGLHD-------FPSSPSGTRYRVPFPELPDKCIDRVPEEYARHHVNHHPVYD 284
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ+SEN++WMP G+KS FPGN+ H +V D N +CE CR+ +HR Q HL+ NI
Sbjct: 285 NQPQYSENVMWMP---AHGEKSAFPGNIIHSPHVVDENSICEQCRMGFHRGQPHLEHSNI 341
Query: 345 GNGLPQVPLSCAECRQ-NRENLVLNAEAKL-PGMYPKD--NDSRSVYNESHCHERGWVLQ 400
NG+ QV CAEC NR+ A+AKL +YP + ND RSV+N++ HERGW LQ
Sbjct: 342 SNGVSQVGNLCAECPPPNRDTFA--ADAKLHSAIYPNEPSNDHRSVFNDTQNHERGWGLQ 399
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
H R+EE+R H+S GHG++ D H++ N+ + GPE+G
Sbjct: 400 HP-TARVEESRVHVS-------------------LGHGSVTDAHNLPSNYVQQQAGPELG 439
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNF--PYGADTIYPVSHGHATAQNLWRNVQNPI 518
ELF + VP + P E+ VRYGN PYG D+ Y V G WRN P+
Sbjct: 440 TELFPEQTVTPVPPIQFPPLEDCNVRYGNSASPYGVDSNYAVPRG--LPPGFWRNTPVPV 497
Query: 519 HVTPL--EASGPV-INGSITPAYL-RGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT 574
H+ P A+ P +NG + A L RG E +P +G DS N W+D SQ++ G GTA
Sbjct: 498 HIGPSYEAATSPQPVNGLMNAAGLIRG--EASPGFFIGPDSQNHWVDSSQKLTGHDGTAI 555
Query: 575 PPEYYYSQTQKMNPQSYNQQNQLP---DPVHQSDSFSA---LVQDKLVSSTTDCNLGLRV 628
P EY Y+ +NP Q+NQ P D +H +A L +L S+ + +V
Sbjct: 556 P-EYPYAHA--LNPLPLGQENQHPVIVDFIHPPQDMNAGTCLKPLQLPKSSFNMVPNQQV 612
Query: 629 ----NNVSEAVRTDENCNLGQEKAANHVVKVEET-----------------------DVK 661
+++EA + N +G+ VVK+E+
Sbjct: 613 LRDDTHLTEAKSFESNGLIGE----GIVVKIEDNVQNPGTQTISFSVQNKIAENACEAAA 668
Query: 662 RSCLEQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASV 721
S +E N + KP ++EK +K PS PEDSK L S LPELIASV
Sbjct: 669 ASSVESNNLKSKPEADCV--------HVEKLADKDPS-VPEDSKHLVDQFSFLPELIASV 719
Query: 722 KRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIE 781
K+AALE A ++KA V+E DS ++ TK+ NE E N HG++E+D +ND V T KIE
Sbjct: 720 KKAALEDAVQLKAAVDEHADSPNHNSDTKDETTNEVEPANAHGDLELDSENDHVDTNKIE 779
Query: 782 PTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPS 841
PT AE EAIA+GLQTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PS
Sbjct: 780 PTRAEEEAIAKGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPS 839
Query: 842 ERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901
ER RLIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFM+NGSLKQFL KKDR
Sbjct: 840 ERARLIADFWKEALMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMINGSLKQFLHKKDR 899
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961
TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+CKIGDLGLSKVKQ
Sbjct: 900 TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQ 959
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
TLVSGGVRGTLPWMAPELLSGKS+MV+EK+ ++S ++L
Sbjct: 960 HTLVSGGVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWEL 1002
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793271|ref|XP_002864520.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310355|gb|EFH40779.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1005 bits (2598), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 568/1024 (55%), Positives = 679/1024 (66%), Gaps = 89/1024 (8%)
Query: 18 NDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGAVV 77
ND+ RVKFLCSFLG ILPRPQDGKLRYVGGETRIVS+ RD+ YEELMS+MRELY+GA V
Sbjct: 19 NDEPHRVKFLCSFLGSILPRPQDGKLRYVGGETRIVSVNRDIRYEELMSKMRELYDGAAV 78
Query: 78 LKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSHSDQDGSNHYVDG 137
LKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRIFLFS +QDGS HYV+
Sbjct: 79 LKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRIFLFSSPEQDGSLHYVER 138
Query: 138 DD-RESERRYVDALNNMNDGNDFRKLQ-HPDSPVISSIDDIHMAERFFNTMSLEGGIHNQ 195
DD RESERRYVDALNN+ +G DFRKLQ +PDSP + +D+ M E N +S+E G +Q
Sbjct: 139 DDQRESERRYVDALNNLIEGTDFRKLQQYPDSPRFNFVDEFSMVEPMLNQLSIETGGGSQ 198
Query: 196 -------PQY-NLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYGHHDPPRPL 247
QY NLHQL +P + SGQ ++QRY E+EG WSP YYSPRH+GHHDP R
Sbjct: 199 RGTEIPTAQYSNLHQLRIPRVGSGQM---LAQRYGEVEGTWSP-YYSPRHHGHHDP-RTF 253
Query: 248 PEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENLIWMPPGNV 301
EFPSSPSSAR+RMP+GE +R+PEEY R +HHP YE Q E+++W+P G +
Sbjct: 254 QEFPSSPSSARYRMPYGEIPDKGFDRMPEEYVRPQASHHPLYEHQAHIPESVVWVPAGAM 313
Query: 302 SGD-KSGFPGNLFH-GHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN-GLPQVPLSCAEC 358
+ K GFPGN+ H G ++G +CE+CR+ YHRN L+QPNIGN G P P+ CA C
Sbjct: 314 PPESKGGFPGNVLHSGPGGYEGGNVCENCRVPYHRNHQLLEQPNIGNNGFP--PVHCAHC 371
Query: 359 RQNRENLVLNAEAKLP--GMYPKDNDSRSVYNESHCHERGWVLQHQLN---PRIEEARTH 413
NRE+ +LN + K G YP NE+ HERG ++Q Q+N PRIEE R+H
Sbjct: 372 PPNRESFLLNTDPKPTHHGAYP---------NETFGHERGRMVQQQVNSNPPRIEEGRSH 422
Query: 414 MSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNELFHD-PAAAVV 472
+S GR NDHY D P N P R G E+ NE FHD P +
Sbjct: 423 ISNVGRPNDHYTPDYPVSNYP----------------LAQRAGHEISNEGFHDKPLGGIP 466
Query: 473 PHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHA-TAQNLWRNVQNPIHVTPLEASGPV 529
+ SAEERV YGN +P G ++I H H QN+W+NV NP+ P P+
Sbjct: 467 LNSANRSAEERVFHYGNNLYPPGPESIQSAGHSHMHPQQNIWQNVSNPVAGPP---GLPM 523
Query: 530 -INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQKMNP 588
ING++ +R +E PR ++GV++ + QR+ GF G +P + YY +
Sbjct: 524 QINGTVNQTIIRNPIETAPRYSIGVENQGVLVGSPQRISGFDGMPSPGQPYYPNPHLQDR 583
Query: 589 QSYNQQNQLPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSEAVRTDENCNLGQEKA 648
N +P + V++ L NL + ++T E+ K
Sbjct: 584 AFPLDPNWVPSENPTVHNEHLQVREPLSGPLLQTNLNAAPIMQTPVIQTPES------KL 637
Query: 649 ANHVVKVEETDVKRSCLEQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLA 708
A K D S + +P+ +EVS PE ++L
Sbjct: 638 AQGGEKFNYVDTGVSNGVPYLDKPQPLAEGKKDMVEVS--------------PEGAELSV 683
Query: 709 HNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEM 768
LS LPEL+ SVKRAALEGA EVKA EES + V+P+ NE+E +N E E+
Sbjct: 684 ERLSFLPELMESVKRAALEGAAEVKAHPEESKNQVRPELVE-----NESEHMNAQDEPEI 738
Query: 769 DYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAI 828
D DND KIE T AEAEA +RGLQ+I+NDDLEE+RELG GTYGSVYHGKW+GSDVAI
Sbjct: 739 DSDNDNPNNFKIEQTKAEAEARSRGLQSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAI 798
Query: 829 KRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888
KRIKASCFAGKPSERERLI DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV EFMV
Sbjct: 799 KRIKASCFAGKPSERERLIEDFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMV 858
Query: 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
NGSLKQFLQKKDRTIDRRKRLIIAMD AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+
Sbjct: 859 NGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPI 918
Query: 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSY 1008
CKIGDLGLSKVKQ+TLVSGGVRGTLPWMAPELLSGKS+MV+EK+ ++S ++L
Sbjct: 919 CKIGDLGLSKVKQKTLVSGGVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGE 978
Query: 1009 DCYS 1012
+ Y+
Sbjct: 979 EPYA 982
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147856633|emb|CAN82456.1| hypothetical protein VITISV_010028 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/901 (58%), Positives = 648/901 (71%), Gaps = 70/901 (7%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSPS S GSND+ PRVKFLCSF G ILPRPQDGKLRYVGGETRIVS+PRD+
Sbjct: 131 MDSPSAT---PSSAXGSNDENPRVKFLCSFSGSILPRPQDGKLRYVGGETRIVSVPRDIG 187
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +M+EL++ A VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 188 YEELMGKMKELFDMAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 247
Query: 121 FLFSHSDQD-GSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMA 179
FLFSH DQD GS+H+VD DD +ERRYVDALNN+ND +DFRK Q +SP +S+IDDIH+A
Sbjct: 248 FLFSHPDQDGGSSHFVDVDD--TERRYVDALNNLNDASDFRKQQVGESPTMSAIDDIHLA 305
Query: 180 ERFFNTMSLEGGIHNQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAY 232
E+FFN++SLEGG+HNQ Q+NLH LT+PHM SG Q QPV+QRYNEME W+PAY
Sbjct: 306 EQFFNSISLEGGLHNQRNCEMPMSQFNLHHLTIPHMGSG-QHQPVAQRYNEMESQWNPAY 364
Query: 233 YSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQ 286
+SPRH+GHHD RPL E+PSSPSSARFRMPFGE +R PEEY+RQ VN Y+ Q
Sbjct: 365 FSPRHHGHHD-ARPLAEYPSSPSSARFRMPFGELPDKCIDRXPEEYSRQPVNPQAPYDHQ 423
Query: 287 PQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN 346
PQ S+N++W+P G +S +K+GFPG++ HG NVF+GN +CEHCR+T+HR HL+QPN+GN
Sbjct: 424 PQASDNVVWLPTGAISSEKAGFPGSMLHGPNVFEGNSICEHCRMTFHR---HLEQPNMGN 480
Query: 347 GLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLN 404
GLP V CAEC RE+ +LN +AK+ G+YPK+ ND RS+YNE+H HERGW+LQHQLN
Sbjct: 481 GLPPVANPCAECPPGRESFLLNTDAKMQHGIYPKEHNDPRSLYNETHNHERGWILQHQLN 540
Query: 405 PRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHH------RTGPE 458
PR E+AR +SGAGRLND Y+VDG G+N P HGNL+D HHVS N+ HH RTG E
Sbjct: 541 PRAEDARAQISGAGRLNDPYIVDGSGVNFPVAHGNLLDNHHVSSNYVHHEDXRYIRTGXE 600
Query: 459 MGNELFHDPAAAVVPHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNLWRNVQN 516
+GN +FHD AAA P ++ P EER VRYGN +PYGAD +Y VSHGH A LWRNVQN
Sbjct: 601 LGNGVFHDQAAAAGPAINVPPLEERAVRYGNLPYPYGADNLYQVSHGHVPAHALWRNVQN 660
Query: 517 PIHVTP-LEASGPVIN--GSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTA 573
P+H P EAS GS+ P +RG EG+PR VG+D+ N W + SQ++ GF G+A
Sbjct: 661 PMHGAPSYEASTSTCQAXGSVNPGPIRGTREGSPRFCVGLDNQNPWGESSQKILGFDGSA 720
Query: 574 TPPEYYYSQTQKMNPQSYNQQNQLP-------------------DPVHQSDSFSALVQDK 614
P+Y Y K+NP ++ Q+ Q P +P+H ++S L+ DK
Sbjct: 721 L-PDYSYGHATKLNPNTHGQEGQHPFTPGPVPSPSDMLKFAAPMEPLHFTNSSPTLMDDK 779
Query: 615 LVSSTTDCNLGLRV-----NNVSEAVRTDENCNLGQEKAANHVVKVEETDVKRSCL-EQN 668
V+S NL NNV++ V + + K H+ KVE+ D+ + L E+N
Sbjct: 780 FVASA---NLSYNPESRNDNNVNQTVIMEAKQAFREGKEEIHMEKVEDNDMPVTSLPEKN 836
Query: 669 MIPEKPIGSTSL--LAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAAL 726
+K SL + + N+ KP + ED+KL NLS LPELIASVKRAAL
Sbjct: 837 NNADKKCEVASLEPVNLPAEDNVFKPVVNDCAPLEEDAKLDVSNLSFLPELIASVKRAAL 896
Query: 727 EGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAE 786
E AEEVKAKV+E+ D+V ++TKEA +NE E N G++E+D DND V T KIEPT AE
Sbjct: 897 ESAEEVKAKVQENADAVHA-SSTKEA-SNELETANALGDLELDSDNDNVNTFKIEPTKAE 954
Query: 787 AEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERL 846
EA++RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSERERL
Sbjct: 955 EEALSRGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERERL 1014
Query: 847 I 847
+
Sbjct: 1015 V 1015
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1033 | ||||||
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.686 | 0.672 | 0.428 | 1.6e-143 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.265 | 0.238 | 0.586 | 4e-126 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.212 | 0.176 | 0.709 | 1e-125 | |
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.263 | 0.216 | 0.588 | 4.2e-120 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.204 | 0.180 | 0.720 | 4.2e-119 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.212 | 0.196 | 0.713 | 3.4e-116 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.337 | 0.334 | 0.491 | 1.2e-112 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.184 | 0.249 | 0.396 | 1.8e-26 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.184 | 0.247 | 0.418 | 1.9e-26 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.177 | 0.177 | 0.39 | 2e-25 |
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1403 (498.9 bits), Expect = 1.6e-143, P = 1.6e-143
Identities = 339/791 (42%), Positives = 443/791 (56%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDS S N + + ND+ RVKFLCSFLG ILPRPQDGKLRYVGGETRIVS+ RD+
Sbjct: 1 MDSGSVNSSVTSLVSSLNDEPHRVKFLCSFLGSILPRPQDGKLRYVGGETRIVSVNRDIR 60
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELMS+MRELY+GA VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 61 YEELMSKMRELYDGAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 120
Query: 121 FLFSHSDQDGSNHYVDGDD-RESERRYVDALNNMNDGNDFRKLQ-HPDSPVISSIDDIHM 178
FLFS +QDGS HYV+ DD RESERRYVDALNN+ +G DFRKLQ +PDSP + +DD M
Sbjct: 121 FLFSTPEQDGSLHYVERDDQRESERRYVDALNNLIEGTDFRKLQQYPDSPRFNLVDDFSM 180
Query: 179 AERFFNTMSLEGGIHNQ-----P--QY-NLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
E N +S+E G +Q P QY NLHQL +P + SGQ ++QRY E+EG WSP
Sbjct: 181 VEPMLNQLSIETGGGSQRGNEIPTAQYSNLHQLRIPRVGSGQM---LAQRYGEVEGTWSP 237
Query: 231 AYYSPRHYGHHDXXXXXXXXXXXXXXARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
+YSPRH+GHHD AR+RMP+GE +R+PEEY R +HHP YE
Sbjct: 238 -FYSPRHHGHHDPRTFQEFPSSPSS-ARYRMPYGEIPDKGLDRMPEEYVRPQASHHPFYE 295
Query: 285 PQPQFSENLIWMPPGNVSGD-KSGFPGNLFHGH-NVFDGNGLCEHCRLTYHRNQLHLDQP 342
Q ++++W+P G + + K GFPGN+ HG ++G CE+CR+ YHRN L+Q
Sbjct: 296 HQAHIPDSVVWVPAGAMPPESKGGFPGNVLHGGPGGYEGGNGCENCRVPYHRNHQLLEQS 355
Query: 343 NIGN-GLPQVPLSCAECRQNRENLVLNAEAKLP--GMYPKDNDSRSVYNESHCHERGWVL 399
NIGN G P P+ CA C NRE+ +LN + K G YP NE+ +RGW++
Sbjct: 356 NIGNNGFP--PVHCAHCPPNRESFLLNTDPKPTHHGAYP---------NETFGPDRGWMV 404
Query: 400 QHQLNP---RIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTG 456
Q Q+NP RIEE R+H+S GR NDHY D P N P G R G
Sbjct: 405 QQQVNPNPPRIEEGRSHISNVGRPNDHYTPDYPVSNYPLGQ----------------RAG 448
Query: 457 PEMGNELFHDPAAAVVP-HLHTPSAEERVVRYGN--FPYGADTIYPVSHGHA--TAQNLW 511
E+ NE FHD +P + SAEER YGN +P G D+I+ H H N+W
Sbjct: 449 HEISNEGFHDKPLGGIPLNSANRSAEERGFHYGNNLYPPGPDSIHSAGHSHMHHPQPNIW 508
Query: 512 RNVQNPIHVTPLEASGPV-INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFK 570
+NV NPI P P+ ING++ +R +E PR + G+++ + QR+ GF
Sbjct: 509 QNVSNPIAGPP---GLPMQINGTVNQTVIRNPIETAPRYSTGMENQGVLVGSPQRISGFD 565
Query: 571 GTATPPEYYYSQTQKMNPQSYNQQNQLP--DPVHQSDSFSALVQDKLVSSTTDCNLGLRV 628
G ++ + Y + N +P +P ++ V++ L NL
Sbjct: 566 GMSSLGQPSYPNPHLQDRAFPLDPNWVPSENPTVHNEHLQ--VREPLPGPLLQTNLTAAP 623
Query: 629 NNVSEAVRTDENCNLGQE-KAANHVVKVEETDVKRSCLEQNMIPEKPIGSTSLLAMEVSG 687
+ ++T L Q + N+V T + Q+ P+ G + G
Sbjct: 624 IMQTPVMQTSVESKLAQGGEQFNYV----NTGISNGVPYQDK-PQPLAGGKKDM-----G 673
Query: 688 NIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRXXXXXXXXXXXXXXXSDDSVKPDT 747
N+ + + + E ++L LS LPEL+ SVKR + D V+P+
Sbjct: 674 NLVEVNPSAAT--LEGAELSVERLSFLPELMESVKRAALEGAAEVKAHPEEAKDQVRPEL 731
Query: 748 TTKEAPANEAE 758
E+ A+
Sbjct: 732 VENESEHMNAQ 742
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 859 (307.4 bits), Expect = 4.0e-126, Sum P(3) = 4.0e-126
Identities = 162/276 (58%), Positives = 206/276 (74%)
Query: 739 SDDSVKPDTTTKEAPANEAELVNIH-GEIEMDYDNDTVKTLKIEPTX-XXXXXXXRGLQT 796
+++ V P E+ +A + N+ + E + + + + P GLQ
Sbjct: 798 TENRVDPQMKVTESEEFDAMVENLRTSDCEQEDEKSETRNAGLPPVGPSLADYDTSGLQI 857
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I NDDLEE++ELGSGT+G+VYHGKWRGSDVAIKRIK SCFAG+ SE+ERL +FW EA +
Sbjct: 858 IMNDDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEI 917
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS LHHPNVV+FYG+V+DGP +LATVTE+MV+GSL+ L +KDR +DRRKRLIIAMDAA
Sbjct: 918 LSKLHHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAA 977
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
FGMEYLH KNIVHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLVSGGVRGTLPWM
Sbjct: 978 FGMEYLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 1037
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
APELL+G S V+EKV +FS +++ + Y+
Sbjct: 1038 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1073
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 1.0e-125, Sum P(4) = 1.0e-125
Identities = 156/220 (70%), Positives = 188/220 (85%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
GLQ IKN+DLEE+RELGSGT+G+VYHGKWRGSDVAIKRIK SCFAG+ SE+ERL +FW
Sbjct: 955 GLQIIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWG 1014
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA +LS LHHPNVV+FYG+V+DGP G+LATVTE+MV+GSL+ L +KDR +DRRKRLIIA
Sbjct: 1015 EAEILSKLHHPNVVAFYGVVKDGPGGTLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIA 1074
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
MDAAFGMEYLH KN VHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLVSGGVRGT
Sbjct: 1075 MDAAFGMEYLHSKNTVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 1134
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
LPWMAPELL+G S V+EKV +FS +++ + Y+
Sbjct: 1135 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1174
|
|
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 4.2e-120, Sum P(3) = 4.2e-120
Identities = 163/277 (58%), Positives = 206/277 (74%)
Query: 740 DDSVKPDTTTKEAP-ANEAELVNIHGEIEMDYDNDTVKTLKIE-PTXXXXXXXX--RGLQ 795
D ++KPD +T P N + + + ++ T TL P R LQ
Sbjct: 908 DGNIKPDVSTITIPDLNTVDTQEDYSQSQIKGAESTDATLNAGVPLIDFMAADSGMRSLQ 967
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
IKNDDLEE++ELGSGT+G+VYHGKWRG+DVAIKRIK SCF G+ SE+ERL ++FW EA
Sbjct: 968 VIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFIGRSSEQERLTSEFWHEAE 1027
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+LS LHHPNV++FYG+V+DGP G+LATVTE+MVNGSL+ L +R +DRRKRLIIAMDA
Sbjct: 1028 ILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLLS-NRHLDRRKRLIIAMDA 1086
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
AFGMEYLH K+IVHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLV+GGVRGTLPW
Sbjct: 1087 AFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1146
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
MAPELLSG S V+EKV +FS +++ + Y+
Sbjct: 1147 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 1183
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 4.2e-119, Sum P(3) = 4.2e-119
Identities = 152/211 (72%), Positives = 177/211 (83%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
LQ IK+ DLEE+RELGSGT+G+VYHGKWRG+DVAIKRI CFAGKPSE+ER+I DFW E
Sbjct: 880 LQIIKDSDLEELRELGSGTFGTVYHGKWRGTDVAIKRINDRCFAGKPSEQERMIDDFWNE 939
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
A L+ LHHPNVV+FYG+V D P GS+ATVTE+MVNGSL+ LQK R DR KR +IAM
Sbjct: 940 AQNLAGLHHPNVVAFYGVVLDSPGGSVATVTEYMVNGSLRNALQKNVRNFDRCKRQLIAM 999
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
D AFGMEYLHGK IVHFDLK +NLLVN+RDP RP+CK+GDLGLSKVK QTL+SGGVRGTL
Sbjct: 1000 DIAFGMEYLHGKKIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLISGGVRGTL 1059
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
PWMAPELL+G S +V+EKV +FS ++L
Sbjct: 1060 PWMAPELLNGTSSLVSEKVDVFSFGIVLWEL 1090
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 845 (302.5 bits), Expect = 3.4e-116, Sum P(4) = 3.4e-116
Identities = 157/220 (71%), Positives = 187/220 (85%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
GLQ IKN DLE++ ELGSGTYG+VYHG WRG+DVAIKRI+ SCFAG+ SE+ERL DFW+
Sbjct: 827 GLQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWR 886
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA +LS+LHHPNVV+FYGIV DG G+LATVTEFMVNGSL+ L KKDR +D RK++IIA
Sbjct: 887 EAQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIA 946
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
MDAAFGMEYLH KNIVHFDLKCENLLVN+RDPQRP+CK+GDLGLS++K+ TLVSGGVRGT
Sbjct: 947 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGT 1006
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
LPWMAPELL+G S V+EKV +FS +++ + Y+
Sbjct: 1007 LPWMAPELLNGSSTRVSEKVDVFSYGISLWEILTGEEPYA 1046
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 825 (295.5 bits), Expect = 1.2e-112, Sum P(3) = 1.2e-112
Identities = 176/358 (49%), Positives = 231/358 (64%)
Query: 657 ETDVKRSCLEQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPE 716
ET+ S ++++ E+ I + L +V SD SKLL L I+ +
Sbjct: 626 ETNSDDSDTQKSLPREESIHYSGLPLRKVGSRETTFMHTQGSDDFFKSKLLGPQL-IVED 684
Query: 717 LIASVKRXXXXXXXXXXXXXXXSDDSVKPDTTTKEAPANEAELVNIHGEIEMDY--DNDT 774
+ V SDD K T KE + E E+E Y +T
Sbjct: 685 VTNEVISDNLLSATIVPQVNRESDDDHKSYTREKEITNADHE-----SEMEEKYKKSRNT 739
Query: 775 VKTLKIEPTXXXXXXXXRGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKAS 834
+ E GLQ IKN DLE++ ELGSGT+G+VY+GKWRG+DVAIKRIK S
Sbjct: 740 DDSFS-EAAMVEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNS 798
Query: 835 CFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ 894
CF+G SE+ R DFW+EA +L++LHHPNVV+FYG+V DGP G++ATVTE+MVNGSL+
Sbjct: 799 CFSGGSSEQARQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRH 858
Query: 895 FLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
LQ+KDR +DRRK+L+I +D+AFGMEYLH KNIVHFDLKC+NLLVN+RDPQRP+CK+GD
Sbjct: 859 VLQRKDRLLDRRKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 918
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
GLS++K+ TLVSGGVRGTLPWMAPELL+G S+ V+EKV +FS +++ + Y+
Sbjct: 919 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYA 976
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 1.8e-26, Sum P(2) = 1.8e-26
Identities = 82/207 (39%), Positives = 116/207 (56%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+DL ++G G+ G+VYHG W GSDVA+K F+ K E +I F +E L+
Sbjct: 485 EDLTIGEQIGQGSCGTVYHGLWFGSDVAVK-----VFS-KQEYSEEIITSFKQEVSLMKR 538
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNV+ F G V P L VTEF+ GSL + LQ+ +D R+R+ +A D A GM
Sbjct: 539 LRHPNVLLFMGAVAS-PQ-RLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGM 596
Query: 920 EYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
YLH I+H DLK NLLV+ + K+ D GLS++K +T ++ RGT WMA
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVD----RNWTVKVADFGLSRIKHETYLTTNGRGTPQWMA 652
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQL 1004
PE+L ++ EK ++S ++L
Sbjct: 653 PEVL--RNEAADEKSDVYSFGVVLWEL 677
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 1.9e-26, P = 1.9e-26
Identities = 87/208 (41%), Positives = 118/208 (56%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
DDL ++G G+ G+VYHG W GSDVA+K F+ + E +I F +E LL+
Sbjct: 492 DDLTIGEQVGQGSCGTVYHGLWFGSDVAVK-----VFSKQEYSAE-VIESFKQEVLLMKR 545
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNV+ F G V P L V+EF+ GSL + LQK +D R+R+ +A+D A GM
Sbjct: 546 LRHPNVLLFMGAVTS-PQ-RLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIHMALDIARGM 603
Query: 920 EYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT-LVSGGVRGTLPWM 976
YLH I+H DLK NLLV D V K+ D GLS++K +T L S +GT WM
Sbjct: 604 NYLHHCSPPIIHRDLKSSNLLV---DKNWTV-KVADFGLSRIKHETYLTSKSGKGTPQWM 659
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQL 1004
APE+L +S EK ++S ++L
Sbjct: 660 APEVLRNES--ADEKSDIYSFGVVLWEL 685
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 326 (119.8 bits), Expect = 2.0e-25, P = 2.0e-25
Identities = 78/200 (39%), Positives = 113/200 (56%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
+G G+YG VY G W G++VA+K+ G+ E +F E ++ L HPN+V
Sbjct: 754 IGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALE------EFRSEVRIMKKLRHPNIVL 807
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN- 926
F G V P+ L+ VTEF+ GSL + + + + +D R+RL +A+DAA GM YLH N
Sbjct: 808 FMGAVTRPPN--LSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNYLHSCNP 865
Query: 927 -IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWMAPELLSGK 984
IVH DLK NLLV+ + V K+ D GLS++K T +S GT WMAPE+L +
Sbjct: 866 MIVHRDLKSPNLLVD----KNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVL--R 919
Query: 985 SHMVTEKVTLFSLKFCCFQL 1004
+ EK ++S ++L
Sbjct: 920 NEPADEKCDVYSYGVILWEL 939
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00031430001 | SubName- Full=Chromosome chr11 scaffold_56, whole genome shotgun sequence; (1063 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1033 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-47 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-20 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-20 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-49
Identities = 76/224 (33%), Positives = 100/224 (44%), Gaps = 40/224 (17%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
LE ++LG G +G VY G +G VA+K +K E +F +EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-------SEEEREEFLEEAS 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HPN+V G+ G L VTE+M G L FL+K + + L +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
A GMEYL KN VH DL N LV + V KI D GLS+ GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT----ENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
+ WMAPE SLK F K S D +S G+L
Sbjct: 168 IKWMAPE----------------SLKDGKFTSK-S-DVWSFGVL 193
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 32/224 (14%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G+VY + + + VAIK IK + L+ + +E +L L+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK-------KEDSSSLLEELLREIEILKKLNHPNI 53
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V YG+ D L V E+ GSLK L++ + + + L I + G+EYLH
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPELLSGK 984
I+H DLK EN+L++ + + K+ D GLSK + + + GT +MAPE+L GK
Sbjct: 112 GIIHRDLKPENILLDSDNGK---VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 985 SHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028
+ +EK D +SLG++ + L + I
Sbjct: 169 GY-YSEKS----------------DIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 4e-47
Identities = 72/226 (31%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L ++LG G +G VY GK +G +VA+K +K E+ I +F +EA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS-------EQQIEEFLREAR 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HPNVV G+ + + L V E+M G L +L+K + L A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTE--EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQI 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
A GMEYL KN +H DL N LV + V KI D GLS+ G + +
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
WMAPE SLK F K WS+ G+L
Sbjct: 168 RWMAPE----------------SLKEGKFTSKSDVWSF-----GVL 192
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 62/99 (62%), Positives = 79/99 (79%), Gaps = 4/99 (4%)
Query: 27 LCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGA--VVLKYQQPD 84
LCS+ GRILPRP DG+LRYVGGETRIVS+ R ++++EL+S++ EL+ V LKYQ PD
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 85 EDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123
EDLDAL+SV ND+D+ NMMEEY++L G RLR+FLF
Sbjct: 61 EDLDALISVSNDEDLKNMMEEYDRL--SGGSARLRVFLF 97
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 6e-46
Identities = 70/227 (30%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L ++LG G +G VY G +G +VA+K +K E+ I +F +EA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS-------EQQIEEFLREAR 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
++ L HPN+V G+ + + L V E+M G L +L+K + + + L A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTE--EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GMEYL KN +H DL N LV V KI D GLS+ G +
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
+ WMAPE SLK F K WS+ G+L
Sbjct: 168 IRWMAPE----------------SLKEGKFTSKSDVWSF-----GVL 193
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E + +LG G++G VY + + + VAIK IK + ++ +E +L L
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIK-------KKKIKKDRERILREIKILKKL 54
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN+V Y + D + L V E+ G L L+K+ R + R + +E
Sbjct: 55 KHPNIVRLYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR-QILSALE 111
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
YLH K IVH DLK EN+L++ + K+ D GL++ GT +MAPE+
Sbjct: 112 YLHSKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167
Query: 981 LSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
L GK + + V D +SLG++ +
Sbjct: 168 LLGKGY--GKAV----------------DIWSLGVILY 187
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 77/227 (33%), Positives = 101/227 (44%), Gaps = 47/227 (20%)
Query: 806 RELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++LG G +G VY GK +G +VA+K +K SE ER DF KEA ++ L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEER--KDFLKEARVMKKL 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIA 912
HPNVV G+ + + L V E+M G L +L+K T+ + L A
Sbjct: 54 GHPNVVRLLGVCTE--EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRG 971
+ A GMEYL K VH DL N LV + V KI D GLS+ G
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISDFGLSRDVYDDDYYRKKTGG 167
Query: 972 TLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
LP WMAPE L +F+ K S D +S G+L
Sbjct: 168 KLPIRWMAPESLKDG---------IFTSK--------S-DVWSFGVL 196
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E +R+LGSG++G+VY K +G+ VA+K +K K SE+ + +E +L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILK------KRSEKSKKDQTARREIRILRR 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPN+V D L V E+ G L +L + + + IA+ G+
Sbjct: 55 LSHPNIVRLIDAFED--KDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGL 111
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLPWMAP 978
EYLH I+H DLK EN+L++ + V KI D GL+K ++ S GT +MAP
Sbjct: 112 EYLHSNGIIHRDLKPENILLD----ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 979 ELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
E+L G + KV D +SLG++ +
Sbjct: 168 EVLLGGN-GYGPKV----------------DVWSLGVILY 190
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 64/191 (33%), Positives = 93/191 (48%), Gaps = 24/191 (12%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++GSVY K G +A+K ++ S + + E +E +LSSL H
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE------REIRILSSLQH 58
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR----TIDRRKRLIIAMDAAFG 918
PN+V +YG RD +L E++ GSL L+K + I + R I+ G
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-----G 113
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG---VRGTLPW 975
+ YLH IVH D+K N+LV+ V K+ D G +K G VRGT W
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 976 MAPELLSGKSH 986
MAPE++ G+ +
Sbjct: 170 MAPEVIRGEEY 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 68/188 (36%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + +L+ +G G +G V G +RG VA+K +K + F EA +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK---------DDSTAAQAFLAEASV 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDA 915
+++L HPN+V G+V G L VTE+M GSL +L+ + R I ++L A+D
Sbjct: 54 MTTLRHPNLVQLLGVVLQG--NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP- 974
GMEYL KN VH DL N+LV+ V K+ D GL+K Q S G LP
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDS----GKLPV 163
Query: 975 -WMAPELL 981
W APE L
Sbjct: 164 KWTAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 65/186 (34%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+L ++ELGSG +G V+ GKWRG DVAIK I+ G SE DF +EA ++
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSED-----DFIEEAKVMMK 55
Query: 860 LHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L HPN+V YG+ + P + VTE+M NG L +L+++ + L + D
Sbjct: 56 LSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWM 976
MEYL +H DL N LV + V K+ D GL++ + Q S G + + W
Sbjct: 113 MEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 977 APELLS 982
PE+
Sbjct: 169 PPEVFD 174
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
E + ++G G +G VY + + G +VAIK IK ++E++I E +L
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKII----NEIQILK 52
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
HPN+V +YG L V EF GSLK L+ ++T+ + + + G
Sbjct: 53 KCKHPNIVKYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+EYLH I+H D+K N+L+ K+ D GLS T + GT WMAP
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDG----EVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
Query: 979 ELLSGKSHMVTEKVTLFSLKFCCFQL 1004
E+++GK + K ++SL +L
Sbjct: 167 EVINGKPY--DYKADIWSLGITAIEL 190
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 62/187 (33%), Positives = 96/187 (51%), Gaps = 23/187 (12%)
Query: 805 VRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ +G G +G V G+ + DVAIK +KA S+++RL DF EA ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLTEASIMGQ 61
Query: 860 LHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
HPN++ G+V + P + +TE+M NGSL +FL++ D + + + A G
Sbjct: 62 FDHPNIIRLEGVVTKSRP---VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGVRGTLPW 975
M+YL N VH DL N+LVN VCK+ D GLS+ + T + G + + W
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 976 MAPELLS 982
APE ++
Sbjct: 175 TAPEAIA 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 66/189 (34%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWRG DVAIK IK G SE E F +EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L H +V YG+ + P + VTE+M NG L +L++ + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRP---IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGT 972
GM YL K +H DL N LV+ + K+ D GLS+ + + S G +
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 973 LPWMAPELL 981
+ W PE+L
Sbjct: 165 VRWSPPEVL 173
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L+ +++LG G +G V ++ G VA+K + S E+ +DF +E
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-------EEQHRSDFERE 56
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L +L H N+V + G+ SL + E++ +GSL+ +LQ+ I+ ++ L+ +
Sbjct: 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS 116
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--G 971
GM+YL + +H DL N+LV + + V KI D GL+KV + V+ G
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILV---ESEDLV-KISDFGLAKVLPEDKDYYYVKEPG 172
Query: 972 TLP--WMAPELL-----SGKSHMVTEKVTLFSL 997
P W APE L S S + + VTL+ L
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 41/226 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ R+LG+G +G V+ G W G+ VA+K +K + F +EA
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQ 53
Query: 856 LLSSLHHPNVVSFYGIVRDG-PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
++ L H +V Y + + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEP---IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRG 971
A GM YL +N +H DL N+LV + VCKI D GL+++ + + G +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADFGLARLIEDDEYTAREGAKF 166
Query: 972 TLPWMAPE-LLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
+ W APE G+ F++K D +S GIL
Sbjct: 167 PIKWTAPEAANYGR----------FTIK---------SDVWSFGIL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 60/180 (33%), Positives = 87/180 (48%), Gaps = 20/180 (11%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
LGSG++GSVY G D +K A + + +E LLS L HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLH 923
+ G R+ +L E + GSL + L+K + I R I+ G+EYLH
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELL 981
+N VH D+K N+LV D V K+ D G++K V+ S +G+ WMAPE++
Sbjct: 120 DRNTVHRDIKGANILV---DTNGVV-KLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I ++ +R+LG+G +G V+ G W + VA+K +K K DF EA
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---------DFLAEAQ 53
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
++ L HP ++ Y + + P + VTE M GSL ++LQ + +LI +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A GM YL +N +H DL N+LV + +CK+ D GL++V ++ +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADFGLARVIKEDIYEAREGAKF 166
Query: 974 P--WMAPE-LLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
P W APE L + FS+K D +S GIL
Sbjct: 167 PIKWTAPEAALYNR----------FSIK---------SDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 64/188 (34%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L ++ELGSG +G V+ GKWR VAIK I G SE DF +EA
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEE-----DFIEEAK 51
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HP +V YG+ + P L VTEFM NG L +L+++ + + L + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGT 972
GMEYL + +H DL N LV+ V K+ D G+++ + + S G +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 973 LPWMAPEL 980
+ W PE+
Sbjct: 165 VKWSPPEV 172
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E ++++G G++G VY + R SD +K I S ERE + E +L
Sbjct: 3 EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLSNM--SEKEREDAL----NEVKILKK 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKRLIIAMDAA 916
L+HPN++ +Y + G L V E+ G L Q ++ K+ + + L +
Sbjct: 56 LNHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG-VRGTLPW 975
++YLH + I+H D+K +N+ + + K+GD G+SKV T+ V GT +
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
++PEL K + K D +SLG + + L
Sbjct: 170 LSPELCQNKPY--NYKS----------------DIWSLGCVLYEL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G +G VY G G VAIK+I E + +E LL +L HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE---KIKEEA---LKSIMQEIDLLKNLKHPN 60
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------G 918
+V + G + SL + E+ NGSL+Q ++K + L+ A + G
Sbjct: 61 IVKYIGSIETS--DSLYIILEYAENGSLRQIIKKFGPF---PESLV----AVYVYQVLQG 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+ YLH + ++H D+K N+L V K+ D G++ K+ + V GT WMA
Sbjct: 112 LAYLHEQGVIHRDIKAANILTTKDG----VVKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 978 PELLSGKSHMVTEKVTLFSL 997
PE++ + ++SL
Sbjct: 168 PEVIEMS--GASTASDIWSL 185
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 68/192 (35%), Positives = 96/192 (50%), Gaps = 22/192 (11%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
DLE V+ LG G+ G VY H K G A+K+I G R++L+ + + L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIH---VDGDEEFRKQLLREL--KTLR 54
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
P VV YG +G ++ V E+M GSL L KK I IA
Sbjct: 55 SCE--SPYVVKCYGAFYK--EGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIARQIL 109
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTL 973
G++YLH K +I+H D+K NLL+N + KI D G+SKV + TL + V GT+
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGISKVLENTLDQCNTFV-GTV 164
Query: 974 PWMAPELLSGKS 985
+M+PE + G+S
Sbjct: 165 TYMSPERIQGES 176
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 806 RELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
R+LGSG +G V+ G W+ VAIK +K S+ DF KE L L H +
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALKRLRHKH 63
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLH 923
++S + + G + +TE M GSL FL+ + + LI +A A GM YL
Sbjct: 64 LISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPELLS 982
+N +H DL N+LV + VCK+ D GL+++ K+ +S + W APE S
Sbjct: 122 EQNSIHRDLAARNILVG----EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 983 GKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
+ FS K D +S GIL +
Sbjct: 178 HGT---------FSTK---------SDVWSFGILLY 195
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ + ++G G G VY R G +VAIK+++ + + LI E L++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------QNKELII---NEILIMKD 71
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN+V +Y L V E+M GSL + + ++ + + + G+
Sbjct: 72 CKHPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG----LSKVKQQ--TLVSGGVRGTL 973
EYLH +N++H D+K +N+L++ K+ D G L+K K + ++V GT
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDG----SVKLADFGFAAQLTKEKSKRNSVV-----GTP 180
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
WMAPE++ K + KV D +SLGI+
Sbjct: 181 YWMAPEVIKRKDY--GPKV----------------DIWSLGIMCI 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 802 LEEVRELGSGTYGSVY------HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+ +R+LG G +G V G G VA+K +K P IAD KE
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-------PESGGNHIADLKKEIE 58
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L +L+H N+V + GI + + + EF+ +GSLK++L + I+ +++L A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRG 971
GM+YL + VH DL N+LV KIGD GL+K K+ V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 972 TLPWMAPE-LLSGKSHMVTE----KVTLFSLKFCC 1001
+ W APE L+ K ++ ++ VTL+ L C
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 71/225 (31%), Positives = 105/225 (46%), Gaps = 40/225 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ +L+ ++ +G G +G V G +RG+ VA+K IK A F EA +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----------FLAEASV 52
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDA 915
++ L H N+V G++ + G L VTE+M GSL +L+ + R++ L+ ++D
Sbjct: 53 MTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP- 974
MEYL N VH DL N+LV+ + V K+ D GL+K T + G LP
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDT----GKLPV 163
Query: 975 -WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
W APE L K FS K D +S GIL +
Sbjct: 164 KWTAPEALREK---------KFSTK---------SDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 52/215 (24%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIA 848
++ D + RELG G +G V+ G+ VA+K +K + R+
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARK---- 53
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR 908
DF +EA LL++ H N+V FYG+ +G V E+M +G L +FL+ K
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 909 -------------LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
L IA+ A GM YL ++ VH DL N LV V KIGD G
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG----YDLVVKIGDFG 167
Query: 956 LS---------KVKQQTLVSGGVRGTLP--WMAPE 979
+S +V T+ LP WM PE
Sbjct: 168 MSRDVYTTDYYRVGGHTM--------LPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ G SE DF +EA
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEE-----DFIEEAQ 51
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HP +V YG+ + + V EFM +G L +L+ + + L + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTE--RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDV 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTL 973
GM YL N++H DL N LV + V K+ D G+++ + Q S G + +
Sbjct: 110 CEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV 165
Query: 974 PWMAPELLS 982
W +PE+ S
Sbjct: 166 KWSSPEVFS 174
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 58/182 (31%), Positives = 90/182 (49%), Gaps = 22/182 (12%)
Query: 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG G YG VY G W+ VA+K +K E + +F KEA ++ + HPN
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 865 VVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGMEYL 922
+V G+ R+ P +TEFM G+L +L++ +R ++ L +A + MEYL
Sbjct: 64 LVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS--GGVRGTLPWMAPEL 980
KN +H DL N LV + + K+ D GLS++ + G + + W APE
Sbjct: 121 EKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 981 LS 982
L+
Sbjct: 177 LA 178
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 58/190 (30%), Positives = 89/190 (46%), Gaps = 25/190 (13%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GTYG VY + + + VA+K+I+ +E+E +E LL L
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKL 55
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFM---VNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HPN+V IV GS+ V E+M + G L K T + K + +
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--FTESQIKCYMKQL--LE 111
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL----SKVKQQTLVSGGVRGTL 973
G++YLH I+H D+K N+L+N V K+ D GL +K + + TL
Sbjct: 112 GLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARPYTKRNSADYTNRVI--TL 165
Query: 974 PWMAPELLSG 983
+ PELL G
Sbjct: 166 WYRPPELLLG 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 40/225 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V++LG+G +G V+ G + G + VAIK +K + F EA
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEAN 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L+ L HP +V Y +V P + +TE+M NGSL FL K I +I M A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEP---IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAA 109
Query: 916 --AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT--LVSGGVRG 971
A GM ++ KN +H DL+ N+LV+ + CKI D GL+++ + G +
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREGAKF 165
Query: 972 TLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
+ W APE ++ + F +K D +S GIL
Sbjct: 166 PIKWTAPE----------------AINYGTFTIK--SDVWSFGIL 192
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.7 bits (244), Expect = 8e-22
Identities = 70/226 (30%), Positives = 105/226 (46%), Gaps = 36/226 (15%)
Query: 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHP 863
+R+LG G++G VY + VA+K + K + + + F +E +L+SL H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAK-----KLESKSKEVERFLREIQILASLNHPP 58
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEY 921
N+V Y +D +GSL V E++ GSL+ L+K R + + L I +EY
Sbjct: 59 NIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-------KQQTLVSGGVRGTLP 974
LH K I+H D+K EN+L+ D V K+ D GL+K+ + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+MAPE+L G S S D +SLGI + L
Sbjct: 174 YMAPEVLLGLS---------------LAYASSSSDIWSLGITLYEL 204
|
Length = 384 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 61/185 (32%), Positives = 87/185 (47%), Gaps = 24/185 (12%)
Query: 807 ELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+LG G++G V G+W S VA+K +K+ K S+ ++ DF KEA ++ SL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS----DKLSD---IMDDFLKEAAIMHSLD 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGME 920
H N++ YG+V P L VTE GSL L+K L A+ A GM
Sbjct: 55 HENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPWM 976
YL K +H DL N+L+ D KIGD GL + + ++ ++ W
Sbjct: 112 YLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 977 APELL 981
APE L
Sbjct: 168 APESL 172
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIAD 849
+ + + +RELG G++G VY G +G + VAIK + + S RER+ +
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-----ASMRERI--E 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRT---- 902
F EA ++ + +VV G+V G V E M G LK +L+ +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 903 --IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+K + +A + A GM YL K VH DL N +V KIGD G+++ +
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMTRDI 169
Query: 960 KQQTLVSGGVRGTLP--WMAPELLS 982
+ G +G LP WMAPE L
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLK 194
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 36/204 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ D + +R LG G +G VY G +RG D VA+K + SC E+ +D
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESD 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT-----VTEFMVNGSLKQFLQKKDRTID 904
F EAL++S +H N+V G+ S + E M G LK FL++ +
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGV-------SFERLPRFILLELMAGGDLKSFLRENRPRPE 108
Query: 905 R------RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R + L A D A G +YL + +H D+ N L+ + P R V KI D G+++
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMAR 167
Query: 959 -VKQQTLVSGGVRGTLP--WMAPE 979
+ + + G R LP WM PE
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPE 191
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 66/182 (36%), Positives = 98/182 (53%), Gaps = 21/182 (11%)
Query: 806 RELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G +G VY G +G+ +VA+K +C + P + +R F +EA +L HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKR---KFLQEAEILKQYDHPN 53
Query: 865 VVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+V G+ V+ P + V E + GSL FL+KK + +K L +++DAA GMEYL
Sbjct: 54 IVKLIGVCVQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLP--WMAPE 979
KN +H DL N LV + V KI D G+S+ ++ + VS G +P W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 980 LL 981
L
Sbjct: 166 AL 167
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 21/189 (11%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D+ E LG G+YGSVY + G VAIK + P E + + + KE +L
Sbjct: 6 DILEK--LGEGSYGSVYKAIHKETGQVVAIKVV--------PVEED--LQEIIKEISILK 53
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
P +V +YG + L V E+ GS+ ++ ++T+ + I G
Sbjct: 54 QCDSPYIVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRGTLPWMA 977
+EYLH +H D+K N+L+N + K+ D G+S T+ V GT WMA
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167
Query: 978 PELLSGKSH 986
PE++ +
Sbjct: 168 PEVIQEIGY 176
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADF 850
I+ +D+ R +G G +G VY G + + VA+K K PS RE+ F
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREK----F 54
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+EA ++ HP++V G++ + P + V E G L+ +LQ ++D ++
Sbjct: 55 LQEAYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLIL 111
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVSGGV 969
+ + + YL K VH D+ N+LV+ P C K+GD GLS+ +
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESYYKAS 166
Query: 970 RGTLP--WMAPE 979
+G LP WMAPE
Sbjct: 167 KGKLPIKWMAPE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 25/196 (12%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLI 847
L+ +K +LE+++ LGSG +G+VY G W VAIK ++ + +E L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEIL- 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
EA +++S+ HP+VV GI + +T+ M G L +++ I +
Sbjct: 58 ----DEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY 110
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQT 963
L + A GM YL K +VH DL N+LV + PQ KI D GL+K+ +++
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLDVDEKEY 166
Query: 964 LVSGGVRGTLPWMAPE 979
GG + + WMA E
Sbjct: 167 HAEGG-KVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 41/219 (18%)
Query: 802 LEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+EEV +G+G +G V G+ R VAIK +K+ +E++R DF EA +
Sbjct: 8 IEEV--IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-----TEKQR--RDFLSEASI 58
Query: 857 LSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+ HPN++ G+V + P + +TEFM NG+L FL++ D + + +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRP---VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI 115
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVSGGVRG 971
A GM+YL N VH DL N+LVN VCK+ D GLS+ + + + G
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 972 TLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSY 1008
+P W APE ++ + KF WSY
Sbjct: 172 KIPIRWTAPEAIAYR-------------KFTSASDVWSY 197
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 39/227 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + ++ V++LG+G +G V+ G + S VA+K +K + + F +EA
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---------VQAFLEEAN 53
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
L+ +L H +V Y +V ++ P + +TE+M GSL FL+ + +LI +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEP---IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRG 971
A GM Y+ KN +H DL+ N+LV+ + +CKI D GL++V + G +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREGAKF 166
Query: 972 TLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
+ W APE ++ F F +K D +S GIL +
Sbjct: 167 PIKWTAPE----------------AINFGSFTIK--SDVWSFGILLY 195
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-20
Identities = 39/89 (43%), Positives = 59/89 (66%), Gaps = 11/89 (12%)
Query: 38 PQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE---GAVVLKYQQPDEDLDALVSVV 94
D KLRY GGETR +S+PRD+++E+L S++ + + + LKYQ DED D LVS+
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLT 56
Query: 95 NDDDVINMMEEYEKLGSGDGFTRLRIFLF 123
+D+D+ +EEY+ LGS +LR+ +F
Sbjct: 57 SDEDLEEAIEEYDSLGSK----KLRLHVF 81
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 59/184 (32%), Positives = 82/184 (44%), Gaps = 26/184 (14%)
Query: 806 RELGSGTYGSVYHGKWR---GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ELG G +GSV G + G +VA+K +K A E F +EA +++ L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE-------FLREASVMAQL 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HP +V G+ + G L V E G L ++L+K R I +A A GM
Sbjct: 54 DHPCIVRLIGVCK-GE--PLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMA 109
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPW 975
YL K+ VH DL N+L+ R KI D G+S+ + G R L W
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRH----QAKISDFGMSRALGAGSDYYRATTAG-RWPLKW 164
Query: 976 MAPE 979
APE
Sbjct: 165 YAPE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-20
Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 38 PQDGKLRYVGGETRIVSLPRDVTYEELMSRMRE-LYEGAVVLKYQQPDEDLDALVSVVND 96
KLRY GG R +S+ +++EEL S++ + V K + PDED D LVS+ +D
Sbjct: 1 TVRVKLRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYPDEDGD-LVSITSD 59
Query: 97 DDVINMMEEYEKLGSGDGFTRLRIFLF 123
+D+ +EE LGS LR+ +F
Sbjct: 60 EDLEEAIEEARSLGSK----TLRLHVF 82
|
Length = 84 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 66/189 (34%), Positives = 97/189 (51%), Gaps = 24/189 (12%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K++ F E ++ + E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP---FDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRR-KRLIIAMDAAFGMEY 921
V +YG +RD D +L+ E+M GS+K L+ T+ R+ R I+ G+EY
Sbjct: 67 VQYYGCLRD--DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-----GVEY 119
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG----VRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q SG V GT WM+
Sbjct: 120 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 978 PELLSGKSH 986
PE++SG+ +
Sbjct: 176 PEVISGEGY 184
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 70/191 (36%), Positives = 94/191 (49%), Gaps = 22/191 (11%)
Query: 802 LEEVRELGSGTYGSV----YH--GKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+ +++LG G +GSV Y G VA+K+++ S E L DF +E
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-------HSTAEHL-RDFEREIE 57
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L SL H N+V + G+ +L V E++ GSL+ +LQK +D RK L+ A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTL 973
GMEYL K VH DL N+LV KIGD GL+KV Q VR G
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVE----SENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 974 P--WMAPELLS 982
P W APE L+
Sbjct: 174 PIFWYAPESLT 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
DDLE + ELG+G G V H + G +A+K I+ + +++++ +E +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIRLE---INEAIQKQIL----RELDI 52
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG + +G ++ E+M GSL + L++ I R IA+
Sbjct: 53 LHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YLH K I+H D+K N+LVN R K+ D G+S +L V GT +
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQ----IKLCDFGVSGQLVNSLAKTFV-GTSSY 165
Query: 976 MAPELLSGKSHMV 988
MAPE + G + V
Sbjct: 166 MAPERIQGNDYSV 178
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-19
Identities = 30/85 (35%), Positives = 51/85 (60%), Gaps = 6/85 (7%)
Query: 40 DGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE-GAVVLKYQQPDEDLDALVSVVNDDD 98
K++Y G R V + R +++E+L S++ E + AV K + PDED D LV++ +D+D
Sbjct: 2 RVKVKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYPDEDGD-LVTISSDED 60
Query: 99 VINMMEEYEKLGSGDGFTRLRIFLF 123
+ +EE + GS +LR+F+F
Sbjct: 61 LEEAIEEARRSGSK----KLRLFVF 81
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 20/187 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ +++LG+G +G V+ G W G + VA+K +K + + F +EA
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQ 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R + + +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGT 972
A GM Y+ N +H DL+ N+LV VCKI D GL+++ + + G +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 973 LPWMAPE 979
+ W APE
Sbjct: 167 IKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 59/179 (32%), Positives = 91/179 (50%), Gaps = 22/179 (12%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
+G G +G+V G++ G VA+K IK A F +E +++ LHH N+V
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA----------FLEETAVMTKLHHKNLVR 63
Query: 868 FYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLHGK 925
G I+ +G L V E M G+L FL+ + R + +L+ ++D A GMEYL K
Sbjct: 64 LLGVILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984
+VH DL N+LV+ + V K+ D GL++V + + + + W APE L K
Sbjct: 120 KLVHRDLAARNILVS----EDGVAKVSDFGLARVGSMGVDNS--KLPVKWTAPEALKHK 172
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 57/177 (32%), Positives = 89/177 (50%), Gaps = 20/177 (11%)
Query: 807 ELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+LG G +G V+ G W G+ VAIK +K + + F +EA ++ L H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQVMKKLRHEKL 63
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLHG 924
V Y +V + P + VTE+M GSL FL+ + R +L+ +A A GM Y+
Sbjct: 64 VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGTLPWMAPE 979
N VH DL+ N+LV + VCK+ D GL+++ + + G + + W APE
Sbjct: 121 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 62/187 (33%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G+G +G V G+ R VAIK +KA +E++R DF EA ++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-----TEKQR--RDFLSEASIMGQF 62
Query: 861 HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN++ G+V + P + VTE+M NGSL FL+K D + + + A GM
Sbjct: 63 DHPNIIHLEGVVTKSKP---VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPW 975
+YL VH DL N+LVN VCK+ D GLS+V + + G + + W
Sbjct: 120 KYLSDMGYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175
Query: 976 MAPELLS 982
APE ++
Sbjct: 176 TAPEAIA 182
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 22/184 (11%)
Query: 808 LGSGTYGSVYHG--KWRG---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+G+G +G V+ G K G VAIK +K +E++R DF EA ++ H
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-----TEKQR--QDFLSEASIMGQFSH 65
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
N++ G+V + +TE+M NG+L ++L+ D + + + A GM+YL
Sbjct: 66 HNIIRLEGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPWMAP 978
N VH DL N+LVN CK+ D GLS+V + T + G + + W AP
Sbjct: 124 SDMNYVHRDLAARNILVN----SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 979 ELLS 982
E ++
Sbjct: 180 EAIA 183
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 53/217 (24%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ + ELG G +G VY G+ G + VAIK +K + +P ++ +F +E
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQ----EFRQE 58
Query: 854 ALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFL-----------QKKDR 901
A L+S L HPN+V G+ ++ P + E++ +G L +FL + D
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQP---TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 902 TI----DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
T+ D L IA+ A GMEYL + VH DL N LV V KI D GLS
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTV-KISDFGLS 171
Query: 958 K-------VKQQTLVSGGVRGTLP--WMAPE-LLSGK 984
+ + Q+ + LP WM PE +L GK
Sbjct: 172 RDIYSADYYRVQS------KSLLPVRWMPPEAILYGK 202
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 36/197 (18%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFA-GKPSE--RERLIADFWKEALLL 857
E++ +LG GTYG VY + + + VA+K+I+ G PS RE I+ LL
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE--IS-------LL 52
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRL---IIA 912
L HPN+V ++ + L V E+ + LK++L K+ + K + ++
Sbjct: 53 KELKHPNIVKLLDVIHT--ERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGV 969
G+ Y H I+H DLK +N+L+N V K+ D GL++ + +T V
Sbjct: 110 -----GLAYCHSHRILHRDLKPQNILINR----DGVLKLADFGLARAFGIPLRTYTHEVV 160
Query: 970 RGTLPWMAPELLSGKSH 986
TL + APE+L G H
Sbjct: 161 --TLWYRAPEILLGSKH 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLI-----ADFWKEALLLSSL 860
R +G G +G V + KR FA K +++ + + E +L L
Sbjct: 6 RVIGKGAFGKVC--------IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+HP +V+ + +D + + V + ++ G L+ L +K + + + + I + +E
Sbjct: 58 NHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALE 114
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPE 979
YLH K I+H D+K +N+L++ ++ I D ++ KV TL + GT +MAPE
Sbjct: 115 YLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIATKVTPDTLTTSTS-GTPGYMAPE 169
Query: 980 LLSGKSHMVTEKVTLFSLKFCCFQL 1004
+L + + V V +SL ++
Sbjct: 170 VLCRQGYSV--AVDWWSLGVTAYEC 192
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 27/191 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ +GSGTYG VY + + VAIK IK P + +E +L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----PGDD---FEIIQQEISML 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HPN+V+++G L V E+ GSL+ Q + + + +
Sbjct: 55 KECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV------KQQTLVSGGVRG 971
G+ YLH +H D+K N+L+ + K+ D G+S K+++ + G
Sbjct: 113 GLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVSAQLTATIAKRKSFI-----G 163
Query: 972 TLPWMAPELLS 982
T WMAPE+ +
Sbjct: 164 TPYWMAPEVAA 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 59/180 (32%), Positives = 90/180 (50%), Gaps = 21/180 (11%)
Query: 804 EVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+V+ LG G +G V+ G W G+ VAIK +K + F +EA ++ L H
Sbjct: 11 DVK-LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQIMKKLRH 60
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEY 921
+V Y +V + P + VTEFM GSL FL++ D + +L+ +A A GM Y
Sbjct: 61 DKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGTLPWMAPE 979
+ N +H DL+ N+LV VCKI D GL+++ + + G + + W APE
Sbjct: 118 IERMNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 49/189 (25%), Positives = 89/189 (47%), Gaps = 18/189 (9%)
Query: 803 EEVRELGSGTYGS--VYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+R LG G +G +Y S V K + + + SE+ER A E ++LS L
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT----RLSEKERRDA--LNEIVILSLL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM--DAAFG 918
HPN++++Y D D +L E+ G+L + ++ + + +++
Sbjct: 57 QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSA 113
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMA 977
+ Y+H I+H D+K N+ + + K+GD G+SK+ + ++ V GT +M+
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGISKILGSEYSMAETVVGTPYYMS 169
Query: 978 PELLSGKSH 986
PEL G +
Sbjct: 170 PELCQGVKY 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++R +G G +G V+ K V IK+I + ++ ERL A E +L L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE----QMTKDERLAAQ--NECQVLKLL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGM 919
HPN++ +Y + D +L V E+ G+L +++QK+ + +D L + +
Sbjct: 57 SHPNIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE 979
++H K I+H DLK +N+L++ + V KIGD G+SK+ + V GT +++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE 171
Query: 980 LLSGKSHMVTEKVTLFSLKFCCFQL 1004
L GK + +K +++L ++L
Sbjct: 172 LCEGKPY--NQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 66/204 (32%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
VR +G G+YG V + R G IK++ S RER A+ +EA LLS L H
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR----NASRRERKAAE--QEAQLLSQLKH 58
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEY 921
PN+V+ Y +G DG L V F G L L ++K + + + + + A ++Y
Sbjct: 59 PNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPEL 980
LH K+I+H DLK +N+ + + + K+GDLG+++V + Q ++ + GT +M+PEL
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 981 LSGKSHMVTEKVTLFSLKFCCFQL 1004
S K + K +++L C +++
Sbjct: 174 FSNKPY--NYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 53/217 (24%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERER-LIADFWKEALLLSSLHHPN 864
+GSG++GSVY G G +A+K+++ + +R+R ++ +E LL L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 865 VVSFYGIVRDG----------PDGSLATV-------TEFMVNGSLKQFLQKKDRTIDRRK 907
+V + G D P GS+A + E +V ++Q L+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK---------- 117
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
G+ YLH + I+H D+K N+LV+ + KI D G+SK + +S
Sbjct: 118 ----------GLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGISKKLEANSLST 163
Query: 968 GVRGTLP-------WMAPELLSGKSHMVTEKVTLFSL 997
G P WMAPE++ K T K ++SL
Sbjct: 164 KTNGARPSLQGSVFWMAPEVV--KQTSYTRKADIWSL 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 22/189 (11%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K+++ F + E + + E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + +L+ E M GS+K L+ + + R I+ G+ Y
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GVSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG----GVRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG V GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 978 PELLSGKSH 986
PE++SG+ +
Sbjct: 178 PEVISGEGY 186
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 28/194 (14%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + +++LG G+YGSVY K R SD A+K + G S++ER D E +L
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDL----GSMSQKER--EDAVNEIRIL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------- 910
+S++HPN++S+ DG L V E+ G L + + K+ + ++LI
Sbjct: 54 ASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKK----RKLIPEQEIWR 107
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
I + G++ LH + I+H DLK N+L+ D + KIGDLG+SKV ++ + +
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNMAKTQI- 162
Query: 971 GTLPWMAPELLSGK 984
GT +MAPE+ G+
Sbjct: 163 GTPHYMAPEVWKGR 176
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 64/189 (33%), Positives = 97/189 (51%), Gaps = 22/189 (11%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A K+++ F + E + ++ E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + +L E+M GS+K L+ + + R I+ GM Y
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-----GMSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVR---GTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG G+R GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 978 PELLSGKSH 986
PE++SG+ +
Sbjct: 178 PEVISGEGY 186
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 48/229 (20%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R +G G +G VYHG SD A+K + + ++ E + F KE +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN------RITDLEE-VEQFLKEGIIMKDF 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPNV+S GI +GS V +M +G L+ F++ + + + + A GME
Sbjct: 54 SHPNVLSLLGICLP-SEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS---------KVKQQTLVSGGVRG 971
YL K VH DL N +++ + K+ D GL+ V T G +
Sbjct: 113 YLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIYDKEYYSVHNHT----GAKL 164
Query: 972 TLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+ WMA E L T+K T S D +S G+L + L
Sbjct: 165 PVKWMALESLQ------TQKFTTKS------------DVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIK-ASCFAGKPSERERLIADFWK-EALLLSSLHHP 863
+G GTYG VY G +A+K+++ + AG+ R++ + + E L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
N+V + G + L+ E++ GS+ L+ R ++ R G+ YLH
Sbjct: 69 NIVQYLGFET-TEE-YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF-TEQVLEGLAYLH 125
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG---VRGTLPWMAPEL 980
K I+H DLK +NLLV+ +CKI D G+SK + ++G++ WMAPE+
Sbjct: 126 SKGILHRDLKADNLLVD----ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 981 LSGKSHMVTEKVTLFSL 997
+ S + KV ++SL
Sbjct: 182 IHSYSQGYSAKVDIWSL 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 63/189 (33%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K++ F E + + E LL +L H +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + L+ E+M GS+K L+ + R R I+ G+ Y
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GVSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG----GVRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG V GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 978 PELLSGKSH 986
PE++SG+ +
Sbjct: 178 PEVISGEGY 186
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 63/197 (31%), Positives = 88/197 (44%), Gaps = 20/197 (10%)
Query: 803 EEVRELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
E +G GTYG VY K G + AIK+ K + + +E LL
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-----KEQYTGISQSACREIALLR 57
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATV---TEFMVNGSLKQFLQKKDRTIDRR--KRLIIAM 913
L H NVVS + + D S+ + E + +K Q K +I K L+ +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGV 969
G+ YLH ++H DLK N+LV P+R V KIGDLGL+++ L V
Sbjct: 118 --LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 970 RGTLPWMAPELLSGKSH 986
T+ + APELL G H
Sbjct: 176 VVTIWYRAPELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + +G G++G VY + ++ VAIK I E E I D +E L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-------EAEDEIEDIQQEIQFL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S P + +YG G L + E+ GS L K +D I +
Sbjct: 54 SQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVRG 971
G+EYLH + +H D+K N+L++ + V K+ D G+S K+ T V G
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLS---EEGDV-KLADFGVSGQLTSTMSKRNTFV-----G 160
Query: 972 TLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
T WMAPE++ + EK ++SL +L
Sbjct: 161 TPFWMAPEVIKQSGY--DEKADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ ++LG+G +G V+ + + + VA+K +K + + F EA
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---------VEAFLAEAN 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ +L H +V + +V P + +TEFM GSL FL+ + + +LI +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM ++ +N +H DL+ N+LV+ VCKI D GL++V + G +
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSL 997
+ W APE ++ S + V F +
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGI 191
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 5e-17
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 43/219 (19%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
LG G++G V + + + A+K + K + + + E +LS ++HP
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII------KRKEVEHTLTERNILSRINHPF 54
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V + + + L V E+ G L L K+ R + R R A + +EYLH
Sbjct: 55 IVKLHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPE 979
I++ DLK EN+L++ K+ D GL+K L S G R GT ++APE
Sbjct: 112 LGIIYRDLKPENILLD----ADGHIKLTDFGLAKE----LSSEGSRTNTFCGTPEYLAPE 163
Query: 980 LLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
+L GK + + W +SLG+L +
Sbjct: 164 VLLGKGY--------------GKAVDW----WSLGVLLY 184
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADF-WKEALLLSS 859
+++ ++G GTYG VY + + G VAIK+IK I +E LL
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK-------LRFESEGIPKTALREIKLLKE 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L+HPN++ + R G L V EFM + L + ++ + R + G+
Sbjct: 55 LNHPNIIKLLDVFRHK--GDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGL 111
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GTL 973
+ H I+H DLK ENLL+N V K+ D GL++ VR T
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEG----VLKLADFGLARS-----FGSPVRPYTHYVVTR 162
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017
+ APELL G + V ++S+ C F + S LF
Sbjct: 163 WYRAPELLLG-DKGYSTPVDIWSVG-CIF-----AELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 58/178 (32%), Positives = 83/178 (46%), Gaps = 16/178 (8%)
Query: 808 LGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G +G V+ G + + VA+K +C P E L F EA +L HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVK----TCKEDLPQE---LKIKFLSEARILKQYDHPNIV 55
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN 926
G+ + V E + G FL+KK + ++ + A+DAA GM YL KN
Sbjct: 56 KLIGVCTQ--RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP--WMAPELLS 982
+H DL N LV + V KI D G+S+ + + S +P W APE L+
Sbjct: 114 CIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 7e-17
Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +++LG GT+GSVY + + G VAIK++K F E L +E L L
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY-SWEECMNL-----REVKSLRKL 54
Query: 861 -HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRK-RLIIAMDAAF 917
HPN+V + R+ + L V E+M G+L Q ++ + + R II
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ- 110
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
G+ ++H H DLK ENLLV+ + V KI D GL++
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 58/190 (30%), Positives = 87/190 (45%), Gaps = 23/190 (12%)
Query: 802 LEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+++R LG G +G V + G VA+K +K C KE
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWK----KEIN 58
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L +L+H N+V + G + L + E++ GSL+ +L K ++ + L+ A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQI 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTL 973
GM YLH ++ +H DL N+L+ D R V KIGD GL+K + VR G
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLL---DNDRLV-KIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 974 P--WMAPELL 981
P W A E L
Sbjct: 173 PVFWYAVECL 182
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--- 862
+G G YG+VY GK G VA+K I P + ++D +E LLS L
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDD---VSDIQREVALLSQLRQSQP 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PN+ +YG GP L + E+ GS++ + K I + +I + ++Y+
Sbjct: 62 PNITKYYGSYLKGP--RLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIG---DLGLSKVKQQTLVSGGVRGTLPWMAPE 979
H ++H D+K N+LV +C G L + K+ T V GT WMAPE
Sbjct: 118 HKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKRSTFV-----GTPYWMAPE 171
Query: 980 LLSGKSHMVTEKVTLFSL 997
+++ K ++SL
Sbjct: 172 VITEGK-YYDTKADIWSL 188
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 18/181 (9%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G +G V+ G+ R + VA+K SC P + L A F +EA +L HPN
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPD---LKAKFLQEARILKQYSHPN 54
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V G+ + V E + G FL+ + + ++ + + +AA GMEYL
Sbjct: 55 IVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGT-LPWMAPELL 981
K+ +H DL N LV ++ V KI D G+S+ ++ + +GG++ + W APE L
Sbjct: 113 KHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 982 S 982
+
Sbjct: 169 N 169
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 71/207 (34%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVY----HGKWRGSD---VAIKRIKASCFAGKPSERERLIAD 849
IK D+ ELG G +G V+ H D VA+K +K + SE R D
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 53
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-----------QK 898
F +EA LL+ L H ++V FYG+ +G L V E+M +G L +FL
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 899 KDRTIDR---RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
+D + + L IA A GM YL + VH DL N LV Q V KIGD G
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----QGLVVKIGDFG 167
Query: 956 LSK-VKQQTLVSGGVRGTLP--WMAPE 979
+S+ + G R LP WM PE
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 801 DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E + ++G G++G V+ K A+K+I S + ERE I EA +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR--EREEAI----DEARVLA 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMDA 915
L ++ +Y D G L V E+ NG L + L+ + D+ R I
Sbjct: 55 KLDSSYIIRYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QI 110
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLP 974
G+ +LH K I+H D+K NL ++ D KIGDLG++K+ T + + GT
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVAKLLSDNTNFANTIVGTPY 166
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKF----CCFQLKWSYDCYSLGIL 1016
+++PEL K + EK +++L CC K +D + G L
Sbjct: 167 YLSPELCEDKPY--NEKSDVWALGVVLYECCTG-KHPFDANNQGAL 209
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 62/197 (31%), Positives = 86/197 (43%), Gaps = 30/197 (15%)
Query: 808 LGSGTYGSVYHGKWRGSD--------VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
LGSG +G VY G VA+K ++ + E F KEA L+S+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-------FLKEAHLMSN 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT------IDRRKRLIIAM 913
+HPN+V G+ + + E M G L +L+ + ++ L I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLSK--VKQQTLVSGGVR 970
D A G YL + +H DL N LV+ + V KIGD GL++ K G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG-E 172
Query: 971 GTLP--WMAPE-LLSGK 984
G LP WMAPE LL GK
Sbjct: 173 GLLPVRWMAPESLLDGK 189
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 50/222 (22%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSE---RERLIADFWKEALLLSSLH 861
LG G +G V K + + A+K + K E E+ I L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI---------LEECN 51
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HP +V Y +D + + E+ + G L L+ + + R IA EY
Sbjct: 52 HPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEY 108
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPWM 976
LH + I++ DLK ENLL++ K+ D G +K K T GT ++
Sbjct: 109 LHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYV 159
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
APE++ K + +S D +SLGIL +
Sbjct: 160 APEIILNKGY------------------DFSVDYWSLGILLY 183
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG---SD----VAIKRIKASCFAGKPSERERLIADFWK 852
++L + LG+G +G V G SD VA+K +K + + SERE L++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS---SEREALMS---- 87
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLI 910
E ++S L +H N+V+ G G G + +TE+ G L FL++K + + L
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQT--LVSG 967
+ A GM +L KN +H DL N+L+ + KI D GL++ + + +V G
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGKIVKICDFGLARDIMNDSNYVVKG 201
Query: 968 GVRGTLPWMAPE 979
R + WMAPE
Sbjct: 202 NARLPVKWMAPE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY G VA+K+++ R+ + KE LL L HP
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCL----KEIDLLKQLDHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDRTIDRRKRLIIAMDAAFGME 920
NV+ + + + L V E G L + + +K+ R I R + +E
Sbjct: 63 NVIKYLASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPE 979
++H K I+H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 980 LLSG 983
+
Sbjct: 177 RIHE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 62/264 (23%), Positives = 104/264 (39%), Gaps = 76/264 (28%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLI-------ADF 850
DD + + +G G++ +V K + ++ AIK + ++ +LI
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL----------DKRQLIKEKKVKYVKI 50
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
KE L + HP ++ Y +D + +L V E+ NG L Q+++K ++ R
Sbjct: 51 EKEVLTRLN-GHPGIIKLYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY 107
Query: 911 IA--MDAAFGMEYLHGKNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKVKQQTLVS 966
A + A +EYLH K I+H DLK EN+L+ +M KI D G +KV
Sbjct: 108 AAEILLA---LEYLHSKGIIHRDLKPENILLDKDMH------IKITDFGTAKVLDPNSSP 158
Query: 967 GGVR---------------------GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK 1005
+ GT +++PELL+ K
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--------------AGK--- 201
Query: 1006 WSYDCYSLGILFFFLQFILCFIDF 1029
S D ++LG + + Q + F
Sbjct: 202 -SSDLWALGCIIY--QMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 65/200 (32%), Positives = 91/200 (45%), Gaps = 32/200 (16%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKAS-CFAGKPSERERLIADFWKEALL--L 857
EE+ E+G G YG+VY + G VA+K+++ G P R IA LL L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA------LLKQL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDG----SLATVTEFMVNGSLKQFLQK------KDRTIDRRK 907
S HPN+V + GP L V E V+ L +L K TI
Sbjct: 56 ESFEHPNIVRLLDVC-HGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLM 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
R ++ G+++LH IVH DLK +N+LV D Q KI D GL+++ +
Sbjct: 114 RQLLR-----GVDFLHSHRIVHRDLKPQNILVT-SDGQ---VKIADFGLARIYSFEMALT 164
Query: 968 GVRGTLPWMAPELLSGKSHM 987
V TL + APE+L S+
Sbjct: 165 SVVVTLWYRAPEVLLQSSYA 184
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 28/194 (14%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
L+E+ LG G +G V+ K +G + A + ++ E L ++F +E + L
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS 66
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK--------RLIIAM 913
H NVV G+ R+ + + E+ G LKQFL+ ++ K ++ +
Sbjct: 67 HKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK--------QQTLV 965
A GM++L VH DL N LV+ QR V K+ L LSK + L+
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVS---SQREV-KVSLLSLSKDVYNSEYYKLRNALI 180
Query: 966 SGGVRGTLPWMAPE 979
L W+APE
Sbjct: 181 P------LRWLAPE 188
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 56/198 (28%), Positives = 79/198 (39%), Gaps = 35/198 (17%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG G +GSV G+ D VA+K +K I +F EA +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT------YSEIEEFLSEAACMKDF 58
Query: 861 HHPNVVSFYGIVRDGPD-GSLAT---VTEFMVNGSLKQFL-----QKKDRTIDRRKRLII 911
HPNV+ G+ + + + FM +G L FL + + L
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG---- 967
+D A GMEYL +N +H DL N M VC + D GLSK + SG
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNC---MLREDMTVC-VADFGLSK----KIYSGDYYR 170
Query: 968 -GVRGTLP--WMAPELLS 982
G +P W+A E L+
Sbjct: 171 QGRIAKMPVKWIAIESLA 188
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 807 ELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIAD-FWKEALLLSSLH 861
ELGSG +G V G ++ DVAIK +K +E E+ + D +EA ++ L
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK--------NENEKSVRDEMMREAEIMHQLD 53
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+P +V G+ +L V E G L +FL K I + + + GM+Y
Sbjct: 54 NPYIVRMIGVCEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110
Query: 922 LHGKNIVHFDLKCEN-LLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPW 975
L GKN VH DL N LLVN + KI D GLSK S G + L W
Sbjct: 111 LEGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKW 164
Query: 976 MAPELL-----SGKSHMVTEKVTLF 995
APE + S +S + + +T++
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 66/214 (30%), Positives = 92/214 (42%), Gaps = 51/214 (23%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIA-------- 848
IK D+ RELG G +G V+ A C+ P++ + L+A
Sbjct: 2 IKRRDIVLKRELGEGAFGKVF--------------LAECYNLSPTKDKMLVAVKALKDPT 47
Query: 849 -----DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
DF +EA LL++L H ++V FYG+ DG L V E+M +G L +FL+
Sbjct: 48 LAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDA 105
Query: 898 ---------KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+ + + L IA A GM YL ++ VH DL N LV +
Sbjct: 106 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLL 161
Query: 949 CKIGDLGLSK-VKQQTLVSGGVRGTLP--WMAPE 979
KIGD G+S+ V G LP WM PE
Sbjct: 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIK-ASCFAGKPSERERLIADFWKEALLLSS 859
++V ++G GTYG VY + + G VA+K+I+ + G PS R I+ LL
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS-------LLKE 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRR--KRLIIAMDAA 916
L+HPN+V +V + L V EF ++ LK+++ T +D K + +
Sbjct: 55 LNHPNIVRLLDVVHS--ENKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ- 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQT--LVSGGV 969
G+ Y H ++H DLK +NLL++ + K+ D GL++ V+ T +V
Sbjct: 111 -GIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLARAFGVPVRTYTHEVV---- 161
Query: 970 RGTLPWMAPELLSGKSHMVT 989
TL + APE+L G T
Sbjct: 162 --TLWYRAPEILLGSRQYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 6e-15
Identities = 63/197 (31%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
DD E ++ LG+G++G V + +GS A+K + KA K E E+ I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRI------ 54
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIA 912
L S+ HP +V+ YG +D D +L V E++ G L L+K R + A
Sbjct: 55 ---LQSIRHPFLVNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR--FYA 107
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGV 969
+EYLH +IV+ DLK ENLL+ D + KI D G +K + TL
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYI-KITDFGFAKRVKGRTYTLC---- 159
Query: 970 RGTLPWMAPELLSGKSH 986
GT ++APE++ K +
Sbjct: 160 -GTPEYLAPEIILSKGY 175
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+ G YG V+ K + G AIK IK + K + L E +LS P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-----TERDILSQAQSPYV 55
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V Y + +L V E++ G L L+ + R+ IA + +EYLH
Sbjct: 56 VKLYYSFQG--KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSN 112
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGG------VRGTLPWM 976
I+H DLK +N+L++ K+ D GLSK V++Q ++ + GT ++
Sbjct: 113 GIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG-ILFFFL 1020
APE++ G+ H D +SLG IL+ FL
Sbjct: 169 APEVILGQGH-----------SKTV-------DWWSLGCILYEFL 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R LG G +GSV + + D VA+K +KA F+ I +F +EA +
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD------IEEFLREAACMKEF 58
Query: 861 HHPNVVSFYGI-VRDGPDGSLA---TVTEFMVNGSLKQFL-----QKKDRTIDRRKRLII 911
HPNV+ G+ +R G L + FM +G L FL ++ T+ + +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG---- 967
+D A GMEYL KN +H DL N M + VC + D GLSK + SG
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNC---MLNENMTVC-VADFGLSK----KIYSGDYYR 170
Query: 968 -GVRGTLP--WMAPELLSGKSHMVTEKVTLF 995
G LP W+A E L+ + V F
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAF 201
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 29/194 (14%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFW-KEALLLSS 859
+ + +G G +G V+ K R + VA+K++ A + E I + +E L +
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALR--RLEGGIPNQALREIKALQA 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-RLIIAMDAAFG 918
HP VV + G V E+M L + L+ ++R + + + + M G
Sbjct: 56 CQHPYVVKLLDVFPHG--SGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-G 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GT 972
+ Y+H I+H DLK NLL++ V KI D GL+++ R T
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADG----VLKIADFGLARL----FSEEEPRLYSHQVAT 163
Query: 973 LPWMAPELLSGKSH 986
+ APELL G
Sbjct: 164 RWYRAPELLYGARK 177
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + E+ LG G GSV + + G A+K I P +++++ +E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQIL----RELEIN 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL----KQFLQKKDRTIDRRKRLIIAM 913
S P +V +YG D S+ E+ GSL K+ ++ R I + IA
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAE 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI---GDLGLSKVKQQTLVSGGVR 970
G+ YLH + I+H D+K N+L+ R Q +C G+L S ++G
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNS-------LAGTFT 164
Query: 971 GTLPWMAPELLSGKSHMVTEKV 992
GT +MAPE + GK + +T V
Sbjct: 165 GTSFYMAPERIQGKPYSITSDV 186
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 60/187 (32%), Positives = 93/187 (49%), Gaps = 21/187 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DDLE + ELG G YG V + + +A+KRI+A+ E++RL+ D + +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL---DISM 54
Query: 858 SSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAM 913
S+ P V+FYG + R +G + E M + SL +F +K K TI IA+
Sbjct: 55 RSVDCPYTVTFYGALFR---EGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV 110
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+EYLH K +++H D+K N+L+N K+ D G+S ++ G
Sbjct: 111 SIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ----VKLCDFGISGYLVDSVAKTIDAGC 166
Query: 973 LPWMAPE 979
P+MAPE
Sbjct: 167 KPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 27/191 (14%)
Query: 799 NDDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
ND E + ELG G +G VY K G A K I+ E E + DF E +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ--------IESEEELEDFMVEIDI 55
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS HPN+V Y + L + EF G+L + + +R + + +
Sbjct: 56 LSECKHPNIVGLYEAYFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+ +LH ++H DLK N+L+ + K+ D G+S K+ T +
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFI----- 164
Query: 971 GTLPWMAPELL 981
GT WMAPE++
Sbjct: 165 GTPYWMAPEVV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 60/184 (32%), Positives = 83/184 (45%), Gaps = 28/184 (15%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GTYG VY + + V AIK I P R + +E L S L H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI--------PERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-------DRTIDRRKRLIIAMDAAFG 918
V + G + G E + GSL L+ K ++TI + I+ G
Sbjct: 68 VQYLGSDSEN--GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-----G 120
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMA 977
++YLH IVH D+K +N+LVN V KI D G SK + + GTL +MA
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 978 PELL 981
PE++
Sbjct: 178 PEVI 181
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 66/220 (30%), Positives = 88/220 (40%), Gaps = 55/220 (25%)
Query: 802 LEEVRELGSGTYGSVY----------------HGKWRGSD--VAIKRIKASCFAGKPSER 843
L V +LG G +G V+ + VA+K ++ P
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR-------PDAS 59
Query: 844 ERLIADFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKD-- 900
+ DF KE +LS L PN+ G+ D P L + E+M NG L QFLQK
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP---LCMIMEYMENGDLNQFLQKHVAE 116
Query: 901 --------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
+++ L +A A GM YL N VH DL N LV + KI
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG----KNYTIKIA 172
Query: 953 DLGLSKVKQQTLVSGG---VRGTLP----WMAPE-LLSGK 984
D G+S+ L S V+G P WMA E +L GK
Sbjct: 173 DFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 23/190 (12%)
Query: 808 LGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG+G + S Y + G+ +A+K++ SE+E ++ KE L++ L+HP++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
+ G + D E+M GS+ L K K+ I ++ G+ Y
Sbjct: 66 IRMLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR-----GLSY 118
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQTLVSGGVRGTLPWM 976
LH I+H D+K NLL+ D +I D G +K G + GT+ +M
Sbjct: 119 LHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 977 APELLSGKSH 986
APE+L G+ +
Sbjct: 176 APEVLRGEQY 185
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 41/213 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ D L + LG G +G V + G D VA+K +K +E++ ++D
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKD--LSD 61
Query: 850 FWKEALLLSSL-HHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQ---------K 898
E ++ + H N+++ G+ ++GP L V E+ +G+L+ FL+
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 899 KDRTIDRRKRLI------IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
D + L A A GME+L K +H DL N+LV V KI
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH----VMKIA 174
Query: 953 DLGLSK-VKQQTLVSGGVRGTLP--WMAPELLS 982
D GL++ + G LP WMAPE L
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF 207
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L+ +K +L+ V+ LGSG +G+VY G W +K I + + + +F E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDE 59
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
AL+++S+ HP++V G+ ++ VT+ M +G L ++ + I + L +
Sbjct: 60 ALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV 116
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVR 970
A GM YL + +VH DL N+LV + P KI D GL+++ ++ + G +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLEGDEKEYNADGGK 172
Query: 971 GTLPWMAPELL 981
+ WMA E +
Sbjct: 173 MPIKWMALECI 183
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 60/183 (32%), Positives = 85/183 (46%), Gaps = 35/183 (19%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKD------- 900
DF KE ++S L +PN++ G+ V D P L +TE+M NG L QFL +++
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 901 ----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
++ L +A+ A GM+YL N VH DL N LV KI D G+
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG----NHYTIKIADFGM 175
Query: 957 SKVKQQTLVSGGV-----RGTLP--WMAPE-LLSGKSHMVTE----KVTLFSLKFCCFQL 1004
S+ L SG R LP WMA E +L GK ++ VTL+ + C +
Sbjct: 176 SR----NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231
Query: 1005 KWS 1007
+S
Sbjct: 232 PYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 17/192 (8%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIK-RIKASCFAGKPSERERLIADF 850
L+ +K + ++++ LGSG +G+VY G W G V I IK A P + ++
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL--- 57
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
EA +++S+ +P+V GI ++ +T+ M G L ++++ I + L
Sbjct: 58 -DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 113
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL + +VH DL N+LV + PQ KI D GL+K+ ++ +
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAE 169
Query: 968 GVRGTLPWMAPE 979
G + + WMA E
Sbjct: 170 GGKVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 46/196 (23%)
Query: 808 LGSGTYGSVYHGKWRGSDV------AIKRIKASCFAGKPSERE--RLIADFWKEALLLSS 859
+G GT+G VY ++ A+K I+ + ++ + + IAD E +L
Sbjct: 8 IGGGTFGKVY----TAVNLDTGELMAVKEIRI-----QDNDPKTIKEIAD---EMKVLEL 55
Query: 860 LHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRR--KRLIIA 912
L HPN+V +YG+ R+ + E+ G+L++ L+ D + R +L+
Sbjct: 56 LKHPNLVKYYGVEVHRE----KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE- 110
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSG---- 967
G+ YLH IVH D+K N+ ++ V K+GD G + +K T G
Sbjct: 111 -----GLAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 968 GVRGTLPWMAPELLSG 983
+ GT +MAPE+++G
Sbjct: 162 SLAGTPAYMAPEVITG 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 62/194 (31%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIA-DFWKEALLLSS 859
E+ ++LG GTY VY + + + VAIK+IK G+ E + I +E LL
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQE 58
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI--IAMDAAF 917
L HPN++ + G ++ V EFM L++ + KD++I I +
Sbjct: 59 LKHPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVI--KDKSIVLTPADIKSYMLMTLR 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT----L 973
G+EYLH I+H DLK NLL+ V K+ D GL++ + S + T
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR----SFGSPNRKMTHQVVT 165
Query: 974 PWM-APELLSGKSH 986
W APELL G H
Sbjct: 166 RWYRAPELLFGARH 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 48/211 (22%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIA-------- 848
IK ++ RELG G +G V+ A C+ P + + L+A
Sbjct: 2 IKRHNIVLKRELGEGAFGKVF--------------LAECYNLCPEQDKILVAVKTLKDAS 47
Query: 849 -----DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
DF +EA LL++L H ++V FYG+ +G L V E+M +G L +FL+
Sbjct: 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDA 105
Query: 898 ------KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + L IA A GM YL ++ VH DL N LV + + KI
Sbjct: 106 VLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKI 161
Query: 952 GDLGLSKVKQQT---LVSGGVRGTLPWMAPE 979
GD G+S+ T V G + WM PE
Sbjct: 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKE 853
+K +D +R LG+G++G V ++ D VAIKR + S +++ + + E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSE 81
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L+ ++HP V+ YG +D + L V EF++ G FL++ R A
Sbjct: 82 RKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAA 138
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
EYL NIV+ DLK ENLL++ + K+ D G +KV + + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 974 PWMAPELLSGKSH 986
++APE+L H
Sbjct: 193 EYIAPEILLNVGH 205
|
Length = 340 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 32/195 (16%)
Query: 806 RELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
RELG G++G VY G +G + VAIK + + S RER+ +F EA ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-----SMRERI--EFLNEASVMK 64
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---------RKRL 909
+ +VV G+V G + E M G LK +L+ ++ +K +
Sbjct: 65 EFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGG 968
+A + A GM YL+ VH DL N +V + KIGD G+++ + + G
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 969 VRGTLP--WMAPELL 981
+G LP WM+PE L
Sbjct: 179 GKGLLPVRWMSPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 68/241 (28%), Positives = 102/241 (42%), Gaps = 50/241 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIAD 849
+ + + +RELG G++G VY G R + VA+K + S S RER+ +
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-----SLRERI--E 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ--------KKDR 901
F EA ++ +VV G+V G V E M +G LK +L+ R
Sbjct: 56 FLNEASVMKGFTCHHVVRLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 902 TIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+ +I +A + A GM YL+ K VH DL N +V KIGD G+++ +
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDI 169
Query: 960 KQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017
+ G +G LP WMAPE L T S D +S G++
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGV------FTTSS------------DMWSFGVVL 211
Query: 1018 F 1018
+
Sbjct: 212 W 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 44/211 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
+++E VR++G G +G V+ + G + VA+K +K A + ADF +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQR 57
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---------- 902
EA L++ HPN+V G+ G + + E+M G L +FL+ +
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 903 -----------IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ ++L IA A GM YL + VH DL N LV + V KI
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVKI 171
Query: 952 GDLGLS-KVKQQTLVSGGVRGTLP--WMAPE 979
D GLS + +P WM PE
Sbjct: 172 ADFGLSRNIYSADYYKASENDAIPIRWMPPE 202
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 17/190 (8%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +LG GTY +V+ G+ + ++ VA+K I+ G P R E LL L
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLK 62
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
H N+V+ + IV D SL V E++ + LKQ++ + I G+ Y
Sbjct: 63 HANIVTLHDIVHT--DKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPEL 980
H + ++H DLK +NLL+N +R K+ D GL++ K T TL + P++
Sbjct: 120 CHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 981 LSGKSHMVTE 990
L G S T+
Sbjct: 176 LLGSSEYSTQ 185
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAG-KPSERERLIADFWKEALLLSS 859
D E + +G G++G+V + R SD I K + E+++L++ E +L
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDYGNMTEKEKQQLVS----EVNILRE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAA 916
L HPN+V +Y + D + +L V E+ G L Q +QK + I+ I
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 917 FGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLV 965
+ H G ++H DLK N+ ++ K+GD GL+K+ +T V
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
GT +M+PE L+ S+ EK ++SL ++L
Sbjct: 172 -----GTPYYMSPEQLNHMSY--DEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 70/236 (29%), Positives = 97/236 (41%), Gaps = 53/236 (22%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
E V +G GTYG VY + + G VAIK + E E + E +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKE----EYNI 55
Query: 857 LSSL-HHPNVVSFYGI----VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR--L 909
L +HPN+ +FYG G D L V E GS+ L K R +R +
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEW 114
Query: 910 I--IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
I I + G+ YLH ++H D+K +N+L+ + K+ D G+S TL
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAEVKLVDFGVSAQLDSTL--- 167
Query: 968 GVR----GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSY----DCYSLGI 1015
G R GT WMAPE+++ C Q SY D +SLGI
Sbjct: 168 GRRNTFIGTPYWMAPEVIA-----------------CDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 17/187 (9%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG GTY +VY G+ + +D VA+K I+ G P R E LL L H N
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + I+ + SL V E++ + LKQ+L +I+ + G+ Y H
Sbjct: 66 IVTLHDIIHT--EKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSG 983
+ ++H DLK +NLL+N +R K+ D GL++ K T TL + P++L G
Sbjct: 123 RKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 984 KSHMVTE 990
+ T+
Sbjct: 179 STDYSTQ 185
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 5e-13
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 30/191 (15%)
Query: 811 GTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868
GTYG VY + + + VA+K++K E+E +E +L L HPN+V+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKME------KEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEYLHGKN 926
+V + V E++ + LK ++ + K L++ + + G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS--GVAHLHDNW 126
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-------KVKQQTLVSGGVRGTLPWMAPE 979
I+H DLK NLL+N R + KI D GL+ K Q +V TL + APE
Sbjct: 127 ILHRDLKTSNLLLN----NRGILKICDFGLAREYGSPLKPYTQLVV------TLWYRAPE 176
Query: 980 LLSGKSHMVTE 990
LL G T
Sbjct: 177 LLLGAKEYSTA 187
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++N+DLE + +LG+G GSV K + + + K K S R++++ +E +
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAK-KVVHIGAKSSVRKQIL----RELQI 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDA 915
+ P +VSFYG + + + EFM GSL + +K ++ ++ +A+
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMC--MEFMDCGSLDRIYKKGGPIPVEILGKIAVAV-- 112
Query: 916 AFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLG-LSKVKQQTLVSGGVRGTL 973
G+ YL+ + I+H D+K N+LVN R Q +C G G L T V GT
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIADTFV-----GTS 166
Query: 974 PWMAPELLSGKSHMVTEKV 992
+M+PE + G + V V
Sbjct: 167 TYMSPERIQGGKYTVKSDV 185
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 57/176 (32%), Positives = 76/176 (43%), Gaps = 35/176 (19%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFL----------Q 897
DF KE ++S L PN++ + + P L +TE+M NG L QFL +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
TI + +A A GM+YL N VH DL N LV KI D G+S
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY----TIKIADFGMS 177
Query: 958 KVKQQTLVSGGV-----RGTLP--WMAPE-LLSGKSHMVTE----KVTLFS-LKFC 1000
+ L SG R LP WM+ E +L GK ++ VTL+ L C
Sbjct: 178 R----NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 61/211 (28%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 800 DDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKAS-CFAGKPSERERLIADFWKEALL 856
DD E + +G G VY VAIKRI C + + L KE
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELR----KEVQA 52
Query: 857 LSSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM- 913
+S +HPNVV +Y +V D L V ++ GSL ++ IIA
Sbjct: 53 MSQCNHPNVVKYYTSFVVGD----ELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAIIATV 107
Query: 914 --DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVR 970
+ G+EYLH +H D+K N+L+ + KI D G+S + + VR
Sbjct: 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 971 ----GTLPWMAPELLSGKSHMVTEKVTLFSL 997
GT WMAPE++ H K ++S
Sbjct: 164 KTFVGTPCWMAPEVMEQV-HGYDFKADIWSF 193
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-13
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+K+DD E++ ELG+G G V+ + S + + R K KP+ R ++I +E +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG DG ++ E M GSL Q L+K R I + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVI 113
Query: 917 FGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 976 MAPELLSGKSHMVTEKV 992
M+PE L G + V +
Sbjct: 169 MSPERLQGTHYSVQSDI 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 30/194 (15%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D ++ ++G GTYG VY G+ + G VA+K+I+ SE E + + +E LL
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE------SEEEGVPSTAIREISLLK 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ--KKDRTIDRRKRLIIAMDAA 916
L HPN+V ++ + L + EF+ + LK++L K + +D
Sbjct: 55 ELQHPNIVCLQDVLMQ--ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-------KVKQQTLVSGGV 969
G+ + H + ++H DLK +NLL++ + V K+ D GL+ +V +V
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGLARAFGIPVRVYTHEVV---- 163
Query: 970 RGTLPWMAPELLSG 983
TL + APE+L G
Sbjct: 164 --TLWYRAPEVLLG 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 63/197 (31%), Positives = 87/197 (44%), Gaps = 37/197 (18%)
Query: 808 LGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+G G +G V + + D AIKR+K +A K R DF E +L L HH
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHR-----DFAGELEVLCKLGHH 67
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRK 907
PN+++ G G L E+ +G+L FL+K T+ ++
Sbjct: 68 PNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
L A D A GM+YL K +H DL N+LV + V KI D GLS + Q +
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLS--RGQEVYVK 179
Query: 968 GVRGTLP--WMAPELLS 982
G LP WMA E L+
Sbjct: 180 KTMGRLPVRWMAIESLN 196
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GTYG+V+ K R VA+KR++ + E + + +E LL L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLKEL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
H N+V Y ++ D L V E+ + LK++ + ID G+
Sbjct: 57 KHKNIVRLYDVLHS--DKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+ H N++H DLK +NLL+N + K+ D GL++
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 31/191 (16%)
Query: 804 EVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +LG GTY +VY G+ R G VA+K I G PS R I+ L+ L
Sbjct: 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS-------LMKELK 56
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF---- 917
H N+V + ++ + L V E+M + LK+++ T R L +F
Sbjct: 57 HENIVRLHDVIH--TENKLMLVFEYM-DKDLKKYMD----THGVRGALDPNTVKSFTYQL 109
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
G+ + H ++H DLK +NLL+N +R K+ D GL++ + T + V T
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGLARAFGIPVNTFSNEVV--T 163
Query: 973 LPWMAPELLSG 983
L + AP++L G
Sbjct: 164 LWYRAPDVLLG 174
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E++ ++G GTYG VY + + G VA+K+ + + E + +E LL
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 858 SSLHH-PNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L +V + SL V E++ + LK+F+ R R
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 914 DAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQT- 963
+ G+ + H ++H DLK +NLLV D Q+ + KI DLGL + VK T
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 964 -LVSGGVRGTLPWMAPELLSGKSHMVT 989
+V TL + APE+L G +H T
Sbjct: 171 EIV------TLWYRAPEVLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 58/183 (31%), Positives = 92/183 (50%), Gaps = 23/183 (12%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+LE V +GSG G+VY R + A+K I + R I +E +L
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQIC---REIEILR 127
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
++HPNVV + + G + + EFM GSL+ ++ + R I++ G
Sbjct: 128 DVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-----G 180
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLPWM 976
+ YLH ++IVH D+K NLL+N + V KI D G+S++ QT+ + V GT+ +M
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLINSA---KNV-KIADFGVSRILAQTMDPCNSSV-GTIAYM 235
Query: 977 APE 979
+PE
Sbjct: 236 SPE 238
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+K+DD E + ELG+G G V + + S + + R K KP+ R ++I +E +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG DG ++ E M GSL Q L K+ + I +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSIAVL 113
Query: 917 FGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 976 MAPELLSGKSHMVTEKV 992
M+PE L G + V +
Sbjct: 169 MSPERLQGTHYSVQSDI 185
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++RE+G G++G+VY + + VAIK++ ++GK S + D KE L L
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEK--WQDIIKEVRFLQKLR 73
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HPN + + G L V E+ + GS L+ + + + + A G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE-L 980
LH N++H D+K N+L++ + + K+GD G + + + GT WMAPE +
Sbjct: 131 LHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVI 183
Query: 981 LSGKSHMVTEKVTLFSLKFCCFQL 1004
L+ KV ++SL C +L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 34/193 (17%)
Query: 811 GTYGSVYHGKWRGS------DVAIKRIK--ASCFAGKPSERERLIADFWKEALLLSSLHH 862
GT+G +++G +V +K +K AS + L+ +E+ LL L H
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-----EIQVTLLL----QESCLLYGLSH 67
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-------KDRTIDRRKRLIIAMDA 915
N++ + + + + +M G+LK FLQ+ + + ++ + +A+
Sbjct: 68 QNILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGVRG 971
A GM YLH + ++H D+ N ++ D + V KI D LS+ + L R
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVI---DEELQV-KITDNALSRDLFPMDYHCLGDNENR- 181
Query: 972 TLPWMAPELLSGK 984
+ WMA E L K
Sbjct: 182 PVKWMALESLVNK 194
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 55/186 (29%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG GTY +V+ G K + VA+K I+ G P R E LL +L H N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKNLKHAN 64
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + I+ + L V E++ + LKQ+L + I G+ Y H
Sbjct: 65 IVTLHDIIHT--ERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSG 983
+ I+H DLK +NLL+N ++ K+ D GL++ K T TL + P++L G
Sbjct: 122 RKILHRDLKPQNLLIN----EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 984 KSHMVT 989
+ T
Sbjct: 178 STEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 799 NDDLEEV----RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
DD E++ RE+G G++G+VY VAIK++ ++GK S + D K
Sbjct: 10 KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEK--WQDIIK 64
Query: 853 EALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E L L HPN + + G +R+ + V E+ + GS L+ + + + I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREH---TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAI 120
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ--QTLVSGGV 969
A G+ YLH +H D+K N+L+ + K+ D G + + + V
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGSASLVSPANSFV---- 172
Query: 970 RGTLPWMAPE-LLSGKSHMVTEKVTLFSLKFCCFQL 1004
GT WMAPE +L+ KV ++SL C +L
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 46/206 (22%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E ++++G G++G +Y K IK I + K E + KE +LL+ +
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII-AMDAAFGM 919
HPN+V+F+ ++ +G L V E+ G L + + ++ + +++ + + G+
Sbjct: 57 KHPNIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMAP 978
+++H + I+H D+K +N+ ++ V K+GD G+++ ++ ++ GT +++P
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 979 ELLSGKSHMVTEKVTLFSLKFCCFQL 1004
E+ + + K ++SL ++L
Sbjct: 172 EICQNRPY--NNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 808 LGSGTYGSV-----YHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
LG G +G V + K R + VA+K +K + SE L+++F LL +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEF----NLLKQV 60
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------------------- 899
+HP+V+ YG DG L + E+ GSL+ FL++
Sbjct: 61 NHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 900 --DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+R + + A + GM+YL +VH DL N+LV + KI D GLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV----AEGRKMKISDFGLS 174
Query: 958 K-VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ V ++ +G +P WMA E L H+ T + ++S +++
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G+Y +VY G+ + + VA+K I+ G P R EA LL L H N+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-------EASLLKDLKHANI 65
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V+ + I+ +L V E++ LKQ++ + + G+ Y H +
Sbjct: 66 VTLHDIIH--TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960
++H DLK +NLL++ +R K+ D GL++ K
Sbjct: 123 RVLHRDLKPQNLLIS----ERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
N+ E + ELG G +G VY K + G+ A K I+ ++ E + D+ E +
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE--------TKSEEELEDYMVEIEI 62
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L++ +HP +V G DG L + EF G++ + + DR + + +I
Sbjct: 63 LATCNHPYIVKLLGAFYW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLPW 975
++YLH I+H DLK N+L+ + K+ D G+S +TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 976 MAPELL 981
MAPE++
Sbjct: 177 MAPEVV 182
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E LG+G++G V K +G+ AIK C + + + + +E +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-----CLKKREILKMKQVQHVAQEKSILM 73
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L HP +V+ +D + + + EF+V G L L+K R + + A +
Sbjct: 74 ELSHPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLA 130
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMA 977
EYLH K+I++ DLK ENLL+ D + V K+ D G +K V +T + GT ++A
Sbjct: 131 FEYLHSKDIIYRDLKPENLLL---DNKGHV-KVTDFGFAKKVPDRTFT---LCGTPEYLA 183
Query: 978 PELLSGKSH 986
PE++ K H
Sbjct: 184 PEVIQSKGH 192
|
Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASC-FAGKPSERERLIADFWKEALLLSS 859
++V ++G GTYG VY + + G VA+K+I+ G PS R I+ LL
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-------LLKE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF-- 917
L+HPN+V ++ + L V EF+ + LK+F+ D + L + F
Sbjct: 56 LNHPNIVKLLDVIHT--ENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQL 109
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
G+ + H ++H DLK +NLL+N K+ D GL++ V +T V T
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVV--T 163
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCF 1002
L + APE+L G + V ++SL C F
Sbjct: 164 LWYRAPEILLG-CKYYSTAVDIWSLG-CIF 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 20/183 (10%)
Query: 806 RELGSGTYGSVYHG-----KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R LG+G +G + G R VAI ++A C S+++R F EAL L
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-----SDKQRR--GFLAEALTLGQF 63
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
H N+V G++ G ++ VTE+M NG+L FL+K + + + + + A GM+
Sbjct: 64 DHSNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP--WMAP 978
YL VH L +LVN VCKI + + + + G P W AP
Sbjct: 122 YLSEMGYVHKGLAAHKVLVN----SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 979 ELL 981
E +
Sbjct: 178 EAI 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 63/190 (33%), Positives = 91/190 (47%), Gaps = 14/190 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
DD E++ ELG+G G V R S + + R K KP+ R ++I +E +L
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMAR-KLIHLEIKPAIRNQII----RELKVLHE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ P +V FYG DG ++ E M GSL Q L KK I I++ G+
Sbjct: 56 CNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGL 112
Query: 920 EYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
YL K I+H D+K N+LVN R K+ D G+S ++ + V GT +M+P
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSYMSP 167
Query: 979 ELLSGKSHMV 988
E L G + V
Sbjct: 168 ERLQGTHYTV 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 16/182 (8%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ + G +GSVY K R G AIK +K S K ++ + A+++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK----NQVTNVKAERAIMMIQGES 56
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P V Y + L V E++ G ++ + + IA + G+E L
Sbjct: 57 PYVAKLYYSFQSK--DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDL 113
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982
H + I+H D+K ENLL++ Q K+ D GLS+ L + GT ++APE +
Sbjct: 114 HQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETIL 166
Query: 983 GK 984
G
Sbjct: 167 GV 168
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 51/212 (24%)
Query: 805 VRELGSGTYGSVYHGKWR--GSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ ELG +G +Y G G D VAIK +K + +F +EA L++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-------DINNPQQWGEFQQEASLMA 62
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL------------QKKDRTI--- 903
LHHPN+V G+V + + + E++ G L +FL +D T+
Sbjct: 63 ELHHPNIVCLLGVVTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 904 -DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS----- 957
D L IA+ A GMEYL VH DL N+L+ ++ KI DLGLS
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG----EQLHVKISDLGLSREIYS 176
Query: 958 ----KVKQQTLVSGGVRGTLPWMAPE-LLSGK 984
+V+ ++L+ + WM PE ++ GK
Sbjct: 177 ADYYRVQPKSLLP------IRWMPPEAIMYGK 202
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 26/199 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E+V ++G GTYG VY + R ++ +A+K+I+ E E + + +E LL
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE------QEDEGVPSTAIREISLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ H N+V +V + L V E++ + LK+ + D + D K + +
Sbjct: 56 KEMQHGNIVRLQDVVHS--EKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRLIKTYLY 109
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVR 970
G+ Y H ++H DLK +NLL++ R K+ D GL++ + +T V
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRR---TNALKLADFGLARAFGIPVRTFTHEVV- 165
Query: 971 GTLPWMAPELLSGKSHMVT 989
TL + APE+L G H T
Sbjct: 166 -TLWYRAPEILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 39/204 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + + ++G GTYG VY K G VA+K+++ +E+E +E +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD------NEKEGFPITAIREIKIL 60
Query: 858 SSLHHPNVVSFYGIVRDGPD--------GSLATVTEFM-------VNGSLKQFLQKKDRT 902
L+H N+V+ IV D D G+ V E+M + L F + ++
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--- 959
K+L ++ G+ Y H KN +H D+KC N+L+N + K+ D GL+++
Sbjct: 121 F--MKQL---LE---GLNYCHKKNFLHRDIKCSNILLN----NKGQIKLADFGLARLYNS 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSG 983
++ + V TL + PELL G
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLG 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-11
Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 40/251 (15%)
Query: 746 DTTTKEAP-------ANEAELVNIH-GEIEMDYDNDTVKTLK-----IEPTIAEAEAIAR 792
DTT P A+E +I G++E D+ ++ + PT +A +
Sbjct: 5 DTTPPLPPRSYSGGAADEDLYSDISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVA 64
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFW 851
L ++ L G+ G V+ G D + +I K + LI
Sbjct: 65 SL------GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI-----GQKGTT---LI---- 106
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
EA+LL +++HP+V+ + G + + + L +L K+ R + + LII
Sbjct: 107 -EAMLLQNVNHPSVIRMKDTLVSGA---ITCMVLPHYSSDLYTYLTKRSRPLPIDQALII 162
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
G+ YLH + I+H D+K EN+ +N D VC IGDLG ++ G+ G
Sbjct: 163 EKQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAG 218
Query: 972 TLPWMAPELLS 982
T+ APE+L+
Sbjct: 219 TVETNAPEVLA 229
|
Length = 357 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 804 EVRELGSGTYGSVYHGK-WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++RE+G G++G+VY + R ++V IK ++GK S + D KE L + H
Sbjct: 29 DLREIGHGSFGAVYFARDVRTNEVVA--IKKMSYSGKQSNEK--WQDIIKEVKFLQRIKH 84
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PN + + G L V E+ + GS L+ + + + I A G+ YL
Sbjct: 85 PNSIEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE-LL 981
H N++H D+K N+L + +P + K+ D G + + + GT WMAPE +L
Sbjct: 142 HSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASP---ANSFVGTPYWMAPEVIL 194
Query: 982 SGKSHMVTEKVTLFSLKFCCFQL 1004
+ KV ++SL C +L
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 24/193 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSE-----RERLIADFWKEA 854
DDLE ++ +G+GT+G V+ + RI +A K R + E
Sbjct: 1 DDLERIKTVGTGTFGRVH--------LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK 52
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + HP ++ + D L + E++ G L +L+ L A +
Sbjct: 53 RVLKEVSHPFIIRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASE 109
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTL 973
+EYLH K IV+ DLK EN+L++ ++ K+ D G +K ++ +T + GT
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLD-KEGH---IKLTDFGFAKKLRDRTWT---LCGTP 162
Query: 974 PWMAPELLSGKSH 986
++APE++ K H
Sbjct: 163 EYLAPEVIQSKGH 175
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 6e-11
Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 37/173 (21%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALL 856
++ +GSG YG V K G VAIK+I + D +E L
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI------------SNVFDDLIDAKRILREIKL 52
Query: 857 LSSLHHPNVVSFYGIVR-DGPD--GSLATVTEFMVNGS-LKQFLQ-KKDRTIDRRKRLII 911
L L H N++ I+R P+ + VTE M + L + ++ + T D + +
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLY 110
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQ 962
+ G++YLH N++H DLK N+LVN + C KI D GL++
Sbjct: 111 QI--LRGLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDP 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 800 DDLEEV----RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKE 853
DD EE+ E+G G++G+VY ++ VA+K++ ++GK + + D KE
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEK--WQDIIKE 71
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L L HPN + + G + + V E+ + GS L+ + + + I
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLK--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITH 128
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A G+ YLH N++H D+K N+L + +P + K+ D G + + GT
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSP---ANSFVGTP 181
Query: 974 PWMAPE-LLSGKSHMVTEKVTLFSLKFCCFQL 1004
WMAPE +L+ KV ++SL C +L
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 27/192 (14%)
Query: 808 LGSGTYGSVYHG-KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G YG+VY G +G +A+K+++ +E+E +E LL SL H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE--YEKLQEEVDLLKSLKHVNIV 65
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYL 922
+ G D D +++ EF+ GS+ L + + + + I+ G+ YL
Sbjct: 66 QYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPV------C--KIGDLGLSKVKQQTLVSGGVRGTLP 974
H +VH D+K N+ M P + C ++ +GL L S + GT
Sbjct: 119 HNNCVVHRDIKGNNV---MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPY 173
Query: 975 WMAPELLSGKSH 986
WMAPE+++ +
Sbjct: 174 WMAPEVINESGY 185
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 68/238 (28%), Positives = 101/238 (42%), Gaps = 44/238 (18%)
Query: 793 GLQTIKN--DDLEEVRELGSGTYGSVYH--GKWRGSDVAIKRIKASCFAGKPSERERLIA 848
GL+++ + D E + +G GTYG VY K GS A+K + + E E I
Sbjct: 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI- 71
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPD---GSLATVTEFMVNGSLKQFLQKKDRTIDR 905
L S +HPNVV FYG+ G L V E GS+ + ++ R
Sbjct: 72 -------LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 906 RKRLIIAM---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQ 961
+I+ A G+++LH I+H D+K N+L+ K+ D G+S ++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTS 180
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDC----YSLGI 1015
L GT WMAPE+++ C Q +SYD +SLGI
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIA-----------------CEQQYDYSYDARCDVWSLGI 221
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 54/204 (26%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ +G GTYG VY + S VA+K+++ +ER+ + +E LL +L
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD------NERDGIPISSLREITLLLNL 63
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF--- 917
HPN+V +V S+ F+V +Q L L+ M F
Sbjct: 64 RHPNIVELKEVVVGKHLDSI-----FLVMEYCEQDL----------ASLLDNMPTPFSES 108
Query: 918 -----------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQ 961
G++YLH I+H DLK NLL+ + KI D GL++ K
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGLARTYGLPAKP 164
Query: 962 QT--LVSGGVRGTLPWMAPELLSG 983
T +V TL + APELL G
Sbjct: 165 MTPKVV------TLWYRAPELLLG 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 42/230 (18%)
Query: 799 NDDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D E + +G GTYG V+ K GS A+K + + E E I L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI--------L 68
Query: 857 LSSLHHPNVVSFYGIV--RDGPDG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ HPNVV FYG+ +D +G L V E GS+ ++ + +R + IIA
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 914 ---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGV 969
+A G+++LH +H D+K N+L+ K+ D G+S ++ L
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTS 184
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSY----DCYSLGI 1015
GT WMAPE+++ C QL +Y D +SLGI
Sbjct: 185 VGTPFWMAPEVIA-----------------CEQQLDSTYDARCDVWSLGI 217
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 38/208 (18%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADF 850
+ IK +D+ +G G +G V + + AIK +K FA + R DF
Sbjct: 2 EDIKFEDV-----IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHR-----DF 49
Query: 851 WKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------- 900
E +L L HHPN+++ G + G L E+ G+L FL+K
Sbjct: 50 AGELEVLCKLGHHPNIINLLGACEN--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107
Query: 901 ------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
T+ ++ L A D A GM+YL K +H DL N+LV + KI D
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG----ENLASKIADF 163
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLS 982
GLS+ ++ + R + WMA E L+
Sbjct: 164 GLSRGEEVYVKKTMGRLPVRWMAIESLN 191
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 31/206 (15%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+V+ G +VAIK+I K ++E +I E L++ L +PN
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELII----NEILVMKELKNPN 77
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+F G + L V E++ GSL + + +D + + + +E+LH
Sbjct: 78 IVNFLDSFLVGDE--LFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHA 133
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPWMAP 978
++H D+K +N+L+ M K+ D G + K+ T+V GT WMAP
Sbjct: 134 NQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 184
Query: 979 ELLSGKSHMVTEKVTLFSLKFCCFQL 1004
E+++ K++ KV ++SL ++
Sbjct: 185 EVVTRKAY--GPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-10
Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 30/188 (15%)
Query: 823 GSDVAIK--RIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG--PDG 878
G +VAIK R A E E A F +E L + L+HPN+V+ ++ G P G
Sbjct: 3 GHEVAIKLLRTDAP-------EEEHQRARFRRETALCARLYHPNIVA---LLDSGEAPPG 52
Query: 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936
L V E++ +L++ L + + ++ +DA + H + IVH DLK +N
Sbjct: 53 LLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDA---LACAHNQGIVHRDLKPQN 109
Query: 937 LLVNMRDPQRPVCKIGDLGLSKV--------KQQTLVSGGVRGTLPWMAPELLSGKSHMV 988
++V+ RP K+ D G+ + + V GT + APE L G+ V
Sbjct: 110 IMVSQTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--V 166
Query: 989 TEKVTLFS 996
T L++
Sbjct: 167 TPNSDLYA 174
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLIADF 850
+K +L +++ LGSG +G+V+ G W G VAIK I+ +G+ + +E I D
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQE--ITD- 58
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + SL H +V GI P SL VT+ GSL +++ ++D ++ L
Sbjct: 59 --HMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN 113
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL +VH +L N+L ++ + +I D G++ + +
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKYFYS 169
Query: 968 GVRGTLPWMAPE 979
+ + WMA E
Sbjct: 170 EHKTPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 808 LGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+G G +G V + + D AIKR+K +A K R DF E +L L HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHR-----DFAGELEVLCKLGHH 55
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRK 907
PN+++ G G L E+ +G+L FL+K T+ ++
Sbjct: 56 PNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
L A D A GM+YL K +H DL N+LV + V KI D GLS+ ++ +
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVKKT 169
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKVTLFSL 997
R + WMA E L+ + V + +
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGV 199
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 31/199 (15%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSS 859
LG GTYG V G VAIK++K + ++ +L+ +E +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ H N++ + +G + V + M LK+ + +K R + + + I+ + G+
Sbjct: 77 IKHENIMGLVDVYVEG--DFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQILNGL 132
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG-------- 971
LH +H DL N+ +N + +CKI D GL++ S +
Sbjct: 133 NVLHKWYFMHRDLSPANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 972 -------TLPWMAPELLSG 983
TL + APELL G
Sbjct: 189 EMTSKVVTLWYRAPELLMG 207
|
Length = 335 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 808 LGSGTYGSVYHGKWR---GSDVAIKRIKAS--CFAGKPSERERLIADFWKE-ALLLSSLH 861
LGSG +G VY + + + +A+K I F ER++ I D E ++ L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF---LQKKDRTIDRRKRLIIAMDAAFG 918
HPN+V +Y + L V + + L + L++K + + I +
Sbjct: 68 HPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 919 MEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH K IVH DL N+++ D I D GL+K KQ V GT+ +
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDK----VTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQL 1004
PE++ K+ EK +++ +Q+
Sbjct: 182 PEIV--KNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 16/186 (8%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGK-PSERERLIADFWKEALLLSSLHH 862
LG GT+ ++Y G R + + K R F++ A L+S L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 863 PNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
++V YG+ VRD V E++ G L FL ++ + +L +A A + Y
Sbjct: 61 KHLVKLYGVCVRDEN----IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQR---PVCKIGDLGLSKVKQQTLVSGGVR-GTLPWMA 977
L K +VH ++ +N+LV P K+ D G+ T++S R +PW+A
Sbjct: 117 LEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERIPWIA 172
Query: 978 PELLSG 983
PE +
Sbjct: 173 PECIRN 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 57/168 (33%), Positives = 75/168 (44%), Gaps = 27/168 (16%)
Query: 806 RELGSGTYGSVYHGKWRGSD----VAIKRIK-ASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG G +GSV G+ D VA+K +K A C SE E DF EA+ +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC---TRSEME----DFLSEAVCMKEF 57
Query: 861 HHPNVVSFYGIVRDGPDG----SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM--- 913
HPNV+ G+ + S + FM +G L FL R D + L M
Sbjct: 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDCPQYLPTQMLVK 116
Query: 914 ---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
D A GMEYL K+ +H DL N ++N VC + D GLSK
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVC-VADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 23/195 (11%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLI 847
++ +K +L++V+ LGSG +G+VY G W G + VAIK ++ + P + ++
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEIL 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
EA +++ + P V GI ++ VT+ M G L ++++ I +
Sbjct: 58 ----DEAYVMAGVGSPYVCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQD 110
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTL 964
L + A GM YL +VH DL N+LV + P KI D GL++ + +
Sbjct: 111 LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEY 166
Query: 965 VSGGVRGTLPWMAPE 979
+ G + + WMA E
Sbjct: 167 HADGGKVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
ELGSG +G+V G ++ VA+K +K P+ ++ L+ +EA ++ L +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELL----REANVMQQLDN 55
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V GI S V E G L +FLQK ++ + + + + GM+YL
Sbjct: 56 PYIVRMIGICEAE---SWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYL 111
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAP 978
N VH DL N+L+ + KI D GLSK + G P W AP
Sbjct: 112 EETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 979 ELLS 982
E ++
Sbjct: 168 ECMN 171
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ +GSGTYG VY + G AIK IK +P E ++ +E +++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQ---QEIIMM 60
Query: 858 SSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
H N+V+++G + RD L EF GSL+ + + ++ +
Sbjct: 61 KDCKHSNIVAYFGSYLRRD----KLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRET 115
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLP 974
G+ YLH K +H D+K N+L+ K+ D G+S T+ GT
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVSAQITATIAKRKSFIGTPY 171
Query: 975 WMAPEL 980
WMAPE+
Sbjct: 172 WMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 21/197 (10%)
Query: 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
K D E++ +LG G+Y +VY GK + G VA+K I+ G P R EA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-------EAS 55
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
LL L H N+V + I+ +L V E+ V+ L Q++ K + +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK---QQTLVSGGVRGT 972
G+ Y+H + I+H DLK +NLL++ K+ D GL++ K T + V T
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGLARAKSVPSHTYSNEVV--T 166
Query: 973 LPWMAPELLSGKSHMVT 989
L + P++L G + T
Sbjct: 167 LWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 57/191 (29%), Positives = 89/191 (46%), Gaps = 21/191 (10%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+ +LG G+Y +VY G R G VA+K I G P R EA LL L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-------EASLLKGLKH 62
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
N+V + I+ +L V E+M + L Q++ + + + G+ Y+
Sbjct: 63 ANIVLLHDIIHTKE--TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGTLPWMAPE 979
HG++I+H DLK +NLL++ K+ D GL++ K QT S V TL + P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE----LKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 980 LLSGKSHMVTE 990
+L G + +
Sbjct: 174 VLLGATDYSSA 184
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 55/162 (33%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDR---- 901
DF KE +LS L PN++ G+ D + L +TE+M NG L QFL D+
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 902 -----------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
I L +A+ A GM+YL N VH DL N LV + K
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG----ENLTIK 178
Query: 951 IGDLGLSKVKQQTLVSGGV-----RGTLP--WMAPE-LLSGK 984
I D G+S+ L +G R LP WMA E +L GK
Sbjct: 179 IADFGMSR----NLYAGDYYRIQGRAVLPIRWMAWECILMGK 216
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-10
Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 52/235 (22%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+R +G G G VY + VA+K+I+ SE L F +EA + + L H
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIH 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQ--------KKDRTIDRRKRLIIAM 913
P +V Y I DG T + G +LK L+ K+ K + A
Sbjct: 62 PGIVPVYSICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE---KTSVGAF 115
Query: 914 DAAF-----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ------ 962
+ F +EY+H K ++H DLK +N+L+ + I D G + K+
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEEDLL 171
Query: 963 -------------TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ G + GT +MAPE L G +E +++L +Q+
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
E + ELG G +G VY + + + V + A+ SE E + D+ E +L+S H
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGV----LAAAKVIDTKSEEE--LEDYMVEIDILASCDH 61
Query: 863 PNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
PN+V +FY + +L + EF G++ + + +R + + ++
Sbjct: 62 PNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRGTLPWMA 977
+ YLH I+H DLK N+L + K+ D G+S +T+ GT WMA
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171
Query: 978 PELL 981
PE++
Sbjct: 172 PEVV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY G VA+K+++ + AD KE LL L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-----ADCIKEIDLLKQLNHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDRTIDRRKRLIIAMDAAFGME 920
NV+ +Y + D L V E G L + + +K+ R I + + +E
Sbjct: 63 NVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPE 979
++H + ++H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E + +LG GT+G VY + G VA+K+I +E++ +E +L
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH------NEKDGFPITALREIKIL 61
Query: 858 SSLHHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
L HPNVV + + PD GS+ VT +M + L L+ + +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGG 968
+ G+ YLH +I+H D+K N+L++ + + KI D GL++ GG
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILID----NQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 969 VRG---------TLPWMAPELLSG 983
G T + PELL G
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLG 200
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 31/202 (15%)
Query: 804 EVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++G G G+VY G +VAIK++ + ++E +I E L++
Sbjct: 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELII----NEILVMRENK 74
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HPN+V++ G + L V E++ GSL + + +D + + + +E+
Sbjct: 75 HPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEF 130
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH ++H D+K +N+L+ M K+ D G + K+ T+V GT W
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYW 181
Query: 976 MAPELLSGKSHMVTEKVTLFSL 997
MAPE+++ K++ KV ++SL
Sbjct: 182 MAPEVVTRKAY--GPKVDIWSL 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 41/204 (20%)
Query: 806 RELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ LG G +G V + G D VA+K +K + ++ +AD E L
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMEL 70
Query: 857 LSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-----DRTIDRRKR-- 908
+ + H N+++ G+ +G L + E+ G+L++FL+ + D T D K
Sbjct: 71 MKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 909 --------LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+ A A GMEYL + +H DL N+LV + V KI D GL++ V
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARGV 184
Query: 960 KQQTLVSGGVRGTLP--WMAPELL 981
G LP WMAPE L
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V +G+GTYG VY G+ G AIK + + E E + + +L
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEI---NMLKKY 69
Query: 860 LHHPNVVSFYG-IVRDGP---DGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG ++ P D L V EF GS+ ++ K + I +
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G+ +LH ++H D+K +N+L+ + K+ D G+S +T+ G R
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTV---GRRNTFI 182
Query: 971 GTLPWMAPELLS 982
GT WMAPE+++
Sbjct: 183 GTPYWMAPEVIA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 29/191 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E + +G G YG V + + G VAIK+ K S + E + A +E +L L
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTA--LREVKVLRQL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDAAFG 918
H N+V+ R G L V E+ V +L + L+ + + I + A
Sbjct: 58 RHENIVNLKEAFRR--KGRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GT 972
Y H NI+H D+K EN+LV+ + V K+ D G ++ L + T
Sbjct: 115 --YCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFAR----ALRARPASPLTDYVAT 164
Query: 973 LPWMAPELLSG 983
+ APELL G
Sbjct: 165 RWYRAPELLVG 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 32/194 (16%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E V E+G G YG+VY + G VA+K ++ + + L +E LL L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV------QTNEDGLPLSTVREVALLKRL 56
Query: 861 H---HPNVVSFYGI---VRDGPDGSLATVTEFMVNGSLKQFLQKK-------DRTIDRRK 907
HPN+V + R + + V E V+ L+ +L K + D +
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
+ + G+++LH IVH DLK EN+LV K+ D GL+++ +
Sbjct: 116 QFLR------GLDFLHANCIVHRDLKPENILVT----SGGQVKLADFGLARIYSCQMALT 165
Query: 968 GVRGTLPWMAPELL 981
V TL + APE+L
Sbjct: 166 PVVVTLWYRAPEVL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 41/213 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G D VA+K +K+ E+ +
Sbjct: 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDL 67
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------- 899
+D E ++ + H N+++ G DG L + E+ G+L+++L+ +
Sbjct: 68 SDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + A A GMEYL K +H DL N+LV + V KI
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKI 181
Query: 952 GDLGLSK-VKQQTLVSGGVRGTLP--WMAPELL 981
D GL++ + G LP WMAPE L
Sbjct: 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864
+G GT+ V + R G AIK +K K E+ + +E L L HPN
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQ----VNNLREIQALRRLSPHPN 59
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
++ ++ D G LA V E M + +L + ++ + R + ++ ++++H
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
I H D+K EN+L+ + K+ D G
Sbjct: 119 NGIFHRDIKPENILIK-----DDILKLADFG 144
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 35/199 (17%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + +GSG YG V G VAIK+I F + L +E +
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTL-----RELKI 57
Query: 857 LSSLHHPNVVSFYGIVR-DGPDG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L H N+++ I+R G D + V + M L I + L
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHI-------IHSDQPLTEEHI 109
Query: 915 AAF------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK------VKQQ 962
F G++Y+H N++H DLK NLLVN + +IGD G+++ + +
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFGMARGLSSSPTEHK 165
Query: 963 TLVSGGVRGTLPWMAPELL 981
++ V T + APELL
Sbjct: 166 YFMTEYV-ATRWYRAPELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 26/192 (13%)
Query: 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V +G+GTYG VY G+ G AIK + + E E + + +L
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEI---NMLKKY 59
Query: 860 LHHPNVVSFYG-IVRDGP---DGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG ++ P D L V EF GS+ ++ K T+ I +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G+ +LH ++H D+K +N+L+ + K+ D G+S +T+ G R
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTV---GRRNTFI 172
Query: 971 GTLPWMAPELLS 982
GT WMAPE+++
Sbjct: 173 GTPYWMAPEVIA 184
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKA--SCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ LG G++G+VY K + + A +R+K G+ + E + A+ +EA LLS L HP
Sbjct: 6 QRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNETVQAN--QEAQLLSKLDHP 62
Query: 864 NVVSFYG--IVRDGPDGSLATVTEFMVNGSLK---QFLQKKDRTIDRRKRLIIAMDAAFG 918
+V F+ + RD + +TE+ L + L+ +T+ + + G
Sbjct: 63 AIVKFHASFLERD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMA 977
+ Y+H + I+H DLK +N+ + + + KIGD G+S++ + ++ GT +M+
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 978 PELLSGKSHMVTEKVTLFSL-----KFCCFQ 1003
PE L + + K ++SL + CC
Sbjct: 174 PEALKHQGY--DSKSDIWSLGCILYEMCCLA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 33/192 (17%)
Query: 801 DLEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELL----FNEVVIMR 71
Query: 859 SLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
HPN+V Y +V D L V EF+ G+L + ++ + + +
Sbjct: 72 DYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLAVL 125
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG----LSK--VKQQTLVSGGVR 970
+ +LH + ++H D+K +++L+ D + K+ D G +SK ++++LV
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLT-SDGR---VKLSDFGFCAQVSKEVPRRKSLV----- 176
Query: 971 GTLPWMAPELLS 982
GT WMAPE++S
Sbjct: 177 GTPYWMAPEVIS 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 40/201 (19%)
Query: 805 VRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ELG +G VY G G+ VAIK +K + RE +F EA++
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLRE----EFKHEAMMR 62
Query: 858 SSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK-----------DRTIDR 905
S L HPN+V G+V ++ P L+ + + + L +FL + D+T+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQP---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 906 RKR----LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--- 958
+ I A GME+L ++VH DL N+LV + KI DLGL +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNVKISDLGLFREVY 175
Query: 959 VKQQTLVSGGVRGTLPWMAPE 979
+ G + WM+PE
Sbjct: 176 AADYYKLMGNSLLPIRWMSPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 18/189 (9%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+ ++ G R G + + + S R F++ A ++S L H ++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-YSESFFEAASMMSQLSHKHL 61
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V YG+ G + + V E++ GSL +L+K I+ +L +A A+ + +L K
Sbjct: 62 VLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 926 NIVHFDLKCENLLVNMRDPQR-----PVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAP 978
+ H ++ +N+L+ +R+ R P K+ D G+S + ++ L+ +PW+ P
Sbjct: 120 GLTHGNVCAKNVLL-IREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----RIPWVPP 173
Query: 979 ELLSGKSHM 987
E + ++
Sbjct: 174 ECIENPQNL 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 19/193 (9%)
Query: 803 EEVRELGSGTYGSVYHG---KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL--L 857
E V E+G G YG V+ K G VA+KR++ + E ++ + A+L L
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHL 58
Query: 858 SSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAM 913
+ HPNVV + + R + L V E V+ L +L K + + +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+++LH +VH DLK +N+LV K+ D GL+++ + V TL
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----IKLADFGLARIYSFQMALTSVVVTL 173
Query: 974 PWMAPELLSGKSH 986
+ APE+L S+
Sbjct: 174 WYRAPEVLLQSSY 186
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 41/210 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K E+ ++D
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDL 67
Query: 851 WKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------- 899
E ++ + H N+++ G DG L + E+ G+L+++L+ +
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 900 -----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
D + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADF 181
Query: 955 GLSK-VKQQTLVSGGVRGTLP--WMAPELL 981
GL++ V G LP WMAPE L
Sbjct: 182 GLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G V + + G A K++ + E+ L E +L + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEYLH 923
VS Y + D L V M G LK + + + + A G+E+LH
Sbjct: 56 VSLAYAF--ETKD-DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELLS 982
+ IV+ DLK EN+L++ +I DLGL+ ++K + G GT +MAPE+L
Sbjct: 113 QRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPEVLQ 167
Query: 983 GK 984
G+
Sbjct: 168 GE 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 34/231 (14%)
Query: 804 EVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +G G++G V+ G VAIK I E E I D +E +LS
Sbjct: 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P V +YG G L + E++ GS L+ D + + + G++Y
Sbjct: 61 SPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH + +H D+K N+L++ ++ K+ D G+ +++K+ T V GT W
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQLKW----SYDCYSLGILFFFLQF 1022
MAPE++ ++ K ++SL +L + D + + +LF +
Sbjct: 168 MAPEVIQQSAY--DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN 216
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ ++G G++G V+ G + VAIK I E E I D +E +LS
Sbjct: 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P V +YG D L + E++ GS L+ +D + I + G++Y
Sbjct: 61 SPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPEL 980
LH + +H D+K N+L++ + K+ D G++ ++ + GT WMAPE+
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 981 LSGKSHMVTEKVTLFSLKFCCFQL 1004
+ K K ++SL +L
Sbjct: 173 I--KQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPS------ERERLIADFWKEALLLSS 859
+G GT+G VY + + + A+K + K ER L+ E+ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L SF D L VT++M G L LQK+ R + R + IA + +
Sbjct: 61 LK----FSFQ------TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLAL 109
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAP 978
E+LH +IV+ DLK EN+L++ +C D GLSK + GT ++AP
Sbjct: 110 EHLHKYDIVYRDLKPENILLDA-TGHIALC---DFGLSKANLTDNKTTNTFCGTTEYLAP 165
Query: 979 E-LLSGKSHMVTEKVTLFSLKFCCFQL--KWS 1007
E LL K + T+ V +SL F++ WS
Sbjct: 166 EVLLDEKGY--TKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 807 ELGSGTYGSVYHGKWRG----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++G GTYG VY K + D A+K+I+ + + +E LL L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----------REIALLRELKH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEF-------MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
PNV+S + D + + ++ ++ KK + R +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRG 971
G+ YLH ++H DLK N+LV P+R KI D+G +++ L V
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 972 TLPWMAPELLSGKSH 986
T + APELL G H
Sbjct: 178 TFWYRAPELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GT+G V+ + + + VA+K++ +E+E +E +L L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME------NEKEGFPITALREIKILQLL 68
Query: 861 HHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIA 912
H NVV+ I R GS V EF + L L K T+ K+++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVS 966
+ G+ Y+H I+H D+K N+L+ +D + K+ D GL SK + +
Sbjct: 128 LLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPNRYT 181
Query: 967 GGVRGTLPWMAPELLSGKSH 986
V TL + PELL G+
Sbjct: 182 NRVV-TLWYRPPELLLGERD 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 27/169 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + + +GSG YG V + VAIK++ +P + ++E LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS------RPFQSAIHAKRTYRELRLL 68
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+ H NV+ + P SL VT M L ++ + + D + L+
Sbjct: 69 KHMDHENVIGLLDVFT--PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVY 125
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSK 958
+ G++Y+H I+H DLK N+ VN D C KI D GL++
Sbjct: 126 QI--LRGLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 48/201 (23%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+VY G +VAI+++ + ++E +I E L++ +PN
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELII----NEILVMRENKNPN 78
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V++ G + L V E++ GSL + + +D + + + +E+LH
Sbjct: 79 IVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAPELLSG 983
++H D+K +N+L+ M K+ D G +++ + + GT WMAPE+++
Sbjct: 135 NQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 984 KSHMVTEKVTLFSLKFCCFQL 1004
K++ KV ++SL ++
Sbjct: 191 KAY--GPKVDIWSLGIMAIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +G G++G VY G + VAIK I E E I D +E +LS
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P + +YG G L + E++ GS L K ++ I + G++Y
Sbjct: 61 SPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH + +H D+K N+L++ ++ K+ D G+ +++K+ T V GT W
Sbjct: 117 LHSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
MAPE++ K K ++SL +L
Sbjct: 168 MAPEVI--KQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 17/180 (9%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY VA+K+++ + + D KE LL L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-----DCVKEIDLLKQLNHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ---FLQKKDRTIDRRKRLIIAMDAAFGME 920
NV+ + + D L V E G L Q + +K+ R I R + +E
Sbjct: 63 NVIKYLDSFIE--DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPE 979
++H + ++H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 27/204 (13%)
Query: 806 RELGSGTYGSVYHGK----WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
E+G+G +G V G+ + V +K ++AS P E+ F +E L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLL----FLQEVQPYRELN 53
Query: 862 HPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI----DRRKRLIIAMDAA 916
HPNV+ G + P V EF G LK +L+ + + +A + A
Sbjct: 54 HPNVLQCLGQCIESIP---YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD--LGLSKVKQQTLVSGGVRGT-L 973
G+ +LH + +H DL N + KIGD L L + + ++ L
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLALEQYPEDYYITKDCHAVPL 166
Query: 974 PWMAPELL-SGKSHMVTEKVTLFS 996
W+APEL+ ++ + T S
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKS 190
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+VY G +VAIK++ + ++E +I E L++ +PN
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELII----NEILVMRENKNPN 77
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V++ G + L V E++ GSL + + +D + + + +++LH
Sbjct: 78 IVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHS 133
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPWMAP 978
++H D+K +N+L+ M K+ D G + K+ T+V GT WMAP
Sbjct: 134 NQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 184
Query: 979 ELLSGKSHMVTEKVTLFSLKFCCFQL 1004
E+++ K++ KV ++SL ++
Sbjct: 185 EVVTRKAY--GPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 45/188 (23%), Positives = 92/188 (48%), Gaps = 16/188 (8%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+V+++G G++G K + G IK I S + K E R KE +LS++
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNM 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL-KQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN+V + + +G+L V ++ G L K+ ++ + L + +
Sbjct: 57 KHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMAP 978
+++H + I+H D+K +N+ + +D K+GD G+++V T+ ++ GT +++P
Sbjct: 115 KHVHDRKILHRDIKSQNIFL-TKD---GTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170
Query: 979 ELLSGKSH 986
E+ + +
Sbjct: 171 EICENRPY 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 11/154 (7%)
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
PS R+ +A F++ A L+S + H ++ +G+ G + + V EF+ +G L L+K+
Sbjct: 54 PSHRDIALA-FFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPLDVCLRKE 110
Query: 900 DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---DPQRPVCKIGDLGL 956
+ ++ +A A + YL KN+VH ++ +N+L+ + P K+ D G+
Sbjct: 111 KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170
Query: 957 SKVKQQTLVSGGVR-GTLPWMAPELLSGKSHMVT 989
S T +S R +PW+APE + G + + T
Sbjct: 171 S----FTALSREERVERIPWIAPECVPGGNSLST 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 804 EVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+++++GSG YG+V R G+ VAIK++ +P + E ++E LL +
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMK 72
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H NV+ + PD SL +F + L + ++ + + DR + L+ M
Sbjct: 73 HENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--L 128
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G++Y+H I+H DLK NL VN + KI D GL++ + G T +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQTDSEMT--GYVVTRWYR 182
Query: 977 APELLSGKSHMVTEKVTLFSL 997
APE++ H T+ V ++S+
Sbjct: 183 APEVILNWMHY-TQTVDIWSV 202
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 60/228 (26%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
++++ LG G G V+ + +G+ A+K + +R ++ E +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM----IKRNKVKRVLT-EQEIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
++L HP + + Y S T V ++ G L + LQ++ K L
Sbjct: 56 ATLDHPFLPTLYA--------SFQTETYLCLVMDYCPGGELFRLLQRQ-----PGKCLSE 102
Query: 912 AMDAAF-------GMEYLHGKNIVHFDLKCENLLV---------------NMRDPQRPVC 949
A F +EYLH IV+ DLK EN+L+ PV
Sbjct: 103 E-VARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 950 KIGDLGLSKVKQQTLV------SGGVR-----GTLPWMAPELLSGKSH 986
K G + ++ R GT ++APE++SG H
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 31/172 (18%)
Query: 808 LGSGTYG---SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G YG S H K G VAIK+I P E + +E +L H N
Sbjct: 13 IGEGAYGMVCSATH-KPTGVKVAIKKIS-------PFEHQTFCQRTLREIKILRRFKHEN 64
Query: 865 VVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
++ I+R P S + V E M L + ++ + + D + + + G
Sbjct: 65 IIGILDIIR--PP-SFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQI--LRG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGG 968
++Y+H N++H DLK NLL+N C KI D GL+++ G
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTN------CDLKICDFGLARIADPEHDHTG 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 25/195 (12%)
Query: 807 ELGSGTYGSVYHGKWR-GSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++G GTYG VY K + G D A+K+I+ + + +E LL L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----------REIALLRELKH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEF-------MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
PNV++ + D + + ++ ++ KK + R +
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRG 971
G+ YLH ++H DLK N+LV P+R KI D+G +++ L V
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 972 TLPWMAPELLSGKSH 986
T + APELL G H
Sbjct: 178 TFWYRAPELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 27/197 (13%)
Query: 806 RELGSGTYGSVYHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+ LG G +G V + G D K + + K ++ ++D E ++ + H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRK 907
N+++ G DG L + E+ G+L+++L+ + + + +
Sbjct: 78 KNIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVS 966
+ A A GMEYL + +H DL N+LV + V KI D GL++ V
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYK 191
Query: 967 GGVRGTLP--WMAPELL 981
G LP WMAPE L
Sbjct: 192 KTTNGRLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 56/184 (30%), Positives = 84/184 (45%), Gaps = 26/184 (14%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-RLIADFWKEALLLSSLHHPN 864
+G G+YG V K + G VAIK+ F ++ + IA +E +L L H N
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKK-----FLESEDDKMVKKIA--MREIRMLKQLRHEN 61
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + R L V EF+ + L L+K +D + G+E+ H
Sbjct: 62 LVNLIEVFRR--KKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG-----VRGTLPWMAPE 979
NI+H D+K EN+LV+ Q V K+ D G ++ TL + G T + APE
Sbjct: 119 HNIIHRDIKPENILVS----QSGVVKLCDFGFAR----TLAAPGEVYTDYVATRWYRAPE 170
Query: 980 LLSG 983
LL G
Sbjct: 171 LLVG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 802 LEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELL----FNEVVIMRD 75
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HH NVV Y G + L V EF+ G+L + ++ + + + +
Sbjct: 76 YHHENVVDMYNSYLVGDE--LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRAL 131
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
YLH + ++H D+K +++L+ K+ D G ++V ++ + GT WMAP
Sbjct: 132 SYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
Query: 979 ELLS 982
E++S
Sbjct: 188 EVIS 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
+DL+++ E+G G +G+V + S A+KRI+ S K E++RL+ D + ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEK--EQKRLLMDL--DVVMR 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ----KKDRTIDRRKRLIIAM 913
SS P +V FYG + +G E M + SL +F + I IA+
Sbjct: 59 SS-DCPYIVKFYGALFR--EGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAV 114
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ YL + I+H D+K N+L++ + K+ D G+S ++ G
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 973 LPWMAPE 979
P+MAPE
Sbjct: 171 RPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 21/194 (10%)
Query: 801 DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D++ LG G G+VY +A+K I E ++ I E +L
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIM---SELEILY 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
P ++ FYG + ++ TEFM GSL + + + + R IA+ G
Sbjct: 55 KCDSPYIIGFYGAFF--VENRISICTEFMDGGSLDVYRKIPEHVLGR-----IAVAVVKG 107
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+ YL I+H D+K N+LVN R K+ D G+S ++ V GT +MAP
Sbjct: 108 LTYLWSLKILHRDVKPSNMLVNTRGQ----VKLCDFGVSTQLVNSIAKTYV-GTNAYMAP 162
Query: 979 ELLSGKSHMVTEKV 992
E +SG+ + + V
Sbjct: 163 ERISGEQYGIHSDV 176
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 806 RELGSGTYGSVYHGK----WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+E+G+G +G V G+ + + V +K ++ S A + + F +EA SL
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMK-----FLEEAQPYRSLQ 53
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAF 917
H N++ G + L V EF G LK +L+ + T D +A + A
Sbjct: 54 HSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLP 974
G+ +LH N +H DL N L+ KIGD GLS K + + + L
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 975 WMAPELL 981
W+APEL+
Sbjct: 168 WIAPELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 48/226 (21%), Positives = 80/226 (35%), Gaps = 51/226 (22%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+ + K + VA+K+I E +L+ +E + L HPN+
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSKEDLKLL---QQEIITSRQLQHPNI 61
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM---DAAFGMEYL 922
+ + D L V+ M GS + L K + L IA D ++Y+
Sbjct: 62 LPYVTSFIV--DSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGT--------- 972
H K +H +K ++L+ V LS ++ +++ G R
Sbjct: 118 HSKGFIHRSVKASHILL---SGDGKVV------LSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 973 ---LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGI 1015
LPW++PE+L EK D YS+GI
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKS----------------DIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E +R LG+G YG V+ G G A+K +K + K + ER + +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+ L +LH+ +F D L + +++ G L L +++ + R+
Sbjct: 61 VRRCPFLVTLHY----AFQ------TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
IA + +++LH I++ D+K EN+L+ D + V + D GLSK + ++ +
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILL---DSEGHV-VLTDFGLSKEFLAEEEERAYS 165
Query: 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
GT+ +MAPE++ G S + V +SL F+L
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 40/191 (20%)
Query: 804 EVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+++ +G G +G V + G +VAIK+I KP L ++E LL L
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIM------KPFSTPVLAKRTYRELKLLKHLR 67
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFM--------VNGSL-KQFLQKKDRTIDRRKRLIIA 912
H N++S I P + VTE + + L KQF+Q I R
Sbjct: 68 HENIISLSDIFIS-PLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR------- 119
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVR 970
G++Y+H +VH DLK N+L+N C KI D GL+++ Q ++G V
Sbjct: 120 -----GLKYVHSAGVVHRDLKPSNILINEN------CDLKICDFGLARI-QDPQMTGYV- 166
Query: 971 GTLPWMAPELL 981
T + APE++
Sbjct: 167 STRYYRAPEIM 177
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G +G V + R G A K+++ + E L E +L ++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKQILEKVNSR 60
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
VVS + D +L V M G LK + D + + A + G+E L
Sbjct: 61 FVVSL-AYAYETKD-ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELL 981
H + IV+ DLK EN+L++ R I DLGL+ ++ + + G V GT+ +MAPE++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 22/185 (11%)
Query: 801 DLEEVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E ++ +GSGTYG VY + G A+K IK +P + LI +E ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-----EPGDDFSLIQ---QEIFMVK 61
Query: 859 SLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H N+V+++G + R+ L E+ GSL Q + + + + +
Sbjct: 62 ECKHCNIVAYFGSYLSRE----KLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETL 116
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPW 975
G+ YLH K +H D+K N+L+ K+ D G+ +K+ GT W
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172
Query: 976 MAPEL 980
MAPE+
Sbjct: 173 MAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKAS-CFAGKPSERERLIADFWKEALLLSSL 860
++R LG G+ G V+ D VA+K+I + + K + RE I + L
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKI---------IRRL 59
Query: 861 HHPNVVSFYGIVRDGPDGS-----LATVTEFMVNGSLKQFLQKKDRTIDRRKRL------ 909
H N+V Y ++ GP GS + ++TE ++++++ + + L
Sbjct: 60 DHDNIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ G++Y+H N++H DLK N+ +N D V KIGD GL+++
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 808 LGSGTYGSVYH-GKWRGSDV----AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++G V+ K G D A+K +K + + R ++ E +L+ ++H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM------ERDILAEVNH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V + + +G L + +F+ G L L K+ + + +A + A +++L
Sbjct: 58 PFIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHL 114
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
H I++ DLK EN+L++ + K+ D GLSK + GT+ +MAPE++
Sbjct: 115 HSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 982 SGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
+ + H S D +S G+L F
Sbjct: 171 NRRGH------------------TQSADWWSFGVLMF 189
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 815 SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD-FWKEALLLSSLHHPNVVSFYGIVR 873
S+Y G + +V I+ K K + +++ D E L + N++ YG +
Sbjct: 35 SIYKGIFNNKEVIIRTFK------KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88
Query: 874 DGPDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHF 930
D D L+ + E+ G L++ L K ++ + + +L +A+D G+ L+ N +
Sbjct: 89 DIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK 147
Query: 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+L + LV + KI GL K+
Sbjct: 148 NLTSVSFLVT----ENYKLKIICHGLEKI 172
|
Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIK-ASCFAGKPSERERLIADFWKEALLL 857
+R +G G++G + SD A+K I+ + R KEA+LL
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--------KEAVLL 52
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAA 916
+ + HPN+V+F DG L V E+ G L Q + ++ + L +
Sbjct: 53 AKMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
G++++H K ++H D+K +N+ + Q K+GD G +++
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSARL 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 54/189 (28%), Positives = 82/189 (43%), Gaps = 19/189 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
D++E + ELG G YGSVY R + V A+K I+ K ++ E +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ-------IIMELDIL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRKRLIIAMDA 915
P +V FYG +G++ E+M GSL + T I I
Sbjct: 54 HKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111
Query: 916 AFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++L + NI+H D+K N+LVN K+ D G+S +L + G
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ----VKLCDFGVSGNLVASLAKTNI-GCQS 166
Query: 975 WMAPELLSG 983
+MAPE +
Sbjct: 167 YMAPERIKS 175
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 21/186 (11%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPN 864
LG G +G V +++ + AIK +K + E E L+ + K +S HP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR-DEVESLMCE--KRIFETANSERHPF 63
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + + + + V E+ G L + + + A G++YLH
Sbjct: 64 LVNLFACFQT--EDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHE 119
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGVRGTLPWMAPEL 980
IV+ DLK +NLL+ D + V KI D GL K +T GT ++APE+
Sbjct: 120 NKIVYRDLKLDNLLL---DTEGFV-KIADFGLCKEGMGFGDRT---STFCGTPEFLAPEV 172
Query: 981 LSGKSH 986
L+ S+
Sbjct: 173 LTETSY 178
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 16/178 (8%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + GS A+K ++ K E+ ++A+ +LL +L HP +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + L V +++ G L LQ++ ++ R R A + A + YLH
Sbjct: 59 VGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRARFY-AAEVASAIGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELL 981
NI++ DLK EN+L+ D Q V + D GL K V+ + S GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHVV-LTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 22/185 (11%)
Query: 808 LGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
LG GT +Y G D K IK PS R+ +A F++ A ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLA-FFETASMMRQV 61
Query: 861 HHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H ++V YG+ VRD + V EF+ G L F+ +K + + +A A +
Sbjct: 62 SHKHIVLLYGVCVRDVEN---IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASAL 118
Query: 920 EYLHGKNIVHFDLKCENLLV---NMRDPQRPVCKIGDLG--LSKVKQQTLVSGGVRGTLP 974
YL K++VH ++ +N+L+ + P K+ D G ++ + +Q V +P
Sbjct: 119 SYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RIP 173
Query: 975 WMAPE 979
W+APE
Sbjct: 174 WIAPE 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA LL L HP V++ + G L + L +L + R + + +A
Sbjct: 210 EARLLRRLSHPAVLALLDV---RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG---LSKVKQQTLVSGGV 969
++Y+HG+ I+H D+K EN+LVN P+ +C +GD G ++ T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVN--GPED-IC-LGDFGAACFARGSWSTPFHYGI 322
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQ 1003
GT+ APE+L+G + T V ++S F+
Sbjct: 323 AGTVDTNAPEVLAGDPY--TPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 805 VRELGSGTYGSVYHGKWRGSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++ELG G YG V + + VAIK+I + F+ K + L +E LL
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRAL-----RELKLLRHF 58
Query: 861 H-HPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
H N+ Y IV G L E M L Q ++ D + I
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFI-YQILC 116
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVRG 971
G++Y+H N++H DLK NLLVN D + KI D GL+ + ++ V
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNA-DCE---LKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 972 TLPWMAPELL 981
T + APE++
Sbjct: 172 TRWYRAPEIM 181
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 50/216 (23%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E ++ LG+G YG V+ G G A+K +K + K + ER + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+++ L +LH+ +F D L + +++ G L L +++R ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQ------TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
+ +E+LH I++ D+K EN+L+ D V + D GLSK + + +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILL---DSNGHVV-LTDFGLSKEFHEDEVERAYS 165
Query: 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
GT+ +MAP+++ G + V +S+ ++L
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADF-WKEALL 856
+ E++ ++G G+YG V+ + R G VAIK+ S E + +I +E +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-------EDDPVIKKIALREIRM 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L L HPN+V+ + R L V E+ + L + L+K R + I
Sbjct: 54 LKQLKHPNLVNLIEVFRR--KRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTL 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------ 970
+ + H N +H D+K EN+L+ + K+ D G ++ +++G
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFAR-----ILTGPGDDYTDYV 161
Query: 971 GTLPWMAPELLSG 983
T + APELL G
Sbjct: 162 ATRWYRAPELLVG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 16/189 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ R LG G +G V + R G A KR++ + E L E +L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL-----NEKQILEK 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFG 918
++ VV+ + D +L V M G LK + + + L A + G
Sbjct: 57 VNSQFVVNL-AYAYETKD-ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+E LH +N V+ DLK EN+L++ R I DLGL+ K+ + + G V GT+ +MA
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIR----ISDLGLAVKIPEGESIRGRV-GTVGYMA 169
Query: 978 PELLSGKSH 986
PE+L+ + +
Sbjct: 170 PEVLNNQRY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-06
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 45/221 (20%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIA--DFWK 852
D+E R +G G +G V W G VA+K++ P+ + L++ ++
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKM--------PNVFQNLVSCKRVFR 48
Query: 853 EALLLSSLHHPNVVSFYGIVRD---GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
E +L H NV+S I++ P + VTE M + K + + + D K
Sbjct: 49 ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK-- 106
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-------- 961
+ G++YLH I+H D+K NLLVN V KI D GL++V++
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLARVEEPDESKHMT 162
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCF 1002
Q +V+ R APE+L G H T V ++S+ C F
Sbjct: 163 QEVVTQYYR------APEILMGSRHY-TSAVDIWSVG-CIF 195
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 52/191 (27%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 805 VRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++ LG G YG V+ G G A+K +K + ++ A E +L +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEA 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ HP +V + G G L + E++ G L L+++ ++ ++ + + +
Sbjct: 57 VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLAL 113
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
E+LH + I++ DLK EN+L+ D Q V K+ D GL K +++ G V GT+ +
Sbjct: 114 EHLHQQGIIYRDLKPENILL---DAQGHV-KLTDFGLCK---ESIHEGTVTHTFCGTIEY 166
Query: 976 MAPELLSGKSH 986
MAPE+L H
Sbjct: 167 MAPEILMRSGH 177
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-06
Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 49/297 (16%)
Query: 727 EGAEEVKAKVEESDDSVKPDTTTKE-APANEAELVNIHGEI----------EMDYDNDTV 775
E AE+V E D ++ APA E + + ++ D D +
Sbjct: 61 EAAEKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHL 120
Query: 776 KTLKIEPTIAEAEAIARGLQTIKNDD--LEEVRELGS---GTYGSVYHGKWRGS--DVAI 828
+ P A +A+ +K+DD L R + G +G ++ R S +
Sbjct: 121 DFDEAPPDAAGPVPLAQA--KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEA 178
Query: 829 KRIKASCFAGKPSERERLIADFWK-----------EALLLSSLHHPNVVSFYGIVRDGPD 877
+R S GKP + ERLIA K E L L L+H N++ I+R +
Sbjct: 179 RRGVNSTNQGKP-KCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEAN 237
Query: 878 GSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931
+ T + FM + + KDR + ++ R I+ +EY+H K ++H D
Sbjct: 238 TYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQTRAIMKQLLC-AVEYIHDKKLIHRD 292
Query: 932 LKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLPWMAPELLSGKSH 986
+K EN+ +N +GD G + K++ G GT+ +PE+L+G +
Sbjct: 293 IKLENIFLNCDG----KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345
|
Length = 501 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G +G V + R G A K+++ + E L E +L ++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKRILEKVNSR 60
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
VVS + D +L V M G LK + D ++ + A + G+E L
Sbjct: 61 FVVSL-AYAYETKD-ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELL 981
+ IV+ DLK EN+L++ R R I DLGL+ ++ + V G V GT+ +MAPE++
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVI 173
Query: 982 SGKSH 986
+ + +
Sbjct: 174 NNEKY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 27/197 (13%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E ++ LG+G YG V+ G G A+K ++ + K + ER + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+++ L +LH+ +F + L + +++ G + L ++D + R
Sbjct: 61 VRQSPFLVTLHY----AFQ------TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
+ +E+LH IV+ D+K EN+L+ D + V + D GLSK + ++ +
Sbjct: 111 SG-EIILALEHLHKLGIVYRDIKLENILL---DSEGHVV-LTDFGLSKEFLSEEKERTYS 165
Query: 969 VRGTLPWMAPELLSGKS 985
GT+ +MAPE++ GK
Sbjct: 166 FCGTIEYMAPEIIRGKG 182
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 802 LEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELL----FNEVVIMRD 73
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H NVV Y G + L V EF+ G+L + ++ + +A+ A +
Sbjct: 74 YQHENVVEMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
LH + ++H D+K +++L+ K+ D G ++V ++ + GT WMAP
Sbjct: 132 --LHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 979 ELLS 982
EL+S
Sbjct: 186 ELIS 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+GSG YGSV K G VAIK++ +P + E ++E LL + H NV
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 866 VSFYGIVRDGPDGSLATVTEF-MVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEY 921
+ + S +F +V ++ LQK + D+ + L+ M G++Y
Sbjct: 77 IGLLDVFTSAV--SGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC--GLKY 132
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+H I+H DLK NL VN D + KI D GL++
Sbjct: 133 IHSAGIIHRDLKPGNLAVN-EDCE---LKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 28/70 (40%), Positives = 43/70 (61%), Gaps = 5/70 (7%)
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWM 976
G+E+LH + I++ DLK EN+L++ R I DLGL+ ++K + G GT +M
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 977 APELLSGKSH 986
APELL G+ +
Sbjct: 165 APELLQGEEY 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + A+K ++ K E++ ++A+ +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAE---RNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + D L V +++ G L LQ++ + R R A + A + YLH
Sbjct: 59 VGLHYSFQT-AD-KLYFVLDYVNGGELFFHLQRERSFPEPRARFY-AAEIASALGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
NI++ DLK EN+L+ D Q V + D GL K + + + GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHV-VLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 56/186 (30%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G YG V K VAIK+I A+ F + + L +E LL L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-ANAFDNRIDAKRTL-----REIKLLRHLDHENV 66
Query: 866 VSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
++ I+ P A V E M + L Q ++ D + + G++
Sbjct: 67 IAIKDIMP--PPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLK 122
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKV---KQQTLVSGGVRGTLPW 975
Y+H N++H DLK NLL+N C KI D GL++ K + V T +
Sbjct: 123 YIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLARTTSEKGDFMTEYVV--TRWY 174
Query: 976 MAPELL 981
APELL
Sbjct: 175 RAPELL 180
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 59/220 (26%)
Query: 805 VRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFA--GKPSERERLIADFWKEALL 856
+++LG G YG V W+ D VA+K+I F ++ +R ++E +
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKI----FDAFRNATDAQRT----FREIMF 59
Query: 857 LSSL-HHPNVVSFYGIVRDGPDGSLATVTEFM---VNGSLKQFLQKKDRTIDRRKRLII- 911
L L HPN+V +++ D + V E+M ++ ++ + + D KR I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE-----DVHKRYIMY 114
Query: 912 ----AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
A ++Y+H N++H DLK N+L+N D + K+ D GL++ +L
Sbjct: 115 QLLKA------LKYIHSGNVIHRDLKPSNILLN-SDCR---VKLADFGLAR----SLSEL 160
Query: 968 GVRGTLPWM----------APELLSGKSHMVTEKVTLFSL 997
P + APE+L G S T+ V ++S+
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V + R + A+K I+ + + SE +A E +L+ ++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSR-SEVTHTLA----ERTVLAQVNCPFI 55
Query: 866 V----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
V SF L V F+ G L LQ++ R R R A + +E
Sbjct: 56 VPLKFSFQS------PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALEN 108
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPEL 980
LH N+++ DLK EN+L++ + +C D GL K+ + + GT ++APEL
Sbjct: 109 LHKFNVIYRDLKPENILLDYQG-HIALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPEL 164
Query: 981 LSGKSHMVTEKVTLFSL 997
L G H T+ V ++L
Sbjct: 165 LLG--HGYTKAVDWWTL 179
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 50/223 (22%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLH 861
LG G++G V+ + +G++ FA K +++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVFLAELKGTN--------QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HP + Y + + L V E++ G L +Q + D + A + G+++
Sbjct: 55 HPFLTHLYCTFQTKEN--LFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQF 111
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK------VKQQTLVSGGVRGTLPW 975
LH K IV+ DLK +N+L++ KI D G+ K K T GT +
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGH----IKIADFGMCKENMLGDAKTCTFC-----GTPDY 162
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
+APE+L G+ + S D +S G+L +
Sbjct: 163 IAPEILLGQKY------------------NTSVDWWSFGVLLY 187
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G++G V + + S A+K +K + + + ++ +L + +HP
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL----QDDDVECTMTEKRILSLARNHP 56
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+ Y + PD L V EF VNG F +K R D + A + + +LH
Sbjct: 57 FLTQLYCCFQT-PD-RLFFVMEF-VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
K I++ DLK +N+L++ + CK+ D G+ K + GT ++APE+L
Sbjct: 114 DKGIIYRDLKLDNVLLD-HEGH---CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 7/87 (8%)
Query: 896 LQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
L++ + +D L + A GM +L KN +H DL N+L+ + KI D G
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFG 259
Query: 956 LS---KVKQQTLVSGGVRGTLPWMAPE 979
L+ + +V G R + WMAPE
Sbjct: 260 LARDIRNDSNYVVKGNARLPVKWMAPE 286
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 36/195 (18%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIAD-------FWKEALL 856
+ LG G++G V + +G+D A+K +K ++ ++ D K L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLK----------KDVILQDDDVECTMTEKRVLA 50
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L+ HP + + + D L V E++ G L +Q+ R + R R A +
Sbjct: 51 LAG-KHPFLTQLHSCFQT-KD-RLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY-AAEIV 106
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----G 971
G+++LH + I++ DLK +N+L++ KI D G+ K + GGV G
Sbjct: 107 LGLQFLHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEG----ILGGVTTSTFCG 158
Query: 972 TLPWMAPELLSGKSH 986
T ++APE+LS + +
Sbjct: 159 TPDYIAPEILSYQPY 173
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 21/199 (10%)
Query: 802 LEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
LE ++G G+ G V K G VA+K + K RE L + E +++
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR----KQQRRELL----FNEVVIMRD 74
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H NVV Y G + L + EF+ G+L + + ++ + ++ A +
Sbjct: 75 YQHQNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA--L 130
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
YLH + ++H D+K +++L+ + K+ D G +++ + + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 979 ELLSGKSHMVTEKVTLFSL 997
E++S ++ TE V ++SL
Sbjct: 187 EVIS-RTPYGTE-VDIWSL 203
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 34/205 (16%)
Query: 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKAS--CFAGKPSERERLI-- 847
R LQ +K +D + V+ +G G +G +V + R K+S +A K + +I
Sbjct: 36 RKLQ-MKAEDYDVVKVIGRGAFG----------EVQLVRHKSSQKVYAMKLLSKFEMIKR 84
Query: 848 ---ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
A FW+E +++ + P VV + +D D L V E+M G L + D +
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSNYD--VP 140
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
+ + ++ +H ++H D+K +N+L++ + K+ D G +T
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADFGTCMKMDET- 195
Query: 965 VSGGVR-----GTLPWMAPELLSGK 984
G VR GT +++PE+L +
Sbjct: 196 --GMVRCDTAVGTPDYISPEVLKSQ 218
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 14/177 (7%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V + + + A+K ++ K E+ + + +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS----ERNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + L V +++ G L LQ++ ++ R R A + A + YLH
Sbjct: 59 VGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
NIV+ DLK EN+L+ D Q + + D GL K + + GT ++APE+L
Sbjct: 116 NIVYRDLKPENILL---DSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 16/178 (8%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + G A+K ++ + E++ ++A+ +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAE---RNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAAFGMEYLHG 924
V + + L V +F+ G L LQ++ + R R A + +A G YLH
Sbjct: 59 VGLHYSFQT--TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS 114
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
NIV+ DLK EN+L+ D Q V + D GL K Q+ + GT ++APE++
Sbjct: 115 INIVYRDLKPENILL---DSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 48/222 (21%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLH 861
LG G++G V + +G K FA K +++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVLLAELKG--------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+P + Y + L V EF+ G L +Q K R D + A + G+++
Sbjct: 55 NPFLTHLYCTFQT--KEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQF 111
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWM 976
LH K I++ DLK +N++++ RD KI D G+ K V G R GT ++
Sbjct: 112 LHSKGIIYRDLKLDNVMLD-RDGH---IKIADFGMCKEN----VFGDNRASTFCGTPDYI 163
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
APE+L G + +S D +S G+L +
Sbjct: 164 APEILQG------------------LKYTFSVDWWSFGVLLY 187
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 9e-05
Identities = 31/119 (26%), Positives = 54/119 (45%), Gaps = 9/119 (7%)
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+PN + Y V G + + +++ +G L L+K+ + + + II +
Sbjct: 67 DNPNFIKLYYSV-TTLKGHV-LIMDYIKDGDLFDLLKKEGKLSEAEVKKII-RQLVEALN 123
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE 979
LH NI+H D+K EN+L + + +C D GL K+ GTL + +PE
Sbjct: 124 DLHKHNIIHNDIKLENVLYDRAKDRIYLC---DYGLCKIIGTPSCY---DGTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-04
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 18/181 (9%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G YG V+ K + + VA+KR+K S R L E +L++
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVL-----TERDILTTTKSEW 62
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAAFGMEYLH 923
+V +D D L E++ G + L + R +A M A ++ LH
Sbjct: 63 LVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALH 118
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983
+H DLK EN L++ K+ D GLSK S V G+ +MAPE+L G
Sbjct: 119 ELGYIHRDLKPENFLID----ASGHIKLTDFGLSKGIVTYANS--VVGSPDYMAPEVLRG 172
Query: 984 K 984
K
Sbjct: 173 K 173
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 45/186 (24%), Positives = 86/186 (46%), Gaps = 32/186 (17%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIAD------FWKEALLLSS 859
LG G++G V + +G+D AIK +K ++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLK----------KDVILQDDDVDCTMTEKRILALA 52
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HP + + + + D L V E+ VNG F ++ R D + A + +
Sbjct: 53 AKHPFLTALHCCFQT-KD-RLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
+LH +++ DLK +N+L++ CK+ D G+ K + +++G GT +
Sbjct: 110 MFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162
Query: 976 MAPELL 981
+APE+L
Sbjct: 163 IAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 16/189 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ R LG G +G V + R G A K+++ + E L E +L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL-----NEKQILEK 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFG 918
++ VVS + D +L V M G LK + + + + A + G
Sbjct: 57 VNSRFVVSL-AYAYETKD-ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+E LH + IV+ DLK EN+L++ R I DLGL+ V + + G V GT+ +MA
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIR----ISDLGLAVHVPEGQTIKGRV-GTVGYMA 169
Query: 978 PELLSGKSH 986
PE++ + +
Sbjct: 170 PEVVKNERY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 14/161 (8%)
Query: 800 DDLEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD E ++ +G G +G V K G A+K+++ S + E+E++ A E +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS----EMLEKEQV-AHVRAERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ +P VV Y +D + L + E++ G + L KKD + R IA +
Sbjct: 56 AEADNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
++ +H +H D+K +NLL++ + K+ D GL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 68/289 (23%), Positives = 104/289 (35%), Gaps = 90/289 (31%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L + LG G +G V G D VA+K +K A SE + L+++
Sbjct: 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA---SEHKALMSE 60
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ--------FLQKKDR 901
+L+ +H NVV+ G P+G L + EF G+L F +++
Sbjct: 61 L---KILIHIGNHLNVVNLLGACTK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116
Query: 902 T---------------IDRRKR-------------------------------------- 908
+ +DRR
Sbjct: 117 SPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDL 176
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV- 965
+ + A GME+L + +H DL N+L++ + V KI D GL++ K V
Sbjct: 177 ICYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVR 232
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG 1014
G R L WMAPE + K + V F + L W + +SLG
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGV------LLW--EIFSLG 273
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 14/162 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ + +G YG+VY + + + A+K+I + ++ +++ E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILR-NQIQQVFV----ERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ +P VVS + L V E++ G L+ R+ A +
Sbjct: 56 TFAENPFVVSMFCSFET--KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVL 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+EYLH IVH DLK +NLL+ K+ D GLSK+
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGH----IKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
V E++ G L +Q R + R R A + G+++LH K I++ DLK +N+L++ +
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICGLQFLHKKGIIYRDLKLDNVLLD-K 131
Query: 943 DPQRPVCKIGDLGLSKVKQQTLVSGGVR---GTLPWMAPELLSGKSH 986
D KI D G+ K+ G GT ++APE+L G+ +
Sbjct: 132 DGH---IKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKY 173
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 25/182 (13%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K ++ K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-----VAHTVTESRVLQNTRHPFL 57
Query: 866 VSF-YGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+ Y D L V E+ G L L ++ + R R A + +EYLH
Sbjct: 58 TALKYAFQTHD----RLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPE 979
+++V+ D+K ENL+++ +D KI D GL K + + G GT ++APE
Sbjct: 113 SRDVVYRDIKLENLMLD-KDGH---IKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165
Query: 980 LL 981
+L
Sbjct: 166 VL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K +K K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE-----VAHTLTESRVLQNTRHPFL 57
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+ Y L V E+ NG F ++R + + + YLH
Sbjct: 58 TALKYSF---QTHDRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS 113
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPEL 980
++V+ DLK ENL+++ +D KI D GL K + + G GT ++APE+
Sbjct: 114 CDVVYRDLKLENLMLD-KDGH---IKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 981 L 981
L
Sbjct: 167 L 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 19/179 (10%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K +K K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE-----VAHTLTESRVLKNTRHPFL 57
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
S + L V E+ VNG F ++R + + ++YLH
Sbjct: 58 TSLKYSFQT--KDRLCFVMEY-VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGTLPWMAPELL 981
IV+ DLK ENL+++ +D KI D GL K T+ + GT ++APE+L
Sbjct: 115 KIVYRDLKLENLMLD-KDGH---IKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
V+ + G +G VY G K A+K +K + K + ++ A+ ++AL LS
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK-NMVHQVQAE--RDALALSK--S 63
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V Y ++ + L V E+++ G +K L + I+ + A ++YL
Sbjct: 64 PFIVHLYYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYL 120
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960
H I+H DLK +N+L++ K+ D GLSKV
Sbjct: 121 HRHGIIHRDLKPDNMLIS----NEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 40/223 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVA-----------IKRIKASCFAGKPSERERLIA 848
+D E ++ +G G +G V K + +D +KR + +CF ER+ L+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR---EERDVLVN 57
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRK 907
+ +++LH+ +D + +L V ++ V G L L K +DR +
Sbjct: 58 G---DNQWITTLHYA--------FQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG--LSKVKQQTLV 965
R +A + ++ +H + VH D+K +N+L++M R + D G L ++ T+
Sbjct: 105 RFYLA-EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQ 159
Query: 966 SGGVRGTLPWMAPELLS----GKSHMVTEKVTLFSLKFCCFQL 1004
S GT +++PE+L GK E +SL C +++
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPE-CDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 4e-04
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD E ++ +G G +G V+ + + + A+K ++ S + IA E +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-----IAHVRAERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAA 916
+ P +V Y +D + L V E+M G L L +KD + R IA + A
Sbjct: 56 ADADSPWIVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
++ +H +H D+K +N+L++ D K+ D GL K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILID-ADGH---IKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 4e-04
Identities = 51/228 (22%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++ E ++++G+G +G V+ K + + S K E+ +L+ E ++
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI----EVNVMRE 68
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAA 916
L H N+V + + + L + EF G L + +QK + I+ + I
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 917 FGMEYLH-------GKNIVHFDLKCENLLVNMRDPQ-------------RPVCKIGDLGL 956
+ Y H G+ ++H DLK +N+ ++ RP+ KIGD GL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
SK ++ GT + +PELL ++ +K +++L ++L
Sbjct: 189 SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
|
Length = 1021 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 25/188 (13%)
Query: 806 RELGSGTYGSVYHGK-WRGSDVA---IKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+E+G+G +G V + + + VA +K +KA+ E+ +F ++ L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQN----EFLQQGDPYRILQ 53
Query: 862 HPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLI--IAMDAAF 917
HPN++ G V P V E+ G LK +L Q++ + + L+ +A + A
Sbjct: 54 HPNILQCLGQCVEAIP---YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD--LGLSKVKQQTLVS-GGVRGTLP 974
G+ ++H N +H DL N + K+GD +G S+ K+ + + L
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 975 WMAPELLS 982
W+APEL+
Sbjct: 167 WLAPELVG 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 25/188 (13%)
Query: 802 LEEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ + +GSG YGSV Y + R VA+K++ +P + ++E LL
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLS------RPFQSLIHARRTYRELRLLK 69
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ H NV+ + P S+ E ++ L ++ + + + + LI +
Sbjct: 70 HMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G++Y+H I+H DLK N+ VN + +I D GL++ + G T
Sbjct: 128 --LRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRILDFGLARQADDEMT--GYVATR 179
Query: 974 PWMAPELL 981
+ APE++
Sbjct: 180 WYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 891 SLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
K +D +D L + A GM++L KN +H D+ N+L+ V
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVA 251
Query: 950 KIGDLGLSK---VKQQTLVSGGVRGTLPWMAPE 979
KI D GL++ +V G R + WMAPE
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 45/202 (22%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 803 EEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + +VAIK++ +P + + ++E +L+ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 73
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+H N++S + P SL + +++ +L Q +Q + +D + +
Sbjct: 74 NHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQM 128
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+++LH I+H DLK N++V KI D GL++ + + T +
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 976 MAPELLSGKSHMVTEKVTLFSL 997
APE++ G + E V ++S+
Sbjct: 185 RAPEVILGMGY--KENVDIWSV 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 26/67 (38%), Positives = 35/67 (52%), Gaps = 7/67 (10%)
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV-SGGVRGT 972
A GME+L + +H DL N+L++ + V KI D GL++ K V G R
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 973 LPWMAPE 979
L WMAPE
Sbjct: 239 LKWMAPE 245
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 16/183 (8%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G V K G A K++ K E+ L+ E +L ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
V+ Y L V M G LK +R ++ + + + G+ +LH
Sbjct: 56 VNLAYAF---ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983
+IV+ D+K EN+L++ + C++ DLGL+ + GT +MAPE+L
Sbjct: 113 SMDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168
Query: 984 KSH 986
+ +
Sbjct: 169 EPY 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 15/102 (14%)
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV-SGGVRGT 972
A GME+L + +H DL N+L++ + V KI D GL++ K V G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG 1014
L WMAPE + + + + V F + L W + +SLG
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGV------LLW--EIFSLG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 27/191 (14%)
Query: 800 DDLEEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + + +GSG YGSV + K G VA+K++ +P + ++E L
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLS------RPFQSIIHAKRTYRELRL 69
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + H NV+ + P SL VT M L ++ + T D + LI
Sbjct: 70 LKHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 126
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
+ G++Y+H +I+H DLK NL VN + KI D GL++ + G
Sbjct: 127 YQI--LRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMT--GYV 178
Query: 971 GTLPWMAPELL 981
T + APE++
Sbjct: 179 ATRWYRAPEIM 189
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 37/112 (33%), Positives = 53/112 (47%), Gaps = 17/112 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
D+L+ + LG+G +G V G VA+K +KAS ERE L++
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS---AHTDEREALMS---- 90
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI 903
E +LS L H N+V+ G G G + +TE+ G L FL+KK T
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHG--GPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 29/168 (17%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++EV +G G+YG V G VAIK+I F S+ R++ +E LL
Sbjct: 4 IQEV--IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFE-HVSDATRIL----REIKLLRL 55
Query: 860 LHHPNVVSFYGIV-----RDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAM 913
L HP++V I+ R+ D + V E M L Q ++ D T + + + +
Sbjct: 56 LRHPDIVEIKHIMLPPSRREFKD--IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQL 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKV 959
++Y+H N+ H DLK +N+L N C KI D GL++V
Sbjct: 113 --LRALKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 46/203 (22%), Positives = 87/203 (42%), Gaps = 50/203 (24%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+DLE + E+GSGT G VY +++ G +A+K+++ + G E +R++ D ++L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDL---DVVL 68
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------- 910
S P +V YG F+ + + ++ +D+ + I
Sbjct: 69 KSHDCPYIVKCYGY--------------FITDSDVFICMELMSTCLDKLLKRIQGPIPED 114
Query: 911 ----IAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKV 959
+ + + YL K ++H D+K N+L++ K+ D G+ SK
Sbjct: 115 ILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKLCDFGISGRLVDSKA 170
Query: 960 KQQTLVSGGVRGTLPWMAPELLS 982
K ++ G +MAPE +
Sbjct: 171 KTRS------AGCAAYMAPERID 187
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++++ +GSG G V G +VA+K++ +P + + ++E +LL +
Sbjct: 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKRAYRELVLLKCV 77
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+H N++S + P SL V E M + +L Q + + +D + +
Sbjct: 78 NHKNIISLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQ 131
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V KI D GL++ + T
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTACTNFMMTPYVVTRY 187
Query: 975 WMAPELLSGKSHMVTEKVTLFSL 997
+ APE++ G + E V ++S+
Sbjct: 188 YRAPEVILGMGY--KENVDIWSV 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.002
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 803 EEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + G +VAIK++ +P + ++E +L+ +
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS------RPFQNVTHAKRAYRELVLMKLV 72
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+H N++ + P SL V E M + +L Q +Q D +R L+ M
Sbjct: 73 NHKNIIGLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIQM-DLDHERMSYLLYQM- 127
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V KI D GL++ + + T
Sbjct: 128 -LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 975 WMAPELLSGKSHMVTEKVTLFSL 997
+ APE++ G + E V ++S+
Sbjct: 183 YRAPEVILGMGY--KENVDIWSV 203
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-----------VAIKRIKASCFAGKPSERERLIA 848
DD E ++ +G G +G V K + ++ +KR + +CF ER L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR---EERNVLVN 57
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRK 907
+ +++LH+ +D + L V ++ V G L L K +DR +
Sbjct: 58 G---DCQWITTLHYA--------FQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG--LSKVKQQTLV 965
R IA + + +H + VH D+K +N+L++M R + D G L + T+
Sbjct: 105 RFYIA-EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQ 159
Query: 966 SGGVRGTLPWMAPELL 981
S GT +++PE+L
Sbjct: 160 SSVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 40/220 (18%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAG-KPSERER--------LIADFWK---- 852
R LGSG G+V K R SD +K G +++ R L DF+
Sbjct: 38 RVLGSGATGTVLCAK-RVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 853 -EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKR 908
E +P V +A V ++ G L+Q ++ K +RT +
Sbjct: 97 HEDFAKKDPRNPENVLM-----------IALVLDYANAGDLRQEIKSRAKTNRTFREHEA 145
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
++ + + ++H K+++H D+K N+L+ + K+GD G SK+ T VS
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----SNGLVKLGDFGFSKMYAAT-VSDD 200
Query: 969 VR----GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
V GT ++APE+ K + ++K +FSL ++L
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPY--SKKADMFSLGVLLYEL 238
|
Length = 496 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 44/202 (21%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 803 EEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + +VAIK++ +P + + ++E +L+ +
Sbjct: 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 80
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+H N++ + P SL + +++ +L Q +Q + +D + +
Sbjct: 81 NHKNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQM 135
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+++LH I+H DLK N++V KI D GL++ + + T +
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 191
Query: 976 MAPELLSGKSHMVTEKVTLFSL 997
APE++ G + E V ++S+
Sbjct: 192 RAPEVILGMGY--KENVDIWSV 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 45/195 (23%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLI-----ADFW 851
+K +D E V+ +G G +G V + + +A K + +I A FW
Sbjct: 40 MKAEDYEVVKVIGRGAFGEV--------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E +++ + P VV + +D D L V E+M G L + D ++ R
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYT 148
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVR 970
A + ++ +H +H D+K +N+L++ + K+ D G K+ ++ +V
Sbjct: 149 A-EVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 971 -GTLPWMAPELLSGK 984
GT +++PE+L +
Sbjct: 204 VGTPDYISPEVLKSQ 218
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 32/162 (19%)
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+HP +V + + + L V E++ G L +Q++ + + R A + + +
Sbjct: 54 NHPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALN 110
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWM 976
YLH + I++ DLK +N+L++ K+ D G+ K + L G GT ++
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSEGH----IKLTDYGMCK---EGLRPGDTTSTFCGTPNYI 163
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
APE+L G+ + +S D ++LG+L F
Sbjct: 164 APEILRGEDY------------------GFSVDWWALGVLMF 187
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1033 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.83 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.58 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.58 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.58 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.4 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| smart00666 | 81 | PB1 PB1 domain. Phox and Bem1p domain, present in | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| PF00564 | 84 | PB1: PB1 domain; InterPro: IPR000270 The Phox and | 98.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.4 | |
| cd05992 | 81 | PB1 The PB1 domain is a modular domain mediating s | 98.34 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.33 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.32 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.16 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.16 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.05 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.04 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.95 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.94 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.91 | |
| cd06407 | 82 | PB1_NLP A PB1 domain is present in NIN like protei | 97.88 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.85 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.61 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.61 | |
| cd06408 | 86 | PB1_NoxR The PB1 domain is present in the Epichloe | 97.6 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.52 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.43 | |
| cd06405 | 79 | PB1_Mekk2_3 The PB1 domain is present in the two m | 97.39 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.35 | |
| cd06401 | 81 | PB1_TFG The PB1 domain found in TFG protein, an on | 97.08 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.97 | |
| cd06398 | 91 | PB1_Joka2 The PB1 domain is present in the Nicotia | 96.96 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.96 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.86 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.83 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.81 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.74 | |
| cd06404 | 83 | PB1_aPKC PB1 domain is an essential modular domain | 96.71 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.7 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.67 | |
| cd06396 | 81 | PB1_NBR1 The PB1 domain is an essential part of NB | 96.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.61 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.13 | |
| cd06397 | 82 | PB1_UP1 Uncharacterized protein 1. The PB1 domain | 96.04 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.96 | |
| PLN02236 | 344 | choline kinase | 95.66 | |
| cd06402 | 87 | PB1_p62 The PB1 domain is an essential part of p62 | 95.66 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.4 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.36 | |
| cd06406 | 80 | PB1_P67 A PB1 domain is present in p67 proteins wh | 94.72 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.3 | |
| cd06403 | 80 | PB1_Par6 The PB1 domain is an essential part of Pa | 94.09 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=373.31 Aligned_cols=206 Identities=29% Similarity=0.480 Sum_probs=182.7
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..+|+..++||.|+||+||+|++ ++..||||.+.+..+. .+..+.+..|+.+|+.++|||||++++++..
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~------~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-- 80 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN------KKLVELLLSEIKILKELKHPNIVRLLDCIED-- 80 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC------HHHHHHHHHHHHHHHhcCCcceeeEEEEEec--
Confidence 46799999999999999999988 4778999998876442 2334567889999999999999999999998
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCC--CeEEEEec
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR--PVCKIGDL 954 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~--g~VKLiDF 954 (1033)
.+.+|||||||.||+|.++|++++. +++.+++.++.||+.||++||+++||||||||+||||+.....+ ..+||+||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 6789999999999999999998864 99999999999999999999999999999999999998542233 78999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|+|+.........+.+|++.|||||++... +|+.|+|+||+|+|+|+|++|++||+.-+
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~------------------~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQ------------------QYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhc------------------cccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999999888888889999999999998654 57888899999999999999999998543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.28 Aligned_cols=205 Identities=27% Similarity=0.401 Sum_probs=180.7
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.+..++|++++.||+|+||+||.++. +++-+|+|++++.....+ ..++....|..||.+++||+||.++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 45568899999999999999999977 466799999988765543 33567889999999999999999999999
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+ .+.+|||+||+.||.|+..|++.+. +++..+..++.+|+.||.|||++|||||||||+||||| ..|+++|+|
T Consensus 96 t--~~kLylVld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----~~GHi~LtD 168 (357)
T KOG0598|consen 96 T--EEKLYLVLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----EQGHIKLTD 168 (357)
T ss_pred c--CCeEEEEEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----CCCcEEEec
Confidence 9 6889999999999999999988765 77887777778999999999999999999999999999 889999999
Q ss_pred cCCcccc-ccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 954 LGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~-~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
||||+.. .....+.+++||+.|||||++.+.+ |+..+|+|||||++|+||||.+||..-
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g------------------y~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG------------------YDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHhcCC------------------CCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 9999954 4445566789999999999998864 777889999999999999999999753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.61 Aligned_cols=211 Identities=27% Similarity=0.316 Sum_probs=182.4
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
.++.|.+.+.||+|+||.|-+|.. +++.||||++++......... ........+|+++|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~-~~~~~~v~~EieILkkL~HP~IV~~~d~f~~- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA-IAKTRDVQNEIEILKKLSHPNIVRIKDFFEV- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc-ccchhhhHHHHHHHHhcCCCCEEEEeeeeec-
Confidence 456789999999999999999976 588999999998776653321 1122346799999999999999999999998
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....||||||++||+|.+.+-.++. +.+...+.+++|++.||.|||+.||+||||||+|||+..+. .+..+||+|||
T Consensus 248 -~ds~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-e~~llKItDFG 324 (475)
T KOG0615|consen 248 -PDSSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-EDCLLKITDFG 324 (475)
T ss_pred -CCceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-cceEEEecccc
Confidence 5678999999999999999987654 88888899999999999999999999999999999998443 66899999999
Q ss_pred CccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 956 LAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
+|+.......+.++|||+.|.|||++..+...+ +..++|+||||||||-+|+|.+||.
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~---------------~~~kVDiWSlGcvLfvcLsG~pPFS 382 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEY---------------YPSKVDIWSLGCVLFVCLSGYPPFS 382 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeec---------------ccchheeeeccceEEEEeccCCCcc
Confidence 999998888889999999999999998765221 3358899999999999999999994
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=355.83 Aligned_cols=208 Identities=44% Similarity=0.702 Sum_probs=178.5
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEcCcc-eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~kG~k-VAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
+...++.+.+.||.|+||+||+|.|+|+. ||||++......... .+.|++|+.+|.+++|||||+++|+|.+.
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~------~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES------RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 33444555667999999999999999999 999999865433221 57899999999999999999999999984
Q ss_pred CCCceEEEEeeccCCcHHHHHHh-cCCccCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEEecCCCCCC-eEEEE
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRP-VCKIG 952 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~-~~k~Lse~~rl~Ia~QIa~GLeYLHskG-IVHRDIKPsNILLd~~d~~~g-~VKLi 952 (1033)
. ..+++|||||++|+|.++|.+ ....+++..++.|+.||++||+|||+.+ |||||||++||||+ .+. ++||+
T Consensus 112 ~-~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~----~~~~~~KI~ 186 (362)
T KOG0192|consen 112 P-GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD----LKGKTLKIA 186 (362)
T ss_pred C-CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc----CCCCEEEEC
Confidence 2 268999999999999999988 4677999999999999999999999999 99999999999999 665 99999
Q ss_pred ecCCccccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 953 DLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 953 DFGLAr~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|||+++..... .......||+.|||||++.+... .++.++||||||||||||+||+.||.-.+
T Consensus 187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~----------------~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKS----------------PYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred CCccceeeccccccccCCCCCccccChhhhcCCCC----------------cCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 99999877654 34445789999999999985310 47888999999999999999999997654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=359.75 Aligned_cols=202 Identities=27% Similarity=0.408 Sum_probs=180.1
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.+|+..+.||+|||+.||.+++ .|..||+|++.+..+... ...+...+|++|.+.|+|||||+++++|++ .
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-----~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-----KQREKVLNEIEIHRSLKHPNIVQFYHFFED--S 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-----chHHHHHHHHHHHHhcCCCcEEeeeeEeec--C
Confidence 6799999999999999999987 688999999987655432 233567789999999999999999999999 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+|||+|+|..++|..++++ .+.+++.+++++++||+.||.|||+++|||||||..||||+ .+..|||+|||||
T Consensus 91 ~nVYivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~----~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN----ENMNVKIGDFGLA 165 (592)
T ss_pred CceEEEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec----CcCcEEeccccee
Confidence 789999999999999999984 45699999999999999999999999999999999999999 7789999999999
Q ss_pred cccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 958 r~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
...+.. +...+.||||.|.|||++...+ .+..+||||+|||||.||+|++||+..+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~g------------------HsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSG------------------HSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCC------------------CCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 988754 6777899999999999998664 3445799999999999999999998653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=337.06 Aligned_cols=200 Identities=33% Similarity=0.460 Sum_probs=176.2
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
+...+++.++.||+|..|+|||++++ ++-+|+|++... ......+++.+|+++++.++||+||.+||.|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 44557788899999999999999985 677899998532 123345678899999999999999999999998
Q ss_pred CCCC-ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 875 GPDG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 875 ~~eg-~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
++ .+.|+||||++|+|.+++...+ .+++.....|+.++++||.|||. ++||||||||+||||+ ..|.||||
T Consensus 149 --~~~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN----skGeVKic 221 (364)
T KOG0581|consen 149 --NGEEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN----SKGEVKIC 221 (364)
T ss_pred --CCceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec----cCCCEEec
Confidence 45 5999999999999999998764 49999999999999999999995 8999999999999998 78999999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||.++...+. ...+++||..|||||.+.+.. |+.++||||||++++||.+|++||..
T Consensus 222 DFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~------------------Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 222 DFGVSGILVNS-IANTFVGTSAYMSPERISGES------------------YSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred cccccHHhhhh-hcccccccccccChhhhcCCc------------------CCcccceecccHHHHHHhhCCCCCCC
Confidence 99999988776 667889999999999998863 56678999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.25 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=180.0
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
...++|++++.||.|+||+|.+++.+ +.-+|+|++++.. -.+.+.++....|..+|+.+.||+++++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-----vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-----VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-----HHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 45578999999999999999999874 5668999988653 3456677889999999999999999999999999
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
.+.++|||||++||.|.++|++.++ +++..++.+|.||+.||+|||+++|++|||||+||||| .+|.+||+||
T Consensus 116 --~~~lymvmeyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----~~G~iKitDF 188 (355)
T KOG0616|consen 116 --NSNLYMVMEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----QNGHIKITDF 188 (355)
T ss_pred --CCeEEEEEeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----cCCcEEEEec
Confidence 7889999999999999999988765 89999999999999999999999999999999999999 8899999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|+|+..... +-+.|||+.|+|||++..++ ++.++|+|||||++|||+.|.+||-
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~sk~------------------ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQSKG------------------YNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhhcCC------------------CCcchhHHHHHHHHHHHHcCCCCCc
Confidence 999976554 44689999999999998875 6778899999999999999999994
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=347.58 Aligned_cols=205 Identities=27% Similarity=0.383 Sum_probs=179.6
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f 872 (1033)
.....||.+.+.||+|+|++|++|+. .++.+|||++.+..+ .+++.++...+|..+|.+| .||.|++||..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-----ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-----IKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-----HhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 34457899999999999999999977 577899999886543 3455667788899999999 799999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
++ +..+|+|+||+++|+|.++|.+.+. +++..+++++.+|+.||+|||++|||||||||+||||| .++++||+
T Consensus 144 QD--~~sLYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd----~dmhikIT 216 (604)
T KOG0592|consen 144 QD--EESLYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD----KDGHIKIT 216 (604)
T ss_pred ec--ccceEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc----CCCcEEEe
Confidence 99 6789999999999999999998865 99999999999999999999999999999999999999 88999999
Q ss_pred ecCCccccccccc--------------cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHH
Q 001678 953 DLGLSKVKQQTLV--------------SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018 (1033)
Q Consensus 953 DFGLAr~~~~~~~--------------s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLY 1018 (1033)
|||-|+.+..... ..+++||..|.+||++.... .+.++|+|+||||+|
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~------------------~~~~sDiWAlGCily 278 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP------------------AGPSSDLWALGCILY 278 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC------------------CCcccchHHHHHHHH
Confidence 9999986532211 14689999999999998763 677889999999999
Q ss_pred HHHccCCCCCCC
Q 001678 1019 FLQFILCFIDFF 1030 (1033)
Q Consensus 1019 eLLTGk~PFd~~ 1030 (1033)
+|+.|++||..-
T Consensus 279 QmlaG~PPFra~ 290 (604)
T KOG0592|consen 279 QMLAGQPPFRAA 290 (604)
T ss_pred HHhcCCCCCccc
Confidence 999999999753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=346.90 Aligned_cols=205 Identities=27% Similarity=0.391 Sum_probs=179.4
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
...+.|+.+++||+|+||.||+|++ +++.||+|+++..... +.......+||.||++|+||||++|.++..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~------~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK------EGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC------CcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 3456789999999999999999988 5777999999865422 2334466799999999999999999999998
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...+.+|||+||| .-+|.-++...+..|++.+++.+++||+.||+|||.+||+|||||.+||||| .+|.+||+||
T Consensus 188 ~~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----n~G~LKiaDF 262 (560)
T KOG0600|consen 188 KLSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----NNGVLKIADF 262 (560)
T ss_pred cCCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----CCCCEEeccc
Confidence 6568999999999 5599999998888899999999999999999999999999999999999999 8899999999
Q ss_pred CCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||+++.... .....+-|++|+|||.+.|.. .|++++|+||.||||.||++|++.|.-
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t-----------------~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGAT-----------------SYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCc-----------------ccccceeehhhhHHHHHHHcCCCCcCC
Confidence 9999765443 234555699999999999875 688899999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=341.59 Aligned_cols=214 Identities=24% Similarity=0.347 Sum_probs=181.3
Q ss_pred HHHHhccccccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCc
Q 001678 788 EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865 (1033)
Q Consensus 788 e~~~~~~~~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNI 865 (1033)
+.+......+..++|++++.||+|+||.||+|+. +|.-+|+|+++++.+. +...++..+.|-.+|...++++|
T Consensus 129 e~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-----~~~Qv~hV~aERdiL~~~ds~~v 203 (550)
T KOG0605|consen 129 EYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-----KKNQVEHVRAERDILAEVDSPWV 203 (550)
T ss_pred HHHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-----hhhhHHHHHHHHHHhhhcCCCcE
Confidence 3344444567889999999999999999999976 5777999999987654 34556788999999999999999
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCC
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~ 945 (1033)
|++|..|++ ..++||||||++||++..+|.+.+. +++..+..++.+++.||+-||+.|+|||||||+|+||| .
T Consensus 204 VKLyYsFQD--~~~LYLiMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD----~ 276 (550)
T KOG0605|consen 204 VKLYYSFQD--KEYLYLIMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID----A 276 (550)
T ss_pred EEEEEEecC--CCeeEEEEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec----C
Confidence 999999999 6789999999999999999988765 77777777778999999999999999999999999999 8
Q ss_pred CCeEEEEecCCcccccc----------------------cc-c-------------------------cCCcCCCCcccc
Q 001678 946 RPVCKIGDLGLSKVKQQ----------------------TL-V-------------------------SGGVRGTLPWMA 977 (1033)
Q Consensus 946 ~g~VKLiDFGLAr~~~~----------------------~~-~-------------------------s~~~~GT~~YmA 977 (1033)
.|++||+|||||.-+.. .. . ..+.+|||.|||
T Consensus 277 ~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiA 356 (550)
T KOG0605|consen 277 KGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIA 356 (550)
T ss_pred CCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccc
Confidence 89999999999852110 00 0 013459999999
Q ss_pred cccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 978 PELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 978 PEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
||++.+++ |+..+|+|||||||||||.|.+||..-+
T Consensus 357 PEVll~kg------------------Y~~~cDwWSLG~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 357 PEVLLGKG------------------YGKECDWWSLGCIMYEMLVGYPPFCSET 392 (550)
T ss_pred hHHHhcCC------------------CCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999885 6667899999999999999999997543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.54 Aligned_cols=202 Identities=24% Similarity=0.291 Sum_probs=176.3
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
+.|+.+.++|+|+||+||||+. +|+-||||++..+. +....-+..++|+++|++|+|+|+|.++++|.. .
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese------dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--k 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE------DDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--K 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC------ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--c
Confidence 4588899999999999999987 58889999987542 223344567899999999999999999999998 7
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..++||+|||+. ++.+.|.+....++...+..++.|+++|+.|+|+.++|||||||+||||+ .++.+||||||+|
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit----~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT----QNGVVKLCDFGFA 148 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe----cCCcEEeccchhh
Confidence 889999999955 66666777766789999999999999999999999999999999999999 8899999999999
Q ss_pred cccc-cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 958 r~~~-~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
+.+. .......++-|.||+|||.+.+.. +|+..+||||+||++.||+||.+.|+--|
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDt-----------------qYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDT-----------------QYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccC-----------------cCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 9876 455556677899999999998854 68999999999999999999999997655
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=331.32 Aligned_cols=208 Identities=27% Similarity=0.387 Sum_probs=177.8
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVR 873 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~ 873 (1033)
.....|++.+.||+|+||+|++|.. ++..||||++......... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 4567899999999999999999987 5788999977654222111 122345668999999999 999999999999
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCC-CeEEEE
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR-PVCKIG 952 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~-g~VKLi 952 (1033)
. ...+++||||+.+|+|.+++.+ ...+.+..+..+++||+.|++|||++||+||||||+|||++ .+ +.+||+
T Consensus 91 t--~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld----~~~~~~Kl~ 163 (370)
T KOG0583|consen 91 T--PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD----GNEGNLKLS 163 (370)
T ss_pred c--CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec----CCCCCEEEe
Confidence 8 5569999999999999999998 45588899999999999999999999999999999999999 55 899999
Q ss_pred ecCCcccc-ccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 953 DLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAr~~-~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
|||++... .........+||+.|+|||++.++.. + -+.++||||+|||||.|++|..||+--
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~-Y---------------~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGT-Y---------------SGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCC-c---------------CCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 99999988 45566778999999999999988751 1 145779999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=327.52 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=174.5
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..+|+++++||.|+||.|||+.+ ++..||.|.++-..+. .........|+.+|++|+|||||++|++-...+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md------~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD------AKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc------HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 35688899999999999999976 6888999988743222 233457789999999999999999999444333
Q ss_pred CCceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCcEEEecCCCCCCeE
Q 001678 877 DGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHG--KN--IVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHs--kG--IVHRDIKPsNILLd~~d~~~g~V 949 (1033)
...++||||||..|+|..+|+. ..+.+++.++++++.|++.||..||+ .. |+||||||.||+|+ .+|.|
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~----~~gvv 167 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT----ANGVV 167 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc----CCCce
Confidence 5559999999999999999974 45679999999999999999999999 45 99999999999999 78899
Q ss_pred EEEecCCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 950 KIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
||+||||++...... ...+.+|||.||+||++...+ |+.++||||+||++|||+...+||.
T Consensus 168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~------------------Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG------------------YNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC------------------CCcchhHHHHHHHHHHHHhcCCCcc
Confidence 999999999876554 456889999999999998875 6778899999999999999999996
Q ss_pred CC
Q 001678 1029 FF 1030 (1033)
Q Consensus 1029 ~~ 1030 (1033)
..
T Consensus 230 g~ 231 (375)
T KOG0591|consen 230 GD 231 (375)
T ss_pred cc
Confidence 54
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.90 Aligned_cols=200 Identities=22% Similarity=0.348 Sum_probs=169.4
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||+||+++. +++.||||+++..... .......+.+|+.++..++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDILVEADSLWVVKMFYSFQD--K 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 4799999999999999999987 4678999998754221 22334577889999999999999999999998 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~----~~~~vkL~DFGla 148 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLC 148 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCCEEEeeccCc
Confidence 78999999999999999997754 589999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc------------------------------------ccCCcCCCCcccccccccCCCccccchhhhcccchhh
Q 001678 958 KVKQQTL------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCC 1001 (1033)
Q Consensus 958 r~~~~~~------------------------------------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvil 1001 (1033)
+...... .....+||+.|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---------------- 212 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG---------------- 212 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC----------------
Confidence 7542210 012357999999999987653
Q ss_pred ccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 1002 FQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 1002 ye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++.++|||||||++|+|++|+.||..
T Consensus 213 --~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 213 --YNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred --CCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 56678999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=339.67 Aligned_cols=204 Identities=24% Similarity=0.386 Sum_probs=176.6
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~ 871 (1033)
..+..++|.++++||+|+||+|+++..+ ++.+|||++++..+..+.. ++....|.+|+.... ||.+++++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeecccc
Confidence 4566789999999999999999999885 5668999999887665433 345667777777775 9999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
|++ +.++|+||||+.||++..+. ....+++..+..++..|+.||.|||++|||+||||.+||||| ..|++||
T Consensus 438 fQT--~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----~eGh~ki 509 (694)
T KOG0694|consen 438 FQT--KEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----TEGHVKI 509 (694)
T ss_pred ccc--CCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----ccCcEEe
Confidence 999 78899999999999944332 334589999999999999999999999999999999999999 8899999
Q ss_pred EecCCccccc-cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 952 GDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 952 iDFGLAr~~~-~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+||||++... ....+.++|||+.|||||++.+. +|+.++|||||||+|||||.|..||..
T Consensus 510 ADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~------------------~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ------------------SYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred cccccccccCCCCCccccccCChhhcChhhhccC------------------cccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999754 55567889999999999999876 488889999999999999999999974
|
|
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=275.44 Aligned_cols=95 Identities=65% Similarity=1.140 Sum_probs=91.8
Q ss_pred EeecCCeeecCCCCCCeeeecCceeEEEccCCCChHHHHHHHHHHhCCc--eEEEeeCCCCCCCceeeecChhhHHHHHH
Q 001678 27 LCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGA--VVLKYQQPDEDLDALVSVVNDDDVINMME 104 (1033)
Q Consensus 27 mcsygG~i~pr~~d~~l~Y~gG~tri~~v~r~~~~~~l~~kl~~~~~~~--~~~kyqlp~edld~Lisv~~deDl~~m~~ 104 (1033)
||||||+|+||++||+|+|+||+|||++|+|++||+||++||+++++.+ ++||||||+||||+||||++||||+|||+
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp~edld~Lisv~~DeDl~~M~~ 80 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPDEDLDALISVSNDEDLKNMME 80 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcCCCCcceeEEecCcHHHHHHHH
Confidence 8999999999999999999999999999999999999999999999886 59999999999999999999999999999
Q ss_pred HHHHhcCCCCCCeEEEEEe
Q 001678 105 EYEKLGSGDGFTRLRIFLF 123 (1033)
Q Consensus 105 eydr~~~~~~~~r~r~flf 123 (1033)
||||+ +.+++|+|||||
T Consensus 81 e~~~~--~~~~~rirvflf 97 (97)
T cd06410 81 EYDRL--SGGSARLRVFLF 97 (97)
T ss_pred hhccc--cCCCceEEEEEC
Confidence 99998 567799999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=336.88 Aligned_cols=204 Identities=29% Similarity=0.380 Sum_probs=178.7
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEc
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d 874 (1033)
..++|.++++||.|+||.||+|+. ++..||||.++.....- ++ -.-+||+..|++|. ||||+++.+++.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-----ee--~~nLREvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-----EE--CMNLREVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-----HH--HHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence 346799999999999999999977 57889999998654331 11 13458999999999 9999999999998
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
... .+++||||| ..+|.++++.+++.+++..++.|+.||++||+|+|++|++||||||+|||+. ....|||+||
T Consensus 81 ~~~-~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~----~~~~iKiaDF 154 (538)
T KOG0661|consen 81 NDR-ILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS----GNDVIKIADF 154 (538)
T ss_pred cCc-eEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec----ccceeEeccc
Confidence 533 899999999 6799999999999999999999999999999999999999999999999998 5779999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|+|+......-...++-|.+|+|||++.... .|+.++||||+|||++|+.+.++.|+-.+
T Consensus 155 GLARev~SkpPYTeYVSTRWYRAPEvLLrs~-----------------~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 155 GLAREVRSKPPYTEYVSTRWYRAPEVLLRSG-----------------YYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ccccccccCCCcchhhhcccccchHHhhhcc-----------------ccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 9999887766666778899999999997654 47788899999999999999999997643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.76 Aligned_cols=205 Identities=28% Similarity=0.372 Sum_probs=178.8
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|+.+.+|++|+||.||+|+++ ++-||+|+++... +.+..--..++|+.+|.+++|||||.+-.+.....
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 356999999999999999999984 6679999998653 11222235678999999999999999999998877
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
-+.+||||||| ..+|..+|.+....+...+++.++.|+++||+|||...|+|||||++|+|+. ..|.+||+|||+
T Consensus 149 ~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~----~~G~lKiaDFGL 223 (419)
T KOG0663|consen 149 MDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS----HKGILKIADFGL 223 (419)
T ss_pred cceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec----cCCcEEecccch
Confidence 77899999999 5599999999888899999999999999999999999999999999999998 789999999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|+.+.... .....+-|.+|+|||.+.+.+ .|++++|+||+|||+.||+++++.|.-.|
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~~-----------------tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLGAK-----------------TYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcCCc-----------------ccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 99887653 344566799999999998865 68889999999999999999999997543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=315.15 Aligned_cols=201 Identities=23% Similarity=0.378 Sum_probs=169.8
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+|++ +++.||||++...... .......+.+|+.++..++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQD--E 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--C
Confidence 4799999999999999999988 4778999998754221 12334567889999999999999999999998 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+.+|+|.+++.+.+ .+++..+..|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~ 148 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLC 148 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEeecccc
Confidence 78999999999999999997654 489999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc---------------------------------------ccCCcCCCCcccccccccCCCccccchhhhcccc
Q 001678 958 KVKQQTL---------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLK 998 (1033)
Q Consensus 958 r~~~~~~---------------------------------------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLG 998 (1033)
+...... .....+||+.|+|||++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------- 214 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-------------- 214 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--------------
Confidence 7532110 01124699999999998654
Q ss_pred hhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 999 FCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 999 vilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.++.++||||||||+|+|++|..||...
T Consensus 215 ----~~~~~~DiwSlG~il~el~~G~~Pf~~~ 242 (364)
T cd05599 215 ----GYNKECDWWSLGVIMYEMLVGYPPFCSD 242 (364)
T ss_pred ----CCCCeeeeecchhHHHHhhcCCCCCCCC
Confidence 2567789999999999999999999653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=317.97 Aligned_cols=200 Identities=25% Similarity=0.332 Sum_probs=167.9
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|+++++||+|+||.||+++. .++.||||++..... ......+.+.+|+.+++.++||||++++++|.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--A 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 4799999999999999999987 477899999865321 123345678899999999999999999999998 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~----~~~~~kl~DfGla 148 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID----RGGHIKLSDFGLS 148 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEEeecccc
Confidence 78999999999999999997654 588999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc------------------------------------------------ccCCcCCCCcccccccccCCCcccc
Q 001678 958 KVKQQTL------------------------------------------------VSGGVRGTLPWMAPELLSGKSHMVT 989 (1033)
Q Consensus 958 r~~~~~~------------------------------------------------~s~~~~GT~~YmAPEvi~gk~~~~s 989 (1033)
+...... .....+||+.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 223 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ----- 223 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-----
Confidence 6321100 00124699999999998764
Q ss_pred chhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 990 EKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 990 ekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.++.++||||||||+|+|+||..||..
T Consensus 224 -------------~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 224 -------------GYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred -------------CCCCceeeEecchhhhhhhcCCCCCCC
Confidence 356778999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=318.06 Aligned_cols=200 Identities=21% Similarity=0.283 Sum_probs=168.1
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|++++.||+|+||+||+|++ +++.||||++...... .......+.+|+.+++.++|+||+++++++.+ ..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CC
Confidence 689999999999999999988 4677999998754321 22334678899999999999999999999998 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+.||+||||||+||||+ ..+++||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~----~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID----LDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC----CCCCEEEeeCcCCc
Confidence 8999999999999999997654 488889999999999999999999999999999999998 67899999999975
Q ss_pred ccccc------------------------------------------------cccCCcCCCCcccccccccCCCccccc
Q 001678 959 VKQQT------------------------------------------------LVSGGVRGTLPWMAPELLSGKSHMVTE 990 (1033)
Q Consensus 959 ~~~~~------------------------------------------------~~s~~~~GT~~YmAPEvi~gk~~~~se 990 (1033)
..... ......+||+.|+|||++.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----- 224 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG----- 224 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-----
Confidence 32100 0012356999999999987642
Q ss_pred hhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 991 KVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 991 kvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++.++||||||||+|+|+||+.||...
T Consensus 225 -------------~~~~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 225 -------------YTQLCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred -------------CCCccceeehhhHHHHHHhCCCCCcCC
Confidence 566789999999999999999999654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=324.28 Aligned_cols=198 Identities=34% Similarity=0.537 Sum_probs=170.0
Q ss_pred CCceEEEEecccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~kG-~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
++|.....||+|+||.||+|...+ +.||||++....... ..+|..|+.++.+++|||+|+|+|||.+ .+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e--~~ 144 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--------EREFLNEVEILSRLRHPNLVKLLGYCLE--GG 144 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--------hhHHHHHHHHHhcCCCcCcccEEEEEec--CC
Confidence 667777899999999999999965 789999776542110 2359999999999999999999999998 44
Q ss_pred -ceEEEEeeccCCcHHHHHHhcCC-ccCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 879 -SLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGK---NIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 879 -~l~LVmEYmegGSL~dlL~~~~k-~Lse~~rl~Ia~QIa~GLeYLHsk---GIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
..+||+|||.+|+|.+.|..... .++|..+++||.++++||+|||.. .|||||||++||||| .+...||+|
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD----~~~~aKlsD 220 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD----EDFNAKLSD 220 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC----CCCCEEccC
Confidence 58999999999999999987665 789999999999999999999985 499999999999999 789999999
Q ss_pred cCCcccccc-ccccCCc-CCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 954 LGLSKVKQQ-TLVSGGV-RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~-~~~s~~~-~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||+|+.... ....... .||.+|+|||++... .++.++|||||||||.||+||+.+.+.
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g------------------~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTG------------------KLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccC------------------CcCcccccccchHHHHHHHhCCcccCC
Confidence 999977654 3322222 799999999988653 477889999999999999999988875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.55 Aligned_cols=202 Identities=31% Similarity=0.412 Sum_probs=176.4
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.+|..+++||+|.||.||+|++ +++.||||+++.....+ ..-....+|++.|+.++|+||+.++++|.. .
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd------Gi~~talREIK~Lqel~h~nIi~LiD~F~~--~ 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD------GINRTALREIKLLQELKHPNIIELIDVFPH--K 73 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc------CccHHHHHHHHHHHHccCcchhhhhhhccC--C
Confidence 4688889999999999999988 58899999998764322 222367799999999999999999999998 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+.||+||| ..+|...|+.+...++...++.++.++++||+|||++.|+||||||.|+||+ .++.+||+|||+|
T Consensus 74 ~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis----~~g~lKiADFGLA 148 (318)
T KOG0659|consen 74 SNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS----SDGQLKIADFGLA 148 (318)
T ss_pred CceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc----CCCcEEeecccch
Confidence 7899999999 6699999999999999999999999999999999999999999999999999 7899999999999
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
+...... .....+-|.+|+|||.+.|.. +|+..+||||.|||+.||+-+.++|.--|
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr-----------------~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSR-----------------QYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccch-----------------hcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 9875433 222235699999999998765 68889999999999999999999997544
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=317.06 Aligned_cols=200 Identities=19% Similarity=0.271 Sum_probs=168.1
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|+++++||+|+||.||+|+. .++.||||++..... ........+.+|+.++++++|+||+++++.|.+ ..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CC
Confidence 589999999999999999987 467799999875321 123445678899999999999999999999998 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~----~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEeECCCCc
Confidence 8999999999999999997654 478899999999999999999999999999999999998 67899999999975
Q ss_pred cccc------------------------------------------------ccccCCcCCCCcccccccccCCCccccc
Q 001678 959 VKQQ------------------------------------------------TLVSGGVRGTLPWMAPELLSGKSHMVTE 990 (1033)
Q Consensus 959 ~~~~------------------------------------------------~~~s~~~~GT~~YmAPEvi~gk~~~~se 990 (1033)
.... .......+||+.|+|||++.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----- 224 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG----- 224 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-----
Confidence 3210 00112356999999999987653
Q ss_pred hhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 991 KVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 991 kvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++.++|||||||++|+|+||+.||...
T Consensus 225 -------------~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 225 -------------YTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred -------------CCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=317.44 Aligned_cols=201 Identities=19% Similarity=0.268 Sum_probs=168.0
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+++.. ++.||||++...... .......+.+|+.+++.++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-----MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--K 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 47999999999999999999874 678999998653221 12234567889999999999999999999988 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~ikL~DFG~a 148 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLC 148 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC----CCCCEEEEeCCCC
Confidence 78999999999999999997764 478888999999999999999999999999999999998 6789999999997
Q ss_pred cccccc--------------------------------------------cccCCcCCCCcccccccccCCCccccchhh
Q 001678 958 KVKQQT--------------------------------------------LVSGGVRGTLPWMAPELLSGKSHMVTEKVT 993 (1033)
Q Consensus 958 r~~~~~--------------------------------------------~~s~~~~GT~~YmAPEvi~gk~~~~sekvD 993 (1033)
...... ......+||+.|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------- 220 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-------- 220 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC--------
Confidence 522100 0112357999999999987643
Q ss_pred hcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 994 LFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 994 VwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++.++||||||||+|+|+||+.||...
T Consensus 221 ----------~~~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 221 ----------YTQLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred ----------CCcceeeeeccceeeehhhCCCCCCCC
Confidence 566789999999999999999999654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.38 Aligned_cols=200 Identities=26% Similarity=0.339 Sum_probs=169.1
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|+..+.||+|+||.||++.+ +++.||||++....... ......+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKRILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-----hhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CC
Confidence 378899999999999999987 47889999887543221 1222457789999999999999999999987 56
Q ss_pred ceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.+++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~----~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 799999999999999888653 34589999999999999999999999999999999999998 6778999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.............||..|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~------------------~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNE------------------KYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCC------------------CCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 875444333456789999999998764 356678999999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=333.16 Aligned_cols=200 Identities=30% Similarity=0.439 Sum_probs=174.6
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|.+.+.||+|+||.||||+.+ .+-||||.+.+... .++.++.+.+|++|+++|+||||+.++++|++ .
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr------~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~ 73 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR------NEKELKNLRQEVRILRSLKHPNIVEMLESFET--S 73 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC------chHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--c
Confidence 46888899999999999999764 56689998876532 23446788899999999999999999999998 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++|+||+.| +|+.+|...++ ++++.+..|+.+++.||.|||+.+|+|||+||.||||+ ..+++||||||+|
T Consensus 74 ~~~~vVte~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~----~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 74 AHLWVVTEYAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE----KGGTLKLCDFGLA 147 (808)
T ss_pred ceEEEEehhhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec----CCCceeechhhhh
Confidence 789999999966 99999987765 89999999999999999999999999999999999998 7899999999999
Q ss_pred ccccc-ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 958 KVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 958 r~~~~-~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
+.... ........||+.|||||++.+.+ |+..+|+||||||+|||++|++||-.-|
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~p------------------yd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQP------------------YDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCC------------------ccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 96543 33556778999999999998764 5556799999999999999999996544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=321.43 Aligned_cols=204 Identities=27% Similarity=0.439 Sum_probs=184.4
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..+|++.+.||+|+||+|-+|.. .|..||||.++++.+.+ +.-+-.+.+|++||+.|+||||+++|.+|..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-----eqDlvhIRREIeIMSsLNHPhII~IyEVFEN-- 124 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-----EQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-- 124 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-----HHHHHHHHHHHHHHhhcCCCceeehhhhhcC--
Confidence 45799999999999999999976 58899999999876543 2233478899999999999999999999998
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...+.|||||..+|.|.+++.+++. +++..+..|++||+.|+.|+|+++|+|||||.+||||| .++.+||+||||
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD----~N~NiKIADFGL 199 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD----QNNNIKIADFGL 199 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec----CCCCeeeeccch
Confidence 6789999999999999999998865 89999999999999999999999999999999999999 888999999999
Q ss_pred ccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 957 Ar~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
+..+.......++||++-|.+||+++|.++. +..+|.|||||+||.|..|..|||-++
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~-----------------GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYK-----------------GPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCC-----------------CCccchhhHHHHHHHHhhcccccCCch
Confidence 9999888888899999999999999998743 446799999999999999999999764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.56 Aligned_cols=199 Identities=26% Similarity=0.379 Sum_probs=171.1
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+|++. ++.||||+++..... .......+.+|+.++..++||||+++++++.+ .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--D 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--C
Confidence 47999999999999999999884 678999998754321 12234578889999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+++++|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kL~Dfg~a 148 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLS 148 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEEEeCcCC
Confidence 78999999999999999997654 488999999999999999999999999999999999998 6789999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+.... ......||+.|+|||++.+. .++.++||||||||+|+|++|..||...
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRGK------------------GYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcCC------------------CCCCccceecchHHHhhhhhCCCCCCCC
Confidence 86543 23356789999999998765 2566789999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=304.35 Aligned_cols=199 Identities=27% Similarity=0.383 Sum_probs=169.7
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||+|+++ ++.||||++..... ...+..+.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-----IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--Q 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-----hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--C
Confidence 47899999999999999999885 77899999875321 112234568899999999999999999999887 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+.+++|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~----~~~~~kl~Dfg~~ 148 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD----KEGHIKLTDFGFA 148 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEEecCcc
Confidence 78999999999999999997654 488999999999999999999999999999999999998 6788999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+..... .....||+.|+|||++.+.. ++.++|||||||++|+|+||+.||...
T Consensus 149 ~~~~~~--~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 149 KKLRDR--TWTLCGTPEYLAPEVIQSKG------------------HNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred hhccCC--cccccCChhhcCHHHHcCCC------------------CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 865432 22356899999999987642 456789999999999999999999653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.58 Aligned_cols=201 Identities=27% Similarity=0.381 Sum_probs=172.1
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
...++|++.+.||+|+||.||+|+++ ++.||||+++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 34578999999999999999999884 677999998754221 22334578899999999999999999999988
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
.+.+++||||+.+++|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus 90 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~Df 162 (329)
T PTZ00263 90 --ENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD----NKGHVKVTDF 162 (329)
T ss_pred --CCEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC----CCCCEEEeec
Confidence 678999999999999999998754 478889999999999999999999999999999999998 6789999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+++...... ....||+.|+|||++.+.. ++.++|||||||++|+|+||..||..
T Consensus 163 g~~~~~~~~~--~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 163 GFAKKVPDRT--FTLCGTPEYLAPEVIQSKG------------------HGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred cCceEcCCCc--ceecCChhhcCHHHHcCCC------------------CCCcceeechHHHHHHHHcCCCCCCC
Confidence 9998664332 2356899999999987653 45678999999999999999999954
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.68 Aligned_cols=207 Identities=27% Similarity=0.397 Sum_probs=167.5
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcc
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIV 866 (1033)
+++..++|++.++||+|+||.||+|.+. +..||||+++... .......+.+|+.++..+ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-------TASEHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-------chHHHHHHHHHHHHHHHhccCccee
Confidence 3456778999999999999999999742 3569999886431 112235688999999999 899999
Q ss_pred eEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC----------------------------------------------
Q 001678 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------------------------------- 900 (1033)
Q Consensus 867 rLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------------------------------------- 900 (1033)
+++++|... .+.+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 75 NLLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eEEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 999998763 456899999999999999997532
Q ss_pred ---------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc-
Q 001678 901 ---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL- 964 (1033)
Q Consensus 901 ---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~- 964 (1033)
..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++......
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~----~~~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPD 229 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc----CCCcEEEeecccccccccCcc
Confidence 2367788899999999999999999999999999999998 66789999999998643221
Q ss_pred --ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCCC
Q 001678 965 --VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFFS 1031 (1033)
Q Consensus 965 --~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~s 1031 (1033)
......++..|+|||++.+. .++.++|||||||++|+|++ |..||....
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDK------------------VYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred hhcccCCCCCccccCcHHhhcC------------------CCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12233467889999998654 35678899999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.25 Aligned_cols=200 Identities=28% Similarity=0.419 Sum_probs=167.2
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|+++++||+|+||.||+|+. +++.||||+++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-------TPFTAIREASLLKGLKHANIVLLHDIIHT-- 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-------cchhHHHHHHHHhhCCCCCcCeEEEEEec--
Confidence 46899999999999999999988 47789999987542111 11246689999999999999999999988
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
....++||||+ .++|.+++.+....+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 149 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGL 149 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECCCCc
Confidence 56799999999 5788888877666689999999999999999999999999999999999998 678899999999
Q ss_pred ccccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++..... .......||+.|+|||++.+.. .++.++|||||||++|+|+||+.||..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGST-----------------EYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCCC-----------------CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 8754322 1223456899999999986542 356677999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=321.48 Aligned_cols=213 Identities=29% Similarity=0.412 Sum_probs=173.4
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCC------CchhHHHHHHHHHHHHHHHHhcCCCCcce
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAG------KPSERERLIADFWKEALLLSSLHHPNVVS 867 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~------k~~ere~~i~~f~rEi~ILskL~HPNIVr 867 (1033)
....+.|++++.||+|.||.|-+|+. .++-||||++.+..... .......-++...+|+.+|++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34457899999999999999999988 47779999987554321 11112223467889999999999999999
Q ss_pred EEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCc-cCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCC
Q 001678 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1033)
Q Consensus 868 LyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~-Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~ 946 (1033)
|+++..+.....+|||+|||..|.+...= ..+. +++.++++++++++.||+|||.+|||||||||+|+||+ .+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~----~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS----SD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc----CC
Confidence 99999998889999999999988776532 2233 89999999999999999999999999999999999999 77
Q ss_pred CeEEEEecCCccccccc------cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHH
Q 001678 947 PVCKIGDLGLSKVKQQT------LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020 (1033)
Q Consensus 947 g~VKLiDFGLAr~~~~~------~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeL 1020 (1033)
++|||+|||.+...... .......||+.|||||.+.+... .+..+.+.||||+||+||+|
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~--------------~~~~g~a~DiWalGVTLYCl 312 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS--------------FSYSGFALDIWALGVTLYCL 312 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC--------------ccccchhhhhhhhhhhHHHh
Confidence 99999999998765222 12233679999999998876421 11346677999999999999
Q ss_pred HccCCCCC
Q 001678 1021 QFILCFID 1028 (1033)
Q Consensus 1021 LTGk~PFd 1028 (1033)
++|++||-
T Consensus 313 lfG~~PF~ 320 (576)
T KOG0585|consen 313 LFGQLPFF 320 (576)
T ss_pred hhccCCcc
Confidence 99999995
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=310.18 Aligned_cols=203 Identities=29% Similarity=0.458 Sum_probs=172.2
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEcC---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~kG---~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
.+..++|++.+.||+|+||.||+|++++ ..||+|++...... .....+.+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 4556789999999999999999998642 46999988754321 123345688999999999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
.+ .+.+++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 101 ~~--~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~ikL~ 173 (340)
T PTZ00426 101 KD--ESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMT 173 (340)
T ss_pred Ee--CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEe
Confidence 88 578999999999999999997654 489999999999999999999999999999999999998 67899999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
|||+++..... .....||+.|+|||++.+.. ++.++|+||||||+|+|+||..||...
T Consensus 174 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 174 DFGFAKVVDTR--TYTLCGTPEYIAPEILLNVG------------------HGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred cCCCCeecCCC--cceecCChhhcCHHHHhCCC------------------CCccccccchhhHHHHHhcCCCCCCCC
Confidence 99999865432 23457899999999987642 456789999999999999999999643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.92 Aligned_cols=194 Identities=24% Similarity=0.325 Sum_probs=164.1
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
+.||+|+||.||+++. .++.||||+++..... .......+.+|+.+++.++||||+++++++.. .+.+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEE
Confidence 3699999999999987 4778999998754321 12334567889999999999999999999988 6789999
Q ss_pred EeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-c
Q 001678 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~-~ 962 (1033)
|||+.+++|.+++.+.. .+++..+..++.||+.||+|||+.||+||||||+|||++ .++.+||+|||+++... .
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEeeCCCCcccccC
Confidence 99999999999997654 589999999999999999999999999999999999998 67889999999987532 2
Q ss_pred ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 963 ~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.......+||+.|+|||++.+. .++.++|||||||++|+|+||+.||..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDN------------------DYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred CCcccceecCccccChhhhcCC------------------CCCccccCcccchhhhhhhcCCCCCCC
Confidence 2233456799999999998764 356778999999999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.10 Aligned_cols=201 Identities=22% Similarity=0.352 Sum_probs=169.2
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+++. .++.||||+++..... .......+.+|+.++..++|+||+++++.+.+ .
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQD--K 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 4789999999999999999987 4678999998753221 12334577889999999999999999999988 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||||+ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~----~~~~vkL~DfG~~ 148 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSDFGLC 148 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEeeccCC
Confidence 78999999999999999997654 488999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc------------------------------------ccCCcCCCCcccccccccCCCccccchhhhcccchhh
Q 001678 958 KVKQQTL------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCC 1001 (1033)
Q Consensus 958 r~~~~~~------------------------------------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvil 1001 (1033)
+...... .....+||+.|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---------------- 212 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG---------------- 212 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC----------------
Confidence 7432110 012356999999999987653
Q ss_pred ccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 1002 FQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 1002 ye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++.++|||||||++|+|+||+.||...
T Consensus 213 --~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 213 --YNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred --CCCcceeccccceeeecccCCCCCCCC
Confidence 566789999999999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.38 Aligned_cols=201 Identities=24% Similarity=0.404 Sum_probs=172.2
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+|++. ++.||||+++...... ......+.+|+.++..++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-----RNQIAHVRAERDILADADSPWIVKLYYSFQD--E 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-----ccHHHHHHHHHHHHHhcCCCCccchhhheec--C
Confidence 47999999999999999999985 7889999987543221 1234568889999999999999999999987 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~----~~~~~kL~Dfg~~ 148 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLADFGLC 148 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEeecCCCC
Confidence 7899999999999999999876 4589999999999999999999999999999999999998 6789999999999
Q ss_pred ccccccc------------------------------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcc
Q 001678 958 KVKQQTL------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWS 1007 (1033)
Q Consensus 958 r~~~~~~------------------------------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~k 1007 (1033)
....... ......||+.|+|||++.+. .++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~ 210 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT------------------PYGLE 210 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC------------------CCCCc
Confidence 7654332 22345689999999998765 35677
Q ss_pred cchHHHHHHHHHHHccCCCCCCC
Q 001678 1008 YDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 1008 vDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+||||||||+|+|++|+.||...
T Consensus 211 ~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 211 CDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred eeeEecchhhhhhccCCCCCCCC
Confidence 89999999999999999999654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=304.31 Aligned_cols=201 Identities=24% Similarity=0.378 Sum_probs=167.9
Q ss_pred CceEEEEecccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEc
Q 001678 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~-----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d 874 (1033)
+|++++.||+|+||.||+++. +++.||+|++...... ......+.+.+|+.+++.++ |+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh----hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 589999999999999999876 4677999998754322 12233456788999999994 9999999999987
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
.+.+++||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Df 149 (332)
T cd05614 77 --EAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD----SEGHVVLTDF 149 (332)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC----CCCCEEEeeC
Confidence 678999999999999999997654 488999999999999999999999999999999999998 6679999999
Q ss_pred CCccccccc--cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~--~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+++..... .......||+.|+|||++.+.. .++.++||||||||+|+|+||+.||..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------------~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-----------------GHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCC-----------------CCCCccccccchhhhhhhhcCCCCCCC
Confidence 999754322 1223467999999999987542 245678999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.61 Aligned_cols=201 Identities=26% Similarity=0.403 Sum_probs=167.8
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|+++++||+|+||.||+|.. ++..||+|+++...... ....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKNLKHANIVTLHDIIHT-- 74 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-------cchhHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 46799999999999999999987 46789999987542111 11356689999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
....++||||+. ++|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~DfG~ 149 (288)
T cd07871 75 ERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFGL 149 (288)
T ss_pred CCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 567999999996 599999987766689999999999999999999999999999999999998 678899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++...... ......||+.|+|||++.+.. .++.++|||||||++|+|+||+.||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLGST-----------------EYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcCCc-----------------ccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 97643322 223456799999999886532 3566789999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=304.24 Aligned_cols=207 Identities=20% Similarity=0.253 Sum_probs=171.3
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+++.. ++.||||++..... ......+.+.+|+.++..++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQD--E 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--C
Confidence 47999999999999999999874 67899999874321 122234568889999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+.+++|.+++.+....+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~ 149 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLADFGSC 149 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC----CCCCEEEEECCce
Confidence 789999999999999999987666789999999999999999999999999999999999998 6788999999998
Q ss_pred ccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
....... ......||+.|+|||++....... ..++.++|||||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-------------~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGK-------------GRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccc-------------cCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 7653322 122346899999999986421100 13566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=324.85 Aligned_cols=205 Identities=34% Similarity=0.544 Sum_probs=172.2
Q ss_pred ccccccCCCceEEEEecccCcEEEEEEEEcCc-ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 793 ~~~~i~~~dYeilekLGeGgFG~VYkAk~kG~-kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
..+.+....+.+++.||+|-||.|+.|+++++ +||+|.++...+.. +.|.+|+.+|++|+|+|||+++++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---------~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---------EAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---------hHHHHHHHHHHhCcccCeEEEEEE
Confidence 34445555667778999999999999999876 89999998764332 478899999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHh-cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~-~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
|.. ++.++||||||+.|+|.++|+. .+..+.....+.|+.||++||+||+++++|||||..+||||+ .+..+|
T Consensus 270 ~~~--~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----~~~~vK 343 (468)
T KOG0197|consen 270 CTK--QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----EDLVVK 343 (468)
T ss_pred Eec--CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec----cCceEE
Confidence 998 4579999999999999999997 566789999999999999999999999999999999999999 778999
Q ss_pred EEecCCccccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCC
Q 001678 951 IGDLGLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFI 1027 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PF 1027 (1033)
|+|||||+...+... ...-.-...|.|||.+.... ++.++|||||||+||||+| |+.|+
T Consensus 344 IsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~------------------FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 344 ISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK------------------FSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred EcccccccccCCCceeecCCCCCCceecCHHHHhhCC------------------cccccceeehhhhHHHHhccCCCCC
Confidence 999999996544332 22223467799999987653 5667899999999999987 66666
Q ss_pred CCC
Q 001678 1028 DFF 1030 (1033)
Q Consensus 1028 d~~ 1030 (1033)
+-.
T Consensus 406 ~~m 408 (468)
T KOG0197|consen 406 PGM 408 (468)
T ss_pred CCC
Confidence 543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=310.41 Aligned_cols=208 Identities=21% Similarity=0.325 Sum_probs=172.7
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.+..++|++++.||+|+||.||++++. ++.||+|++...... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 345678999999999999999999884 677999998753221 1122346778999999999999999999998
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+ ...+++||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++ ..+.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----~~~~~kL~D 185 (370)
T cd05621 114 D--DKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLAD 185 (370)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEEe
Confidence 8 67899999999999999999754 478889999999999999999999999999999999998 678999999
Q ss_pred cCCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
||+|....... ......||+.|+|||++.+.... ..++.++|+|||||++|+|+||+.||...
T Consensus 186 FG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~--------------~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 186 FGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD--------------GYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred cccceecccCCceecccCCCCcccCCHHHHhccCCC--------------CCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 99998654322 22356799999999998654211 02566789999999999999999999654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=303.89 Aligned_cols=207 Identities=20% Similarity=0.248 Sum_probs=171.3
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+++.+ ++.||+|++..... ........+.+|+.++..++|+||+++++++.+ .
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQD--E 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 47999999999999999999874 56799999875321 122234567889999999999999999999988 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+.+|+|.+++.+....+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~----~~~~~kl~DfG~a 149 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLADFGSC 149 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc----CCCCEEEEeccce
Confidence 789999999999999999987666789999999999999999999999999999999999998 6778999999999
Q ss_pred ccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+...... ......||+.|+|||++.+..... ..++.++|+|||||++|+|+||+.||...
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-------------~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM-------------GKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCC-------------CCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 7654332 122356999999999986532100 13566789999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=302.66 Aligned_cols=195 Identities=23% Similarity=0.330 Sum_probs=164.1
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
+.||+|+||.||+++. .++.||+|+++..... .......+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEE
Confidence 3699999999999987 4778999998764322 12234567789999999999999999999988 5789999
Q ss_pred EeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc-
Q 001678 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ- 962 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~- 962 (1033)
|||+++++|..++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc----CCCCEEecccHHhccccCC
Confidence 99999999999887654 589999999999999999999999999999999999998 678899999999875322
Q ss_pred ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 ~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDND------------------YGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCccccccCCcCcCCcccccCCC------------------CCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 22233467999999999986642 566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=325.98 Aligned_cols=205 Identities=31% Similarity=0.513 Sum_probs=176.1
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
+.+..+++.+...||+|.||+||+|+|-|. ||||+++..... ...++.|+.|+.++++-+|.||+-+.|+|..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt------~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPT------PEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCC------HHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 445556677889999999999999999875 999999865432 2367899999999999999999999999997
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
+ .+.||+-||+|.+|..+|+-....++..+.+.||+||++|+.|||.++|||||||..||+|. ++++|||+||
T Consensus 460 p---~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~----~~~kVkIgDF 532 (678)
T KOG0193|consen 460 P---PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH----EDLKVKIGDF 532 (678)
T ss_pred C---ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc----cCCcEEEecc
Confidence 3 35999999999999999998777799999999999999999999999999999999999998 6789999999
Q ss_pred CCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 955 GLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 955 GLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
||+....... ....-.|...|||||++.... ...++..+||||||||+|||+||..||.
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd---------------~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQD---------------DNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcc---------------cCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 9998654432 223345788999999997432 1257889999999999999999999997
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.89 Aligned_cols=200 Identities=22% Similarity=0.315 Sum_probs=166.5
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~e 877 (1033)
+|++++.||+|+||.||+|+++ ++.||||+++..... .....+.+..|..++..+ +|++|+++++++.+ .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--M 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--C
Confidence 5889999999999999999885 567999998864321 122234566677777777 58999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kL~DfG~~ 148 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC----CCCcEEEccCCCc
Confidence 68999999999999999987654 488999999999999999999999999999999999998 6789999999999
Q ss_pred cccc-cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~-~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+... .........||+.|+|||++.+. .++.++|||||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAYQ------------------PYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcCC------------------CCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 7543 22233456799999999998765 3567889999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.79 Aligned_cols=200 Identities=23% Similarity=0.303 Sum_probs=166.0
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEcCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP-NVVSFYGIVRDGPD 877 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HP-NIVrLyG~f~d~~e 877 (1033)
+|++++.||+|+||.||+|+++ ++.||||+++...... ....+.+..|+.++..+.|+ +|+++++++.+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-----DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--M 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--C
Confidence 5899999999999999999885 5579999988643221 22335677899999999765 58888888887 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~~ 148 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMC 148 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc----CCCCEEEeecCcc
Confidence 67999999999999999997654 478999999999999999999999999999999999998 6788999999998
Q ss_pred cccc-cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~-~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+... .........||+.|+|||++.+.. ++.++|||||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAYQP------------------YGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcCCC------------------CCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 7432 222233456899999999987653 466789999999999999999999643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=307.24 Aligned_cols=208 Identities=20% Similarity=0.311 Sum_probs=172.7
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.+..++|++.+.||+|+||.||+++++ ++.||+|++...... .......+.+|+.+++.++||||+++++.+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 455689999999999999999999884 677999998653211 1222346788999999999999999999998
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+ ...+++||||+++|+|.+++.+. .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----~~~~ikL~D 185 (371)
T cd05622 114 D--DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (371)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----CCCCEEEEe
Confidence 7 57899999999999999998764 378888999999999999999999999999999999998 678999999
Q ss_pred cCCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
||+++...... ......||+.|+|||++.+.... ..++.++|||||||++|+|++|+.||...
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~--------------~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD--------------GYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCC--------------ccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 99998654322 22356799999999998654211 02567889999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=306.50 Aligned_cols=203 Identities=31% Similarity=0.404 Sum_probs=171.6
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEcCC-
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDGP- 876 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPN-IVrLyG~f~d~~- 876 (1033)
.|+.+++||+|+||+||+|+. +|+.||+|+++..... +..-....+|+.+++.|+|+| |+.+++++.+..
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 466677899999999999987 5788999999865431 112235678999999999999 999999998732
Q ss_pred ---CCceEEEEeeccCCcHHHHHHhcC---CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 877 ---DGSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 877 ---eg~l~LVmEYmegGSL~dlL~~~~---k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
.+.++||+||+ ..+|..++.... ..++...++.++.||++||+|||+++|+||||||.||||+ ..+.+|
T Consensus 86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----~~G~lK 160 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----SSGVLK 160 (323)
T ss_pred ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC----CCCcEe
Confidence 23899999999 779999998866 3578889999999999999999999999999999999999 689999
Q ss_pred EEecCCccccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 951 IGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 951 LiDFGLAr~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+|||+|+...-. ......++|.+|+|||++.+.. .|.+.+||||+|||++||+++++.|+.
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~-----------------~Ys~~vDiWs~GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST-----------------SYSTSVDIWSLGCIFAEMFTRRPLFPG 223 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCC-----------------cCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence 9999999976533 2344566899999999998864 477888999999999999999999986
Q ss_pred CC
Q 001678 1030 FS 1031 (1033)
Q Consensus 1030 ~s 1031 (1033)
.|
T Consensus 224 ~s 225 (323)
T KOG0594|consen 224 DS 225 (323)
T ss_pred Cc
Confidence 54
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.94 Aligned_cols=198 Identities=28% Similarity=0.361 Sum_probs=169.1
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|+..+++|.|+||.||+|+. .++.||||+...+.- ---+|+.+|+.++|||||++..+|....++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------------~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------------YKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------------cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 478889999999999999988 467899998765421 112689999999999999999998764444
Q ss_pred ---ceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 879 ---SLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 879 ---~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
++.+|||||+ .+|.++++. .+..++...++.++.||++||.|||+.||+||||||.|||+| +..+.+|||
T Consensus 93 d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKIC 168 (364)
T ss_pred chhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEec
Confidence 6679999995 489999874 355688888889999999999999999999999999999998 466999999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|||.|+.....+...+..-|..|+|||.+.+.. +|++++||||.|||+.||+-|++.|.--|
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~-----------------~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-----------------EYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCcc-----------------ccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 999999987776666666688999999998865 79999999999999999999999997654
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.95 Aligned_cols=207 Identities=19% Similarity=0.246 Sum_probs=170.2
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|+++++||+|+||.||+++.+ ++.+|+|++.+... ........+.+|+.++..++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQD--E 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--C
Confidence 47999999999999999999885 56689998864321 122233457889999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+.+|+|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~----~~~~~kL~DfG~a 149 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADFGSC 149 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEeecchh
Confidence 789999999999999999987666789999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
....... ......||+.|+|||++....... -.++.++|||||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-------------~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK-------------GKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCC-------------CCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 7543221 223456999999999986321000 03566889999999999999999999654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=323.25 Aligned_cols=194 Identities=28% Similarity=0.429 Sum_probs=172.6
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
..|....+||+|+.|.||.|+. +++.||||++...+...+ +-++.|+.+|+.++|+|||.+++.|.. .
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--------eLilnEi~Vm~~~~H~NiVnfl~Sylv--~ 342 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--------ELLLNEILVMRDLHHPNIVNFLDSYLV--G 342 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--------hhhHHHHHHHHhccchHHHHHHHHhcc--c
Confidence 4588889999999999999977 467799999987654432 246789999999999999999999988 4
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.++.|||||++|+|.+.+.... +++.++..|++++++||+|||.+||||||||.+|||++ .++.+||+|||+|
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~----~~g~vKltDFGFc 416 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT----MDGSVKLTDFGFC 416 (550)
T ss_pred ceeEEEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec----cCCcEEEeeeeee
Confidence 67999999999999999997653 89999999999999999999999999999999999999 6678999999999
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
..+.... .....+||+.|||||++..+ +|++++||||||++++||+-|.+||
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk------------------~YG~KVDIWSLGIMaIEMveGEPPY 469 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRK------------------PYGPKVDIWSLGIMAIEMVEGEPPY 469 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhc------------------ccCccccchhhhhHHHHHhcCCCCc
Confidence 8775544 66788999999999999876 4888999999999999999999998
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.21 Aligned_cols=192 Identities=24% Similarity=0.341 Sum_probs=162.6
Q ss_pred ecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 808 LGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
||+|+||.||++++. ++.||+|+++..... .......+.+|+.++++++||||+++++++.+ ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEc
Confidence 799999999999884 667999998754221 12234567889999999999999999999987 578999999
Q ss_pred eccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc-cc
Q 001678 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ-TL 964 (1033)
Q Consensus 886 YmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~-~~ 964 (1033)
|+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.... ..
T Consensus 74 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC----CCCcEEEEECcccccCccCCC
Confidence 999999999997654 489999999999999999999999999999999999998 678999999999985422 22
Q ss_pred ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 965 ~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.-
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGH------------------GYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred ccccccCCcccCCHHHHcCC------------------CCCCccceechhHHHHHHHhCCCCcCC
Confidence 33456799999999998764 256678999999999999999999964
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.60 Aligned_cols=195 Identities=25% Similarity=0.335 Sum_probs=164.3
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
+.||+|+||.||+++. .++.||||++...... .......+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEE
Confidence 3699999999999987 4778999998754322 12234577889999999999999999999988 6789999
Q ss_pred EeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc-
Q 001678 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ- 962 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~- 962 (1033)
|||+++++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~Ey~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~----~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD----KDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC----CCCcEEEecCcCCccCCCc
Confidence 99999999999987654 589999999999999999999999999999999999998 678899999999875322
Q ss_pred ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 ~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.......+||+.|+|||++.+. .++.++|||||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDN------------------DYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred ccccccccCCcCccChhhhcCC------------------CCCccCCccccchHHHHHhhCCCCCCCC
Confidence 2223456799999999998764 2566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.40 Aligned_cols=195 Identities=24% Similarity=0.381 Sum_probs=163.9
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||++++ .++.||||+++..... .....+.+.+|..++..+ +||||++++++|.+ ...+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-----DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEE
Confidence 3699999999999988 4677999999864322 122345677899999988 69999999999988 578999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc-c
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-Q 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~-~ 961 (1033)
||||+++++|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEECcCcccccccc
Confidence 999999999999987654 589999999999999999999999999999999999998 6789999999998752 2
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.........||+.|+|||++.+. .++.++|+|||||++|+|+||+.||+..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGE------------------DYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred CCCccccccCCccccCHHHHcCC------------------CCCCccceechHHHHHHHHHCCCCcccc
Confidence 22233456799999999998764 2566789999999999999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=306.45 Aligned_cols=208 Identities=19% Similarity=0.291 Sum_probs=172.5
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.+..++|++++.||+|+||.||+++.+ ++.||||++...... .....+.+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 455678999999999999999999874 678999998753221 1122345778999999999999999999998
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+ ...+++||||+++|+|.+++.+. .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~~kL~D 185 (370)
T cd05596 114 D--DKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (370)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----CCCCEEEEe
Confidence 8 57899999999999999998754 378888899999999999999999999999999999998 678999999
Q ss_pred cCCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
||++....... ......||+.|+|||++.+.... ..++.++|+|||||++|+|+||+.||...
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--------------~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD--------------GYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCC--------------CCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 99998654322 22345799999999998654210 13567889999999999999999999654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.54 Aligned_cols=196 Identities=26% Similarity=0.362 Sum_probs=163.3
Q ss_pred EEecccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCce
Q 001678 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~-----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l 880 (1033)
+.||+|+||.||+++. .++.||||+++...... .......+..|+.+++.++||||++++++|.+ ++.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh----hhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeE
Confidence 6799999999999975 36679999987543211 11223467789999999999999999999988 5789
Q ss_pred EEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
++||||+.+++|.+++.+.+ .+.+..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD----AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEeeCcCCeec
Confidence 99999999999999997654 478888889999999999999999999999999999998 6789999999998753
Q ss_pred c-cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 961 Q-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 961 ~-~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
. .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRSG------------------HGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred ccCCCcccccCCCccccChhhccCCC------------------CCCcceecccHHHHHHHhcCCCCCCCC
Confidence 2 222334467999999999987642 456789999999999999999999653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=289.09 Aligned_cols=202 Identities=26% Similarity=0.370 Sum_probs=162.7
Q ss_pred CCceEEEEecccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc---CCCCcceEEEEEE
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVR 873 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k---G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL---~HPNIVrLyG~f~ 873 (1033)
++|++++.||+|+||.||+|++. ++.||||+++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC------chHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36899999999999999999872 56789998875432211 112344566666555 6999999999986
Q ss_pred c---CCCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 874 D---GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 874 d---~~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
. .....+++||||+. ++|.+++.+. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~----~~~~~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc----CCCCE
Confidence 3 22456899999995 6999998764 34488999999999999999999999999999999999998 67899
Q ss_pred EEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|++||..
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS------------------SYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHhCC------------------CCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 99999999876544444556789999999998654 256678999999999999999999964
Q ss_pred C
Q 001678 1030 F 1030 (1033)
Q Consensus 1030 ~ 1030 (1033)
.
T Consensus 212 ~ 212 (290)
T cd07862 212 S 212 (290)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=322.30 Aligned_cols=196 Identities=29% Similarity=0.448 Sum_probs=173.2
Q ss_pred ccccccCCCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 793 ~~~~i~~~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
+.+++..+.+..++-||.|+.|.||+|+..+..||||+++.. -..+|+-|++|+|+||+.|.|+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEeeee
Confidence 455666666677788999999999999999999999987632 12467789999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
.. ..++|||||||..|-|...|+... .+.......+..+|+.||.|||.+.|||||||.-||||. .+..|||+
T Consensus 182 tq--sPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs----~~d~VKIs 254 (904)
T KOG4721|consen 182 TQ--SPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS----YDDVVKIS 254 (904)
T ss_pred cC--CceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee----ccceEEec
Confidence 98 568999999999999999997654 478888889999999999999999999999999999999 55689999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|||-++........-.++||..|||||+|.+.+ ...|+|||||||||||||||..||.
T Consensus 255 DFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP------------------csEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 255 DFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP------------------CSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred cccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC------------------cccccceehhHHHHHHHHhcCCCcc
Confidence 999999887777777899999999999999875 5677899999999999999999984
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=301.28 Aligned_cols=207 Identities=22% Similarity=0.265 Sum_probs=172.3
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||+++. .++.||||+++..... .....+.+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPWIPQLQYAFQD--K 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--C
Confidence 4699999999999999999987 4778999998854321 22334567889999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+++++|.+++.+....+++..+..++.||+.||.|||+.+|+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~----~~~~~kL~Dfg~a 149 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSA 149 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC----CCCCEEeccCCCC
Confidence 679999999999999999988756799999999999999999999999999999999999998 6789999999999
Q ss_pred ccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....... ......||+.|+|||++........ -.++.++||||||||+|+|+||+.||..
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------------~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK------------GTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhcccccccc------------CCCCCcceeecccceeeeeccCCCCCCC
Confidence 8654322 2223468999999999864321100 1366788999999999999999999964
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.29 Aligned_cols=200 Identities=25% Similarity=0.284 Sum_probs=166.2
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||+++++ ++.||||+++..... ....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 72 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN------EEVKETTLRELKMLRTLKQENIVELKEAFRR--R 72 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc------ccchhhHHHHHHHHHhCCCccccchhhhEec--C
Confidence 47999999999999999999884 667999998754221 1223467789999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+.++.|..+. +....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~----~~~~~kl~Dfg~~ 147 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFA 147 (287)
T ss_pred CEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccCc
Confidence 7899999999887666544 4445689999999999999999999999999999999999998 6778999999999
Q ss_pred ccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
....... ......||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAP------------------YGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCC------------------CCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 8754322 223456899999999987642 456789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=295.81 Aligned_cols=202 Identities=25% Similarity=0.283 Sum_probs=164.4
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC--
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~-- 876 (1033)
+|++.++||+|+||.||+|++ +++.||||+++..... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 589999999999999999987 4778999988743211 112246788999999999999999999886532
Q ss_pred -CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 877 -eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
...+++||||+ +++|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN----ADCKLKICDFG 148 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEccCc
Confidence 23589999999 578999987654 489999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+++...... ......||+.|+|||++.+... .++.++|||||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----------------~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS----------------KYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhcccc----------------ccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 997543221 1234568999999998754211 3566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=296.95 Aligned_cols=198 Identities=24% Similarity=0.377 Sum_probs=163.1
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHH---HHhcCCCCcceEEEEEEcCC
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALL---LSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~I---LskL~HPNIVrLyG~f~d~~ 876 (1033)
|++++.||+|+||.||++.+ +++.||||+++...... ....+.+.+|+.+ ++.++||||+++++++.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-- 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-----RDEVESLMCEKRIFETANSERHPFLVNLFACFQT-- 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--
Confidence 67899999999999999987 46789999987543221 1223345556554 456789999999999988
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
.+.+++||||+++++|..++.+ ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~----~~~~~kL~Dfg~ 147 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD----TEGFVKIADFGL 147 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCcEEeCcccC
Confidence 5789999999999999988864 3589999999999999999999999999999999999998 678999999999
Q ss_pred cccccc-ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~-~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++.... ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTET------------------SYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcCC------------------CCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 875322 2233456799999999998764 2566789999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=308.91 Aligned_cols=206 Identities=31% Similarity=0.387 Sum_probs=182.3
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~ 875 (1033)
...|++.+.||.|.||.||+++. +|+.+|+|.+.+.....+. ....+.+|+.+|+++. |||||.++++|.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~- 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFED- 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEc-
Confidence 45688999999999999999987 4788999999877655432 2357889999999999 9999999999999
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
...+++|||++.||.|.+.|.+. .+++..+..++.||+.+++|||+.||+||||||+|+|+.......+.+|++|||
T Consensus 108 -~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 108 -PDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred -CCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 56899999999999999999877 389999999999999999999999999999999999998665445799999999
Q ss_pred CccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 956 LAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
++............+||+.|+|||++... .|+..+||||+||++|.|+.|.+||...+
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~------------------~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGR------------------PYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCC------------------CCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 99988776667788999999999999765 37778899999999999999999997544
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.47 Aligned_cols=194 Identities=25% Similarity=0.343 Sum_probs=162.7
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
+.||+|+||.||+++. +++.||+|+++..... .......+..|+.++..++||||+++++++.. .+.+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEE
Confidence 3699999999999987 4778999998754322 12234567789999999999999999999988 6789999
Q ss_pred EeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-
Q 001678 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~- 961 (1033)
|||+.+++|.+++.+.. .+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 ~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~----~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC----CCCCEEEecCCCCeecCC
Confidence 99999999999887654 58999999999999999999997 7999999999999998 67899999999987532
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.........||+.|+|||++.+. .++.++|||||||++|+|+||+.||..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDN------------------DYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred CCcccccccCCcccCCHHHHccC------------------CCCCccccccccceeeeeccCCCCCCC
Confidence 22233345699999999998664 256678999999999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=295.26 Aligned_cols=200 Identities=30% Similarity=0.437 Sum_probs=170.4
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
+..++|++++.||+|+||.||++++. +..+|+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 45678999999999999999999885 6678999886431 12234578899999999999999999999988
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHsk-GIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
.+.+++||||+++++|.+++.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----~~~~~kl~D 147 (331)
T cd06649 75 --DGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCD 147 (331)
T ss_pred --CCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc----CCCcEEEcc
Confidence 578999999999999999997654 488999999999999999999986 699999999999998 678899999
Q ss_pred cCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||++...... ......||..|+|||++.+. .++.++|+|||||++|+|+||+.||..
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGT------------------HYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcCC------------------CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9998765433 23345689999999998764 255678999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=306.64 Aligned_cols=200 Identities=26% Similarity=0.386 Sum_probs=160.6
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.++...+.||+|+||.||++... +...|||.+..... . ..+.+.+|+.+|++++|||||+++|.......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~-----~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS-----P---TSESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc-----h---hHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 45677789999999999999885 68899998875410 1 14568899999999999999999997444212
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCC-CCeEEEEecCC
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ-RPVCKIGDLGL 956 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~-~g~VKLiDFGL 956 (1033)
..++++|||+.+|+|.+++.+.+..+++..++.+++||++||+|||++|||||||||+||||+ . ++.+||+|||+
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~----~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD----PSNGDVKLADFGL 164 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe----CCCCeEEeccCcc
Confidence 368999999999999999998765799999999999999999999999999999999999999 5 68999999999
Q ss_pred cccccc----ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 957 SKVKQQ----TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 957 Ar~~~~----~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
++.... ......+.||+.|||||++... .... .++|||||||++.||+||+.|+.
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~----------------~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNG-EVAR----------------RESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCC-CcCC----------------ccchhhhcCCEEEeccCCCCcch
Confidence 987653 2234467899999999999852 1111 24566666666666666666653
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=296.28 Aligned_cols=195 Identities=23% Similarity=0.356 Sum_probs=162.1
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+|++. ++.||||+++..... .....+.+..|..++..+ +||||+++++++.+ .+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEE
Confidence 36999999999999885 567999998764322 122234566788888766 79999999999998 578999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+++++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~----~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 74 VMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeecccceeccc
Confidence 999999999999987654 488999999999999999999999999999999999998 678999999999875422
Q ss_pred -ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 -~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
........||+.|+|||++.+. .++.++|||||||++|+|+||+.||+..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQEL------------------EYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred CCccccccccCccccCHHHHcCC------------------CCCCccceechhHHHHHHhcCCCCCCCC
Confidence 2233456689999999998654 2566789999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=319.74 Aligned_cols=203 Identities=27% Similarity=0.359 Sum_probs=178.9
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.-|++.+.||.|+-|.|-+|++ +|+.+|||++.+..... ......+.+|+.||+.+.||||+++|+++.+ +
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-----~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~ 84 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-----SSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--K 84 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc-----cccccchhhhhHHHHHhcCCCeeeeeeeecc--C
Confidence 4578889999999999999988 79999999987653211 1223467799999999999999999999998 7
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+|+|+||+++|.|+++|-+++. +.+.+++++++||+.|+.|+|..+|+||||||+|+||| .++.+||+|||||
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd----~~~nIKIADFGMA 159 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD----VKNNIKIADFGMA 159 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh----cccCEeeecccee
Confidence 889999999999999999998876 77888888999999999999999999999999999999 5566999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
..........+-||++-|.|||++.|+++. +.++||||-|||||.||||+.|||--+
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYd-----------------G~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYD-----------------GRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCC-----------------CCccccchhHHHHHHHHhCCCCCCCcc
Confidence 988888788889999999999999998743 456799999999999999999998433
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=296.53 Aligned_cols=194 Identities=23% Similarity=0.364 Sum_probs=163.1
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+++.. ++.||+|+++..... .....+.+.+|+.++.++ +|+||+++++++.+ ...+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEE
Confidence 36999999999999874 677999998864321 223345678899999888 59999999999988 577999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~- 961 (1033)
||||+++++|..++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD----ADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe----CCCCEEEeccccceeccC
Confidence 999999999999887654 489999999999999999999999999999999999998 67889999999987532
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
........+||+.|+|||++.+. .++.++|||||||++|+|+||+.||+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRGE------------------EYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CCCceecccCCcccCCHHHHCCC------------------CCCchheeehhHHHHHHHHhCCCCCCc
Confidence 22233456799999999998764 356678999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=296.25 Aligned_cols=195 Identities=26% Similarity=0.394 Sum_probs=162.1
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+|+++ ++.||||+++..... .....+.+..|..++..+ +||||+++++++.+ ...+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEE
Confidence 36999999999999884 677999998754321 122334667788888776 69999999999988 578999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~- 961 (1033)
||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~----~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeeCCCCeecCc
Confidence 999999999999987654 489999999999999999999999999999999999998 67889999999987532
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.........||+.|+|||++.+. .++.++|||||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEM------------------LYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred CCCcccccccCccccCHHHHcCC------------------CCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 22233456799999999998654 2566789999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=288.13 Aligned_cols=201 Identities=26% Similarity=0.329 Sum_probs=169.1
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|++.+.||+|+||.||++.. +++.||||++...... .......+.+|+.+++.++|+||+++++.+.+ ..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CC
Confidence 488999999999999999987 4778999998754321 11223456789999999999999999999987 46
Q ss_pred ceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.+++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 799999999999999988654 34589999999999999999999999999999999999998 6788999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.............|+..|+|||++.+. .++.++|+|||||++|+|++|..||...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNE------------------RYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCC------------------CCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 876443333455789999999998654 2556789999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=298.12 Aligned_cols=194 Identities=24% Similarity=0.382 Sum_probs=162.1
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+++.+ ++.||+|+++...... ......+.+|+.++.++ +||||+++++++.+ .+.+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-----hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEE
Confidence 36999999999999874 6679999988643221 12234677888888776 79999999999988 678999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~- 961 (1033)
||||+++++|..++.+.. .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~E~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~----~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCCEEEeeCCccccccC
Confidence 999999999999887654 589999999999999999999999999999999999998 67899999999987532
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.........||+.|+|||++.+. .++.++|+|||||++|+|+||+.||+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRGE------------------DYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCCccccccCCccccCHHHHcCC------------------CCCCccceecccHHHHHHhhCCCCCcc
Confidence 22233456799999999998765 256678999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=295.16 Aligned_cols=195 Identities=25% Similarity=0.377 Sum_probs=159.5
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILsk-L~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+|+++ ++.||||+++...... ....+.+..|..++.. ++||||+++++++.. .+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-----DDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEE
Confidence 36999999999999884 5679999988643221 1122344556666654 489999999999987 568999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD----KDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC----CCCCEEEccCcCCeECCC
Confidence 999999999999997654 488999999999999999999999999999999999998 678999999999975432
Q ss_pred -ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 -~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKGQ------------------KYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CCCccccccCCccccCHHHHcCC------------------CCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 2233456799999999998764 2566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=302.90 Aligned_cols=203 Identities=26% Similarity=0.317 Sum_probs=172.1
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc---
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD--- 874 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d--- 874 (1033)
..|..++.||+|+||.|..+.+ +++.||||++... .......++..+|+++|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh------hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 4456679999999999999987 5788999987632 1233445678899999999999999999999876
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
..-..+|+|+|+| +.+|...|+... .++...+..++.||++||+|+|+.+|+||||||+|+|++ .+..+|||||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n----~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN----ADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeec----cCCCEEeccc
Confidence 3345699999999 779999987654 489999999999999999999999999999999999998 7788999999
Q ss_pred CCcccccc---ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 955 GLSKVKQQ---TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 955 GLAr~~~~---~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|+|+.... ....+..+-|.+|+|||++.... +|+.++||||+||||.|||+|++.|...+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~-----------------~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSS-----------------EYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccc-----------------cccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 99998753 33345566799999999986532 68899999999999999999999998654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=288.21 Aligned_cols=201 Identities=29% Similarity=0.428 Sum_probs=162.7
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc------------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHH
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR------------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k------------------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILs 858 (1033)
+..++|++.++||+|+||.||+|.+. +..||||++.... .......+.+|+.++.
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~ 74 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILS 74 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHh
Confidence 34578999999999999999999752 2358999886532 1223457889999999
Q ss_pred hcCCCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC------------------CccCHHHHHHHHHHHHHHHH
Q 001678 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------------RTIDRRKRLIIAMDAAFGME 920 (1033)
Q Consensus 859 kL~HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~------------------k~Lse~~rl~Ia~QIa~GLe 920 (1033)
+++||||+++++++.+ ....++||||+.+++|.+++.... ..+++..++.++.||+.||.
T Consensus 75 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 75 RLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred hcCCCCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999988 567999999999999999986532 23677888999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhccc
Q 001678 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSL 997 (1033)
Q Consensus 921 YLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSL 997 (1033)
|||+.||+||||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+.
T Consensus 153 ~lH~~~ivH~dlkp~Nill~----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------- 215 (304)
T cd05096 153 YLSSLNFVHRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG------------- 215 (304)
T ss_pred HHHHCCccccCcchhheEEc----CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-------------
Confidence 99999999999999999998 67899999999997643321 22334467889999988654
Q ss_pred chhhccCCcccchHHHHHHHHHHHcc--CCCCC
Q 001678 998 KFCCFQLKWSYDCYSLGILFFFLQFI--LCFID 1028 (1033)
Q Consensus 998 Gvilye~t~kvDVWSLGVVLYeLLTG--k~PFd 1028 (1033)
.++.++|||||||++|+|+++ ..||.
T Consensus 216 -----~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 216 -----KFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred -----CCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 256678999999999999874 45554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=293.88 Aligned_cols=200 Identities=22% Similarity=0.308 Sum_probs=165.7
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~e 877 (1033)
+|++.+.||+|+||.||+|+.+ ++.||||++...... .....+.+..|..++..+. |++|+++++++.+ .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--V 73 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEec--C
Confidence 4788999999999999999874 678999998754321 1222346677888888886 5778889998887 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+++|+|.+++.+.. .+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~----~~~~ikL~Dfg~~ 148 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeccccc
Confidence 67999999999999999997654 489999999999999999999999999999999999998 6788999999998
Q ss_pred cccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+..... .......||+.|+|||++.+.. ++.++|+|||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQP------------------YGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcCCC------------------CCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 754322 2233456899999999987642 566789999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=294.49 Aligned_cols=195 Identities=25% Similarity=0.361 Sum_probs=159.0
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHH-HHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEA-LLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi-~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+|++ .++.||+|++...... .......+.+|. .+++.++||||+++++++.+ .+.+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEE
Confidence 3699999999999988 4677999998754321 111223444554 46788999999999999987 568999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+++++|...+.+.. .+++..+..++.||+.||.|||+.+|+||||||+||||+ .++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEccCCCCccCCC
Confidence 999999999999887643 478888999999999999999999999999999999998 678999999999875322
Q ss_pred -ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 -~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKEP------------------YDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred CCCccccccCCcccCCHHHhcCCC------------------CCCcCcccccchhhhhhhcCCCCCCCC
Confidence 22334567899999999986542 556789999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=304.81 Aligned_cols=205 Identities=26% Similarity=0.381 Sum_probs=176.2
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEcC--cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~kG--~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.+..+.|++++.||+|.-|+||+++.++ ..+|+|++.+..+.. +..+.+.+.|.+||+.++||.++.||..|+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-----rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-----RKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-----hhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 4455678899999999999999999976 568999998775543 455677888999999999999999999999
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
. +...|+|||||.||+|..+++++ ++.+++..++.++.+++.||+|||-.|||+|||||+||||. ++|+|-|+
T Consensus 148 t--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr----edGHIMLs 221 (459)
T KOG0610|consen 148 T--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR----EDGHIMLS 221 (459)
T ss_pred c--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe----cCCcEEee
Confidence 8 78899999999999999999865 56699999999999999999999999999999999999998 88999999
Q ss_pred ecCCccccc----------------------------------c-c----------------------cccCCcCCCCcc
Q 001678 953 DLGLSKVKQ----------------------------------Q-T----------------------LVSGGVRGTLPW 975 (1033)
Q Consensus 953 DFGLAr~~~----------------------------------~-~----------------------~~s~~~~GT~~Y 975 (1033)
||.|+.... . . ....+++||-+|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 999874210 0 0 012356799999
Q ss_pred cccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 976 mAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+|||++.|.++ +.++|||+|||++||||+|+.||.-
T Consensus 302 lAPEvI~G~GH------------------gsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 302 LAPEVIRGEGH------------------GSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred ccceeeecCCC------------------CchhhHHHHHHHHHHHHhCCCCcCC
Confidence 99999998863 4568999999999999999999954
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=294.92 Aligned_cols=195 Identities=24% Similarity=0.354 Sum_probs=159.6
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~-ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||+||+|++ +++.||||++....... ......+..|.. +++.++||||+++++.+.+ ...+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-----KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEE
Confidence 3699999999999988 47789999987543221 112233444444 5688999999999999987 578999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+.+++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeccCCCccccc
Confidence 999999999999997654 588999999999999999999999999999999999998 678999999999875322
Q ss_pred -ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 -~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
........||+.|+|||++.+. .++.++|||||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQ------------------PYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred CCCccccccCChhhcChhhhcCC------------------CCCccccccccchhhhhhhcCCCCCCCC
Confidence 2233456799999999998764 2566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=296.26 Aligned_cols=194 Identities=26% Similarity=0.339 Sum_probs=163.3
Q ss_pred EEecccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCce
Q 001678 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~-----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l 880 (1033)
+.||+|+||.||+++. .++.||+|+++..... ......+.+|+.++++++||||+++++++.+ .+.+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------VRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEE
Confidence 6799999999999875 4678999998754321 1122356789999999999999999999988 6789
Q ss_pred EEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
++||||+.+++|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 74 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----CCCcEEEeeccCCccc
Confidence 99999999999999997654 489999999999999999999999999999999999998 6778999999998765
Q ss_pred ccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 961 QQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 961 ~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
... .......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~~------------------~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRRG------------------HTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCCC------------------CCCccceeccceEeeeeccCCCCCCCC
Confidence 433 2333567899999999987642 456789999999999999999999653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=289.03 Aligned_cols=198 Identities=20% Similarity=0.232 Sum_probs=166.8
Q ss_pred EEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc--CCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD--GPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d--~~eg~l~LV 883 (1033)
..|++|+++.||+|+++++.||||+++.... .....++.|.+|+.+|++++||||+++++++.+ .....+++|
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHK-----GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEecccccc-----ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 5799999999999999999999999875421 123345678899999999999999999999876 434578999
Q ss_pred EeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHsk-GIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
|||+.+|+|.+++.+.. .+++...+.++.|++.||.|||+. +++||||||+|||++ .++.+||+|||+++....
T Consensus 101 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~----~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 101 LEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC----CCCcEEEcccchHhhhcc
Confidence 99999999999997654 588999999999999999999984 999999999999998 678999999999886543
Q ss_pred ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 963 ~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
.. ....||..|+|||++.+.. ..++.++|||||||++|+|+||+.||+..+
T Consensus 176 ~~--~~~~~~~~y~aPE~~~~~~----------------~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 176 PP--FKNVNFMVYFSYKMLNDIF----------------SEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred cc--ccccCcccccCHHHhhhcc----------------ccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 22 2345789999999986521 146778899999999999999999997653
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=302.75 Aligned_cols=193 Identities=23% Similarity=0.286 Sum_probs=163.0
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
..+...+|+++++||+|+||.||+|.+ +++.||||.... ..+.+|+.++++|+||||++++++|
T Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~ 152 (391)
T PHA03212 87 AGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTF 152 (391)
T ss_pred cccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEE
Confidence 345667899999999999999999988 467799996431 2456899999999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
.. ....++|||++ .++|..++.... .+++..++.|+.||+.||.|||++|||||||||+|||++ ..+.+||+
T Consensus 153 ~~--~~~~~lv~e~~-~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----~~~~vkL~ 224 (391)
T PHA03212 153 TY--NKFTCLILPRY-KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCLG 224 (391)
T ss_pred EE--CCeeEEEEecC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----CCCCEEEE
Confidence 87 56789999999 578998887654 488999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccc--cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 953 DLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 953 DFGLAr~~~~~--~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
|||+++..... .......||+.|+|||++.+. .++.++||||||||+|+|+||+.||
T Consensus 225 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARD------------------PYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred eCCcccccccccccccccccCccCCCChhhhcCC------------------CCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 99999754322 122346799999999998664 2566789999999999999998765
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=294.57 Aligned_cols=195 Identities=24% Similarity=0.342 Sum_probs=158.1
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHH-HHHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKE-ALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rE-i~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||+||+|++. ++.||+|++....... ......+..| ..+++.++|+||+++++++.+ .+.+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-----hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEE
Confidence 36999999999999884 5669999987542211 1112233344 345788999999999999988 578999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~- 961 (1033)
||||+.+++|.+++.+.. .+.+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~----~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEEccCCCCccccc
Confidence 999999999999997654 477888888999999999999999999999999999998 67789999999987532
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQ------------------PYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred CCCCcccccCCccccCHHHHcCC------------------CCCCccccccccHHHHHHhcCCCCCCCC
Confidence 22233456799999999998764 2566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=289.46 Aligned_cols=196 Identities=28% Similarity=0.394 Sum_probs=160.1
Q ss_pred EEecccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceE
Q 001678 806 RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~ 881 (1033)
++||+|+||.||+|+.+ ++.||+|.+..... ...+.+|+.++++++||||+++++++.......++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 57999999999999863 45689998864321 12456899999999999999999999775566789
Q ss_pred EEEeeccCCcHHHHHHhc--------CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 882 TVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~--------~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+||||+ +++|.+++... ...+++..++.|+.||+.||.|||+.||+||||||+|||++..+...+.+||+|
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 999999 56888887532 224788999999999999999999999999999999999975544678999999
Q ss_pred cCCcccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||+++...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|++||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----------------~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-----------------HYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCC-----------------CcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 99998654321 223456899999999987642 356678999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=284.45 Aligned_cols=194 Identities=25% Similarity=0.354 Sum_probs=161.7
Q ss_pred ecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 808 LGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
||+|+||+||++.+ +++.||+|++...... .....+.+..|+.+++.++|+||+++++++.. ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEe
Confidence 69999999999987 4778999998754221 12223567789999999999999999999887 567999999
Q ss_pred eccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 886 FMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 886 YmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
|+++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD----NDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeCccceecCC
Confidence 9999999988754 334589999999999999999999999999999999999998 667899999999976543
Q ss_pred cc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 TL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 ~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.. ......||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~------------------~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEE------------------YDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCC------------------CCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22 233456899999999987652 556789999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=306.34 Aligned_cols=201 Identities=22% Similarity=0.281 Sum_probs=162.9
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.....+|++.+.||+|+||.||+|.+ .++.||||++.... ....+|+.+++.++|+||+++++++.
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~ 129 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYY 129 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEe
Confidence 34567899999999999999999987 46789999875321 12346999999999999999998875
Q ss_pred cC------CCCceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q 001678 874 DG------PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1033)
Q Consensus 874 d~------~eg~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~ 944 (1033)
.. ....+++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||||+.
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--- 205 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--- 205 (440)
T ss_pred ecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC---
Confidence 42 1224679999996 577777653 3456899999999999999999999999999999999999972
Q ss_pred CCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccC
Q 001678 945 QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024 (1033)
Q Consensus 945 ~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk 1024 (1033)
..+.+||+|||+|+............||+.|+|||++.+.. .++.++||||||||+|+|+||.
T Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----------------~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-----------------NYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred CCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCC-----------------CCCcHHHHHHHHHHHHHHHhCC
Confidence 23479999999998765444444567899999999986542 3566789999999999999999
Q ss_pred CCCCC
Q 001678 1025 CFIDF 1029 (1033)
Q Consensus 1025 ~PFd~ 1029 (1033)
+||..
T Consensus 269 ~pf~~ 273 (440)
T PTZ00036 269 PIFSG 273 (440)
T ss_pred CCCCC
Confidence 99964
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=287.00 Aligned_cols=201 Identities=28% Similarity=0.418 Sum_probs=166.9
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|+++++||+|+||.||+|++ .++.||+|+++...... ....+.+|+.++++++|+||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 75 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIVHT-- 75 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-------cchhHHHHHHHHHhCCCCCcceEEEEEee--
Confidence 46799999999999999999987 46679999987543211 11246689999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
.+..++||||+. ++|.+++.+.+..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 150 (309)
T cd07872 76 DKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (309)
T ss_pred CCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcccc
Confidence 577999999996 589998887766689999999999999999999999999999999999998 678899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++...... ......+|+.|+|||++.+.. .++.++|||||||++|+|+||+.||...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLGSS-----------------EYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhCCC-----------------CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 87643322 223345789999999886532 2456789999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=294.29 Aligned_cols=195 Identities=25% Similarity=0.350 Sum_probs=159.6
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~-ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+|+. +++.||||++....... ......+..|.. +++.++||||+++++++.. .+.+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-----RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEE
Confidence 3699999999999987 47789999987542211 112234445544 5788999999999999988 578999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~- 961 (1033)
||||+.+++|..++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~----~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD----SQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEeecCCcccCCC
Confidence 999999999999887654 589999999999999999999999999999999999998 67899999999987532
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQP------------------YDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCC------------------CCCcCccccccceehhhhcCCCCCCCC
Confidence 222334567999999999987643 456789999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=281.64 Aligned_cols=204 Identities=27% Similarity=0.427 Sum_probs=167.8
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
+...+|++.+.||+|+||.||+|.++ +..||+|.++.... ......+.+|+.++++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------DKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 35567999999999999999999763 45689998875321 1223578899999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
+.. .+..++||||+.+++|.+++.+....+++..++.++.||+.||+|||+.+++||||||+|||++ .++.+||
T Consensus 75 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----~~~~~~l 148 (266)
T cd05064 75 ITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKI 148 (266)
T ss_pred Eec--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----CCCcEEE
Confidence 987 5679999999999999999987666789999999999999999999999999999999999998 6789999
Q ss_pred EecCCcccccccccc--CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCC
Q 001678 952 GDLGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFID 1028 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s--~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd 1028 (1033)
+|||.+......... ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||.
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH------------------HFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhC------------------CccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 999987654322111 122346789999988654 35667899999999999775 999996
Q ss_pred CCC
Q 001678 1029 FFS 1031 (1033)
Q Consensus 1029 ~~s 1031 (1033)
..+
T Consensus 211 ~~~ 213 (266)
T cd05064 211 DMS 213 (266)
T ss_pred cCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=293.81 Aligned_cols=199 Identities=23% Similarity=0.298 Sum_probs=164.1
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||+|+||.||++.+ .+..||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc------chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 46899999999999999999987 477899999864321 1122346778999999999999999999987532
Q ss_pred ----CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 ----eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
...+++||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~----~~~~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 165 (359)
T ss_pred CccccceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEe
Confidence 135799999995 467666643 378888999999999999999999999999999999998 67899999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||+++............||..|+|||++.+. .++.++|||||||++|+|+||+.||..
T Consensus 166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~------------------~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGM------------------GYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred cCCCccccccCccCCCCcccCCCCCchhccCC------------------CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99999865444344456789999999998764 256678999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=312.42 Aligned_cols=203 Identities=27% Similarity=0.434 Sum_probs=180.2
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|+.++++|+|+||.+++++. .++.+|+|++.......+.. +...+|+.++++++|||||.+++.|.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r------~~A~~E~~lis~~~hP~iv~y~ds~~~-- 74 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER------RSAIQEMDLLSKLLHPNIVEYKDSFEE-- 74 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh------HHHHHHHHHHHhccCCCeeeeccchhc--
Confidence 35789999999999999998876 46789999998765543321 266789999999999999999999998
Q ss_pred CCc-eEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 877 DGS-LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 877 eg~-l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
++. ++|||+|++||+|.+.|.+.. ..++++.+..++.||+.|+.|||++.|+|||||+.||+++ .+..|||.||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt----k~~~VkLgDf 150 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT----KDKKVKLGDF 150 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc----ccCceeecch
Confidence 566 999999999999999998754 7799999999999999999999999999999999999999 6778899999
Q ss_pred CCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 955 GLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|+|+...... ...++.||+.||.||++.+.+ |+.++|||||||++|||++.++.|...+
T Consensus 151 GlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p------------------Yn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 151 GLAKILNPEDSLASTVVGTPYYMCPEILSDIP------------------YNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred hhhhhcCCchhhhheecCCCcccCHHHhCCCC------------------CCccCcchhhcchHHHHHhcccccCccc
Confidence 9999887765 667889999999999998874 7888999999999999999999998765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=297.11 Aligned_cols=199 Identities=30% Similarity=0.428 Sum_probs=162.1
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.+|+++++||+|+||.||++++. ++.||||++.... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--N 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--C
Confidence 45777889999999999999884 7889999986431 12234578899999999999999999999987 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+++++|.+.. ...+..+..|+.||+.||.|||+++|+||||||+||||+ .++.+||+|||++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DfG~~ 215 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVS 215 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEcccccc
Confidence 7899999999999986532 356777888999999999999999999999999999998 6789999999999
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+...... ......||..|+|||++....... ...+.++|||||||++|+|++|+.||..
T Consensus 216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-------------~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHG-------------AYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred eecccccccccccccCccccCccccccccccC-------------cCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 8654332 223457899999999875421100 0234578999999999999999999963
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=288.42 Aligned_cols=203 Identities=28% Similarity=0.473 Sum_probs=167.2
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE--cCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~--kG~----kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
.+...+|++++.||+|+||.||+|++ .++ .||||+++... .....+.+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35667899999999999999999987 233 37899876321 112235688899999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
+++.. ...++|+||+.+|+|.+++.+....+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+
T Consensus 76 g~~~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~----~~~~~ 148 (316)
T cd05108 76 GICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK----TPQHV 148 (316)
T ss_pred EEEcC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec----CCCcE
Confidence 99886 346899999999999999988766789999999999999999999999999999999999998 66789
Q ss_pred EEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCC
Q 001678 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILC 1025 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~ 1025 (1033)
||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|+| |+.
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~------------------~~~~~~Di~slGv~l~el~t~g~~ 210 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR------------------IYTHQSDVWSYGVTVWELMTFGSK 210 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccC------------------CCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999986543221 1222346789999988654 25667899999999999997 999
Q ss_pred CCCCC
Q 001678 1026 FIDFF 1030 (1033)
Q Consensus 1026 PFd~~ 1030 (1033)
||+..
T Consensus 211 p~~~~ 215 (316)
T cd05108 211 PYDGI 215 (316)
T ss_pred CCCCC
Confidence 99754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=291.24 Aligned_cols=195 Identities=25% Similarity=0.385 Sum_probs=160.1
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILsk-L~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+|+++ ++.||||+++...... ......+..|..++.. ++||||+++++++.+ .+.+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-----DDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEE
Confidence 36999999999999884 6789999988643211 1122345667777765 489999999999988 678999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+.+++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD----RDGHIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEeCccCCCeeccc
Confidence 999999999999987654 488999999999999999999999999999999999998 677899999999875321
Q ss_pred -ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 -~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLK------------------YTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCC------------------CCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 22234567999999999987642 566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=291.70 Aligned_cols=201 Identities=30% Similarity=0.442 Sum_probs=169.4
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
+..++|++.++||+|+||.||++.++ +..+|+|.+.... .......+.+|++++++++|+||++++++|.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 45678999999999999999999884 6678889876431 11233568899999999999999999999998
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHsk-GIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
.+.+++||||+.+++|.+++.+.+ .+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----~~~~~kL~D 147 (333)
T cd06650 75 --DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 147 (333)
T ss_pred --CCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc----CCCCEEEee
Confidence 678999999999999999997654 488899999999999999999975 799999999999998 667899999
Q ss_pred cCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
||++...... ......||..|+|||++.+. .++.++|+|||||++|+|++|+.||+..
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~------------------~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGT------------------HYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcCC------------------CCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9998765332 22345689999999998654 2456789999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=284.93 Aligned_cols=196 Identities=27% Similarity=0.385 Sum_probs=159.4
Q ss_pred EEecccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceE
Q 001678 806 RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~ 881 (1033)
.+||+|+||.||+|+.+ +..||+|.+..... ...+.+|+.+++.++||||+++++++.......++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 57999999999999864 35689998764321 12466899999999999999999999765567889
Q ss_pred EEEeeccCCcHHHHHHhc--------CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 882 TVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~--------~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+||||+. ++|.+++... ...+++..+..++.||+.||.|||+.+|+||||||+|||+..++...+.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9999985 5888877531 224788899999999999999999999999999999999965544678999999
Q ss_pred cCCcccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||+++...... ......||..|+|||++.+.. .++.++|||||||++|+|+||++||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----------------~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-----------------HYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCC-----------------ccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99998654322 123456899999999986532 356678999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=290.89 Aligned_cols=195 Identities=26% Similarity=0.385 Sum_probs=159.8
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILsk-L~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+|+++ ++.||||+++...... ......+..|..++.. ++||||+++++++.+ .+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEE
Confidence 36999999999999884 5679999988643211 1122345567777775 489999999999988 567999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD----TDGHIKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEccCCcceECCC
Confidence 999999999999997653 478899999999999999999999999999999999998 677899999999875322
Q ss_pred -ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 963 -~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
........||..|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLGQK------------------YNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred CCCceeeecCCccccCHHHHcCCC------------------CCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 12233456899999999987642 566789999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=312.90 Aligned_cols=196 Identities=27% Similarity=0.292 Sum_probs=168.4
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-C-----CCcceEEEEE
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-H-----PNVVSFYGIV 872 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-H-----PNIVrLyG~f 872 (1033)
+|++++.||+|+||.|.+|.+ +++.||||+++.. .........|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 799999999999999999987 4788999999853 233445667899999997 3 3899999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
.. .+++|||+|.+ ..+|.++|+.+. ..++...++.|+.||+.||.+||+.+|||+||||+||||..- ....|||
T Consensus 258 ~f--r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--~r~~vKV 332 (586)
T KOG0667|consen 258 YF--RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--KRSRIKV 332 (586)
T ss_pred cc--ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC--CcCceeE
Confidence 99 78999999998 779999998653 458999999999999999999999999999999999999733 4569999
Q ss_pred EecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+|||.|........ ...-+..|+|||+|.|-+ |+++.||||||||+.||++|.+.|.--
T Consensus 333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp------------------Y~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP------------------YDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred EecccccccCCcce--eeeeccccccchhhccCC------------------CCCccceeehhhhHHhHhcCccccCCC
Confidence 99999987655433 344577899999999864 788889999999999999999999653
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=290.15 Aligned_cols=195 Identities=23% Similarity=0.357 Sum_probs=162.3
Q ss_pred EEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||+||+++++ ++.||||+++...... ......+.+|..++..+ +||||+++++++.+ .+.+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-----DDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEE
Confidence 36999999999999884 6679999988643221 12234567788888887 69999999999987 568999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~- 961 (1033)
||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD----SEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC----CCCcEEecccCCCeecCc
Confidence 999999999999987664 489999999999999999999999999999999999998 67899999999987532
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
........+||+.|+|||++.+.. ++.++|+|||||++|+|+||+.||...
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~~~------------------~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSYQP------------------YGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred CCCcccceecCccccCHHHhcCCC------------------CCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 222233456899999999987642 566789999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=279.75 Aligned_cols=200 Identities=27% Similarity=0.357 Sum_probs=160.5
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEcC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVRDG 875 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL---~HPNIVrLyG~f~d~ 875 (1033)
+|++++.||+|+||.||+|+++ ++.||+|.++........ ...+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 5889999999999999999884 677999988754322111 11234556555554 799999999998752
Q ss_pred ---CCCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 876 ---PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 876 ---~eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
....+++||||+. ++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKL 149 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEE
Confidence 2345899999996 58999887643 3489999999999999999999999999999999999998 6788999
Q ss_pred EecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+|||+++............||..|+|||++.+. .++.++|||||||++|+|++|++||..
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS------------------TYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhCC------------------CCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 999999876544444455689999999998654 256678999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=306.56 Aligned_cols=199 Identities=20% Similarity=0.295 Sum_probs=166.7
Q ss_pred CCceEEEEecccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k---G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..|.+.+.||+|+||.||+|... +..||+|.+... .......+.+|+.+++.++||||++++++|..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-- 136 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKS-- 136 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--
Confidence 34999999999999999999763 456888865432 11223467789999999999999999999988
Q ss_pred CCceEEEEeeccCCcHHHHHHhc---CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~---~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
.+.++|||||+++|+|.++|.+. ...+++..+..++.||+.||.|||+++|+||||||+||||+ ..+.+||+|
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~~kL~D 212 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGD 212 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC----CCCcEEEEe
Confidence 67899999999999999988642 34588999999999999999999999999999999999998 678999999
Q ss_pred cCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 954 LGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||...
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK------------------RYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCC------------------CCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99998654322 23456799999999998664 2566789999999999999999999653
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=280.69 Aligned_cols=200 Identities=27% Similarity=0.326 Sum_probs=167.8
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|+..+.||+|+||+||++.+. ++.||+|.+...... .......+.+|+.+++.++|+||+.+++.+.+ ...
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~ 74 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDA 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCE
Confidence 778899999999999999884 778999988654221 11223456789999999999999999999887 568
Q ss_pred eEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 880 LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
+++||||+.+++|.+++...+ ..+++..+..++.|++.||.|||+++|+||||||+|||++ ..+.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~----~~~~~kl~Dfg~~~ 150 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC----CCCCEEEecCCcce
Confidence 999999999999999887543 4589999999999999999999999999999999999998 66789999999987
Q ss_pred ccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
............|+..|+|||++.+. .++.++|+|||||++|+|+||..||...
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~~~~------------------~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVLNNQ------------------RYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHhcCC------------------CCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 65433333345789999999998654 2566789999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=292.42 Aligned_cols=200 Identities=23% Similarity=0.289 Sum_probs=165.5
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++|+||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 46899999999999999999987 477899998864321 1223356778999999999999999999987521
Q ss_pred ----CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 ----eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
....++||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~----~~~~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 161 (355)
T ss_pred cccccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC----CCCCEEEe
Confidence 235799999995 467777653 378888999999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
|||+++............||..|+|||++.+. .++.++|+|||||++|+|++|+.||...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGM------------------GYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred eCcccccCCCccccCCccccCCccCHHHHcCC------------------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999876555444556789999999998764 2566789999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=294.10 Aligned_cols=190 Identities=26% Similarity=0.381 Sum_probs=160.6
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
+...+|++++.||+|+||.||+|++. +..||+|+.... ....|+.++++++|+||+++++++..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34567999999999999999999985 457899974322 23468899999999999999999998
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
....++||||+ .++|.+++.+....+++..++.|+.||+.||.|||+++||||||||+|||++ ..+.+||+||
T Consensus 129 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kl~Df 201 (357)
T PHA03209 129 --GAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDL 201 (357)
T ss_pred --CCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEecC
Confidence 56789999999 5789999987777799999999999999999999999999999999999998 6778999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~ 1025 (1033)
|+++............||..|+|||++.+. .++.++|||||||++|+|+++..
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DiwSlGvvl~ell~~~~ 254 (357)
T PHA03209 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARD------------------KYNSKADIWSAGIVLFEMLAYPS 254 (357)
T ss_pred ccccccccCcccccccccccccCCeecCCC------------------CCCchhhHHHHHHHHHHHHHcCC
Confidence 999764433333456689999999998764 25667899999999999997543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=281.70 Aligned_cols=200 Identities=26% Similarity=0.340 Sum_probs=167.5
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|++.+.||+|+||.||++.+. ++.||||.+....... ......+.+|+.+++.++|++|+.+++.+.+ ..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-----hHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CC
Confidence 3788899999999999999884 6789999887543221 1223456789999999999999999999987 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeccce
Confidence 8999999999999999986543 3588999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.............||..|+|||++.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~------------------~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVKNER------------------YTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred eecCCCccccCCCCCccccChHHHcCCC------------------CCCccccHHHHHHHHHHHhCCCCCCC
Confidence 7654333333456899999999987642 55678999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=280.98 Aligned_cols=194 Identities=23% Similarity=0.316 Sum_probs=161.1
Q ss_pred ecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 808 LGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
||+|+||.||+++.+ ++.||+|++........ .....+..|+.++++++||||+++++++.+ ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-----SGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-----hhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEe
Confidence 799999999999874 78899999875432211 112345569999999999999999999987 567999999
Q ss_pred eccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc
Q 001678 886 FMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1033)
Q Consensus 886 YmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~ 964 (1033)
|+.+++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc----CCCCEEEeeceeeeecCCCc
Confidence 999999999886543 3488899999999999999999999999999999999998 67789999999988665443
Q ss_pred ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 965 ~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
......||..|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~------------------~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEP------------------YSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred eeeccCCCCCccCHHHHccCC------------------CCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 334456899999999986642 566789999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=272.44 Aligned_cols=198 Identities=34% Similarity=0.484 Sum_probs=167.2
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|++.+.||+|+||+||+++.. ++.||+|++.... ..........+|+.++++++|+||+++++++.+ ...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNY 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccc--ccc
Confidence 788999999999999999995 4469999988642 112222334569999999999999999999998 678
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++||||+.+++|.+++.+. ..+++..++.++.||++||.+||+.+++|+||||+|||++ .++.+||+|||++..
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~----~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD----ENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES----TTSEEEESSGTTTEE
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 99999999999999999843 4589999999999999999999999999999999999999 778999999999875
Q ss_pred c-ccccccCCcCCCCccccccccc-CCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 960 K-QQTLVSGGVRGTLPWMAPELLS-GKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 960 ~-~~~~~s~~~~GT~~YmAPEvi~-gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
. ..........+|..|+|||++. +. ..+.++|+||||+++|+|++|..||.-.
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQGK------------------KYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTTTS------------------SBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccc------------------cccccccccccccccccccccccccccc
Confidence 3 2333444567899999999987 32 3567789999999999999999998753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=296.70 Aligned_cols=207 Identities=26% Similarity=0.352 Sum_probs=175.5
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
..+..++|++..+||.|..++||+|++ +++.||||++....-. ..++.+.+|+..|+.++||||++++..|
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-------~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-------NDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-------hhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 345668899999999999999999988 5788999999864211 1256788999999999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
.. +..+|+||.||.+|++.++++.. ...+++..+..|++++++||.|||++|.||||||+.||||+ .+|.|||
T Consensus 94 vv--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~----~dG~VkL 167 (516)
T KOG0582|consen 94 VV--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID----SDGTVKL 167 (516)
T ss_pred Ee--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc----CCCcEEE
Confidence 98 67899999999999999999864 33489999999999999999999999999999999999999 7899999
Q ss_pred EecCCcccccc-cc---cc-CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCC
Q 001678 952 GDLGLSKVKQQ-TL---VS-GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCF 1026 (1033)
Q Consensus 952 iDFGLAr~~~~-~~---~s-~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~P 1026 (1033)
+|||.+..... .. .. ..++||++|||||++...-. -|+.|+||||||++..||.+|..|
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~----------------GYdfKaDIwSfGITA~ELA~G~aP 231 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH----------------GYDFKADIWSFGITACELAHGHAP 231 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhccc----------------CccchhhhhhhhHHHHHHhcCCCC
Confidence 99998764322 11 11 56789999999999654432 367788999999999999999999
Q ss_pred CCCC
Q 001678 1027 IDFF 1030 (1033)
Q Consensus 1027 Fd~~ 1030 (1033)
|.-+
T Consensus 232 f~k~ 235 (516)
T KOG0582|consen 232 FSKY 235 (516)
T ss_pred cccC
Confidence 9643
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=274.25 Aligned_cols=199 Identities=32% Similarity=0.532 Sum_probs=165.8
Q ss_pred CCCceEEEEecccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~kG-~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.++|++++.||+|+||.||++.++. ..+|+|.+...... .+.+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---------EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--Q 71 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---------HHHHHHHHHHHHHCCCCCceeEEEEEcc--C
Confidence 3578999999999999999998854 47899987643211 2367889999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||+++++|.+++......+++..++.++.|++.||+|||+.+++||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~d~g~~ 147 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMT 147 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc----CCCeEEECCCCCc
Confidence 679999999999999999986655689999999999999999999999999999999999998 6778999999998
Q ss_pred cccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 958 KVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
+....... .....++..|+|||++.+.. ++.++|+||||+++|+|++ |+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNFSK------------------YSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred cccCCCceeccCCCCCchhhCChhhcccCc------------------cchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 76432221 12233566899999986542 4567899999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=292.60 Aligned_cols=200 Identities=22% Similarity=0.280 Sum_probs=165.3
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||+|+||.||++.+ .++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC------chhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 46899999999999999999987 4677999988643211 122346778999999999999999999886521
Q ss_pred ----CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 ----eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
...+++||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC----CCCcEEEE
Confidence 235799999995 577777753 378888999999999999999999999999999999998 67899999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
|||+++............||..|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~------------------~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGM------------------GYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhCC------------------CCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 99999876554444456789999999998764 2566789999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.95 Aligned_cols=193 Identities=26% Similarity=0.347 Sum_probs=157.6
Q ss_pred ecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEcCCCCceEE
Q 001678 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 808 LGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL---~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
||+|+||+||+|+++ ++.||||++...... .......+..|..++..+ +||||+++++++.+ ...+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEE
Confidence 799999999999874 778999998653221 122233455666666655 69999999999988 567999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~- 961 (1033)
||||+.+++|.+++.+.. .+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD----ATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEecCCcCcCCCC
Confidence 999999999999987654 489999999999999999999999999999999999998 67789999999987532
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.........||+.|+|||++.+.. .++.++|||||||++|+|+||+.||..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~-----------------~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEK-----------------GYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCC-----------------CCCCccceeccccEEEEeccCCCCCCC
Confidence 222334567999999999986542 256678999999999999999999854
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=294.49 Aligned_cols=201 Identities=27% Similarity=0.354 Sum_probs=164.4
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC--
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~-- 876 (1033)
+|++++.||+|+||.||++.+ +++.||||++.... ......+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 478889999999999999986 57889999876421 11122356789999999999999999999988632
Q ss_pred -CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 877 -eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC----CCCCEEecccc
Confidence 126899999995 6888887654 3589999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+++...... ......+|..|+|||++.+.. .++.++||||||||+|+|++|+.||+..
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSR-----------------HYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCCC-----------------CCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 998653321 223345789999999987643 3456789999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=296.84 Aligned_cols=205 Identities=30% Similarity=0.413 Sum_probs=166.6
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcc
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIV 866 (1033)
+.+..++|++.+.||+|+||.||+|.+. +..||||+++.... ......+.+|+.+++.+ +|+||+
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------TDEREALMSELKILSHLGQHKNIV 105 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------HHHHHHHHHHHHHHHhhccCCcee
Confidence 3455678999999999999999999762 24699999875321 11235678899999999 899999
Q ss_pred eEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC----------------------------------------------
Q 001678 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------------------------------- 900 (1033)
Q Consensus 867 rLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------------------------------------- 900 (1033)
+++++|.+ .+.+++||||+.+|+|.+++....
T Consensus 106 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (374)
T cd05106 106 NLLGACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE 183 (374)
T ss_pred eEeeEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence 99999988 568999999999999999986431
Q ss_pred -----------------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 901 -----------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 901 -----------------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++..+++|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~----~~~~~kL~DfGla 259 (374)
T cd05106 184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGLA 259 (374)
T ss_pred cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe----CCCeEEEeeceee
Confidence 1367788899999999999999999999999999999998 6778999999999
Q ss_pred ccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 958 KVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
+...... ......++..|||||++.+. .++.++|||||||++|+|++ |+.||...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDC------------------VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred eeccCCcceeeccCCCCccceeCHHHhcCC------------------CCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 7653322 12223356789999998654 35678899999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=310.50 Aligned_cols=211 Identities=33% Similarity=0.526 Sum_probs=175.1
Q ss_pred HHhccccccCCCceEEEEecccCcEEEEEEEEc--Cc---c-eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCC
Q 001678 790 IARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GS---D-VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863 (1033)
Q Consensus 790 ~~~~~~~i~~~dYeilekLGeGgFG~VYkAk~k--G~---k-VAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HP 863 (1033)
+.+..+++..++..+.++||+|+||.||+|+.+ +. . ||||..+.... ..+..+..|.+|+++|++++||
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-----~~~~~~~e~m~EArvMr~l~H~ 221 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-----LTKEQIKEFMKEARVMRQLNHP 221 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-----ccHHHHHHHHHHHHHHHhCCCC
Confidence 345667788888899999999999999999873 11 2 79998875221 2244567899999999999999
Q ss_pred CcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q 001678 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 864 NIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d 943 (1033)
|||++||++.. +..+++|||+|.||+|.++|++.+..++..+++.++.+.+.||+|||++++|||||..+|+|++
T Consensus 222 NVVr~yGVa~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~--- 296 (474)
T KOG0194|consen 222 NVVRFYGVAVL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS--- 296 (474)
T ss_pred CEEEEEEEEcC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---
Confidence 99999999988 6789999999999999999999887899999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCccccccccccC-CcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc
Q 001678 944 PQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF 1022 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~~~~~s~-~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT 1022 (1033)
.++.+||+||||++....-.... ...-...|+|||.+... .++.++|||||||++||+++
T Consensus 297 -~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~------------------~~s~kTDV~sfGV~~~Eif~ 357 (474)
T KOG0194|consen 297 -KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG------------------IFSFKTDVWSFGVLLWEIFE 357 (474)
T ss_pred -CCCeEEeCccccccCCcceeeccccccCcceecChhhhccC------------------ccccccchhheeeeEEeeec
Confidence 66779999999998654222222 22346889999998764 25667788999999999888
Q ss_pred -cCCCCCC
Q 001678 1023 -ILCFIDF 1029 (1033)
Q Consensus 1023 -Gk~PFd~ 1029 (1033)
|..||.-
T Consensus 358 ~g~~Py~g 365 (474)
T KOG0194|consen 358 NGAEPYPG 365 (474)
T ss_pred cCCCCCCC
Confidence 6777754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=302.97 Aligned_cols=202 Identities=23% Similarity=0.335 Sum_probs=179.3
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
-|.+.+.||+|.|+.|-+|++ +|.+||||++.+..+.. .....+.+|++.|+..+|||||++|++..+ ..
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~------~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QT 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT------LSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QT 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch------hhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cc
Confidence 367778999999999999976 89999999998765432 223467899999999999999999999888 67
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+|||+|.-++|+|++||-+....+.+..+.+++.||+.||.|+|+..||||||||+|+.+. ..-|.|||+|||++.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF---EKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF---EKLGLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe---eecCceEeeeccccc
Confidence 89999999999999999999888899999999999999999999999999999999999987 356899999999999
Q ss_pred ccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.+.........||++.|.|||++.|..++ ..++||||||||||.|.+|++||.-.
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYD-----------------APAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYD-----------------APAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccC-----------------CcchhhhHHHHHHHHHHhCCCccccc
Confidence 88888778889999999999999987532 23679999999999999999999644
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=286.25 Aligned_cols=206 Identities=28% Similarity=0.392 Sum_probs=178.7
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
.+...++|++.+.||+|.||.||+|+.+ +.-||+|++.+..+ ........+.+|++|-+.|+||||+++|++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-----~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-----LKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-----HHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 3455678999999999999999999885 45589999887643 2333446788999999999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHh-cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~-~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
.+ ...+||++||...|+|...|+. ....+++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||
T Consensus 92 hd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----~~~~lki 165 (281)
T KOG0580|consen 92 HD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----SAGELKI 165 (281)
T ss_pred ec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----CCCCeec
Confidence 99 6789999999999999999984 344588888999999999999999999999999999999998 7789999
Q ss_pred EecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+|||.+.... .......|||..|.+||+..+.. .+..+|+|++||+.|+++.|.+||..-
T Consensus 166 AdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~------------------hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 166 ADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG------------------HDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred cCCCceeecC-CCCceeeecccccCCHhhcCCCC------------------ccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 9999987665 44556789999999999998874 566789999999999999999999754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=295.27 Aligned_cols=204 Identities=28% Similarity=0.415 Sum_probs=165.5
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcce
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~-------kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVr 867 (1033)
.+..++|++.++||+|+||.||+|++ .+..||||+++.... ....+.+.+|+.++..+ +||||++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~il~~l~~HpnIv~ 103 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHINIVN 103 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------cHHHHHHHHHHHHHHHhcCCcceee
Confidence 34556899999999999999999975 244699998874321 11234678899999999 8999999
Q ss_pred EEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC-----------------------------------------------
Q 001678 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------------------------------- 900 (1033)
Q Consensus 868 LyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~----------------------------------------------- 900 (1033)
++++|.+ .+..++||||+++|+|.+++.+..
T Consensus 104 l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 104 LLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 9999988 567899999999999999996532
Q ss_pred ---------------------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 901 ---------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 901 ---------------------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
..+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~----~~~~~kl~D 257 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICD 257 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE----CCCcEEEec
Confidence 1367888899999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 954 LGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
||+++...... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||..
T Consensus 258 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 258 FGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC------------------VYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred CccceeccCcccccccCCCCCCcceeChhHhcCC------------------CCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 99998653321 12223356779999998654 25667899999999999997 8888865
Q ss_pred C
Q 001678 1030 F 1030 (1033)
Q Consensus 1030 ~ 1030 (1033)
.
T Consensus 320 ~ 320 (375)
T cd05104 320 M 320 (375)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=268.15 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=169.7
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.+.||+|++|.||++.+ +++.|++|.+...... ......+.+|+.+++.++||||+++++++.+ .+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN------RREREEAIDEARVLAKLDSSYIIRYYESFLD--KG 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC------HHHHHHHHHHHHHHHhcCCCCeehheeeecc--CC
Confidence 588899999999999999987 4788999988654221 2234578899999999999999999999987 57
Q ss_pred ceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~----~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe----CCCCEEEcccccc
Confidence 899999999999999999875 45689999999999999999999999999999999999998 6688999999998
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+...... ......|++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKP------------------YNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCC------------------CCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 8654332 223456889999999987642 456789999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=279.62 Aligned_cols=202 Identities=28% Similarity=0.435 Sum_probs=167.8
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
+.++|+++++||+|+||.||+|+++ ++.||+|.++...... ....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~- 75 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIIHT- 75 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-------chhHHHHHHHHHHhcCCCCcceEEEEEec-
Confidence 3467999999999999999999874 6779999887542211 11246689999999999999999999987
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....++||||+. ++|.+++.+....+++..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||
T Consensus 76 -~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~dfg 149 (301)
T cd07873 76 -EKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFG 149 (301)
T ss_pred -CCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----CCCcEEECcCc
Confidence 578999999996 699999987766789999999999999999999999999999999999998 67789999999
Q ss_pred Ccccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++....... ......+++.|+|||++.+.. .++.++|||||||++|+|+||++||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----------------~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 150 LARAKSIPTKTYSNEVVTLWYRPPDILLGST-----------------DYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred chhccCCCCCcccccceeecccCcHHHhCCC-----------------CCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 987643222 222345688999999886542 3456789999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=294.82 Aligned_cols=194 Identities=20% Similarity=0.275 Sum_probs=162.5
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
+...+|++++.||+|+||.||++... +..||+|.+... ..+.+|+.++++++|+||+++++++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 34567999999999999999999763 456888876532 1345799999999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
.. ...+++|||++ .++|.+++... ..+++..++.|+.||+.||.|||++|||||||||+|||++ ..+.+||+
T Consensus 156 ~~--~~~~~lv~e~~-~~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~----~~~~~~l~ 227 (392)
T PHA03207 156 RW--KSTVCMVMPKY-KCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD----EPENAVLG 227 (392)
T ss_pred ee--CCEEEEEehhc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEc
Confidence 87 57899999999 57899988443 4589999999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD------------------PYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCC------------------CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999997654322 12345699999999998764 256678999999999999999999843
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=271.17 Aligned_cols=205 Identities=28% Similarity=0.384 Sum_probs=169.0
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.+|++.+.||+|+||.||++++ ++..||||++...... ......++.+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 4789999999999999999987 4678999987643211 1122345678899999999999999999999887555
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+++|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD----SVGNVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----CCCCEEECcCccc
Confidence 67889999999999999997654 478888999999999999999999999999999999998 6789999999998
Q ss_pred cccccc----cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~----~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+..... .......|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEG------------------YGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCC------------------CCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 754321 1122356889999999886542 456789999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=275.80 Aligned_cols=199 Identities=29% Similarity=0.426 Sum_probs=170.1
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||++++ .++.||+|++...... .....+.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--D 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--C
Confidence 4789999999999999999988 4678999988754221 12334678899999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+.|++|+||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~dfg~~ 148 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFA 148 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 67999999999999999997764 589999999999999999999999999999999999998 6688999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
...... .....|++.|+|||.+.+.. .+.++|+||||+++|+|++|+.||...
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIILSKG------------------YGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhcCCC------------------CCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 876443 33456899999999886542 456789999999999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=274.84 Aligned_cols=203 Identities=28% Similarity=0.470 Sum_probs=166.1
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE--cCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~--kG~----kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
.+...+|+++++||+|+||+||+|++ ++. .||+|+++... .......+.+|+.+++.++|+||++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 35567899999999999999999986 333 37899876432 112234678899999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
+++.. ...+++|||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+
T Consensus 76 ~~~~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~----~~~~~ 148 (279)
T cd05109 76 GICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK----SPNHV 148 (279)
T ss_pred EEEcC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc----CCCcE
Confidence 99876 347899999999999999987666789999999999999999999999999999999999998 56789
Q ss_pred EEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCC
Q 001678 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILC 1025 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~ 1025 (1033)
||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|+| |..
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~Di~slG~~l~el~t~g~~ 210 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR------------------RFTHQSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccC------------------CCCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999986543221 1122346789999998654 25667899999999999998 899
Q ss_pred CCCCC
Q 001678 1026 FIDFF 1030 (1033)
Q Consensus 1026 PFd~~ 1030 (1033)
||+..
T Consensus 211 p~~~~ 215 (279)
T cd05109 211 PYDGI 215 (279)
T ss_pred CCCCC
Confidence 98653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=291.72 Aligned_cols=205 Identities=25% Similarity=0.350 Sum_probs=179.5
Q ss_pred cccccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 794 ~~~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
...+..++|..+++||+|.||+|.+++. .++-+|||++++..+..+ ..+..-+.|-++|+..+||.+..+...
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak-----dEVAHTlTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK-----DEVAHTLTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh-----HHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence 3455678899999999999999999977 477799999998766543 234577789999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
|+. +..+|+||||..||.|...|.+.. .+++.....+..+|+.||.|||+++||+||||.+|+||| .+|++||
T Consensus 237 FQt--~drlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD----kDGHIKi 309 (516)
T KOG0690|consen 237 FQT--QDRLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD----KDGHIKI 309 (516)
T ss_pred hcc--CceEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec----cCCceEe
Confidence 998 788999999999999999998754 477777778888999999999999999999999999999 8899999
Q ss_pred EecCCccc-cccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 952 GDLGLSKV-KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 952 iDFGLAr~-~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
+|||+++. +.....+..+|||+.|+|||++... .|+.++|+|.+|||||+|++|+.||-
T Consensus 310 tDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDn------------------DYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDN------------------DYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eecccchhcccccceeccccCChhhcCchhhccc------------------cccceeehhhhhHHHHHHHhccCccc
Confidence 99999985 3455567789999999999999765 47788999999999999999999994
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=273.39 Aligned_cols=200 Identities=32% Similarity=0.542 Sum_probs=166.6
Q ss_pred cCCCceEEEEecccCcEEEEEEEEcCc-ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~kG~-kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
...+|++++.||+|+||.||++++.+. .+|||.+...... ...+.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 70 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMKLSHEKLVQLYGVCTK-- 70 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---------HHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 346799999999999999999988654 5999987643211 2467889999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+||+|||+
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~d~g~ 146 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGL 146 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCCEEECCCcc
Confidence 5678999999999999999987665789999999999999999999999999999999999998 667899999999
Q ss_pred ccccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 957 SKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~------------------~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLYS------------------KFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHhcC------------------cccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 875433221 1122356779999988654 25567899999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=304.76 Aligned_cols=201 Identities=26% Similarity=0.358 Sum_probs=175.1
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
....|+.+++||+|+||.||+|.+ .++.||||++..... +..++++.+|+.++.+++++||.++|+.+..
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-------~deIediqqei~~Ls~~~~~~it~yygsyl~- 82 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-------EDEIEDIQQEISVLSQCDSPNITEYYGSYLK- 82 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhc-------chhhHHHHHHHHHHHhcCcchHHhhhhheee-
Confidence 345688889999999999999988 467799999986532 3345688899999999999999999999998
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
...++++||||.||++.++|+..+ .+++..+..|+++++.||.|||.++.+|||||+.|||+. ..+.|||+|||
T Consensus 83 -g~~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s----~~g~vkl~Dfg 156 (467)
T KOG0201|consen 83 -GTKLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS----ESGDVKLADFG 156 (467)
T ss_pred -cccHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEe----ccCcEEEEecc
Confidence 577999999999999999997654 358888888999999999999999999999999999998 66899999999
Q ss_pred Ccccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.+....... ....++||+.|||||++.+. .|+.++||||||+++|||++|.+|+.-+
T Consensus 157 Va~ql~~~~~rr~tfvGTPfwMAPEVI~~~------------------~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 157 VAGQLTNTVKRRKTFVGTPFWMAPEVIKQS------------------GYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred eeeeeechhhccccccccccccchhhhccc------------------cccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 998776554 33688999999999999865 4778889999999999999999998543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=275.80 Aligned_cols=201 Identities=31% Similarity=0.507 Sum_probs=164.9
Q ss_pred CCCceEEEEecccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~kG-------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
..+|++++.||+|+||.||+|...+ ..||+|.++... .......+.+|+.++.+++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 4578999999999999999998743 358999876431 12234568899999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsN 936 (1033)
+.. ....+++|||+++++|.+++.+.. ..+++..++.++.|++.||.|||+++++|+||||+|
T Consensus 77 ~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N 154 (283)
T cd05048 77 CTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN 154 (283)
T ss_pred EcC--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence 987 567899999999999999997642 347888999999999999999999999999999999
Q ss_pred EEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHH
Q 001678 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSL 1013 (1033)
Q Consensus 937 ILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSL 1013 (1033)
||++ .++.+||+|||+++...... ......+++.|+|||.+.+. .++.++|+|||
T Consensus 155 il~~----~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~sDv~sl 212 (283)
T cd05048 155 CLVG----EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG------------------KFTTESDIWSF 212 (283)
T ss_pred EEEc----CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC------------------cCchhhhHHHH
Confidence 9998 67789999999987543221 12234468889999988654 24567899999
Q ss_pred HHHHHHHHc-cCCCCCCC
Q 001678 1014 GILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1014 GVVLYeLLT-Gk~PFd~~ 1030 (1033)
||++|+|++ |..||...
T Consensus 213 G~il~el~~~g~~p~~~~ 230 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred HHHHHHHHcCCCCCCCCC
Confidence 999999998 99888643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=268.40 Aligned_cols=202 Identities=30% Similarity=0.420 Sum_probs=168.6
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|++|.||++.. .+..||+|.+...... .......+.+.+|+.++++++||||+++++++.+ .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--C
Confidence 4688899999999999999976 4788999988754221 1222335678899999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+++||||||+||+++ .++.+||+|||++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~----~~~~~~l~dfg~~ 151 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 151 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 68999999999999999997654 488899999999999999999999999999999999998 6678999999998
Q ss_pred ccccccccc----CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTLVS----GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~~s----~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+........ ....|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||.-
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG------------------YGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC------------------CCchhhhHHHHHHHHHHHhCCCCccc
Confidence 765332111 2345788999999987642 45678999999999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=299.42 Aligned_cols=202 Identities=20% Similarity=0.301 Sum_probs=159.6
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC------CCCcceE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH------HPNVVSF 868 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~------HPNIVrL 868 (1033)
+..++|+++++||+|+||+||+|.+ .++.||||+++... .....+..|+.+++.++ |.+|+++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 3457899999999999999999987 46679999986421 11123445666665554 4568899
Q ss_pred EEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCC---
Q 001678 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDP--- 944 (1033)
Q Consensus 869 yG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~--- 944 (1033)
+++|... .+.+|+|||++ +++|.+++.+.+ .+++..++.|+.||+.||+|||+ .|||||||||+||||+.++.
T Consensus 197 ~~~~~~~-~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 197 QRYFQNE-TGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEEEEcC-CceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccc
Confidence 9998763 45789999998 888999887654 48999999999999999999998 59999999999999984321
Q ss_pred ---------CCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHH
Q 001678 945 ---------QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGI 1015 (1033)
Q Consensus 945 ---------~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGV 1015 (1033)
....+||+|||++..... .....+||+.|+|||++.+.. ++.++|||||||
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~------------------~~~~~DiwSlGv 333 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLG------------------WMYSTDMWSMGC 333 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCC------------------CCcHHHHHHHHH
Confidence 123699999998864322 233567999999999987653 566789999999
Q ss_pred HHHHHHccCCCCCCC
Q 001678 1016 LFFFLQFILCFIDFF 1030 (1033)
Q Consensus 1016 VLYeLLTGk~PFd~~ 1030 (1033)
|+|+|+||+.||+..
T Consensus 334 il~elltG~~pf~~~ 348 (467)
T PTZ00284 334 IIYELYTGKLLYDTH 348 (467)
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=302.62 Aligned_cols=205 Identities=24% Similarity=0.309 Sum_probs=170.0
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
..++|++.+.||+|+||+||++++ +++.||||++...... ......+.+|+.++..++|+||+++++.+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 456899999999999999999987 5788999998754321 22345678899999999999999998877642
Q ss_pred CC------CceEEEEeeccCCcHHHHHHhc---CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCC
Q 001678 876 PD------GSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1033)
Q Consensus 876 ~e------g~l~LVmEYmegGSL~dlL~~~---~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~ 946 (1033)
.. ..+++||||+.+|+|.++|... ...+++..+..|+.|++.||.|||+.+|+||||||+||||+ .+
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~----~~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----SN 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe----CC
Confidence 21 1368999999999999999753 34588999999999999999999999999999999999998 67
Q ss_pred CeEEEEecCCccccccc---cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc
Q 001678 947 PVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI 1023 (1033)
Q Consensus 947 g~VKLiDFGLAr~~~~~---~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG 1023 (1033)
+.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------------------~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP------------------YSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCC------------------CCcHHHHHHHHHHHHHHHHC
Confidence 89999999999865432 1233567999999999987642 56678999999999999999
Q ss_pred CCCCCCC
Q 001678 1024 LCFIDFF 1030 (1033)
Q Consensus 1024 k~PFd~~ 1030 (1033)
+.||...
T Consensus 242 ~~Pf~~~ 248 (496)
T PTZ00283 242 KRPFDGE 248 (496)
T ss_pred CCCCCCC
Confidence 9999753
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.17 Aligned_cols=199 Identities=22% Similarity=0.318 Sum_probs=164.4
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||+|+||.||+|.+ .++.||||++.... ........+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF------QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 36799999999999999999987 46679999886431 11122346778999999999999999999886421
Q ss_pred ----CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 ----eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
...++++||++ +++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~----~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC----CCCCEEEc
Confidence 23578999998 8899988754 3489999999999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||+++..... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||..
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-----------------~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLNWM-----------------HYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcCCc-----------------cCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999865443 23456899999999986532 356778999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=271.58 Aligned_cols=199 Identities=32% Similarity=0.555 Sum_probs=164.9
Q ss_pred CCCceEEEEecccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~kG-~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
..+|++.+.||+|+||.||++++++ ..+|+|++...... ...+.+|+.+++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTK--Q 71 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcC--C
Confidence 3468889999999999999998854 46899987643211 1357789999999999999999999887 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+++||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~dfg~~ 147 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLA 147 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC----CCCcEEECCcccc
Confidence 679999999999999999987666789999999999999999999999999999999999998 6788999999998
Q ss_pred ccccccccc--CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 958 KVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~~s--~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
+........ ....++..|+|||.+.+. .++.++|+|||||++|+|+| |+.||+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~------------------~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYS------------------RFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccC------------------CCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 765332211 112235679999988654 24567899999999999999 89999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=269.87 Aligned_cols=201 Identities=29% Similarity=0.527 Sum_probs=167.1
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
.+..++|+++++||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---------hHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 355678999999999999999999874 56789998764211 13568899999999999999999999887
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
....++||||+.+++|.+++.+. ...+++..++.++.|++.||.|||+.+++||||||+||+++ .++.+||+|
T Consensus 73 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~d 146 (261)
T cd05072 73 --EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIAD 146 (261)
T ss_pred --CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec----CCCcEEECC
Confidence 56789999999999999999753 45588889999999999999999999999999999999998 678999999
Q ss_pred cCCccccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 954 LGLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
||++........ .....++..|+|||++.+. .++.++|+|||||++|+|+| |..||..
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFG------------------SFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred CccceecCCCceeccCCCccceecCCHHHhccC------------------CCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 999986543321 1223456789999988654 24556799999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=297.40 Aligned_cols=205 Identities=24% Similarity=0.335 Sum_probs=175.4
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEcCc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~kG~--kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~ 871 (1033)
..+...+|.++.+||+|+||+|.+|..+|+ .+|||+++++.+....... --..|.++|.... -|.++++...
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDve-----ctm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVE-----CTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCccc-----ceehhhhheecCCCCchHHHHHHH
Confidence 356778999999999999999999988755 4899999988765443321 2234666776664 7889999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
|++ -+.+|+||||+.||+|...|++.++ +.+..+..+|.+|+.||-+||++|||+||||.+||||+ ..|++||
T Consensus 419 FQT--mDRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd----~eGHiKi 491 (683)
T KOG0696|consen 419 FQT--MDRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKI 491 (683)
T ss_pred hhh--hhheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec----cCCceEe
Confidence 998 5789999999999999999998876 77888888999999999999999999999999999999 7889999
Q ss_pred EecCCcccc-ccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 952 GDLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 952 iDFGLAr~~-~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+|||+++.. -....+.+++||+.|+|||++...+ |+.++|+||+||+|||||.|.+||+-
T Consensus 492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP------------------YgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP------------------YGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred eecccccccccCCcceeeecCCCcccccceEEecc------------------cccchhHHHHHHHHHHHHcCCCCCCC
Confidence 999999864 3344566899999999999998764 67788999999999999999999985
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=274.82 Aligned_cols=206 Identities=29% Similarity=0.432 Sum_probs=170.6
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
..+.|+++++||.|+||.||+++.. ++.+++|.+... .....+.+.+|+.+++.++|+||+++++.+..
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW- 80 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-
Confidence 4467999999999999999999874 677899987642 12234578889999999999999999999987
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
.+.+++||||+++++|..++.+....+++..++.++.||+.+|.|||+.+++||||||+||+++ .++.+||+|||
T Consensus 81 -~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~dfg 155 (292)
T cd06644 81 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT----LDGDIKLADFG 155 (292)
T ss_pred -CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc----CCCCEEEccCc
Confidence 5789999999999999998877666789999999999999999999999999999999999998 66789999999
Q ss_pred Ccccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++....... ......++..|+|||++.+..... ..++.++|+|||||++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-------------~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 156 VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD-------------TPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred cceeccccccccceecCCccccCceeeccccccC-------------CCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 987543221 223455789999999985432111 13567789999999999999999999654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=272.08 Aligned_cols=199 Identities=28% Similarity=0.435 Sum_probs=163.9
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++++.||+|++|.||+|+. +++.||||+++..... +...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE------EGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ES 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc------CCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CC
Confidence 588999999999999999987 4778999988653211 1122456789999999999999999999987 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcC--CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~--k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+||+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc----CCCcEEECcccc
Confidence 8999999996 68988886533 5689999999999999999999999999999999999998 678899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+....... ......+++.|+|||++.+.. .++.++|+|||||++|+|+||++||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSP-----------------RYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCCC-----------------CcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 87543221 122335688999999886542 245577999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=265.73 Aligned_cols=203 Identities=28% Similarity=0.377 Sum_probs=170.5
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.+.||+|+||.||+++.. ++.+++|++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 71 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--------DDFEIIQQEISMLKECRHPNIVAYFGSYLR-- 71 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--------hhHHHHHHHHHHHHhCCCCChhceEEEEEe--
Confidence 367999999999999999999873 67799999875321 123577899999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...++++|||+.+++|.+++......+++..++.++.|++.||.|||+.+++|+||||+||+++ .++.+||+|||+
T Consensus 72 ~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~ 147 (262)
T cd06613 72 RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGV 147 (262)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC----CCCCEEECcccc
Confidence 5679999999999999999987656689999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+....... ......++..|+|||.+.+... ..++.++|+|||||++|+|+||+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~---------------~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERK---------------GGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhccccc---------------CCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 87654322 2234568889999998865410 02456789999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=272.52 Aligned_cols=203 Identities=27% Similarity=0.430 Sum_probs=163.5
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
+..++|++.+.||+|+||.||+|.++ +..||||++.... .......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 45678999999999999999999764 3458999875321 111234688999999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd 940 (1033)
+++.+ ....++||||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+.+++||||||+|||++
T Consensus 76 ~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~ 153 (277)
T cd05062 76 GVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEcC--CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc
Confidence 99887 567999999999999999997532 2356788899999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHH
Q 001678 941 MRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017 (1033)
Q Consensus 941 ~~d~~~g~VKLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVL 1017 (1033)
.++.+||+|||+++....... .....++..|+|||++.+. .++.++|+|||||++
T Consensus 154 ----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l 211 (277)
T cd05062 154 ----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG------------------VFTTYSDVWSFGVVL 211 (277)
T ss_pred ----CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC------------------CcCchhHHHHHHHHH
Confidence 678899999999875432211 1123457789999998654 256678999999999
Q ss_pred HHHHc-cCCCCCCC
Q 001678 1018 FFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1018 YeLLT-Gk~PFd~~ 1030 (1033)
|+|++ |..||...
T Consensus 212 ~el~~~~~~p~~~~ 225 (277)
T cd05062 212 WEIATLAEQPYQGM 225 (277)
T ss_pred HHHHcCCCCCCCCC
Confidence 99999 68888643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=272.61 Aligned_cols=202 Identities=30% Similarity=0.470 Sum_probs=164.5
Q ss_pred cCCCceEEEEecccCcEEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~------kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
.-.+|++.+.||+|+||.||+|.+ .+..||+|.++... .......+.+|+.+++.++|+||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 346789999999999999999975 34668999876421 11223568889999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcC----------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~----------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPs 935 (1033)
+.. ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+
T Consensus 76 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 76 VTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred Eec--CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 887 567899999999999999986432 24788889999999999999999999999999999
Q ss_pred cEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHH
Q 001678 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012 (1033)
Q Consensus 936 NILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWS 1012 (1033)
|||++ .++.+||+|||+++...... ......++..|+|||++.+. .++.++|+||
T Consensus 154 nili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Dv~s 211 (283)
T cd05090 154 NILIG----EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG------------------KFSSDSDIWS 211 (283)
T ss_pred eEEEc----CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC------------------CCCchhhhHH
Confidence 99998 66789999999997643221 22334457789999988654 2566789999
Q ss_pred HHHHHHHHHc-cCCCCCCC
Q 001678 1013 LGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1013 LGVVLYeLLT-Gk~PFd~~ 1030 (1033)
|||++|+|++ |..||...
T Consensus 212 lG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 212 FGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred HHHHHHHHHcCCCCCCCCC
Confidence 9999999998 99888543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=268.37 Aligned_cols=198 Identities=32% Similarity=0.539 Sum_probs=166.3
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
+...+|++.+.||+|+||.||++..++..||+|.++... ..+.+.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 71 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE- 71 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-
Confidence 345689999999999999999999999999999875321 124678899999999999999999987653
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCC-ccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k-~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....++||||+++++|.+++.+... .+++..++.++.||+.||.|||++|++||||||+||+++ .++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg 147 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFG 147 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----CCCcEEecCCc
Confidence 4578999999999999999986543 478999999999999999999999999999999999998 67899999999
Q ss_pred CccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
+++...... ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||..
T Consensus 148 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~------------------~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 148 LTKEASSTQ--DTGKLPVKWTAPEALREK------------------KFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred cceeccccC--CCCccceeecCHHHHccC------------------CCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 987643322 223456789999988654 25567899999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=268.72 Aligned_cols=200 Identities=31% Similarity=0.500 Sum_probs=166.0
Q ss_pred CCCceEEEEecccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k-----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.++|++.+.||+|+||.||+|+++ ...||||+++... .......|.+|+.++++++|+||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence 467999999999999999999874 2368999876432 1222356888999999999999999999988
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
. .+..++||||+.+++|.+++......+++..++.++.|++.||.|||+.+|+|+||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----~~~~~~l~d 149 (266)
T cd05033 76 K--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSD 149 (266)
T ss_pred c--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCCEEECc
Confidence 7 5779999999999999999987666789999999999999999999999999999999999998 678899999
Q ss_pred cCCccccccc--c-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 954 LGLSKVKQQT--L-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~--~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
||+++..... . ......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.-
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~------------------~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR------------------KFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccC------------------CCccccchHHHHHHHHHHHccCCCCCCC
Confidence 9999876411 1 11122346789999988654 24567899999999999998 9988853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=269.21 Aligned_cols=200 Identities=25% Similarity=0.330 Sum_probs=165.9
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+++++ ++.||+|++....... ...+.+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 72 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP------VIKKIALREIRMLKQLKHPNLVNLIEVFRR--K 72 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc------cccHHHHHHHHHHHhCCCCCEeeeeeEEee--C
Confidence 46899999999999999999884 7789999886432111 112356789999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||++++.|..++... ..+++..++.++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~ 147 (286)
T cd07847 73 RKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT----KQGQIKLCDFGFA 147 (286)
T ss_pred CEEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc----CCCcEEECccccc
Confidence 6789999999998888876544 3589999999999999999999999999999999999998 6678999999999
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....... ......++..|+|||++.+.. .++.++|+|||||++|+|++|+.||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------------~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDT-----------------QYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCC-----------------CcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 8664432 223445788999999886532 245678999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=292.44 Aligned_cols=205 Identities=29% Similarity=0.384 Sum_probs=166.6
Q ss_pred cccccCCCceEEEEecccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCc
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNV 865 (1033)
Q Consensus 794 ~~~i~~~dYeilekLGeGgFG~VYkAk~kG-------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNI 865 (1033)
...+..++|++.++||+|+||.||+|++.+ ..||||+++.... ....+.+.+|+.+++++. ||||
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-------SSEKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhcCCCCCe
Confidence 344567789999999999999999998632 3589998864321 122357889999999996 9999
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------------------------------------------
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------------------------------------------- 900 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~--------------------------------------------- 900 (1033)
++++++|.+ .+.++|||||+++|+|.++|.+..
T Consensus 104 v~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (400)
T cd05105 104 VNLLGACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMK 181 (400)
T ss_pred eeEEEEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccc
Confidence 999999987 578999999999999999986531
Q ss_pred --------------------------------------------------CccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001678 901 --------------------------------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1033)
Q Consensus 901 --------------------------------------------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHR 930 (1033)
..+++..++.++.||+.||+|||+.+|+||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~ 261 (400)
T cd05105 182 QADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHR 261 (400)
T ss_pred cccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 236777888999999999999999999999
Q ss_pred CCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcc
Q 001678 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWS 1007 (1033)
Q Consensus 931 DIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~k 1007 (1033)
||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+. .++.+
T Consensus 262 dikp~Nill~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~ 319 (400)
T cd05105 262 DLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN------------------LYTTL 319 (400)
T ss_pred CCChHhEEEe----CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC------------------CCCch
Confidence 9999999998 67789999999998653221 12234467889999988654 25667
Q ss_pred cchHHHHHHHHHHHc-cCCCCCC
Q 001678 1008 YDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 1008 vDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
+|||||||++|+|++ |..||..
T Consensus 320 ~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 320 SDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred hhHHHHHHHHHHHHHCCCCCCcc
Confidence 899999999999996 8888864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.73 Aligned_cols=208 Identities=24% Similarity=0.289 Sum_probs=178.6
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~e 877 (1033)
.|+-.+.||.|..+.|.++.. ++..+|+|++....-........++.+.-.+|+.||+++. ||+|+.+.++++. .
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~ 95 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--D 95 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--c
Confidence 455557899999999998865 5788999998765544333345566777889999999985 9999999999998 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++|+|.|+.|.|+|+|...- .++++....|++|++.|++|||.++||||||||+|||++ ++-.+||+|||+|
T Consensus 96 sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld----dn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD----DNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec----cccceEEecccee
Confidence 78999999999999999998764 589999999999999999999999999999999999999 6778999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
+.+.........|||++|+|||.+...-.... .-|+..+|+|+.|||||.||.|.+||
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~------------pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENH------------PGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCC------------CCccchhhHHHHHHHHHHHHcCCCch
Confidence 99998888888999999999999864321111 14677889999999999999999998
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=269.54 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=167.0
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
....+|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.++++++|+||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------DDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------chHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 3456899999999999999999987 467799998864311 112356789999999999999999999987
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...+++||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.+||+||
T Consensus 78 --~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~----~~~~~~l~df 150 (267)
T cd06646 78 --REKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADF 150 (267)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEECcC
Confidence 578999999999999999987654 589999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 955 GLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|++....... ......|+..|+|||.+...... .++.++|+|||||++|+|++|..||.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~---------------~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 151 GVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG---------------GYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred ccceeecccccccCccccCccccCHhHcccccCC---------------CCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998653322 22345688999999987532100 24567899999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=271.24 Aligned_cols=197 Identities=28% Similarity=0.466 Sum_probs=162.0
Q ss_pred ceEEEEecccCcEEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 802 LEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~------kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
|++++.||+|+||+||++.+ .+..||+|.++.... ......+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 48999999999999988754 356799998864321 11234678899999999999999999998875
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....+++||||+.+++|.+++.+. .+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD----NDRLVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc----CCCcEEEeecc
Confidence 556789999999999999999764 389999999999999999999999999999999999998 66789999999
Q ss_pred Cccccccccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 956 LSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+++....... .....++..|+|||.+.+. .++.++|||||||++|+|+||..||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~------------------~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN------------------KFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhccc------------------CCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 9986543221 1122356679999988654 356678999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=307.95 Aligned_cols=205 Identities=23% Similarity=0.350 Sum_probs=173.9
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC---
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP--- 876 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~--- 876 (1033)
+...+.||+|+||.||+++. +|..||||.++...... ..+..-+|+++|++|+|+|||+++++-.+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r-------~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR-------PRERWCREIEILKKLNHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccc-------hHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence 45567899999999999986 58899999988654221 1234568999999999999999999866543
Q ss_pred -CCceEEEEeeccCCcHHHHHHh--cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 877 -DGSLATVTEFMVNGSLKQFLQK--KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 877 -eg~l~LVmEYmegGSL~dlL~~--~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
...-.+|||||.+|||+..|.+ +-..+++.+.+.+..++..||.|||..||+||||||.||++....+.....||||
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 3446799999999999999985 3345899999999999999999999999999999999999975554667889999
Q ss_pred cCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
||.|+...+.....++.||..|++||++.... .|+..+|.|||||++|++.||..||..+
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~-----------------~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQK-----------------KYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhcc-----------------CcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999888888999999999999987422 3667789999999999999999999654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=271.63 Aligned_cols=203 Identities=27% Similarity=0.415 Sum_probs=166.8
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|++++.||+|+||.||++.+. +..+++|.+.... ....+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~ 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--------EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENN 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCE
Confidence 577789999999999999885 4567888775321 1234578889999999999999999999988 568
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++||||+.+++|..++.+....+++..+..++.||+.||.|||+.|++||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~----~~~~~kl~dfg~~~~ 152 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT----LDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----cCCCEEEcccccccc
Confidence 8999999999999998877666789999999999999999999999999999999999998 677899999999875
Q ss_pred cccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 960 KQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 960 ~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
.... .......+|..|+|||++........ .++.++|+|||||++|+|++|++||..++
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-------------~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 153 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDR-------------PYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ccccccccccccccccccCHhhccccCCCCC-------------CCCccchhhhHHHHHHHHccCCCCccccC
Confidence 4322 12234568999999999853221100 35667899999999999999999997543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=273.11 Aligned_cols=205 Identities=28% Similarity=0.418 Sum_probs=170.8
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||.|+||.||++.+. +..+|+|++... .....+.+.+|+.++++++|+||+++++.+..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 73 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFY-- 73 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--
Confidence 356889999999999999999874 677999988643 12234578899999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...+++||||+.+++|.+++.+.+..+++..++.++.|++.||.|||+.+|+|+||||+||+++ .++.+||+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~----~~~~~~l~d~g~ 149 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT----LDGDVKLADFGV 149 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC----CCCCEEEccCcc
Confidence 5689999999999999999988777799999999999999999999999999999999999998 678999999999
Q ss_pred ccccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+...... .......++..|+|||++..+..... .++.++|+|||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-------------~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 150 SAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN-------------PYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred chhhcccccccceeecchhhcCHHHHhhcccCCC-------------CCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 8654322 12234568999999998754321110 2566789999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=263.92 Aligned_cols=202 Identities=27% Similarity=0.394 Sum_probs=170.0
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++++.||.|+||.||++.. .++.||+|++...... ....+.+..|+.++++++|+||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 588999999999999999977 4677999988753221 22235677899999999999999999988765566
Q ss_pred ceEEEEeeccCCcHHHHHHhc---CCccCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~---~k~Lse~~rl~Ia~QIa~GLeYLH-----skGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
.++++|||+.+++|.+++... ...+++..++.++.||+.||.||| +.+++|+||||+||+++ .++.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----~~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe----cCCCEE
Confidence 789999999999999999753 456899999999999999999999 88999999999999998 678999
Q ss_pred EEecCCccccccccc-cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 951 IGDLGLSKVKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~-s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+|||++........ .....++..|+|||++.+.. ++.++|+||||+++|+|++|+.||+.
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~------------------~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS------------------YDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCC------------------CCchhHHHHHHHHHHHHHHCCCcccC
Confidence 999999987654432 33456899999999986542 45678999999999999999999976
Q ss_pred C
Q 001678 1030 F 1030 (1033)
Q Consensus 1030 ~ 1030 (1033)
.
T Consensus 213 ~ 213 (265)
T cd08217 213 R 213 (265)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=270.65 Aligned_cols=199 Identities=34% Similarity=0.522 Sum_probs=163.2
Q ss_pred CCCceEEEEecccCcEEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~------kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
..+|++++.||+|+||.||++.. .+..||||++.... ....+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------AEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 45789999999999999999874 36679999876431 22345788999999999999999999988
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
.......+++||||+++++|.+++.+....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----~~~~~~l~ 150 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----SENRVKIG 150 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC----CCCeEEEC
Confidence 76545678999999999999999987666689999999999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 953 DFGLAr~~~~~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
|||++........ .....++..|+|||++.+.. ++.++|+|||||++|+|+++..++
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK------------------FSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCC------------------cChHHHHHHHHHHHHHHhhcCCcC
Confidence 9999986543221 11122345699999886542 456779999999999999976554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=266.57 Aligned_cols=193 Identities=28% Similarity=0.482 Sum_probs=158.9
Q ss_pred EecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEE
Q 001678 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVm 884 (1033)
.||+|+||.||+|.+ +++.||+|.+.... .......+.+|+.++++++|+||+++++++.. ....++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEE
Confidence 689999999999987 57789999875321 12233568899999999999999999999987 56799999
Q ss_pred eeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc
Q 001678 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1033)
Q Consensus 885 EYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~ 964 (1033)
||+.+++|.+++.+....+++..++.++.|++.||.|||+++++||||||+|||++ .++.+||+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc----CCCcEEECccccCccccccc
Confidence 99999999999987666689999999999999999999999999999999999998 66789999999987644321
Q ss_pred cc---CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 965 VS---GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 965 ~s---~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
.. ....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||+..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGR------------------YSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCC------------------CChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 11 1112345699999886542 4556799999999999997 88888654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=269.26 Aligned_cols=199 Identities=25% Similarity=0.348 Sum_probs=168.7
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.+.||+|+||.||+|++ .++.||+|++...... ......+.+|+.++++++|+||+++++++.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE------GGIPNQALREIKALQACQHPYVVKLLDVFPH--GS 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc------chhhHHHHHHHHHHHhCCCCCCcceeeEEec--CC
Confidence 588999999999999999987 4778999998754321 1223568899999999999999999999988 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++||||+ +++|.+++......+++..++.++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~----~~~~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS----ADGVLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc----CCCcEEEeeeeecc
Confidence 899999999 9999999987667799999999999999999999999999999999999998 67889999999988
Q ss_pred cccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ......|+..|+|||++.+.. .++.++|||||||++|+|+||.++|..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGAR-----------------KYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccc-----------------cCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 654332 123446899999999886532 245678999999999999999888853
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=267.03 Aligned_cols=200 Identities=25% Similarity=0.422 Sum_probs=166.8
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||+|+. +++.||||.++...... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-----AKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--D 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC-----HHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--C
Confidence 5799999999999999999987 57889999876432211 2233567889999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++++|+||||+|||++ .++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----~~~~~~l~d~ 150 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc----CCCCEEECcc
Confidence 678999999999999998863 234578899999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 955 GLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|++....... ......|++.|+|||.+.+.. ++.++|+||||+++|+|+||..||.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------------------~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG------------------YNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCC------------------CCchhhHHHHHHHHHHHhcCCCCCc
Confidence 9988654322 223456889999999886542 4556799999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=267.80 Aligned_cols=201 Identities=29% Similarity=0.542 Sum_probs=166.9
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
+...+|++.+.||+|+||.||+|.++ ++.||+|++.... .....+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 44567899999999999999999874 6779999876421 113467889999999999999999999987
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
.+.+++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++++||||||+|||++ .++.+||+|
T Consensus 74 --~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~d 147 (263)
T cd05052 74 --EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVAD 147 (263)
T ss_pred --CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCcEEeCC
Confidence 57789999999999999999764 34589999999999999999999999999999999999998 678999999
Q ss_pred cCCcccccccccc--CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 954 LGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~~s--~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
||++......... ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||+..
T Consensus 148 f~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 148 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK------------------FSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred CccccccccceeeccCCCCCccccCCHHHhccCC------------------CCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999865443221 1223466799999886542 4567899999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=272.24 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=164.1
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcc----eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~k----VAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
+...+|++++.||+|+||.||+|++ .+.. +++|.+... ........+..|+.+++++.||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 3456889999999999999999988 3443 566665321 11223356778888999999999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
++.. ...++|+||+.+|+|.+++......+++..++.|+.||+.||.|||+++++||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~----~~~~~k 149 (279)
T cd05111 77 ICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK----SDSIVQ 149 (279)
T ss_pred EECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEE
Confidence 8754 457899999999999999987777789999999999999999999999999999999999998 678999
Q ss_pred EEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCC
Q 001678 951 IGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCF 1026 (1033)
Q Consensus 951 LiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~P 1026 (1033)
|+|||+++...... ......++..|+|||++.+. .++.++|+|||||++|+|++ |..|
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~------------------~~~~~~Dv~slG~il~el~t~g~~p 211 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG------------------RYTHQSDVWSYGVTVWEMMSYGAEP 211 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccC------------------CcCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999998643221 12234467789999988654 25667899999999999998 9999
Q ss_pred CCCC
Q 001678 1027 IDFF 1030 (1033)
Q Consensus 1027 Fd~~ 1030 (1033)
|...
T Consensus 212 ~~~~ 215 (279)
T cd05111 212 YAGM 215 (279)
T ss_pred CCCC
Confidence 8643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=271.25 Aligned_cols=193 Identities=31% Similarity=0.402 Sum_probs=162.9
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||+|.+ .++.||||++.... .......+.+|+.++++++||||+++++.+.. .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-------TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--E 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--C
Confidence 3688899999999999999987 47779999886431 11123468889999999999999999999998 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||+++++|..+. .+++..+..++.|++.||.|||+.+|+|+||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~----~~~~~~l~dfg~~ 142 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVS 142 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC----CCCCEEEeeCCcc
Confidence 7789999999999997652 367888899999999999999999999999999999998 6789999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ......||..|+|||++.+. .++.++|+|||||++|+|+||+.||..
T Consensus 143 ~~~~~~-~~~~~~~~~~y~aPE~~~~~------------------~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 143 TQLVNS-IAKTYVGTNAYMAPERISGE------------------QYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred eecccc-cccCCCCChhhcCceeecCC------------------CCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 765433 23345789999999998754 246678999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=275.35 Aligned_cols=197 Identities=31% Similarity=0.421 Sum_probs=166.3
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||++++. +..+|+|.++... .......+.+|+.++++++||||+++++.|.+ .
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--D 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 46899999999999999999884 5668888776421 12234567889999999999999999999988 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
+.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+++|+||||+|||++ .++.+||+|||+
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 146 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGV 146 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe----cCCcEEEccCCC
Confidence 7899999999999999999766 458899999999999999999997 5999999999999998 667899999999
Q ss_pred ccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+...... ......|+..|+|||++.+. .++.++|+|||||++|+|+||+.||..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~------------------~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 147 SGQLIDS-MANSFVGTRSYMSPERLQGT------------------HYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ccccccc-ccccCCCCcCccChhHhcCC------------------CCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 8765332 22345789999999988654 245678999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=276.82 Aligned_cols=202 Identities=31% Similarity=0.437 Sum_probs=162.5
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--Ccc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGI 871 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~k--VAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~ 871 (1033)
+.-++|++.+.||+|+||.||+|.++ +.. +|+|.++... .......+.+|+.++.++ +|+||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 45578999999999999999999874 333 4666654321 122335778899999999 89999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsN 936 (1033)
+.+ .+.+++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 77 CEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred ECC--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 987 577999999999999999997542 247889999999999999999999999999999999
Q ss_pred EEEecCCCCCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHH
Q 001678 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016 (1033)
Q Consensus 937 ILLd~~d~~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVV 1016 (1033)
||++ .++.+||+|||++.............++..|+|||++.+. .++.++|||||||+
T Consensus 155 ili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~i 212 (303)
T cd05088 155 ILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS------------------VYTTNSDVWSYGVL 212 (303)
T ss_pred EEec----CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc------------------CCcccccchhhhhH
Confidence 9998 6678999999998743322112222346679999988654 24567899999999
Q ss_pred HHHHHc-cCCCCCC
Q 001678 1017 FFFLQF-ILCFIDF 1029 (1033)
Q Consensus 1017 LYeLLT-Gk~PFd~ 1029 (1033)
+|+|+| |..||..
T Consensus 213 l~ellt~g~~p~~~ 226 (303)
T cd05088 213 LWEIVSLGGTPYCG 226 (303)
T ss_pred HHHHHhcCCCCccc
Confidence 999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=265.22 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=167.4
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.++||+|+||.||++++ .+..+|+|.++.... ....+.+.+|+.+++.++|+||+++++.+.+ .+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CC
Confidence 588999999999999999987 477899998864321 1223567789999999999999999999987 67
Q ss_pred ceEEEEeeccCCcHHHHHHh-cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~-~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.+++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+|+|+||||+|||++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~----~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC----CCCcEEEcccCcc
Confidence 89999999999999998865 344578999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
....... ......|+..|+|||++.+. .++.++|+||||+++|+|++|..||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~------------------~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWENM------------------PYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred eeecccccccccccCCccccCHHHHccC------------------CcCchhhhhhhchhheehhhccCCCCCC
Confidence 7654322 22345689999999998654 2556789999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=271.82 Aligned_cols=197 Identities=30% Similarity=0.548 Sum_probs=161.1
Q ss_pred eEEEEecccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 803 EEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~k------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
++.+.||.|.||.||+|.+. +..|+||.++... .....+.|.+|+.++++++||||++++|++..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-- 72 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-- 72 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeecccccccccccccccccccccc--
Confidence 56789999999999999987 5679999985421 12234678899999999999999999999996
Q ss_pred CCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
.+.+++||||+.+|+|.++|... ...+++..++.|+.||+.||.|||+++++|+||+++|||++ .++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~----~~~~~Kl~~f~ 148 (259)
T PF07714_consen 73 NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD----SNGQVKLSDFG 148 (259)
T ss_dssp SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE----TTTEEEEESTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 56699999999999999999887 56689999999999999999999999999999999999999 77899999999
Q ss_pred Cccccccc---cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 956 LSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~---~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
++...... ...........|+|||.+.... ++.++||||||+++|||+| |+.||.-+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------------------~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE------------------YTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSE------------------ESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccc------------------cccccccccccccccccccccccccccc
Confidence 99876221 1222334677899999986642 5667899999999999999 67888654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=271.07 Aligned_cols=201 Identities=32% Similarity=0.472 Sum_probs=165.5
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
...+|.+++.||+|+||.||+|+.. +..||||+++.... ....+.+.+|+++++.++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-------NDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-------HHHHHHHHHHHHHHHhcCCCCchheee
Confidence 3457888999999999999999763 35689998864311 122357889999999999999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcC-------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD-------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENL 937 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~-------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNI 937 (1033)
++.. ....++||||+++++|.+++...+ ..+++..+..++.||+.||.|||+++++||||||+||
T Consensus 76 ~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 76 VCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred EEec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 9988 578999999999999999997542 3468888999999999999999999999999999999
Q ss_pred EEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHH
Q 001678 938 LVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG 1014 (1033)
Q Consensus 938 LLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLG 1014 (1033)
|++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++||||||
T Consensus 154 li~----~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG 211 (280)
T cd05049 154 LVG----YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR------------------KFTTESDVWSFG 211 (280)
T ss_pred EEc----CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC------------------CcchhhhHHHHH
Confidence 998 67899999999987543221 12233457889999998764 356678999999
Q ss_pred HHHHHHHc-cCCCCCC
Q 001678 1015 ILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 1015 VVLYeLLT-Gk~PFd~ 1029 (1033)
|++|+|++ |+.||.-
T Consensus 212 ~il~e~~~~g~~p~~~ 227 (280)
T cd05049 212 VVLWEIFTYGKQPWYG 227 (280)
T ss_pred HHHHHHHhcCCCCCCC
Confidence 99999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=266.42 Aligned_cols=201 Identities=30% Similarity=0.540 Sum_probs=166.4
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
+..++|++.+.||+|+||.||+|.+. ++.||||.++..... .+.+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---------PKDFLAEAQIMKKLRHPKLIQLYAVCTL- 72 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---------HHHHHHHHHHHHHCCCCCccceeEEEec-
Confidence 45577999999999999999999874 556999988753211 2357789999999999999999999887
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
.+..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++ .++.+||+||
T Consensus 73 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~df 147 (261)
T cd05068 73 -EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADF 147 (261)
T ss_pred -CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc----CCCCEEECCc
Confidence 567899999999999999997643 5689999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccccccc--CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 955 GLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 955 GLAr~~~~~~~s--~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
|+++........ .....+..|+|||++.+. .++.++|+|||||++|+|+| |+.||+..
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYN------------------RFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred ceEEEccCCcccccCCCcCceeccCccccccC------------------CCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 999866432211 112234579999988654 24667899999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=268.21 Aligned_cols=203 Identities=29% Similarity=0.461 Sum_probs=166.0
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~kG-------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
+..++|++.+.||+|+||.||++.+++ ..||+|.+.... .......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEEE
Confidence 456789999999999999999998743 569999875331 112234678899999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd 940 (1033)
+++.. ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+++||||||+|||++
T Consensus 76 ~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~ 153 (277)
T cd05032 76 GVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEcC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc
Confidence 99988 577999999999999999997532 2367888999999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHH
Q 001678 941 MRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017 (1033)
Q Consensus 941 ~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVL 1017 (1033)
.++.+||+|||+++...... ......++..|+|||.+.+. .++.++|+|||||++
T Consensus 154 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~il 211 (277)
T cd05032 154 ----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG------------------VFTTKSDVWSFGVVL 211 (277)
T ss_pred ----CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC------------------CCCcccchHHHHHHH
Confidence 67889999999987543321 12233467889999988653 255678999999999
Q ss_pred HHHHc-cCCCCCCC
Q 001678 1018 FFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1018 YeLLT-Gk~PFd~~ 1030 (1033)
|+|+| |..||...
T Consensus 212 ~el~t~g~~p~~~~ 225 (277)
T cd05032 212 WEMATLAEQPYQGL 225 (277)
T ss_pred HHhhccCCCCCccC
Confidence 99998 99998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=271.05 Aligned_cols=200 Identities=27% Similarity=0.426 Sum_probs=165.3
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.+.||+|++|.||+|+. .++.||||.+........ ...+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 74 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-------PFTAIREASLLKDLKHANIVTLHDIIHT-- 74 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-------chhHHHHHHHHhhCCCcceeeEEEEEec--
Confidence 46799999999999999999987 467899999875422111 1245679999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
....++||||+. ++|.+++.+....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~ 149 (291)
T cd07844 75 KKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGL 149 (291)
T ss_pred CCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----CCCCEEECcccc
Confidence 578999999996 599999987666789999999999999999999999999999999999998 677899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++...... ......++..|+|||++.+.. .++.++|||||||++|+|++|+.||..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------------~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLGST-----------------EYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhcCc-----------------ccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 87543221 112234688899999876532 245678999999999999999999954
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=272.63 Aligned_cols=197 Identities=27% Similarity=0.396 Sum_probs=163.3
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++++.||+|+||.||+|++ .++.||+|+++...... .....+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~------~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~ 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLYDVLHS--DK 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc------cCccchhHHHHHHHhcCCCCeeeHHHHhcc--CC
Confidence 488999999999999999988 47789999987542211 122356789999999999999999999987 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++|+||+. ++|.+++......+++..++.++.||++||.|||+++++||||||+||+++ .++.+||+|||+++
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~----~~~~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc----CCCcEEECccchhh
Confidence 8999999995 588888876666689999999999999999999999999999999999998 67889999999987
Q ss_pred cccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
...... ......++..|+|||++.+.. .++.++|+|||||++|+|+||..||
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAK-----------------LYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCc-----------------ccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 653321 122345788999999886542 2456789999999999999998885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=262.62 Aligned_cols=201 Identities=28% Similarity=0.443 Sum_probs=167.0
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++++.||+|++|.||+++. .++.||+|++...... ....+.+.+|+.++++++|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS------RRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 489999999999999999987 4677999998643221 22234678899999999999999999987642 45
Q ss_pred ceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.+++||||+++++|.+++... ...+++..++.++.+++.||.+||+.|++|+||||+||+++ ..+.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~----~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe----cCCcEEEecccce
Confidence 689999999999999999763 34589999999999999999999999999999999999998 6789999999999
Q ss_pred cccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
...... .......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNK------------------PYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCC------------------CCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 865432 223345689999999998654 2456779999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=264.61 Aligned_cols=198 Identities=28% Similarity=0.427 Sum_probs=171.0
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.+.||+|+||.||++++. +..+++|.+.... ..+.+.+|+.++++++|+||+++++.+.+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-- 69 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----------DLQEIIKEISILKQCDSPYIVKYYGSYFK-- 69 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----------HHHHHHHHHHHHHhCCCCcEeeeeeeeec--
Confidence 367899999999999999999885 5779999876431 14578899999999999999999999998
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...+++++||+.+++|.+++......+++..++.++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||+
T Consensus 70 ~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~----~~~~~~l~dfg~ 145 (256)
T cd06612 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGV 145 (256)
T ss_pred CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----CCCcEEEccccc
Confidence 5789999999999999999987777789999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+....... ......++..|+|||++.+. .++.++|+||||||+|+|+||+.||+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 146 SGQLTDTMAKRNTVIGTPFWMAPEVIQEI------------------GYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred chhcccCccccccccCCccccCHHHHhcC------------------CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 88765433 23344578999999998664 2556789999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=283.53 Aligned_cols=204 Identities=27% Similarity=0.404 Sum_probs=165.7
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcce
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVr 867 (1033)
.+..++|++.+.||+|+||.||+|.+. ++.||+|+++.... ....+.+.+|+.++.++ +|+||++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~E~~~~~~l~~h~niv~ 75 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------ASEYKALMTELKILIHIGHHLNVVN 75 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------HHHHHHHHHHHHHHHhhccCcchhh
Confidence 455678999999999999999999653 35699998864321 11234677899999999 7999999
Q ss_pred EEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC-----------------------------------------------
Q 001678 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------------------------------- 900 (1033)
Q Consensus 868 LyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~----------------------------------------------- 900 (1033)
++++|... ...+++||||+.+++|.++|....
T Consensus 76 ~~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (337)
T cd05054 76 LLGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLS 154 (337)
T ss_pred eeeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchh
Confidence 99988763 467899999999999999986421
Q ss_pred -------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc---
Q 001678 901 -------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--- 964 (1033)
Q Consensus 901 -------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~--- 964 (1033)
..+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++......
T Consensus 155 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~----~~~~vkL~DfG~a~~~~~~~~~~ 230 (337)
T cd05054 155 DVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYV 230 (337)
T ss_pred hcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe----CCCcEEEeccccchhcccCcchh
Confidence 2478889999999999999999999999999999999998 66789999999998653221
Q ss_pred ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 965 ~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
......++..|+|||++.+. .++.++|||||||++|+|++ |..||..
T Consensus 231 ~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 231 RKGDARLPLKWMAPESIFDK------------------VYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred hccCCCCCccccCcHHhcCC------------------CCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 12234457789999988664 36678899999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=265.67 Aligned_cols=205 Identities=26% Similarity=0.418 Sum_probs=169.8
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCC-chhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGK-PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k-~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
+|.+...||+|+||.||+|.+ .++.+|+|.+........ ........+.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 366778999999999999987 467899998876543322 22334456789999999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||+++++|.+++.+.+ .+++..+..++.|++.||.|||+.+++||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~----~~~~~~l~dfg~~ 153 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGIS 153 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc----CCCCEEecccCCC
Confidence 78899999999999999997653 478889999999999999999999999999999999998 6788999999998
Q ss_pred ccccccc-------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL-------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~-------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+...... ......|+..|+|||.+.+.. ++.++|+|||||++|+|++|+.||+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~------------------~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS------------------YTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCC------------------CCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 8654211 112345788999999886542 455679999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=269.34 Aligned_cols=201 Identities=26% Similarity=0.378 Sum_probs=164.2
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||+|+||.||+|.. +++.||||++....... ....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-- 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-------VPFTAIREASLLKGLKHANIVLLHDIIHT-- 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-------CcHHHHHHHHHHHhcCCCCEeEEEEEEec--
Confidence 36799999999999999999977 47889999986542211 11245689999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
....++||||+. ++|.+++......+.+..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Dfg~ 149 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS----YLGELKLADFGL 149 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc----CCCcEEEecccc
Confidence 567899999995 788777766555678888889999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++...... ......++..|+|||++.+.. .++.++|+|||||++|+|+||+.||+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 150 ARAKSIPSQTYSSEVVTLWYRPPDVLLGAT-----------------DYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ccccCCCCCCCCCccccccccCCceeecCC-----------------CCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 87543221 223345789999999886532 2455679999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=263.07 Aligned_cols=199 Identities=26% Similarity=0.437 Sum_probs=168.4
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++++.||+|+||.||.++. ++..+++|.+...... ......+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS------EKERRDALNEIVILSLLQHPNIIAYYNHFMD--DN 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CC
Confidence 589999999999999988876 4778999988644221 1223467899999999999999999999988 57
Q ss_pred ceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.+++||||+++++|.+++.+. ...+++..+..++.|++.+|.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~----~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe----CCCCEEECcCcce
Confidence 899999999999999999765 45589999999999999999999999999999999999998 6678999999999
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....... ......|+..|+|||++.+. .++.++|+||||+++|+|++|..||+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~------------------~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGV------------------KYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCC------------------CCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 8654332 23345689999999988654 245577999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=323.00 Aligned_cols=208 Identities=21% Similarity=0.279 Sum_probs=179.0
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.+..++|++++.||+|+||.|.+++.+ ++-+|+|++++-.+... ....-|+.|-.+|...+.+.|++++..|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-----~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-----AETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-----hhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 456789999999999999999999885 56689999887543322 22357999999999999999999999999
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+ +.++|||||||+||+|..+|.+.+ .+++.-++.++..|+.||.-||+.|+|||||||+||||| ..|++||+|
T Consensus 146 D--~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld----~~GHikLAD 218 (1317)
T KOG0612|consen 146 D--ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD----KSGHIKLAD 218 (1317)
T ss_pred C--ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec----ccCcEeecc
Confidence 9 789999999999999999999988 689998888889999999999999999999999999999 889999999
Q ss_pred cCCccccc-ccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 954 LGLSKVKQ-QTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 954 FGLAr~~~-~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
||.|-... ++. .....+|||.|.+||++...... ...|+..+||||+||++||||+|..||=
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~-------------~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDG-------------KGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCC-------------ccccCCccchhhhHHHHHHHHcCCCcch
Confidence 99876554 443 34567799999999998644321 1268899999999999999999999993
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=270.23 Aligned_cols=205 Identities=29% Similarity=0.481 Sum_probs=164.7
Q ss_pred cCCCceEEEEecccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~kG-------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
..++|.+.+.||+|+||.||+|.+.+ ..||+|.+.... .......|.+|+.+++.++|+||+++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLIG 76 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 44679999999999999999998854 457888765321 1122346888999999999999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcC------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~ 944 (1033)
++.+ ....++||||+.+++|.+++.+.. ..+++..++.++.||+.||+|||+++++||||||+|||++.++
T Consensus 77 ~~~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~- 153 (277)
T cd05036 77 VSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG- 153 (277)
T ss_pred EEcc--CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-
Confidence 9887 567899999999999999997653 2488999999999999999999999999999999999998432
Q ss_pred CCCeEEEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHH
Q 001678 945 QRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQ 1021 (1033)
Q Consensus 945 ~~g~VKLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLL 1021 (1033)
....+||+|||+++....... ......+..|+|||++.+. .++.++|||||||++|+|+
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG------------------IFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC------------------CcCchhHHHHHHHHHHHHH
Confidence 345799999999986532211 1122235679999998654 3567789999999999999
Q ss_pred c-cCCCCCCC
Q 001678 1022 F-ILCFIDFF 1030 (1033)
Q Consensus 1022 T-Gk~PFd~~ 1030 (1033)
+ |..||+..
T Consensus 216 ~~g~~pf~~~ 225 (277)
T cd05036 216 SLGYMPYPGR 225 (277)
T ss_pred cCCCCCCCCC
Confidence 7 99998753
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=315.03 Aligned_cols=211 Identities=24% Similarity=0.332 Sum_probs=173.2
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
...++|+++++||+|+||+||++++. +..||+|++...... ......|..|+.+++.|+||||++++++|..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK------EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 44578999999999999999999884 556899988754322 1233578899999999999999999999977
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhc---CCccCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCcEEEecCC-
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGK-------NIVHFDLKCENLLVNMRD- 943 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~---~k~Lse~~rl~Ia~QIa~GLeYLHsk-------GIVHRDIKPsNILLd~~d- 943 (1033)
.....++|||||+.+++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+...
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 5567799999999999999999753 34589999999999999999999984 499999999999996321
Q ss_pred ------------CCCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchH
Q 001678 944 ------------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCY 1011 (1033)
Q Consensus 944 ------------~~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVW 1011 (1033)
.....+||+|||++.............||+.|+|||++.+... .++.++|||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~----------------~~s~KSDVW 227 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETK----------------SYDDKSDMW 227 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCC----------------CCCchhHHH
Confidence 1245699999999987654444455679999999999865321 356678999
Q ss_pred HHHHHHHHHHccCCCCCC
Q 001678 1012 SLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 1012 SLGVVLYeLLTGk~PFd~ 1029 (1033)
|||||||+|+||+.||..
T Consensus 228 SLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 228 ALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred HHHHHHHHHHHCCCCCCc
Confidence 999999999999999964
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=312.78 Aligned_cols=201 Identities=27% Similarity=0.379 Sum_probs=166.9
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.++||+|+||.||+|.+. ++.||||++...... .....+++.+|+.++++++||||+++++++.+ .
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~-----~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE-----NPLLKKRFLREAKIAADLIHPGIVPVYSICSD--G 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc-----CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--C
Confidence 57999999999999999999874 778999998753211 12334578899999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhc----------CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCC
Q 001678 878 GSLATVTEFMVNGSLKQFLQKK----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~----------~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g 947 (1033)
+..++||||+++++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++ ..+
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd----~dg 150 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG----LFG 150 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc----CCC
Confidence 7899999999999999998642 12345667889999999999999999999999999999998 677
Q ss_pred eEEEEecCCccccccc-------------------cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCccc
Q 001678 948 VCKIGDLGLSKVKQQT-------------------LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSY 1008 (1033)
Q Consensus 948 ~VKLiDFGLAr~~~~~-------------------~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kv 1008 (1033)
.+||+|||+++..... .......||+.|+|||++.+.. ++.++
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~------------------~S~kS 212 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP------------------ASEST 212 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC------------------CCcHh
Confidence 8999999999765110 1112356999999999987653 46678
Q ss_pred chHHHHHHHHHHHccCCCCCC
Q 001678 1009 DCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 1009 DVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||||||++|+|+||+.||..
T Consensus 213 DIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 213 DIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred HHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999964
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=271.71 Aligned_cols=202 Identities=32% Similarity=0.500 Sum_probs=165.6
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
++..+|.+.+.||+|+||.||+++.. +..+|+|.+.... ......+.+|+.++++++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------DNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 34567999999999999999999752 2347888776321 22345788999999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcC------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENL 937 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNI 937 (1033)
+++.. ...+++||||+.+++|.+++...+ ..+++..++.++.||+.||+|||++|++||||||+||
T Consensus 74 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEec--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 99987 578999999999999999997543 2489999999999999999999999999999999999
Q ss_pred EEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHH
Q 001678 938 LVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG 1014 (1033)
Q Consensus 938 LLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLG 1014 (1033)
|++ .++.+||+|||+++...... ......++..|+|||++.+. .++.++|+||||
T Consensus 152 li~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~sDiwslG 209 (288)
T cd05093 152 LVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR------------------KFTTESDVWSLG 209 (288)
T ss_pred EEc----cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC------------------CCCchhhHHHHH
Confidence 998 67899999999987543221 12233357789999988654 255678999999
Q ss_pred HHHHHHHc-cCCCCCCC
Q 001678 1015 ILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1015 VVLYeLLT-Gk~PFd~~ 1030 (1033)
|++|+|+| |..||...
T Consensus 210 ~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 210 VVLWEIFTYGKQPWYQL 226 (288)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=266.51 Aligned_cols=204 Identities=29% Similarity=0.389 Sum_probs=168.9
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.+|+..+.||+|+||.||++.. ++..||+|++....... ...+....+.+|+.+++.++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP---ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc---hhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 4688899999999999999987 47789999887543211 223345678899999999999999999999887555
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..++++|||+.+++|.+++.+.. .+++..++.++.|++.||+|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~----~~~~~~l~dfg~~ 153 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEccCCCc
Confidence 67899999999999999997654 478899999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE------------------GYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC------------------CCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 7543211 11234578999999998654 245677999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=272.54 Aligned_cols=199 Identities=31% Similarity=0.426 Sum_probs=159.9
Q ss_pred CCceEEEEecccCcEEEEEEEEc--Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEc
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~--kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d 874 (1033)
++|++.+.||+|+||.||+|..+ +. .+++|.++... .....+.+.+|+.++.++ +||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 57899999999999999999874 22 36888766321 112235688899999999 79999999999887
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLV 939 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILL 939 (1033)
.+.+++||||+++++|.+++.+.. ..+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 --RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred --CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 567999999999999999997532 247888999999999999999999999999999999999
Q ss_pred ecCCCCCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHH
Q 001678 940 NMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFF 1019 (1033)
Q Consensus 940 d~~d~~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYe 1019 (1033)
+ .++.+||+|||++..............+..|+|||++.+. .++.++|||||||++|+
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~DvwSlG~il~e 210 (297)
T cd05089 153 G----ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS------------------VYTTKSDVWSFGVLLWE 210 (297)
T ss_pred C----CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccC------------------CCCchhhHHHHHHHHHH
Confidence 8 6788999999998754322111122235579999988654 24567899999999999
Q ss_pred HHc-cCCCCCC
Q 001678 1020 LQF-ILCFIDF 1029 (1033)
Q Consensus 1020 LLT-Gk~PFd~ 1029 (1033)
|++ |..||..
T Consensus 211 l~t~g~~pf~~ 221 (297)
T cd05089 211 IVSLGGTPYCG 221 (297)
T ss_pred HHcCCCCCCCC
Confidence 997 9999854
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=285.94 Aligned_cols=204 Identities=22% Similarity=0.315 Sum_probs=178.1
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
...+.|++.+.||+|.|+.||++.. +|+++|+|++....+... -.+.+.+|++|-+.|+||||+++.+.+.+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~ 81 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQE 81 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence 3456678888999999999999866 688999999887665543 23467799999999999999999999887
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
.+..+||+|+|.|++|..-|-.+ ...++..+-.+++||+.+|.|+|.++|||||+||.|+||.... ..--+||+||
T Consensus 82 --~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-~~A~vKL~~F 157 (355)
T KOG0033|consen 82 --ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-KGAAVKLADF 157 (355)
T ss_pred --cceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-CCCceeeccc
Confidence 78999999999999998877665 3478889999999999999999999999999999999997654 4567999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|+|..........++.|||.|||||++...+ |+..+|||+-|||||.||.|.+||-
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp------------------y~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP------------------YSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcCC------------------CCCcchhhhhhHHHHHHHhCCCCCC
Confidence 9999888777778899999999999998764 6778899999999999999999994
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=268.32 Aligned_cols=200 Identities=25% Similarity=0.319 Sum_probs=155.0
Q ss_pred EecccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~k----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+||+|+||.||+|... ...+|+|.+.... .......+.+|+.+++.++|+||+++++.+.+ ....++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEE
Confidence 5899999999999752 2346777654321 12223467889999999999999999999987 567999
Q ss_pred EEeeccCCcHHHHHHhcCC----ccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 883 VTEFMVNGSLKQFLQKKDR----TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k----~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
||||+.+|+|.+++.+... ..++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----CCCcEEEecccccc
Confidence 9999999999999976432 246778889999999999999999999999999999998 67899999999987
Q ss_pred cccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 959 VKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
...... ......++..|+|||++........ ...++.++|||||||++|+|++ |..||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-----------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLL-----------PKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhcccccc-----------ccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 532211 1223345778999999864321100 1135678899999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=264.94 Aligned_cols=202 Identities=25% Similarity=0.379 Sum_probs=168.1
Q ss_pred CceEEEEecccCcEEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 801 DLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
+|++.+.||+|+||.||+|.. +++.+|||.++...... ....+....+.+|+.++++++|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV--LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch--hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCe
Confidence 477889999999999999987 56779999887543221 2233445678899999999999999999999988 578
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
+++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+++|+||||+||+++ .++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC----CCCeEEeccchhhHh
Confidence 999999999999999997654 478899999999999999999999999999999999998 678999999999875
Q ss_pred ccc-------ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 960 KQQ-------TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 960 ~~~-------~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
... ........|+..|+|||++.+. .++.++|+|||||++|+|++|+.||..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------------------~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINES------------------GYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCC------------------CCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 421 1112245689999999998654 245678999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=263.50 Aligned_cols=199 Identities=34% Similarity=0.534 Sum_probs=169.3
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
+..++|++.+.||.|+||.||+|...++.||||.++.... ..+.+.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-- 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcC--
Confidence 3456899999999999999999999999999999874321 24578899999999999999999999887
Q ss_pred CCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....++||||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+.+++|+||||+||+++ .++.+||+|||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~----~~~~~~l~d~g 147 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS----EDLVAKVSDFG 147 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe----CCCCEEEcccc
Confidence 577999999999999999997654 2589999999999999999999999999999999999998 67889999999
Q ss_pred CccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
+++....... ...++..|+|||.+... .++.++|+||||+++|+|++ |..||...
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~ape~~~~~------------------~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 148 LAKEASQGQD--SGKLPVKWTAPEALREK------------------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cccccccccc--cCCCcccccCchhhcCC------------------cCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9987643322 23346779999988654 24557799999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=261.19 Aligned_cols=194 Identities=35% Similarity=0.532 Sum_probs=164.7
Q ss_pred EEecccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCce
Q 001678 806 RELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k-----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l 880 (1033)
+.||+|+||.||+|.+. +..|++|+++..... ...+.+.+|+.+++.++|+||+++++++.+ ...+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-------EERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch-------hHHHHHHHHHHHHhhcCCCChheeeeeecC--CCce
Confidence 36899999999999885 667999988754221 134578899999999999999999999988 6789
Q ss_pred EEEEeeccCCcHHHHHHhc--------CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 881 ATVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~--------~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
++||||+.+++|.+++... ...+++..++.++.|++.||+|||+++++|+||||+||+++ .++.+||+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----~~~~~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----CCCcEEEc
Confidence 9999999999999999876 46689999999999999999999999999999999999998 66899999
Q ss_pred ecCCccccccc---cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCC
Q 001678 953 DLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFID 1028 (1033)
Q Consensus 953 DFGLAr~~~~~---~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd 1028 (1033)
|||.+...... .......++..|+|||.+... .++.++|+|||||++|+|++ |..||+
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG------------------IFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccC------------------CcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 99999876443 223345578899999987654 24567899999999999999 599987
Q ss_pred CC
Q 001678 1029 FF 1030 (1033)
Q Consensus 1029 ~~ 1030 (1033)
..
T Consensus 210 ~~ 211 (262)
T cd00192 210 GL 211 (262)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=268.03 Aligned_cols=199 Identities=31% Similarity=0.510 Sum_probs=164.0
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
+...+|++.++||+|+||.||+|++. ...||+|+++..... .+.+.+|+.++++++|+||+++++.+.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---------HHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 34567999999999999999999875 346899988743211 1357889999999999999999998754
Q ss_pred CCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...++||||+.+++|.+++.+. ...+++..+..++.|++.||.|||+.+++||||||+||+++ .++.+||+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~----~~~~~~L~df 146 (262)
T cd05071 73 --EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADF 146 (262)
T ss_pred --CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc----CCCcEEeccC
Confidence 4579999999999999999763 34578999999999999999999999999999999999998 6788999999
Q ss_pred CCccccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
|+++....... .....++..|+|||++.+. .++.++|+|||||++|+|+| |..||+.
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG------------------RFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccC------------------CCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99976543321 1233467789999987654 35667899999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=296.34 Aligned_cols=191 Identities=26% Similarity=0.346 Sum_probs=161.5
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
....|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|+.++++|+|+||+++++++..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~- 231 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVV- 231 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEE-
Confidence 3457999999999999999999884 56799995321 135579999999999999999999887
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
.+..++|||++ .++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+ ..+.+||+|||
T Consensus 232 -~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~----~~~~vkL~DFG 305 (461)
T PHA03211 232 -GGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN----GPEDICLGDFG 305 (461)
T ss_pred -CCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC----CCCCEEEcccC
Confidence 57789999999 5799999877666799999999999999999999999999999999999998 66789999999
Q ss_pred Ccccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 956 LSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 956 LAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
+++...... ......||..|+|||++.+.. ++.++||||||||||+|++|..++
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------------------~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP------------------YTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCC------------------CCchHHHHHHHHHHHHHHHcCCCc
Confidence 998653321 222456999999999987652 566789999999999999987543
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=269.78 Aligned_cols=200 Identities=27% Similarity=0.391 Sum_probs=165.6
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.++||+|+||.||+|++ .++.||+|+++.... .....+.+|+.+++.++||||+++++.+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-- 77 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-- 77 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--
Confidence 45788889999999999999987 477899998864311 112457789999999999999999999988
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
.+.+++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~~l~dfg~ 152 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGV 152 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECccee
Confidence 578999999999999999987654 589999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
+....... ......|+..|+|||++..... -.++.++|+|||||++|+|++|..||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---------------~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERK---------------GGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred eeEccCcccccccccCcccccChhhhccccC---------------CCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 87543322 2234568999999998742210 024567899999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=261.00 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=169.2
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.+.||+|+||.||++.. .++.+|||++...... ......+.+|+.+++.++|+||+++++.+.. .+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLE--DK 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEec--CC
Confidence 588999999999999999877 4677999998754322 1223578899999999999999999999887 57
Q ss_pred ceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.+++||||+++++|.+++.+. ...+++..++.++.+++.+|+|||+++++|+||||+||+++. .+..+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK---HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccCCCc
Confidence 899999999999999999865 345899999999999999999999999999999999999972 3457899999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.............|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||+..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGK------------------PYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred eecCCCccccccccCCcccCchhccCC------------------CCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 876554444445689999999988654 2456789999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=266.66 Aligned_cols=201 Identities=30% Similarity=0.477 Sum_probs=164.4
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--C---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--G---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G---~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
..+|++.+.||+|+||.||+|.++ + ..||||.++... .......|..|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 356889999999999999999874 2 248999876431 1223457889999999999999999999988
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+ ....++||||+.+++|.+++......+++..++.++.|++.||.|||++|++|+||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----~~~~~kl~d 149 (269)
T cd05065 76 K--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSD 149 (269)
T ss_pred C--CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----CCCcEEECC
Confidence 7 5678999999999999999987766789999999999999999999999999999999999998 677899999
Q ss_pred cCCccccccccccC----CcC--CCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCC
Q 001678 954 LGLSKVKQQTLVSG----GVR--GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCF 1026 (1033)
Q Consensus 954 FGLAr~~~~~~~s~----~~~--GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~P 1026 (1033)
||++.......... ... .+..|+|||.+.+. .++.++|+|||||++|+|++ |..|
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~DvwslG~~l~e~l~~g~~p 211 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR------------------KFTSASDVWSYGIVMWEVMSYGERP 211 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccC------------------cccchhhhhhhHHHHHHHhcCCCCC
Confidence 99987653322111 111 24579999988654 25667899999999999886 9999
Q ss_pred CCCC
Q 001678 1027 IDFF 1030 (1033)
Q Consensus 1027 Fd~~ 1030 (1033)
|.-.
T Consensus 212 ~~~~ 215 (269)
T cd05065 212 YWDM 215 (269)
T ss_pred CCCC
Confidence 8543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=264.53 Aligned_cols=204 Identities=27% Similarity=0.371 Sum_probs=168.8
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.+|++.+.||+|+||.||++.+ +++.||+|++...... .........+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS---QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc---chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 4789999999999999999987 4778999987532211 1123345678899999999999999999999887655
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+++++|.+++.+.+. +++..++.++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECccccc
Confidence 678999999999999999976543 78889999999999999999999999999999999998 6678999999999
Q ss_pred cccccc----cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~----~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+..... .......|+..|+|||++.+.. .+.++|+|||||++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG------------------YGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCC------------------CCccccHHHHHHHHHHHHhCCCCCCc
Confidence 865321 1122356899999999986642 45567999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=267.25 Aligned_cols=201 Identities=32% Similarity=0.503 Sum_probs=165.1
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--C---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--G---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G---~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
..+|++.+.||+|+||.||+|++. + ..+|+|.++... .....+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999999863 2 258888876431 1122457888999999999999999999998
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
. .+..++||||+++++|.+++.+....+++..+..|+.|++.||.|||+.+++||||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~~~~~l~d 149 (267)
T cd05066 76 K--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVSD 149 (267)
T ss_pred c--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----CCCeEEeCC
Confidence 7 5679999999999999999987766789999999999999999999999999999999999998 678999999
Q ss_pred cCCccccccccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCC
Q 001678 954 LGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFID 1028 (1033)
Q Consensus 954 FGLAr~~~~~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd 1028 (1033)
||++........ .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~------------------~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR------------------KFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccC------------------ccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 999986533211 1122235679999998654 25567899999999999886 999985
Q ss_pred CC
Q 001678 1029 FF 1030 (1033)
Q Consensus 1029 ~~ 1030 (1033)
..
T Consensus 212 ~~ 213 (267)
T cd05066 212 EM 213 (267)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=270.79 Aligned_cols=199 Identities=31% Similarity=0.521 Sum_probs=164.2
Q ss_pred CCceEEEEecccCcEEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~------kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.-|++++.||+|+||.||++++ .+..||+|.++... .......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 4478899999999999999974 35679999876431 1223457889999999999999999999998
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
.......++||||+++++|.+++.+....+++..++.++.||+.||+|||++|++||||||+|||++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----CCCCEEECC
Confidence 7544678999999999999999977665689999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 954 FGLAr~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
||+++...... ......++..|+|||++.+. .++.++|+|||||++|+|+|+..++
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~------------------~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS------------------KFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccC------------------CCCccccchhhhhhhhhhhcCCCCC
Confidence 99998654321 12234567789999988654 2556789999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=267.13 Aligned_cols=206 Identities=27% Similarity=0.392 Sum_probs=166.0
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~ 875 (1033)
.+.|++.+.||+|+||.||+|.+ .++.||+|++.... . ....+..|+.+++++ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---D------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---c------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 34678888999999999999987 46778999886431 1 113567889999998 699999999998753
Q ss_pred C----CCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 876 P----DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 876 ~----eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
. ...+++||||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+|+||||+||+++ .++.+|
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~----~~~~~~ 151 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVK 151 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC----CCCCEE
Confidence 2 24588999999999999999864 34589999999999999999999999999999999999998 677899
Q ss_pred EEecCCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 951 IGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 951 LiDFGLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+|||++....... ......|+..|+|||++........ .++.++|+|||||++|+|++|+.||+-
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-------------~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 152 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA-------------TYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred EccCCCceecccccccCCcccccccccCHhHhccccCcCC-------------CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999998654322 2334568999999999864321100 356678999999999999999999964
Q ss_pred C
Q 001678 1030 F 1030 (1033)
Q Consensus 1030 ~ 1030 (1033)
.
T Consensus 219 ~ 219 (272)
T cd06637 219 M 219 (272)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=270.48 Aligned_cols=202 Identities=33% Similarity=0.473 Sum_probs=165.3
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
+..+|.+.+.||+|+||.||++++. ...+++|.+.... ....+.+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------LAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------HHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4567899999999999999999753 2347888765321 122356889999999999999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPs 935 (1033)
++.. ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 75 ~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 75 VCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred EEcc--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 9987 567999999999999999997532 24788999999999999999999999999999999
Q ss_pred cEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHH
Q 001678 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012 (1033)
Q Consensus 936 NILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWS 1012 (1033)
|||++ .++.+||+|||++....... ......++..|+|||++.+. .++.++|+||
T Consensus 153 Nil~~----~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~s 210 (291)
T cd05094 153 NCLVG----ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR------------------KFTTESDVWS 210 (291)
T ss_pred eEEEc----cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC------------------CCCchhhHHH
Confidence 99998 67899999999987543221 12234467889999988654 2556789999
Q ss_pred HHHHHHHHHc-cCCCCCCCC
Q 001678 1013 LGILFFFLQF-ILCFIDFFS 1031 (1033)
Q Consensus 1013 LGVVLYeLLT-Gk~PFd~~s 1031 (1033)
|||++|+|+| |+.||...+
T Consensus 211 lG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 211 FGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred HHHHHHHHHhCCCCCCCCCC
Confidence 9999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=272.42 Aligned_cols=204 Identities=26% Similarity=0.364 Sum_probs=167.4
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
..++|++.+.||+|+||.||+|++ +++.||+|+++...... .....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD------GIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC------CCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 346799999999999999999987 47889999987542211 1112455799999999999999999999875
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....+++||||+. ++|.+++......+++..++.++.||+.||.|||+.|++||||||+||+++ ..+.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~kL~dfg 153 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFG 153 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEECccc
Confidence 4567899999995 589999887666789999999999999999999999999999999999998 67799999999
Q ss_pred Ccccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++....... ......++..|+|||++.+.. .++.++|+|||||++|+|++|.+||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLGCT-----------------TYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcCCC-----------------CcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 998654331 122233578899999886532 356678999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=266.63 Aligned_cols=200 Identities=28% Similarity=0.352 Sum_probs=157.4
Q ss_pred EecccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~k----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
.||+|+||.||+|++. +..+|+|.++.... ......+.+|+.+++.++||||+++++++.+ ...+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 72 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLL 72 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEE
Confidence 5899999999999864 24588897764321 1122467889999999999999999999987 567899
Q ss_pred EEeeccCCcHHHHHHhcC----CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 883 VTEFMVNGSLKQFLQKKD----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~----k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
||||+++++|.+++.... ...++..+..++.|++.||.|||+.+++||||||+||+++ ..+.+||+|||+++
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----~~~~~kL~dfg~~~ 148 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSH 148 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEECCccccc
Confidence 999999999999997532 2356778888999999999999999999999999999998 67889999999987
Q ss_pred cccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 959 VKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
...... ......++..|+|||++.+.... .....++.++|+|||||++|+|++ |+.||+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-----------~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN-----------LLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhcccccc-----------ccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 543221 12234578889999998643210 011135778999999999999996 99999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=270.22 Aligned_cols=204 Identities=27% Similarity=0.375 Sum_probs=167.9
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||++++. +..||+|.++... .......+.+|+.++++++|+||+++++.+.. .
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--E 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--C
Confidence 36889999999999999999884 7889999886421 11223578899999999999999999999887 6
Q ss_pred CceEEEEeeccCCcHHHHHHhc--CCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 878 GSLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~--~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
+.+++||||+++++|..++... ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++ .++.+||+||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~df 147 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDF 147 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC----CCCCEEEeec
Confidence 7899999999999999998764 2358999999999999999999996 5999999999999998 5778999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|++...... ......++..|+|||++.+...... ..++.++|+|||||++|+|+||+.||+.
T Consensus 148 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~------------~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 148 GVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQN------------PTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred CCcccccCC-ccccCCCccCccCcchhcCCCCCcc------------CCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 998765333 2233457889999998865431110 1356788999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=261.83 Aligned_cols=201 Identities=25% Similarity=0.416 Sum_probs=168.3
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||+|... ++.||+|.++...... ....+.+.+|+.++++++|+||+++++.+.+ .
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-----AKARQDCLKEIDLLKQLDHPNVIKYLASFIE--N 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--C
Confidence 57999999999999999999884 7889999887533221 1223568899999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
+..++||||+++++|.+++.+ ....+++..++.++.+++.||.|||+.|++|+||||+||+++ .++.+||+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----~~~~~~l~d~ 150 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC----CCCcEEEecc
Confidence 678999999999999999864 234578999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|++....... ......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~------------------~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG------------------YNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccCC------------------CCchhcHHHHHHHHHHHHHCCCCccc
Confidence 9987654322 223346889999999886542 45678999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=269.03 Aligned_cols=202 Identities=30% Similarity=0.428 Sum_probs=165.5
Q ss_pred cCCCceEEEEecccCcEEEEEEEEcC------------------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWRG------------------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~kG------------------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILsk 859 (1033)
...+|++.++||+|+||.||+++... ..||+|++..... ....+.+.+|+.++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-------DNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-------HHHHHHHHHHHHHHHh
Confidence 34679999999999999999987642 3478898764321 1334678899999999
Q ss_pred cCCCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC----------CccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001678 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1033)
Q Consensus 860 L~HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~----------k~Lse~~rl~Ia~QIa~GLeYLHskGIVH 929 (1033)
++|+||+++++++.. ....++||||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+.+|+|
T Consensus 76 l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 999999999999987 578999999999999999997654 25889999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCc
Q 001678 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKW 1006 (1033)
Q Consensus 930 RDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~ 1006 (1033)
|||||+||+++ ..+.+||+|||+++...... ......++..|+|||++.+. .++.
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~ 211 (296)
T cd05051 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG------------------KFTT 211 (296)
T ss_pred cccchhceeec----CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC------------------CCCc
Confidence 99999999998 66899999999987643322 22334467889999987653 2566
Q ss_pred ccchHHHHHHHHHHHc--cCCCCCCC
Q 001678 1007 SYDCYSLGILFFFLQF--ILCFIDFF 1030 (1033)
Q Consensus 1007 kvDVWSLGVVLYeLLT--Gk~PFd~~ 1030 (1033)
++|||||||++|+|++ +..||...
T Consensus 212 ~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 212 KSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred cchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 7899999999999998 66676543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=300.07 Aligned_cols=199 Identities=30% Similarity=0.464 Sum_probs=167.9
Q ss_pred cccccCCCceEEEEecccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 794 ~~~i~~~dYeilekLGeGgFG~VYkAk~kG-~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
..++..+.+.+.++||+|-||.|.+|...+ .+||+|+++...- ....++|.+|+++|.+|+||||++++|+|
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-------~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-------KNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-------hhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 444556778888999999999999999876 8999999986532 22246899999999999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCcc-CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTI-DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~L-se~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
.. ++.++||||||++|+|.++|.+..... .......|+.||+.||+||.+.++|||||.++|+|++ .++++||
T Consensus 605 ~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~----~e~~iKi 678 (807)
T KOG1094|consen 605 VQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD----GEFTIKI 678 (807)
T ss_pred ec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec----CcccEEe
Confidence 98 678999999999999999999875443 5566778999999999999999999999999999999 8899999
Q ss_pred EecCCccccccc---cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc
Q 001678 952 GDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI 1023 (1033)
Q Consensus 952 iDFGLAr~~~~~---~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG 1023 (1033)
+|||+++.+-.. ...+..+-.++|||||.+... +.++++|+|+|||++||+++.
T Consensus 679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg------------------kFttaSDvWafgvTlwE~~~~ 735 (807)
T KOG1094|consen 679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG------------------KFTTASDVWAFGVTLWEVFML 735 (807)
T ss_pred cCcccccccccCCceeeecceeeeeeehhHHHHHhc------------------cccchhhhhhhHHHHHHHHHH
Confidence 999999954322 233455668899999977543 467888999999999998764
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=270.74 Aligned_cols=202 Identities=29% Similarity=0.396 Sum_probs=167.2
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++++.||+|+||.||+|.+ .++.||||+++...... ........+..|+.++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CC
Confidence 478899999999999999987 46789999987654321 112233456789999999999999999999998 67
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++||||+ +++|.+++......+++..++.++.||++||.|||++||+|+||||+|||++ .++.+||+|||+++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----CCCCEEEccceeee
Confidence 899999999 9999999987654689999999999999999999999999999999999998 67899999999998
Q ss_pred cccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ......++..|+|||.+.+.. .++.++|+|||||++|+|++|.++|+.
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGAR-----------------HYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCC-----------------CCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 654432 222334678899999875432 245567999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=265.86 Aligned_cols=201 Identities=23% Similarity=0.364 Sum_probs=172.0
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.+.||.|+||.||+++++ ++.||+|++...... .....+.+.+|+.++++++||||+++++.+.+ ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----chhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CC
Confidence 4889999999999999999885 788999998754221 12345678899999999999999999999887 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
..++||||+.+++|.+++.+. ..+++..+..++.||++||.|||+.+++|+||||+||+++ .++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~----~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc----CCCCEEEeeccccc
Confidence 799999999999999999776 4588999999999999999999999999999999999998 67889999999988
Q ss_pred ccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 959 ~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
............|+..|+|||++.+.. ++.++|+||||+++|+|++|..||+..+
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~------------------~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQG------------------YSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcccC------------------CCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 765443334566889999999986642 4567899999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=260.60 Aligned_cols=203 Identities=29% Similarity=0.444 Sum_probs=169.4
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|+..+.||+|+||.||+|.. ++..|++|.+........ .....+.+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT---GQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc---chHHHHHHHHHHHHHHhcCCCCchheeeeEec--CC
Confidence 467778999999999999987 478899999875432211 22334578899999999999999999999887 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----~~~~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----TNGVVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccce
Confidence 7999999999999999997654 478999999999999999999999999999999999998 67899999999988
Q ss_pred ccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
............|+..|+|||.+.... .++.++|+|||||++|+|++|..||+..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-----------------~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG-----------------GYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC-----------------CCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 654443344566899999999876532 2456779999999999999999999654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=269.19 Aligned_cols=205 Identities=28% Similarity=0.473 Sum_probs=166.8
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcc
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~kG-------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIV 866 (1033)
..+..++|++.+.||+|+||.||++.+.+ ..+|+|.+.... .......+.+|+.+++++ +|+||+
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 34566789999999999999999998742 458999876431 112234688899999999 799999
Q ss_pred eEEEEEEcCCCCceEEEEeeccCCcHHHHHHhc---------------CCccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 001678 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (1033)
Q Consensus 867 rLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~---------------~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRD 931 (1033)
++++++.. .+.+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+|+|||
T Consensus 80 ~~~~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d 157 (293)
T cd05053 80 NLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD 157 (293)
T ss_pred eEEEEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 99999987 56799999999999999999643 34588999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCCCeEEEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCccc
Q 001678 932 LKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSY 1008 (1033)
Q Consensus 932 IKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kv 1008 (1033)
|||+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++
T Consensus 158 lkp~Nil~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~ 215 (293)
T cd05053 158 LAARNVLVT----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR------------------VYTHQS 215 (293)
T ss_pred cceeeEEEc----CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC------------------CcCccc
Confidence 999999998 678999999999986543221 1122346779999987654 256678
Q ss_pred chHHHHHHHHHHHc-cCCCCCCC
Q 001678 1009 DCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1009 DVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
|||||||++|+|++ |..||...
T Consensus 216 Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 216 DVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999997 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=272.88 Aligned_cols=204 Identities=27% Similarity=0.450 Sum_probs=164.4
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEcC---------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCc
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~kG---------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNI 865 (1033)
.+..++|.+.+.||+|+||.||++++.+ ..+|+|.++... .......+.+|+.+++.+ +|+||
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCCE
Confidence 3445679999999999999999997632 358999886431 112234677899999999 79999
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHR 930 (1033)
+++++++.. .+.+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.|++||
T Consensus 87 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 87 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred eeEEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999987 568999999999999999997642 247888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCCCeEEEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcc
Q 001678 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWS 1007 (1033)
Q Consensus 931 DIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~k 1007 (1033)
||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.+
T Consensus 165 dlkp~Nill~----~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~ 222 (307)
T cd05098 165 DLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR------------------IYTHQ 222 (307)
T ss_pred cccHHheEEc----CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC------------------CCCcH
Confidence 9999999998 667899999999876533211 1122245689999988654 25567
Q ss_pred cchHHHHHHHHHHHc-cCCCCCCC
Q 001678 1008 YDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1008 vDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
+|+|||||++|+|++ |..||...
T Consensus 223 ~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 223 SDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCcC
Confidence 899999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=262.22 Aligned_cols=198 Identities=30% Similarity=0.534 Sum_probs=165.6
Q ss_pred CCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
..+|++.+.||+|+||.||++.+. +..+|+|++...... ...+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTE--R 71 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEcc--C
Confidence 457899999999999999999875 678999987643221 1357789999999999999999999887 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||+.+++|.+++......+++..++.++.|++.+|.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 147 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMT 147 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc----CCCeEEECCCcce
Confidence 678999999999999999987666689999999999999999999999999999999999998 6778999999998
Q ss_pred cccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 958 KVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
........ .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~------------------~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFSK------------------YSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhccCC------------------cChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 75533221 11233567899999886542 4557799999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=270.49 Aligned_cols=203 Identities=28% Similarity=0.368 Sum_probs=168.9
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||+|++. ++.+|||.++..... ......+.+|+.++.+++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 46888999999999999999984 677999998754322 1122356789999999999999999999987544
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||+. ++|.+++......+++..++.++.||+.||+|||+.+++|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCcEEEeecCce
Confidence 78999999996 599999987666789999999999999999999999999999999999998 6789999999998
Q ss_pred cccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
...... .......++..|+|||.+.+.. .++.++|+|||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------------~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGAK-----------------EYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred eeccCCccccccccccccccCchhhcCCc-----------------cccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 865443 2223345788999999886543 2456789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=297.23 Aligned_cols=205 Identities=28% Similarity=0.411 Sum_probs=181.2
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
.....|.++++||+|.|++|.++++ ++..||||.+.+..... .....+.+|+++|+.|+|||||+++.+...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~------~~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP------SKRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh------HHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 3456799999999999999999987 68899999998765432 122347899999999999999999999998
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...+|+||||+.+|.++++|.+.+.. .+..+..++.|+++|++|||+++|||||||.+||||+ .+-.+||+||
T Consensus 127 --~~~lylV~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~----~~mnikIaDf 199 (596)
T KOG0586|consen 127 --EATLYLVMEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD----ENMNIKIADF 199 (596)
T ss_pred --cceeEEEEEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc----cccceeeecc
Confidence 67899999999999999999988874 4488888899999999999999999999999999999 6667999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|++..+.......+++|++.|.|||++.+.. +.+..+|+||+|||+|-|+.|..|||.-+
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~-----------------y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKK-----------------YDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcc-----------------cCCcceehhhhhhhheeeeecccccCCcc
Confidence 9999998888888999999999999999886 34557799999999999999999998543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=271.29 Aligned_cols=201 Identities=28% Similarity=0.439 Sum_probs=162.3
Q ss_pred CCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
..+|+++++||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 345777889999999999999863 3569999887431 11234568889999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhc---------------CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~---------------~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsN 936 (1033)
+.+ ....++++||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 77 ~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 77 VTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EcC--CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 987 56789999999999999998532 1247788889999999999999999999999999999
Q ss_pred EEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHH
Q 001678 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSL 1013 (1033)
Q Consensus 937 ILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSL 1013 (1033)
||++ .++.+||+|||+++...... ......+++.|+|||++.+. .++.++|||||
T Consensus 155 il~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Dv~sl 212 (283)
T cd05091 155 VLVF----DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG------------------KFSIDSDIWSY 212 (283)
T ss_pred eEec----CCCceEecccccccccccchheeeccCccCCccccCHHHHhcC------------------CCCcchhHHHH
Confidence 9998 66789999999987643221 12233457889999988653 24567899999
Q ss_pred HHHHHHHHc-cCCCCCCC
Q 001678 1014 GILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1014 GVVLYeLLT-Gk~PFd~~ 1030 (1033)
||++|+|++ |..||...
T Consensus 213 G~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 213 GVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred HHHHHHHHcCCCCCCCCC
Confidence 999999998 88887643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=269.86 Aligned_cols=206 Identities=30% Similarity=0.380 Sum_probs=166.0
Q ss_pred CceEEEEecccCcEEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.|++.++||+|+||.||+|++ .+..||||.+....... ......+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-----TGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc-----cCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 488999999999999999988 35789999988643211 112245678999999999999999999999854
Q ss_pred CCceEEEEeeccCCcHHHHHHhc----CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKK----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~----~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
...+++||||+. ++|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++...+.+||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 578999999996 4777776532 23578999999999999999999999999999999999998544458999999
Q ss_pred ecCCcccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 953 DLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 953 DFGLAr~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|||++....... ......+|..|+|||++.+.. .++.++|+|||||++|+|++|..||.
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR-----------------HYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCC-----------------CCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 999988653321 123446789999999876532 24567899999999999999999996
Q ss_pred C
Q 001678 1029 F 1029 (1033)
Q Consensus 1029 ~ 1029 (1033)
.
T Consensus 218 ~ 218 (316)
T cd07842 218 G 218 (316)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=305.66 Aligned_cols=208 Identities=23% Similarity=0.337 Sum_probs=166.5
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~ 871 (1033)
.++...++++.+.|.+|||+.||+|.+. +.+||+|++... .+..++.+.+|+.+|++|. |+|||.+++.
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 3456678899999999999999999984 378999988643 2344567889999999998 9999999993
Q ss_pred E-Ec--CCC--CceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEecCC
Q 001678 872 V-RD--GPD--GSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 872 f-~d--~~e--g~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskG--IVHRDIKPsNILLd~~d 943 (1033)
. .. ... -.++|.||||.+|.|.|++.++ ...|++.++++|+.|+++|+.+||... |||||||-+||||.
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls--- 180 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS--- 180 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---
Confidence 2 21 111 2467999999999999999853 234999999999999999999999885 99999999999998
Q ss_pred CCCCeEEEEecCCcccccccc-ccC---------CcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHH
Q 001678 944 PQRPVCKIGDLGLSKVKQQTL-VSG---------GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSL 1013 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~~~~-~s~---------~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSL 1013 (1033)
.++..||||||.+...-... ... ...-|+.|+|||+|. +|+ .+.|++|+|||+|
T Consensus 181 -~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID-----------lys----g~pI~eKsDIWAL 244 (738)
T KOG1989|consen 181 -ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID-----------LYS----GLPIGEKSDIWAL 244 (738)
T ss_pred -CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHh-----------hhc----CCCCcchhHHHHH
Confidence 77899999999986421111 000 112499999999873 222 1358999999999
Q ss_pred HHHHHHHHccCCCCCC
Q 001678 1014 GILFFFLQFILCFIDF 1029 (1033)
Q Consensus 1014 GVVLYeLLTGk~PFd~ 1029 (1033)
||+||-||+...||+-
T Consensus 245 GclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 245 GCLLYKLCYFTTPFEE 260 (738)
T ss_pred HHHHHHHHHhCCCcCc
Confidence 9999999999999974
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=263.64 Aligned_cols=201 Identities=25% Similarity=0.383 Sum_probs=161.0
Q ss_pred ceEEEEecccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 802 LEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k-----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
|.+.+.||+|+||.||+|+.. +..||||+++.... .......+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 567789999999999999873 25699998874321 1223457889999999999999999999887632
Q ss_pred C----CceEEEEeeccCCcHHHHHHhc-----CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCC
Q 001678 877 D----GSLATVTEFMVNGSLKQFLQKK-----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1033)
Q Consensus 877 e----g~l~LVmEYmegGSL~dlL~~~-----~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g 947 (1033)
. ...++||||+.+++|..++... ...+++..++.++.|++.||.|||+.+++||||||+||+++ .++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~----~~~ 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR----EDM 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC----CCC
Confidence 2 2478999999999999998542 23588999999999999999999999999999999999998 678
Q ss_pred eEEEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-c
Q 001678 948 VCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-I 1023 (1033)
Q Consensus 948 ~VKLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-G 1023 (1033)
.+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------------------~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR------------------VYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccC------------------CCCcccchHHHHHHHHHHHhCC
Confidence 999999999986533221 1122346789999987654 25667899999999999999 8
Q ss_pred CCCCCCC
Q 001678 1024 LCFIDFF 1030 (1033)
Q Consensus 1024 k~PFd~~ 1030 (1033)
..||...
T Consensus 213 ~~p~~~~ 219 (273)
T cd05035 213 QTPYPGV 219 (273)
T ss_pred CCCCCCC
Confidence 8988643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=263.96 Aligned_cols=200 Identities=31% Similarity=0.523 Sum_probs=166.1
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
+..++|+++++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEANLMKQLQHPRLVRLYAVVTQ- 72 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---------HHHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence 4567899999999999999999987 4677999988743221 2367889999999999999999998754
Q ss_pred CCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...++||||+.+++|.+++... +..+++..+..++.|++.||+|||+.|++||||||+||+++ .++.++|+||
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~df 146 (260)
T cd05067 73 --EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADF 146 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc----CCCCEEEccC
Confidence 5689999999999999998753 34688999999999999999999999999999999999998 6788999999
Q ss_pred CCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 955 GLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
|++....... ......++..|+|||++... .++.++|+|||||++|+|++ |+.||...
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~------------------~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 147 GLARLIEDNEYTAREGAKFPIKWTAPEAINYG------------------TFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred cceeecCCCCcccccCCcccccccCHHHhccC------------------CcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9997654222 12233457789999988654 24567899999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=264.47 Aligned_cols=192 Identities=29% Similarity=0.420 Sum_probs=156.9
Q ss_pred EecccCcEEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 807 ELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+||+|+||.||+|.+ ++..+|+|+++... ......+.+.+|+.+++.++|+||+++++++.. ...++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEE
Confidence 589999999999975 35679999876432 122345678899999999999999999998864 45789
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+.+++|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 73 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~----~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc----CCCeEEECCCccccccCC
Confidence 999999999999997654 589999999999999999999999999999999999998 667899999999976533
Q ss_pred ccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 963 TLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 963 ~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
... .....++..|+|||.+... .++.++|+|||||++|+|+| |+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYY------------------KFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccC------------------CcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 1122345789999987643 24557899999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=263.90 Aligned_cols=199 Identities=31% Similarity=0.540 Sum_probs=164.2
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
+..++|+++++||+|+||.||+|.+. +..+|+|.+...... .+.+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 44567999999999999999999874 567899988753221 1357889999999999999999998754
Q ss_pred CCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+++||||||+|||++ .++.+||+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~----~~~~~~l~df 146 (260)
T cd05070 73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADF 146 (260)
T ss_pred --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe----CCceEEeCCc
Confidence 4578999999999999999764 34589999999999999999999999999999999999998 6789999999
Q ss_pred CCccccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
|++........ .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||..
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG------------------RFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcC------------------CCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 99976543221 1223356679999987654 35667899999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=270.41 Aligned_cols=202 Identities=25% Similarity=0.397 Sum_probs=168.4
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||+|... ++.||||.+...... .....+.+..|+.+++.++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQT--E 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeec--C
Confidence 46899999999999999999884 688999998754221 12344578899999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 878 GSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...++||||+.+++|.+++.+. +..+++..++.++.||+.||.|||+.|++|+||||+|||++ .++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~ 149 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH----ESGHIMLSDFDL 149 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc----CCCCEEEeecch
Confidence 7899999999999999999764 34689999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc------------------------------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCc
Q 001678 957 SKVKQQTL------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKW 1006 (1033)
Q Consensus 957 Ar~~~~~~------------------------------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~ 1006 (1033)
+....... ......||..|+|||++.+.. ++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------------------~~~ 211 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG------------------HGS 211 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC------------------CCc
Confidence 87542111 112346889999999986542 456
Q ss_pred ccchHHHHHHHHHHHccCCCCCCC
Q 001678 1007 SYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 1007 kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++|||||||++|+|++|+.||...
T Consensus 212 ~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 212 AVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred hHHHHHHHHHHHHHhhCCCCCCCC
Confidence 779999999999999999999643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=266.49 Aligned_cols=198 Identities=27% Similarity=0.371 Sum_probs=168.5
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||.|+||.||+|++ .++.||+|++..... ......+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--G 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--C
Confidence 3688889999999999999987 467899998864321 1223467789999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++|+||+.+++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 145 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVS 145 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEcccccc
Confidence 7899999999999999999765 589999999999999999999999999999999999998 6788999999999
Q ss_pred cccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+..... .......++..|+|||++.+.. ++.++|+|||||++|+|+||+.||+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------------------~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSG------------------YDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred eeecccccccccccCCccccChhhhccCC------------------CCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 876543 2233456888999999987642 566789999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=262.88 Aligned_cols=203 Identities=26% Similarity=0.434 Sum_probs=167.7
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|+..+.||+|+||.||+++. +++.||+|++..... .........+.+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRN--TSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccC--CchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CC
Confidence 467788999999999999986 578899999874321 112333456788999999999999999999999987 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++||||+.+++|.+++.+.. .+++..++.++.||+.||.|||++|++|+||||+||+++. ....+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~---~~~~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS---TGQRLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccccccc
Confidence 7899999999999999997654 4789999999999999999999999999999999999972 23469999999987
Q ss_pred cccccc-----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~-----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ......|+..|+|||++.+. .++.++|+|||||++|+|++|..||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~------------------~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE------------------QYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccC------------------CCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 654321 12234678999999998654 245678999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=265.71 Aligned_cols=203 Identities=30% Similarity=0.478 Sum_probs=166.7
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~----kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
++..+|++.+.||+|+||.||+|.++ +. .+|+|.+..... ......+.+|+.++++++|+||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 45578999999999999999999863 22 478887764321 223356888999999999999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
++.. ...++||||+.+++|.+++.+....+++..++.++.||+.||+|||+.+++||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~----~~~~~k 149 (279)
T cd05057 77 ICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK----TPQHVK 149 (279)
T ss_pred EEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc----CCCeEE
Confidence 9886 568999999999999999988766789999999999999999999999999999999999998 667899
Q ss_pred EEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCC
Q 001678 951 IGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCF 1026 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~P 1026 (1033)
|+|||+++....... .....++..|+|||.+... .++.++|+|||||++|+|++ |+.|
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~Di~slG~~l~el~~~g~~p 211 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR------------------IYTHKSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcC------------------CcCchhhHHHHHHHHHHHhcCCCCC
Confidence 999999986543221 1122235679999987543 24567899999999999998 9999
Q ss_pred CCCCC
Q 001678 1027 IDFFS 1031 (1033)
Q Consensus 1027 Fd~~s 1031 (1033)
|+..+
T Consensus 212 ~~~~~ 216 (279)
T cd05057 212 YEGIP 216 (279)
T ss_pred CCCCC
Confidence 97654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=263.91 Aligned_cols=202 Identities=24% Similarity=0.454 Sum_probs=164.8
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~kG-----~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
+...+|.+.++||+|+||.||+|.+.. ..||||....... ....+.+.+|+.+++.++|+||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-------PSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-------HHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 345678999999999999999998742 3588897764311 1233578889999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
+.+ ...++||||+++++|.+++.+....+++..++.++.|++.||+|||+.+++|+||||+|||++ ..+.+||
T Consensus 76 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l 148 (270)
T cd05056 76 ITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS----SPDCVKL 148 (270)
T ss_pred EcC---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe----cCCCeEE
Confidence 876 457899999999999999987666689999999999999999999999999999999999998 6779999
Q ss_pred EecCCccccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCC
Q 001678 952 GDLGLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFID 1028 (1033)
Q Consensus 952 iDFGLAr~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd 1028 (1033)
+|||+++....... .....++..|+|||.+.... ++.++|+|||||++|+|++ |..||.
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR------------------FTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred ccCceeeecccccceecCCCCccccccChhhhccCC------------------CCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 99999876543321 11223456799999876542 4567899999999999986 999986
Q ss_pred CC
Q 001678 1029 FF 1030 (1033)
Q Consensus 1029 ~~ 1030 (1033)
..
T Consensus 211 ~~ 212 (270)
T cd05056 211 GV 212 (270)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-29 Score=269.22 Aligned_cols=200 Identities=25% Similarity=0.398 Sum_probs=165.7
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||+|+||.||++... ++.||||.+..... ........+.+|+.+++.++||||+++++.+.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFET--K 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--C
Confidence 47899999999999999999874 56799998875421 112334577889999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..+++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+++||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~----~~~~~~l~dfg~~ 148 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLS 148 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC----CCCCEEEeeCCCc
Confidence 67999999999999999997664 488999999999999999999999999999999999998 6789999999998
Q ss_pred cccccc----------------cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHH
Q 001678 958 KVKQQT----------------LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQ 1021 (1033)
Q Consensus 958 r~~~~~----------------~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLL 1021 (1033)
+..... .......++..|+|||.+.+.. ++.++|+|||||++|+|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slG~vl~el~ 210 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG------------------YGKPVDWWAMGIILYEFL 210 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCC------------------CCchhhHHHHHHHHHHHH
Confidence 642110 0111245788999999886542 456779999999999999
Q ss_pred ccCCCCCC
Q 001678 1022 FILCFIDF 1029 (1033)
Q Consensus 1022 TGk~PFd~ 1029 (1033)
+|+.||..
T Consensus 211 ~g~~pf~~ 218 (305)
T cd05609 211 VGCVPFFG 218 (305)
T ss_pred hCCCCCCC
Confidence 99999853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=265.28 Aligned_cols=191 Identities=30% Similarity=0.452 Sum_probs=156.2
Q ss_pred EecccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~k----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ...++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEE
Confidence 3899999999999763 3458999876431 12233578899999999999999999998764 46899
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+++++|.+++......+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc----CCCcEEeccCCccccccC
Confidence 9999999999999987666789999999999999999999999999999999999998 678899999999975432
Q ss_pred ccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 963 TLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 963 ~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
... .....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||.-
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRK------------------FSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCC------------------CCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 211 11122357899999886542 4567899999999999996 9999854
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=270.74 Aligned_cols=202 Identities=29% Similarity=0.440 Sum_probs=162.8
Q ss_pred cCCCceEEEEecccCcEEEEEEEEcC----------------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWRG----------------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~kG----------------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~ 861 (1033)
..++|++.++||+|+||.||+++..+ ..||+|.++... .......+.+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-------TKTARNDFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-------CHHHHHHHHHHHHHHHhCC
Confidence 45689999999999999999987632 237999876431 1122356889999999999
Q ss_pred CCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC-----------CccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001678 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1033)
Q Consensus 862 HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~-----------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHR 930 (1033)
|+||+++++++.. ....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++||
T Consensus 76 h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 76 NPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred CCCcCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 9999999999987 567899999999999999996532 136788889999999999999999999999
Q ss_pred CCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcc
Q 001678 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWS 1007 (1033)
Q Consensus 931 DIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~k 1007 (1033)
||||+|||++ .++.+||+|||++....... ......++..|+|||++.+.. ++.+
T Consensus 154 dlkp~Nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~ 211 (295)
T cd05097 154 DLATRNCLVG----NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK------------------FTTA 211 (295)
T ss_pred ccChhhEEEc----CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC------------------cCch
Confidence 9999999998 56789999999987543221 122334577899999886542 4667
Q ss_pred cchHHHHHHHHHHHc--cCCCCCCC
Q 001678 1008 YDCYSLGILFFFLQF--ILCFIDFF 1030 (1033)
Q Consensus 1008 vDVWSLGVVLYeLLT--Gk~PFd~~ 1030 (1033)
+|+|||||++|+|++ +..||+.+
T Consensus 212 ~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 212 SDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCccc
Confidence 899999999999988 56677654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=264.90 Aligned_cols=201 Identities=30% Similarity=0.481 Sum_probs=166.8
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
...+|++.++||.|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 73 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--------LLKQQDFQKEVQALKRLRHKHLISLFAVCSV-- 73 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--------hhhHHHHHHHHHHHhcCCCcchhheeeeEec--
Confidence 3457889999999999999999885 5678999876432 1123467789999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....++||||+++++|.+++.+. +..+++..+..++.||+.||.|||++|++|+||||+|||++ .++.+||+|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~----~~~~~kl~d~g 149 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLVCKVADFG 149 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc----CCceEEEcccc
Confidence 56789999999999999999763 34589999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
++....... ......++..|+|||++.... ++.++|+||||+++|+|++ |+.||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~------------------~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 150 LARLIKEDVYLSSDKKIPYKWTAPEAASHGT------------------FSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred chhhcCCccccccCCCCceEecCHHHHccCC------------------CCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 997654332 122334577899999886542 4557799999999999998 89999654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=263.58 Aligned_cols=202 Identities=29% Similarity=0.486 Sum_probs=165.0
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--Cc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~---kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
..++|+..+.||+|+||.||+|+.+ ++ .+|+|.++... .....+.+..|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 4567889999999999999999874 32 58888876431 112235688899999999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
.. .+..++||||+.+++|.+++.+....+++..+..++.|++.||.|||+.+++||||||+|||++ .++.+||+
T Consensus 76 ~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~----~~~~~kl~ 149 (268)
T cd05063 76 TK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN----SNLECKVS 149 (268)
T ss_pred cc--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc----CCCcEEEC
Confidence 87 5678999999999999999987666789999999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCC
Q 001678 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFI 1027 (1033)
Q Consensus 953 DFGLAr~~~~~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PF 1027 (1033)
|||++........ ......+..|+|||++.+. .++.++|+|||||++|+|++ |+.||
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR------------------KFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred CCccceecccccccceeccCCCcCceecCHHHhhcC------------------CcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 9999875532211 1112234579999988654 24567799999999999997 99998
Q ss_pred CCC
Q 001678 1028 DFF 1030 (1033)
Q Consensus 1028 d~~ 1030 (1033)
...
T Consensus 212 ~~~ 214 (268)
T cd05063 212 WDM 214 (268)
T ss_pred CcC
Confidence 644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=263.79 Aligned_cols=198 Identities=23% Similarity=0.306 Sum_probs=162.5
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCCC
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~eg 878 (1033)
|+++++||+|+||.||+++. +++.||+|+++...... . .....+|+.++.++. |+||+++++++.+...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---E----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---h----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 67889999999999999987 46789999887532111 1 113346888888885 99999999999985457
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++||||+. ++|.+++......+++..++.++.||+.||+|||+.+++||||||+||+++ . +.+||+|||+++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~----~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK----D-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc----C-CCeEEEeccccc
Confidence 8999999996 688888877656789999999999999999999999999999999999998 4 899999999998
Q ss_pred ccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
............++..|+|||++.... .++.++|+|||||++|+|++|+.||+-
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDG-----------------YYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCC-----------------CCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 764443333456789999999765432 245678999999999999999999963
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=311.95 Aligned_cols=205 Identities=34% Similarity=0.554 Sum_probs=169.9
Q ss_pred cccccCCCceEEEEecccCcEEEEEEEEc---Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcc
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR---GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (1033)
Q Consensus 794 ~~~i~~~dYeilekLGeGgFG~VYkAk~k---G~----kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIV 866 (1033)
+..+.....++...||+|.||.||.|... +. .||||.++... .+..+.+|.+|..+|++++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCccee
Confidence 34456677889999999999999999873 22 38888877542 234457899999999999999999
Q ss_pred eEEEEEEcCCCCceEEEEeeccCCcHHHHHHhc------CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q 001678 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (1033)
Q Consensus 867 rLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~------~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd 940 (1033)
+++|++.+ .+..++++|||++|+|..+|++. ...++....+.|+.||++|++||+++.+|||||..+|+||+
T Consensus 759 ~liGv~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~ 836 (1025)
T KOG1095|consen 759 SLIGVCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD 836 (1025)
T ss_pred eEEEeecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec
Confidence 99999998 67889999999999999999987 67799999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEEEecCCcccccccc-c-cC-CcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHH
Q 001678 941 MRDPQRPVCKIGDLGLSKVKQQTL-V-SG-GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017 (1033)
Q Consensus 941 ~~d~~~g~VKLiDFGLAr~~~~~~-~-s~-~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVL 1017 (1033)
....|||+|||||+.+.... . .. ...-...|||||.+... .+++++|||||||+|
T Consensus 837 ----~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~------------------iFtskSDvWsFGVll 894 (1025)
T KOG1095|consen 837 ----ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG------------------IFTSKSDVWSFGVLL 894 (1025)
T ss_pred ----ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc------------------ccccccchhhhHHHH
Confidence 77999999999999432221 1 11 11235689999998753 367788999999999
Q ss_pred HHHHc-cCCCCCC
Q 001678 1018 FFLQF-ILCFIDF 1029 (1033)
Q Consensus 1018 YeLLT-Gk~PFd~ 1029 (1033)
||++| |..||.-
T Consensus 895 WEifslG~~PY~~ 907 (1025)
T KOG1095|consen 895 WEIFSLGATPYPS 907 (1025)
T ss_pred HHHHhCCCCCCCC
Confidence 99997 5566643
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=267.56 Aligned_cols=201 Identities=33% Similarity=0.471 Sum_probs=164.3
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~-------kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
++..+|.+.++||+|+||.||+++. ++..+|+|.+.... ......+.+|+.+++.++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--------HHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 3456788999999999999999964 24467888765321 23345788999999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcC--------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~--------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPs 935 (1033)
+++.. ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+++||||||+
T Consensus 74 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 74 GVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEEec--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 99987 567899999999999999997643 24788999999999999999999999999999999
Q ss_pred cEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHH
Q 001678 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012 (1033)
Q Consensus 936 NILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWS 1012 (1033)
|||++ .++.+||+|||+++...... ......+++.|+|||++.+.. ++.++||||
T Consensus 152 nil~~----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~s 209 (280)
T cd05092 152 NCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK------------------FTTESDIWS 209 (280)
T ss_pred hEEEc----CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC------------------cCchhhHHH
Confidence 99998 67889999999987543221 112233577899999887642 556789999
Q ss_pred HHHHHHHHHc-cCCCCCC
Q 001678 1013 LGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 1013 LGVVLYeLLT-Gk~PFd~ 1029 (1033)
|||++|+|++ |+.||.-
T Consensus 210 lG~il~el~~~g~~p~~~ 227 (280)
T cd05092 210 FGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred HHHHHHHHHcCCCCCCcc
Confidence 9999999998 8999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=263.71 Aligned_cols=202 Identities=31% Similarity=0.410 Sum_probs=161.7
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEcCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~-ILskL~HPNIVrLyG~f~d~~ 876 (1033)
++|++++.||+|+||.||++++. ++.||||+++...... . ...+..|+. .++.++|+||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-- 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ------E-QKRLLMDLDISMRSVDCPYTVTFYGALFR-- 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH------H-HHHHHHHHHHHHHHcCCCCeeeeeEEEec--
Confidence 47899999999999999999884 7889999987542211 1 123444555 4677789999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 DGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHsk-GIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
.+.+++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||++ .++.+||+
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----~~~~~kl~ 146 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----RNGQVKLC 146 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEEe
Confidence 567999999995 788888764 234589999999999999999999997 999999999999998 67899999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||++.............|+..|+|||++.+... .-.++.++|+|||||++|+|++|+.||+.
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--------------~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELN--------------QKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCCccc--------------ccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 9999986544333334568899999998865321 01356678999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=264.38 Aligned_cols=200 Identities=26% Similarity=0.451 Sum_probs=167.3
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||++.+ ++..+|||.+...... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-----DAKARADCIKEIDLLKQLNHPNVIKYYASFIE--D 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-----hHHHHHHHHHHHHHHHHccCCchhhhhheeEe--C
Confidence 4688889999999999999986 5788999987653211 12234578899999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
+..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||+++ .++.+||+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df 150 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEECcc
Confidence 689999999999999999864 234579999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 955 GLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|++....... ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~------------------~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG------------------YNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCC------------------ccchhhHHHHHHHHHHHHhCCCCcc
Confidence 9987654322 223456899999999986542 4556799999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=260.75 Aligned_cols=206 Identities=28% Similarity=0.373 Sum_probs=168.6
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~ 875 (1033)
.++|++.+.||+|+||.||+|+.+ ++.+++|++..... ....+.+|+.+++++ +|+||+++++++.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 478999999999999999999884 56799998874321 124688999999999 699999999999863
Q ss_pred C----CCceEEEEeeccCCcHHHHHHhc---CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCe
Q 001678 876 P----DGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1033)
Q Consensus 876 ~----eg~l~LVmEYmegGSL~dlL~~~---~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~ 948 (1033)
. ...+++||||+++++|.+++... +..+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~----~~~~ 151 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAE 151 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc----cCCe
Confidence 2 34589999999999999998753 35689999999999999999999999999999999999998 6688
Q ss_pred EEEEecCCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 949 VKLiDFGLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
+||+|||++....... ......|+..|+|||++....... ..++.++|+|||||++|+|++|+.||
T Consensus 152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-------------~~~~~~~Dv~slG~il~~l~~g~~p~ 218 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPD-------------ASYDARSDVWSLGITAIELADGKPPL 218 (275)
T ss_pred EEECCCccceecccchhhhcCccccccccCHhHhccccccc-------------CCccccccHHHhHHHHHHHHhCCCCc
Confidence 9999999987653322 223455899999999885432110 13567889999999999999999999
Q ss_pred CCC
Q 001678 1028 DFF 1030 (1033)
Q Consensus 1028 d~~ 1030 (1033)
...
T Consensus 219 ~~~ 221 (275)
T cd06608 219 CDM 221 (275)
T ss_pred ccc
Confidence 643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=261.31 Aligned_cols=200 Identities=30% Similarity=0.533 Sum_probs=166.6
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
+..++|++.++||+|+||.||++..+ +..||||.+...... .+.+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQIMKKLRHDKLVQLYAVCSE- 72 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---------HHHHHHHHHHHhhCCCCCEeeeeeeeec-
Confidence 55678999999999999999999874 456899988743211 2467889999999999999999999887
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
....++||||+++++|.+++.+.. ..+++..+..++.||+.||.|||+++++|+||||+||+++ .++.+||+||
T Consensus 73 -~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~----~~~~~~l~d~ 147 (261)
T cd05034 73 -EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADF 147 (261)
T ss_pred -CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc----CCCCEEECcc
Confidence 567899999999999999997643 4689999999999999999999999999999999999998 6789999999
Q ss_pred CCccccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
|++........ .....++..|+|||.+.+.. ++.++|+|||||++|+|+| |+.||.-
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------------------~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 148 GLARLIEDDEYTAREGAKFPIKWTAPEAANYGR------------------FTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred ccceeccchhhhhhhccCCCccccCHHHhccCC------------------cCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99876543211 11223466899999887542 4567799999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=263.25 Aligned_cols=200 Identities=26% Similarity=0.369 Sum_probs=159.0
Q ss_pred eEEEEecccCcEEEEEEEEcCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC--
Q 001678 803 EEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~kG~----kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~-- 876 (1033)
.+.+.||+|+||.||+|.+... .||+|.++.... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 4568899999999999987432 589998765321 1223467888999999999999999999875421
Q ss_pred --CCceEEEEeeccCCcHHHHHHh-----cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 877 --DGSLATVTEFMVNGSLKQFLQK-----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 877 --eg~l~LVmEYmegGSL~dlL~~-----~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
....++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----ENMNV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----CCCCE
Confidence 2346899999999999998743 223478999999999999999999999999999999999998 67889
Q ss_pred EEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCC
Q 001678 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILC 1025 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~ 1025 (1033)
||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------------------~~~~~~Di~slG~il~el~~~g~~ 213 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR------------------VYTTKSDVWSFGVTMWEIATRGQT 213 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCC------------------CcChHHHHHHHHHHHHHHHcCCCC
Confidence 9999999986543221 1222357789999988654 25667899999999999999 889
Q ss_pred CCCCC
Q 001678 1026 FIDFF 1030 (1033)
Q Consensus 1026 PFd~~ 1030 (1033)
||...
T Consensus 214 p~~~~ 218 (272)
T cd05075 214 PYPGV 218 (272)
T ss_pred CCCCC
Confidence 98643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=301.10 Aligned_cols=198 Identities=28% Similarity=0.467 Sum_probs=169.6
Q ss_pred eEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCce
Q 001678 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l 880 (1033)
+....||+|+|-+||||.++ |..||--.++...+.. ..+.+++|..|+.+|+.|+|+||+++|.+|.+..+..+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 45578999999999999884 5566655555444333 23445689999999999999999999999999777789
Q ss_pred EEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHsk--GIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+|+|.+..|+|+.|+++.++ ++.+.++.|++||++||.|||++ .|||||||.+||+|+ ...|.|||+|+|||.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceeecchhHHH
Confidence 999999999999999988765 89999999999999999999987 799999999999998 367899999999999
Q ss_pred ccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 959 ~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
......... +.|||.|||||++.. +|+..+||||||..|+||.|+.+||.
T Consensus 195 l~r~s~aks-vIGTPEFMAPEmYEE-------------------~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 195 LLRKSHAKS-VIGTPEFMAPEMYEE-------------------NYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred Hhhccccce-eccCccccChHHHhh-------------------hcchhhhhhhhhHHHHHHHhccCChh
Confidence 887776554 789999999999864 47777899999999999999999873
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=271.79 Aligned_cols=204 Identities=27% Similarity=0.409 Sum_probs=166.7
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcce
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVr 867 (1033)
.+..++|++.+.||+|+||.||++.+. +..||||.++... .....+.+.+|+.+++++ +|+||++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-------HSSEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-------ChHHHHHHHHHHHHHHhccCCCCcce
Confidence 355568999999999999999999752 3358899876431 112245788999999999 7999999
Q ss_pred EEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCC
Q 001678 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1033)
Q Consensus 868 LyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~ 946 (1033)
+++++.. .+..++||||+.+++|.+++.... ..+++.+++.++.||+.||.|||+++|+|+||||+|||++ .+
T Consensus 104 ~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~ 177 (302)
T cd05055 104 LLGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----HG 177 (302)
T ss_pred EEEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc----CC
Confidence 9999987 567999999999999999997643 3489999999999999999999999999999999999998 67
Q ss_pred CeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-
Q 001678 947 PVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF- 1022 (1033)
Q Consensus 947 g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT- 1022 (1033)
+.+||+|||+++...... ......++..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~DiwslGvil~el~t~ 239 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV------------------YTFESDVWSYGILLWEIFSL 239 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC------------------CCcHhHHHHHHHHHHHHHhC
Confidence 789999999998553321 122334578899999886542 4567899999999999998
Q ss_pred cCCCCCCC
Q 001678 1023 ILCFIDFF 1030 (1033)
Q Consensus 1023 Gk~PFd~~ 1030 (1033)
|..||...
T Consensus 240 g~~p~~~~ 247 (302)
T cd05055 240 GSNPYPGM 247 (302)
T ss_pred CCCCcCCC
Confidence 99998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=265.42 Aligned_cols=195 Identities=23% Similarity=0.376 Sum_probs=155.7
Q ss_pred EEecccCcEEEEEEEEc--------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 806 RELGSGTYGSVYHGKWR--------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--------------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
+.||+|+||.||+|+.. ..+|++|++... .......+.+|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 36899999999999752 224777876532 12234578889999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC---CCCe
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP---QRPV 948 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~---~~g~ 948 (1033)
+.. ....++||||+.+++|..++.+....+++..++.|+.||+.||.|||+++|+||||||+|||++.++. ....
T Consensus 73 ~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 73 CVR--DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred Eec--CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 987 56789999999999999998876667899999999999999999999999999999999999974321 1234
Q ss_pred EEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHH-ccCCCC
Q 001678 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQ-FILCFI 1027 (1033)
Q Consensus 949 VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLL-TGk~PF 1027 (1033)
+||+|||++...... ....++..|+|||++.... .++.++|||||||++|+|+ +|..||
T Consensus 151 ~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwslG~~l~el~~~~~~p~ 210 (262)
T cd05077 151 IKLSDPGIPITVLSR---QECVERIPWIAPECVEDSK-----------------NLSIAADKWSFGTTLWEICYNGEIPL 210 (262)
T ss_pred eEeCCCCCCccccCc---ccccccccccChhhhcCCC-----------------CCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 899999998654322 2345788999999875322 2556789999999999997 588888
Q ss_pred CCC
Q 001678 1028 DFF 1030 (1033)
Q Consensus 1028 d~~ 1030 (1033)
...
T Consensus 211 ~~~ 213 (262)
T cd05077 211 KDK 213 (262)
T ss_pred CCc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=268.94 Aligned_cols=202 Identities=27% Similarity=0.407 Sum_probs=162.2
Q ss_pred cCCCceEEEEecccCcEEEEEEEEcC------------------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWRG------------------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~kG------------------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILsk 859 (1033)
..++|++.++||+|+||.||++++.+ ..||+|+++... .......+.+|+.+++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHh
Confidence 34679999999999999999986432 247888876431 12234578899999999
Q ss_pred cCCCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC----------CccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001678 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1033)
Q Consensus 860 L~HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~----------k~Lse~~rl~Ia~QIa~GLeYLHskGIVH 929 (1033)
++|+||+++++++.. ....++||||+.+++|.+++.+.. ..+++.++..++.||+.||+|||+.|++|
T Consensus 76 l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 153 (296)
T cd05095 76 LKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153 (296)
T ss_pred CCCCCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 999999999999988 567899999999999999997643 23677889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCc
Q 001678 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKW 1006 (1033)
Q Consensus 930 RDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~ 1006 (1033)
|||||+|||++ .++.+||+|||+++...... ......++..|+|||+..+. .++.
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~------------------~~~~ 211 (296)
T cd05095 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG------------------KFTT 211 (296)
T ss_pred ccCChheEEEc----CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC------------------Cccc
Confidence 99999999998 67789999999987543221 12223346789999987554 2566
Q ss_pred ccchHHHHHHHHHHHc--cCCCCCCC
Q 001678 1007 SYDCYSLGILFFFLQF--ILCFIDFF 1030 (1033)
Q Consensus 1007 kvDVWSLGVVLYeLLT--Gk~PFd~~ 1030 (1033)
++|+|||||++|+|+| |..||...
T Consensus 212 ~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 212 ASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 7899999999999998 66777544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=269.83 Aligned_cols=204 Identities=26% Similarity=0.429 Sum_probs=164.9
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCc
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k---------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNI 865 (1033)
.+...+|++.+.||+|+||.||++++. +..||+|.+.... .......+.+|+.+++.+ +||||
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCCc
Confidence 455678999999999999999999752 2358999876321 112235688999999999 79999
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHR 930 (1033)
+++++++.. ....++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++|++||
T Consensus 84 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 84 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred hheeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999987 567899999999999999997642 246788899999999999999999999999
Q ss_pred CCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcc
Q 001678 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWS 1007 (1033)
Q Consensus 931 DIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~k 1007 (1033)
||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+.. ++.+
T Consensus 162 dlkp~Nili~----~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~ 219 (304)
T cd05101 162 DLAARNVLVT----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV------------------YTHQ 219 (304)
T ss_pred ccccceEEEc----CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC------------------CCch
Confidence 9999999998 67899999999998654321 122233567899999886542 4567
Q ss_pred cchHHHHHHHHHHHc-cCCCCCCC
Q 001678 1008 YDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1008 vDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
+|||||||++|+|++ |..||+..
T Consensus 220 ~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 220 SDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred hhHHHHHHHHHHHHcCCCCCcccC
Confidence 899999999999998 78888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=259.39 Aligned_cols=193 Identities=32% Similarity=0.512 Sum_probs=159.0
Q ss_pred EecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 807 ELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
.||+|+||.||++... ++.+|+|+++.... ......+.+|+.++++++|+||+++++++.. ....++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-------QELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC-------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEE
Confidence 6899999999999874 56789998764321 1222468889999999999999999999987 567899999
Q ss_pred eccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccccc
Q 001678 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965 (1033)
Q Consensus 886 YmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~ 965 (1033)
|+++++|.+++......+++..++.++.|++.+|.|||+.|++||||||+||+++ .++.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc----CCCeEEECCCccceecccccc
Confidence 9999999999987666689999999999999999999999999999999999998 677899999999875433221
Q ss_pred c--CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 966 S--GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 966 s--~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
. ....++..|+|||++.+. .++.++|+|||||++|+|++ |..||...
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYG------------------RYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred ccCCCCCCcccccCHHHhccC------------------CCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1 122346679999988654 24567799999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=265.75 Aligned_cols=204 Identities=24% Similarity=0.310 Sum_probs=164.7
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|+++++||+|+||.||+|+. +++.||||++....... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 35799999999999999999987 47789999886432111 11124567999999999999999999987632
Q ss_pred ------CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 877 ------eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
....++||||+. ++|.+++.+....+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~k 159 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT----KDGILK 159 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC----CCCcEE
Confidence 235699999995 589888877666789999999999999999999999999999999999998 678999
Q ss_pred EEecCCccccccccc-----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCC
Q 001678 951 IGDLGLSKVKQQTLV-----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~-----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~ 1025 (1033)
|+|||++........ .....++..|+|||++.+.. .++.++|+||||+++|+|+||..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Di~slG~~l~el~t~~~ 222 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER-----------------DYGPPIDMWGAGCIMAEMWTRSP 222 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc-----------------ccCchhhhHHHHHHHHHHHhCCC
Confidence 999999976533221 12345788899999876532 24567899999999999999999
Q ss_pred CCCCC
Q 001678 1026 FIDFF 1030 (1033)
Q Consensus 1026 PFd~~ 1030 (1033)
||...
T Consensus 223 ~~~~~ 227 (310)
T cd07865 223 IMQGN 227 (310)
T ss_pred CCCCC
Confidence 98654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=277.76 Aligned_cols=204 Identities=27% Similarity=0.417 Sum_probs=163.5
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~-------kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrL 868 (1033)
+..++|++.+.||+|+||.||+|.+ .++.||||+++.... ......+.+|+.++.++ +|+||+++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------hHHHHHHHHHHHHHHhccCCccHhhh
Confidence 4567899999999999999999974 356799999874321 12235678899999999 68999999
Q ss_pred EEEEEcCCCCceEEEEeeccCCcHHHHHHhcC------------------------------------------------
Q 001678 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------------------------------------------ 900 (1033)
Q Consensus 869 yG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~------------------------------------------------ 900 (1033)
++++... ...+++||||+++|+|.+++....
T Consensus 77 ~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 77 LGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred cceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 9988763 457899999999999999986532
Q ss_pred ------------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 901 ------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 901 ------------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~----~~~~~kl~dfg~~~~~~~ 231 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYK 231 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc----CCCcEEEEeccccccccc
Confidence 1357778889999999999999999999999999999998 667999999999876422
Q ss_pred cc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 963 TL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 963 ~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
.. ......++..|+|||++.+. .++.++|+|||||++|+|++ |..||...
T Consensus 232 ~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 232 DPDYVRKGDARLPLKWMAPETIFDR------------------VYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CcchhhcCCCCCCcceECcHHhcCC------------------CCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 11 12223456789999988654 25667899999999999996 99998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=260.33 Aligned_cols=201 Identities=28% Similarity=0.476 Sum_probs=165.9
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
.+..++|++.++||+|+||.||++.+. +..+|+|.+.... .....+.+|+.++++++|+||+++++.+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 355678999999999999999999874 5678999876421 123468889999999999999999999876
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
...++||||+.+++|.+++.+. ...+++..+..++.||+.||.|||+.+++|+||||+||+++ ..+.+||+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d 145 (260)
T cd05073 73 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIAD 145 (260)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECC
Confidence 5689999999999999999763 44578889999999999999999999999999999999998 678999999
Q ss_pred cCCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
||++....... ......++..|+|||++... .++.++|+|||||++|+|+| |+.||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFG------------------SFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred CcceeeccCCCcccccCCcccccccCHhHhccC------------------CcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 99987654322 11223356779999988654 24567899999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=259.11 Aligned_cols=201 Identities=28% Similarity=0.396 Sum_probs=168.5
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||.|+||+||+|.. .+..+|+|++...... .....+.+|+.+++.++|+||+++++.+.. .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-------TSVDELRKEVQAMSQCNHPNVVKYYTSFVV--G 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-------hHHHHHHHHHHHHHhcCCCCEEEEEEEEee--C
Confidence 4789999999999999999987 4667999988643211 134578899999999999999999999887 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcC--CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~--k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
...++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++ .++.+||+|||
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~----~~~~~~l~df~ 147 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFG 147 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEcccc
Confidence 67999999999999999997642 4589999999999999999999999999999999999998 66789999999
Q ss_pred Ccccccccc-----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~-----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++....... ......|+..|+|||++.... ..+.++|+|||||++|+|++|+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-----------------~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH-----------------GYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHcccc-----------------CcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 987654322 123446899999999886542 2456789999999999999999999654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-31 Score=298.78 Aligned_cols=211 Identities=26% Similarity=0.331 Sum_probs=186.9
Q ss_pred HHHhccccccCCCceEEEEecccCcEEEEEEEEcCcc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcc
Q 001678 789 AIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (1033)
Q Consensus 789 ~~~~~~~~i~~~dYeilekLGeGgFG~VYkAk~kG~k--VAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIV 866 (1033)
.+......+...+++++..||-|+||.|=+++..++. +|+|++++....+ .+..+.+..|.+||..++.|.||
T Consensus 409 ~~~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-----tkQqeHv~sEr~Im~~~~s~fIv 483 (732)
T KOG0614|consen 409 DFAEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-----TKQQEHVFSERNIMMECRSDFIV 483 (732)
T ss_pred HHHhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-----hhHHHHHHhHHHHHHhcCchHHH
Confidence 3444566677788999999999999999999887666 7999888765443 33446788899999999999999
Q ss_pred eEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCC
Q 001678 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1033)
Q Consensus 867 rLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~ 946 (1033)
++|-.|.+ ..++||+||-|-||.|+..|++++. ++..++..++..++.|++|||++|||+|||||+|+||+ .+
T Consensus 484 rLYrTfrd--~kyvYmLmEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----~~ 556 (732)
T KOG0614|consen 484 RLYRTFRD--SKYVYMLMEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----NR 556 (732)
T ss_pred HHHHHhcc--chhhhhhHHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec----cC
Confidence 99999998 7899999999999999999998876 78888888888999999999999999999999999999 78
Q ss_pred CeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCC
Q 001678 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCF 1026 (1033)
Q Consensus 947 g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~P 1026 (1033)
|-+||.|||+|+.+.....+-++|||+.|.|||++.++++ +.++|.||||+++||||||.+|
T Consensus 557 Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGH------------------D~avDyWaLGIli~ELL~G~pP 618 (732)
T KOG0614|consen 557 GYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGH------------------DRAVDYWALGILIYELLTGSPP 618 (732)
T ss_pred CceEEeehhhHHHhccCCceeeecCCcccccchhhhccCc------------------chhhHHHHHHHHHHHHHcCCCC
Confidence 8999999999999998888889999999999999998874 3457999999999999999999
Q ss_pred CCC
Q 001678 1027 IDF 1029 (1033)
Q Consensus 1027 Fd~ 1029 (1033)
|..
T Consensus 619 Fs~ 621 (732)
T KOG0614|consen 619 FSG 621 (732)
T ss_pred CCC
Confidence 964
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=267.64 Aligned_cols=198 Identities=29% Similarity=0.407 Sum_probs=160.2
Q ss_pred CceEEEEecccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 801 DLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~kG-------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
+|++.+.||+|+||.||+|.... ..+++|.+.... .......+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-------SSSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-------CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47788999999999999998632 347888775321 1122357889999999999999999999998
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcC-----------------------CccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKD-----------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~-----------------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHR 930 (1033)
. .+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++||
T Consensus 74 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 Q--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred c--CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 7 567899999999999999986421 236788999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcc
Q 001678 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWS 1007 (1033)
Q Consensus 931 DIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~k 1007 (1033)
||||+|||++ .++.+||+|||+++...... ......++..|+|||.+.+. .++.+
T Consensus 152 dikp~nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~------------------~~~~~ 209 (290)
T cd05045 152 DLAARNVLVA----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH------------------IYTTQ 209 (290)
T ss_pred hhhhheEEEc----CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC------------------CcchH
Confidence 9999999998 66799999999987542221 11223457789999987654 24567
Q ss_pred cchHHHHHHHHHHHc-cCCCCCC
Q 001678 1008 YDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 1008 vDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
+||||||+++|+|+| |..||+.
T Consensus 210 ~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 210 SDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hHHHHHHHHHHHHHhcCCCCCCC
Confidence 899999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=264.03 Aligned_cols=207 Identities=27% Similarity=0.359 Sum_probs=165.5
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEc
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d 874 (1033)
..++|++++.||+|+||.||+++. .++.+|+|++..... ....+..|+.+++.+ +|+||+++++++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---------IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---------hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 457899999999999999999987 467899998754211 113567889999999 69999999998853
Q ss_pred ---CCCCceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCe
Q 001678 875 ---GPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1033)
Q Consensus 875 ---~~eg~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~ 948 (1033)
.....+++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+++||||||+||+++ ..+.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----TEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC----CCCC
Confidence 124568999999999999998763 234578889999999999999999999999999999999998 5678
Q ss_pred EEEEecCCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 949 VKLiDFGLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
+||+|||++....... ......|+..|+|||++....... -.++.++|+|||||++|+|++|+.||
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-------------~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLD-------------STYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhcc-------------ccccchhhhhhHHHHHHHHhcCCCCC
Confidence 9999999987654322 223446899999999885431100 02566789999999999999999998
Q ss_pred CCC
Q 001678 1028 DFF 1030 (1033)
Q Consensus 1028 d~~ 1030 (1033)
...
T Consensus 230 ~~~ 232 (286)
T cd06638 230 ADL 232 (286)
T ss_pred CCC
Confidence 644
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=266.07 Aligned_cols=202 Identities=30% Similarity=0.451 Sum_probs=161.3
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
+..++|++.+.||+|+||.||+|..+ +..||+|.+.... . ......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~--~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-----S--LRERIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-----C--HHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 45678999999999999999998753 3368999865321 1 11223577899999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd 940 (1033)
+++.+ ....++||||+.+|+|.+++.+.. ..++...++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~ 153 (288)
T cd05061 76 GVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 153 (288)
T ss_pred EEEcC--CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc
Confidence 99887 567899999999999999997532 2345677888999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHH
Q 001678 941 MRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017 (1033)
Q Consensus 941 ~~d~~~g~VKLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVL 1017 (1033)
.++.+||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++
T Consensus 154 ----~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~------------------~~~~~~DvwslG~~l 211 (288)
T cd05061 154 ----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG------------------VFTTSSDMWSFGVVL 211 (288)
T ss_pred ----CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC------------------CCChHhHHHHHHHHH
Confidence 678899999999875432211 1122356789999988654 245677999999999
Q ss_pred HHHHc-cCCCCCC
Q 001678 1018 FFLQF-ILCFIDF 1029 (1033)
Q Consensus 1018 YeLLT-Gk~PFd~ 1029 (1033)
|+|++ |..||.-
T Consensus 212 ~el~~~~~~p~~~ 224 (288)
T cd05061 212 WEITSLAEQPYQG 224 (288)
T ss_pred HHHHhCCCCCCCC
Confidence 99998 7888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=260.10 Aligned_cols=194 Identities=25% Similarity=0.406 Sum_probs=155.5
Q ss_pred EEecccCcEEEEEEEEcCcc------------eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 806 RELGSGTYGSVYHGKWRGSD------------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG~k------------VAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
+.||+|+||.||+|.+..+. +++|.+.... .. ...+.+|+.++++++|+||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-------~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-------RD--SLAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-------hh--HHHHHHHHHHHHcCCCcchhheeeEEe
Confidence 36899999999999885433 6777655321 11 357888999999999999999999988
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC---CCCCeEE
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD---PQRPVCK 950 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d---~~~g~VK 950 (1033)
. ...++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .....+|
T Consensus 72 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 72 R---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred c---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 6 346899999999999999987665689999999999999999999999999999999999998332 1122799
Q ss_pred EEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
|+|||++..... .....++..|+|||++.+.. ..++.++|+|||||++|+|++ |..||..
T Consensus 149 l~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~----------------~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 149 LSDPGIPITVLS---REERVERIPWIAPECIRNGQ----------------ASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred eCCCCccccccc---ccccccCCCccChhhhcCCC----------------CCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 999999886543 22344677899999986541 135667899999999999999 5777754
Q ss_pred C
Q 001678 1030 F 1030 (1033)
Q Consensus 1030 ~ 1030 (1033)
.
T Consensus 210 ~ 210 (259)
T cd05037 210 L 210 (259)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=266.59 Aligned_cols=194 Identities=25% Similarity=0.374 Sum_probs=155.7
Q ss_pred EecccCcEEEEEEEEc--------------------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc
Q 001678 807 ELGSGTYGSVYHGKWR--------------------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~k--------------------------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL 860 (1033)
.||+|+||.||+|... ...||+|++... .......+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 5999999999998741 123788876532 122345688899999999
Q ss_pred CCCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q 001678 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (1033)
Q Consensus 861 ~HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd 940 (1033)
+||||+++++++.+ ....++||||+++++|..++.+....+++..+..++.||++||+|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 99999999999988 5678999999999999999987666789999999999999999999999999999999999997
Q ss_pred cCC---CCCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHH
Q 001678 941 MRD---PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017 (1033)
Q Consensus 941 ~~d---~~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVL 1017 (1033)
..+ .....+||+|||++...... ....++..|+|||.+.+.. .++.++|+|||||++
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~-----------------~~~~~~Dv~slG~~l 211 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGN-----------------SLSTAADKWSFGTTL 211 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCC-----------------CCCcHHHHHHHHHHH
Confidence 432 12346899999987643221 2234688899999886532 356678999999999
Q ss_pred HHH-HccCCCCCCC
Q 001678 1018 FFL-QFILCFIDFF 1030 (1033)
Q Consensus 1018 YeL-LTGk~PFd~~ 1030 (1033)
|+| ++|+.||...
T Consensus 212 ~el~~~g~~p~~~~ 225 (274)
T cd05076 212 LEICFDGEVPLKER 225 (274)
T ss_pred HHHHhCCCCCcccc
Confidence 998 4799998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=268.70 Aligned_cols=197 Identities=23% Similarity=0.354 Sum_probs=166.1
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..+|++++.||+|+||.||++.+ .+..||+|.+...... ....+.+|+.+++.+.|+||+++++.+..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-- 88 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV-- 88 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--
Confidence 35899999999999999999986 4678999988753211 12467789999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
....++||||+.+++|.+++.+. .+++..++.++.|++.||.|||+.||+||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----~~~~~kl~dfg~ 162 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCCCEEECcccc
Confidence 56899999999999999998653 478899999999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+....... ......|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA------------------YGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred chhccccccccCcccCCccccCHHHHcCCC------------------CCccchHHHHHHHHHHHHhCCCCCCC
Confidence 87643322 223346889999999886542 45678999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=293.17 Aligned_cols=197 Identities=30% Similarity=0.470 Sum_probs=171.8
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
+.||.|-||+||-|++ +|+.||||++.+..+..+.. ..+..|+.||+.++||.||.+...|++ ...++.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe------sqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE------SQLRNEVAILQNLHHPGIVNLECMFET--PERVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH------HHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEE
Confidence 6799999999999977 58999999999877765433 356789999999999999999999998 5789999
Q ss_pred EeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccc
Q 001678 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~ 963 (1033)
||-+.|-=|.-+|......+++...+.+..||+.||.|||-++|+|+||||+||||...+ .-..+||||||+|+.+...
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchh
Confidence 999944444445555556699999999999999999999999999999999999998653 5679999999999999988
Q ss_pred cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 964 ~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....+++||+.|+|||++.+++ |+.+-|+||+|||+|--|.|..||+-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkG------------------yNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKG------------------YNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcc------------------ccccccceeeeEEEEEEecccccCCC
Confidence 8888999999999999998875 56677999999999999999999963
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=261.49 Aligned_cols=195 Identities=31% Similarity=0.518 Sum_probs=163.7
Q ss_pred CCCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.++|++.+.||+|+||.||+++..++.||+|.++... ....+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 71 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILH---N 71 (254)
T ss_pred HHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---C
Confidence 3578999999999999999999999999999886421 12467889999999999999999999875 3
Q ss_pred ceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----~~~~~kl~Dfg~~ 147 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGLA 147 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCcEEECCCccc
Confidence 4799999999999999997653 3578999999999999999999999999999999999998 6778999999998
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
....... .....+..|+|||.+.+. .++.+.|+|||||++|+|++ |+.||...
T Consensus 148 ~~~~~~~--~~~~~~~~y~~pe~~~~~------------------~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 148 RVGSMGV--DNSKLPVKWTAPEALKHK------------------KFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred eeccccC--CCCCCCceecCHHHhccC------------------CcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 7643321 223346679999988654 24567899999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=263.88 Aligned_cols=201 Identities=28% Similarity=0.399 Sum_probs=167.8
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++++.||.|++|.||++.+ .++.+|+|.+..... ......+.+|+++++.++|+||++++++|.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 4689999999999999999988 467799998874321 1223568889999999999999999999987656
Q ss_pred CceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
+.+++||||+++++|.+++.. ....+++..+..|+.||+.||.|||+.+++|+||+|+||+++ ..+.+||+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----~~~~~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----RKGQVKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe----cCCeEEEeec
Confidence 689999999999999998753 334578889999999999999999999999999999999998 5678999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
|++........ ....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||+..
T Consensus 150 g~~~~~~~~~~-~~~~~~~~y~~pE~~~~~------------------~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 150 GVSGELVNSLA-GTFTGTSFYMAPERIQGK------------------PYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccccccccc-ccccCCccccCHHHhcCC------------------CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 99875543221 234578899999988654 2456789999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=307.45 Aligned_cols=205 Identities=32% Similarity=0.471 Sum_probs=168.5
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcce
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVr 867 (1033)
..+...+.+..++||+|.||+||+|+.. .+.||||.++... ......+|++|++++..|+|||||+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-------~~~~~~dF~REaeLla~l~H~nIVr 553 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-------ENQARQDFRREAELLAELQHPNIVR 553 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-------cHHHHHHHHHHHHHHHhccCCCeEE
Confidence 3456677888999999999999999863 3459999888542 2334579999999999999999999
Q ss_pred EEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------Cc----cCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001678 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RT----IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKC 934 (1033)
Q Consensus 868 LyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------k~----Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKP 934 (1033)
|+|+|.+ ...++||+|||..|||.++|.... .. ++..+.+.||.||+.||+||-++.+|||||..
T Consensus 554 LlGVC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT 631 (774)
T KOG1026|consen 554 LLGVCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT 631 (774)
T ss_pred EEEEEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence 9999999 578999999999999999997431 22 78889999999999999999999999999999
Q ss_pred CcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchH
Q 001678 935 ENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCY 1011 (1033)
Q Consensus 935 sNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVW 1011 (1033)
+|+||. ++..|||+||||++..-... ..+...-.++||+||.|...+ +++++|||
T Consensus 632 RNCLVg----e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k------------------FTteSDVW 689 (774)
T KOG1026|consen 632 RNCLVG----ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK------------------FTTESDVW 689 (774)
T ss_pred hhceec----cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc------------------ccchhhhh
Confidence 999998 88999999999998643222 111223478899999887653 67788999
Q ss_pred HHHHHHHHHHc-cCCCCCCC
Q 001678 1012 SLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1012 SLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
||||||||+++ |+-|+--+
T Consensus 690 s~GVvLWEIFsyG~QPy~gl 709 (774)
T KOG1026|consen 690 SFGVVLWEIFSYGKQPYYGL 709 (774)
T ss_pred hhhhhhhhhhccccCccccc
Confidence 99999999885 55555433
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=266.10 Aligned_cols=200 Identities=27% Similarity=0.346 Sum_probs=165.6
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|+++++||+|+||.||+|.++ ++.||+|++...... ....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRR--K 72 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhccc--C
Confidence 46899999999999999999884 678999987643211 1223467789999999999999999999987 6
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+++|+||+|+||+++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~----~~~~~~l~dfg~~ 147 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFA 147 (286)
T ss_pred CeEEEEEecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCcEEEEeeeee
Confidence 78999999999998888765543 489999999999999999999999999999999999998 6789999999998
Q ss_pred cccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... .......++..|+|||++.+.. .++.++|||||||++|+|++|++||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDT-----------------KYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhcccc-----------------ccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 765332 2223455788999999886532 245567999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=270.35 Aligned_cols=204 Identities=27% Similarity=0.448 Sum_probs=164.3
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCc
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k---------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNI 865 (1033)
.+...+|.+.++||+|+||.||+++.. ...+|+|.++... .......+.+|+.+++.+ +||||
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 80 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMELMKLIGKHKNI 80 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhccCCCCe
Confidence 445568999999999999999999752 3358999876431 112245688899999999 59999
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHR 930 (1033)
+++++++.. .+.+++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++||
T Consensus 81 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 81 INLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred eeEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999987 567999999999999999997632 347888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCCCeEEEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcc
Q 001678 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWS 1007 (1033)
Q Consensus 931 DIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~k 1007 (1033)
||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+.. ++.+
T Consensus 159 dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~ 216 (314)
T cd05099 159 DLAARNVLVT----EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV------------------YTHQ 216 (314)
T ss_pred cccceeEEEc----CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC------------------cCcc
Confidence 9999999998 667899999999986543211 11122456799999886542 5567
Q ss_pred cchHHHHHHHHHHHc-cCCCCCCC
Q 001678 1008 YDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1008 vDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
+|+|||||++|+|++ |..||...
T Consensus 217 ~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 217 SDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred chhhHHHHHHHHHHhCCCCCCCCC
Confidence 899999999999999 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=268.25 Aligned_cols=200 Identities=30% Similarity=0.440 Sum_probs=168.6
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
..++|++++.||+|+||+||++.+. ++.||+|++.... .....+.+.+|+.+++.++|+||+++++.+..
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 74 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLN- 74 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEec-
Confidence 4567889999999999999999885 7789999876431 12234578899999999999999999999998
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...+++||||+++++|.+++.+.+ .+++..+..++.+++.+|.|||+ .+++||||||+||+++ .++.++|+||
T Consensus 75 -~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~d~ 148 (284)
T cd06620 75 -ENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCDF 148 (284)
T ss_pred -CCEEEEEEecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC----CCCcEEEccC
Confidence 578999999999999999987654 58999999999999999999997 5999999999999998 6778999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
|++....... .....|+..|+|||++.+. .++.++|+|||||++|+|+||..||+..
T Consensus 149 gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~------------------~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 149 GVSGELINSI-ADTFVGTSTYMSPERIQGG------------------KYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred Ccccchhhhc-cCccccCcccCCHHHHccC------------------CCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 9987543222 2345689999999988654 2556789999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=275.06 Aligned_cols=200 Identities=23% Similarity=0.293 Sum_probs=165.2
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||+|+||.||+|+. +++.||||++..... .......+.+|+.++++++|+||++++++|....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 46799999999999999999987 577899998764211 1122345678999999999999999999987521
Q ss_pred ----CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 ----eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
....++||||+. ++|.+.+... +++..+..++.||+.||+|||+.||+||||||+|||++ .++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~----~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEc
Confidence 235799999994 5888887643 78889999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
|||+++............++..|+|||++.+. .++.++|+|||||++|+|++|+.||...
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGM------------------GYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHhCC------------------CCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999876554444455688999999998664 2566789999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=261.13 Aligned_cols=198 Identities=31% Similarity=0.520 Sum_probs=162.4
Q ss_pred cCCCceEEEEecccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~kG-~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..++|++.++||+|+||.||++.+.+ ..+|+|.+..... ..+.+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 72 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-- 72 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 34678999999999999999998854 4689998764321 12367789999999999999999998754
Q ss_pred CCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
+..++||||+.+++|.+++.+. ...+++..+..++.|++.||.|||+.|++|+||||+|||++ .++.+||+|||
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~----~~~~~~l~dfg 147 (260)
T cd05069 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIADFG 147 (260)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCeEEECCCc
Confidence 4578999999999999999764 34578999999999999999999999999999999999998 67889999999
Q ss_pred Cccccccccc--cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 956 LSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~~~--s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
++........ .....++..|+|||.+.+. .++.++|+|||||++|+|+| |+.||.-
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~------------------~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYG------------------RFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cceEccCCcccccCCCccchhhCCHHHhccC------------------CcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9976543221 1223456789999987654 24567799999999999999 8999853
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=272.46 Aligned_cols=199 Identities=21% Similarity=0.275 Sum_probs=160.2
Q ss_pred EEEEeccc--CcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 804 EVRELGSG--TYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 804 ilekLGeG--gFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
++++||+| +|++||++.. +++.||||++..... .....+.+.+|+.+++.++||||++++++|.. ++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNE 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCE
Confidence 45789999 7899999987 477899999875421 12234467789999999999999999999998 577
Q ss_pred eEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 880 LATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~----~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe----cCCcEEEcccchhh
Confidence 99999999999999999754 34489999999999999999999999999999999999998 66789999998654
Q ss_pred cccccc--------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 959 VKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~--------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
...... ......++..|+|||++.+... .++.++|||||||++|+|++|+.||+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----------------~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ----------------GYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccC----------------CCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 321110 1112346778999999865321 2566789999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=262.79 Aligned_cols=203 Identities=25% Similarity=0.359 Sum_probs=166.7
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
+..++|++.+.||+|+||.||+|.+. +..|++|++.... .......+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45678999999999999999999874 3668888875321 2233467889999999999999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcC-------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD-------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~-------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d 943 (1033)
++... ....++++||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+++||||||+|||++
T Consensus 76 ~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~--- 151 (280)
T cd05043 76 VCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--- 151 (280)
T ss_pred EEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---
Confidence 88764 456889999999999999997642 3588999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHH
Q 001678 944 PQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeL 1020 (1033)
.++.+||+|||+++...... ......++..|+|||++.+.. ++.++|||||||++|++
T Consensus 152 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~------------------~~~~~Di~slG~~l~el 212 (280)
T cd05043 152 -EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE------------------YSSASDVWSFGVLLWEL 212 (280)
T ss_pred -CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC------------------CCchhhHHHhHHHHHHH
Confidence 66899999999998543221 112334677899999886542 45678999999999999
Q ss_pred Hc-cCCCCCC
Q 001678 1021 QF-ILCFIDF 1029 (1033)
Q Consensus 1021 LT-Gk~PFd~ 1029 (1033)
++ |+.||+.
T Consensus 213 ~~~g~~p~~~ 222 (280)
T cd05043 213 MTLGQTPYVE 222 (280)
T ss_pred hcCCCCCcCc
Confidence 99 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=290.97 Aligned_cols=207 Identities=18% Similarity=0.284 Sum_probs=171.5
Q ss_pred ccccccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 793 ~~~~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
....++..-|..++.||-|+||.|.++... ...+|+|.+++.... .+..+...+.|..||...+.+.||+||.
T Consensus 622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-----~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-----MRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-----hhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 344566777999999999999999998763 445799988765332 3345667889999999999999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
.|++ ...+|+||||++||++..+|.+.+- |.+..+..++.++..|+++.|+.|+|||||||+||||| .+|++|
T Consensus 697 SFQD--kdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID----rdGHIK 769 (1034)
T KOG0608|consen 697 SFQD--KDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIK 769 (1034)
T ss_pred Eecc--CCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc----cCCcee
Confidence 9999 7889999999999999999998876 66666666666999999999999999999999999999 789999
Q ss_pred EEecCCccccc---------cc----------------------------------cccCCcCCCCcccccccccCCCcc
Q 001678 951 IGDLGLSKVKQ---------QT----------------------------------LVSGGVRGTLPWMAPELLSGKSHM 987 (1033)
Q Consensus 951 LiDFGLAr~~~---------~~----------------------------------~~s~~~~GT~~YmAPEvi~gk~~~ 987 (1033)
|+|||||.-.. .. ......+||+.|+|||++...+
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-- 847 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-- 847 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC--
Confidence 99999985210 00 0113456999999999997654
Q ss_pred ccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 988 VTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 988 ~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++...|+||.|||||+|+.|.+||-.
T Consensus 848 ----------------~~q~cdwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 848 ----------------YTQLCDWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred ----------------ccccchhhHhhHHHHHHhhCCCCccC
Confidence 56678999999999999999999943
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=264.23 Aligned_cols=194 Identities=25% Similarity=0.322 Sum_probs=162.0
Q ss_pred ecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 808 LGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
||+|+||+||++.. +++.||+|++...... .......+..|+.+++.++||||+++++++.. .+..++|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-----KRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-----hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEe
Confidence 68999999999976 4778999988753221 11223456789999999999999999999987 577999999
Q ss_pred eccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc
Q 001678 886 FMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1033)
Q Consensus 886 YmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~ 964 (1033)
|+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+++||||||+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~----~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccCcchhhhccCC
Confidence 999999999997654 3589999999999999999999999999999999999998 67789999999987654433
Q ss_pred ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 965 ~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
......++..|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~------------------~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEV------------------YDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccccccCCCCcCCHHHhcCCC------------------CCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 334456788999999986542 456789999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=251.26 Aligned_cols=198 Identities=32% Similarity=0.492 Sum_probs=170.9
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|+..+.||+|++|.||++.+. ++.+++|++..... .....+.+|+.++++++|+||+++++.+.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KD 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CC
Confidence 5788999999999999999885 77899999875421 234578899999999999999999999988 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
..++++||+.+++|.+++......+++..+..++.|++.+|.+||..+++|+||+|+||+++ .++.+||+|||++.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----cCCeEEEeeccccc
Confidence 78999999999999999987656789999999999999999999999999999999999998 67899999999998
Q ss_pred ccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
............++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~~~------------------~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVINGKP------------------YDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cccccccccceecCCcccCHHHHcCCC------------------CCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 765443234556899999999886542 456789999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=270.25 Aligned_cols=202 Identities=30% Similarity=0.501 Sum_probs=163.9
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE--cCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~--kG~----kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
.+...+|+.++.||+|+||.||++.+ .+. .||+|.+..... ......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-------PKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 45667899999999999999999987 343 368887654311 12223578899999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
+++.. ...++|+||+.+|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~----~~~~~ 148 (303)
T cd05110 76 GVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK----SPNHV 148 (303)
T ss_pred EEEcC---CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec----CCCce
Confidence 99875 346799999999999999987766689999999999999999999999999999999999998 56789
Q ss_pred EEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCC
Q 001678 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILC 1025 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~ 1025 (1033)
||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~DiwslG~~l~el~t~g~~ 210 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR------------------KFTHQSDVWSYGVTIWELMTFGGK 210 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccC------------------CCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999986543221 1223357789999988654 25667899999999999997 888
Q ss_pred CCCC
Q 001678 1026 FIDF 1029 (1033)
Q Consensus 1026 PFd~ 1029 (1033)
||.-
T Consensus 211 p~~~ 214 (303)
T cd05110 211 PYDG 214 (303)
T ss_pred CCCC
Confidence 8854
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=262.62 Aligned_cols=200 Identities=26% Similarity=0.306 Sum_probs=166.2
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|+||.||+|.++ ++.||||+++..... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 72 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD------EDVKKTALREVKVLRQLRHENIVNLKEAFRR--K 72 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc------ccchhHHHHHHHHHHhcCCCCeeehhheEEE--C
Confidence 36899999999999999999884 677999988753211 1223567889999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
+.+++||||+.++.|..++.+ ...+++..++.++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~----~~~~~kl~d~g~~ 147 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFA 147 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEEeeecc
Confidence 679999999988767665544 34589999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....... ......++..|+|||++.+.. .++.++|+||||+++|+|++|+.||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----------------~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDT-----------------NYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCC-----------------CcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 8765433 233456789999999986642 245678999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=262.14 Aligned_cols=206 Identities=30% Similarity=0.392 Sum_probs=166.7
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEc
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d 874 (1033)
..++|++.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.++.++ +|+||+++++++..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 357899999999999999999987 46789999876421 1123566788899998 79999999999876
Q ss_pred CC---CCceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCe
Q 001678 875 GP---DGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1033)
Q Consensus 875 ~~---eg~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~ 948 (1033)
.+ .+..++||||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+++||||||+||+++ .++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~----~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT----TEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCC
Confidence 32 2468999999999999998863 345689999999999999999999999999999999999998 6678
Q ss_pred EEEEecCCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 949 VKLiDFGLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
+||+|||++....... ......|+..|+|||++...... -..++.++|+|||||++|+|++|+.||
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-------------~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY-------------DYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCc-------------ccccCCccchHHHHHHHHHHhhCCCCC
Confidence 9999999988654322 22345688999999987543210 013567889999999999999999998
Q ss_pred CC
Q 001678 1028 DF 1029 (1033)
Q Consensus 1028 d~ 1029 (1033)
..
T Consensus 234 ~~ 235 (291)
T cd06639 234 FD 235 (291)
T ss_pred CC
Confidence 54
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=259.93 Aligned_cols=193 Identities=27% Similarity=0.464 Sum_probs=154.7
Q ss_pred EecccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceE
Q 001678 807 ELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~k-----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~ 881 (1033)
.||+|+||.||+|++. ...||||.+.... .....+.+.+|+.+++.++||||+++++++... ++..+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 73 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPL 73 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcE
Confidence 5899999999999863 2458999865321 122345778899999999999999999987653 45688
Q ss_pred EEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
+||||+.+++|.+++.+.....++..+..++.||+.||.|||+.+++||||||+|||++ ..+.+||+|||+++...
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~----~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIY 149 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCcccccccc
Confidence 99999999999999987666678888899999999999999999999999999999998 67789999999987543
Q ss_pred ccc-----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc-CCCCCC
Q 001678 962 QTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI-LCFIDF 1029 (1033)
Q Consensus 962 ~~~-----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG-k~PFd~ 1029 (1033)
... ......++..|+|||.+.+. .++.++|||||||++|+|++| .+||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQ------------------KFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccC------------------ccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 211 11233457789999987654 245678999999999999994 666653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=251.63 Aligned_cols=202 Identities=32% Similarity=0.459 Sum_probs=172.5
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|.+.+.||+|++|.||+|... ++.|++|++...... ....+.+.+|+.++++++|+||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4788899999999999999885 788999998754321 23346788999999999999999999999884337
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
..++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD----SDGVVKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcccccEE
Confidence 8999999999999999998765 689999999999999999999999999999999999998 67899999999998
Q ss_pred ccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 959 VKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 959 ~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
....... .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~------------------~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEE------------------YGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCC------------------CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7655432 34456899999999886642 4567899999999999999999997653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=262.84 Aligned_cols=203 Identities=27% Similarity=0.355 Sum_probs=161.0
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~ 876 (1033)
++|++.+.||+|+||.||+|.+ +++.||||+++..... ......+.+|+.+++.+. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE------EGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc------cCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 4689999999999999999987 4778999987653211 112245778999999995 699999999987632
Q ss_pred C---CceEEEEeeccCCcHHHHHHhc----CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 877 D---GSLATVTEFMVNGSLKQFLQKK----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 877 e---g~l~LVmEYmegGSL~dlL~~~----~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
. ..+++||||+.+ +|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++. .++.+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~---~~~~~ 150 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK---QKGLL 150 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec---CCCeE
Confidence 1 237999999975 898888653 235799999999999999999999999999999999999982 26799
Q ss_pred EEEecCCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 950 KIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
||+|||++....... ......+++.|+|||++.+.. .++.++|+|||||++|+|++|..||.
T Consensus 151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------------~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST-----------------HYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred EEeecccceecCCCccccCCcccccCCCChHHhhCCC-----------------CCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 999999987543221 112234688899999876532 24667899999999999999999986
Q ss_pred C
Q 001678 1029 F 1029 (1033)
Q Consensus 1029 ~ 1029 (1033)
.
T Consensus 214 ~ 214 (295)
T cd07837 214 G 214 (295)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=259.96 Aligned_cols=206 Identities=27% Similarity=0.425 Sum_probs=168.7
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCC--CchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAG--KPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~--k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
+|.+.+.||+|+||.||+|.. .++.+|||.++...... .........+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 477889999999999999976 47789999886432211 112223345678899999999999999999999887
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...+++||||+.+++|.+++.+.+ .+++..+..++.||+.||.|||+.+++||||||+||+++ .++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~----~~~~~~l~d~~~ 154 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD----ADGICKISDFGI 154 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc----CCCeEEEeeccc
Confidence 567999999999999999998764 588999999999999999999999999999999999998 678999999999
Q ss_pred cccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++...... ......|+..|+|||++..... .++.++|+||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~----------------~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ----------------GYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccC----------------CCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 87543221 1223457899999998865421 256678999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=279.83 Aligned_cols=204 Identities=28% Similarity=0.401 Sum_probs=171.8
Q ss_pred CCceEEEEecccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
..|+.++.||+|+||.||+|..+ ...+|||.++..... ........+|+.+++.++||||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~------tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG------TGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC------CCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 46889999999999999999542 235899988754221 112235668999999999999999999888
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHh----cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~----~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
.- +.+++|++||.+ -+|...|+- +.+.++...++.|++||+.|+.|||+.-|+||||||.||||..++++.|.|
T Consensus 98 ~~-d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 98 SH-DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cc-CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 75 678999999995 589998862 335689999999999999999999999999999999999999888889999
Q ss_pred EEEecCCcccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCC
Q 001678 950 KIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~ 1025 (1033)
||+|||+++.+.... ....++-|.+|+|||.+.|.. +|+.++|+|++|||+.||||.++
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~-----------------hYT~AiDvWAiGCIfaElLtl~P 238 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR-----------------HYTKAIDVWAIGCIFAELLTLEP 238 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccc-----------------cccchhhhHHHHHHHHHHHccCc
Confidence 999999999876543 234566799999999999875 68888999999999999999999
Q ss_pred CCC
Q 001678 1026 FID 1028 (1033)
Q Consensus 1026 PFd 1028 (1033)
.|-
T Consensus 239 lF~ 241 (438)
T KOG0666|consen 239 LFK 241 (438)
T ss_pred ccc
Confidence 884
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=266.52 Aligned_cols=198 Identities=24% Similarity=0.360 Sum_probs=167.0
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..+|++.++||.|+||.||++.+ .++.||||.+...... ..+.+.+|+.+++.++|+||+++++++..
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 87 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--------KKELIINEILVMKELKNPNIVNFLDSFLV-- 87 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--------hHHHHHHHHHHHHhcCCCceeeeeeeEec--
Confidence 35699999999999999999986 5788999988643211 12457789999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...+++||||+.+++|.+++.+. .+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~----~~~~~kl~dfg~ 161 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG----MDGSVKLTDFGF 161 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCcc
Confidence 56899999999999999998654 479999999999999999999999999999999999998 677899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+....... ......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA------------------YGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred chhcccccccCCCcCCCccccCcchhcCCC------------------CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 87653322 223456889999999886542 455789999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=258.80 Aligned_cols=193 Identities=30% Similarity=0.473 Sum_probs=160.8
Q ss_pred EEecccCcEEEEEEEEcC---c--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCce
Q 001678 806 RELGSGTYGSVYHGKWRG---S--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG---~--kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l 880 (1033)
+.||+|++|.||+|.+.. + .||||.+...... ...+.+.+|+.++++++|+||+++++++.+ ...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPL 70 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeE
Confidence 368999999999998732 2 4899988754321 445688899999999999999999999886 678
Q ss_pred EEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 881 ATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+++++|+||||+|||++ .++.+||+|||+++.
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~----~~~~~kl~dfg~~~~ 146 (257)
T cd05040 71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRA 146 (257)
T ss_pred EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe----cCCEEEecccccccc
Confidence 99999999999999998765 5689999999999999999999999999999999999998 668999999999986
Q ss_pred ccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 960 KQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 960 ~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
..... ......++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~------------------~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTR------------------TFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhccc------------------CcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 54321 11234467889999988654 25667899999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=263.24 Aligned_cols=202 Identities=23% Similarity=0.368 Sum_probs=165.9
Q ss_pred CceEEEEecccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEc
Q 001678 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~-----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d 874 (1033)
+|++.+.||+|+||.||+++. ++..||+|+++...... .....+.+.+|+.+++++ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh----cchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478899999999999999986 46789999987532211 112234677899999999 59999999999887
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+++||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df 149 (290)
T cd05613 77 --DTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDF 149 (290)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC----CCCCEEEeeC
Confidence 567899999999999999997654 478889999999999999999999999999999999998 6789999999
Q ss_pred CCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|++....... ......|+..|+|||.+..... .++.++|+||||+++|+|+||..||+.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----------------~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG----------------GHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCC----------------CCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 9987654322 2224568999999998864321 245577999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=261.64 Aligned_cols=198 Identities=26% Similarity=0.404 Sum_probs=163.8
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|+++++||.|++|.||+|++ .++.||||+++...... ....+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-------TPSTAIREISLMKELKHENIVRLHDVIHT--EN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-------chHHHHHHHHHHHhhcCCCEeeeeeeEee--CC
Confidence 588999999999999999998 47789999987543211 12356679999999999999999999998 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcC--CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~--k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+++||||||+||+++ .++.+||+|||+
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~----~~~~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGL 146 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCcEEEeecch
Confidence 7899999997 58999887654 4589999999999999999999999999999999999998 677899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+....... ......++..|++||++.+.. .++.++|+|||||++|+|++|+.||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----------------~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGSR-----------------TYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCCC-----------------CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 87543321 122345688999999876532 245577999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=256.02 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=169.0
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|.+.+.||+|+||.||++.. .++.||+|.++..... ....+.+..|+.+++.++|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND------PKTIKEIADEMKVLELLKHPNLVKYYGVEVH--RE 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc------hHHHHHHHHHHHHHHhCCCCChhheeeeEec--CC
Confidence 588899999999999999987 4678999998754211 3345678899999999999999999999877 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++|+||+.+++|.+++.+.. .+++..+..|+.|++.||.|||+.+|+|+||||+||+++ ..+.+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccccccc
Confidence 7999999999999999997653 478899999999999999999999999999999999998 67889999999988
Q ss_pred ccccccc-----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 959 VKQQTLV-----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~~-----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
....... .....++..|+|||++.+.. ...++.++|+||||+++|+|++|..||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---------------~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK---------------GKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCC---------------CCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 6543221 11345788999999986542 013567889999999999999999999644
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=262.61 Aligned_cols=199 Identities=32% Similarity=0.442 Sum_probs=168.8
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||.|+||.||++.++ ++.+|+|++..... ......+.+|+.++++++||||+++++.+.. .
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-------EAIQKQILRELDILHKCNSPYIVGFYGAFYN--N 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-------hHHHHHHHHHHHHHHHCCCCchhhhheeeec--C
Confidence 36788889999999999999885 77799998875421 1223567889999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
..+++|+||+.+++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++ .++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~----~~~~~~l~d~g~ 147 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDFGV 147 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC----CCCCEEEeeccc
Confidence 78999999999999999998765678999999999999999999999 9999999999999998 677899999999
Q ss_pred ccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+......... ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 148 ~~~~~~~~~~-~~~~~~~y~~PE~~~~~------------------~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 148 SGQLVNSLAK-TFVGTSSYMAPERIQGN------------------DYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred chhhHHHHhh-cccCChhccCHHHHcCC------------------CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 8765433222 26688999999988664 2556789999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=261.83 Aligned_cols=202 Identities=28% Similarity=0.467 Sum_probs=167.7
Q ss_pred CCCceEEEEecccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
..+|++++.||+|+||.||++++. ++.+|||+++.... . ...+.+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~------~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE------E-QHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc------h-HHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 356888899999999999999864 56799998875421 1 2345788999999999999999999998
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
........++||||+++++|.+++......+++..+..++.|++.||+|||++|++|+||||+|||++ .++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE----SEDLVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEc
Confidence 87555678999999999999999987766689999999999999999999999999999999999998 66899999
Q ss_pred ecCCccccccccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 953 DFGLAr~~~~~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|||++........ .....++..|+|||.+.+. .++.++|+||||+++|+|+||..||.
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~------------------~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS------------------KFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccC------------------CCCcccchHHHhhhhheeeccCCCcc
Confidence 9999987642211 1122345679999987654 24567899999999999999998875
Q ss_pred C
Q 001678 1029 F 1029 (1033)
Q Consensus 1029 ~ 1029 (1033)
.
T Consensus 214 ~ 214 (284)
T cd05038 214 S 214 (284)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=259.21 Aligned_cols=194 Identities=26% Similarity=0.370 Sum_probs=164.2
Q ss_pred ecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 808 LGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
||.|+||.||+++.. ++.||+|++....... ....+.+.+|+.+++.++|+||+++++.+.+ ...+++|||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-----TGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-----hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEe
Confidence 689999999999986 7889999987543221 1223578899999999999999999999887 567999999
Q ss_pred eccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccccc
Q 001678 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965 (1033)
Q Consensus 886 YmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~ 965 (1033)
|+++++|.+++.+.. .+++..+..++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++........
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~----~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc----CCCCEEEeeCCcccccCcccc
Confidence 999999999997654 488999999999999999999999999999999999998 677899999999987654433
Q ss_pred cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 966 SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 966 s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
.....|+..|++||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 149 ~~~~~~~~~~~~PE~~~~~------------------~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNK------------------GYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cccccCCcCccChhHhcCC------------------CCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 3345689999999987654 24567799999999999999999996543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=288.22 Aligned_cols=205 Identities=26% Similarity=0.361 Sum_probs=177.5
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
+.+..+.|..-+.||+|+||.||-+.. +|+-+|.|.+.+..+..+.. ....+.|..||.+++.+.||.+-..|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g-----e~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG-----ETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh-----hHHhhHHHHHHHHhccCcEEEEeeee
Confidence 456678899999999999999998755 68888999876543322222 23566889999999999999998888
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
.+ ...+|+||..|.||+|...|.+.+ ..+++..++.++.+|+.||++||+.+||+|||||+||||| +.|+|+|
T Consensus 255 eT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD----d~GhvRI 328 (591)
T KOG0986|consen 255 ET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD----DHGHVRI 328 (591)
T ss_pred cC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec----cCCCeEe
Confidence 88 678999999999999999998765 4589999999999999999999999999999999999999 8899999
Q ss_pred EecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
+|+|||..+.......+.+||.+|||||++.++. |+.+.|+|||||++|+|+.|..||.
T Consensus 329 SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~------------------Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV------------------YDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred eccceEEecCCCCccccccCcccccCHHHHcCCc------------------ccCCccHHHHHhHHHHHHcccCchh
Confidence 9999999887766656668999999999998874 6667899999999999999999995
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=283.50 Aligned_cols=205 Identities=28% Similarity=0.392 Sum_probs=165.7
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcc
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVV 866 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~kG-------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIV 866 (1033)
..+..++|.+.++||+|+||.||+|++.+ +.||||+++.... ......+.+|+.++.++. ||||+
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~~H~niv 104 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------SSEKQALMSELKIMSHLGPHLNIV 104 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------hhHHHHHHHHHHHHHhcCCCCCeE
Confidence 44556678889999999999999998643 4699999875321 112246788999999998 99999
Q ss_pred eEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC----------------------------------------------
Q 001678 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------------------------------- 900 (1033)
Q Consensus 867 rLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------------------------------------- 900 (1033)
++++++.. .+.+++||||+.+|+|.++|.+..
T Consensus 105 ~~~~~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 105 NLLGACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred EEEEEEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 99999988 567999999999999999997532
Q ss_pred ---------------------------------------------------CccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001678 901 ---------------------------------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1033)
Q Consensus 901 ---------------------------------------------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVH 929 (1033)
..+++..++.|+.||+.||+|||+.+|+|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 12566678889999999999999999999
Q ss_pred cCCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCc
Q 001678 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKW 1006 (1033)
Q Consensus 930 RDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~ 1006 (1033)
|||||+|||++ ..+.+||+|||+++...... ......++..|+|||++.+.. ++.
T Consensus 263 rdlkp~NiLl~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~ 320 (401)
T cd05107 263 RDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL------------------YTT 320 (401)
T ss_pred ccCCcceEEEe----CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC------------------CCc
Confidence 99999999998 67899999999998643221 122345678899999886542 456
Q ss_pred ccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 1007 SYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1007 kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
++|+|||||++|+|++ |..||+..
T Consensus 321 ~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 321 LSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred HhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 7799999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=263.93 Aligned_cols=194 Identities=24% Similarity=0.407 Sum_probs=156.2
Q ss_pred EecccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 807 ELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~k---------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.||+|+||.||+|... ...+|+|.+... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~ 71 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--G 71 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--C
Confidence 5899999999999763 223677765432 12334578889999999999999999999998 4
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC----CCCeEEEEe
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP----QRPVCKIGD 953 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~----~~g~VKLiD 953 (1033)
...++||||+.+|+|.+++...+..+++..++.++.||+.||+|||+++|+||||||+|||++.++. ..+.+||+|
T Consensus 72 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 72 DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 6689999999999999999877667899999999999999999999999999999999999984321 223589999
Q ss_pred cCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc-CCCCCCC
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI-LCFIDFF 1030 (1033)
Q Consensus 954 FGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG-k~PFd~~ 1030 (1033)
||++...... ....++..|+|||++.+.. .++.++|+|||||++|+|++| ..||...
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQ-----------------NLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCC-----------------CCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 9998754332 2345788999999986532 245678999999999999998 4666543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.96 Aligned_cols=199 Identities=33% Similarity=0.484 Sum_probs=169.8
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|++|.||+++.. ++.|+||++...... .....+.+|+.++.+++|+||+++++++.. .
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPYVVKCYGAFYK--E 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--C
Confidence 46889999999999999999884 778999988754211 234578899999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++ .++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~----~~~~~~l~df~~ 146 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGI 146 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC----CCCCEEEccCcc
Confidence 7899999999999999999866 458999999999999999999999 9999999999999998 678999999999
Q ss_pred cccccccccc-CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTLVS-GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~~s-~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+......... ....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~------------------~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGE------------------SYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCC------------------CCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 8865443322 245678999999987654 2566789999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=261.96 Aligned_cols=198 Identities=27% Similarity=0.432 Sum_probs=165.2
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEcC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDG 875 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~---HPNIVrLyG~f~d~ 875 (1033)
.|++++.||+|+||.||+|.+ .++.||+|.++.... ......+.+|+.+++.++ |+||+++++++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~- 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK- 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-
Confidence 477889999999999999987 467899998864321 122346778999999997 9999999999987
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....++||||+.+++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++ ..+.+||+|||
T Consensus 74 -~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~----~~~~~~l~dfg 146 (277)
T cd06917 74 -GPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT----NTGNVKLCDFG 146 (277)
T ss_pred -CCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc----CCCCEEEccCC
Confidence 56789999999999999998654 588999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++....... ......|+..|+|||.+.+.. .++.++|+|||||++|+|++|..||+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEGK-----------------YYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccCC-----------------ccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 987654332 223446899999999875432 2456789999999999999999999654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=262.15 Aligned_cols=192 Identities=32% Similarity=0.445 Sum_probs=153.6
Q ss_pred EecccCcEEEEEEEEcC--c--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCCCCceE
Q 001678 807 ELGSGTYGSVYHGKWRG--S--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~kG--~--kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~eg~l~ 881 (1033)
.||+|+||.||+|++++ . .+++|.++... .......+.+|+.++.++ +||||+++++++.. .+.++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCce
Confidence 58999999999998743 2 36778766321 112234678899999999 79999999999987 56789
Q ss_pred EEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCC
Q 001678 882 TVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~ 946 (1033)
+||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+++||||||+|||++ .+
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----~~ 148 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----EN 148 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----CC
Confidence 9999999999999997532 2478889999999999999999999999999999999998 67
Q ss_pred CeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCC
Q 001678 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILC 1025 (1033)
Q Consensus 947 g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~ 1025 (1033)
+.+||+|||++..............+..|+|||++... .++.++|+|||||++|+|++ |..
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~------------------~~~~~~Di~slG~il~el~~~g~~ 210 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS------------------VYTTNSDVWSYGVLLWEIVSLGGT 210 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccC------------------CCCchhhHHHHHHHHHHHHcCCCC
Confidence 89999999998643222111122235679999988654 24567899999999999997 999
Q ss_pred CCCC
Q 001678 1026 FIDF 1029 (1033)
Q Consensus 1026 PFd~ 1029 (1033)
||.-
T Consensus 211 pf~~ 214 (270)
T cd05047 211 PYCG 214 (270)
T ss_pred Cccc
Confidence 9853
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=266.96 Aligned_cols=197 Identities=23% Similarity=0.353 Sum_probs=166.3
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..+|++++.||+|+||.||++.. .++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++..
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 87 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV-- 87 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 36799999999999999999986 5788999988643211 12457789999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
....++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+++||||||+|||++ .++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~----~~~~~~l~Dfg~ 161 (297)
T cd06656 88 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 161 (297)
T ss_pred CCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 56799999999999999998653 478889999999999999999999999999999999998 678899999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+....... ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA------------------YGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred ceEccCCccCcCcccCCccccCHHHHcCCC------------------CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 87653322 222346889999999886642 45577999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=264.78 Aligned_cols=203 Identities=27% Similarity=0.397 Sum_probs=163.8
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.++||+|+||.||+|.+ +++.+|||++........ ....+.+|+.+++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG------FPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC------cchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 47899999999999999999987 467899998865432211 1124568999999999999999999886532
Q ss_pred ------CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 877 ------eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
...+++||||+. ++|...+......+++..++.++.||++||.|||++||+|+||||+|||++ .++.+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~----~~~~~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQGILK 155 (311)
T ss_pred ccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEE
Confidence 235799999995 578887776666799999999999999999999999999999999999998 678999
Q ss_pred EEecCCccccccccc------------cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHH
Q 001678 951 IGDLGLSKVKQQTLV------------SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~------------s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLY 1018 (1033)
|+|||++........ .....++..|+|||++.+.. .++.++|||||||++|
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~il~ 218 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER-----------------RYTTAVDIWGIGCVFA 218 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC-----------------ccCchhHhHHHHHHHH
Confidence 999999975432211 12235688899999876532 2566789999999999
Q ss_pred HHHccCCCCCC
Q 001678 1019 FLQFILCFIDF 1029 (1033)
Q Consensus 1019 eLLTGk~PFd~ 1029 (1033)
+|++|++||..
T Consensus 219 el~~g~~~~~~ 229 (311)
T cd07866 219 EMFTRRPILQG 229 (311)
T ss_pred HHHhCCCCCCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=255.14 Aligned_cols=197 Identities=34% Similarity=0.540 Sum_probs=163.5
Q ss_pred ceEEEEecccCcEEEEEEEEcC------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 802 LEEVRELGSGTYGSVYHGKWRG------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~kG------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
+++.+.||.|+||.||++++.. ..||+|+++.... ....+.+..|+.+++.++|+||+++++++.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------EQQIEEFLREARIMRKLDHPNIVKLLGVCTE- 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------hHHHHHHHHHHHHHHhcCCCchheEEEEEcC-
Confidence 3567899999999999998854 6799999865421 1134578899999999999999999999988
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCc-cCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~-Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
.+..++||||+++++|.+++...... +++..+..++.|++.||.|||+.+++|+||||+||+++ ..+.+||+||
T Consensus 73 -~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~----~~~~~~l~df 147 (258)
T smart00219 73 -EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDF 147 (258)
T ss_pred -CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc----cCCeEEEccc
Confidence 47899999999999999999865444 89999999999999999999999999999999999998 6679999999
Q ss_pred CCccccccccccC--CcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCC
Q 001678 955 GLSKVKQQTLVSG--GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~~s~--~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~ 1029 (1033)
|++.......... ...++..|+|||.+.+. .++.++|+||||+++|+|++ |..||+.
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~------------------~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG------------------KFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred CCceecccccccccccCCCcccccChHHhccC------------------CCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9998654332111 22367899999987543 24567899999999999998 8888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=260.09 Aligned_cols=201 Identities=29% Similarity=0.403 Sum_probs=166.6
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|++.++||+|+||.||+|++. ++.+|+|++.... . .......+.+|+.+++.++|+||+++++++.....+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--E----KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--c----cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999884 5789999988653 1 1122346778999999999999999999998743378
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++||||+. ++|.+++.+....+++..++.++.||+.||+|||+.+++|+||||+|||++ .++.+||+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~----~~~~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARP 149 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc----CCCCEEEccccceee
Confidence 999999996 589999877656789999999999999999999999999999999999998 678999999999986
Q ss_pred ccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 960 KQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 960 ~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
..... ......++..|+|||.+.+.. .++.++||||||+++|+|+||+.||...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----------------~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGAT-----------------RYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred ccCCCcccccccccccccCCceeeEccc-----------------cCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 64432 122345688899999876532 2456789999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=262.00 Aligned_cols=201 Identities=26% Similarity=0.368 Sum_probs=162.1
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
++|++.+.||+|++|.||+|+++ ++.||||++...... ......+.+|+.++++++|+||+++++++.. .
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 73 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHS--E 73 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc------ccchHHHHHHHHHHHhccCCCEeeEEEEEec--C
Confidence 57999999999999999999874 678999987654221 1123467789999999999999999999987 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++++|+||||+||+++. .++.+||+|||+
T Consensus 74 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~dfg~ 149 (294)
T PLN00009 74 KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGL 149 (294)
T ss_pred CeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEccccc
Confidence 68999999995 58888876543 33678888899999999999999999999999999999972 245799999999
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+....... ......+++.|+|||++.+.. .++.++|+|||||++|+|+||..||..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----------------~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLGSR-----------------HYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhCCC-----------------CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 97543221 122345688999999886532 245677999999999999999999964
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.47 Aligned_cols=192 Identities=30% Similarity=0.436 Sum_probs=157.2
Q ss_pred EEecccCcEEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCce
Q 001678 806 RELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG-----~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l 880 (1033)
++||+|+||.||+|++.. ..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++++.. ...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---Cce
Confidence 369999999999998732 56899988754221 233568889999999999999999998764 457
Q ss_pred EEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||..+++|+||||+|||++ .++.+||+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~----~~~~~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV----NRHQAKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc----CCCcEEecccccccee
Confidence 99999999999999998765 589999999999999999999999999999999999998 6788999999998865
Q ss_pred ccccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 961 QQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 961 ~~~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYG------------------KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCC------------------CCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 33221 1112235679999988654 25567899999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=262.89 Aligned_cols=193 Identities=25% Similarity=0.326 Sum_probs=154.2
Q ss_pred EecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHH---HHHHhcCCCCcceEEEEEEcCCCCceE
Q 001678 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEA---LLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi---~ILskL~HPNIVrLyG~f~d~~eg~l~ 881 (1033)
.||+|+||.||+++. +++.+|+|.+........... ..+.+|. .++...+|+||+.+++++.. .+..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-----TLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH-----HHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEE
Confidence 389999999999987 467899998875433221111 1223333 34444579999999999987 56799
Q ss_pred EEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
+||||+.+++|.+++.+.+ .+++..+..|+.|++.||.|||+.+|+||||||+|||++ .++.+||+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~----~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC----CCCCEEEccCCcceecc
Confidence 9999999999999987654 489999999999999999999999999999999999998 67789999999987553
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
... .....||..|+|||.+.+.. .++.++|+|||||++|+|++|..||..
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQKGT-----------------AYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcCCC-----------------CCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 322 22346899999999875421 255678999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=263.67 Aligned_cols=201 Identities=28% Similarity=0.466 Sum_probs=162.6
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
+..++|++.+.||+|+||.||+++.. ++.||+|++.... .......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 34578999999999999999999863 4668999876431 112335688899999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------------------CccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIV 928 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------------k~Lse~~rl~Ia~QIa~GLeYLHskGIV 928 (1033)
+++.+ ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++
T Consensus 75 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~ 152 (288)
T cd05050 75 GVCAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152 (288)
T ss_pred EEEcC--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99887 567899999999999999997532 2367888899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCC
Q 001678 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK 1005 (1033)
Q Consensus 929 HRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t 1005 (1033)
||||||+|||++ .++.+||+|||++....... .......+..|+|||++.+. .++
T Consensus 153 H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~ 210 (288)
T cd05050 153 HRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN------------------RYT 210 (288)
T ss_pred cccccHhheEec----CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC------------------CCC
Confidence 999999999998 67889999999987543221 11222346679999987654 256
Q ss_pred cccchHHHHHHHHHHHc-cCCCCC
Q 001678 1006 WSYDCYSLGILFFFLQF-ILCFID 1028 (1033)
Q Consensus 1006 ~kvDVWSLGVVLYeLLT-Gk~PFd 1028 (1033)
.++|+|||||++|+|++ |..||.
T Consensus 211 ~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 211 TESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCC
Confidence 67899999999999997 777774
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=270.71 Aligned_cols=205 Identities=25% Similarity=0.413 Sum_probs=164.7
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCC
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k---------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPN 864 (1033)
+.+...+|++.+.||+|+||.||++.+. ...||+|.++... .....+.+.+|+.+++++ +|+|
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCCC
Confidence 3455567999999999999999999752 1258999776421 112245788999999999 7999
Q ss_pred cceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001678 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1033)
Q Consensus 865 IVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVH 929 (1033)
|++++++|.. .+.+++||||+.+++|.++|.+.. ..+++..++.++.||+.||.|||++|++|
T Consensus 80 iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 80 IINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred eeeeeEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 9999999987 567999999999999999997532 24778889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCCCeEEEEecCCccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCc
Q 001678 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKW 1006 (1033)
Q Consensus 930 RDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~ 1006 (1033)
|||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.
T Consensus 158 ~dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~ 215 (334)
T cd05100 158 RDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR------------------VYTH 215 (334)
T ss_pred cccccceEEEc----CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC------------------CcCc
Confidence 99999999998 667899999999976543221 1122345679999988654 2556
Q ss_pred ccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 1007 SYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 1007 kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
++|||||||++|+|++ |..||...
T Consensus 216 ~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 216 QSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 7899999999999998 88888644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=255.85 Aligned_cols=199 Identities=22% Similarity=0.411 Sum_probs=166.5
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++++.||+|+||.||+++. .++.||+|++...... ....+.+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEE--NG 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CC
Confidence 588999999999999999987 4778999998753221 1223467889999999999999999999987 57
Q ss_pred ceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+++|+||+|+|||++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~----~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEEeeccce
Confidence 899999999999999998764 33578999999999999999999999999999999999998 6678999999999
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....... ......|++.|+|||++.+.. .+.++|+|||||++|+|++|+.||..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~------------------~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRP------------------YNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCC------------------CCCccchhHHHHHHHHHHcCCCCccC
Confidence 7654332 222345788999999986542 45578999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=262.19 Aligned_cols=196 Identities=25% Similarity=0.306 Sum_probs=155.2
Q ss_pred EecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEE
Q 001678 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVm 884 (1033)
.||+|+||.||+++. .++.||||.+........... .........+.+++...||+|+.+++++.. ...+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--TLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH--HHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEE
Confidence 389999999999987 467899999875433221111 111111223345556689999999999988 56799999
Q ss_pred eeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc
Q 001678 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1033)
Q Consensus 885 EYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~ 964 (1033)
||+.+++|.+++.+.+ .+++..++.|+.|++.||.|||+.+|+||||||+|||++ .++.+||+|||++......
T Consensus 77 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~----~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC----CCCCEEEccCcCccccCcc-
Confidence 9999999999987654 589999999999999999999999999999999999998 6678999999998755332
Q ss_pred ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 965 ~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
......|+..|+|||++.+.. .++.++|+|||||++|+|++|+.||..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Di~s~G~~l~~l~~g~~p~~~ 198 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGV-----------------AYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCC-----------------CCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 223456899999999986432 256678999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=289.21 Aligned_cols=215 Identities=22% Similarity=0.307 Sum_probs=175.4
Q ss_pred ccccccCCCceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEE
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYG 870 (1033)
Q Consensus 793 ~~~~i~~~dYeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG 870 (1033)
....++...|+++++||+||.+.||++... .+.+|+|++... ......+..|..|+.+|.+|+ |.+|++||+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL------EADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh------hcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 445677888999999999999999999885 455788866543 123456788999999999997 999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
|-.. ++.+||||||- ..+|..+|+++...+..-.++.+..||+.+++++|..||||.||||.|+|+- .|.+|
T Consensus 428 YEv~--d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LK 499 (677)
T KOG0596|consen 428 YEVT--DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLK 499 (677)
T ss_pred eecc--CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEE
Confidence 9887 78999999987 7799999998876665446777889999999999999999999999999995 68999
Q ss_pred EEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 951 IGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 951 LiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
|+|||+|......+ .....+||+.||+||.+...... +.. +---+.+..++||||||||||+|+.|++||
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~--~~~-----~~~k~Ki~r~SDvWSLGCILYqMvYgktPf 572 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS--REN-----GKSKIKISRKSDVWSLGCILYQMVYGKTPF 572 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhcccc--ccC-----CCcceeecCccchhhhhhHHHHHHhcCCch
Confidence 99999999776544 34567899999999988533211 000 000125788999999999999999999999
Q ss_pred C
Q 001678 1028 D 1028 (1033)
Q Consensus 1028 d 1028 (1033)
.
T Consensus 573 ~ 573 (677)
T KOG0596|consen 573 G 573 (677)
T ss_pred H
Confidence 5
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=259.83 Aligned_cols=206 Identities=26% Similarity=0.368 Sum_probs=165.4
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEc
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d 874 (1033)
..+.|++.+.||.|+||.||+|++ .++.+|+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 346788999999999999999988 46778999875421 1124577889999988 69999999999864
Q ss_pred C----CCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 875 G----PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 875 ~----~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
. ....+++||||+.+++|.+++... ...+++..+..++.||+.||.|||+.+|+|+||||+||+++ .++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCE
Confidence 2 245789999999999999999763 34578888899999999999999999999999999999998 66789
Q ss_pred EEEecCCccccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 950 KIGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 950 KLiDFGLAr~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
||+|||++...... .......|+..|+|||++........ .++.++|+|||||++|+|++|+.||.
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~-------------~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA-------------TYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCc-------------CCCcccchhHHHHHHHHHHhCCCCcc
Confidence 99999998755322 12334568999999998764211000 35667899999999999999999995
Q ss_pred C
Q 001678 1029 F 1029 (1033)
Q Consensus 1029 ~ 1029 (1033)
.
T Consensus 228 ~ 228 (282)
T cd06636 228 D 228 (282)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=260.88 Aligned_cols=199 Identities=28% Similarity=0.404 Sum_probs=163.2
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++++.||.|++|.||+|++ .++.||||+++...... .....+.+|+.++++++||||+++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHT--EN 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc------ccchHHHHHHHHHHhcCCCCCcchhhhccc--CC
Confidence 488999999999999999987 47789999886543211 122467789999999999999999999887 57
Q ss_pred ceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~----~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEeeccch
Confidence 8999999995 6898888653 34589999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....... ......++..|+|||++.+.. .++.++|+|||||++|+|+||+.||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGCK-----------------YYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred hhcccCccccccccccccccCCeEEecCC-----------------CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 7553321 122334688999999886532 235567999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=257.30 Aligned_cols=200 Identities=30% Similarity=0.380 Sum_probs=162.1
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.+.....||+|+||.||+|++. +..||+|.+.... ....+.+.+|+.++++++|+||+++++++.. ..
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 78 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NG 78 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CC
Confidence 3444568999999999999874 5568999876431 1223578899999999999999999999988 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCcc--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTI--DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~L--se~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
..++|+||+.+++|.+++......+ ++..+..++.||+.||.|||+++|+||||||+||+++. ..+.+||+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~---~~~~~~l~dfg~ 155 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT---YSGVVKISDFGT 155 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCeEEEecchh
Confidence 8999999999999999998754445 78888899999999999999999999999999999972 256899999999
Q ss_pred ccccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+...... .......|+..|+|||++.+... .++.++|+|||||++|+|++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----------------~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPR----------------GYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccc----------------cCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 8755322 22233457899999999865321 245677999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=259.73 Aligned_cols=200 Identities=22% Similarity=0.334 Sum_probs=154.0
Q ss_pred EecccCcEEEEEEEEc-Ccc---eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 807 ELGSGTYGSVYHGKWR-GSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~k-G~k---VAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+||+|+||.||+++.. +.. +++|.+.... .....+.+.+|+.+++.++||||+++++.|.+ ....++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEE
Confidence 5999999999999753 332 4555544321 11224578899999999999999999999987 567899
Q ss_pred EEeeccCCcHHHHHHhcC---CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 883 VTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~---k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
||||+++++|.+++.+.. ...++..++.++.||+.||+|||+.+++||||||+|||++ .++.+||+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~----~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----CCccEEecccccccc
Confidence 999999999999997642 3356677888999999999999999999999999999998 678899999999864
Q ss_pred cccc---cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 960 KQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 960 ~~~~---~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
.... .......++..|+|||++..... +.....++.++|||||||++|+|++ +..||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----------~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHG-----------GLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccC-----------ccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 3211 12234567889999998854321 1111245778899999999999996 57787543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=258.76 Aligned_cols=200 Identities=27% Similarity=0.405 Sum_probs=163.2
Q ss_pred CCCceEEEEecccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k-------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
..+|++++.||+|+||.||+|+.+ .+.|++|.+.... .......+.+|+.++++++|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-------DENLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-------chHHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 467999999999999999999863 3458888765321 12245678899999999999999999999
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcC--------CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD--------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~--------k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d 943 (1033)
+.+ ....++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~--- 151 (275)
T cd05046 77 CRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS--- 151 (275)
T ss_pred ECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---
Confidence 887 567899999999999999997644 1489999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHH
Q 001678 944 PQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQ 1021 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLL 1021 (1033)
.++.+||+|||++....... ......++..|+|||.+.+.. .+.++|+|||||++|+|+
T Consensus 152 -~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------------------~~~~~Di~slG~~l~~l~ 212 (275)
T cd05046 152 -SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD------------------FSTKSDVWSFGVLMWEVF 212 (275)
T ss_pred -CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC------------------CCchhhHHHHHHHHHHHH
Confidence 67789999999987442221 222334677899999886542 345679999999999999
Q ss_pred c-cCCCCCC
Q 001678 1022 F-ILCFIDF 1029 (1033)
Q Consensus 1022 T-Gk~PFd~ 1029 (1033)
+ |..||..
T Consensus 213 ~~~~~p~~~ 221 (275)
T cd05046 213 TQGELPFYG 221 (275)
T ss_pred hCCCCCccc
Confidence 8 7888854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=261.06 Aligned_cols=196 Identities=27% Similarity=0.366 Sum_probs=164.9
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|+.+++||+|+||.||+|.+ .++.||||++.... .......+.+|+.+++++.|+||+++++.+.+ ..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GT 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CC
Confidence 477788999999999999987 46789999876431 12234678899999999999999999999988 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.+++|+||+|+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~----~~~~~~l~dfg~~~ 149 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAG 149 (277)
T ss_pred EEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc----CCCCEEEcccccce
Confidence 899999999999999998653 478889999999999999999999999999999999998 66789999999997
Q ss_pred cccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ......++..|+|||++.+.. .+.++|+|||||++|+|+||+.||..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~------------------~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSA------------------YDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred eccCCccccccccCcccccCHhHhccCC------------------CccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 654322 223345788999999886542 45677999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=253.70 Aligned_cols=194 Identities=32% Similarity=0.504 Sum_probs=160.5
Q ss_pred EEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEE
Q 001678 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVm 884 (1033)
++||+|+||.||++.+. ++.||+|++...... .....+.+|+.++++++|+||+++++++.+ ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVM 71 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEE
Confidence 36899999999999875 788999987653211 223568889999999999999999999987 56789999
Q ss_pred eeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc
Q 001678 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1033)
Q Consensus 885 EYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~ 964 (1033)
||+.+++|.+++.+....+++..+..++.+++.+|.|||+++++||||||+|||++ .++.+||+|||++.......
T Consensus 72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~----~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc----CCCcEEEeeccccccccCCc
Confidence 99999999999987666688999999999999999999999999999999999998 67799999999997654221
Q ss_pred cc---CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCC
Q 001678 965 VS---GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 965 ~s---~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~ 1030 (1033)
.. ....++..|+|||.+.+.. ++.++|+|||||++|+|+| |..||...
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~------------------~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGR------------------YTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred ceeccccCcceeccCChHhhccCC------------------CCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 11 1122356799999886542 4567899999999999999 88888543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=261.58 Aligned_cols=203 Identities=27% Similarity=0.373 Sum_probs=164.8
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.+.||+|+||.||+|.+ +++.||||+++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE------GFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc------CchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 46789999999999999999988 46789999987542211 11235668999999999999999999987632
Q ss_pred --------CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCe
Q 001678 877 --------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1033)
Q Consensus 877 --------eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~ 948 (1033)
.+.+++||||+.+ +|..++......+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~ 154 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN----NKGQ 154 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCc
Confidence 3478999999965 77787776655689999999999999999999999999999999999998 6789
Q ss_pred EEEEecCCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCC
Q 001678 949 CKIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCF 1026 (1033)
Q Consensus 949 VKLiDFGLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~P 1026 (1033)
+||+|||++....... ......++..|+|||++.+.. .++.++|||||||++|+|++|++|
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----------------~~~~~~Di~slG~~~~el~~g~~~ 217 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE-----------------RYGPAIDVWSCGCILGELFTKKPI 217 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCC-----------------CCCchhHHHHHHHHHHHHHhCCCC
Confidence 9999999998654332 112234577899999875432 235578999999999999999999
Q ss_pred CCC
Q 001678 1027 IDF 1029 (1033)
Q Consensus 1027 Fd~ 1029 (1033)
|..
T Consensus 218 ~~~ 220 (302)
T cd07864 218 FQA 220 (302)
T ss_pred CCC
Confidence 974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=289.80 Aligned_cols=204 Identities=21% Similarity=0.301 Sum_probs=154.0
Q ss_pred CCCceEEEEecccCcEEEEEEEEcC---cceEEEEeeccc---------cCCCchhHHHHHHHHHHHHHHHHhcCCCCcc
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWRG---SDVAIKRIKASC---------FAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~kG---~kVAIKvlk~~~---------~~~k~~ere~~i~~f~rEi~ILskL~HPNIV 866 (1033)
..+|+++++||+|+||+||++..+. ..+++|.+.... ...+..........+.+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4679999999999999999987632 112222111000 0000011122345688999999999999999
Q ss_pred eEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC----CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q 001678 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (1033)
Q Consensus 867 rLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~----k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~ 942 (1033)
++++++.. ....++|+|++ .++|.+++.... .......++.|+.||+.||+|||++|||||||||+||||+
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~-- 301 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN-- 301 (501)
T ss_pred cEeEEEEE--CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence 99999998 56789999998 567877775432 1234556778999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHH
Q 001678 943 DPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020 (1033)
Q Consensus 943 d~~~g~VKLiDFGLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeL 1020 (1033)
.++.+||+|||+++...... ......||..|+|||++.+.. ++.++||||||||+|+|
T Consensus 302 --~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwSlGvil~el 361 (501)
T PHA03210 302 --CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG------------------YCEITDIWSCGLILLDM 361 (501)
T ss_pred --CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC------------------CCcHHHHHHHHHHHHHH
Confidence 67889999999998664332 223467999999999987653 55678999999999999
Q ss_pred HccCCCC
Q 001678 1021 QFILCFI 1027 (1033)
Q Consensus 1021 LTGk~PF 1027 (1033)
++|..++
T Consensus 362 l~~~~~p 368 (501)
T PHA03210 362 LSHDFCP 368 (501)
T ss_pred HHCCCCC
Confidence 9987543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=263.19 Aligned_cols=208 Identities=20% Similarity=0.162 Sum_probs=152.9
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEcCc-----ceEEEEeeccccCCCchhHHHH------HHHHHHHHHHHHhcCCCC
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERL------IADFWKEALLLSSLHHPN 864 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~kG~-----kVAIKvlk~~~~~~k~~ere~~------i~~f~rEi~ILskL~HPN 864 (1033)
.+...+|++.++||+|+||+||+|.+.+. .+|+|+..... .....+.. ......+...+..+.|+|
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---CchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34567899999999999999999987543 45666533221 11111110 112233445567778999
Q ss_pred cceEEEEEEcCCCC--ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q 001678 865 VVSFYGIVRDGPDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (1033)
Q Consensus 865 IVrLyG~f~d~~eg--~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~ 942 (1033)
|+++++.+...... ..+++||++ ..++.+++.... ..++..++.|+.|++.||.|||+++|+||||||+|||++
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~-- 160 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD-- 160 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--
Confidence 99999876653211 346778877 446777766543 357888899999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCccccccc--------cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHH
Q 001678 943 DPQRPVCKIGDLGLSKVKQQT--------LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG 1014 (1033)
Q Consensus 943 d~~~g~VKLiDFGLAr~~~~~--------~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLG 1014 (1033)
..+.+||+|||+|+..... .......||+.|+|||++.+. .++.++||||||
T Consensus 161 --~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~------------------~~~~~~DiwSlG 220 (294)
T PHA02882 161 --GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA------------------CVTRRGDLESLG 220 (294)
T ss_pred --CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC------------------CCCcHHHHHHHH
Confidence 6678999999999764321 111234699999999998765 356678999999
Q ss_pred HHHHHHHccCCCCCCC
Q 001678 1015 ILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 1015 VVLYeLLTGk~PFd~~ 1030 (1033)
|++|+|++|+.||...
T Consensus 221 ~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 221 YCMLKWAGIKLPWKGF 236 (294)
T ss_pred HHHHHHHhCCCCCCcc
Confidence 9999999999999765
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=270.17 Aligned_cols=200 Identities=23% Similarity=0.331 Sum_probs=162.5
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.++||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++|+||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 46799999999999999999987 47889999886321 1122346778999999999999999999876532
Q ss_pred ---CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 877 ---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 877 ---eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
...+++|+||+. ++|.+++... .+++..+..++.|++.||.|||+.+|+||||||+|||++ ..+.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~----~~~~~kl~d 149 (336)
T cd07849 77 FESFNDVYIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICD 149 (336)
T ss_pred ccccceEEEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEECc
Confidence 235799999995 5888887543 489999999999999999999999999999999999998 678899999
Q ss_pred cCCcccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||++....... ......||..|+|||++.+.. .++.++|+|||||++|+|++|+.||..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK-----------------GYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCC-----------------CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99987653322 112356899999999875432 245677999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=249.21 Aligned_cols=200 Identities=28% Similarity=0.507 Sum_probs=170.0
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.+.||.|+||.||++.+. +..||+|++...... ......+.+|+++++.++|+|++++++.+.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS------EKEREDALNEVKILKKLNHPNIIKYYESFEE--KG 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC------hHHHHHHHHHHHHHHhcCCCChhheEEEEec--CC
Confidence 5889999999999999999985 788999998754321 2223467789999999999999999999988 47
Q ss_pred ceEEEEeeccCCcHHHHHHhc---CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~---~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
..++|+||+++++|.+++.+. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++ .++.+||+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~----~~~~~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc----CCCcEEECCcc
Confidence 899999999999999999875 36689999999999999999999999999999999999998 67889999999
Q ss_pred Ccccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++....... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~------------------~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKP------------------YNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhccCC------------------CCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 998654432 333456889999999876542 456789999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=272.69 Aligned_cols=208 Identities=22% Similarity=0.367 Sum_probs=180.0
Q ss_pred cccccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEE
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYG 870 (1033)
Q Consensus 794 ~~~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG 870 (1033)
.+.+..++|.++..||+|+|++|.+++.+ .+.+|+|++++..+..++. +.-.+.|..+.... +||.+|-+..
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded-----idwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED-----IDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc-----chhHHhhHHHHHhccCCCeEEehhh
Confidence 34456789999999999999999999774 5668999998876554332 34566777777766 5999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
.|++ +..+++|.||++||+|...+++..+ ++++.+..+..+|+.||.|||++|||+||||.+|+||| ..+++|
T Consensus 319 cfqt--esrlffvieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld----aeghik 391 (593)
T KOG0695|consen 319 CFQT--ESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD----AEGHIK 391 (593)
T ss_pred hhcc--cceEEEEEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc----cCCcee
Confidence 9998 7889999999999999999887655 88888888888999999999999999999999999999 788999
Q ss_pred EEecCCcccc-ccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 951 IGDLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 951 LiDFGLAr~~-~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+|+|+++.. .....+.+++||+.|.|||++.+. +|+.++|+|+|||+|++|+.|+.|||+
T Consensus 392 ltdygmcke~l~~gd~tstfcgtpnyiapeilrge------------------eygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE------------------EYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred ecccchhhcCCCCCcccccccCCCcccchhhhccc------------------ccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9999999863 455567789999999999999987 578889999999999999999999997
Q ss_pred CC
Q 001678 1030 FS 1031 (1033)
Q Consensus 1030 ~s 1031 (1033)
..
T Consensus 454 vg 455 (593)
T KOG0695|consen 454 VG 455 (593)
T ss_pred ec
Confidence 54
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=257.27 Aligned_cols=205 Identities=25% Similarity=0.414 Sum_probs=167.2
Q ss_pred CceEEEEecccCcEEEEEEEEc---CcceEEEEeeccccCCC--chhHHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEc
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGK--PSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRD 874 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k---G~kVAIKvlk~~~~~~k--~~ere~~i~~f~rEi~ILsk-L~HPNIVrLyG~f~d 874 (1033)
+|++.+.||+|+||.||++.++ ++.+|+|.+........ ..........+.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999885 46789998865432211 11233445667788888865 799999999999988
Q ss_pred CCCCceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEE
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+|||++ .++.+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~----~~~~~~ 154 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG----EDDKVT 154 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC----CCCcEE
Confidence 6789999999999999998853 34468999999999999999999996 7899999999999998 678999
Q ss_pred EEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+|||++.............|+..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~------------------~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP------------------YGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCCC------------------CchHHHHHHHHHHHHHHHhCCCcccc
Confidence 99999998765443344566899999999886542 45577999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=261.76 Aligned_cols=201 Identities=27% Similarity=0.400 Sum_probs=165.2
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
...|++++.||+|+||.||+++. .++.||+|++...... .......+.+|+.+++.++||||++++++|.+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-- 86 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-- 86 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--
Confidence 35588999999999999999987 4788999988643211 12233567889999999999999999999998
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
....++||||+. |+|.+++......+++..+..++.||+.||.|||+.+|+|+||+|+||+++ .++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----~~~~~kL~dfg~ 161 (307)
T cd06607 87 EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGS 161 (307)
T ss_pred CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----CCCCEEEeecCc
Confidence 567899999995 678888776556689999999999999999999999999999999999998 678899999999
Q ss_pred ccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+...... ....++..|+|||++..... ..++.++||||||+++|+|+||+.||..
T Consensus 162 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~---------------~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 162 ASLVSPA---NSFVGTPYWMAPEVILAMDE---------------GQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred ceecCCC---CCccCCccccCceeeeccCC---------------CCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 8765432 23467889999998753210 0355678999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=261.32 Aligned_cols=202 Identities=24% Similarity=0.358 Sum_probs=161.0
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~ 876 (1033)
++|+..+.||+|+||.||++++ .++.||||.+...... .....+.+|+.++.++. |+||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-- 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-- 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--
Confidence 3566778899999999999988 4678999988743211 22356788999999996 9999999999887
Q ss_pred CCceEEEEeeccCCcHHHHHH---h-cCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEecCCCCCCeEEE
Q 001678 877 DGSLATVTEFMVNGSLKQFLQ---K-KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~---~-~~k~Lse~~rl~Ia~QIa~GLeYLHsk-GIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
.+..+++|||+. ++|.++.. . ....+++..+..++.|++.||+|||+. +++||||||+|||++ .++.+||
T Consensus 75 ~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl 149 (288)
T cd06616 75 EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKL 149 (288)
T ss_pred CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc----cCCcEEE
Confidence 567889999984 46555432 2 235689999999999999999999975 999999999999998 6678999
Q ss_pred EecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+|||+++............|+..|+|||++.+... -.++.++|+|||||++|+|++|+.||...
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---------------~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAR---------------DGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccc---------------cCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 99999976544433334568999999999865410 03566789999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=292.24 Aligned_cols=196 Identities=29% Similarity=0.454 Sum_probs=165.1
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|.-++.||.|+||.||.|++ +...||||++.-+ ++. ......++++|+..|++++|||++.+-|+|.. +..
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS---GKQ--s~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS---GKQ--SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHT 100 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeecccc---ccc--cHHHHHHHHHHHHHHHhccCCCcccccceeec--cch
Confidence 55667899999999999987 4667899988643 332 23446789999999999999999999999987 567
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.+|||||| -|+..|+|.-..+.+.+..+..|+.+.+.||.|||+.+.||||||..||||+ ..+.|||+|||.|.+
T Consensus 101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs----e~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS----EPGLVKLADFGSASI 175 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec----CCCeeeeccccchhh
Confidence 89999999 6688888877777899999999999999999999999999999999999999 889999999999987
Q ss_pred cccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 960 ~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
.... .+++|||.|||||+|..-. -.+|+-++||||||++..+|.-.++|.
T Consensus 176 ~~PA---nsFvGTPywMAPEVILAMD---------------EGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 176 MAPA---NSFVGTPYWMAPEVILAMD---------------EGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred cCch---hcccCCccccchhHheecc---------------ccccCCccceeeccchhhhhhhcCCCc
Confidence 6543 4688999999999985321 126777888888888888888887774
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=262.70 Aligned_cols=196 Identities=27% Similarity=0.381 Sum_probs=163.0
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|+.++.||+|+||.||+|.+ .+..||+|.+.... .....+.+.+|+.++++++|+||+++++.+.. ..
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhccccc--CC
Confidence 355667799999999999987 46679999876431 11234578899999999999999999999987 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
..++||||+.+++|.+++.. ..+++..+..++.||+.||.|||+++++|+||+|+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe----CCCCEEEccccccc
Confidence 79999999999999999864 3478899999999999999999999999999999999998 66789999999987
Q ss_pred cccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ......|+..|+|||++.+.. ++.++|+|||||++|+|+||+.||..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSA------------------YDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcCC------------------CchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 654322 222345788999999986542 45678999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=257.71 Aligned_cols=198 Identities=28% Similarity=0.409 Sum_probs=162.6
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|+++++||.|++|.||+|.+ .++.||||++....... .....+.+|+.+++.++|+||+++++++.+ ...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE------GVPSTAIREISLLKELNHPNIVRLLDVVHS--ENK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc------cchhHHHHHHHHHHhcCCCCccCHhheecc--CCe
Confidence 57789999999999999987 47889999987543211 122356789999999999999999999987 578
Q ss_pred eEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 880 LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.++||||+ +++|.+++.... ..+++..++.++.|+++||+|||+.+++||||+|+||+++ .++.+||+|||++.
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLAR 147 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCcEEEeeccccc
Confidence 99999999 568999987654 3589999999999999999999999999999999999998 57899999999987
Q ss_pred cccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ......++..|+|||++.+.. .++.++|+|||||++|+|+||+.||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------------~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGSR-----------------QYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecCc-----------------ccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 543221 112234688999999876532 245567999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=292.42 Aligned_cols=194 Identities=30% Similarity=0.411 Sum_probs=166.5
Q ss_pred EEecccCcEEEEEEEEcCcc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG~k--VAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
-+||+|+||+||-|++..++ +|||.+.... .+..+-+..|+.+.+.|+|.|||+++|.+-+ ++.+-|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIF 650 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--------SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIF 650 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--------chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEE
Confidence 46999999999999986655 5889876431 2234567789999999999999999999877 7888899
Q ss_pred EeeccCCcHHHHHHhcCCcc--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 884 TEFMVNGSLKQFLQKKDRTI--DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~L--se~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
||-++||+|.++|+.+-.++ .+.+...+.+||++||+|||...|||||||-+|+||+. -.|.+||+|||-++.+.
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT---ySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT---YSGVLKISDFGTSKRLA 727 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee---ccceEEecccccchhhc
Confidence 99999999999999887777 88899999999999999999999999999999999983 46899999999988764
Q ss_pred c-ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 962 Q-TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 962 ~-~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
. ...+.++.||+.|||||++...+. -|+.++|||||||++.||.||++||-
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~R----------------GYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPR----------------GYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCc----------------CCCchhhhhhccceeEeeccCCCCee
Confidence 3 335667899999999999965542 36677899999999999999999993
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=256.66 Aligned_cols=197 Identities=29% Similarity=0.443 Sum_probs=156.2
Q ss_pred EecccCcEEEEEEEEcC--------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 807 ELGSGTYGSVYHGKWRG--------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~kG--------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.||+|+||.||+|++.. ..+|||.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NE 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CC
Confidence 58999999999998743 4588897753311 1123467889999999999999999999987 56
Q ss_pred ceEEEEeeccCCcHHHHHHhc------CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC-CCCCeEEE
Q 001678 879 SLATVTEFMVNGSLKQFLQKK------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKI 951 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~------~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d-~~~g~VKL 951 (1033)
..++||||+++++|.+++.+. ...+++..++.++.||+.||.|||+++++|+||||+|||++.++ .....+||
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 799999999999999999752 23478889999999999999999999999999999999998322 12238999
Q ss_pred EecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCC
Q 001678 952 GDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFI 1027 (1033)
Q Consensus 952 iDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PF 1027 (1033)
+|||+++...... ......++..|+|||++.+. .++.++|||||||++|+|+| |+.||
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Dv~slG~il~ellt~g~~p~ 214 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG------------------KFTTQSDVWSFGVLMWEILTLGQQPY 214 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccC------------------CcccchhHHHHHHHHHHHHHcCCCCC
Confidence 9999987543221 11223457889999988654 24667899999999999998 99998
Q ss_pred CCC
Q 001678 1028 DFF 1030 (1033)
Q Consensus 1028 d~~ 1030 (1033)
...
T Consensus 215 ~~~ 217 (269)
T cd05044 215 PAL 217 (269)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=268.37 Aligned_cols=201 Identities=24% Similarity=0.357 Sum_probs=164.4
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~ 875 (1033)
.++|++.+.||+|+||.||+|.+ .++.+|||++...... ......+.+|+.+++++ +|+||++++++|...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc------chhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 45788899999999999999987 4678999987642111 11124567899999999 999999999998765
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....+++||||+. ++|.+++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~----~~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN----SDCRVKLADFG 152 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeecc
Confidence 4556899999996 5999988765 578899999999999999999999999999999999998 77899999999
Q ss_pred Ccccccccc------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 956 LSKVKQQTL------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~~------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++....... ......||..|+|||++.+.. .++.++|+|||||++|+|+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGST-----------------RYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccc-----------------cccccchHHHHHHHHHHHHhCCCCCCC
Confidence 987553221 222356899999999875432 245678999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=253.08 Aligned_cols=191 Identities=26% Similarity=0.367 Sum_probs=155.5
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHH-HHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALL-LSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~I-LskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+||.||+|.. .++.||||++....... ......+..|..+ ...++|+||+++++++.. ...+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-----KNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-----HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEE
Confidence 5699999999999987 47789999886432211 1112234445444 455689999999999987 568999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+++|+||+|+|||++ .++.+||+|||+++....
T Consensus 75 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEeecccceeccc
Confidence 999999999999997654 488999999999999999999999999999999999998 677899999999876433
Q ss_pred ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 963 ~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.....|+..|+|||.+.+.. ++.++|+||||+++|+|+||..||..
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~------------------~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVG------------------DDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred ---cccCCCCcCccChhhhcCCC------------------CcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 23456789999999987642 45678999999999999999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=254.10 Aligned_cols=201 Identities=29% Similarity=0.378 Sum_probs=161.2
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEcCC
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL---~HPNIVrLyG~f~d~~ 876 (1033)
|++.+.||+|+||.||+++++ ++.||||+++..... ......+.+|+.+++++ +|+||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc------chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999984 688999998754221 11122455676666555 6999999999998732
Q ss_pred C---CceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 D---GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 e---g~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
. ..++++|||+. ++|.+++.+.. ..+++..++.++.||+.||.|||+.+++|+||||+||+++ .++.+||+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~----~~~~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIA 149 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc----cCCCEEEe
Confidence 1 13899999996 58999887643 3589999999999999999999999999999999999998 66899999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|||++.............++..|+|||++.+.. ++.++|+|||||++|+|++|.+||+..+
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~------------------~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS------------------YATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhccCC------------------CCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 999998765443333445788999999986542 4567899999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=256.27 Aligned_cols=200 Identities=27% Similarity=0.410 Sum_probs=169.4
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
..+.|++.+.||+|+||.||+++++ ++.|++|++..... ....+.+|+.+++.++|+||+++++.+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLV- 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-
Confidence 3456888899999999999999885 78899999875321 23467789999999999999999999988
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....++|+||+.+++|.+++......+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.+||+|||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----~~~~~~l~d~~ 161 (286)
T cd06614 87 -GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----KDGSVKLADFG 161 (286)
T ss_pred -CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----CCCCEEECccc
Confidence 5789999999999999999988765689999999999999999999999999999999999998 67789999999
Q ss_pred Ccccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++....... ......++..|+|||++.+. .++.++|+||||||+|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 162 FAAQLTKEKSKRNSVVGTPYWMAPEVIKRK------------------DYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred hhhhhccchhhhccccCCcccCCHhHhcCC------------------CCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 987543321 22234578899999988654 2456789999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=256.21 Aligned_cols=197 Identities=27% Similarity=0.386 Sum_probs=164.1
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
-|++++.||+|+||.||+|.+ .+..||||++.... .......+.+|+.++++++|+||+++++.+.+ ..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CC
Confidence 367789999999999999976 46789999875331 11234578899999999999999999999988 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
..++||||+.+++|.+++... .+++..+..++.|++.+|.|||+.+++|+||||+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC----CCCCEEEeecccce
Confidence 799999999999999998653 478999999999999999999999999999999999998 66789999999987
Q ss_pred cccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
...... ......++..|+|||.+.+. ..+.++|+|||||++|+|++|..||...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~------------------~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQS------------------AYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred ecccchhhhccccCCccccChhhhccC------------------CCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 654322 22334678899999988653 2345679999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=264.57 Aligned_cols=194 Identities=23% Similarity=0.380 Sum_probs=161.2
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|.....||+|+||.||++.. ++..||||++.... ....+.+.+|+.+++.++|+||+++++.+.. .+.
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~ 93 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--------QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDE 93 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--------HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCe
Confidence 44456799999999999987 47789999876421 1223467889999999999999999999887 567
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++||||+++++|.+++... .+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kL~dfg~~~~ 167 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccCcchhh
Confidence 99999999999999988543 478999999999999999999999999999999999998 667899999999875
Q ss_pred ccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 960 ~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
..... ......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||..
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~------------------~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRL------------------PYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred cccccccCceeecCccccCHHHHccC------------------CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43222 22345689999999988654 245678999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=246.66 Aligned_cols=198 Identities=29% Similarity=0.420 Sum_probs=168.3
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.+.||+|++|.||+++. .++.|++|.+...... +.....+.+|++++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SD 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CC
Confidence 588899999999999999987 4678999998754321 2334678899999999999999999999887 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
..++||||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++ .++.+||+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT----KDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC----CCCCEEEeccccce
Confidence 899999999999999999776 4589999999999999999999999999999999999998 56889999999998
Q ss_pred ccccccc-cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~~-s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~------------------~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMSG------------------ASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCCC------------------CCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 6654322 23456889999999876542 45567999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=251.79 Aligned_cols=193 Identities=28% Similarity=0.428 Sum_probs=162.0
Q ss_pred ecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 808 LGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
||.|+||.||++++. ++.+++|++..... ......+.+.+|+.++++++|+||+++++.+.. ....++|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEe
Confidence 689999999999984 78899998865432 122345678899999999999999999999887 677999999
Q ss_pred eccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccccc-
Q 001678 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL- 964 (1033)
Q Consensus 886 YmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~- 964 (1033)
|+.+++|.+++.+.+ .+++..++.++.||+.||.|||+.+++|+||+|+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~----~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc----CCCCEEEEecccchhcccCcc
Confidence 999999999998765 589999999999999999999999999999999999998 67899999999987543221
Q ss_pred --------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 965 --------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 965 --------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
......++..|+|||.+.... .+.++|+||||+++|+|++|+.||+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~------------------~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQG------------------HSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCC------------------CCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 223445788999999876542 455679999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=267.97 Aligned_cols=198 Identities=25% Similarity=0.286 Sum_probs=162.3
Q ss_pred EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCCCceEE
Q 001678 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+.||+|+|+.|-.++. ++..+|||++.+..- -...+..+|++++..++ |+||++++++|++ +..+||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--------HsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--------HSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCc--------hHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEE
Confidence 5699999999998865 788999999876421 12347889999999997 9999999999999 688999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
|||-|.||.|...|+++. .+++.++.++.++|+.||.|||.+||.||||||+|||... .+.-.-||||||.|..-...
T Consensus 154 VfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~-pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES-PNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC-CCCcCceeeecccccccccc
Confidence 999999999999998764 4899999999999999999999999999999999999963 33556799999999764322
Q ss_pred cc--------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 963 TL--------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 963 ~~--------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
.. ...+.+|+..|||||++.-- .-- ...|+.+.|.||||||||.||.|.+||-
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~f-----------v~q--A~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVF-----------VDQ--ATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhh-----------ccc--cccccccccHHHHHHHHHHHHhCCCCcc
Confidence 11 12245689999999986321 110 1147888999999999999999999995
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=262.73 Aligned_cols=209 Identities=24% Similarity=0.279 Sum_probs=171.1
Q ss_pred cccccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 794 ~~~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~ 871 (1033)
...+.+++|++.++||+|||+.||+++. ++..+|+|++.... .+.++..++|+...++++||||++++++
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh 86 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDH 86 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHH
Confidence 3456788999999999999999999985 57779999988653 1224567899999999999999999887
Q ss_pred EEcC---CCCceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEecCC
Q 001678 872 VRDG---PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 872 f~d~---~eg~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskG--IVHRDIKPsNILLd~~d 943 (1033)
.... .....|++++|...|+|.+.+.+ ++..+++..+++|+.+|++||++||... ++||||||.|||+.
T Consensus 87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls--- 163 (302)
T KOG2345|consen 87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS--- 163 (302)
T ss_pred HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---
Confidence 6542 13358999999999999999875 3557999999999999999999999997 99999999999998
Q ss_pred CCCCeEEEEecCCccccccccc----------cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHH
Q 001678 944 PQRPVCKIGDLGLSKVKQQTLV----------SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSL 1013 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~~~~~----------s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSL 1013 (1033)
..+.++|.|||.+....-... .....-|..|+|||.+.-+.+. .+++++|||||
T Consensus 164 -~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~---------------ti~ertDIWSL 227 (302)
T KOG2345|consen 164 -DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC---------------TITERTDIWSL 227 (302)
T ss_pred -CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc---------------ccccccchhhh
Confidence 568999999999875321100 0111248889999998655321 37889999999
Q ss_pred HHHHHHHHccCCCCCC
Q 001678 1014 GILFFFLQFILCFIDF 1029 (1033)
Q Consensus 1014 GVVLYeLLTGk~PFd~ 1029 (1033)
||+||.||+|..||+.
T Consensus 228 GCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 228 GCTLYAMMFGESPFER 243 (302)
T ss_pred hHHHHHHHHcCCcchH
Confidence 9999999999999975
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=260.51 Aligned_cols=198 Identities=24% Similarity=0.352 Sum_probs=165.5
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||+|+||.||++.. .+..||+|.+..... ...+.+.+|+.++++++||||+++++.+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-- 87 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--------PKKELIINEILVMRENKHPNIVNYLDSYLV-- 87 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--------hHHHHHHHHHHHHhhcCCCCeeehhheeee--
Confidence 36799999999999999999976 467799998753211 112467889999999999999999999987
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
....++|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+||+++ .++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~----~~~~~kL~dfg~ 161 (293)
T cd06647 88 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 161 (293)
T ss_pred CCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc----CCCCEEEccCcc
Confidence 56789999999999999998754 378889999999999999999999999999999999998 667899999998
Q ss_pred cccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ar~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+....... ......|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------------------~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA------------------YGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred eecccccccccccccCChhhcCchhhccCC------------------CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 87543322 223446888999999886542 456789999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=250.48 Aligned_cols=201 Identities=23% Similarity=0.439 Sum_probs=165.4
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.+.||+|+||.||++.. .+..+|+|.+....... ...+.+.+|+.+++.++|+||+++++.+.. ..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQE--NG 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheecc--CC
Confidence 588999999999999999988 46789999886542211 122467789999999999999999999887 57
Q ss_pred ceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..++|+||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+.+++|+||||+||+++. ....+||+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK---NGMVAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC---CCCeEEecccccc
Confidence 8999999999999999997643 34789999999999999999999999999999999999982 2246799999998
Q ss_pred ccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
....... ......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~------------------~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRP------------------YNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCC------------------CCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 7654332 222345889999999876532 456789999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=264.51 Aligned_cols=194 Identities=23% Similarity=0.349 Sum_probs=161.8
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|.....||+|+||.||++.. .++.||||++..... ...+.+.+|+.+++.++||||+++++.+.. ...
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~ 92 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEE 92 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--------chHHHHHHHHHHHHhCCCCchhhhhhheee--CCe
Confidence 44556799999999999987 478899999864321 112357789999999999999999999987 578
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+++||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~----~~~~~kL~dfg~~~~ 166 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT----LDGRVKLSDFGFCAQ 166 (297)
T ss_pred EEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc----cCCcEEEeechhHhh
Confidence 9999999999999998765 3478999999999999999999999999999999999998 678999999999875
Q ss_pred ccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 960 ~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
..... ......|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 167 ISKDVPKRKSLVGTPYWMAPEVISRTP------------------YGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred cccccccccceecCccccCHHHHccCC------------------CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43322 223456899999999986542 45678999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=282.15 Aligned_cols=213 Identities=23% Similarity=0.326 Sum_probs=176.1
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
+++|-++.+||+|||+.||+|.+ ..+-||+|+-...... ++..++...+...+|..|.+.|+||-||++|++|.-+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~W-rdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNW-RDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD- 539 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccch-hhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-
Confidence 45688889999999999999977 3556899986654333 3344566777888999999999999999999999864
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHsk--GIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...+|-|+|||+|-+|..+|+... .+++..+..|+.||+.||.||... .|||-||||.||||. ++..-|.+||+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv-~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV-NGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe-cCcccceeEeeec
Confidence 567899999999999999997664 589999999999999999999975 899999999999996 4447789999999
Q ss_pred CCcccccccc--------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCC
Q 001678 955 GLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCF 1026 (1033)
Q Consensus 955 GLAr~~~~~~--------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~P 1026 (1033)
||++..+... .+....||.+|++||.+.-...+ ..++.++||||+|||+|++++|+.|
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkeP--------------PKIsnKVDVWSvGVIFyQClYGrKP 683 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEP--------------PKISNKVDVWSVGVIFYQCLYGRKP 683 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCC--------------CccccceeeEeeehhhhhhhccCCC
Confidence 9999765432 34456799999999977432111 1478899999999999999999999
Q ss_pred CCC
Q 001678 1027 IDF 1029 (1033)
Q Consensus 1027 Fd~ 1029 (1033)
|..
T Consensus 684 FGh 686 (775)
T KOG1151|consen 684 FGH 686 (775)
T ss_pred CCC
Confidence 954
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=290.76 Aligned_cols=202 Identities=24% Similarity=0.387 Sum_probs=170.8
Q ss_pred CceEEEEecccCcEEEEEEEEcCcce--EEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~kG~kV--AIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
-++++..||.|+||+||+|..+.+.+ |.|++... .+..+++++-|+.||..++||+||++|+.|.. ++
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~--en 102 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--EN 102 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cC
Confidence 46778899999999999998875543 56665432 23456789999999999999999999998887 68
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.++|+.|||.||-...++-.-+..+++..+..+++|++.||.|||+.+|||||||..|||++ .+|.++|+|||.+.
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T----ldGdirLADFGVSA 178 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT----LDGDIRLADFGVSA 178 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE----ecCcEeeecccccc
Confidence 89999999999999999988888999999999999999999999999999999999999999 77899999999876
Q ss_pred cccc-ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~-~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.... .....++.||++|||||++........ .|+.++||||||++|.+|.-+.+|.--
T Consensus 179 Kn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~-------------PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 179 KNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQ-------------PYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred cchhHHhhhccccCCcccccchheeeccccCC-------------CchhhhhHHhhhhHHHHHhccCCCccc
Confidence 5433 234567889999999999865431111 477888999999999999999998643
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=266.60 Aligned_cols=202 Identities=27% Similarity=0.322 Sum_probs=164.5
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..+|.+++.||+|+||.||+++. +++.||||.+...... ......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN------RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 35799999999999999999987 4778999988643211 111235668999999999999999999887532
Q ss_pred C---CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 877 D---GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 877 e---g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
. ..+++||||+ +++|.+++.+.. .+++..++.++.||+.||.|||+++++||||||+|||++ .++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----~~~~~kL~D 151 (337)
T cd07858 78 REAFNDVYIVYELM-DTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICD 151 (337)
T ss_pred ccccCcEEEEEeCC-CCCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECc
Confidence 1 3589999999 478999887654 589999999999999999999999999999999999998 667899999
Q ss_pred cCCccccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 954 LGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||++...... .......++..|+|||++.... .++.++|+|||||++|+|++|+.||..
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 152 FGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS-----------------EYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred CccccccCCCcccccccccccCccChHHHhcCC-----------------CCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 9999865433 2223456789999999876432 245678999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=259.40 Aligned_cols=206 Identities=23% Similarity=0.321 Sum_probs=166.4
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f 872 (1033)
.+..++|++.+.||+|+||.||++++. ++.||||.++..... .....+.+|+.++.++. |+||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-------EENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-------HHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 455678999999999999999999986 788999998753211 11234556776666665 99999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
.+ ...+++||||+ .++|.+++......+++..+..++.||+.||.|||+ .+|+||||+|+||+++ .++.+||
T Consensus 84 ~~--~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~----~~~~~kL 156 (296)
T cd06618 84 IT--DSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKL 156 (296)
T ss_pred ec--CCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc----CCCCEEE
Confidence 88 56799999998 558888887755678999999999999999999997 5999999999999998 6789999
Q ss_pred EecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+|||++.............++..|+|||.+.+.... ..++.++|+||||+++|+|++|+.||..
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--------------~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPN--------------PKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CccccchhccCCCcccCCCCCccccCHhhcCCCCCc--------------cccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 999998765443333344578899999998654210 0356678999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=249.01 Aligned_cols=199 Identities=30% Similarity=0.488 Sum_probs=167.3
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|++.++||+|+||.||++++ .++.+|+|.+...... ......+.+|+.+++.++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS------QKEREDAVNEIRILASVNHPNIISYKEAFLD--GN 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc------HHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CC
Confidence 588999999999999999987 4677999988754321 1223466789999999999999999999987 57
Q ss_pred ceEEEEeeccCCcHHHHHHhc---CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~---~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
..++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~----~~~~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV----ANDLVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe----cCCcEEEeecc
Confidence 899999999999999998762 34588999999999999999999999999999999999998 56789999999
Q ss_pred CccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
++...... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||+..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~------------------~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWKGRP------------------YSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHCCCC------------------CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99876544 223355789999999986542 455679999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=270.27 Aligned_cols=196 Identities=27% Similarity=0.317 Sum_probs=164.6
Q ss_pred CCceEE-EEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcC
Q 001678 800 DDLEEV-RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1033)
Q Consensus 800 ~dYeil-ekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~ 875 (1033)
++|++- ++||-|-.|+|..+.. +++++|+|++.... ...+|+++.-.. .|||||.++++|...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------------KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------------KARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------------HHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 455543 5799999999999876 58889999887541 345677765555 599999999998752
Q ss_pred --CCCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 876 --PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 876 --~eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
...++.+|||.|+||.|+..+++++ ..++++++..|++||..|+.|||+.+|.||||||+|+|..... .+..+||+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLt 206 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLT 206 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEec
Confidence 3557889999999999999998765 4589999999999999999999999999999999999998554 67899999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
|||+|+.........+-+-|+.|.|||++..++ |+.+.|+||+|||||.||.|.+||
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK------------------ydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK------------------YDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchh------------------cCCCCCccchhHHHHHhhcCCCcc
Confidence 999999877555555667799999999986653 666789999999999999999998
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=265.92 Aligned_cols=201 Identities=24% Similarity=0.344 Sum_probs=165.0
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC--
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG-- 875 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~-- 875 (1033)
.+|++.+.||+|+||.||++.. +++.||+|++...... ......+.+|+.++++++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc------ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 6799999999999999999987 4788999988743211 12234667899999999999999999987642
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEecccc
Confidence 2346899999994 68999987654 489999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc-----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 956 LSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~~-----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++....... ......|+..|+|||++.... .++.++|+|||||++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----------------~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-----------------EYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCc-----------------ccccccchHHHHHHHHHHHcCCCccCC
Confidence 987643221 112446899999999875432 356778999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=253.55 Aligned_cols=201 Identities=28% Similarity=0.410 Sum_probs=168.8
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~ 876 (1033)
++|.+.+.||+|+||.||+++. .++.||+|++...... .....+.+.+|+.++++++ |+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-- 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-- 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--
Confidence 4789999999999999999988 5788999998764322 1222356788999999999 9999999999887
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
.+.+++||||+.+++|.+++.+.+ .+++..++.|+.|++.||.|||+.|++|+||||+||+++ .++.++|+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~----~~~~~~l~df~~ 148 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGT 148 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEecCCcc
Confidence 568999999999999999998764 589999999999999999999999999999999999998 677899999999
Q ss_pred cccccccc---------------------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHH
Q 001678 957 SKVKQQTL---------------------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGI 1015 (1033)
Q Consensus 957 Ar~~~~~~---------------------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGV 1015 (1033)
+....... ......++..|+|||++.... ++.++|+||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~------------------~~~~~Di~slG~ 210 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP------------------AGKSSDLWALGC 210 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC------------------CChhhhHHHHHH
Confidence 87543321 122345788999999876542 455789999999
Q ss_pred HHHHHHccCCCCCCC
Q 001678 1016 LFFFLQFILCFIDFF 1030 (1033)
Q Consensus 1016 VLYeLLTGk~PFd~~ 1030 (1033)
++|+|++|..||...
T Consensus 211 ~l~~l~~g~~p~~~~ 225 (280)
T cd05581 211 IIYQMLTGKPPFRGS 225 (280)
T ss_pred HHHHHHhCCCCCCCc
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=252.47 Aligned_cols=200 Identities=27% Similarity=0.384 Sum_probs=158.1
Q ss_pred ceEEEEecccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 802 LEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k-----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
|++.+.||+|+||.||+|.++ +..||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS------SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC------hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567789999999999999763 567999988753211 223456888999999999999999999887532
Q ss_pred CC----ceEEEEeeccCCcHHHHHHhc-----CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCC
Q 001678 877 DG----SLATVTEFMVNGSLKQFLQKK-----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1033)
Q Consensus 877 eg----~l~LVmEYmegGSL~dlL~~~-----~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g 947 (1033)
.. ..++++||+.+++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~----~~~ 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN----ENM 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc----CCC
Confidence 21 246889999999999887532 12478889999999999999999999999999999999998 677
Q ss_pred eEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-c
Q 001678 948 VCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-I 1023 (1033)
Q Consensus 948 ~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-G 1023 (1033)
.+||+|||+++...... ......++..|++||.+.... ++.++|||||||++|+|++ |
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~------------------~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV------------------YTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc------------------cchhhhhHHHHHHHHHHhhCC
Confidence 89999999988653221 112233567899999886542 4567799999999999999 8
Q ss_pred CCCCCC
Q 001678 1024 LCFIDF 1029 (1033)
Q Consensus 1024 k~PFd~ 1029 (1033)
++||..
T Consensus 213 ~~p~~~ 218 (273)
T cd05074 213 QTPYAG 218 (273)
T ss_pred CCCCCC
Confidence 888854
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=263.53 Aligned_cols=199 Identities=24% Similarity=0.323 Sum_probs=163.0
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.+.||+|+||.||++.. +++.||+|+++.... .....+.+.+|+.++++++|+||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 47799999999999999999976 477899998864311 1122346778999999999999999999886421
Q ss_pred ----CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 ----eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
....+++++++ +++|.+++... .+++..++.++.||++||.|||+.+|+||||||+||+++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc----CCCCEEEe
Confidence 23478888887 88999888653 488999999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||+++..... .....++..|+|||++.+.. .++.++|+|||||++|+|++|+.||..
T Consensus 163 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 163 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWM-----------------HYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred ccccccccccc--ccccccCCCccCHHHHhCcc-----------------CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99998765432 23456789999999875532 255678999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=255.37 Aligned_cols=195 Identities=22% Similarity=0.367 Sum_probs=162.6
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|...+.||+|++|.||++.. .++.+++|++..... ...+.+.+|+.+++.++|+||+++++++.. ..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~ 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--------QRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GD 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--------hHHHHHHHHHHHHHHcCCCChheEEEEEEc--CC
Confidence 456678999999999999986 467799998753211 112457789999999999999999999887 56
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
..++|+||+.+++|.+++.. ..+++..+..++.|++.||+|||+.+++||||||+||+++ .++.+||+|||++.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc----CCCcEEEcccccch
Confidence 78999999999999999877 3488999999999999999999999999999999999998 67899999999887
Q ss_pred cccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ......|+..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLP------------------YGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCC------------------CCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 543322 223456899999999986542 45678999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=254.24 Aligned_cols=197 Identities=29% Similarity=0.411 Sum_probs=163.7
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCCC
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~eg 878 (1033)
|++.+.||+|+||.||+|+.. ++.|+||++....... . .....+|+..+++++ |+||+++++++.+ .+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~---~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---E----ECMNLREVKSLRKLNEHPNIVKLKEVFRE--ND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch---h----HHHHHHHHHHHHhccCCCCchhHHHHhhc--CC
Confidence 678899999999999999984 6679999876532110 0 123446888999999 9999999999988 67
Q ss_pred ceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
..++||||+ +++|.+++.... ..+++..++.++.|++.+|.|||+++++|+||||+||+++ .++.+||+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~----~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCCEEEeecccc
Confidence 899999999 889999887654 4689999999999999999999999999999999999998 6789999999999
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.............++..|+|||++.... .++.++|+||||+++|+|++|++||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------------~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLRST-----------------SYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeecCc-----------------CcCCccchhhHHHHHHHHHhCCCccCC
Confidence 8665443334456788999999875432 245678999999999999999999854
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=262.09 Aligned_cols=205 Identities=24% Similarity=0.344 Sum_probs=161.7
Q ss_pred CCce-EEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHH------HHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 800 DDLE-EVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERER------LIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 800 ~dYe-ilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~------~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
++|. +.+.||.|+||+||+|.+ .++.||||+++............. ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 446799999999999987 477899999875433221100000 1124678999999999999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
++.. ....++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+|||++ .++.+|
T Consensus 88 ~~~~--~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~----~~~~~k 159 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN----SKGICK 159 (335)
T ss_pred EEec--CCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC----CCCCEE
Confidence 9987 578999999995 69999987543 489999999999999999999999999999999999998 677999
Q ss_pred EEecCCccccccc---------------cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHH
Q 001678 951 IGDLGLSKVKQQT---------------LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGI 1015 (1033)
Q Consensus 951 LiDFGLAr~~~~~---------------~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGV 1015 (1033)
|+|||++...... .......++..|+|||.+.+.. .++.++|+|||||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~ 222 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-----------------KYHFAVDMWSVGC 222 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC-----------------CCCcHHHHHHHHH
Confidence 9999998754411 1112234688899999886542 2456779999999
Q ss_pred HHHHHHccCCCCCC
Q 001678 1016 LFFFLQFILCFIDF 1029 (1033)
Q Consensus 1016 VLYeLLTGk~PFd~ 1029 (1033)
++|+|+||+.||..
T Consensus 223 ~l~el~tg~~p~~~ 236 (335)
T PTZ00024 223 IFAELLTGKPLFPG 236 (335)
T ss_pred HHHHHHhCCCCCCC
Confidence 99999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=253.30 Aligned_cols=198 Identities=30% Similarity=0.407 Sum_probs=165.0
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|++.+.||.|++|.||+++. .++.+++|++....... .....+.+|+.++++++|+||+++++++.. ...
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE------GIPKTALREIKLLKELNHPNIIKLLDVFRH--KGD 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc------hhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCC
Confidence 56778999999999999987 47779999887543211 223467789999999999999999999887 578
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++||||+. ++|.+++......+++..+..++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||.+..
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLARS 147 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----CCCcEEEeeeeeeEe
Confidence 999999996 589998887666789999999999999999999999999999999999998 667899999999876
Q ss_pred ccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 960 ~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
..... ......++..|+|||.+.+.. .++.++|+||||+++|+|+||+.||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-----------------~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDK-----------------GYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCC-----------------CCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 64432 222345788899999886542 246678999999999999999999854
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-30 Score=275.55 Aligned_cols=194 Identities=26% Similarity=0.402 Sum_probs=171.4
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|.++++||+|+||.||+|.+ .|..+|||.+.... -+..+.+|+.+|.+++.+++|++||.+.. +..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sD 102 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----------DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSD 102 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----------hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCc
Confidence 55678999999999999976 58889999876432 13567789999999999999999998887 678
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
+++|||||-.|++.+.++-+++.+++..+..|++..++||+|||...-||||||..||||+ .+|..||+|||.|..
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN----T~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN----TDGIAKLADFGVAGQ 178 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc----ccchhhhhhccccch
Confidence 9999999999999999999999999999999999999999999999999999999999998 678999999999988
Q ss_pred ccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 960 ~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+.+.. ....+.||+.|||||++..- -|+++.||||||++..+|.-|++|+.-
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EI------------------GY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEI------------------GYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHh------------------ccchhhhHhhhcchhhhhhcCCCCccc
Confidence 76654 34567899999999999754 367788999999999999999999853
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=257.71 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=164.2
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
..|+.++.||+|+||.||++++ .+..||+|++...... .......+.+|+.++++++|+||+++++++.+ .
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--E 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-----chHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--C
Confidence 4477889999999999999987 4678999988654221 12334578889999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||+. |+|.+++......+++..+..++.||+.||.|||+.+|+||||+|+||+++ .++.+||+|||++
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~----~~~~~kl~dfg~~ 172 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSA 172 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC----CCCCEEEecCCCc
Confidence 67899999996 588888876666689999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ....|+..|+|||++..... -.++.++|+|||||++|+|++|+.||..
T Consensus 173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~---------------~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 173 SIASPA---NSFVGTPYWMAPEVILAMDE---------------GQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred cccCCc---ccccCCccccChhhhhcCCC---------------CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 754332 23457889999998743110 0256678999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=253.27 Aligned_cols=188 Identities=25% Similarity=0.353 Sum_probs=151.8
Q ss_pred CceEEEE--ecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcC
Q 001678 801 DLEEVRE--LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1033)
Q Consensus 801 dYeilek--LGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~ 875 (1033)
+|++.+. ||+|+||.||++.. .+..+|+|++....... .|+.....+ +|+||+++++.|..
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 4455555 59999999999987 46778999876532211 012122222 69999999999988
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCC-eEEEEec
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDL 954 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g-~VKLiDF 954 (1033)
.+.+++||||+++++|.+++.+.. .+++..++.++.||++||.|||+.+++||||||+||+++ ..+ .+||+||
T Consensus 81 -~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~~l~df 154 (267)
T PHA03390 81 -LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----RAKDRIYLCDY 154 (267)
T ss_pred -CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----CCCCeEEEecC
Confidence 568999999999999999997764 689999999999999999999999999999999999998 445 8999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|++...... ....++..|+|||++.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 155 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~------------------~~~~~DvwslG~il~~l~~g~~p~~~ 208 (267)
T PHA03390 155 GLCKIIGTP---SCYDGTLDYFSPEKIKGHN------------------YDVSFDWWAVGVLTYELLTGKHPFKE 208 (267)
T ss_pred ccceecCCC---ccCCCCCcccChhhhcCCC------------------CCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 998765432 2345799999999987643 45577999999999999999999963
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=253.37 Aligned_cols=202 Identities=24% Similarity=0.358 Sum_probs=164.9
Q ss_pred CceEEEEecccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEc
Q 001678 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~-----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d 874 (1033)
+|++.+.||+|+||.||+++. +++.||||+++..... ........+.+|+.++.++ +|+||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 488999999999999999875 3567999998753221 2223345678899999999 59999999999887
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...+++||||+.+++|.+++.... .+++..++.++.|++++|.|||+.+++||||||+||+++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df 149 (288)
T cd05583 77 --DTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDF 149 (288)
T ss_pred --CCEEEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEEEC
Confidence 567899999999999999987653 488899999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+++...... ......|+..|+|||.+.+... ..+.++|+||||+++|+|+||..||..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----------------~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG----------------GHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCC----------------CCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 9987643322 2223568999999998765421 134567999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=260.36 Aligned_cols=201 Identities=25% Similarity=0.292 Sum_probs=160.5
Q ss_pred CceEEEEecccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~ 875 (1033)
+|++.+.||+|+||.||++++. ++.||||++..... .....+.+.+|+.+++++ +|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS------KKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4889999999999999999885 55799998764211 111234677899999999 599999999876432
Q ss_pred --CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 876 --~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
....+++++||+ +++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||+|
T Consensus 75 ~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~----~~~~~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELM-EADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN----ADCELKICD 148 (332)
T ss_pred cccCCcEEEEEecc-cCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----CCCCEEeCc
Confidence 234578899998 46899988654 4589999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc-----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 954 LGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 954 FGLAr~~~~~~-----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
||+++...... ......||..|+|||++.+.. .++.++|+|||||++|+|++|+.||.
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----------------~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ-----------------SYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCC-----------------CCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 99997643221 123456899999999875432 25667899999999999999999997
Q ss_pred CC
Q 001678 1029 FF 1030 (1033)
Q Consensus 1029 ~~ 1030 (1033)
..
T Consensus 212 ~~ 213 (332)
T cd07857 212 GK 213 (332)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=260.65 Aligned_cols=200 Identities=28% Similarity=0.333 Sum_probs=166.4
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC--
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~-- 876 (1033)
+|++.+.||.|+||.||+|+.. ++.||||++..... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 5889999999999999999874 68899998875321 1222356888999999999999999999988732
Q ss_pred -CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 877 -eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
...+++||||+. ++|.+++.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~----~~~~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNCDLKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEcccC
Confidence 236899999996 58999887654 689999999999999999999999999999999999998 66899999999
Q ss_pred Ccccccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 956 LSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++....... ......++..|+|||++.+.. .++.++|+||||+++|+|++|..||..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-----------------RYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeeccc-----------------CCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 998765432 233456789999999987652 255678999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=261.86 Aligned_cols=199 Identities=24% Similarity=0.355 Sum_probs=163.5
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++++.||+|+||.||++.. ++..||||++..... .......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 56799999999999999999987 477899998764211 1222346778999999999999999999987632
Q ss_pred C----CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 e----g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
. ..+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~----~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN----EDCELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEe
Confidence 1 2468999999 7899988864 3489999999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||++...... .....++..|+|||++.+.. .++.++|+|||||++|+|++|..||..
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNWM-----------------HYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhCCC-----------------CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999865432 22346789999999886432 245677999999999999999999963
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=249.98 Aligned_cols=198 Identities=30% Similarity=0.426 Sum_probs=164.5
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|++.+.||+|+||.||+|+.. ++.||+|++..... .....+.+..|+.++++++|+||+++++++.+ ...
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCc
Confidence 567789999999999999884 78899999876431 11223456789999999999999999999887 578
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++||||+. ++|.+++.+....+++..++.++.|++.||.|||+.+|+||||+|+||+++ .++.+||+|||+++.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~----~~~~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc----CCCCEEEecCCcccc
Confidence 999999996 599999987655689999999999999999999999999999999999998 678999999999876
Q ss_pred ccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 960 ~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
..... ......++..|+|||.+.+.. .++.++|+|||||++|+|++|..||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------------~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSK-----------------HYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCc-----------------CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 54332 222334578899999886542 245678999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=287.62 Aligned_cols=202 Identities=31% Similarity=0.513 Sum_probs=169.1
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k-----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLy 869 (1033)
..+......+.+.||.|.||.|++|+.+ ...||||.++... .++...+|+.|+.||.+++||||++|.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------tekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------cHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 3456778889999999999999999874 3459999998652 344557899999999999999999999
Q ss_pred EEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeE
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 870 G~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
|+... ...+.||+|||++|+|+.+|+++...++..++.-+++.|+.||+||-+.++|||||..+|||++ .+..+
T Consensus 697 GVVTk--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN----snLvC 770 (996)
T KOG0196|consen 697 GVVTK--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN----SNLVC 770 (996)
T ss_pred EEEec--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec----cceEE
Confidence 99987 5678999999999999999999988899999999999999999999999999999999999999 88999
Q ss_pred EEEecCCccccccccc--cCCc--CCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHH-ccC
Q 001678 950 KIGDLGLSKVKQQTLV--SGGV--RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQ-FIL 1024 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~~--s~~~--~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLL-TGk 1024 (1033)
|++||||++.+++... .... .-..+|.|||.|..++ .+.++||||+||||||.| +|.
T Consensus 771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK------------------FTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK------------------FTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred EeccccceeecccCCCccccccCCccceeecChhHhhhcc------------------cCchhhccccceEEEEecccCC
Confidence 9999999998865431 1111 1257799999998764 455678888888888654 466
Q ss_pred CCC
Q 001678 1025 CFI 1027 (1033)
Q Consensus 1025 ~PF 1027 (1033)
.|+
T Consensus 833 RPY 835 (996)
T KOG0196|consen 833 RPY 835 (996)
T ss_pred Ccc
Confidence 555
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=255.43 Aligned_cols=200 Identities=20% Similarity=0.230 Sum_probs=161.3
Q ss_pred eEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
.+.+.+|.|+++.||+++.+++.||||+++.... .....+.+.+|+.+++.++|+||+++++++.+ ....++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYV 76 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEecccc------chhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEE
Confidence 3445566777777777777889999999875421 12234578899999999999999999999987 567899
Q ss_pred EEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 883 VTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
+|||+.+++|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++ .++.+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~----~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS----GDGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe----cCCceEEecCccceeec
Confidence 99999999999999864 34588999999999999999999999999999999999998 66789999999886442
Q ss_pred ccc--------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 962 QTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 962 ~~~--------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
... ......++..|+|||++..... .++.++|+|||||++|+|++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----------------~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ----------------GYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCC----------------CCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 1123446788999999865321 2566789999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=259.27 Aligned_cols=199 Identities=24% Similarity=0.350 Sum_probs=161.2
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... +.....+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS------EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc------ccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 35799999999999999999986 4788999988643211 112345778999999999999999999987532
Q ss_pred C----CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 e----g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
. ..+++||||+. .+|..++. ..+++..+..++.|++.||.|||+.+++||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~----~~~~~kL~ 159 (342)
T cd07879 88 SGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN----EDCELKIL 159 (342)
T ss_pred cCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEe
Confidence 1 34689999995 47776652 3488999999999999999999999999999999999998 67899999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
|||+++..... .....++..|+|||++.+.. .++.++|+|||||++|+|++|+.||...
T Consensus 160 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 160 DFGLARHADAE--MTGYVVTRWYRAPEVILNWM-----------------HYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred eCCCCcCCCCC--CCCceeeecccChhhhcCcc-----------------ccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998765332 23456788999999876532 2556789999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=253.85 Aligned_cols=198 Identities=27% Similarity=0.403 Sum_probs=162.7
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|..+++||+|+||+||+|+. .++.|+||++...... .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHT 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-----chHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCE
Confidence 66678899999999999987 4778999988654221 12234567889999999999999999999988 567
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++||||+. ++|.+++......+++..++.++.||+.+|.|||+.|++|+||||+||+++ .++.+||+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~----~~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC----CCCCEEEeecCCCcc
Confidence 899999994 688888877666789999999999999999999999999999999999998 667899999999865
Q ss_pred cccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 960 ~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
... .....|+..|+|||++..... ..++.++|+|||||++|+|++|..||.-
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~---------------~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDE---------------GQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred cCC---CCCccccccccChhhccccCC---------------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 332 234568899999998753110 0245678999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=257.01 Aligned_cols=199 Identities=25% Similarity=0.354 Sum_probs=162.7
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
..++|++++.||.|+||.||+++. +++.||||++....... ...+.+.+|+.+++.++||||++++++|...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------VLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc------chhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 456799999999999999999986 46779999876432111 1224677899999999999999999998763
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....++||||+ +++|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 82 -~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~----~~~~~~l~dfg 153 (328)
T cd07856 82 -LEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN----ENCDLKICDFG 153 (328)
T ss_pred -CCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC----CCCCEEeCccc
Confidence 35688999999 67899888643 478888889999999999999999999999999999998 67889999999
Q ss_pred CccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
++...... .....++..|+|||++.+.. .++.++|+|||||++|+|+||+.||..
T Consensus 154 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 154 LARIQDPQ--MTGYVSTRYYRAPEIMLTWQ-----------------KYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred cccccCCC--cCCCcccccccCceeeeccC-----------------CcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 98754332 22345788999999875422 255678999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=258.23 Aligned_cols=197 Identities=22% Similarity=0.303 Sum_probs=157.3
Q ss_pred EEeccc--CcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceE
Q 001678 806 RELGSG--TYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 806 ekLGeG--gFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~ 881 (1033)
..||+| +||+||++++ .++.||||++...... ....+.+.+|+.+++.++||||++++++|.. ...++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~ 75 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLW 75 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceE
Confidence 346666 9999999988 5888999988743211 1234678899999999999999999999998 56789
Q ss_pred EEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 882 TVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
+||||+.+++|.+++.+.. ..+++..+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+||+.+...
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~----~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS----GDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe----CCCcEEEechHHHhhh
Confidence 9999999999999998643 3488999999999999999999999999999999999998 6678999999865322
Q ss_pred ccccc--------cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 961 QQTLV--------SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 961 ~~~~~--------s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
..... .....++..|+|||++.+... .++.++|||||||++|+|++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----------------~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY----------------GYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCC----------------CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 11100 011234667999999865421 2456789999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=246.88 Aligned_cols=201 Identities=24% Similarity=0.379 Sum_probs=160.8
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
+|.+.+.||+|+||.||++++. +..+++|+++........ ......+.+|+.++++++||||+++++++.+ ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLE--RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CC
Confidence 5889999999999999999885 344666766543322111 1112346678999999999999999999887 56
Q ss_pred ceEEEEeeccCCcHHHHHHh---cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 879 SLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~---~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
..++||||+++++|.+++.+ ....+++..++.++.|++.||.|||+.|++|+||||+||+++ . +.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~-~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----N-NLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----c-CCEeecccC
Confidence 78999999999999998864 345689999999999999999999999999999999999997 2 469999999
Q ss_pred Cccccccc-cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 956 LSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 956 LAr~~~~~-~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
+++..... .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~------------------~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALKHQG------------------YDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHccCC------------------CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 98765332 2233456889999999876542 44567999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=241.99 Aligned_cols=193 Identities=27% Similarity=0.368 Sum_probs=163.0
Q ss_pred ecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 808 LGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
||+|+||.||++.++ ++.+|+|++....... ......+..|+.++++++|+||+++++.+.. ....++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-----RKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-----hHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEe
Confidence 689999999999884 7889999987653221 2234578889999999999999999999887 678999999
Q ss_pred eccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccc-c
Q 001678 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT-L 964 (1033)
Q Consensus 886 YmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~-~ 964 (1033)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++ ..+.++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~----~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc----CCCcEEEeecCcceecccCCC
Confidence 999999999997664 489999999999999999999999999999999999998 6678999999998765443 2
Q ss_pred ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 965 ~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
......++..|+|||.+.+.. .+.+.|+||||+++|+|++|..||...
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~------------------~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKG------------------YGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred cccCCcCCccccChHHhCCCC------------------CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 234456889999999886542 455679999999999999999999654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=259.72 Aligned_cols=200 Identities=23% Similarity=0.346 Sum_probs=160.5
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
..+|++.+.||.|+||.||+|..+ ++.||+|++..... ...+.+.+|+.++++++||||+++++.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 368999999999999999999874 67899998865421 12346778999999999999999998776532
Q ss_pred C------------CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q 001678 877 D------------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1033)
Q Consensus 877 e------------g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~ 944 (1033)
. ...++||||+. ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--- 149 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--- 149 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---
Confidence 1 34789999996 6898888643 4789999999999999999999999999999999999972
Q ss_pred CCCeEEEEecCCccccccccc----cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHH
Q 001678 945 QRPVCKIGDLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020 (1033)
Q Consensus 945 ~~g~VKLiDFGLAr~~~~~~~----s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeL 1020 (1033)
.++.+||+|||+++....... .....++..|+|||++.... .++.++|+|||||++|+|
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DiwSlGvil~el 212 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN-----------------NYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCcc-----------------ccCchhhHHHHHHHHHHH
Confidence 346799999999976532211 12234788999999875432 355678999999999999
Q ss_pred HccCCCCCC
Q 001678 1021 QFILCFIDF 1029 (1033)
Q Consensus 1021 LTGk~PFd~ 1029 (1033)
++|+.||..
T Consensus 213 ~~g~~pf~~ 221 (342)
T cd07854 213 LTGKPLFAG 221 (342)
T ss_pred HhCCCCCCC
Confidence 999999953
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=282.02 Aligned_cols=148 Identities=25% Similarity=0.446 Sum_probs=130.1
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|.++++||+|+||.||+|.+. ++.||||+++..... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-- 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQS-- 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--
Confidence 367999999999999999999985 788999998754322 12334578889999999999999999999887
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
...++|||||+.+++|.+++...+ .+++..++.|+.||+.||.|||.++||||||||+||||+ .++.+||+|||+
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~----~~g~vkL~DFGl 150 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGL 150 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc----CCCCEEEEeCCC
Confidence 578999999999999999997654 478899999999999999999999999999999999998 667999999999
Q ss_pred cc
Q 001678 957 SK 958 (1033)
Q Consensus 957 Ar 958 (1033)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 86
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=283.28 Aligned_cols=198 Identities=30% Similarity=0.441 Sum_probs=164.1
Q ss_pred ceEEEEecccCcEEEEEEEE--c----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 802 LEEVRELGSGTYGSVYHGKW--R----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--k----G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
++..++||+|+||+||+|.| + ..+||||++....... ....+++|+-+|.+|+|||++++++++...
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-------~s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-------ASIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-------hhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 34458899999999999988 3 3458999887543221 224688999999999999999999999973
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
.+.||++||+.|+|.++++.....+-....+.|..||++||.|||.+.+|||||..+|||+. .-..+||+|||
T Consensus 771 ---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk----sP~hvkitdfg 843 (1177)
T KOG1025|consen 771 ---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK----SPNHVKITDFG 843 (1177)
T ss_pred ---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec----CCCeEEEEecc
Confidence 48899999999999999998888899999999999999999999999999999999999998 66799999999
Q ss_pred Cccccccccc---cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCCCCC
Q 001678 956 LSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFFS 1031 (1033)
Q Consensus 956 LAr~~~~~~~---s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd~~s 1031 (1033)
+++....... ...-...+.|||-|.+.... ++.++|||||||++||||| |..|++-++
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~------------------~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK------------------YTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccC------------------CCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 9998754321 22333467799999887653 6778899999999999987 666776554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=259.85 Aligned_cols=199 Identities=24% Similarity=0.339 Sum_probs=163.5
Q ss_pred CCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~ 876 (1033)
.++|++.+.||+|+||.||+|++. ++.||||++..... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ------SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 467999999999999999999884 67799998764311 1122346778999999999999999998876532
Q ss_pred C----CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 e----g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
. ..+++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~----~~~~~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN----EDCELKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEc
Confidence 1 2489999999 7799999875 3489999999999999999999999999999999999998 67889999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||++...... .....++..|+|||.+.+.. .++.++|+|||||++|+|+||+.||..
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-----------------~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWM-----------------HYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCC-----------------CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999865433 23456788999999875432 245678999999999999999999953
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=274.43 Aligned_cols=203 Identities=29% Similarity=0.542 Sum_probs=170.5
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f 872 (1033)
+.+...++..-.+||-|-||.||.|.|+ ...||||.++.+. ..++.|++|+.+|+.++|||+|+|+|+|
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---------MeveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---------hhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 4455667778899999999999999996 5568999888553 3467899999999999999999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCC-ccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k-~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
.. +..+|||+|||..|+|.++|++.++ .++.-..++++.||..||+||..+++|||||..+|+|+. ++..||+
T Consensus 333 T~--EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg----EnhiVKv 406 (1157)
T KOG4278|consen 333 TH--EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHIVKV 406 (1157)
T ss_pred cc--CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc----ccceEEe
Confidence 98 6789999999999999999987654 466677889999999999999999999999999999998 7889999
Q ss_pred EecCCcccccccccc--CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc-cCCCCC
Q 001678 952 GDLGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFID 1028 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s--~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT-Gk~PFd 1028 (1033)
+||||+++....+.+ .+..-.+.|.|||-+.... ..-++|||+|||+|||+.| |+.||+
T Consensus 407 ADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNt------------------FSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT------------------FSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred eccchhhhhcCCceecccCccCcccccCcccccccc------------------cccchhhHHHHHHHHHHHhcCCCCCC
Confidence 999999987655422 2333477899999876543 3446799999999999865 778876
Q ss_pred CC
Q 001678 1029 FF 1030 (1033)
Q Consensus 1029 ~~ 1030 (1033)
-+
T Consensus 469 Gi 470 (1157)
T KOG4278|consen 469 GI 470 (1157)
T ss_pred Cc
Confidence 54
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=247.79 Aligned_cols=201 Identities=26% Similarity=0.378 Sum_probs=168.4
Q ss_pred CceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
.|..+++||+|+||+||+|+. +++.||+|.++.+... +..-...++|+.+++.|+|.|||+++++... ++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd------egvpssalreicllkelkhknivrl~dvlhs--dk 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHS--DK 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC------CCCcHHHHHHHHHHHHhhhcceeehhhhhcc--Cc
Confidence 456678999999999999977 4677999998865322 1122356789999999999999999999877 67
Q ss_pred ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+-+|+||| ..+|..+...-+..++.+.+..++.|+++||.|+|+++++||||||.|+||+ .+|++||+|||+++
T Consensus 75 kltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin----~ngelkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN----RNGELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec----cCCcEEecccchhh
Confidence 899999999 6699999988888899999999999999999999999999999999999998 78999999999998
Q ss_pred cccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHH-ccCCCCCCCC
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQ-FILCFIDFFS 1031 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLL-TGk~PFd~~s 1031 (1033)
...-.. .....+-|.+|++|.++.+.+ -|+++.|+||-|||+.||. .|.+.|+-.+
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgak-----------------ly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAK-----------------LYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeee-----------------hhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 665432 223334699999999997754 3778889999999999987 4677776544
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=252.87 Aligned_cols=200 Identities=28% Similarity=0.427 Sum_probs=162.7
Q ss_pred CCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
..|...+.||+|+||.||+|+. .+..+|||.+...... ......++.+|+.+++.++|+||+++++++.. .
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 87 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--E 87 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--C
Confidence 3467778899999999999987 4677999988643211 11223567789999999999999999999988 5
Q ss_pred CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
...++||||+. ++|.+++......+++..++.++.|++.||.|||+.+++||||||+|||++ .++.+||+|||++
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~ 162 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 162 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC----CCCcEEECCcccc
Confidence 67899999995 688888876666689999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 r~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
...... ....++..|+|||++.+... -.++.++|||||||++|+|++|+.||.-
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~---------------~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 163 SIMAPA---NXFVGTPYWMAPEVILAMDE---------------GQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred eeecCc---ccccCCccccCHHHHhhccc---------------CCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 765432 23457899999998753110 0245678999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=252.19 Aligned_cols=191 Identities=23% Similarity=0.348 Sum_probs=158.7
Q ss_pred EEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEE
Q 001678 805 VRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~L 882 (1033)
..+||+|+||.||++.. +++.||||++.... ......+.+|+.+++.++|+||+++++.+.. ....++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 94 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWV 94 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEE
Confidence 35699999999999987 47789999875321 1123468889999999999999999999988 568999
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
||||+++++|.+++... .+++..++.++.|++.||+|||+.|++|+||||+||+++ .++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~----~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 95 VMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEcccccceeccc
Confidence 99999999999987543 478899999999999999999999999999999999998 667899999999875433
Q ss_pred cc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 963 TL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 963 ~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.. ......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||..
T Consensus 169 ~~~~~~~~~~~~~y~~pE~~~~~~------------------~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 169 EVPRRKSLVGTPYWMAPELISRLP------------------YGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ccccccccccCccccCHHHhcCCC------------------CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22 223456889999999876532 45577999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=254.75 Aligned_cols=203 Identities=23% Similarity=0.330 Sum_probs=167.8
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEc
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d 874 (1033)
..++++++..||.|+.|.|++++.+ +...|||.+..... ....++++..+.++.+.+ .|+||+++|+|..
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-------kee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-------KEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-------HHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 3456677788999999999999885 47789999875421 122346666777766665 9999999999998
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+..+++.||.| ...+..+|++....+++..+-++...+++||.||-. ++|||||+||+|||+| ..|.+||||
T Consensus 163 --n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD----e~GniKlCD 235 (391)
T KOG0983|consen 163 --NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGNIKLCD 235 (391)
T ss_pred --CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc----cCCCEEeec
Confidence 56688899998 668888888887889999999999999999999985 5999999999999999 889999999
Q ss_pred cCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 954 FGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||++-...+......-.|-+.|||||.+.-+. .. .|+-.+||||||+.++||.||..||..
T Consensus 236 FGIsGrlvdSkAhtrsAGC~~YMaPERidp~~---~~------------kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 236 FGISGRLVDSKAHTRSAGCAAYMAPERIDPPD---KP------------KYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ccccceeecccccccccCCccccCccccCCCC---CC------------ccchhhhhhhhccchhhhhcccCCCCC
Confidence 99998877666655667899999999885431 11 366678999999999999999999976
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=273.59 Aligned_cols=205 Identities=27% Similarity=0.369 Sum_probs=172.8
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC---CCCcceEEEEE
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIV 872 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~---HPNIVrLyG~f 872 (1033)
+..+|+.++.||+|+||.|++|.++ ...|+||.+.+.....+.-.+.+.+-..--|+.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3467999999999999999999885 556899998766544333333333444556999999998 99999999999
Q ss_pred EcCCCCceEEEEeec-cCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEE
Q 001678 873 RDGPDGSLATVTEFM-VNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYm-egGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKL 951 (1033)
++ ++++||+||-. ++.+|+++|..+. .+++..++.|++|++.|+++||+.||||||||-+|++++ .+|.+||
T Consensus 639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd----~~g~~kl 711 (772)
T KOG1152|consen 639 ED--DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD----SNGFVKL 711 (772)
T ss_pred ec--CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEe----cCCeEEE
Confidence 99 78899999976 4669999997664 489999999999999999999999999999999999999 8899999
Q ss_pred EecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 952 iDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
+|||.|...+... ...++||..|.|||++.|.++ .+...|||+||++||.+.+...||
T Consensus 712 idfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y-----------------~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKY-----------------LGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred eeccchhhhcCCC-cceeeeeccccchhhhCCCcc-----------------CCCcchhhhhhheeeEEEeccCCC
Confidence 9999998766553 346789999999999998863 455679999999999999888886
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=269.38 Aligned_cols=195 Identities=24% Similarity=0.478 Sum_probs=162.9
Q ss_pred ceEEEEecccCcEEEEEEEEc----Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 802 LEEVRELGSGTYGSVYHGKWR----GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k----G~--kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
.+..++||+|-||.||+|.+. |. .||||..+.++..++ .+.|+.|..+|+.++||||++++|+|.+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-------tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-------TEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-------HHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 444578999999999999873 33 388998876543221 3578999999999999999999999997
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
...++|||.++-|.|..+|+.+...++..+...++.||+.||.|||++.+|||||..+|||+. ....|||+|||
T Consensus 463 --~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs----Sp~CVKLaDFG 536 (974)
T KOG4257|consen 463 --QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS----SPQCVKLADFG 536 (974)
T ss_pred --cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec----Ccceeeecccc
Confidence 468999999999999999999888899999999999999999999999999999999999998 66799999999
Q ss_pred CccccccccccC--CcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHH-ccCCCCC
Q 001678 956 LSKVKQQTLVSG--GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQ-FILCFID 1028 (1033)
Q Consensus 956 LAr~~~~~~~s~--~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLL-TGk~PFd 1028 (1033)
+++..+...... ...-.+.|||||.++.+. .++++|||-|||.|||++ .|..||.
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRr------------------FTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRR------------------FTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhc------------------ccchhhHHHHHHHHHHHHHhcCCccc
Confidence 999876554322 222366799999987663 567789999999999865 4666764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=240.28 Aligned_cols=179 Identities=20% Similarity=0.198 Sum_probs=147.2
Q ss_pred cCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEeecc
Q 001678 811 GTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888 (1033)
Q Consensus 811 GgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmEYme 888 (1033)
|.||.||++++ +++.||+|++.... .+.+|...+....||||+++++++.+ ....++||||+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCC
Confidence 89999999988 47789999987542 12234445556679999999999987 567999999999
Q ss_pred CCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccccccCC
Q 001678 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968 (1033)
Q Consensus 889 gGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~s~~ 968 (1033)
+++|.+++.+.. .+++..+..++.|++.||+|||+++|+||||||+||+++ .++.+||+|||++....... ..
T Consensus 69 ~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~df~~~~~~~~~~--~~ 141 (237)
T cd05576 69 GGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWSEVEDSC--DG 141 (237)
T ss_pred CCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEEEecccchhcccccc--cc
Confidence 999999997654 489999999999999999999999999999999999998 66789999999876554322 23
Q ss_pred cCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 969 ~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
..++..|+|||.+.+.. ++.++|+||+||++|+|++|+.+|+.
T Consensus 142 ~~~~~~y~aPE~~~~~~------------------~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 142 EAVENMYCAPEVGGISE------------------ETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CCcCccccCCcccCCCC------------------CCchhhHHHHHHHHHHHHHCcchhhc
Confidence 34577899999876542 45677999999999999999988754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=244.43 Aligned_cols=205 Identities=29% Similarity=0.442 Sum_probs=166.4
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-cCCCCcceEEEEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVR 873 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILsk-L~HPNIVrLyG~f~ 873 (1033)
+..+++.-+..||+|++|.|-+-++ .|+-.|+|.+..... .+..++.+.|+.+..+ ..+|.+|.+||...
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 3445566678899999999866655 688889999886532 2233566777776544 46999999999888
Q ss_pred cCCCCceEEEEeeccCCcHHHHHH---hcCCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEecCCCCCCeE
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~---~~~k~Lse~~rl~Ia~QIa~GLeYLHsk-GIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
. ++.+++.||.| ..+|..+.+ +++..+++..+-+|+..++.||.|||++ .|||||+||+||||+ ..|+|
T Consensus 116 r--egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn----~~GqV 188 (282)
T KOG0984|consen 116 R--EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN----YDGQV 188 (282)
T ss_pred c--cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc----cCCcE
Confidence 7 78899999999 668877765 3677799999999999999999999976 999999999999999 78899
Q ss_pred EEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 950 KLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
||||||++-.+.+........|-..|||||.+..+.. .+ .|+-++||||||++++||.+++.|++.
T Consensus 189 KiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n---~~-----------gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 189 KICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELN---QK-----------GYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred EEcccccceeehhhhHHHHhcCCCccCChhhcCcccC---cc-----------cceeehhhhhhhhhhhhhhhccccccc
Confidence 9999999988776655555668889999999865421 11 367788999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=264.75 Aligned_cols=200 Identities=30% Similarity=0.419 Sum_probs=161.2
Q ss_pred CCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEcCC-
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS--LHHPNVVSFYGIVRDGP- 876 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILsk--L~HPNIVrLyG~f~d~~- 876 (1033)
..+++++.||+|.||.||||+.+++.||||++... ..+.|+.|.+|++. |+|+||++++++-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 34566788999999999999999999999998742 12467777777654 57999999998865432
Q ss_pred -CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCcEEEecCCCCC
Q 001678 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK---------NIVHFDLKCENLLVNMRDPQR 946 (1033)
Q Consensus 877 -eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHsk---------GIVHRDIKPsNILLd~~d~~~ 946 (1033)
...++||+||.+.|+|.++|+.+ .++|....+|+..+++||+|||+. .|+|||||.+||||. ++
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK----~D 352 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK----ND 352 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc----cC
Confidence 34689999999999999999876 489999999999999999999962 799999999999998 78
Q ss_pred CeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc
Q 001678 947 PVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI 1023 (1033)
Q Consensus 947 g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG 1023 (1033)
++..|+|||||..+.... .....+||.+|||||++.+.-...+. .--.++||||+|.|||||++.
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~------------~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDR------------DAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccH------------HHHHHHHHHHHHHHHHHHHhh
Confidence 899999999998765432 22346799999999999775422211 112367999999999999987
Q ss_pred CCCCC
Q 001678 1024 LCFID 1028 (1033)
Q Consensus 1024 k~PFd 1028 (1033)
...++
T Consensus 421 C~~~~ 425 (534)
T KOG3653|consen 421 CTDAD 425 (534)
T ss_pred ccccc
Confidence 65553
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=285.74 Aligned_cols=198 Identities=31% Similarity=0.491 Sum_probs=158.7
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC-
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~- 875 (1033)
..+|++++.||+||||.|||++. +|+.+|||++.... .......+.+|+.++.+|+|||||++|..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 35688889999999999999976 69999999987542 233345788999999999999999998643100
Q ss_pred --------------------------------------------------------------------------------
Q 001678 876 -------------------------------------------------------------------------------- 875 (1033)
Q Consensus 876 -------------------------------------------------------------------------------- 875 (1033)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred ----------------------------CC--------CceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHH
Q 001678 876 ----------------------------PD--------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919 (1033)
Q Consensus 876 ----------------------------~e--------g~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GL 919 (1033)
.+ -.+||-||||+...|.+++.++...-.....++++++|+.||
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence 00 237889999999888888876644325778899999999999
Q ss_pred HHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc-------------------cccccCCcCCCCccccccc
Q 001678 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-------------------QTLVSGGVRGTLPWMAPEL 980 (1033)
Q Consensus 920 eYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~-------------------~~~~s~~~~GT~~YmAPEv 980 (1033)
.|+|+.|||||||||.||+|+ ....|||+|||+|.... .....++.+||.-|+|||+
T Consensus 711 aYIH~~giIHRDLKP~NIFLd----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLD----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHhCceeeccCCcceeEEc----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999999999999999999 77899999999998621 0002245679999999999
Q ss_pred ccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc
Q 001678 981 LSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF 1022 (1033)
Q Consensus 981 i~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT 1022 (1033)
+.+... ..|+.|+|||||||||+||+.
T Consensus 787 l~~~~~---------------~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 787 LSDTSS---------------NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred hccccc---------------ccccchhhhHHHHHHHHHHhc
Confidence 876531 147888999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=259.87 Aligned_cols=194 Identities=29% Similarity=0.494 Sum_probs=156.1
Q ss_pred CCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEcC--
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS--LHHPNVVSFYGIVRDG-- 875 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILsk--L~HPNIVrLyG~f~d~-- 875 (1033)
.+..+++.||+|.||.||+|+|+|..||||++.... .....+|.+|++. |+|+||+.+++.-..+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 457888999999999999999999999999987431 1356677777654 5899999999874432
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEEecCCCCCC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRP 947 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHsk--------GIVHRDIKPsNILLd~~d~~~g 947 (1033)
.-.+++||++|.+.|||.|+|.+. .++.+..+++++.++.||.+||.. .|.|||||..|||+. .++
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK----kn~ 353 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNG 353 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc----cCC
Confidence 233699999999999999999874 589999999999999999999953 699999999999998 789
Q ss_pred eEEEEecCCcccccccc-----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc
Q 001678 948 VCKIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF 1022 (1033)
Q Consensus 948 ~VKLiDFGLAr~~~~~~-----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT 1022 (1033)
.+.|+|+|||-...... .....+||.+|||||++...-. +-.++--..+||||||.|+||+..
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin------------~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETIN------------MKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcC------------hhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99999999997654332 2345679999999999864321 112223345699999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=271.12 Aligned_cols=205 Identities=28% Similarity=0.414 Sum_probs=171.6
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEc
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d 874 (1033)
..+-|++++.||.|.+|.||+++. .++..|+|++......+ +.+..|.+|++.+ +|||++.+||+|.-
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---------eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---------EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---------HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 345689999999999999999865 58889999887653221 2445678888877 59999999999864
Q ss_pred ---CCCCceEEEEeeccCCcHHHHHHh-cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 875 ---GPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 875 ---~~eg~l~LVmEYmegGSL~dlL~~-~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
...+.++||||||.+|+..|+++. .+..+.|..+.+|++.++.||.+||...+||||||-.|||++ .++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT----~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT----ENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----ccCcEE
Confidence 335689999999999999999975 356689999999999999999999999999999999999999 788999
Q ss_pred EEecCCcccccccc-ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 951 IGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 951 LiDFGLAr~~~~~~-~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|+|||.+.....+. ...+..||+.|||||++........ .|+..+|+||||++..||--|.+|+-
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~-------------tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDA-------------TYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCC-------------CcccccchhhccceeehhcCCCCCcc
Confidence 99999998876654 3456789999999999976542221 47778899999999999999999973
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=225.10 Aligned_cols=198 Identities=31% Similarity=0.484 Sum_probs=166.1
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
|.+.+.||.|++|.||++... ++.+|||.+...... ...+.+.+|+..++.++|+||+++++++.. ...
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFED--PEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCc
Confidence 567789999999999999885 588999998754321 234678899999999999999999999887 567
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.++++||+.+++|.+++......+++..+..++.+++.+|.+||+.+++|+||++.||+++ ..+.++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~----~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG----MDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeeCceeeE
Confidence 8999999999999999987544378999999999999999999999999999999999998 568999999999987
Q ss_pred ccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 960 KQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 960 ~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
..... ......++..|++||.+. ... .++.++|+|+||+++|+|++|+.||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~----------------~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL-GGK----------------GYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc-CCC----------------CCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 65442 233456788999999874 111 345578999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=283.99 Aligned_cols=184 Identities=22% Similarity=0.324 Sum_probs=149.7
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
+...+.||+|+||.||+|++ .+..||||+++.... ....|+.++++++||||++++++|.+ ...
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~ 757 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRS--EKG 757 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEc--CCC
Confidence 44557899999999999986 477899998764311 11235778999999999999999988 567
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH---GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLH---skGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
.++||||+++|+|.++++. +++..+..|+.||++||+||| +.+|+||||||+||+++ .+...+++ ||.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~----~~~~~~~~-~~~ 828 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----GKDEPHLR-LSL 828 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC----CCCceEEE-ecc
Confidence 8999999999999999963 789999999999999999999 66999999999999998 44555654 665
Q ss_pred ccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 957 Ar~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
....... ....||+.|+|||++.+. .++.++|||||||++|||+||+.||+.
T Consensus 829 ~~~~~~~---~~~~~t~~y~aPE~~~~~------------------~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 829 PGLLCTD---TKCFISSAYVAPETRETK------------------DITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccccC---CCccccccccCcccccCC------------------CCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 5433211 223578999999998654 367788999999999999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=265.37 Aligned_cols=227 Identities=20% Similarity=0.199 Sum_probs=158.7
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE------------------cCcceEEEEeeccccCCCchhH------HHHHHHHH
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW------------------RGSDVAIKRIKASCFAGKPSER------ERLIADFW 851 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~------------------kG~kVAIKvlk~~~~~~k~~er------e~~i~~f~ 851 (1033)
.+..++|++.++||+|+||.||+|.+ .++.||||+++........... ....+.+.
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 35678999999999999999999864 2456999998643211000000 00112344
Q ss_pred HHHHHHHhcCCCCc-----ceEEEEEEcC------CCCceEEEEeeccCCcHHHHHHhcC--------------------
Q 001678 852 KEALLLSSLHHPNV-----VSFYGIVRDG------PDGSLATVTEFMVNGSLKQFLQKKD-------------------- 900 (1033)
Q Consensus 852 rEi~ILskL~HPNI-----VrLyG~f~d~------~eg~l~LVmEYmegGSL~dlL~~~~-------------------- 900 (1033)
.|+.++.+++|.++ ++++++|... ..+..+|||||+.+++|.++|....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777888876654 6777776531 1356899999999999999986421
Q ss_pred ---CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccccccCC--cCCCCcc
Q 001678 901 ---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--VRGTLPW 975 (1033)
Q Consensus 901 ---k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~s~~--~~GT~~Y 975 (1033)
..+++..++.|+.|++.+|.|||+.+|+||||||+|||++ .++.+||+|||++........... ..+|+.|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~----~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y 376 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT----VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC----CCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence 1235667888999999999999999999999999999998 567899999999975433222122 2347899
Q ss_pred cccccccCCCccccchhhhcccchh------hccCCcccchHHHHHHHHHHHccCC-CCC
Q 001678 976 MAPELLSGKSHMVTEKVTLFSLKFC------CFQLKWSYDCYSLGILFFFLQFILC-FID 1028 (1033)
Q Consensus 976 mAPEvi~gk~~~~sekvDVwSLGvi------lye~t~kvDVWSLGVVLYeLLTGk~-PFd 1028 (1033)
+|||++.... ...+++.++++.+ .|....+.|+||+|||+|+|+++.. ||.
T Consensus 377 ~aPE~l~~~~--~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 377 SPPEELVMPQ--SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred eChhhhcCCC--CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9999986432 2223333333322 2333445799999999999999875 654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=292.00 Aligned_cols=201 Identities=26% Similarity=0.356 Sum_probs=162.4
Q ss_pred ceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~ 879 (1033)
+....+||.|.||.||.|.. +|.-.|+|.++..... .+......+|..++..|+|||||++||+-.. +..
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rek 1308 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REK 1308 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeec--HHH
Confidence 34456899999999999976 5777899988764322 3334567789999999999999999999877 567
Q ss_pred eEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 880 l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.+|.||||++|+|.+++... .-.++.....+..|++.||.|||+.|||||||||+||||+ .+|.+|+.|||.|..
T Consensus 1309 v~IFMEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld----~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD----FNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee----cCCcEEeecccceeE
Confidence 89999999999999998654 3467777777888999999999999999999999999999 778999999999987
Q ss_pred ccccc-----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 960 KQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 960 ~~~~~-----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
..... ......||+.|||||++.+..... -.-+.||||||||..||+||+.|..-+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG---------------~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKG---------------HGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCC---------------CCcchhhhcccceEEEeecCCCchhhc
Confidence 65432 123567999999999997643111 233569999999999999999887433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-27 Score=254.32 Aligned_cols=206 Identities=25% Similarity=0.394 Sum_probs=165.5
Q ss_pred cccccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHH-HHhcCCCCcceEEE
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL-LSSLHHPNVVSFYG 870 (1033)
Q Consensus 794 ~~~i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~I-LskL~HPNIVrLyG 870 (1033)
..++..++++.+..||.|+||+|+|-.++ |+..|||+++.... ++..++++.|... ++.-+.||||++||
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-------~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-------EKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-------hHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 34455667777889999999999998774 77789999986532 2233567777765 55557999999999
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHh----cCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCC
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQ 945 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~----~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d~~ 945 (1033)
++.. ++..+|.||.| ..+|..+.+. ....+++..+-.|+.-++.||+||-. ..||||||||+||||+ .
T Consensus 131 a~F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld----r 203 (361)
T KOG1006|consen 131 ALFS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD----R 203 (361)
T ss_pred hhhc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe----c
Confidence 9887 78899999999 6677766543 34458999999999999999999985 5999999999999999 7
Q ss_pred CCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCC
Q 001678 946 RPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 946 ~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~ 1025 (1033)
.|.|||||||++-.+..........|-..|||||.+..... -|+-++|+||||++|||+.||++
T Consensus 204 ~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~----------------gyDiRSDvWSLGITL~EvAtG~f 267 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDK----------------GYDIRSDVWSLGITLYEVATGNF 267 (361)
T ss_pred CCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccC----------------CcchhhhhhhhcceEeeeecCCC
Confidence 88999999999988776666666678889999999865432 24556799999999999999999
Q ss_pred CCCC
Q 001678 1026 FIDF 1029 (1033)
Q Consensus 1026 PFd~ 1029 (1033)
|++-
T Consensus 268 Pyr~ 271 (361)
T KOG1006|consen 268 PYRK 271 (361)
T ss_pred Ccch
Confidence 9864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=268.99 Aligned_cols=193 Identities=29% Similarity=0.480 Sum_probs=159.0
Q ss_pred CCCceEEEEecccCcEEEEEEEEc---Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR---GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k---G~--kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~ 873 (1033)
.+++.+.++||+|.||.|++|.|+ |+ .||||.++...... .+.+|++|+.+|.+|+|+|+++|||+..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 344556688999999999999995 32 48999998664321 4679999999999999999999999998
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHh-cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~-~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
+ ..+.||||+++.|+|.+.|++ ....+--...-.++.||+.||.||..+++|||||..+||||. ...+||||
T Consensus 182 ~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----sprtVKI~ 254 (1039)
T KOG0199|consen 182 D---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----SPRTVKIC 254 (1039)
T ss_pred c---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----ccceeeee
Confidence 7 457899999999999999988 444466667778999999999999999999999999999998 56799999
Q ss_pred ecCCcccccccccc----CCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc
Q 001678 953 DLGLSKVKQQTLVS----GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI 1023 (1033)
Q Consensus 953 DFGLAr~~~~~~~s----~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG 1023 (1033)
||||++-+...... ....-...|+|||.++... .+.++|+|+|||++|||+|+
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k------------------FShaSDvWmyGVTiWEMFty 311 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK------------------FSHASDVWMYGVTIWEMFTY 311 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhcccc------------------ccccchhhhhhhhHHhhhcc
Confidence 99999976554322 1222356799999997753 45677999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=265.51 Aligned_cols=217 Identities=21% Similarity=0.248 Sum_probs=145.3
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG 870 (1033)
...++|++.++||+|+||.||+|++. +..||||++.... ..+. ...| .+....+.++..++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~----~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEI----WMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHH----HHHH--HHHhhchhhHHHHHH
Confidence 45678999999999999999999884 5679999875321 1111 1111 111122222222221
Q ss_pred EE----EcCCCCceEEEEeeccCCcHHHHHHhcCCc-------------------cCHHHHHHHHHHHHHHHHHHHhCCc
Q 001678 871 IV----RDGPDGSLATVTEFMVNGSLKQFLQKKDRT-------------------IDRRKRLIIAMDAAFGMEYLHGKNI 927 (1033)
Q Consensus 871 ~f----~d~~eg~l~LVmEYmegGSL~dlL~~~~k~-------------------Lse~~rl~Ia~QIa~GLeYLHskGI 927 (1033)
.+ .......+++||||+.+++|.+++...... .....+..|+.||+.||.|||+++|
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 11 112256789999999999999998754311 1233456799999999999999999
Q ss_pred cccCCCCCcEEEecCCCCCCeEEEEecCCccccccc--cccCCcCCCCcccccccccCCCccccchh----hhcccchhh
Q 001678 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKV----TLFSLKFCC 1001 (1033)
Q Consensus 928 VHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~--~~s~~~~GT~~YmAPEvi~gk~~~~sekv----DVwSLGvil 1001 (1033)
+||||||+|||++. ..+.+||+|||+|+..... .....+.+|+.|+|||.+.........++ -.++-.++.
T Consensus 277 iHRDLKP~NILl~~---~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 277 VHRDVKPQNIIFSE---GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred EeCcCCHHHEEEeC---CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 99999999999982 2468999999999865322 23345678999999997643322211111 011112223
Q ss_pred ccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 1002 FQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 1002 ye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
..+..++||||||||||+|+++..+++
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 356778899999999999999776654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=260.96 Aligned_cols=204 Identities=21% Similarity=0.295 Sum_probs=173.0
Q ss_pred cccccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC------CCCc
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH------HPNV 865 (1033)
Q Consensus 794 ~~~i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~------HPNI 865 (1033)
+..+...+|.+....|+|-|++|.+|++ .+..||||++... +.+-+.-++|+.||++|+ --++
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---------E~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---------EVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---------hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 3445678899999999999999999988 4788999999853 344456778999999996 3479
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCc--cCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~--Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d 943 (1033)
++++-.|.. .+++|||+|-+ ..+|.++|++.+.. +...++..++.|++.||..|-..||+|.||||+|||++
T Consensus 497 lrl~r~F~h--knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--- 570 (752)
T KOG0670|consen 497 LRLFRHFKH--KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--- 570 (752)
T ss_pred HHHHHHhhh--cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec---
Confidence 999999998 78999999988 88999999987653 67788999999999999999999999999999999997
Q ss_pred CCCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc
Q 001678 944 PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI 1023 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG 1023 (1033)
.....+||||||.|.......++.. ..+-.|.|||++.|.+ |+...|+||+||.||||.||
T Consensus 571 E~k~iLKLCDfGSA~~~~eneitPY-LVSRFYRaPEIiLG~~------------------yd~~iD~WSvgctLYElYtG 631 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEITPY-LVSRFYRAPEIILGLP------------------YDYPIDTWSVGCTLYELYTG 631 (752)
T ss_pred cCcceeeeccCccccccccccccHH-HHHHhccCcceeecCc------------------ccCCccceeeceeeEEeecc
Confidence 3567999999999988776665433 2356699999999875 55667999999999999999
Q ss_pred CCCCCCCC
Q 001678 1024 LCFIDFFS 1031 (1033)
Q Consensus 1024 k~PFd~~s 1031 (1033)
+..|+-.+
T Consensus 632 kIlFpG~T 639 (752)
T KOG0670|consen 632 KILFPGRT 639 (752)
T ss_pred ceecCCCC
Confidence 99997543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-27 Score=250.46 Aligned_cols=203 Identities=23% Similarity=0.354 Sum_probs=166.2
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc--
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD-- 874 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d-- 874 (1033)
.+.|+.+.+||+|.||.||+|+. .+++||+|++... .+++..-...++|+.+|..|+|+|++.++++|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme------neKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME------NEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 34577778999999999999976 4777888765421 1122223456789999999999999999887753
Q ss_pred ----CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 875 ----GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 875 ----~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
+....++|||.+| ..+|..+|.+....++..++.+++.+++.||.|+|+..|+|||+|++|+||+ .++++|
T Consensus 90 Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt----~dgilk 164 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT----KDGILK 164 (376)
T ss_pred CCcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc----CCceEE
Confidence 2345699999999 5599999998877899999999999999999999999999999999999999 779999
Q ss_pred EEecCCcccccccc-----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCC
Q 001678 951 IGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 951 LiDFGLAr~~~~~~-----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~ 1025 (1033)
|+|||+++...... .....+.|++|++||.+.|.. +|+++.|+|+-||||.+|.|+.+
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-----------------~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-----------------EYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhccc-----------------ccCCcchhHhHHHHHHHHHccCc
Confidence 99999997543221 122344599999999998875 78899999999999999999988
Q ss_pred CCCC
Q 001678 1026 FIDF 1029 (1033)
Q Consensus 1026 PFd~ 1029 (1033)
-|.-
T Consensus 228 imqg 231 (376)
T KOG0669|consen 228 IMQG 231 (376)
T ss_pred cccC
Confidence 7754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=220.34 Aligned_cols=186 Identities=32% Similarity=0.467 Sum_probs=158.4
Q ss_pred CcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEeeccC
Q 001678 812 TYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVN 889 (1033)
Q Consensus 812 gFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmEYmeg 889 (1033)
+||.||++++. ++.+|+|++........ .+.+.+|+.++++++|+||+++++.+.. ....++++||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-------RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-------HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCC
Confidence 58999999985 58899999875432110 3578899999999999999999999987 4678999999999
Q ss_pred CcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccccccCCc
Q 001678 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969 (1033)
Q Consensus 890 GSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~s~~~ 969 (1033)
++|.+++..... +++..+..++.+++.+|.|||+.+++|+||+|+||+++ .++.++|+|||++............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~----~~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD----EDGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC----CCCcEEEccccceeeeccccccccc
Confidence 999999976554 88999999999999999999999999999999999998 5689999999999876654444456
Q ss_pred CCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 970 ~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.++..|++||.+.+. .++.++|+||||+++|+|++|..||+.
T Consensus 147 ~~~~~~~~pE~~~~~------------------~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 147 VGTPEYMAPEVLLGK------------------GYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred cCCcCCCCHHHHccC------------------CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 688999999988643 245578999999999999999999865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=259.63 Aligned_cols=193 Identities=23% Similarity=0.292 Sum_probs=159.7
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~ 875 (1033)
...|++...+|.|+|+.|-++.. +++..++|++..... +..+|+.++... +||||+++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------------~~~~e~~~~~~~~~h~niv~~~~v~~~- 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------------DNQDEIPISLLVRDHPNIVKSHDVYED- 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------------ccccccchhhhhcCCCcceeecceecC-
Confidence 56788889999999999999977 577789999876511 223456454444 69999999999998
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
....++|||.+.++-|.+.+..... +. ..+..|+.+|+.|+.|||.+|||||||||+|||++ ...++++|||||
T Consensus 388 -~~~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~lrltyFG 461 (612)
T KOG0603|consen 388 -GKEIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHLRLTYFG 461 (612)
T ss_pred -CceeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---CCCCcEEEEEec
Confidence 6789999999999999888876543 23 67778999999999999999999999999999995 267899999999
Q ss_pred CccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
.++..+.... ..+-|..|.|||++... +|+.++||||||++||+||+|+.||..-
T Consensus 462 ~a~~~~~~~~--tp~~t~~y~APEvl~~~------------------~yt~acD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 462 FWSELERSCD--TPALTLQYVAPEVLAIQ------------------EYTEACDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred hhhhCchhhc--ccchhhcccChhhhccC------------------CCCcchhhHHHHHHHHHHHhCCCccccC
Confidence 9998766622 23458899999998743 6888999999999999999999999754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-26 Score=238.83 Aligned_cols=197 Identities=23% Similarity=0.336 Sum_probs=168.8
Q ss_pred cCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEc
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d 874 (1033)
..++|++.+++|+|.|+.||.|.. +.++++||++++.. .+.+.+|+.||..|. ||||+.++++..+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 457899999999999999999974 67889999998652 246779999999998 9999999999999
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
+......||+||+.+.+...+.. .++.-.+..++.++++||.|+|+.||+|||+||.|++|| .....++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId---h~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID---HELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec---hhhceeeeeec
Confidence 87778889999999988877764 367778888999999999999999999999999999998 35678999999
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|+|..+.........+.+..|.-||.+..-. .|+.+-|+|||||+|..|++.+-||=.
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy~-----------------~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDYQ-----------------MYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheeech-----------------hccccHHHHHHHHHHHHHHhccCcccC
Confidence 9999887666555556677889999886543 466777999999999999999999843
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-26 Score=246.86 Aligned_cols=200 Identities=28% Similarity=0.372 Sum_probs=161.1
Q ss_pred eEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC--
Q 001678 803 EEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG-- 878 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg-- 878 (1033)
+-.+.||.|+||.||-+.+ +++.||+|++... ..+....+++.+|+++|..++|.|++..+++.+-..-+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchH------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 3347799999999998877 5888999987643 12334457899999999999999999998876642111
Q ss_pred -ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 879 -SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 879 -~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.+|.|+|.| ..+|..+|-.. ..++...++-+..||++||+|||+.+|+||||||.|+|++ .+..+||||||++
T Consensus 130 qEiYV~TELm-QSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN----SNCvLKICDFGLA 203 (449)
T KOG0664|consen 130 QELYVLTELM-QSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN----SNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHHH-HhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec----cCceEEecccccc
Confidence 267888888 66888777544 3488888899999999999999999999999999999998 8899999999999
Q ss_pred ccccccc--ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 958 r~~~~~~--~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
+.-+... .....+-|..|+|||++.|.. .|+.++||||+|||+.|||..+..|..-+
T Consensus 204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaR-----------------hYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 204 RTWDQRDRLNMTHEVVTQYYRAPELLMGAR-----------------RYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred cccchhhhhhhHHHHHHHHhccHHHhhcch-----------------hhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 9754332 222334588999999998865 57788999999999999999999886543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=259.70 Aligned_cols=203 Identities=30% Similarity=0.434 Sum_probs=163.4
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCC
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPN 864 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k---------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPN 864 (1033)
+.+..+++.+.+.||+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+. |+|
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-------~~~~~~~~El~~m~~~g~H~n 363 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-------SEKKDLMSELNVLKELGKHPN 363 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-------HHHHHHHHHHHHHHHhcCCcc
Confidence 3444555566679999999999999753 345899988765322 23457889999999995 999
Q ss_pred cceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcC---------------CccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001678 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1033)
Q Consensus 865 IVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~---------------k~Lse~~rl~Ia~QIa~GLeYLHskGIVH 929 (1033)
|+.++|+|.. .+.+++|+||+..|+|.++|+.+. ..++....+.++.||+.|++||+++.+||
T Consensus 364 iv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vH 441 (609)
T KOG0200|consen 364 IVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVH 441 (609)
T ss_pred hhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 9999999998 788999999999999999998776 34888999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCCCeEEEEecCCcccccccccc--CCcC--CCCcccccccccCCCccccchhhhcccchhhccCC
Q 001678 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS--GGVR--GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK 1005 (1033)
Q Consensus 930 RDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~s--~~~~--GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t 1005 (1033)
|||..+|||+. .+..+||+|||+|+........ ..-. -...|||||.+... .++
T Consensus 442 RDLAaRNVLi~----~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~------------------~ft 499 (609)
T KOG0200|consen 442 RDLAARNVLIT----KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR------------------VFT 499 (609)
T ss_pred hhhhhhhEEec----CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC------------------ccc
Confidence 99999999998 7789999999999854332211 1111 24459999998764 367
Q ss_pred cccchHHHHHHHHHHHcc-CCCCC
Q 001678 1006 WSYDCYSLGILFFFLQFI-LCFID 1028 (1033)
Q Consensus 1006 ~kvDVWSLGVVLYeLLTG-k~PFd 1028 (1033)
.++|||||||+|||++|. ..|+.
T Consensus 500 ~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 500 SKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred ccchhhHHHHHHHHHhhCCCCCCC
Confidence 788999999999999874 44554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=246.34 Aligned_cols=202 Identities=23% Similarity=0.267 Sum_probs=165.1
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC--CC----CcceE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HP----NVVSF 868 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~--HP----NIVrL 868 (1033)
....+|+++.+||+|+||.|-.+.+. +..||||+++... +..+..+-|+.++.++. -| -++++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---------kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---------KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---------HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 34678999999999999999999774 5679999988542 22334567899999994 22 37888
Q ss_pred EEEEEcCCCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC----
Q 001678 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD---- 943 (1033)
Q Consensus 869 yG~f~d~~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d---- 943 (1033)
.+||.. ++++|||+|.+ |.|+.++|.++ ...++...+..|++|++++++|||+.+++|-||||+|||+....
T Consensus 157 ~~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 157 RDWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ehhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 888887 78999999998 88999999874 45688999999999999999999999999999999999985321
Q ss_pred ------------CCCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchH
Q 001678 944 ------------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCY 1011 (1033)
Q Consensus 944 ------------~~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVW 1011 (1033)
.....|||+|||.|....... ...+-|.-|+|||++.+-+ ++...|||
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG------------------wS~pCDvW 293 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG------------------WSQPCDVW 293 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC------------------cCCccCce
Confidence 125579999999998765443 3456688999999998754 55677999
Q ss_pred HHHHHHHHHHccCCCCCCC
Q 001678 1012 SLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 1012 SLGVVLYeLLTGk~PFd~~ 1030 (1033)
|+||||+||+||...|..-
T Consensus 294 SiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 294 SIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeeeEEEEeeccceecccC
Confidence 9999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-23 Score=199.94 Aligned_cols=183 Identities=37% Similarity=0.620 Sum_probs=148.8
Q ss_pred ecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 808 LGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
||+|.+|.||++... ++.+++|++....... ....+.+|+..++.++|++|+++++++.. ....+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEe
Confidence 689999999999996 7889999987543211 23578899999999999999999999988 478999999
Q ss_pred eccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCC-CCeEEEEecCCcccccccc
Q 001678 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ-RPVCKIGDLGLSKVKQQTL 964 (1033)
Q Consensus 886 YmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~-~g~VKLiDFGLAr~~~~~~ 964 (1033)
|+.+++|.+++......+++..++.++.+++++|.+||+.+++|+||+|.||+++ . .+.++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~----~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD----SDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe----CCCCcEEEecCCceEEccCCc
Confidence 9999999999987644589999999999999999999999999999999999998 4 6789999999998664432
Q ss_pred -ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHH
Q 001678 965 -VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020 (1033)
Q Consensus 965 -~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeL 1020 (1033)
......+...|++||.+... .. .+.+.|+|+||+++|+|
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~-~~----------------~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK-GY----------------YSEKSDIWSLGVILYEL 187 (215)
T ss_pred chhhcccCCCCccChhHhccc-CC----------------CCchhhhHHHHHHHHHH
Confidence 12234578889999988653 12 33445666666666655
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=232.68 Aligned_cols=134 Identities=24% Similarity=0.323 Sum_probs=111.7
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-----C---CCcc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----H---PNVV 866 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-----H---PNIV 866 (1033)
+...+|.+.++||.|-|++||+|.+. .+-||+|+.+... ...+..+.||.+|++++ | ..||
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---------hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---------HYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---------HHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 45589999999999999999999884 4559999988542 23346678999999884 3 3699
Q ss_pred eEEEEEEc-C-CCCceEEEEeeccCCcHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEe
Q 001678 867 SFYGIVRD-G-PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVN 940 (1033)
Q Consensus 867 rLyG~f~d-~-~eg~l~LVmEYmegGSL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHsk-GIVHRDIKPsNILLd 940 (1033)
+|++.|.. + ...++|||+|++ |-+|..+|.+. .+.++...++.|++||+.||.|||++ ||||-||||+||||.
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99999975 2 234799999999 88999999864 34589999999999999999999975 999999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-24 Score=231.30 Aligned_cols=198 Identities=24% Similarity=0.315 Sum_probs=163.7
Q ss_pred CCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC-
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~- 875 (1033)
..+|.-++.+|.|.- .|.-+.+ .++.||||++... +... ...++..+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~-----~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQ-----THAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccC-----ccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 457888889999988 6655655 5888999987644 2222 2234667899999999999999999998642
Q ss_pred ---CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 876 ---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 876 ---~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
....+|+||||| ..+|...+.. .++-+++.+|..|++.|++|||+.||+||||||+||++. .+..+||+
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~----~~~~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN----SDCTLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec----chhheeec
Confidence 123578999999 7799998873 378889999999999999999999999999999999998 78899999
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
|||+|+........+..+.|..|+|||++.+-. +.+.+||||+|||+.||++|+..|+.
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~------------------~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG------------------YKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC------------------CcccchhhhhhhHHHHHhhceEEecC
Confidence 999998766555566677899999999997753 56678999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-24 Score=253.03 Aligned_cols=191 Identities=29% Similarity=0.424 Sum_probs=152.2
Q ss_pred EEecccCcE-EEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYG-SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG-~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
+.+|.|+.| .||+|.+.++.||||.+.... .....+|+.+|...+ |||||++|+.-++ +..+||.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----------~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF~YIa 581 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----------FDFAQREIQLLQESDEHPNVIRYYCSEQD--RQFLYIA 581 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhHh-----------HHHHHHHHHHHHhccCCCceEEEEeeccC--CceEEEE
Confidence 458899987 579999999999999876432 235668999998886 9999999887555 7889999
Q ss_pred EeeccCCcHHHHHHhcCCcc---CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC-CCCCeEEEEecCCccc
Q 001678 884 TEFMVNGSLKQFLQKKDRTI---DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~L---se~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d-~~~g~VKLiDFGLAr~ 959 (1033)
.|.| ..+|.+++....... .....+.+..|++.||.+||+.+||||||||.||||+..+ .....++|+|||+|+.
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 679999998731111 1134567888999999999999999999999999998632 2347899999999997
Q ss_pred ccccc----ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc-CCCCC
Q 001678 960 KQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI-LCFID 1028 (1033)
Q Consensus 960 ~~~~~----~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG-k~PFd 1028 (1033)
..... ...+..||.+|+|||++..... +.++||||||||+|+.++| +.||.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~------------------~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRK------------------TQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhcccc------------------CcccchhhcCceEEEEecCCccCCC
Confidence 64332 2346679999999999976531 3367999999999999888 88884
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-21 Score=196.76 Aligned_cols=203 Identities=34% Similarity=0.493 Sum_probs=166.6
Q ss_pred ceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEcCCCCce
Q 001678 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP-NVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HP-NIVrLyG~f~d~~eg~l 880 (1033)
|++.+.||.|+|+.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +|+++++.+.. ....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEE
Confidence 778899999999999999988 7789998876533221 2356788999999999988 79999999965 4558
Q ss_pred EEEEeeccCCcHHHHHHhcC--CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCC-eEEEEecCCc
Q 001678 881 ATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLS 957 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~~--k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g-~VKLiDFGLA 957 (1033)
+++++|+.+++|.+++.... ..+.......++.|++.+|.|+|+.+++||||||+|||++ ... .+|++|||++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~----~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD----RDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----CCCCeEEEeccCcc
Confidence 99999999999997776654 2588999999999999999999999999999999999998 445 7999999999
Q ss_pred ccccccc-------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCC
Q 001678 958 KVKQQTL-------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 r~~~~~~-------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~ 1030 (1033)
+...... ......||..|+|||.+.+.. ...+....|+||+|+++++++++..||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~---------------~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS---------------LAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCC---------------CCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 8554332 235667999999999987631 013556779999999999999999998765
Q ss_pred C
Q 001678 1031 S 1031 (1033)
Q Consensus 1031 s 1031 (1033)
.
T Consensus 215 ~ 215 (384)
T COG0515 215 K 215 (384)
T ss_pred C
Confidence 4
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=225.06 Aligned_cols=204 Identities=25% Similarity=0.336 Sum_probs=159.6
Q ss_pred CCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEcCC
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 800 ~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-~HPNIVrLyG~f~d~~ 876 (1033)
+.|.+.+.||+|.||.+-+++++ .+.+|+|.+.... ..+++|.+|..---.| .|.||+.-|+.-...
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt- 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT- 93 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---------hhHHHHHHHhccceeeccchhhhHHHHHHhhc-
Confidence 55888899999999999999996 4568999776432 2356889998765555 489999887654332
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCC
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGL 956 (1033)
.+.+++++||++-|+|.+-+...+ +-+...++++.|++.||+|||++++||||||.+||||-.. +...|||||||+
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~--df~rvKlcDFG~ 169 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA--DFYRVKLCDFGL 169 (378)
T ss_pred CceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC--CccEEEeeeccc
Confidence 467889999999999999887654 7888899999999999999999999999999999999733 456999999999
Q ss_pred ccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCCC
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFSI 1032 (1033)
Q Consensus 957 Ar~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~si 1032 (1033)
.+.....- ....-+..|.+||+..... .++ +......|+|.||+|+|.+|||++|..-.++
T Consensus 170 t~k~g~tV--~~~~~~~~y~~pe~~~~~~---ne~----------~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 170 TRKVGTTV--KYLEYVNNYHAPELCDTVV---NEK----------LVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred ccccCcee--hhhhhhcccCCcHHHhhcc---ccc----------eEecccccchheeeeeeeeecCCCcchhhhc
Confidence 87543221 1222466799999764332 111 3567788999999999999999999875544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=244.13 Aligned_cols=197 Identities=27% Similarity=0.407 Sum_probs=159.4
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
-..++|+.++.+|.|+||.|||+++ +++..|+|+++...-. ......+|+-+++.++|+||+.+++.+..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--------d~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--------DFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--------cccccccceeeeecCCCcChHHHHhhhhh
Confidence 3567899999999999999999988 4778899998854211 12356689999999999999999999887
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
...+++.||||.+|+|.+..+-.+ .+++..+.++++..++||+|||+.|-+|||||-.|||++ ..+.+||+||
T Consensus 84 --~dklwicMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt----d~gDvklaDf 156 (829)
T KOG0576|consen 84 --RDKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT----DEGDVKLADF 156 (829)
T ss_pred --hcCcEEEEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceeec----ccCceeeccc
Confidence 677999999999999999765544 489999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccccc-ccCCcCCCCccccccccc-CCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccC
Q 001678 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLS-GKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024 (1033)
Q Consensus 955 GLAr~~~~~~-~s~~~~GT~~YmAPEvi~-gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk 1024 (1033)
|.+..+.... ....+.||+.|||||+.. ++...+. ...|+|++|+...+|--..
T Consensus 157 gvsaqitati~KrksfiGtpywmapEvaaverkggyn----------------qlcdiwa~gitAiel~eLq 212 (829)
T KOG0576|consen 157 GVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN----------------QLCDIWALGITAIELGELQ 212 (829)
T ss_pred CchhhhhhhhhhhhcccCCccccchhHHHHHhccccc----------------ccccccccccchhhhhhcC
Confidence 9988765443 445788999999999862 3333344 4456666666655554333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=217.22 Aligned_cols=169 Identities=18% Similarity=0.131 Sum_probs=126.5
Q ss_pred cccCCCceEEEEecccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcce-EEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS-FYGI 871 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~k---G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVr-LyG~ 871 (1033)
.....+|++.+.||+|+||+||+|.++ ++.||||++........ .....+.|.+|+.+|++++|+||+. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS---KPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc---cHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 344578999999999999999999773 55679998653211000 1123356889999999999999985 4432
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEEecCCCCCCeEE
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL-KCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDI-KPsNILLd~~d~~~g~VK 950 (1033)
+..++||||+++++|.. +... . ...++.+++++|.|||+.||+|||| ||+|||++ .++.+|
T Consensus 91 ------~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~----~~~~ik 152 (365)
T PRK09188 91 ------GKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG----PDGEAA 152 (365)
T ss_pred ------CCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc----CCCCEE
Confidence 34799999999999963 2111 1 1457889999999999999999999 99999997 567899
Q ss_pred EEecCCccccccccc---------cCCcCCCCcccccccccCCC
Q 001678 951 IGDLGLSKVKQQTLV---------SGGVRGTLPWMAPELLSGKS 985 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~---------s~~~~GT~~YmAPEvi~gk~ 985 (1033)
|+|||+|+....... .....++..|+|||.+..+.
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999999986543221 12456888999999986543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-22 Score=220.32 Aligned_cols=193 Identities=21% Similarity=0.291 Sum_probs=157.5
Q ss_pred CCCceEEEEecccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEE
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~-----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f 872 (1033)
.+.|..+++||+|+|+.||++.+ +...||+|.+...... .++..|+++|..+. +.||+.+.+.+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----------~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----------SRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----------hHHHHHHHHHHHhccchhhhcchhhh
Confidence 35688899999999999999966 3456999988754322 35778999999996 89999999999
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
.. ++..++||||++.....+++.. ++...+..+++.++.||.++|..|||||||||+|+|.+. ..+.-.|+
T Consensus 105 rn--nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~---~t~rg~Lv 175 (418)
T KOG1167|consen 105 RN--NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR---RTQRGVLV 175 (418)
T ss_pred cc--CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc---ccCCceEE
Confidence 88 6789999999999999998864 567888899999999999999999999999999999983 44667899
Q ss_pred ecCCccccc-----------------c--cc--------------------------ccCCcCCCCcccccccccCCCcc
Q 001678 953 DLGLSKVKQ-----------------Q--TL--------------------------VSGGVRGTLPWMAPELLSGKSHM 987 (1033)
Q Consensus 953 DFGLAr~~~-----------------~--~~--------------------------~s~~~~GT~~YmAPEvi~gk~~~ 987 (1033)
|||+|.... . .. ......||++|+|||++..-+
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-- 253 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-- 253 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc--
Confidence 999986110 0 00 001234999999999986533
Q ss_pred ccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 988 VTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 988 ~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
.-++++||||.|||+..+++++.||
T Consensus 254 ---------------~QttaiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 254 ---------------RQTTAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred ---------------CcCCccceeeccceeehhhcccccc
Confidence 3567889999999999999999998
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=204.66 Aligned_cols=202 Identities=21% Similarity=0.202 Sum_probs=157.9
Q ss_pred CceEEEEecccCcEEEEEEEEcCc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC----CCCcceEEEEEE
Q 001678 801 DLEEVRELGSGTYGSVYHGKWRGS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH----HPNVVSFYGIVR 873 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~kG~---kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~----HPNIVrLyG~f~ 873 (1033)
+|.+.++||+|+||.||++..... .+|+|+......... ..+..|..++..+. -.++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999988543 588887664322111 13446777777776 358889988874
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC-CCCCeEEE
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKI 951 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d-~~~g~VKL 951 (1033)
......++||+.+ |.+|.++..... ..++..+++.|+.|++.+|++||+.|+|||||||+|+++.... .....++|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 1256789999988 999999987655 7799999999999999999999999999999999999998443 22367999
Q ss_pred EecCCcc--cccccc--------c-cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHH
Q 001678 952 GDLGLSK--VKQQTL--------V-SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020 (1033)
Q Consensus 952 iDFGLAr--~~~~~~--------~-s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeL 1020 (1033)
+|||+++ ...... . ...+.||..|.++.+..+. +.+.+.|+||++.++.+|
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~------------------e~~r~DDles~~Y~l~el 230 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI------------------EQGRRDDLESLFYMLLEL 230 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC------------------ccCCchhhhhHHHHHHHH
Confidence 9999998 321110 1 2345699999999988775 466677999999999999
Q ss_pred HccCCCCCCC
Q 001678 1021 QFILCFIDFF 1030 (1033)
Q Consensus 1021 LTGk~PFd~~ 1030 (1033)
+.|..|....
T Consensus 231 ~~g~LPW~~~ 240 (322)
T KOG1164|consen 231 LKGSLPWEAL 240 (322)
T ss_pred hcCCCCCccc
Confidence 9998776443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=208.36 Aligned_cols=205 Identities=24% Similarity=0.363 Sum_probs=162.5
Q ss_pred ccccccCCCceEEEEecccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCc
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865 (1033)
Q Consensus 793 ~~~~i~~~dYeilekLGeGgFG~VYkAk~kG-------~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNI 865 (1033)
...++...+++....+-+|.||.||+|.|.. +.|-+|.++.. ..+..+..++.|.-++..+.|||+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-------AS~iQv~~~L~es~lly~~sH~nl 349 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-------ASQIQVNLLLQESMLLYGASHPNL 349 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-------ccHHHHHHHHHHHHHHhcCcCCCc
Confidence 3345566778888899999999999997742 33566665532 234556789999999999999999
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHh-------cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLL 938 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~-------~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNIL 938 (1033)
..+.+++.+. ....+.++.++.-|+|..+|.. .-..++..+...++.|++.|++|||+.+|||.||..+|.+
T Consensus 350 l~V~~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 350 LSVLGVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCV 428 (563)
T ss_pred cceeEEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcce
Confidence 9999998874 4566788999999999999983 1234677788889999999999999999999999999999
Q ss_pred EecCCCCCCeEEEEecCCcccccccc---ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHH
Q 001678 939 VNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGI 1015 (1033)
Q Consensus 939 Ld~~d~~~g~VKLiDFGLAr~~~~~~---~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGV 1015 (1033)
|| +..+|||+|-.+++-.-... .....-....||++|.+.++ +++.++|+|||||
T Consensus 429 Id----d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~------------------~yssasDvWsfGV 486 (563)
T KOG1024|consen 429 ID----DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS------------------HYSSASDVWSFGV 486 (563)
T ss_pred eh----hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh------------------hhcchhhhHHHHH
Confidence 99 77999999999998543221 11122236779999999876 5777889999999
Q ss_pred HHHHHHc-cCCCC
Q 001678 1016 LFFFLQF-ILCFI 1027 (1033)
Q Consensus 1016 VLYeLLT-Gk~PF 1027 (1033)
+||||+| |+.|+
T Consensus 487 llWELmtlg~~Py 499 (563)
T KOG1024|consen 487 LLWELMTLGKLPY 499 (563)
T ss_pred HHHHHHhcCCCCc
Confidence 9999998 45554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-21 Score=237.59 Aligned_cols=151 Identities=23% Similarity=0.278 Sum_probs=115.5
Q ss_pred hcCC-CCcceEEEEEEcC-----CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001678 859 SLHH-PNVVSFYGIVRDG-----PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (1033)
Q Consensus 859 kL~H-PNIVrLyG~f~d~-----~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDI 932 (1033)
.+.| .||++++++|... ....++++|||+ +++|.++|......+++..++.|++||++||.|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5788888887321 124577889988 77999999876666999999999999999999999999999999
Q ss_pred CCCcEEEecCC---------------CCCCeEEEEecCCccccccc-----------------cccCCcCCCCccccccc
Q 001678 933 KCENLLVNMRD---------------PQRPVCKIGDLGLSKVKQQT-----------------LVSGGVRGTLPWMAPEL 980 (1033)
Q Consensus 933 KPsNILLd~~d---------------~~~g~VKLiDFGLAr~~~~~-----------------~~s~~~~GT~~YmAPEv 980 (1033)
||+||||+..+ ...+.+||+|||+++..... .......||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996211 13456788888887642110 00112458999999999
Q ss_pred ccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 981 LSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 981 i~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
+.+.. ++.++||||||||||||+++.+||.
T Consensus 187 ~~~~~------------------~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 187 DNGSS------------------SNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred hccCC------------------CCchhhhhhHHHHHHHHhhCCCchh
Confidence 87653 5678899999999999999988875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=201.68 Aligned_cols=203 Identities=19% Similarity=0.251 Sum_probs=167.9
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVR 873 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~ 873 (1033)
+..-.|.+.++||+|+||.++.|+. .++.||||.-..... .-.+..|.+.++.|. .++|...|.+-+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----------APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----------APQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----------cchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 4456799999999999999999976 799999996432211 124567888888885 789999988877
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC-CCCCeEEEE
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIG 952 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d-~~~g~VKLi 952 (1033)
+ ..+-.||||.+ |-+|+|++.-.++.++.+++..||.|++.-++|+|++.+|+|||||+|+||..-+ .....+.|+
T Consensus 95 e--G~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 E--GKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred c--cchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 6 34567999998 9999999999999999999999999999999999999999999999999997532 234578999
Q ss_pred ecCCccccccccc--------cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccC
Q 001678 953 DLGLSKVKQQTLV--------SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024 (1033)
Q Consensus 953 DFGLAr~~~~~~~--------s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk 1024 (1033)
|||||+.+.+... ..+..||.+||+-....++. -+..-|+-|||-|+++.|.|.
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE------------------QSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE------------------QSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccch------------------hhhhhhHHHhhhhhhhhccCC
Confidence 9999998765432 34677999999999888874 455669999999999999999
Q ss_pred CCCCCC
Q 001678 1025 CFIDFF 1030 (1033)
Q Consensus 1025 ~PFd~~ 1030 (1033)
.|..-+
T Consensus 234 LPWQGL 239 (449)
T KOG1165|consen 234 LPWQGL 239 (449)
T ss_pred Cccccc
Confidence 998654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=192.30 Aligned_cols=202 Identities=20% Similarity=0.266 Sum_probs=161.4
Q ss_pred ccCCCceEEEEecccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCC-CCcceEEEEEE
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYGIVR 873 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~H-PNIVrLyG~f~ 873 (1033)
+....|.++++||.|+||.+|.|.. .|..||||+-....-.. .+..|..+.+.|++ ..|..+..+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----------qL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----------QLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----------chhHHHHHHHHhccCCCCchhhhhcc
Confidence 4567899999999999999999976 68999999865443221 45578888888874 56777777776
Q ss_pred cCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEe
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiD 953 (1033)
+ ...-.||||.+ |-+|.+++.-..+.++..+++-++-|++.-|+|+|.+++|||||||+|+|+..+- ....+.|+|
T Consensus 82 e--~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LID 157 (341)
T KOG1163|consen 82 E--KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLID 157 (341)
T ss_pred c--cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEEe
Confidence 6 56778999998 9999999988888899999999999999999999999999999999999997543 345799999
Q ss_pred cCCcccccccc--------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCC
Q 001678 954 LGLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 954 FGLAr~~~~~~--------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~ 1025 (1033)
||+|+.+.+.. ......||.+|.+--...+. +-+..-|+-|+|.+|.++..|..
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~------------------eqSRRDDmeSvgYvLmYfnrG~L 219 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI------------------EQSRRDDMESVGYVLMYFNRGSL 219 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhh------------------hhhhhhhhhhhcceeeeeecCCC
Confidence 99998764332 12356689999886654433 44556688888888888888888
Q ss_pred CCCCC
Q 001678 1026 FIDFF 1030 (1033)
Q Consensus 1026 PFd~~ 1030 (1033)
|..-+
T Consensus 220 PWQgl 224 (341)
T KOG1163|consen 220 PWQGL 224 (341)
T ss_pred ccccc
Confidence 87543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=190.18 Aligned_cols=147 Identities=12% Similarity=0.114 Sum_probs=118.1
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHH------HHHHHHHHHhcCCCCcceE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLHHPNVVSF 868 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~------f~rEi~ILskL~HPNIVrL 868 (1033)
..+..++|+.++.||.|+||.||+...++.++|||++...... .+..... +.+|+..+.++.|++|..+
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 3455789999999999999999998878889999998765321 1222223 6799999999999999999
Q ss_pred EEEEEcCC------CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q 001678 869 YGIVRDGP------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (1033)
Q Consensus 869 yG~f~d~~------eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~ 942 (1033)
.+++.... .+..+|||||++|.+|.++.. +++ ....+++.+|..||+.|++||||||+|||++
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~-- 169 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS-- 169 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe--
Confidence 98876532 235789999999999988742 232 2355899999999999999999999999998
Q ss_pred CCCCCeEEEEecCCcccc
Q 001678 943 DPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 943 d~~~g~VKLiDFGLAr~~ 960 (1033)
.++ ++|+|||..+..
T Consensus 170 --~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 170 --KNG-LRIIDLSGKRCT 184 (232)
T ss_pred --CCC-EEEEECCCcccc
Confidence 455 999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-19 Score=182.18 Aligned_cols=147 Identities=24% Similarity=0.161 Sum_probs=109.7
Q ss_pred EEEecccCcEEEEEEEE-cCcceEEEEeeccccCCCch------------------hHHHHHHHHHHHHHHHHhcCCCCc
Q 001678 805 VRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPS------------------ERERLIADFWKEALLLSSLHHPNV 865 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~~------------------ere~~i~~f~rEi~ILskL~HPNI 865 (1033)
.+.||+|+||.||+|.. +|+.||||+++......... .+........+|+.++.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999987 58899999998653221110 000111234569999999988776
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCcEEEecCCC
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL-HGKNIVHFDLKCENLLVNMRDP 944 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYL-HskGIVHRDIKPsNILLd~~d~ 944 (1033)
.....+... ..+|||||+.+++|...+.+. ..++...+..++.|++.+|.+| |+.||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 82 PCPEPILLK----SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCcEEEec----CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 543333222 238999999888776554333 3588899999999999999999 799999999999999997
Q ss_pred CCCeEEEEecCCccccc
Q 001678 945 QRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 945 ~~g~VKLiDFGLAr~~~ 961 (1033)
. +.++|+|||+|....
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 2 579999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.8e-18 Score=174.42 Aligned_cols=147 Identities=22% Similarity=0.151 Sum_probs=111.1
Q ss_pred EEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCc------------------hhHHHHHHHHHHHHHHHHhcCCCCc
Q 001678 805 VRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKP------------------SERERLIADFWKEALLLSSLHHPNV 865 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~------------------~ere~~i~~f~rEi~ILskL~HPNI 865 (1033)
++.||+|+||.||+|... |+.||||+++........ .........+.+|...+.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999874 899999999865321100 0111112345689999999999987
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHH-HHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCC
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQF-LQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dl-L~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d 943 (1033)
.....+... ..+|||||+.++++... +.+ ..++......++.|++.+|.+||+ .||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--- 152 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--- 152 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence 554444333 23899999988755443 432 346788889999999999999999 9999999999999997
Q ss_pred CCCCeEEEEecCCcccccc
Q 001678 944 PQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~~ 962 (1033)
++.++|+|||++.....
T Consensus 153 --~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 --DGKPYIIDVSQAVELDH 169 (190)
T ss_pred --CCCEEEEEcccceecCC
Confidence 35799999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=171.20 Aligned_cols=106 Identities=24% Similarity=0.279 Sum_probs=91.9
Q ss_pred CcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccccccCCc
Q 001678 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969 (1033)
Q Consensus 890 GSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~s~~~ 969 (1033)
|+|.+++.+.+..+++..++.|+.||+.||.|||+.+ ||+|||++ .++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~----~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT----WDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc----Cccceee--ccceEeecccc----C
Confidence 6899999877777999999999999999999999998 99999998 6778888 99988654432 2
Q ss_pred CCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 970 ~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
.||+.|||||++.+.. ++.++||||||||+|+|+||+.||..
T Consensus 65 ~g~~~y~aPE~~~~~~------------------~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 65 RVDPYFMAPEVIQGQS------------------YTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred CCcccccChHHhcCCC------------------CcchhhHHHHHHHHHHHHhCCCCccc
Confidence 5799999999997653 55678999999999999999999854
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-17 Score=169.57 Aligned_cols=143 Identities=18% Similarity=0.240 Sum_probs=116.4
Q ss_pred EEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEe
Q 001678 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmE 885 (1033)
+.||+|++|.||+|.+.+..|++|+...................+.+|+.++..+.|++|.....++.+ ....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEEE
Confidence 579999999999999999999999876543332222223334568889999999999998776666655 456789999
Q ss_pred eccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 886 YmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
|++|++|.+++.... . .+..++.+++.+|.+||+.+++|+||+|.|||++ .+.++|+|||++...
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-----~~~~~liDf~~a~~~ 144 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-----GGKIYLIDFGLAEFS 144 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-----CCCEEEEECCcccCC
Confidence 999999999986532 2 7788999999999999999999999999999997 357999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.7e-19 Score=207.68 Aligned_cols=186 Identities=27% Similarity=0.358 Sum_probs=153.0
Q ss_pred ecccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCCCceE
Q 001678 808 LGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 808 LGeGgFG~VYkAk~-----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~eg~l~ 881 (1033)
+|+|+||.|++++. .+.-+|+|++++.....+... ....|..++...+ ||.++++...|+. ++.++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQT--DGKLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeecc--ccchh
Confidence 79999999997643 466689998876654433222 3445677888887 9999999999998 78899
Q ss_pred EEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
++++|..+|+|...+.+... +++.....+...++.+++++|+.+++|||+|++||+++ .+|++|+.|||+++..-
T Consensus 74 l~ld~~rgg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld----~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL----LEGHIKLTDFGLSKEAV 148 (612)
T ss_pred HhhhhcccchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec----ccCccccCCchhhhHhH
Confidence 99999999999999877665 45555555556899999999999999999999999999 78999999999999765
Q ss_pred cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 962 ~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
..++. |||..|||||++++. ..++|+||||+++|+|+||..||..
T Consensus 149 ~~~~~---cgt~eymApEI~~gh--------------------~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIINGH--------------------LSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhhc---ccchhhhhhHhhhcc--------------------CCcccchhhhhhHHHHhhCCCCCch
Confidence 55443 899999999999842 3456999999999999999999954
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=174.76 Aligned_cols=144 Identities=19% Similarity=0.245 Sum_probs=107.3
Q ss_pred eEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhc-----CCCCcceEEEEEEcCCC
Q 001678 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-----HHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL-----~HPNIVrLyG~f~d~~e 877 (1033)
.-.+.||+|+|+.||.....+. .+||++...... ..+.+.+|+.+++.+ .||||+++||++.+...
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CCcceecCCCceEEEECCCCcC-eEEEEEeccccc--------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 3457899999999996332333 478887643211 124678999999999 57999999999998421
Q ss_pred -CceE-EEEee--ccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 878 -GSLA-TVTEF--MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM-EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 878 -g~l~-LVmEY--megGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GL-eYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
+.++ +|||| +.+++|.+++++. .+++. ..++.+++.++ +|||+.+||||||||+|||++..+.....++|+
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 3434 78999 5579999999763 25555 34567888887 999999999999999999998654455689999
Q ss_pred e-cCCccc
Q 001678 953 D-LGLSKV 959 (1033)
Q Consensus 953 D-FGLAr~ 959 (1033)
| ||....
T Consensus 152 Dg~G~~~~ 159 (210)
T PRK10345 152 DNIGESTF 159 (210)
T ss_pred ECCCCcce
Confidence 9 454433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-17 Score=174.21 Aligned_cols=186 Identities=15% Similarity=0.035 Sum_probs=136.2
Q ss_pred EEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCCCceEE
Q 001678 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLAT 882 (1033)
Q Consensus 804 ilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~eg~l~L 882 (1033)
+...|++|+||+||.+...+.+++.+.+...... .+......+.+|+++|++|+ +++|++++++ ...++
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW----LRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHL 75 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhh----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEE
Confidence 4578999999999998888888887776654321 11112235789999999996 5889999886 23699
Q ss_pred EEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL-KCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 883 VmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDI-KPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
+|||+.|.+|...+.. ....++.|++.+|++||+.||+|||| ||+|||++ .++.++|+|||+|....
T Consensus 76 vmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~----~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ----EDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc----CCCCEEEEECCCceecC
Confidence 9999999998754321 11346789999999999999999999 79999998 56789999999998543
Q ss_pred cccc--------------cCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 962 QTLV--------------SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 962 ~~~~--------------s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
.... ......++.|++|+...--. .+ -....++++.|.-+|.++|+..|+
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~----~~------------~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK----RT------------SWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc----cc------------hhHHHHHHHhcchHHHHHhccCCc
Confidence 2211 11122578888888542110 00 012458899999999999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-17 Score=165.22 Aligned_cols=139 Identities=22% Similarity=0.236 Sum_probs=110.4
Q ss_pred EecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEee
Q 001678 807 ELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEF 886 (1033)
Q Consensus 807 kLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmEY 886 (1033)
.||+|+||.||++.+.+..|++|+..................++.+|+.++..+.+++|.....++.. ....++||||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEEEE
Confidence 38999999999999999999999876544333333333345678899999999998875544444444 3456899999
Q ss_pred ccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 887 MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 887 megGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
++|++|.+++..... .++.+++.+|.+||+.|++|+||+|.|||++ .+.++|+|||++...
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-----DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-----CCcEEEEECCCCcCC
Confidence 999999998765321 6788999999999999999999999999997 367999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-17 Score=202.16 Aligned_cols=198 Identities=21% Similarity=0.266 Sum_probs=154.0
Q ss_pred cccCCCceEEEEecccCcEEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC---CCCcceEEEE
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGI 871 (1033)
Q Consensus 796 ~i~~~dYeilekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~---HPNIVrLyG~ 871 (1033)
.+....|.+-+.||+|+||.||+|.. +++.||+|+-+...... |.-=.+++.+|+ -+.|+.+...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----------fYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----------FYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----------eeehHHHHHhhchhhhcchHHHHHH
Confidence 45567799999999999999999977 57889999877654332 111123344444 2334444444
Q ss_pred EEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC---CCCCCe
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---DPQRPV 948 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~---d~~~g~ 948 (1033)
... .+.-++|+||.+.|+|.+++. ..+.+++..+..|..|+++.++.||..+|||+||||+|+||... +....-
T Consensus 763 ~~~--~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 763 HVF--QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred Hcc--CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 333 234579999999999999997 45568999999999999999999999999999999999999643 334678
Q ss_pred EEEEecCCccc---cccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCC
Q 001678 949 CKIGDLGLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 949 VKLiDFGLAr~---~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~ 1025 (1033)
++|+|||.+.- ..+......+++|-.+-.+|+..|++ +++.+|.|.|+-+++.||+|++
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp------------------WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP------------------WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC------------------CchhhhhHHHHHHHHHHHHHHH
Confidence 99999998753 34445556677899999999999986 5567799999999999999975
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=188.88 Aligned_cols=144 Identities=22% Similarity=0.209 Sum_probs=115.9
Q ss_pred ceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceE
Q 001678 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~ 881 (1033)
|...+.||+|+||+||++.+.+..+++|+........+........+++.+|+.+++.++|++|+..+.++.+ ....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCCE
Confidence 3556889999999999999988888777654433322222222334678899999999999999887777666 34578
Q ss_pred EEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
+||||+++++|.+++. ....++.+++.+|.+||+.+++||||||+|||++ ++.++|+|||+++...
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-----~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-----DDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-----CCcEEEEeCcccccCC
Confidence 9999999999999885 3467889999999999999999999999999995 3579999999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=197.88 Aligned_cols=199 Identities=28% Similarity=0.370 Sum_probs=148.5
Q ss_pred eEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCce
Q 001678 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l 880 (1033)
.....+|.|++|.|+..... ...++.|..... .... .........+..|+.+-..|.|+||+..+..+.+. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~-~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPT-ESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCc-ccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccc
Confidence 34577999999977776552 333444443311 1011 11222233377888889999999998877766662 334
Q ss_pred EEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
..+||||++ +|..++...+ .++...+-.++.|++.|++|||..||.|||||++|+|+. ..+.+||+|||.+...
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~----~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT----ENGILKIIDFGAASVF 470 (601)
T ss_pred hhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe----cCCceEEeecCcceee
Confidence 445999999 9999997753 478888889999999999999999999999999999999 7789999999998764
Q ss_pred ccc-----cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 961 QQT-----LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 961 ~~~-----~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
... .....++|+..|+|||++.+..+.. ..+||||.|||+..|.+|+.|+-
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydp-----------------r~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDP-----------------RAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCc-----------------chhhhhhccceEEEEecCCCccc
Confidence 322 3456788999999999998765322 24699999999999999988764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.3e-16 Score=167.65 Aligned_cols=151 Identities=21% Similarity=0.113 Sum_probs=113.0
Q ss_pred CceEEEEecccCcEEEEEEE-E--cCcceEEEEeeccccCCC----------------chhHHHHHHHHHHHHHHHHhcC
Q 001678 801 DLEEVRELGSGTYGSVYHGK-W--RGSDVAIKRIKASCFAGK----------------PSERERLIADFWKEALLLSSLH 861 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk-~--kG~kVAIKvlk~~~~~~k----------------~~ere~~i~~f~rEi~ILskL~ 861 (1033)
-|.+.+.||+|+||.||+|. . +++.||||+++....... ..........+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 2 688999999886432110 0111122235678999999997
Q ss_pred CCC--cceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEE
Q 001678 862 HPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN-IVHFDLKCENLL 938 (1033)
Q Consensus 862 HPN--IVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskG-IVHRDIKPsNIL 938 (1033)
+.. +.+++++ ...++||||+.+.+|..++... ..+....+..++.||+.+|.+||+.| |+||||||+|||
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 633 4445442 1248999999998887665332 23566667889999999999999999 999999999999
Q ss_pred EecCCCCCCeEEEEecCCccccccc
Q 001678 939 VNMRDPQRPVCKIGDLGLSKVKQQT 963 (1033)
Q Consensus 939 Ld~~d~~~g~VKLiDFGLAr~~~~~ 963 (1033)
++ .+.++|+|||++......
T Consensus 182 i~-----~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 182 VH-----DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred EE-----CCCEEEEEChhhhccCCc
Confidence 97 357999999998865443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.7e-16 Score=157.59 Aligned_cols=143 Identities=18% Similarity=0.023 Sum_probs=107.7
Q ss_pred ceEEEEecccCcEEEEEEEE-cCcceEEEEeeccccCCCch--------------hHHHHHHHHHHHHHHHHhcCCCC--
Q 001678 802 LEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPS--------------ERERLIADFWKEALLLSSLHHPN-- 864 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~~--------------ere~~i~~f~rEi~ILskL~HPN-- 864 (1033)
|.+.+.||+|+||.||++.. +++.||||++.......... ........+.+|+.++..+.+.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67778999999999999988 58899999876532110000 00111234678899999998874
Q ss_pred cceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q 001678 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1033)
Q Consensus 865 IVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~ 944 (1033)
+...++. ...++||||+++++|..+... .....++.+++.++.+||+.||+||||||+||+++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---- 159 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---- 159 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc----
Confidence 4555442 345899999999998775431 33457888999999999999999999999999998
Q ss_pred CCCeEEEEecCCccccc
Q 001678 945 QRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 945 ~~g~VKLiDFGLAr~~~ 961 (1033)
.++.+||+|||++....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 57899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.6e-15 Score=167.85 Aligned_cols=152 Identities=21% Similarity=0.275 Sum_probs=117.7
Q ss_pred CCCCcceEEEEEEc-------------------------CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHH
Q 001678 861 HHPNVVSFYGIVRD-------------------------GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915 (1033)
Q Consensus 861 ~HPNIVrLyG~f~d-------------------------~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QI 915 (1033)
+|||||+++.+|.+ +....+|+||..+ ..+|++++-.+. .+....+-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999988753 2234689999988 569999997653 5777788888999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccc-------cccCCcCCCCcccccccccCCCccc
Q 001678 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT-------LVSGGVRGTLPWMAPELLSGKSHMV 988 (1033)
Q Consensus 916 a~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~-------~~s~~~~GT~~YmAPEvi~gk~~~~ 988 (1033)
++|+.|||++||.|||+|.+||||..+++.-..+.|+|||.+---+.. ...-..-|...-||||+....+.+.
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 999999999999999999999999888777888999999987432211 0111233777899999987665432
Q ss_pred cchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCC
Q 001678 989 TEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 989 sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PF 1027 (1033)
. + ..| .+.|.|+.|-+.||+++...||
T Consensus 431 a---------v--vny-~kAD~WA~GalaYEIfg~~NPF 457 (598)
T KOG4158|consen 431 A---------V--VNY-EKADTWAAGALAYEIFGRSNPF 457 (598)
T ss_pred e---------e--ecc-chhhhhhhhhhHHHHhccCCcc
Confidence 2 1 122 2569999999999999999998
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.4e-16 Score=188.60 Aligned_cols=209 Identities=18% Similarity=0.137 Sum_probs=151.3
Q ss_pred CceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCce
Q 001678 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l 880 (1033)
++...+.||.+.|=+|.+|+++...|+||++-+..-.-. .+-..+-++|++ ...+++||++.+.-+... +...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~s----L~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTIS----LRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCC----chHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHH
Confidence 677889999999999999999777799999875432211 111122334454 677789999998776555 4567
Q ss_pred EEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 881 ~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
|||-+|+ ..+|.|.|..+. .+..-+.++|+.||+.||..+|+.||.|+|||.+||||+ .=.-+.|+||..-+-.
T Consensus 97 ylvRqyv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT----SWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT----SWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe----eechhhhhcccccCCc
Confidence 8888888 669999998764 477888889999999999999999999999999999999 5567889999765421
Q ss_pred c----cccccCCc----CCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc-CCCCCC
Q 001678 961 Q----QTLVSGGV----RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI-LCFIDF 1029 (1033)
Q Consensus 961 ~----~~~~s~~~----~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG-k~PFd~ 1029 (1033)
- ++.....+ ..-.+|+|||.+........-..|-| -++.+.||||+|||++||++= .++|++
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~-------~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAP-------LLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCccc-------ccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 1 11111111 12456999998854332222222221 267888999999999999874 888864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.2e-16 Score=164.91 Aligned_cols=200 Identities=25% Similarity=0.430 Sum_probs=155.6
Q ss_pred CCCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCC
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg 878 (1033)
..++.++-+|.+.-.|..|+|+|+|..+++|+++.... ..++.++|..|.-.|+-+.||||+.+++.|..+ .
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~------t~risrdfneefp~lrifshpnilpvlgacnsp--p 260 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV------TARISRDFNEEFPALRIFSHPNILPVLGACNSP--P 260 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc------chhhcchhhhhCcceeeecCCchhhhhhhccCC--C
Confidence 34455667788999999999999999999998875432 234456899999999999999999999999984 5
Q ss_pred ceEEEEeeccCCcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhC-Ccc-ccCCCCCcEEEecCCCCCCeEEEE--e
Q 001678 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGK-NIV-HFDLKCENLLVNMRDPQRPVCKIG--D 953 (1033)
Q Consensus 879 ~l~LVmEYmegGSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHsk-GIV-HRDIKPsNILLd~~d~~~g~VKLi--D 953 (1033)
.+.+|..||+.|+|..+|.... ...+..++.+++.+|++|+.|||+. .+| ---|....++|| ++.+.+|. |
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid----edltarismad 336 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID----EDLTARISMAD 336 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec----chhhhheeccc
Confidence 6899999999999999998653 3467888999999999999999986 333 346888999998 45555542 3
Q ss_pred cCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCCCCC
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 954 FGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
--++-. ..+..-.+.||+||.+..++.+.+. .+.|+|||++++|||-|...||.-+|
T Consensus 337 ~kfsfq------e~gr~y~pawmspealqrkped~n~---------------raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 337 TKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNI---------------RAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred ceeeee------ccccccCcccCCHHHHhcCchhcch---------------hhhhHHHHHHHHHHhhccccccccCC
Confidence 222111 1122347889999999887654432 35699999999999999999997654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.57 E-value=7e-15 Score=162.01 Aligned_cols=208 Identities=19% Similarity=0.225 Sum_probs=130.2
Q ss_pred ceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCC----------CCcceEE
Q 001678 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH----------PNVVSFY 869 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~H----------PNIVrLy 869 (1033)
+...+.||.|+++.||.+.+. ++++|+|+....... ....++.+++|.-....+.+ -.++-.+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~-----~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA-----SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTT-----HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEeccccc-----chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 566788999999999999994 688999998765421 12234556666544433221 1222222
Q ss_pred EEEEc---------CC-CC-----ceEEEEeeccCCcHHHHHHh---cCC---ccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001678 870 GIVRD---------GP-DG-----SLATVTEFMVNGSLKQFLQK---KDR---TIDRRKRLIIAMDAAFGMEYLHGKNIV 928 (1033)
Q Consensus 870 G~f~d---------~~-eg-----~l~LVmEYmegGSL~dlL~~---~~k---~Lse~~rl~Ia~QIa~GLeYLHskGIV 928 (1033)
+...- .. .. ..+++|+-+ .++|.+++.- ... .+....++.+..|+++.+++||..|+|
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 22221 10 01 246788877 7788888652 222 244556677889999999999999999
Q ss_pred ccCCCCCcEEEecCCCCCCeEEEEecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCccc
Q 001678 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSY 1008 (1033)
Q Consensus 929 HRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kv 1008 (1033)
|+||||+|+|++ .+|.++|+||+........... ...+..|.+||....... +.. --..++.+.
T Consensus 168 Hgdi~~~nfll~----~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~-~~~---------~~~~~t~~~ 231 (288)
T PF14531_consen 168 HGDIKPENFLLD----QDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQ-FGQ---------NNAPYTFAT 231 (288)
T ss_dssp EST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTS-CHH---------SEEEE-HHH
T ss_pred ecccceeeEEEc----CCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcc-cCc---------ccceeeecc
Confidence 999999999999 7899999999876654433222 234677999997633210 000 012467788
Q ss_pred chHHHHHHHHHHHccCCCCCCCC
Q 001678 1009 DCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 1009 DVWSLGVVLYeLLTGk~PFd~~s 1031 (1033)
|.|+||+++|.|.++..||+..+
T Consensus 232 DaW~LG~~ly~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 232 DAWQLGITLYSLWCGRLPFGLSS 254 (288)
T ss_dssp HHHHHHHHHHHHHHSS-STCCCG
T ss_pred CHHHHHHHHHHHHHccCCCCCCC
Confidence 99999999999999999998653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-15 Score=183.89 Aligned_cols=162 Identities=27% Similarity=0.420 Sum_probs=118.1
Q ss_pred cCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~ 875 (1033)
...+|..++.|..|+||.||..+++ .+++|+|+-+ ..+ +.+- ++.....|.
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-------------ilRn--ilt~a~npf----------- 133 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-------------ILRN--ILTFAGNPF----------- 133 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-------------hhhc--cccccCCcc-----------
Confidence 3567899999999999999999875 7778885432 211 1110 222222222
Q ss_pred CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecC
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFG 955 (1033)
.| |+-..+++..+. ++ .+++.+++|||+.||+|||+||+|+||+ .-|++|++|||
T Consensus 134 ------vv------gDc~tllk~~g~-lP--------vdmvla~Eylh~ygivhrdlkpdnllIT----~mGhiKlTDfg 188 (1205)
T KOG0606|consen 134 ------VV------GDCATLLKNIGP-LP--------VDMVLAVEYLHSYGIVHRDLKPDNLLIT----SMGHIKLTDFG 188 (1205)
T ss_pred ------ee------chhhhhcccCCC-Cc--------chhhHHhHhhccCCeecCCCCCCcceee----ecccccccchh
Confidence 22 455555554433 22 1337889999999999999999999999 88999999999
Q ss_pred Cccccc----------------cccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHH
Q 001678 956 LSKVKQ----------------QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFF 1019 (1033)
Q Consensus 956 LAr~~~----------------~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYe 1019 (1033)
+++..- .......++||+.|+|||++..++ |+..+|||++|+|+|+
T Consensus 189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg------------------ygkpvdwwamGiIlye 250 (1205)
T KOG0606|consen 189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG------------------YGKPVDWWAMGIILYE 250 (1205)
T ss_pred hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc------------------cCCCccHHHHHHHHHH
Confidence 987421 011234678999999999987653 7788999999999999
Q ss_pred HHccCCCCCC
Q 001678 1020 LQFILCFIDF 1029 (1033)
Q Consensus 1020 LLTGk~PFd~ 1029 (1033)
.+-|+.||.-
T Consensus 251 FLVgcvpffG 260 (1205)
T KOG0606|consen 251 FLVGCVPFFG 260 (1205)
T ss_pred HheeeeeccC
Confidence 9999999964
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.1e-14 Score=135.33 Aligned_cols=132 Identities=22% Similarity=0.162 Sum_probs=109.3
Q ss_pred EEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEcCCCCceE
Q 001678 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 804 ilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~H--PNIVrLyG~f~d~~eg~l~ 881 (1033)
+++.||+|.++.||++...+..++||....... ...+.+|+.+++.+++ ..+++++.++.. .+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGES--DGWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccE
Confidence 457899999999999999888899998764321 2367789999999986 589999888776 46789
Q ss_pred EEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK---NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHsk---GIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
++|||+.++.+..+ +......++.+++++|.+||.. +++|+||+|+|||++ ..+.++|+|||.+.
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----~~~~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----DGKILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE----CCcEEEEEeccccc
Confidence 99999988877654 4455667788999999999985 799999999999998 56789999999886
Q ss_pred c
Q 001678 959 V 959 (1033)
Q Consensus 959 ~ 959 (1033)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 4
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.6e-14 Score=152.12 Aligned_cols=146 Identities=15% Similarity=0.139 Sum_probs=107.6
Q ss_pred EEec-ccCcEEEEEEEEcCcceEEEEeeccccCCCch-----hHHHHHHHHHHHHHHHHhcCCCCc--ceEEEEEEcCCC
Q 001678 806 RELG-SGTYGSVYHGKWRGSDVAIKRIKASCFAGKPS-----ERERLIADFWKEALLLSSLHHPNV--VSFYGIVRDGPD 877 (1033)
Q Consensus 806 ekLG-eGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~-----ere~~i~~f~rEi~ILskL~HPNI--VrLyG~f~d~~e 877 (1033)
..|| .|+.|+||+++..+..++||.+.......+-. ........+.+|+.++..|.|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 88889999998888999999886432211110 111223567889999999998875 677776544211
Q ss_pred C--ceEEEEeeccC-CcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 878 G--SLATVTEFMVN-GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 878 g--~l~LVmEYmeg-GSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
. ..++||||+++ .+|.+++.+. .++.. .+.+|+.+|.+||+.||+||||||.|||++ .++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~----~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD----PDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc----CCCCEEEEEC
Confidence 1 23599999997 6999988653 24443 356899999999999999999999999998 4568999999
Q ss_pred CCccccc
Q 001678 955 GLSKVKQ 961 (1033)
Q Consensus 955 GLAr~~~ 961 (1033)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9987643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.9e-14 Score=143.85 Aligned_cols=144 Identities=21% Similarity=0.081 Sum_probs=98.0
Q ss_pred EEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHH----------------HHHHHHHHHHHHHHhcCCCC--c
Q 001678 805 VRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERE----------------RLIADFWKEALLLSSLHHPN--V 865 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~ere----------------~~i~~f~rEi~ILskL~HPN--I 865 (1033)
.+.||+|+||.||+|... ++.||||+++............ ........|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 367999999999999886 8889999987543221111100 00011235666666665433 4
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHH-HHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCC
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQ-FLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~d-lL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~d 943 (1033)
.+.++. ...++||||+.++.+.. .+.... .. ..+..++.+++.++.+||. .+|+|+||||+||+++
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--- 149 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--- 149 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---
Confidence 555543 23589999999854321 121111 11 5567889999999999999 9999999999999997
Q ss_pred CCCCeEEEEecCCcccccc
Q 001678 944 PQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~~ 962 (1033)
++.++|+|||.+.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 46799999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.7e-14 Score=161.65 Aligned_cols=121 Identities=27% Similarity=0.377 Sum_probs=102.6
Q ss_pred CCceEEEEeeccCCcHHHHHHh--cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 877 DGSLATVTEFMVNGSLKQFLQK--KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~--~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
..++++.|++|...+|.++|.. .....++...+.++.|++.|++| ++.+|||+||.||+.. .+..+||.||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~----~d~q~kIgDF 400 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS----DDDQLKIGDF 400 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc----cchhhhhhhh
Confidence 3458899999999999999964 34456778888999999999999 9999999999999997 5568999999
Q ss_pred CCcccccccc-------ccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHc
Q 001678 955 GLSKVKQQTL-------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF 1022 (1033)
Q Consensus 955 GLAr~~~~~~-------~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLT 1022 (1033)
|+........ .....+||.+||+||.+.+. +|+.++||||||+||+||++
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~------------------~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ------------------QYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhh------------------hhhhhcchhhHHHHHHHHHH
Confidence 9987654433 33456799999999999886 57888899999999999997
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.3e-13 Score=155.11 Aligned_cols=157 Identities=34% Similarity=0.461 Sum_probs=127.8
Q ss_pred HHhcCCCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCC
Q 001678 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNI-VHFDLKCE 935 (1033)
Q Consensus 857 LskL~HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGI-VHRDIKPs 935 (1033)
|+.+.|.||.+++|.+.++ ...+.|.+||..|+|.|.+......+++.-...++++|+.||.|||...| .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4568899999999999994 77899999999999999999877789999999999999999999998766 99999999
Q ss_pred cEEEecCCCCCCeEEEEecCCccccccc---cccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHH
Q 001678 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012 (1033)
Q Consensus 936 NILLd~~d~~~g~VKLiDFGLAr~~~~~---~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWS 1012 (1033)
|.+++ ....+||+|||+....... .......-..-|.|||.+.+....... ...+.+.|+||
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~-----------~~~~~~gdiYs 143 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLE-----------SALTQKGDIYS 143 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccc-----------ccccccCCeeh
Confidence 99999 8899999999998776421 111111124459999999765321111 13566789999
Q ss_pred HHHHHHHHHccCCCCCCC
Q 001678 1013 LGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 1013 LGVVLYeLLTGk~PFd~~ 1030 (1033)
||+|++|+++.+-||+..
T Consensus 144 ~~ii~~ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLR 161 (484)
T ss_pred HHHHHHHHHhccCccccc
Confidence 999999999999999763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.26 E-value=2e-11 Score=141.95 Aligned_cols=148 Identities=18% Similarity=0.173 Sum_probs=99.0
Q ss_pred EEecccCcEEEEEEEE-cCcceEEEEeeccccCCCchh--------------------------HHHH------HHHHHH
Q 001678 806 RELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSE--------------------------RERL------IADFWK 852 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~~e--------------------------re~~------i~~f~r 852 (1033)
+.||.|++|.||+|+. +|+.||||+.+......-..+ -+.. .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999988 589999999875421100000 0000 013556
Q ss_pred HHHHHHhcC----CCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHH-HHHHHHhCCc
Q 001678 853 EALLLSSLH----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF-GMEYLHGKNI 927 (1033)
Q Consensus 853 Ei~ILskL~----HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~-GLeYLHskGI 927 (1033)
|...+.++. +.+-+.+-.++.+. .+..+|||||++|++|.+++.......+ ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666653 32223332333221 2346899999999999988754322222 3446666665 4788999999
Q ss_pred cccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 928 VHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
+|+|+||.||+++ .++.++|+|||++....
T Consensus 279 ~H~D~hPgNilv~----~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVL----KDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEEC----CCCcEEEEeCCCeeECC
Confidence 9999999999998 66789999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.7e-11 Score=119.79 Aligned_cols=128 Identities=15% Similarity=0.077 Sum_probs=94.8
Q ss_pred EEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEcCCCCceEEE
Q 001678 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-VSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNI-VrLyG~f~d~~eg~l~LV 883 (1033)
++.|+.|.++.||+++..+..|++|+....... ...+.+|+.+++.+...++ .+++....+ ..++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---------LINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc---------ccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEE
Confidence 467899999999999999999999987543210 1134578888888865554 455554332 24799
Q ss_pred EeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNI-----VHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGI-----VHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
|||+++.++.+. . . ....++.+++++|..||+.++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 70 ~e~i~G~~l~~~-----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-----~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTE-----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-----DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCccccc-----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-----CCeEEEEeccccc
Confidence 999999887653 0 1 112356789999999999885 9999999999997 2468999999986
Q ss_pred c
Q 001678 959 V 959 (1033)
Q Consensus 959 ~ 959 (1033)
.
T Consensus 136 ~ 136 (170)
T cd05151 136 M 136 (170)
T ss_pred C
Confidence 4
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.1e-13 Score=159.84 Aligned_cols=203 Identities=25% Similarity=0.256 Sum_probs=155.6
Q ss_pred CCCceEEEEecccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEc
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1033)
Q Consensus 799 ~~dYeilekLGeGgFG~VYkAk~k---G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d 874 (1033)
...|.+.+.||+|+|+.|-..... ...+|+|.+.... + ..........|..+-+.+. |.|++.+++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~---~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---K---SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---C---ccchhhhcCccccccccccccccccccCCccCC
Confidence 456788888999999999877552 3335666554332 1 1112234556777777887 9999999998877
Q ss_pred CCCCceEEEEeeccCCcHHHHH-HhcCCccCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEecCCCCCC-eEEE
Q 001678 875 GPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLKCENLLVNMRDPQRP-VCKI 951 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL-~~~~k~Lse~~rl~Ia~QIa~GLeYLH-skGIVHRDIKPsNILLd~~d~~~g-~VKL 951 (1033)
....+++++|..++++.+.+ .......+...+..++.|+..+|.|+| ..++.||||||+|.+++ ..+ .+|+
T Consensus 93 --~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~----~s~~~l~~ 166 (601)
T KOG0590|consen 93 --PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD----ESGSALKI 166 (601)
T ss_pred --CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc----cCCCcccC
Confidence 56688999999999999988 433324666777788899999999999 99999999999999998 455 8999
Q ss_pred EecCCcccccc-c---cccCCcCC-CCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCC
Q 001678 952 GDLGLSKVKQQ-T---LVSGGVRG-TLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCF 1026 (1033)
Q Consensus 952 iDFGLAr~~~~-~---~~s~~~~G-T~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~P 1026 (1033)
.|||+|..... . ......+| ++.|+|||...++. ......|+||.|+++.-+++|..|
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~-----------------~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA-----------------YRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchh-----------------hcCCCcccccccccccccccCCCC
Confidence 99999987654 1 12334568 99999999987642 245567999999999999999988
Q ss_pred CCCC
Q 001678 1027 IDFF 1030 (1033)
Q Consensus 1027 Fd~~ 1030 (1033)
-++-
T Consensus 230 ~~~~ 233 (601)
T KOG0590|consen 230 WDFP 233 (601)
T ss_pred cccc
Confidence 7654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-10 Score=120.93 Aligned_cols=154 Identities=19% Similarity=0.188 Sum_probs=118.4
Q ss_pred EEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEE
Q 001678 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 804 ilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
.+..|-+|+-+.|+++.+.|+..+||.-....+..+..+......+.++|++++.++.--.|.-..=+|.+ ...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cCCCeEE
Confidence 46789999999999999999999999866666666555555666788899999999975555433334444 2345789
Q ss_pred EeeccC-CcHHHHHHhcCCccCHHHH-HHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 884 TEFMVN-GSLKQFLQKKDRTIDRRKR-LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 884 mEYmeg-GSL~dlL~~~~k~Lse~~r-l~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
|||+++ .++.+++......-..+.. ..++..|-+.|.-||..+|||+||..+||+|..++ ....+.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-NQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-CcCceEEEeecchhcc
Confidence 999966 4888888765433333333 67888999999999999999999999999997554 4566789999998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-10 Score=120.35 Aligned_cols=139 Identities=19% Similarity=0.231 Sum_probs=107.8
Q ss_pred EEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCc--ceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV--VSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNI--VrLyG~f~d~~eg~l~LV 883 (1033)
..+++|+-+.+|.+.+.|..+++|.-.+..+..+..+......+..+|+.++.+++--.| ..+|++ + .....|+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D--~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--D--PDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--c--CCCCEEE
Confidence 357899999999999988888888776666666555555555677889999999975444 444444 4 2345799
Q ss_pred EeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 884 mEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
|||++|-.|.++|... ...++..+-.-+.-||..||||+||.++||++. .+.+.++||||+....
T Consensus 78 me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~-----~~~i~~IDfGLg~~s~ 142 (204)
T COG3642 78 MEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS-----GGRIYFIDFGLGEFSD 142 (204)
T ss_pred EEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-----CCcEEEEECCcccccc
Confidence 9999999999998765 244666777778899999999999999999997 3349999999998543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-10 Score=119.62 Aligned_cols=144 Identities=18% Similarity=0.093 Sum_probs=101.4
Q ss_pred EEecccCcEEEEEEEEc--------CcceEEEEeeccccCCCc------------------hhHHHHHHHHHHHHHHHHh
Q 001678 806 RELGSGTYGSVYHGKWR--------GSDVAIKRIKASCFAGKP------------------SERERLIADFWKEALLLSS 859 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k--------G~kVAIKvlk~~~~~~k~------------------~ere~~i~~f~rEi~ILsk 859 (1033)
..||.|.-+.||.|... +..+|||+.+.....-+. ..+........+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 56899999999999764 368999998754321110 1111222234489999999
Q ss_pred cCC--CCcceEEEEEEcCCCCceEEEEeeccCCcHHH-HHHhcCCccCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCC
Q 001678 860 LHH--PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ-FLQKKDRTIDRRKRLIIAMDAAFGMEYL-HGKNIVHFDLKCE 935 (1033)
Q Consensus 860 L~H--PNIVrLyG~f~d~~eg~l~LVmEYmegGSL~d-lL~~~~k~Lse~~rl~Ia~QIa~GLeYL-HskGIVHRDIKPs 935 (1033)
|.. -++.+++++ ...+|||||+.+..+.. .|++ ..++......+..+++.+|..| |+.||||+||++.
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 963 467777765 23589999996643422 2322 1245556677788999999998 8999999999999
Q ss_pred cEEEecCCCCCCeEEEEecCCcccccc
Q 001678 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 936 NILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
|||+. ++.++|+|||.+.....
T Consensus 155 NIL~~-----~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-----DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-----CCcEEEEECCCceeCCC
Confidence 99996 35799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.4e-11 Score=140.20 Aligned_cols=152 Identities=18% Similarity=0.239 Sum_probs=94.9
Q ss_pred CceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCC-------------------------C-chhHHHHHH----
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAG-------------------------K-PSERERLIA---- 848 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~-------------------------k-~~ere~~i~---- 848 (1033)
+|+. +.||.|++|.||+|+.+ |+.||||++++..... + ....++..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 78999999999999883 7999999998542100 0 000011111
Q ss_pred --HHHHHHHHHHhcC----CCCcceEEEEEEcCCCCceEEEEeeccCCcHHHH--HHhcCC---ccCHHHHHHHHHHHHH
Q 001678 849 --DFWKEALLLSSLH----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF--LQKKDR---TIDRRKRLIIAMDAAF 917 (1033)
Q Consensus 849 --~f~rEi~ILskL~----HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dl--L~~~~k---~Lse~~rl~Ia~QIa~ 917 (1033)
++.+|+..+.++. +...+.+-.++.+- .+..+|||||+.|+.|.++ +...+. .+.+..+..++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~----- 273 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF----- 273 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-----
Confidence 3445555555553 43334433333332 2346899999999999875 333221 12222222233
Q ss_pred HHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 918 GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
.-+...|++|+|+||.||+++.++...+.++++|||++....
T Consensus 274 --~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 --TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 334568999999999999998554455699999999987654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.2e-09 Score=106.09 Aligned_cols=143 Identities=21% Similarity=0.224 Sum_probs=101.5
Q ss_pred EEecccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEcCC-CCceE
Q 001678 806 RELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVRDGP-DGSLA 881 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG-~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~H--PNIVrLyG~f~d~~-eg~l~ 881 (1033)
+.|+.|..+.||++...+ ..+++|+....... .....+.+|+.+++.+.+ ..+.+++.+..... .+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 678999999999998865 78999987643211 012356788999999875 34577777655421 13568
Q ss_pred EEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 001678 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG------------------------------------- 924 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs------------------------------------- 924 (1033)
+||||++|.+|.+.+.. ..++......++.+++++|..||+
T Consensus 77 ~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 77 YVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99999999888765431 235556666666677777776663
Q ss_pred -------------------CCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 925 -------------------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 925 -------------------kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
..++|+|+++.|||++.+ ..+.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~--~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD--EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC--CCcEEEEEecccccc
Confidence 246999999999999821 146789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00666 PB1 PB1 domain | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.6e-09 Score=93.53 Aligned_cols=75 Identities=49% Similarity=0.848 Sum_probs=66.1
Q ss_pred CCeeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCe
Q 001678 41 GKLRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTR 117 (1033)
Q Consensus 41 ~~l~Y~gG~tri~~v~r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r 117 (1033)
.+++| ||++|.+.|+++++|.+|+.++++.++. .+.|||+ .||-| +|++++|+||..||+.+.+.. ...
T Consensus 4 vK~~~-~~~~~~~~~~~~~s~~dL~~~i~~~~~~~~~~~~l~Y~--Dedgd-~v~l~sd~Dl~~a~~~~~~~~----~~~ 75 (81)
T smart00666 4 VKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLTSDEDLEEAIEEYDSLG----SKK 75 (81)
T ss_pred EEEEE-CCEEEEEEECCCCCHHHHHHHHHHHhCCCCCCeEEEEE--CCCCC-EEEecCHHHHHHHHHHHHHcC----Cce
Confidence 46778 8999999999999999999999999986 5999999 77766 999999999999999998753 356
Q ss_pred EEEEEe
Q 001678 118 LRIFLF 123 (1033)
Q Consensus 118 ~r~flf 123 (1033)
|||++|
T Consensus 76 l~l~v~ 81 (81)
T smart00666 76 LRLHVF 81 (81)
T ss_pred EEEEeC
Confidence 999886
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-09 Score=127.73 Aligned_cols=196 Identities=24% Similarity=0.257 Sum_probs=145.0
Q ss_pred CCceEEEEecc--cCcEEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEE
Q 001678 800 DDLEEVRELGS--GTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (1033)
Q Consensus 800 ~dYeilekLGe--GgFG~VYkAk~----kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f 872 (1033)
..+.+.+.+|. |.+|.||.++. .+..+|+|.-+...-..... .+-.+|+...++++ |+|+++.+..+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~------~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS------KRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc------ccccchhhcccccCccccccccCccc
Confidence 44566678999 99999999876 36668888744321111111 12235666666665 99999988888
Q ss_pred EcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCcEEEecCCCCC-C
Q 001678 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQR-P 947 (1033)
Q Consensus 873 ~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~----GLeYLHskGIVHRDIKPsNILLd~~d~~~-g 947 (1033)
.+ .+.+++-+|++ +.+|..+.......++...++.+..++.. ||.++|..+++|-|+||.||++. .+ .
T Consensus 188 e~--~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~----~~~~ 260 (524)
T KOG0601|consen 188 EG--SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT----SDWT 260 (524)
T ss_pred cc--CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc----cccc
Confidence 87 67889999998 68899888877777888899999999999 99999999999999999999998 44 7
Q ss_pred eEEEEecCCccccccccccC------CcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHH
Q 001678 948 VCKIGDLGLSKVKQQTLVSG------GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQ 1021 (1033)
Q Consensus 948 ~VKLiDFGLAr~~~~~~~s~------~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLL 1021 (1033)
..|++|||+...+....... ...|...|++||..++- ++...|+|+||.+..+..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-------------------~~~~~di~sl~ev~l~~~ 321 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-------------------ATFASDIFSLGEVILEAI 321 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-------------------cchHhhhcchhhhhHhhH
Confidence 89999999988765543221 22467789999998764 334456666666666666
Q ss_pred ccCCCC
Q 001678 1022 FILCFI 1027 (1033)
Q Consensus 1022 TGk~PF 1027 (1033)
++...+
T Consensus 322 l~~~~~ 327 (524)
T KOG0601|consen 322 LGSHLP 327 (524)
T ss_pred hhcccc
Confidence 554443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.1e-08 Score=103.64 Aligned_cols=133 Identities=24% Similarity=0.162 Sum_probs=84.6
Q ss_pred EEEEEEE-cCcceEEEEeeccccCCC------------------chhHHHHHHHHHHHHHHHHhcCCC--CcceEEEEEE
Q 001678 815 SVYHGKW-RGSDVAIKRIKASCFAGK------------------PSERERLIADFWKEALLLSSLHHP--NVVSFYGIVR 873 (1033)
Q Consensus 815 ~VYkAk~-kG~kVAIKvlk~~~~~~k------------------~~ere~~i~~f~rEi~ILskL~HP--NIVrLyG~f~ 873 (1033)
.||.|.. ++..+|||+.+.....-+ ............+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 577899999865321110 112233345678899999999865 567777652
Q ss_pred cCCCCceEEEEeecc--CCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 874 DGPDGSLATVTEFMV--NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY-LHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 874 d~~eg~l~LVmEYme--gGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeY-LHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
..++||||+. |..|..+.... ++......++.+++..+.. +|+.||||+||.+.|||++ .+ .+.
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~-~~~ 146 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DG-KVY 146 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TT-CEE
T ss_pred -----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cc-eEE
Confidence 2489999998 65665543322 1234455677788885555 5799999999999999998 33 899
Q ss_pred EEecCCccccc
Q 001678 951 IGDLGLSKVKQ 961 (1033)
Q Consensus 951 LiDFGLAr~~~ 961 (1033)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.6e-08 Score=105.37 Aligned_cols=145 Identities=14% Similarity=0.115 Sum_probs=97.8
Q ss_pred EEEEEEEcCcceEEEEeeccccCC--CchhH-HHHHHHHHHHHHHHHhcCCCC--cceEEEEEEcCC---CCceEEEEee
Q 001678 815 SVYHGKWRGSDVAIKRIKASCFAG--KPSER-ERLIADFWKEALLLSSLHHPN--VVSFYGIVRDGP---DGSLATVTEF 886 (1033)
Q Consensus 815 ~VYkAk~kG~kVAIKvlk~~~~~~--k~~er-e~~i~~f~rEi~ILskL~HPN--IVrLyG~f~d~~---eg~l~LVmEY 886 (1033)
.|++..+.|+.+.||......... +.... ..-...+.+|...+.+|..-+ .+.++++..... ....++|||+
T Consensus 37 rvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~ 116 (268)
T PRK15123 37 RTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITED 116 (268)
T ss_pred eEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEee
Confidence 466777788889999764322100 00000 000113678888888885333 334445543321 2346899999
Q ss_pred ccCC-cHHHHHHhc-CCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC---CCCCCeEEEEecCCccc
Q 001678 887 MVNG-SLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---DPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 887 megG-SL~dlL~~~-~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~---d~~~g~VKLiDFGLAr~ 959 (1033)
+++. +|.+++... ....+...+..++.+++..+.-||..||+|+|+++.|||++.+ +.....+.|+||+.+..
T Consensus 117 l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 117 LAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9876 899998642 2335566777899999999999999999999999999999842 22457899999998864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.8e-08 Score=117.42 Aligned_cols=162 Identities=22% Similarity=0.281 Sum_probs=117.8
Q ss_pred cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCC
Q 001678 822 RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901 (1033)
Q Consensus 822 kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k 901 (1033)
.+..|.|..++...- .......+-+.-|+.|+||||+++++.+.. ++.+|+|+|.+ .-|..++++.+
T Consensus 36 ~~~~vsVF~~~~~~~--------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV--~Pl~~~lk~l~- 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--------EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERV--RPLETVLKELG- 102 (690)
T ss_pred cCCceEEEEEeCCCc--------hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeecc--ccHHHHHHHhH-
Confidence 466777776654321 112334566778999999999999999988 67899999998 45777776643
Q ss_pred ccCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEecCCCCCCeEEEEecCCccccccccc-cCCcCCCCcccccc
Q 001678 902 TIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRGTLPWMAPE 979 (1033)
Q Consensus 902 ~Lse~~rl~Ia~QIa~GLeYLH-skGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~-s~~~~GT~~YmAPE 979 (1033)
.......+.||+.||.||| +.+++|++|.-+-|+++ ..|..||.+|.++........ .....--..|..|+
T Consensus 103 ---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn----~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 103 ---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN----ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc----CCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 5556677789999999998 56999999999999999 889999999998765433221 11111122356666
Q ss_pred cccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc
Q 001678 980 LLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI 1023 (1033)
Q Consensus 980 vi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG 1023 (1033)
.+... ....|.|-|||++|+++.|
T Consensus 176 ~~~~s--------------------~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS--------------------EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc--------------------ccchhhhhHHHHHHHHhCc
Confidence 54321 1234999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.8e-09 Score=122.25 Aligned_cols=190 Identities=22% Similarity=0.185 Sum_probs=128.6
Q ss_pred ccccCCCceEEEEecccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEE
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYG 870 (1033)
Q Consensus 795 ~~i~~~dYeilekLGeGgFG~VYkAk~k---G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG 870 (1033)
......+|.++..||.|.|+.|++...+ +..+++|.+.......... ..-..|+.+...+. |.+++..+.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d------i~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD------IFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh------hcchhhhhHhhHhhcccccCCCCC
Confidence 3445678999999999999999987653 5678888876554332111 12234555555554 888888776
Q ss_pred EEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEE
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 ~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VK 950 (1033)
.|.. ....++-.||++++++...+. ....+++..++++..|++.++.++|++.++|+|+||+||++..++ +..+
T Consensus 334 ~W~~--~r~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~ 407 (524)
T KOG0601|consen 334 SWSQ--LRQGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSK 407 (524)
T ss_pred Cccc--cccccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhh
Confidence 6665 345668999999998877663 223477888889999999999999999999999999999998332 7788
Q ss_pred EEecCCccccccccccCCcCCCCccc-ccccccCCCccccchhhhcccch
Q 001678 951 IGDLGLSKVKQQTLVSGGVRGTLPWM-APELLSGKSHMVTEKVTLFSLKF 999 (1033)
Q Consensus 951 LiDFGLAr~~~~~~~s~~~~GT~~Ym-APEvi~gk~~~~sekvDVwSLGv 999 (1033)
+.|||......-. ......+-+++ ..|++... +....++|+|+|+.
T Consensus 408 ~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~ 454 (524)
T KOG0601|consen 408 LGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGL 454 (524)
T ss_pred cccccccccccee--cccccccccccccchhhccc-cccccccccccccc
Confidence 9999987642211 11222344455 35655433 22333444444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.6e-09 Score=129.42 Aligned_cols=203 Identities=19% Similarity=0.188 Sum_probs=142.8
Q ss_pred ccCCCceEEEEecccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEc
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 i~~~dYeilekLGeGgFG~VYkAk~k--G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d 874 (1033)
...+.+.+++-+-.|.++.++.++-. +-..++|+........+.. .+....+-.++..-++|.++.....+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~-----~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND-----YESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc-----ccccCCccCccccCCCCceecccCCCCC
Confidence 34566788888889999999987653 3224555544332222211 1223334444444556777766555333
Q ss_pred CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
....+||++|+.+++|...|+..+. .+.+........+.++++|||...++|+|++|.|+|+. ..+..+++||
T Consensus 876 --rsP~~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~----~~gh~~l~~~ 948 (1205)
T KOG0606|consen 876 --RSPLPLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA----YDGHRPLTDF 948 (1205)
T ss_pred --CCCcchhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccccchhhcccccccchhhc----ccCCcccCcc
Confidence 5678999999999999999988764 44444444555788999999999999999999999998 6788899999
Q ss_pred CCccccc--------------------------------cccccCCcCCCCcccccccccCCCccccchhhhcccchhhc
Q 001678 955 GLSKVKQ--------------------------------QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCF 1002 (1033)
Q Consensus 955 GLAr~~~--------------------------------~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvily 1002 (1033)
|..+... +........||+.|.+||...+..
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~----------------- 1011 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR----------------- 1011 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-----------------
Confidence 8332100 001123456899999999988764
Q ss_pred cCCcccchHHHHHHHHHHHccCCCCCC
Q 001678 1003 QLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 1003 e~t~kvDVWSLGVVLYeLLTGk~PFd~ 1029 (1033)
-....|+|++|+++++.++|.+||+.
T Consensus 1012 -hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 1012 -HGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred -CCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 34566999999999999999999974
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.6e-07 Score=97.03 Aligned_cols=110 Identities=21% Similarity=0.147 Sum_probs=83.4
Q ss_pred HHHHHHHHHHhcCCC--CcceEEEEEEcCCC--CceEEEEeeccCC-cHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHH
Q 001678 849 DFWKEALLLSSLHHP--NVVSFYGIVRDGPD--GSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923 (1033)
Q Consensus 849 ~f~rEi~ILskL~HP--NIVrLyG~f~d~~e--g~l~LVmEYmegG-SL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLH 923 (1033)
+..+|...+..|..- .+.+.+++...... ...++|||++++. +|.+++..... .+......++.+++..+.-||
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHH
Confidence 566788877777533 34456666554211 2358999999874 89999876433 566677889999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 924 skGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
..||+|+|+++.|||++.++ ....+.|+||+.++..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCC-CceeEEEEcchhceeC
Confidence 99999999999999998443 4458999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF00564 PB1: PB1 domain; InterPro: IPR000270 The Phox and Bem1p domain, is present in many eukaryotic cytoplasmic signalling proteins | Back alignment and domain information |
|---|
Probab=98.47 E-value=6.4e-07 Score=80.87 Aligned_cols=74 Identities=39% Similarity=0.699 Sum_probs=61.1
Q ss_pred eeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEE
Q 001678 43 LRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLR 119 (1033)
Q Consensus 43 l~Y~gG~tri~~v~r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r~r 119 (1033)
++|.|+..|++.++++++|.+|+.++++.++. .+.|+|+ .|| +.+|+|++|+||..|++.+.+. +..+||
T Consensus 6 ~~~~~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~Y~--D~d-gD~V~i~sd~Dl~~a~~~~~~~----~~~~lr 78 (84)
T PF00564_consen 6 VRYGGDIRRIISLPSDVSFDDLRSKIREKFGLLDEDFQLKYK--DED-GDLVTISSDEDLQEAIEQAKES----GSKTLR 78 (84)
T ss_dssp EEETTEEEEEEEECSTSHHHHHHHHHHHHHTTSTSSEEEEEE--ETT-SSEEEESSHHHHHHHHHHHHHC----TTSCEE
T ss_pred EEECCeeEEEEEcCCCCCHHHHHHHHHHHhCCCCccEEEEee--CCC-CCEEEeCCHHHHHHHHHHHHhc----CCCcEE
Confidence 34444444569999999999999999999987 5899998 555 4899999999999999999986 334799
Q ss_pred EEEe
Q 001678 120 IFLF 123 (1033)
Q Consensus 120 ~flf 123 (1033)
||+.
T Consensus 79 l~v~ 82 (84)
T PF00564_consen 79 LFVQ 82 (84)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 9986
|
The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate.; GO: 0005515 protein binding; PDB: 1IPG_A 1IP9_A 2KFK_A 1WMH_A 1VD2_A 1WI0_A 1OEY_C 1PQS_A 1Q1O_A 1TZ1_A .... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.9e-07 Score=100.91 Aligned_cols=147 Identities=22% Similarity=0.337 Sum_probs=102.8
Q ss_pred HHHHhcCCCCcceEEEEEEcC---CCCceEEEEeeccCCcHHHHHHhc---CCccCHHHHHHHHHHHHHHHHHHHhC--C
Q 001678 855 LLLSSLHHPNVVSFYGIVRDG---PDGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGK--N 926 (1033)
Q Consensus 855 ~ILskL~HPNIVrLyG~f~d~---~eg~l~LVmEYmegGSL~dlL~~~---~k~Lse~~rl~Ia~QIa~GLeYLHsk--G 926 (1033)
..|-++.|.|||+++.|+.+. +.....+++|||..|+|..+|++. .+.+....-.+|+.||+.||.|||+. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 345566799999999998762 234678999999999999999863 44577888889999999999999986 7
Q ss_pred ccccCCCCCcEEEecCCCCCCeEEEEecCCcccc-----ccccccCCcCCCCcccccccccCCCccccchhhhcccchhh
Q 001678 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-----QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCC 1001 (1033)
Q Consensus 927 IVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~-----~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvil 1001 (1033)
|+|+++..+-|++. .++.+||.--...... ..........+-++|.|||.=.. .
T Consensus 199 iihgnlTc~tifiq----~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--t--------------- 257 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQ----HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--T--------------- 257 (458)
T ss_pred cccCCcchhheeec----CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--c---------------
Confidence 99999999999998 7778886422111110 00111223346788999995322 1
Q ss_pred ccCCcccchHHHHHHHHHHHcc
Q 001678 1002 FQLKWSYDCYSLGILFFFLQFI 1023 (1033)
Q Consensus 1002 ye~t~kvDVWSLGVVLYeLLTG 1023 (1033)
..+.++|||+||.-..+|..+
T Consensus 258 -n~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 258 -NTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred -ccccchhhhhhhHHHHHHHHh
Confidence 234455666666555555544
|
|
| >cd05992 PB1 The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.1e-06 Score=75.94 Aligned_cols=74 Identities=36% Similarity=0.657 Sum_probs=59.1
Q ss_pred CeeeecCceeEEEcc-CCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCe
Q 001678 42 KLRYVGGETRIVSLP-RDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTR 117 (1033)
Q Consensus 42 ~l~Y~gG~tri~~v~-r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r 117 (1033)
+++|- |++|.+.|+ ++++|.+|+++|.+.++. .+.|||. .||- .+|++++|+||..|++.+.+ ....+
T Consensus 4 K~~~~-~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~y~--D~e~-d~v~l~sd~Dl~~a~~~~~~----~~~~~ 75 (81)
T cd05992 4 KVKYG-GEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP--DEDG-DLVTISSDEDLEEAIEEARR----SGSKK 75 (81)
T ss_pred EEEec-CCCEEEEEecCCCCHHHHHHHHHHHhCCCCCcEEEEee--CCCC-CEEEeCCHHHHHHHHHHHhh----cCCcc
Confidence 34555 566777777 999999999999999987 4677777 5553 78999999999999999977 34467
Q ss_pred EEEEEe
Q 001678 118 LRIFLF 123 (1033)
Q Consensus 118 ~r~flf 123 (1033)
+||+++
T Consensus 76 l~l~v~ 81 (81)
T cd05992 76 LRLFVF 81 (81)
T ss_pred EEEEeC
Confidence 888875
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2e-06 Score=94.73 Aligned_cols=142 Identities=19% Similarity=0.044 Sum_probs=102.4
Q ss_pred eEEEEecccCcEEEEEEEE-cCcceEEEEeeccccCCCc------------h--hHHHHHHHHHHHHHHHHhcCCC--Cc
Q 001678 803 EEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKP------------S--ERERLIADFWKEALLLSSLHHP--NV 865 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~------------~--ere~~i~~f~rEi~ILskL~HP--NI 865 (1033)
.+...||.|.-+.||.|.. +|.++|||.-+.....-+. . .........++|..+|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4557899999999999988 4899999975533211000 0 0012234567899999999865 78
Q ss_pred ceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCC
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945 (1033)
Q Consensus 866 VrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~ 945 (1033)
.+.+++ +..++||||++|-.|...- ++.+....|+..|+.-+.-+-..||||+|+.+=|||++ .
T Consensus 174 P~P~~~------nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~----~ 237 (304)
T COG0478 174 PKPIAW------NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT----E 237 (304)
T ss_pred CCcccc------ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe----c
Confidence 888775 5579999999886665432 12334445566666666666689999999999999999 7
Q ss_pred CCeEEEEecCCcccc
Q 001678 946 RPVCKIGDLGLSKVK 960 (1033)
Q Consensus 946 ~g~VKLiDFGLAr~~ 960 (1033)
+|.++++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 788999999776543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=9.5e-06 Score=86.90 Aligned_cols=145 Identities=16% Similarity=0.151 Sum_probs=101.9
Q ss_pred ecccCcEEEEEEEEcCcceEEEEeeccccCC-C-chhHHHHHHHHHHHHHHHHhcCCCC--cceEEEEEE---cCCCCce
Q 001678 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAG-K-PSERERLIADFWKEALLLSSLHHPN--VVSFYGIVR---DGPDGSL 880 (1033)
Q Consensus 808 LGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~-k-~~ere~~i~~f~rEi~ILskL~HPN--IVrLyG~f~---d~~eg~l 880 (1033)
-|+||.+-|++....|+.+-+|......... . +.. ...|.+|+..+..|..-+ +.++. ++. .+..-..
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g----~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA 100 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFG----RPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA 100 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCC----chHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence 3569999999988888888888764211110 0 111 247889999998886332 44444 222 2222346
Q ss_pred EEEEeeccC-CcHHHHHHhcC-CccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 881 ATVTEFMVN-GSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 881 ~LVmEYmeg-GSL~dlL~~~~-k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
+||+|-+.+ -+|.+++.+.. ...+...+..+..+|++.|.-||+.|+.|+|+.+.|||++..+ ...++++||.-++
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g--~~~v~lIDlEk~r 178 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG--KAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC--CeeEEEEEhhccc
Confidence 799998753 58999886532 2356677778899999999999999999999999999998332 3469999999776
Q ss_pred c
Q 001678 959 V 959 (1033)
Q Consensus 959 ~ 959 (1033)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.2e-06 Score=94.81 Aligned_cols=197 Identities=18% Similarity=0.143 Sum_probs=129.1
Q ss_pred EEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHH-HhcCCCCcceEEEE----EEcCCCCc
Q 001678 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPNVVSFYGI----VRDGPDGS 879 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~IL-skL~HPNIVrLyG~----f~d~~eg~ 879 (1033)
...||+|+.+.+|..-.-+.. +.|++....... .. +.+..| +.-.||-+-.-+.| .....++.
T Consensus 16 gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~----~a-------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAA----QA-------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CccccCCccceeeecchhhch-hheeecCCCchH----HH-------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 467999999999965333333 448776542211 11 112222 33345543321111 11222333
Q ss_pred -eEEEEeeccCCc-HHHHHH-----hcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEE
Q 001678 880 -LATVTEFMVNGS-LKQFLQ-----KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 880 -l~LVmEYmegGS-L~dlL~-----~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLi 952 (1033)
+-++|..+.+.. +..++. +......|.-.++.++.|+.+...||..|.+-+|+.++|+|+. +.+.|.|.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs----d~~~V~LV 159 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS----DDSKVVLV 159 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee----cCceEEEE
Confidence 678888887652 333332 1223478999999999999999999999999999999999998 67889998
Q ss_pred ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHcc-CCCCCCC
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI-LCFIDFF 1030 (1033)
Q Consensus 953 DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTG-k~PFd~~ 1030 (1033)
|-..-....+......-+|...|.+||.-.-+. +.-.+-+...|-|.|||++|+||+| ..||.-+
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~s-------------f~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPS-------------FVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhcccc-------------ccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 865443334444455667899999999754221 1112456678999999999999998 8888543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.7e-05 Score=84.01 Aligned_cols=148 Identities=16% Similarity=0.117 Sum_probs=98.1
Q ss_pred ccccccCCCceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHH------HHHHHHHHhcC---CC
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADF------WKEALLLSSLH---HP 863 (1033)
Q Consensus 793 ~~~~i~~~dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f------~rEi~ILskL~---HP 863 (1033)
-...+...+|..++.+-......|.+-..+++.+++|..+... ...++....| .+++..+.++. --
T Consensus 24 l~~~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~-----~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~ 98 (229)
T PF06176_consen 24 LGEKILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREEN-----RRPERRFKSFFKGSEYSRLINNTDKIRNEGFT 98 (229)
T ss_pred HHHHHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhh-----hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence 3445667899999999999999999999999999999876432 1122222222 22333333332 22
Q ss_pred CcceEEEEEEc---CCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q 001678 864 NVVSFYGIVRD---GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (1033)
Q Consensus 864 NIVrLyG~f~d---~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd 940 (1033)
.+..++.+..- .--...+|||||++|..|.++.. +++ .++..|.++|.-||+.|++|+|+.|.|++++
T Consensus 99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS 169 (229)
T ss_pred ccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence 23332222221 00123568999999988877642 222 2445677889999999999999999999997
Q ss_pred cCCCCCCeEEEEecCCccc
Q 001678 941 MRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 941 ~~d~~~g~VKLiDFGLAr~ 959 (1033)
++.++++||+..+.
T Consensus 170 -----~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 170 -----NNGIRIIDTQGKRM 183 (229)
T ss_pred -----CCcEEEEECccccc
Confidence 34599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.9e-05 Score=92.90 Aligned_cols=165 Identities=18% Similarity=0.167 Sum_probs=119.8
Q ss_pred EEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcC--CCCceEEEEeeccC
Q 001678 814 GSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG--PDGSLATVTEFMVN 889 (1033)
Q Consensus 814 G~VYkAk~--kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~--~eg~l~LVmEYmeg 889 (1033)
.+.||+.. +|..|++|+++........ ..-.-+++++++.|.|||++.++|.+. ....+++|++|+++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n--------k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTN--------KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcc--------cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 57788865 6888999998544332221 112346789999999999999988742 13468899999975
Q ss_pred -CcHHHHHHh--------------cCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEec
Q 001678 890 -GSLKQFLQK--------------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 890 -GSL~dlL~~--------------~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDF 954 (1033)
++|.++.-. .+...+++.+|.++.|+..||.++|+.|+.-+-|.+.+||++ .+-+++|...
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~----G~~RIriS~C 437 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT----GKMRIRISGC 437 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee----CcceEEEecc
Confidence 477776532 133467889999999999999999999999999999999998 5558999888
Q ss_pred CCccccccccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccC
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024 (1033)
Q Consensus 955 GLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk 1024 (1033)
|+......... |.+ +...+-|.=.||.+++-|.||.
T Consensus 438 ~i~Dvl~~d~~-------------~~l---------------------e~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 438 GIMDVLQEDPT-------------EPL---------------------ESQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred cceeeecCCCC-------------cch---------------------hHHhhhhHHHHHHHHHHHhhcc
Confidence 87765433210 112 1223447788888888888873
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.5e-05 Score=95.16 Aligned_cols=147 Identities=18% Similarity=0.183 Sum_probs=94.1
Q ss_pred EEecccCcEEEEEEEEc-CcceEEEEeeccccCCCc--------------------------hhHH------HHHHHHHH
Q 001678 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKP--------------------------SERE------RLIADFWK 852 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~--------------------------~ere------~~i~~f~r 852 (1033)
.-|+.++-|.||+|+.. |+.||||+.++.....-. ..-+ ...-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999996 899999998754321000 0001 11123455
Q ss_pred HHHHHHhcC-----CCCcceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHH-HHHHHhCC
Q 001678 853 EALLLSSLH-----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG-MEYLHGKN 926 (1033)
Q Consensus 853 Ei~ILskL~-----HPNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~G-LeYLHskG 926 (1033)
|...+.++. .++|. +=.++.+- .+.-.|+|||++|..+.+........++.+. ++..++++ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~-VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVY-VPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeE-eceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 666665553 33322 22222221 2345899999999999988543333355333 33333333 34444589
Q ss_pred ccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 927 IVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
++|.|..|.||+++ .++.+.+.|||+.....
T Consensus 286 ffHaDpHpGNi~v~----~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVR----SDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEe----cCCcEEEEcCcceecCC
Confidence 99999999999999 66899999999987554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.8e-05 Score=82.85 Aligned_cols=132 Identities=27% Similarity=0.284 Sum_probs=95.3
Q ss_pred eEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcc-eEEEEEEcCCCCceE
Q 001678 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV-SFYGIVRDGPDGSLA 881 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIV-rLyG~f~d~~eg~l~ 881 (1033)
.+.+.|++|++|.||++.|.+..+|+|+-+.+.. ...+..|+++|..+.-.++. ++|.+-. .+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----------r~~l~kEakiLeil~g~~~~p~vy~yg~------~~ 88 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----------RRNLEKEAKILEILAGEGVTPEVYFYGE------DF 88 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcc----------hhhHHHHHHHHHHhhhcCCCceEEEech------hh
Confidence 4457899999999999999999999998775432 13677899999999877765 5555533 36
Q ss_pred EEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC--CcEEEecCCCCCCeEEEEecCCccc
Q 001678 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKC--ENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 882 LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKP--sNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
+.|||+.|-.|.++-... +...+ ..++..---|-..||-|+.|.- .||++. ++.+.|+||..|+.
T Consensus 89 i~me~i~G~~L~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-----~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVN-----DRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEec-----CCcEEEEEccchhh
Confidence 679999988888765321 22222 2344554456678999999974 566664 44899999999986
Q ss_pred cccc
Q 001678 960 KQQT 963 (1033)
Q Consensus 960 ~~~~ 963 (1033)
...+
T Consensus 156 k~~p 159 (201)
T COG2112 156 KKKP 159 (201)
T ss_pred ccCC
Confidence 5443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.2e-05 Score=83.72 Aligned_cols=147 Identities=22% Similarity=0.115 Sum_probs=99.2
Q ss_pred EEEEecccCcEEEEEEEE-cCcceEEEEeeccccCCCc----------------hhHHHHHHHHHHHHHHHHhcC--CCC
Q 001678 804 EVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKP----------------SERERLIADFWKEALLLSSLH--HPN 864 (1033)
Q Consensus 804 ilekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~----------------~ere~~i~~f~rEi~ILskL~--HPN 864 (1033)
....|..|.-+.||+|.. .+..+|+|+++......+. ..+.....-..+|+..|+++. +-.
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 345788999999999976 5788999998765432221 111122223456788888875 455
Q ss_pred cceEEEEEEcCCCCceEEEEeeccCC-cHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecC
Q 001678 865 VVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMR 942 (1033)
Q Consensus 865 IVrLyG~f~d~~eg~l~LVmEYmegG-SL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs-kGIVHRDIKPsNILLd~~ 942 (1033)
+.+-+.+... .|||||+... .-.-.|+.. .+.......+..++++.+.-|-. .++||+||+.=|||+.
T Consensus 132 vP~Pi~~~~n------VLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-- 201 (268)
T COG1718 132 VPEPIAFRNN------VLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-- 201 (268)
T ss_pred CCCceeecCC------eEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE--
Confidence 6666665433 7999999433 111112222 12333566677788999988877 8999999999999997
Q ss_pred CCCCCeEEEEecCCccccccc
Q 001678 943 DPQRPVCKIGDLGLSKVKQQT 963 (1033)
Q Consensus 943 d~~~g~VKLiDFGLAr~~~~~ 963 (1033)
.+.+.|||||.|.....+
T Consensus 202 ---~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 ---DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred ---CCeEEEEECccccccCCC
Confidence 468999999998765433
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.4e-05 Score=80.17 Aligned_cols=136 Identities=16% Similarity=0.191 Sum_probs=80.9
Q ss_pred EEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCC--cceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN--VVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPN--IVrLyG~f~d~~eg~l~LV 883 (1033)
..||+|..+.||+. .+.++++|...... . .....+|.++++.+..-. +.+.+++... .+...+|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~------~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF------D----KETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC------C----HHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeee
Confidence 67899999999984 35578889876422 0 123467888888886443 4667777665 4557889
Q ss_pred EeeccCCc-HHHHH--------------Hh-------cC-CccCHHHHH-HHHH----------HHHH-HHHHHHh----
Q 001678 884 TEFMVNGS-LKQFL--------------QK-------KD-RTIDRRKRL-IIAM----------DAAF-GMEYLHG---- 924 (1033)
Q Consensus 884 mEYmegGS-L~dlL--------------~~-------~~-k~Lse~~rl-~Ia~----------QIa~-GLeYLHs---- 924 (1033)
||+++|.+ +...+ .+ -. ......... .+.. .+.. ...+|..
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99998863 21111 10 00 000101000 0000 1111 1223331
Q ss_pred CCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 925 kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
..++|+|+.|.||+++ ..+ +.|+||+.+..-
T Consensus 153 ~~~~HgD~~~~Nii~~----~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 153 STCLHGDFQIGNLITS----GKG-TYWIDLGDFGYG 183 (226)
T ss_pred CceEecCCCCCcEEEc----CCC-cEEEechhcCcC
Confidence 2578999999999998 445 889999988643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00015 Score=74.33 Aligned_cols=80 Identities=18% Similarity=0.209 Sum_probs=56.5
Q ss_pred EEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCC--CcceEEEEEEcC-CCCceE
Q 001678 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVRDG-PDGSLA 881 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HP--NIVrLyG~f~d~-~eg~l~ 881 (1033)
++.|+.|..+.||+....+..+++|..... .....+.+|..+++.|... -+.+++...... .....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 578999999999999998889999986532 1223566788888877533 356777654332 233578
Q ss_pred EEEeeccCCcHHH
Q 001678 882 TVTEFMVNGSLKQ 894 (1033)
Q Consensus 882 LVmEYmegGSL~d 894 (1033)
++|+|+++..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.91 E-value=6e-05 Score=80.38 Aligned_cols=135 Identities=23% Similarity=0.214 Sum_probs=94.8
Q ss_pred CCceEEEEecccCc-EEEEEEEEcCcceEEEEeeccccCCCch------h-------HHHHHHHHHHHHHHHHhcC---C
Q 001678 800 DDLEEVRELGSGTY-GSVYHGKWRGSDVAIKRIKASCFAGKPS------E-------RERLIADFWKEALLLSSLH---H 862 (1033)
Q Consensus 800 ~dYeilekLGeGgF-G~VYkAk~kG~kVAIKvlk~~~~~~k~~------e-------re~~i~~f~rEi~ILskL~---H 862 (1033)
.+++.++.||.|.- |.||+++..|..+|+|+++.-.+..... . ......-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 9999999999999999943222211110 0 0123446778888777775 5
Q ss_pred CCc--ceEEEEEEcC----------------CCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh
Q 001678 863 PNV--VSFYGIVRDG----------------PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924 (1033)
Q Consensus 863 PNI--VrLyG~f~d~----------------~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs 924 (1033)
.++ |+++||..-. ......||.||+.... .+... -+.+|++-|..||+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 556 8999998432 1112467888875543 12222 24567788899999
Q ss_pred CCccccCCCCCcEEEecCCCCCCeEEEEecCCc
Q 001678 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 925 kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLA 957 (1033)
.||+-+|+|+.|..= =||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~~---------G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYRG---------GKLVDFSSS 206 (207)
T ss_pred CCeeeccCccccccC---------CEEEecccC
Confidence 999999999999962 269999864
|
|
| >cd06407 PB1_NLP A PB1 domain is present in NIN like proteins (NLP), a key enzyme in a process of establishment of symbiosis betweeen legumes and nitrogen fixing bacteria (Rhizobium) | Back alignment and domain information |
|---|
Probab=97.88 E-value=9e-05 Score=68.37 Aligned_cols=71 Identities=25% Similarity=0.419 Sum_probs=61.1
Q ss_pred ecCceeEEEccCCCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEE
Q 001678 46 VGGETRIVSLPRDVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIF 121 (1033)
Q Consensus 46 ~gG~tri~~v~r~~~~~~l~~kl~~~~~~----~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r~r~f 121 (1033)
.|||++.+.++.+++|.+|+.++++.++. .++|||. .|| .-.|+++||+||+.-++-|... +..++|||
T Consensus 7 ~~~d~~r~~l~~~~~~~~L~~~i~~r~~~~~~~~f~LkY~--Dde-gd~v~ltsd~DL~eai~i~~~~----~~~~v~l~ 79 (82)
T cd06407 7 YGEEKIRFRLPPSWGFTELKQEIAKRFKLDDMSAFDLKYL--DDD-EEWVLLTCDADLEECIDVYRSS----GSHTIRLL 79 (82)
T ss_pred eCCeEEEEEcCCCCCHHHHHHHHHHHhCCCCCCeeEEEEE--CCC-CCeEEeecHHHHHHHHHHHHHC----CCCeEEEE
Confidence 38899999999999999999999999874 5999999 666 8899999999999888877553 45678888
Q ss_pred Ee
Q 001678 122 LF 123 (1033)
Q Consensus 122 lf 123 (1033)
+-
T Consensus 80 v~ 81 (82)
T cd06407 80 VH 81 (82)
T ss_pred ee
Confidence 74
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes like osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-inte |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00019 Score=76.46 Aligned_cols=77 Identities=17% Similarity=0.110 Sum_probs=52.3
Q ss_pred EEecccCc-EEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEcCCCCceEEE
Q 001678 806 RELGSGTY-GSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLATV 883 (1033)
Q Consensus 806 ekLGeGgF-G~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNIVrLyG~f~d~~eg~l~LV 883 (1033)
..|..|.+ +.||+....+.+++||+..... ...+.+|+.+++.+. +--+.+++++... .+..++|
T Consensus 4 ~~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv 70 (244)
T cd05150 4 ERVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLL 70 (244)
T ss_pred eecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEE
Confidence 34555655 8899987777778888765431 113456777877774 3346677777665 3567899
Q ss_pred EeeccCCcHHHH
Q 001678 884 TEFMVNGSLKQF 895 (1033)
Q Consensus 884 mEYmegGSL~dl 895 (1033)
||+++|.+|...
T Consensus 71 ~e~i~G~~l~~~ 82 (244)
T cd05150 71 TSAVPGVPAAAL 82 (244)
T ss_pred EEeeCCccHhHh
Confidence 999998877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00011 Score=87.97 Aligned_cols=150 Identities=17% Similarity=0.121 Sum_probs=94.6
Q ss_pred EEecccCcEEEEEEEEc-CcceEEEEeeccccCCCchh-----------------------HHH------HHHHHHHHHH
Q 001678 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSE-----------------------RER------LIADFWKEAL 855 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~~e-----------------------re~------~i~~f~rEi~ 855 (1033)
+.|+..+.|.||+|+.+ |+.||||+.++.....-..+ -.+ ..-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56999999999999884 77899999875532110000 000 0113455555
Q ss_pred HHHhc----CCCC------cceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHH-HHHHh
Q 001678 856 LLSSL----HHPN------VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM-EYLHG 924 (1033)
Q Consensus 856 ILskL----~HPN------IVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GL-eYLHs 924 (1033)
...+. .|-+ |.++|-.+. +.-.|+||||+|..+.|+-.-....++...+ +..+.++. +-|=.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHh
Confidence 44333 3444 444443332 3458999999998777764433333555543 33333332 22345
Q ss_pred CCccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 925 kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
.|++|+|=.|.||++..+...+..+.|.|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 79999999999999985544578899999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.61 E-value=1.2e-05 Score=96.11 Aligned_cols=171 Identities=16% Similarity=0.123 Sum_probs=114.5
Q ss_pred ceEEEEecccCcEEEEEEEEcCcce-EEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKWRGSDV-AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~kG~kV-AIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPN-IVrLyG~f~d~~eg~ 879 (1033)
+.....+++|++++++|.+...++. ..+.+... ....-++++|.+++||| .+..++-++. +..
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCc--ccc
Confidence 4445568899999999987654432 23333221 12234678999999999 5554444333 678
Q ss_pred eEEEEeeccCC-cHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCCCCeEEEEecCCcc
Q 001678 880 LATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 880 l~LVmEYmegG-SL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr 958 (1033)
.+++++++..+ +-...+......+.+-+...+.+.-+++|++||+..-+|+| |||.. ....|+.||+...
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----EEEVKLLDFAVPP 379 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----ccccccccccCCc
Confidence 88999999776 22222111112233344456667778899999998889999 88875 3678999999988
Q ss_pred ccccccccCCcCCCCcccccccccCCCccccchhhhcccc
Q 001678 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLK 998 (1033)
Q Consensus 959 ~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLG 998 (1033)
.+..........+|+.|+|||++.... +..+.|.|+++
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~--~~~~p~~~~~~ 417 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENT--IDGCPDSGSLA 417 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccc--cccCCCccCCC
Confidence 877665666778999999999887653 33444444444
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00063 Score=85.69 Aligned_cols=81 Identities=15% Similarity=0.229 Sum_probs=56.2
Q ss_pred EEEEecccCcEEEEEEEEcC----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC-CCCc--ceEEEEEEcC-
Q 001678 804 EVRELGSGTYGSVYHGKWRG----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNV--VSFYGIVRDG- 875 (1033)
Q Consensus 804 ilekLGeGgFG~VYkAk~kG----~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~-HPNI--VrLyG~f~d~- 875 (1033)
.++.|+.|.++.+|+....+ ..+++|+......... ...+.+|+.+|+.+. |.+| .+++.++.+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~ 114 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS 114 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence 45788999999999987754 3678786543221110 125678999999996 6665 7888887652
Q ss_pred CCCceEEEEeeccCCc
Q 001678 876 PDGSLATVTEFMVNGS 891 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGS 891 (1033)
..+..|+||||++|..
T Consensus 115 v~G~~flVME~v~G~~ 130 (822)
T PLN02876 115 VIGTAFYIMEYLEGRI 130 (822)
T ss_pred cCCCceEEEEecCCcc
Confidence 1246789999998764
|
|
| >cd06408 PB1_NoxR The PB1 domain is present in the Epichloe festucae NoxR protein (NADPH oxidase regulator), a key regulator of NADPH oxidase isoform, NoxA | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00026 Score=65.96 Aligned_cols=72 Identities=15% Similarity=0.391 Sum_probs=59.3
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCC--ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcC--CCCCCeEEEEE
Q 001678 47 GGETRIVSLPRDVTYEELMSRMRELYEG--AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGS--GDGFTRLRIFL 122 (1033)
Q Consensus 47 gG~tri~~v~r~~~~~~l~~kl~~~~~~--~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~--~~~~~r~r~fl 122 (1033)
+|++|++.|+.+|+|.+|..|+.+.|+. .++|||+ .| ...|++++++||+-.+.-.-...+ .+.-+|+-+.+
T Consensus 10 ~~Dv~~i~v~~~i~f~dL~~kIrdkf~~~~~~~iKyk--DE--GD~iti~sq~DLd~Ai~~a~~~~~~~~~~~~~~e~w~ 85 (86)
T cd06408 10 QDDTRYIMIGPDTGFADFEDKIRDKFGFKRRLKIKMK--DD--GDMITMGDQDDLDMAIDTARSEARKQGSDMGKLEIWV 85 (86)
T ss_pred cCcEEEEEcCCCCCHHHHHHHHHHHhCCCCceEEEEE--cC--CCCccccCHHHHHHHHHHHHHHHHhhcccccceeeec
Confidence 7899999999999999999999999987 4999999 54 789999999999999988864322 22336666554
|
NoxA is essential for growth control of the fungal endophyte in plant tissue in the process of symbiotic interaction between a fungi and its plant host. The Epichloe festucae p67(phox)-like regulator, NoxR, dispensable in culture but essential in plants for the symbiotic interaction. Plants infected with a noxR deletion mutant show severe stunting and premature senescence, whereas hyphae in the meristematic tissues show increased branching leading to increased fungal colonization of pseudostem and leaf blade tissue. The PB1 domain is a modular domain mediating specific protein-protein interactions which a play role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00025 Score=74.45 Aligned_cols=98 Identities=26% Similarity=0.183 Sum_probs=78.9
Q ss_pred HHHHHHHhcCC-CCcceEEEEEEcCCCCceEEEEeeccCCcHHHH---HHhcCCccCHHHHHHHHHHHHHHHHHHHh---
Q 001678 852 KEALLLSSLHH-PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF---LQKKDRTIDRRKRLIIAMDAAFGMEYLHG--- 924 (1033)
Q Consensus 852 rEi~ILskL~H-PNIVrLyG~f~d~~eg~l~LVmEYmegGSL~dl---L~~~~k~Lse~~rl~Ia~QIa~GLeYLHs--- 924 (1033)
.|.-+++.+++ +++.+++|+|-. ++|+||...+++... +.+. ...+|..+++||.++++.+++|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 57788888986 699999999865 779999987766421 1111 236899999999999999999987
Q ss_pred CCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 925 kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
..+.-.|++++|+-++ .++.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~----~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVN----DDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEe----CCCcEEEEechhcchh
Confidence 3588899999999998 6788999999977543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0011 Score=70.52 Aligned_cols=139 Identities=19% Similarity=0.226 Sum_probs=92.7
Q ss_pred EEecccCcEEEEEEEEcCcceEEEEeeccccCCCch--------hHHHHHHHHHHHHHHHHhcC------CCCcceEEEE
Q 001678 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPS--------ERERLIADFWKEALLLSSLH------HPNVVSFYGI 871 (1033)
Q Consensus 806 ekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~--------ere~~i~~f~rEi~ILskL~------HPNIVrLyG~ 871 (1033)
..||+|+.=.||.--. +...+||++.......... ......+...+|+.-...+. +..|.++||+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 5699999999996443 3446889887654110000 00111234556666555554 8889999999
Q ss_pred EEcCCCCceEEEEeeccC------CcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCC
Q 001678 872 VRDGPDGSLATVTEFMVN------GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945 (1033)
Q Consensus 872 f~d~~eg~l~LVmEYmeg------GSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~~ 945 (1033)
.++ +-...+|+|.+.+ -+|.+++.+.. ++. .... .+-.-.+||-...|+.+||+|.||++...+..
T Consensus 86 veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VET--NLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred Eec--CCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 998 4557889998753 36888885543 444 2222 33344578888999999999999999876544
Q ss_pred CCeEEEEe
Q 001678 946 RPVCKIGD 953 (1033)
Q Consensus 946 ~g~VKLiD 953 (1033)
...+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 44788887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00065 Score=72.35 Aligned_cols=75 Identities=17% Similarity=0.164 Sum_probs=44.5
Q ss_pred EEecccCcE-EEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCC---CcceEEEEEEcCCC-Cce
Q 001678 806 RELGSGTYG-SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP---NVVSFYGIVRDGPD-GSL 880 (1033)
Q Consensus 806 ekLGeGgFG-~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HP---NIVrLyG~f~d~~e-g~l 880 (1033)
+.|+.|+.. .||+. +..+++|..+... ....+.+|..++..|... -+.++++.....+. +..
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 567777766 58875 3457778644311 113567788888877532 34455554333211 234
Q ss_pred EEEEeeccCCcHH
Q 001678 881 ATVTEFMVNGSLK 893 (1033)
Q Consensus 881 ~LVmEYmegGSL~ 893 (1033)
++||++++|.++.
T Consensus 70 ~~l~~~i~G~~l~ 82 (235)
T cd05155 70 WSVYRWLEGETAT 82 (235)
T ss_pred eEEEEeecCCCCC
Confidence 7899999886653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd06405 PB1_Mekk2_3 The PB1 domain is present in the two mitogen-activated protein kinase kinases MEKK2 and MEKK3 which are two members of the signaling kinase cascade involved in angiogenesis and early cardiovascular development | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0008 Score=60.84 Aligned_cols=70 Identities=26% Similarity=0.542 Sum_probs=60.4
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001678 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (1033)
Q Consensus 47 gG~tri~~v~r~~~~~~l~~kl~~~~~~~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r~r~flf 123 (1033)
-||-||+.++|.+.|.||..|+.+.||..+.+-|-.= .-||-+.|.|||+.-|+-.|+ .+ ....||+.|-
T Consensus 8 ~gEKRIi~f~RPvkf~dl~~kv~~afGq~mdl~ytn~----eL~iPl~~Q~DLDkAie~ld~-s~--~~ksLRilL~ 77 (79)
T cd06405 8 NGEKRIIQFPRPVKFKDLQQKVTTAFGQPMDLHYTNN----ELLIPLKNQEDLDRAIELLDR-SP--HMKSLRILLS 77 (79)
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEecc----cEEEeccCHHHHHHHHHHHcc-Cc--cccceeEeEe
Confidence 4899999999999999999999999999999998732 279999999999999999999 22 2345888775
|
The PB1 domain of MEKK2 (and/or MEKK3) interacts with the PB1 domain of another member of the kinase cascade Map2k5. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, f |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0019 Score=68.12 Aligned_cols=73 Identities=12% Similarity=0.131 Sum_probs=46.6
Q ss_pred EEEecccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEcCCCCce
Q 001678 805 VRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP-NVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~k---G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HP-NIVrLyG~f~d~~eg~l 880 (1033)
++.|..|-...+|+.... +..|++|+....... . ....+|+.+++.+... -..++++.+..
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~~------ 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--I-------IDRERELRIHKLLSKHGLAPKLYATFQN------ 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--e-------ecHHHHHHHHHHHHhCCCCCeEEEEeCC------
Confidence 467888888999998875 467889976532111 0 1223577778777533 34555554322
Q ss_pred EEEEeeccCCcH
Q 001678 881 ATVTEFMVNGSL 892 (1033)
Q Consensus 881 ~LVmEYmegGSL 892 (1033)
.+||||++|.++
T Consensus 68 ~~l~e~i~G~~l 79 (235)
T cd05157 68 GLIYEFIPGRTL 79 (235)
T ss_pred cEEEEeeCCCcC
Confidence 479999988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=5.8e-05 Score=91.25 Aligned_cols=84 Identities=24% Similarity=0.348 Sum_probs=59.1
Q ss_pred HHHHHHHHHHhC-CccccCCCCCcEEEecCCCCCCeEEEEecCCccccccccc----------cCCcCCCCccccccccc
Q 001678 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV----------SGGVRGTLPWMAPELLS 982 (1033)
Q Consensus 914 QIa~GLeYLHsk-GIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~~~~----------s~~~~GT~~YmAPEvi~ 982 (1033)
+++.||.|+|.. ++||+.|.|++|.++ ..+..||+.|+++........ .....-...|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n----a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN----ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec----cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 455899999965 999999999999998 788999999998765433111 11112456699999987
Q ss_pred CCCccccchhhhcccchhhcc
Q 001678 983 GKSHMVTEKVTLFSLKFCCFQ 1003 (1033)
Q Consensus 983 gk~~~~sekvDVwSLGvilye 1003 (1033)
+. ..+.++|+||+|+.+|-
T Consensus 183 ~~--~~~~~sd~fSlG~li~~ 201 (700)
T KOG2137|consen 183 GT--TNTPASDVFSLGVLIYT 201 (700)
T ss_pred cc--cccccccceeeeeEEEE
Confidence 63 34445555555554443
|
|
| >cd06401 PB1_TFG The PB1 domain found in TFG protein, an oncogenic gene product and fusion partner to nerve growth factor tyrosine kinase receptor TrkA and to the tyrosine kinase ALK | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0023 Score=59.07 Aligned_cols=53 Identities=30% Similarity=0.670 Sum_probs=44.9
Q ss_pred cCceeEEEccC-CCChHHHHHHHHHHhC------CceEEEeeCCCCCCCceeeecChhhHHHH
Q 001678 47 GGETRIVSLPR-DVTYEELMSRMRELYE------GAVVLKYQQPDEDLDALVSVVNDDDVINM 102 (1033)
Q Consensus 47 gG~tri~~v~r-~~~~~~l~~kl~~~~~------~~~~~kyqlp~edld~Lisv~~deDl~~m 102 (1033)
|||.|.+.++. .++|.+|+..+..++. .+|.|||. .|| ..||+||+++||.--
T Consensus 8 g~DiR~~~~~~~~~t~~~L~~~v~~~F~~~~~~~~~flIKYk--D~d-GDlVTIts~~dL~~A 67 (81)
T cd06401 8 GDDIRRIPIHNEDITYDELLLMMQRVFRGKLGSSDDVLIKYK--DED-GDLITIFDSSDLSFA 67 (81)
T ss_pred CCeEEEEeccCccccHHHHHHHHHHHhccccCCcccEEEEEE--CCC-CCEEEeccHHHHHHH
Confidence 99999999998 5899999999987775 25899999 333 569999999999754
|
The PB1 domain is a modular domain mediating specific protein-protein interaction in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The PB1 domains of TFG represent a type I/II PB1 domain. The physiological function of TFG remains unknown. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.004 Score=71.78 Aligned_cols=148 Identities=24% Similarity=0.145 Sum_probs=99.5
Q ss_pred EEEEecccCcEEEEEEEE-cCcceEEEEeeccccCCCchhH------------------HHHHHHHHHHHHHHHhcCCCC
Q 001678 804 EVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSER------------------ERLIADFWKEALLLSSLHHPN 864 (1033)
Q Consensus 804 ilekLGeGgFG~VYkAk~-kG~kVAIKvlk~~~~~~k~~er------------------e~~i~~f~rEi~ILskL~HPN 864 (1033)
+-.+|..|.-+.||.|.. .|..+|||+++.+.+.-+..++ ....-...+|++.|++|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 446888999999999976 5788999998866544332221 111223446778888887655
Q ss_pred cceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEecCC
Q 001678 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLKCENLLVNMRD 943 (1033)
Q Consensus 865 IVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLH-skGIVHRDIKPsNILLd~~d 943 (1033)
|...--+... ...|||+|+- .+=+-.=.-+...++...+..+-.+++.-|.-|- ..++||.||.-=|+|+.
T Consensus 228 IP~PePIlLk----~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh--- 299 (520)
T KOG2270|consen 228 IPCPEPILLK----NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH--- 299 (520)
T ss_pred CCCCCceeee----cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE---
Confidence 5432222221 3579999993 3321111112234666677777788888888875 56999999999999996
Q ss_pred CCCCeEEEEecCCccccc
Q 001678 944 PQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 944 ~~~g~VKLiDFGLAr~~~ 961 (1033)
.|.+.|+|.+.+-...
T Consensus 300 --dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 --DGKLYIIDVSQSVEHD 315 (520)
T ss_pred --CCEEEEEEccccccCC
Confidence 6899999999876543
|
|
| >cd06398 PB1_Joka2 The PB1 domain is present in the Nicotiana plumbaginifolia Joka2 protein which interacts with sulfur stress inducible UP9 protein | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0055 Score=57.79 Aligned_cols=74 Identities=30% Similarity=0.599 Sum_probs=57.9
Q ss_pred eeeecCceeEEEccC-----CCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCC
Q 001678 43 LRYVGGETRIVSLPR-----DVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGD 113 (1033)
Q Consensus 43 l~Y~gG~tri~~v~r-----~~~~~~l~~kl~~~~~~----~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~ 113 (1033)
..| ||++|-++++. +++|.+|..|+++++.. .+.|||. .|| ..+|.++||+||+.-|+..-+ ++
T Consensus 5 v~y-~~~~rRf~l~~~~~~~d~~~~~L~~kI~~~f~l~~~~~~~l~Y~--Ded-gd~V~l~~D~DL~~a~~~~~~---~~ 77 (91)
T cd06398 5 VKY-GGTLRRFTFPVAENQLDLNMDGLREKVEELFSLSPDADLSLTYT--DED-GDVVTLVDDNDLTDAIQYFCS---GS 77 (91)
T ss_pred EEe-CCEEEEEEeccccccCCCCHHHHHHHHHHHhCCCCCCcEEEEEE--CCC-CCEEEEccHHHHHHHHHHHhc---cC
Confidence 344 88999999995 79999999999999864 5899998 543 589999999999987775423 34
Q ss_pred CCCeEEEEEe
Q 001678 114 GFTRLRIFLF 123 (1033)
Q Consensus 114 ~~~r~r~flf 123 (1033)
+..-|||++-
T Consensus 78 ~~~~lrl~v~ 87 (91)
T cd06398 78 RLNPLRIDVT 87 (91)
T ss_pred CCceEEEEEE
Confidence 4455888764
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.004 Score=67.12 Aligned_cols=135 Identities=14% Similarity=0.116 Sum_probs=76.2
Q ss_pred ecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEcCCCCceEEEEee
Q 001678 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-VSFYGIVRDGPDGSLATVTEF 886 (1033)
Q Consensus 808 LGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNI-VrLyG~f~d~~eg~l~LVmEY 886 (1033)
+..|-.+.+|+....+.++++|......... ..+..+|..+++.+..-.+ .+++.... -++||||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--------~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--------GVDRQREYQILQALSALGLAPKPILVNE------HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc--------cCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEe
Confidence 4567788999988778889999754321110 0023467778877764333 44554432 2689999
Q ss_pred ccCCcHHH--------------HHHh---c---CCccCHHHH-HHHHH---------HHHHHHHHHHh--------CCcc
Q 001678 887 MVNGSLKQ--------------FLQK---K---DRTIDRRKR-LIIAM---------DAAFGMEYLHG--------KNIV 928 (1033)
Q Consensus 887 megGSL~d--------------lL~~---~---~k~Lse~~r-l~Ia~---------QIa~GLeYLHs--------kGIV 928 (1033)
++|..+.. .|.+ . +..++.... ..+.. .+...++.+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 98866432 1111 1 111111111 11110 11122222221 2589
Q ss_pred ccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 929 HRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
|+|+.+.|||++ +++ ++|+||+.|....
T Consensus 150 H~Dl~~~Nil~~----~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 150 HMDVHAYNLVVT----PQG-LKLIDWEYASDGD 177 (256)
T ss_pred cCCCCcCcEEEe----CCC-CEEEeccccCcCC
Confidence 999999999998 333 7899999987543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0063 Score=67.01 Aligned_cols=74 Identities=22% Similarity=0.336 Sum_probs=45.9
Q ss_pred EEEecccCcEEEEEEEEc--------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEcC
Q 001678 805 VRELGSGTYGSVYHGKWR--------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDG 875 (1033)
Q Consensus 805 lekLGeGgFG~VYkAk~k--------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPN-IVrLyG~f~d~ 875 (1033)
++.|..|-...+|+.... ++.+++|+....... .....+|..+++.+.... ..++++.+..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC-
Confidence 356667777899988764 367899986643211 113346777777775333 3456665542
Q ss_pred CCCceEEEEeeccCCcHH
Q 001678 876 PDGSLATVTEFMVNGSLK 893 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~ 893 (1033)
.+|+||++|..+.
T Consensus 73 -----~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -----GRIEEFIPSRTLT 85 (302)
T ss_pred -----CchhheeCCCcCC
Confidence 3589999886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0086 Score=65.57 Aligned_cols=142 Identities=14% Similarity=0.106 Sum_probs=82.4
Q ss_pred eEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCC--CcceEEEEEE----cCC
Q 001678 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVR----DGP 876 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HP--NIVrLyG~f~----d~~ 876 (1033)
.-++.|..|....+|+....+..+++|+.... . . .....|+.++..|..- .+.+++.... ...
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~--~------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~ 85 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTDSGRYVLTLFEKV---S--A------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSEL 85 (296)
T ss_pred hheecccCccccceEEEEeCCCcEEEEEcCCC---C--h------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeee
Confidence 34577888888999998877778999987531 1 1 1344566667666432 2445443210 011
Q ss_pred CCceEEEEeeccCCcHHH-----------HH---Hhc--C--C------ccCHHHHH----------HHHHHHHHHHHHH
Q 001678 877 DGSLATVTEFMVNGSLKQ-----------FL---QKK--D--R------TIDRRKRL----------IIAMDAAFGMEYL 922 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~d-----------lL---~~~--~--k------~Lse~~rl----------~Ia~QIa~GLeYL 922 (1033)
.+..++|++|++|..+.. .| +.. . . ...+.... .....+..++.++
T Consensus 86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 165 (296)
T cd05153 86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQ 165 (296)
T ss_pred CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHH
Confidence 345789999998865421 11 110 0 0 01111100 0111123344454
Q ss_pred Hh-------CCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 923 HG-------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 923 Hs-------kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
-+ .+++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 166 ~~~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~iIDfe~a~~ 205 (296)
T cd05153 166 DAFDPSDLPRGVIHADLFRDNVLFD----GDELSGVIDFYFACT 205 (296)
T ss_pred HhhhhhcCCCcCCccCcCcccEEEe----CCceEEEeehhhhcC
Confidence 43 4799999999999998 455668999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.022 Score=66.71 Aligned_cols=84 Identities=19% Similarity=0.069 Sum_probs=53.1
Q ss_pred eEEEEecccCcEEEEEEEEcCc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEcCCC
Q 001678 803 EEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~kG~--kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~---HPNIVrLyG~f~d~~e 877 (1033)
...+.||.|.+..||++...+. .|+||............. ....+++..|.+.|..+. ...+.++|.+- .
T Consensus 29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~w-pl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~ 103 (401)
T PRK09550 29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESW-PLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----E 103 (401)
T ss_pred ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccc-cccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----C
Confidence 3457899999999999988643 799998542211000000 011235556777777653 35677888773 2
Q ss_pred CceEEEEeeccCCc
Q 001678 878 GSLATVTEFMVNGS 891 (1033)
Q Consensus 878 g~l~LVmEYmegGS 891 (1033)
...++||||+++..
T Consensus 104 ~~~~lVME~L~~~~ 117 (401)
T PRK09550 104 ELAVTVMEDLSDHK 117 (401)
T ss_pred CCCEEEEecCCCcc
Confidence 44689999997643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0002 Score=92.21 Aligned_cols=202 Identities=14% Similarity=0.038 Sum_probs=135.1
Q ss_pred CceEEEEecccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEcCCC
Q 001678 801 DLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~k---G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~e 877 (1033)
.+++.--++-+. -+++++- -..+.+|+.+.-.+.. -.+-..+....|...++...|+++...+.-......
T Consensus 1230 ~~EV~l~i~~~~---~~R~k~Lr~kid~Fk~~I~ke~d~e~---LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1230 HSEVNLGISNHF---HFRNKWLRSKIDWFKFSIYKEYDFEN---LSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred hhheeeecccce---eeccchHhhhhceeEEEeehhhhHHH---HhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 344443444443 3455552 2234666665433221 112223344556666777889999888777666556
Q ss_pred CceEEEEeeccCCcHHHHHHhcC---CccCHHHHHHHHHHHHHHHHHHHhC-----CccccCCCCCcEEEecCCCCCCeE
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGK-----NIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 878 g~l~LVmEYmegGSL~dlL~~~~---k~Lse~~rl~Ia~QIa~GLeYLHsk-----GIVHRDIKPsNILLd~~d~~~g~V 949 (1033)
...+.+++|+.+|.+.+.|.+.- ..+.+.-+.....+.+....-+|+. -.+|++||+.|.+|. .+..+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIV----tny~v 1379 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIV----TNYNV 1379 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhcccee----cCCcc
Confidence 67789999999999999997642 2234444444444546667777754 368999999999998 66789
Q ss_pred EEEecCCcccccc-ccccCCcCCCCcccccccccCCCccccchhhhcccchhhccCCcccchHHHHHHHHHHHccCCCCC
Q 001678 950 KIGDLGLSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 950 KLiDFGLAr~~~~-~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLGvilye~t~kvDVWSLGVVLYeLLTGk~PFd 1028 (1033)
|+.++|+.+.... ....+...+++.|+++++.+.- +++.++|+|..|+-+|.+..|..+|-
T Consensus 1380 ~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i------------------k~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1380 KLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI------------------KFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred cccccccccccCchHhhhhhhhCCHHHHHHHHHHHH------------------hhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999994433 3344566788889999976542 34445799999999999999988885
Q ss_pred CC
Q 001678 1029 FF 1030 (1033)
Q Consensus 1029 ~~ 1030 (1033)
++
T Consensus 1442 ~f 1443 (2724)
T KOG1826|consen 1442 FF 1443 (2724)
T ss_pred HH
Confidence 44
|
|
| >cd06404 PB1_aPKC PB1 domain is an essential modular domain of the atypical protein kinase C (aPKC) which in complex with Par6 and Par3 proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.012 Score=54.51 Aligned_cols=72 Identities=22% Similarity=0.366 Sum_probs=59.0
Q ss_pred ecCceeEEEccCCCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEE
Q 001678 46 VGGETRIVSLPRDVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIF 121 (1033)
Q Consensus 46 ~gG~tri~~v~r~~~~~~l~~kl~~~~~~----~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r~r~f 121 (1033)
-+|+-+|..++.+++|.+|..|+.++|.. .+++||- .|| .-+|++++|++|+.-+..|..- +..-|-+-
T Consensus 7 y~gdi~it~~d~~~s~e~L~~~v~~~c~~~~~q~ft~kw~--DEE-GDp~tiSS~~EL~EA~rl~~~n----~~~~l~ih 79 (83)
T cd06404 7 YNGDIMITSIDPSISLEELCNEVRDMCRFHNDQPFTLKWI--DEE-GDPCTISSQMELEEAFRLYELN----KDSELNIH 79 (83)
T ss_pred ecCcEEEEEcCCCcCHHHHHHHHHHHhCCCCCCcEEEEEE--CCC-CCceeecCHHHHHHHHHHHHhc----CcccEEEE
Confidence 46788899999999999999999999975 5999998 544 4589999999999888777653 23457777
Q ss_pred Eec
Q 001678 122 LFS 124 (1033)
Q Consensus 122 lf~ 124 (1033)
+||
T Consensus 80 vfp 82 (83)
T cd06404 80 VFP 82 (83)
T ss_pred ecC
Confidence 776
|
PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.014 Score=64.71 Aligned_cols=145 Identities=16% Similarity=0.125 Sum_probs=81.8
Q ss_pred CceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCC--CcceEEEEEE----c
Q 001678 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVR----D 874 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HP--NIVrLyG~f~----d 874 (1033)
....++.++.|....+|+.+..+.++++|+..... . . .....|..++..|... .+.+++.... .
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~---~-~------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~ 92 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV---K-A------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLS 92 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCC---C-H------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence 34456778888888999988777788899765321 0 1 1223455566555322 2444443211 1
Q ss_pred CCCCceEEEEeeccCCcHH-----------HHH---HhcCCc-----------cCHHHHH------------HHHHHHHH
Q 001678 875 GPDGSLATVTEFMVNGSLK-----------QFL---QKKDRT-----------IDRRKRL------------IIAMDAAF 917 (1033)
Q Consensus 875 ~~eg~l~LVmEYmegGSL~-----------dlL---~~~~k~-----------Lse~~rl------------~Ia~QIa~ 917 (1033)
...+..+++|||++|..+. ..| +..... ..|.... .....+.+
T Consensus 93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~ 172 (307)
T TIGR00938 93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK 172 (307)
T ss_pred hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence 1145678999999875421 111 110000 0111100 00112334
Q ss_pred HHHHHHh-------CCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 918 GMEYLHG-------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 918 GLeYLHs-------kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.+++|.. .+++|+|+.+.||+++ .++.+.|+||+.+..
T Consensus 173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~----~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFD----GDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHhhhhhcCCCccCCCCCCcCcEEEE----CCceEEEeecccccC
Confidence 5555542 5899999999999998 445678999999853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0012 Score=74.98 Aligned_cols=140 Identities=15% Similarity=0.025 Sum_probs=95.7
Q ss_pred ceEEEEecccCcEEEEEEEEc-CcceEEEEeeccccCCCc--h------------hHHHHHHHHHHHHHHHHhcC-CCC-
Q 001678 802 LEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKP--S------------ERERLIADFWKEALLLSSLH-HPN- 864 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~k-G~kVAIKvlk~~~~~~k~--~------------ere~~i~~f~rEi~ILskL~-HPN- 864 (1033)
+.+.++||-|.-+.||.+-+. |++.++|.-+.....-.. . ......-...+|+..|+.|. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567789999999999999874 888999865432211000 0 00111123557888888886 332
Q ss_pred cceEEEEEEcCCCCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q 001678 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1033)
Q Consensus 865 IVrLyG~f~d~~eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHskGIVHRDIKPsNILLd~~d~ 944 (1033)
+.+.+++ ...++|||++.+..|...-+- .+. ..+...+..-|.-|-..|+||+|+.-=||+|+
T Consensus 174 VPkpiD~------~RH~Vvmelv~g~Pl~~v~~v----~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---- 236 (465)
T KOG2268|consen 174 VPKPIDH------NRHCVVMELVDGYPLRQVRHV----EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---- 236 (465)
T ss_pred CCCcccc------cceeeHHHhhcccceeeeeec----CCh---HHHHHHHHHHHHHHHHcCceecccchheeEEe----
Confidence 4555553 557999999988887665321 122 23444556667788899999999999999998
Q ss_pred CCCeEEEEecCCcc
Q 001678 945 QRPVCKIGDLGLSK 958 (1033)
Q Consensus 945 ~~g~VKLiDFGLAr 958 (1033)
.+..++++||-.+.
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 56789999997654
|
|
| >cd06396 PB1_NBR1 The PB1 domain is an essential part of NBR1 protein, next to BRCA1, a scaffold protein mediating specific protein-protein interaction with both titin protein kinase and with another scaffold protein p62 | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.012 Score=54.51 Aligned_cols=69 Identities=16% Similarity=0.282 Sum_probs=57.1
Q ss_pred cCceeEEEccC--CCChHHHHHHHHHHhCCc-eEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001678 47 GGETRIVSLPR--DVTYEELMSRMRELYEGA-VVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (1033)
Q Consensus 47 gG~tri~~v~r--~~~~~~l~~kl~~~~~~~-~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r~r~flf 123 (1033)
||+++.+.++. +.+|.+|.+.+++.|+.. +.|||= .|| .--|+++||.||+.-++-|.|- .-.||+++.
T Consensus 8 ~~d~~rf~~~~~~~~~~~~L~~ev~~rf~l~~f~lKYl--Dde-~e~v~lssd~eLeE~~rl~~~~-----~~~l~~~v~ 79 (81)
T cd06396 8 NGESQSFLVSDSENTTWASVEAMVKVSFGLNDIQIKYV--DEE-NEEVSVNSQGEYEEALKSAVRQ-----GNLLQMNVY 79 (81)
T ss_pred CCeEEEEEecCCCCCCHHHHHHHHHHHhCCCcceeEEE--cCC-CCEEEEEchhhHHHHHHHHHhC-----CCEEEEEEe
Confidence 67888999999 789999999999999974 899997 544 5789999999998877776662 266888874
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The NBR1 protein contains a type I PB1 domain. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.04 Score=61.21 Aligned_cols=31 Identities=19% Similarity=0.275 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 925 kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.+++|+|+.+.|||++ .+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~----~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFE----GDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEE----CCceEEEEecccccC
Confidence 3899999999999998 444557999998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.039 Score=61.75 Aligned_cols=108 Identities=14% Similarity=0.084 Sum_probs=70.5
Q ss_pred CceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCC---CCcceEEEEEEcC-C
Q 001678 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH---PNVVSFYGIVRDG-P 876 (1033)
Q Consensus 801 dYeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~H---PNIVrLyG~f~d~-~ 876 (1033)
.....+.||.|..+.||+....+.++++|..+... . ...+..|...|+.|.- -.+.++++++... .
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccc-c---------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 45566889999999999987766677778754210 0 1257788888888863 3578889887652 1
Q ss_pred CCceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHHh
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924 (1033)
Q Consensus 877 eg~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLHs 924 (1033)
.+..+||||++++.++.+. ..+......++.+++++|.-||+
T Consensus 85 ~g~~~LVmE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 85 PGPDVLLLERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred CCCeEEEEeccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhC
Confidence 3568999999998876541 01222233344455555555554
|
|
| >cd06397 PB1_UP1 Uncharacterized protein 1 | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.021 Score=52.66 Aligned_cols=57 Identities=25% Similarity=0.434 Sum_probs=47.2
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHH
Q 001678 47 GGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEY 106 (1033)
Q Consensus 47 gG~tri~~v~r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~deDl~~m~~ey 106 (1033)
||+||=+++++.-+|++|.+||..++.. ++.|+|- .|| .-+|++++|+||+..+...
T Consensus 8 ~g~~RRf~~~~~pt~~~L~~kl~~Lf~lp~~~~~vtYi--DeD-~D~ITlssd~eL~d~~~~~ 67 (82)
T cd06397 8 LGDTRRIVFPDIPTWEALASKLENLYNLPEIKVGVTYI--DND-NDEITLSSNKELQDFYRLS 67 (82)
T ss_pred CCceEEEecCCCccHHHHHHHHHHHhCCChhHeEEEEE--cCC-CCEEEecchHHHHHHHHhc
Confidence 5677777799999999999999999885 4899997 443 3799999999998776543
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.013 Score=75.19 Aligned_cols=167 Identities=21% Similarity=0.136 Sum_probs=111.0
Q ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEEcCC-CC-ceEEEEeeccCCcHHHHHHhcCCccCHHHHHHHHHHHHHHHHHHH
Q 001678 846 LIADFWKEALLLSSLHHPNVVSFYGIVRDGP-DG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923 (1033)
Q Consensus 846 ~i~~f~rEi~ILskL~HPNIVrLyG~f~d~~-eg-~l~LVmEYmegGSL~dlL~~~~k~Lse~~rl~Ia~QIa~GLeYLH 923 (1033)
.+.....|+..+.++.|+|++.++.|-.+.. .+ .+.+..+++..-++.+.++..+. ++..+.+.+..+++.||.|+|
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-IPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-cCHHHHHHHHHHHhhhHHHHH
Confidence 3445567888899999999999998876521 12 22344578888888888876654 788888888999999999999
Q ss_pred hCCccccCCCCC---cEEEecCCCCCCeEEEE--ecCCccccccccccCCcCCCCcccccccccCCCccccchhhhcccc
Q 001678 924 GKNIVHFDLKCE---NLLVNMRDPQRPVCKIG--DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLK 998 (1033)
Q Consensus 924 skGIVHRDIKPs---NILLd~~d~~~g~VKLi--DFGLAr~~~~~~~s~~~~GT~~YmAPEvi~gk~~~~sekvDVwSLG 998 (1033)
+..+.|.-|..+ +-..+ ..+.+.+. ||+.++............-+..|.++|....+........|+|.+|
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~----~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVD----GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred HhccceeEEecccccccccC----ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHH
Confidence 986555544444 22222 45667776 9998887655544333444667889998877665555555666665
Q ss_pred hhhccCCcccchHHHHHHH
Q 001678 999 FCCFQLKWSYDCYSLGILF 1017 (1033)
Q Consensus 999 vilye~t~kvDVWSLGVVL 1017 (1033)
.....+....++=..+.+.
T Consensus 380 ll~~~~~~~~~i~~~~~~~ 398 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVP 398 (1351)
T ss_pred HHHhhhhhcCcccccccch
Confidence 5555555544443333333
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.095 Score=59.92 Aligned_cols=140 Identities=17% Similarity=0.215 Sum_probs=78.5
Q ss_pred eEEEEecccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCCCCcc-eEEEEEEcC
Q 001678 803 EEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV-SFYGIVRDG 875 (1033)
Q Consensus 803 eilekLGeGgFG~VYkAk~k------G~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~HPNIV-rLyG~f~d~ 875 (1033)
.-+..|-.|-...+|+.... ++.|++|+..... . ..+ +-.+|..+++.+..-++. ++++.+..
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~------~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~- 108 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--E------LFF-DRDDEIRTFECMSRHGQGPRLLGRFPN- 108 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--C------eee-chHHHHHHHHHHHHcCCCCceEEEECC-
Confidence 34456666888899998753 2568889775432 1 111 124677777777644433 56666533
Q ss_pred CCCceEEEEeeccCCcHHHH--------------HH---hcC----C-ccCHHHHHHHHHH-----------------HH
Q 001678 876 PDGSLATVTEFMVNGSLKQF--------------LQ---KKD----R-TIDRRKRLIIAMD-----------------AA 916 (1033)
Q Consensus 876 ~eg~l~LVmEYmegGSL~dl--------------L~---~~~----k-~Lse~~rl~Ia~Q-----------------Ia 916 (1033)
+ .|++|+++.+|... |. +.. . ..-+..+.++..+ +.
T Consensus 109 --g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 109 --G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred --c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 2 58999977665321 11 111 0 0111122122111 11
Q ss_pred HHHHHH----H----hCCccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 917 FGMEYL----H----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 917 ~GLeYL----H----skGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
..+..| . ...++|+|+++.|||++. .++.++|+||..|...
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~---~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDE---ETRAITIIDYEYASYN 232 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeC---CCCcEEEEeehhcccc
Confidence 112222 1 236899999999999972 2367999999998754
|
|
| >cd06402 PB1_p62 The PB1 domain is an essential part of p62 scaffold protein (alias sequestosome 1,SQSTM) involved in cell signaling, receptor internalization, and protein turnover | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.045 Score=51.43 Aligned_cols=64 Identities=20% Similarity=0.457 Sum_probs=50.5
Q ss_pred ceeEEEccC--CCChHHHHHHHHHHhC----CceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEE
Q 001678 49 ETRIVSLPR--DVTYEELMSRMRELYE----GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFL 122 (1033)
Q Consensus 49 ~tri~~v~r--~~~~~~l~~kl~~~~~----~~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r~r~fl 122 (1033)
|-|-.++++ +++|.+|+.++.++|. ..|+|||. .|| .-||+++|||||.--+.... .+-||||+
T Consensus 15 EIRRf~l~~~~~~s~~~L~~~V~~~f~~l~~~~ftlky~--Dee-GDlvtIssdeEL~~A~~~~~-------~~~~RlyI 84 (87)
T cd06402 15 EIRRFAIDEDVSTSYEYLVEKVAAVFPSLRGKNFQLFWK--DEE-GDLVAFSSDEELVMALGSLN-------DDTFRIYI 84 (87)
T ss_pred ceEEEEecCCCCcCHHHHHHHHHHHccccCCCcEEEEEE--CCC-CCEEeecCHHHHHHHHHcCC-------CCcEEEEE
Confidence 668888865 5699999999999984 36999999 444 46999999999987665443 25599987
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.097 Score=59.79 Aligned_cols=150 Identities=18% Similarity=0.166 Sum_probs=84.4
Q ss_pred ceEEEEecccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEcCCCCc
Q 001678 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVRDGPDGS 879 (1033)
Q Consensus 802 YeilekLGeGgFG~VYkAk~kG~kVAIKvlk~~~~~~k~~ere~~i~~f~rEi~ILskL~H--PNIVrLyG~f~d~~eg~ 879 (1033)
..+++.+..|-...+|....+++++++. ... .... ........+|+.+++.+.- .-+...+++|.++.-+.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~-~~~~-----~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~ 99 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDTGQKYVLR-KPP-RGDP-----VESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGT 99 (321)
T ss_pred CceeeeccCCcccceEEEecCCceEEEe-cCC-cccc-----chhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCC
Confidence 4455556555555666666667788887 221 1010 1112345578888887753 23445677777653357
Q ss_pred eEEEEeeccCCc------------------HHHHHHhc-----------CCc--cCHHHHHHHHH--------------H
Q 001678 880 LATVTEFMVNGS------------------LKQFLQKK-----------DRT--IDRRKRLIIAM--------------D 914 (1033)
Q Consensus 880 l~LVmEYmegGS------------------L~dlL~~~-----------~k~--Lse~~rl~Ia~--------------Q 914 (1033)
.+.||+|++|.. |.++|..- ++. .....+..+.. .
T Consensus 100 pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 100 PFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 799999998722 22222110 000 00001111111 1
Q ss_pred HHHHHHHHHhC--------CccccCCCCCcEEEecCCCCCCeEEEEecCCcccccc
Q 001678 915 AAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1033)
Q Consensus 915 Ia~GLeYLHsk--------GIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~~ 962 (1033)
...-..||+.+ .++|+|+.+.||+++ +.+.+-++||+++..-..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~----~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIID----PGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEe----CCCeeEEEeccccccCCc
Confidence 22334566543 589999999999999 444588999999986543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.1 Score=57.94 Aligned_cols=33 Identities=27% Similarity=0.290 Sum_probs=25.8
Q ss_pred CccccCCCCCcEEEecCCCCCCeEEEEecCCccccc
Q 001678 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1033)
Q Consensus 926 GIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~~ 961 (1033)
.++|+|+.+.|||++. .....-|+||+.+..-.
T Consensus 186 ~lvHGD~~~~Nilv~~---~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDE---DARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeC---CCCEEEEECcHhcccCC
Confidence 5899999999999982 13346799999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.16 Score=55.79 Aligned_cols=30 Identities=17% Similarity=0.330 Sum_probs=25.1
Q ss_pred CCccccCCCCCcEEEecCCCCCCeEEEEecCCccc
Q 001678 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 925 kGIVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~ 959 (1033)
.+++|+|+.+.|||++ . +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~----~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK----D-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEe----C-CcEEEEECccccc
Confidence 4789999999999998 3 4578999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd06406 PB1_P67 A PB1 domain is present in p67 proteins which forms a signaling complex with p40, a crucial step for activation of NADPH oxidase during phagocytosis | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.095 Score=48.58 Aligned_cols=59 Identities=19% Similarity=0.360 Sum_probs=48.2
Q ss_pred CeeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHH
Q 001678 42 KLRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEE 105 (1033)
Q Consensus 42 ~l~Y~gG~tri~~v~r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~deDl~~m~~e 105 (1033)
+++|-+ |-+|.|+++++|++|..|+++-.+. .+.|.|. .|+=..++.+ +|+||+.++.-
T Consensus 6 KV~f~~--tIaIrvp~~~~y~~L~~ki~~kLkl~~e~i~LsYk--de~s~~~v~l-~d~dle~aws~ 67 (80)
T cd06406 6 KVHFKY--TVAIQVARGLSYATLLQKISSKLELPAEHITLSYK--SEASGEDVIL-SDTNMEDVWSQ 67 (80)
T ss_pred EEEEEE--EEEEEcCCCCCHHHHHHHHHHHhCCCchhcEEEec--cCCCCCccCc-ChHHHHHHHHh
Confidence 456665 9999999999999999999997765 4889998 4554567788 89999988764
|
PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes . A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. The p67 proteins contain |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.29 Score=55.64 Aligned_cols=31 Identities=23% Similarity=0.221 Sum_probs=26.0
Q ss_pred ccccCCCCCcEEEecCCCCCCeEEEEecCCcccc
Q 001678 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 927 IVHRDIKPsNILLd~~d~~~g~VKLiDFGLAr~~ 960 (1033)
+.|.|+.+.|||++. .++.++|+||+.|...
T Consensus 184 ~CHnDl~~~NiL~~~---~~~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLNE---DEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEeC---CCCcEEEEcccccCCC
Confidence 799999999999971 3467999999998754
|
|
| >cd06403 PB1_Par6 The PB1 domain is an essential part of Par6 protein which in complex with Par3 and aPKC proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.22 Score=46.12 Aligned_cols=67 Identities=27% Similarity=0.478 Sum_probs=53.2
Q ss_pred eecCceeEEEccCC--CChHHHHHHHHHHhC---CceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEE
Q 001678 45 YVGGETRIVSLPRD--VTYEELMSRMRELYE---GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLR 119 (1033)
Q Consensus 45 Y~gG~tri~~v~r~--~~~~~l~~kl~~~~~---~~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~r~r 119 (1033)
+-++|+|=.+++|+ .+|.||.+.|..+.. .++.|+|.=|..| |+.|+|||.+..-+. + ..+-||
T Consensus 6 kfdaEfRRFsl~r~~~~~f~ef~~ll~~lH~l~~~~f~i~Y~D~~gD---LLPInNDdNf~kAls-------s-a~plLR 74 (80)
T cd06403 6 KFDAEFRRFSLDRNKPGKFEDFYKLLEHLHHIPNVDFLIGYTDPHGD---LLPINNDDNFLKALS-------S-ANPLLR 74 (80)
T ss_pred ccCCeEEEEEeccccCcCHHHHHHHHHHHhCCCCCcEEEEEeCCCCC---EecccCcHHHHHHHH-------c-CCCceE
Confidence 46899999999998 899999999988764 4799999977544 899999998764432 2 246689
Q ss_pred EEE
Q 001678 120 IFL 122 (1033)
Q Consensus 120 ~fl 122 (1033)
||+
T Consensus 75 l~i 77 (80)
T cd06403 75 IFI 77 (80)
T ss_pred EEE
Confidence 886
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. The |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1033 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 9e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 9e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-04 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 4e-75
Identities = 70/238 (29%), Positives = 114/238 (47%), Gaps = 28/238 (11%)
Query: 784 IAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPS 841
+ +E L T+ ++++E +++G G +G V+ G+ S VAIK + G+
Sbjct: 3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 842 ERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901
E+ +F +E ++S+L+HPN+V YG++ + P V EF+ G L L K
Sbjct: 63 MIEKF-QEFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAH 117
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSK 958
I +L + +D A G+EY+ +N IVH DL+ N+ + D PVC K+ D GLS+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
+ G+ G WMAPE + + TEK D YS ++
Sbjct: 178 QSVHS--VSGLLGNFQWMAPETIGAEEESYTEKA----------------DTYSFAMI 217
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 8e-72
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I +L +G G +G VY W G +VA+K + + + I + +EA L
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAAR----HDPDEDISQTIENVRQEAKL 59
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ L HPN+++ G+ P+ L V EF G L + L K I + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIA 115
Query: 917 FGMEYLHGKN---IVHFDLKCENLLVNMR----DPQRPVCKIGDLGLSKVKQQTLVSGGV 969
GM YLH + I+H DLK N+L+ + D + KI D GL++ +T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
G WMAPE++ ++ D +S G+L
Sbjct: 176 -GAYAWMAPEVIRASM--FSKGS----------------DVWSYGVL 203
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 4e-71
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + + + +GSG++G+VY GKW G DVA+K + + + + F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN------VTAPTPQQLQAFKNEVGV 73
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L H N++ F G LA VT++ SL L + + +K + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS---GGVRGTL 973
GM+YLH K+I+H DLK N+ ++ + KIGD GL+ K + S + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 974 PWMAPELLSGKSH-MVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
WMAPE++ + + + D Y+ GI+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQS----------------DVYAFGIV 214
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-71
Identities = 85/259 (32%), Positives = 126/259 (48%), Gaps = 41/259 (15%)
Query: 763 HGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR 822
H DYD T + L + + + I DL ++G+G++G+V+ +W
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDD------MDIPWCDLNIKEKIGAGSFGTVHRAEWH 59
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
GSDVA+K + F + +F +E ++ L HPN+V F G V P+ L+
Sbjct: 60 GSDVAVKILMEQDFH------AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN--LSI 111
Query: 883 VTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLL 938
VTE++ GSL + L K +D R+RL +A D A GM YLH +N IVH +LK NLL
Sbjct: 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171
Query: 939 VNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWMAPELLSGKSHMVTEKVTLFSL 997
V+ ++ K+ D GLS++K T +S GT WMAPE+L + EK
Sbjct: 172 VD----KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP--SNEKS----- 220
Query: 998 KFCCFQLKWSYDCYSLGIL 1016
D YS G++
Sbjct: 221 -----------DVYSFGVI 228
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 5e-71
Identities = 49/224 (21%), Positives = 84/224 (37%), Gaps = 34/224 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I L + +L G ++ G+W+G+D+ +K +K ++ R DF +E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS------TRKSRDFNEECPR 60
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDA 915
L HPNV+ G + P +T +M GSL L + + +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 916 AFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A GM +LH I L +++++ +I + Q G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDM----TARISMADVKFSFQSP----GRMYAP 172
Query: 974 PWMAPELLSGK-SHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
W+APE L K D +S +L
Sbjct: 173 AWVAPEALQKKPEDTNRRSA----------------DMWSFAVL 200
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-67
Identities = 62/227 (27%), Positives = 89/227 (39%), Gaps = 29/227 (12%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + LE +G G +G VYHG+W G +VAI+ I + E + F +E +
Sbjct: 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLID------IERDNEDQLKAFKREVM 81
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
H NVV F G P LA +T +L ++ +D K IA +
Sbjct: 82 AYRQTRHENVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG------GV 969
GM YLH K I+H DLK +N+ + I D GL +
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYDNG-----KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
G L +APE++ S E FS D ++LG +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKH-S--------DVFALGTI 232
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-66
Identities = 64/228 (28%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L I ++E +G G +G V KWR DVAIK+I++ E F E
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES----------ESERKAFIVE 51
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRKRLII 911
LS ++HPN+V YG + + V E+ GSL L + +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 912 AMDAAFGMEYLHG---KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
+ + G+ YLH K ++H DLK NLL+ V KI D G + Q + +
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG---TVLKICDFGTACDIQTHMTNN- 163
Query: 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
+G+ WMAPE+ G ++ +EK D +S GI+
Sbjct: 164 -KGSAAWMAPEVFEGSNY--SEKC----------------DVFSWGII 192
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-59
Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 50/243 (20%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+Q ++ V+++G G YG V+ GKWRG VA+K + A E E
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---------TE 81
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+ H N++ F G L +T++ NGSL +L+ T+D + L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKL 139
Query: 912 AMDAAFGMEYLHGKN--------IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
A + G+ +LH + I H DLK +N+LV + C I DLGL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVKFISD 195
Query: 964 -----LVSGGVRGTLPWMAPELLSGKSHMV----TEKVTLFSLKFCCFQLKWSYDCYSLG 1014
+ GT +M PE+L + D YS G
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA----------------DMYSFG 239
Query: 1015 ILF 1017
++
Sbjct: 240 LIL 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 8e-57
Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 49/237 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
+ DL LG G +G R + + +K + + E + F KE
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI------RFDEETQ--RTFLKEV 58
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HPNV+ F G++ L +TE++ G+L+ ++ D +R+ A D
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----------- 963
A GM YLH NI+H DL N LV + + D GL+++
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 964 ----LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
V G WMAPE+++G+S+ EKV D +S GI+
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSY--DEKV----------------DVFSFGIV 211
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-51
Identities = 58/244 (23%), Positives = 96/244 (39%), Gaps = 54/244 (22%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
Q + +G G +G V+ GKWRG +VA+K R +++EA
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIF-----------SSREERSWFREA 85
Query: 855 --LLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L H N++ F L V+++ +GSL +L + T+ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIK 143
Query: 911 IAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+A+ A G+ +LH + I H DLK +N+LV + C I DLGL+
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDS 199
Query: 963 T-----LVSGGVRGTLPWMAPELLSGKSHM----VTEKVTLFSLKFCCFQLKWSYDCYSL 1013
+ GT +MAPE+L +M ++ D Y++
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA----------------DIYAM 243
Query: 1014 GILF 1017
G++F
Sbjct: 244 GLVF 247
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 61/241 (25%), Positives = 96/241 (39%), Gaps = 46/241 (19%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+Q D+ + +G G YG V+ G W+G +VA+K R +++E
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIF-----------SSRDEKSWFRE 50
Query: 854 A--LLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
L H N++ F S L +T + GSL +LQ T+D L
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCL 108
Query: 910 IIAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961
I + A G+ +LH + I H DLK +N+LV C I DLGL+ +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG----QCCIADLGLAVMHS 164
Query: 962 QT-----LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
Q+ + + GT +MAPE+L + S K D ++ G++
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFD----SYKRV--------DIWAFGLV 212
Query: 1017 F 1017
Sbjct: 213 L 213
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-45
Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 42/228 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
+ ++DL ++G G +G V+ G+ R VA+K + + + A F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-----PPDLK--AKFLQEA 163
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L HPN+V G+ + V E + G FL+ + + + L + D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTL 973
AA GMEYL K +H DL N LV ++ V KI D G+S+ + G +
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQV 277
Query: 974 P--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
P W APE +L + + + WS+ GIL
Sbjct: 278 PVKWTAPE----------------ALNYGRYSSESDVWSF-----GIL 304
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 45/230 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I +D+ R LG G +G VY G + VA+K K C + + F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-----TLDNK--EKFM 61
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
EA+++ +L HP++V GI+ + P + E G L +L++ ++ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
++ M YL N VH D+ N+LV + K+GD GLS+ +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 972 TLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
LP WM+PE S+ F F W + +
Sbjct: 175 RLPIKWMSPE----------------SINFRRFTTASDVWMF-----AVC 203
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 45/230 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K S+ R F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-----SDSVR--EKFL 64
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
A + + YL K VH D+ N+LV+ D K+GD GLS+ + + +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 972 TLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
LP WMAPE S+ F F W + G+
Sbjct: 178 KLPIKWMAPE----------------SINFRRFTSASDVWMF-----GVC 206
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 44/227 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+K +++ ++ELGSG +G V GKW+G DVA+K IK + +F++EA
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-----MSED----EFFQEAQ 55
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+ L HP +V FYG+ ++ P + VTE++ NG L +L+ + ++ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
GM +L +H DL N LV+ K+ D G+++ V P
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 975 --WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
W APE + + K W++ GIL
Sbjct: 169 VKWSAPE----------------VFHYFKYSSKSDVWAF-----GIL 194
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 53/241 (21%), Positives = 87/241 (36%), Gaps = 53/241 (21%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++ L+ + G +G V+ + VA+K + E E
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW--QNE-------YEVYS 71
Query: 857 LSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L + H N++ F G + G L +T F GSL FL+ + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 915 AAFGMEYLHGK----------NIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKVK-- 960
A G+ YLH I H D+K +N+L+ N+ I D GL+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL------TACIADFGLALKFEA 183
Query: 961 -QQTLVSGGVRGTLPWMAPELLSGK---SHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
+ + G GT +MAPE+L G ++ D Y++G++
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI----------------DMYAMGLV 227
Query: 1017 F 1017
Sbjct: 228 L 228
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 68/227 (29%), Positives = 100/227 (44%), Gaps = 44/227 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWRG DVAIK IK + +F +EA
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSED----EFIEEAK 71
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ +L H +V YG+ + P + +TE+M NG L +L++ ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
MEYL K +H DL N LVN + V K+ D GLS+ + V P
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFP 184
Query: 975 --WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
W PE L + F K W++ G+L
Sbjct: 185 VRWSPPE----------------VLMYSKFSSKSDIWAF-----GVL 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-43
Identities = 57/245 (23%), Positives = 89/245 (36%), Gaps = 51/245 (20%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
++ D+L+ + +G G YG+VY G VA+K + +E K
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINE---------KNIY 59
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGS---LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
+ + H N+ F V E+ NGSL ++L T D +A
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLA 117
Query: 913 MDAAFGMEYLHG---------KNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKVKQ 961
G+ YLH I H DL N+LV + C I D GLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT------CVISDFGLSMRLT 171
Query: 962 QTLVSG---------GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
+ GT+ +MAPE+L G ++ + L + D Y+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQV-----------DMYA 220
Query: 1013 LGILF 1017
LG+++
Sbjct: 221 LGLIY 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-43
Identities = 66/235 (28%), Positives = 98/235 (41%), Gaps = 50/235 (21%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ +++LG G +GSV ++ VA+K+++ DF
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLR----DF 58
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L SL H N+V + G+ +L + E++ GSL+ +LQK ID K L
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVS 966
GMEYL K +H DL N+LV + KIGD GL+KV K+ V
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEFFKVK 174
Query: 967 GGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
G P W APE SL F + WS+ G++
Sbjct: 175 EP--GESPIFWYAPE----------------SLTESKFSVASDVWSF-----GVV 206
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-43
Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 49/235 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ +R+LG G +G V ++ VA+K +K AD
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-----GGNHI--ADL 70
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
KE +L +L+H N+V + GI + + + EF+ +GSLK++L K I+ +++L
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVS 966
A+ GM+YL + VH DL N+LV KIGD GL+K + V
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTVK 186
Query: 967 GGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
P W APE L F + WS+ G+
Sbjct: 187 DD--RDSPVFWYAPE----------------CLMQSKFYIASDVWSF-----GVT 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 62/227 (27%), Positives = 92/227 (40%), Gaps = 44/227 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ E DF +EA
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEE----DFIEEAE 55
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HP +V YG+ P + VTEFM +G L +L+ + L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP---ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
GM YL ++H DL N LV + V K+ D G+++ + P
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168
Query: 975 --WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
W +PE F + K WS+ G+L
Sbjct: 169 VKWASPE----------------VFSFSRYSSKSDVWSF-----GVL 194
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 70/243 (28%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 780 IEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGK 839
+ ++A + R + +L+ ++ +G G +G V G +RG+ VA+K IK
Sbjct: 1 MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----- 55
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
+ + F EA +++ L H N+V G++ + G L VTE+M GSL +L+ +
Sbjct: 56 -ATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSR 109
Query: 900 DRTIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R++ L+ ++D MEYL G N VH DL N+LV+ + V K+ D GL+
Sbjct: 110 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT- 164
Query: 959 VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSL 1013
K+ + G LP W APE +L+ F K WS+
Sbjct: 165 -KEASSTQDT--GKLPVKWTAPE----------------ALREKKFSTKSDVWSF----- 200
Query: 1014 GIL 1016
GIL
Sbjct: 201 GIL 203
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 47/235 (20%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-----SPKAN-- 61
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI + +T+ M G L ++++ I +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
+ G + + WMA E S+ + + WSY G+
Sbjct: 175 HAEGGKVPIKWMALE----------------SILHRIYTHQSDVWSY-----GVT 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 74/273 (27%), Positives = 109/273 (39%), Gaps = 51/273 (18%)
Query: 759 LVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYH 818
+ H DYD T + L + + A Q + L+ +++LG G +GSV
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEM 59
Query: 819 GKWRGSD------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872
++ VA+K+++ DF +E +L SL H N+V + G+
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQH----STEEHLR----DFEREIEILKSLQHDNIVKYKGVC 111
Query: 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932
+L + E++ GSL+ +LQK ID K L GMEYL K +H DL
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171
Query: 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVSGGVRGTLP--WMAPELLSGKSH 986
N+LV + KIGD GL+KV Q V G P W APE
Sbjct: 172 ATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKVKEP--GESPIFWYAPE------- 218
Query: 987 MVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
SL F + WS+ G++
Sbjct: 219 ---------SLTESKFSVASDVWSF-----GVV 237
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 64/232 (27%), Positives = 90/232 (38%), Gaps = 45/232 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I DL + +LG G++G V G+W VA+K +K + + DF
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----PEAMDDFI 69
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E + SL H N++ YG+V P + VTE GSL L+K
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
A+ A GM YL K +H DL NLL+ RD + KIGD GL + ++
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQE 182
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
+ W APE SLK F W + G+
Sbjct: 183 HRKVPFAWCAPE----------------SLKTRTFSHASDTWMF-----GVT 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 9e-42
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V LG+G +G V+ G + G VA+K +K + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPD----AFLAEAN 60
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
L+ L H +V Y +V P + +TE+M NGSL FL+ +L+ +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM ++ +N +H DL+ N+LV+ CKI D GL+++ + + P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 975 --WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
W APE ++ + F +K WS+ GIL
Sbjct: 174 IKWTAPE----------------AINYGTFTIKSDVWSF-----GIL 199
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 66/229 (28%), Positives = 100/229 (43%), Gaps = 46/229 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E E +F KEA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVE----EFLKEA 60
Query: 855 LLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IA 912
++ + HPN+V G+ R+ P +TEFM G+L +L++ +R L+ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ MEYL KN +H DL N LV + K+ D GLS++ +
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 973 LP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
P W APE SL + F +K W++ G+L
Sbjct: 174 FPIKWTAPE----------------SLAYNKFSIKSDVWAF-----GVL 201
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 50/235 (21%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ + +LG G +GSV ++ VA+K+++ S +++R DF
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-----PDQQR---DF 71
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +LH +V + G+ SL V E++ +G L+ FLQ+ +D + L+
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVS 966
+ GMEYL + VH DL N+LV KI D GL+K+ +V
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEA----HVKIADFGLAKLLPLDKDYYVVR 187
Query: 967 GGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
G P W APE SL F + WS+ G++
Sbjct: 188 EP--GQSPIFWYAPE----------------SLSDNIFSRQSDVWSF-----GVV 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
I+N+DL LG GT+ ++ G R V +K + + E
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK----AHRNYSE--- 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
F++ A ++S L H ++V YG+ G V EF+ GSL +L+K I+
Sbjct: 58 -SFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR----PVCKIGDLGLSKVKQQT 963
+L +A A M +L ++H ++ +N+L+ + ++ P K+ D G+S
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP- 173
Query: 964 LVSGGVRGTLPWMAPE 979
++ +PW+ PE
Sbjct: 174 --KDILQERIPWVPPE 187
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 22/193 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
+ + +G G +G VYHG +D A+K + E + F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEV--SQFL 74
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +++ HPNV+S GI +GS V +M +G L+ F++ + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGG 968
+ A GM+YL K VH DL N +++ ++ K+ D GL++ V
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 969 VRGTLP--WMAPE 979
LP WMA E
Sbjct: 190 TGAKLPVKWMALE 202
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 72/251 (28%), Positives = 102/251 (40%), Gaps = 48/251 (19%)
Query: 780 IEPTIAEA--EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-----DVAIKRIK 832
EP E A + I+ + + +GSG G V +G+ R VAIK +K
Sbjct: 27 AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86
Query: 833 ASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL 892
A +ER+R DF EA ++ HPN++ G+V G VTE+M NGSL
Sbjct: 87 AGY-----TERQR--RDFLSEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSL 137
Query: 893 KQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
FL+ D + + + GM YL VH DL N+LV+ VCK+
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCKVS 193
Query: 953 DLGLSKV--KQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK--- 1005
D GLS+V G +P W APE ++ F F
Sbjct: 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE----------------AIAFRTFSSASDV 237
Query: 1006 WSYDCYSLGIL 1016
WS+ G++
Sbjct: 238 WSF-----GVV 243
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 72/263 (27%), Positives = 116/263 (44%), Gaps = 49/263 (18%)
Query: 769 DYDNDTVKTLKIEPTIAEA--EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-- 824
DYD T + L + + +A+ + I + + +G+G +G VY G + S
Sbjct: 11 DYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG 70
Query: 825 ----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880
VAIK +KA +E++R DF EA ++ H N++ G++ +
Sbjct: 71 KKEVPVAIKTLKAGY-----TEKQR--VDFLGEAGIMGQFSHHNIIRLEGVISKYK--PM 121
Query: 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940
+TE+M NG+L +FL++KD + + + A GM+YL N VH DL N+LVN
Sbjct: 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 941 MRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTLP--WMAPELLSGKSHMVTEKVTLFS 996
VCK+ D GLS+V + + G +P W APE +
Sbjct: 182 ----SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE----------------A 221
Query: 997 LKFCCFQLK---WSYDCYSLGIL 1016
+ + F WS+ GI+
Sbjct: 222 ISYRKFTSASDVWSF-----GIV 239
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 65/232 (28%), Positives = 91/232 (39%), Gaps = 47/232 (20%)
Query: 797 IKNDDLEEVR-ELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFW 851
+K D+L ELG G +GSV G +R DVAIK +K + + +
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-----EKADT--EEMM 58
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EA ++ L +P +V G+ + L V E G L +FL K I +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGV 969
+ GM+YL KN VH DL N+L+ R KI D GLSK + +
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGADDSYYTARS 171
Query: 970 RGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
G P W APE + F F + WSY G+
Sbjct: 172 AGKWPLKWYAPE----------------CINFRKFSSRSDVWSY-----GVT 202
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 46/230 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEA 854
R +G G +G VYHG++ AIK + ++ F +E
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQV--EAFLREG 73
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
LL+ L+HPNV++ GI+ +G + +M +G L QF++ R + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVRG 971
A GMEYL + VH DL N +++ + K+ D GL++ ++ V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 972 TLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
LP W A E SL+ F K WS+ G+L
Sbjct: 189 RLPVKWTALE----------------SLQTYRFTTKSDVWSF-----GVL 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 51/235 (21%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
L+++R+LG G +G V + ++ VA+K +KA + R + +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-----GPQHR--SGW 80
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +L+H +++ + G D SL V E++ GSL+ +L + +I + L+
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLL 138
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL----VS 966
A GM YLH ++ +H DL N+L++ + KIGD GL+K + V
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRVR 194
Query: 967 GGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
G P W APE LK F WS+ G+
Sbjct: 195 ED--GDSPVFWYAPE----------------CLKEYKFYYASDVWSF-----GVT 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-40
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 48/238 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ ++ +R LG G +G VY G+ G VA+K + C SE++ D
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LD 79
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK------KDRTI 903
F EAL++S +H N+V G+ + E M G LK FL++ + ++
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQ 961
L +A D A G +YL + +H D+ N L+ P R V KIGD G+++ +
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRA 196
Query: 962 QTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
GG LP WM PE + G F+ K D +S G+L
Sbjct: 197 SYYRKGG-CAMLPVKWMPPEAFMEGI----------FTSK---------TDTWSFGVL 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 7e-40
Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 22/193 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
+ + +G G +G VYHG +D A+K + E + F
Sbjct: 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEV--SQFL 138
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +++ HPNV+S GI +GS V +M +G L+ F++ + + +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGG 968
+ A GM++L K VH DL N +++ ++ K+ D GL++ V
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 969 VRGTLP--WMAPE 979
LP WMA E
Sbjct: 254 TGAKLPVKWMALE 266
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-40
Identities = 70/243 (28%), Positives = 111/243 (45%), Gaps = 48/243 (19%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKP 840
E T+A + R + +L+ ++ +G G +G V G +RG+ VA+K IK
Sbjct: 174 EGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDAT 229
Query: 841 SERERLIADFWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK 899
++ F EA +++ L H N+V G++ + L VTE+M GSL +L+ +
Sbjct: 230 AQ------AFLAEASVMTQLRHSNLVQLLGVIVEEKGG--LYIVTEYMAKGSLVDYLRSR 281
Query: 900 DRTIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R++ L+ ++D MEYL G N VH DL N+LV+ + V K+ D GL+
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT- 336
Query: 959 VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSL 1013
K+ + + LP W APE +L+ F K WS+
Sbjct: 337 -KEASSTQDTGK--LPVKWTAPE----------------ALREKKFSTKSDVWSF----- 372
Query: 1014 GIL 1016
GIL
Sbjct: 373 GIL 375
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-40
Identities = 66/257 (25%), Positives = 108/257 (42%), Gaps = 49/257 (19%)
Query: 774 TVKTLKIEPTIAEA--EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----V 826
++T ++P E + + + + ++ + +G+G +G V G+ + V
Sbjct: 18 GLRTF-VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 827 AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEF 886
AIK +K +E++R DF EA ++ HPN++ G+V + VTE+
Sbjct: 77 AIKTLKVGY-----TEKQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEY 127
Query: 887 MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
M NGSL FL+K D + + + A GM+YL VH DL N+L+N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--- 184
Query: 947 PVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCF 1002
VCK+ D GL +V G +P W +PE ++ + F
Sbjct: 185 -VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE----------------AIAYRKF 227
Query: 1003 QLK---WSYDCYSLGIL 1016
WSY GI+
Sbjct: 228 TSASDVWSY-----GIV 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 67/228 (29%), Positives = 99/228 (43%), Gaps = 44/228 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K E F +EA
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPE----AFLQEAQ 231
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM Y+ N VH DL+ N+LV VCK+ D GL+++ + + P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 975 --WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGILF 1017
W APE + + F +K WS+ GIL
Sbjct: 345 IKWTAPE----------------AALYGRFTIKSDVWSF-----GILL 371
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 23/195 (11%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-----SPKAN-- 61
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI + +T+ M G L ++++ I +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 965 VSGGVRGTLPWMAPE 979
+ G + + WMA E
Sbjct: 175 HAEGGKVPIKWMALE 189
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 61/242 (25%), Positives = 98/242 (40%), Gaps = 54/242 (22%)
Query: 794 LQTIKNDDLE--------EVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPS 841
L+ I+ ++ E +ELGSG +G+V G ++ VA+K +K A P+
Sbjct: 3 LEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPA 60
Query: 842 ERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901
++ + EA ++ L +P +V GI V E G L ++LQ+ +R
Sbjct: 61 LKD----ELLAEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQ-NR 112
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-- 959
+ + + + + GM+YL N VH DL N+L+ + KI D GLSK
Sbjct: 113 HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALR 168
Query: 960 KQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLG 1014
+ G P W APE + + F K WS+ G
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPE----------------CINYYKFSSKSDVWSF-----G 207
Query: 1015 IL 1016
+L
Sbjct: 208 VL 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-39
Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 50/239 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ ++ +R LG G +G VY G+ G VA+K + C SE++ D
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LD 120
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK------KDRT 902
F EAL++S +H N+V G+ + P + E M G LK FL++ + +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--K 960
+ L +A D A G +YL + +H D+ N L+ P R V KIGD G+++ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR 236
Query: 961 QQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
GG LP WM PE + G F+ K D +S G+L
Sbjct: 237 AGYYRKGG-CAMLPVKWMPPEAFMEGI----------FTSK---------TDTWSFGVL 275
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 50/232 (21%), Positives = 89/232 (38%), Gaps = 47/232 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
K +L +++ LGSG +G+V+ G W V IK I+ +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQSF--QAV 62
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + SL H ++V G+ L VT+++ GSL +++ + + L
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL +VH +L N+L+ ++ D G++ + + L+
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS----QVQVADFGVADLLPPDDKQLLYS 175
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
+ + WMA E S+ F + + WSY G+
Sbjct: 176 EAKTPIKWMALE----------------SIHFGKYTHQSDVWSY-----GVT 206
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-38
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 44/227 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ ++LG+G +G V+ + VA+K +K E F EA
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVE----AFLAEAN 235
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ +L H +V + +V P + +TEFM GSL FL+ + + +LI +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM ++ +N +H DL+ N+LV+ VCKI D GL++V + + P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 975 --WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGIL 1016
W APE ++ F F +K WS+ GIL
Sbjct: 349 IKWTAPE----------------AINFGSFTIKSDVWSF-----GIL 374
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 55/199 (27%), Positives = 79/199 (39%), Gaps = 26/199 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I + L + LG G +GSV G + D VA+K +K S+RE +F
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS----SQREI--EEFL 84
Query: 852 KEALLLSSLHHPNVVSFYGIV-RDGPDGSLAT--VTEFMVNGSLKQFLQK-----KDRTI 903
EA + HPNV+ G+ G + FM G L +L + I
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQ 962
+ L +D A GMEYL +N +H DL N ++ + D GLSK +
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR----DDMTVCVADFGLSKKIYSG 200
Query: 963 TLVSGGVRGTLP--WMAPE 979
G +P W+A E
Sbjct: 201 DYYRQGRIAKMPVKWIAIE 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-38
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 39/227 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K S+ R F
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-----SDSVR--EKFL 439
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
A + + YL K VH D+ N+LV+ D K+GD GLS+ + + +G
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 552
Query: 972 TLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
LP WMAPE S+ F F S D + G+
Sbjct: 553 KLPIKWMAPE----------------SINFRRFTSA-S-DVWMFGVC 581
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 27/200 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I R LG G +GSV + + D VA+K +KA + + +F
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII----ASSDI--EEFL 73
Query: 852 KEALLLSSLHHPNVVSFYGIV-RDGPDGSLAT---VTEFMVNGSLKQFLQK-----KDRT 902
+EA + HP+V G+ R G L + FM +G L FL
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQ 961
+ + + +D A GMEYL +N +H DL N ++ + + D GLS K+
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA----EDMTVCVADFGLSRKIYS 189
Query: 962 QTLVSGGVRGTLP--WMAPE 979
G LP W+A E
Sbjct: 190 GDYYRQGCASKLPVKWLALE 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-38
Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 46/231 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E E +F KEA
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVE----EFLKEA 267
Query: 855 LLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IA 912
++ + HPN+V G+ R+ P +TEFM G+L +L++ +R L+ +A
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ MEYL KN +H +L N LV + K+ D GLS++ +
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 973 LP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCYSLGILFF 1018
P W APE SL + F +K W++ G+L +
Sbjct: 381 FPIKWTAPE----------------SLAYNKFSIKSDVWAF-----GVLLW 410
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
E+G G++ +VY G +VA ++ SER+R +EA +L L HPN
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFK----EEAEMLKGLQHPN 86
Query: 865 VVSFYGIVRDGP--DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+V FY + VTE M +G+LK +L K+ + + + G+++L
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 923 HGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
H + I+H DLKC+N+ + KIGDLGL+ +K+ + V GT +MAPE+
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAK-AVIGTPEFMAPEM 201
Query: 981 LSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGI 1015
K E V D Y+ G+
Sbjct: 202 YEEK---YDESV----------------DVYAFGM 217
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-38
Identities = 67/225 (29%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K E F +EA
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPE----AFLQEAQ 314
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM Y+ N VH DL+ N+LV VCK+ D GL+++ + + P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 975 --WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017
W APE + + F +K D +S GIL
Sbjct: 428 IKWTAPE----------------AALYGRFTIK--SDVWSFGILL 454
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-37
Identities = 61/215 (28%), Positives = 89/215 (41%), Gaps = 23/215 (10%)
Query: 774 TVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVR-ELGSGTYGSVYHGKWRGS----DVAI 828
+ T E ++ E + +K D+L ELG G +GSV G +R DVAI
Sbjct: 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 829 KRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888
K +K + + + +EA ++ L +P +V G+ + L V E
Sbjct: 369 KVLKQGT-----EKADT--EEMMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAG 418
Query: 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
G L +FL K I + + GM+YL KN VH +L N+L+ R
Sbjct: 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----Y 474
Query: 949 CKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPE 979
KI D GLSK + + G P W APE
Sbjct: 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ + + RELG G++G VY G +G VAIK + + S RER +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----SMRER--IE 74
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------D 900
F EA ++ + +VV G+V G + E M G LK +L+
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 901 RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KV 959
K + +A + A GM YL+ VH DL N +V + KIGD G++ +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 188
Query: 960 KQQTLVSGGVRGTLP--WMAPE-LLSGK 984
+ G +G LP WM+PE L G
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGV 216
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 63/216 (29%), Positives = 89/216 (41%), Gaps = 43/216 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
I + + ELG +G VY G G VAIK +K R +
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLR--EE 58
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
F EA+L + L HPNVV G+V +D P L+ + + +G L +FL +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
++ + + A GMEYL ++VH DL N+LV + KI D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNVKISD 171
Query: 954 LGLSKV--KQQTLVSGGVRGTLP--WMAPE-LLSGK 984
LGL + G LP WMAPE ++ GK
Sbjct: 172 LGLFREVYAADYYKLLG-NSLLPIRWMAPEAIMYGK 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 66/215 (30%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
IK D+ RELG G +G V+ + VA+K +K + R D
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAAR--KD 63
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK---------- 898
F +EA LL++L H ++V FYG+ P L V E+M +G L +FL+
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 899 -----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + L IA A GM YL ++ VH DL N LV + KIGD
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGD 176
Query: 954 LGLSK-VKQQTLVSGGVRGTLP--WMAPE-LLSGK 984
G+S+ V G LP WM PE ++ K
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 62/254 (24%), Positives = 100/254 (39%), Gaps = 62/254 (24%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D EE+ LG G +G V + AIK+I+ + + ++ E +LL
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTIL----SEVMLL 56
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT-----------VTEFMVNGSLKQFLQKKDRTIDRR 906
+SL+H VV +Y + + E+ NG+L + ++ R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
+ + + Y+H + I+H DLK N+ + D R V KIGD GL+K ++L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV-KIGDFGLAKNVHRSLDI 172
Query: 967 GGVR---------------GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCY 1011
+ GT ++A E+L G H EK+ D Y
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-NEKI----------------DMY 215
Query: 1012 SLGILFFFLQFILC 1025
SLGI+F F +
Sbjct: 216 SLGIIF----FEMI 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 39/206 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD----VAIKRIKASCFAGKPSERERLIADFWK 852
+ +D++ +G G +G V + + AIKR+K S+ + DF
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-----SKDDH--RDFAG 74
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +L L HHPN+++ G G L E+ +G+L FL+K
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGY---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 900 ----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
T+ ++ L A D A GM+YL K +H DL N+LV + V KI D G
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFG 187
Query: 956 LSKVKQQTLVSGGVRGTLP--WMAPE 979
LS+ ++ + G LP WMA E
Sbjct: 188 LSRGQEVYVKKTM--GRLPVRWMAIE 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 69/214 (32%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
IK D+ ELG G +G V+ + VA+K +K + SE R D
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESAR--QD 89
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR-- 906
F +EA LL+ L H ++V F+G+ P L V E+M +G L +FL+
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 907 -----------KRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+L+ +A A GM YL G + VH DL N LV Q V KIGD
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG----QGLVVKIGDF 202
Query: 955 GLSK-VKQQTLVSGGVRGTLP--WMAPE-LLSGK 984
G+S+ + G R LP WM PE +L K
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 63/245 (25%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
++L+ + LG+G +G V G VA+K +K++ E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADEK--EALMS 98
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR---- 906
E ++S L H N+V+ G GP + +TE+ G L FL++K R ++
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 907 --------KRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+ L+ + A GM +L KN +H D+ N+L+ V KIGD GL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT----NGHVAKIGDFGLA 211
Query: 958 -KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WSYDCY 1011
+ + LP WMAPE S+ C + ++ WSY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPE----------------SIFDCVYTVQSDVWSY--- 252
Query: 1012 SLGIL 1016
GIL
Sbjct: 253 --GIL 255
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 51/224 (22%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+++E VR++G G +G V+ + G VA+K +K S + AD
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADMQ--AD 96
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK---------- 898
F +EA L++ +PN+V G+ P + + E+M G L +FL+
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 899 -------------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945
+ ++L IA A GM YL + VH DL N LV +
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----E 209
Query: 946 RPVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPE-LLSGK 984
V KI D GLS+ + G +P WM PE + +
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADG-NDAIPIRWMPPESIFYNR 252
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 51/238 (21%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D +E+ +GSG +G V+ K R G IKR+K E+ +E L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAE----REVKAL 58
Query: 858 SSLHHPNVVSFYG--------------IVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRT 902
+ L H N+V + G L EF G+L+Q+++K +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+D+ L + G++Y+H K +++ DLK N+ + KIGD GL +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK----QVKIGDFGLVTSLKN 174
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+GTL +M+PE +S + + ++V D Y+LG++ L
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDY--GKEV----------------DLYALGLILAEL 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 56/246 (22%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E ++ LG G +G V+ K + + AIKRI+ + RE+++ +E L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKVM----REVKAL 57
Query: 858 SSLHHPNVVSFYG----------IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ L HP +V ++ + P L + +LK ++ + +R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 908 RLI--IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965
+ I + A +E+LH K ++H DLK N+ M D V K+GD GL Q
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEE 173
Query: 966 SGGVR-------------GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
V GT +M+PE + G S+ + KV D +S
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY--SHKV----------------DIFS 215
Query: 1013 LGILFF 1018
LG++ F
Sbjct: 216 LGLILF 221
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 62/254 (24%), Positives = 95/254 (37%), Gaps = 72/254 (28%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWK 852
+L + LG G +G V VA+K +K + S E D
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSEL--RDLLS 75
Query: 853 EALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK------------ 899
E +L ++HP+V+ YG +DGP L + E+ GSL+ FL++
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 900 -----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+R + + A + GM+YL +VH DL N+LV +
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRK 188
Query: 949 CKIGDLGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK 1005
KI D GLS V ++ +G +P WMA E SL + +
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE----------------SLFDHIYTTQ 232
Query: 1006 ---WSYDCYSLGIL 1016
WS+ G+L
Sbjct: 233 SDVWSF-----GVL 241
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 67/249 (26%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K +E++ +D
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDL--SDL 87
Query: 851 WKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E ++ + H N+++ G +DGP L + E+ G+L+++L+ +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 200
Query: 954 LGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WS 1007
GL+ + G LP WMAPE +L + + WS
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPE----------------ALFDRVYTHQSDVWS 244
Query: 1008 YDCYSLGIL 1016
+ G+L
Sbjct: 245 F-----GVL 248
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-34
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 67/249 (26%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K +E++ +D
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDL--SDL 133
Query: 851 WKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E ++ + H N+++ G +DGP L + E+ G+L+++L+ +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 246
Query: 954 LGLSKVKQQTLV-SGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WS 1007
GL++ G LP WMAPE +L + + WS
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPE----------------ALFDRVYTHQSDVWS 290
Query: 1008 YDCYSLGIL 1016
+ G+L
Sbjct: 291 F-----GVL 294
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 58/249 (23%), Positives = 92/249 (36%), Gaps = 62/249 (24%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L+ + LG G +G V G D VA+K +K + E
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSEH--RA 76
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E +L + HH NVV+ G P G L + EF G+L +L+ K
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + A GME+L + +H DL N+L++ ++ V KI D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICD 191
Query: 954 LGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WS 1007
GL+ + + LP WMAPE ++ + ++ WS
Sbjct: 192 FGLARDIYKDPDYVRKGDARLPLKWMAPE----------------TIFDRVYTIQSDVWS 235
Query: 1008 YDCYSLGIL 1016
+ G+L
Sbjct: 236 F-----GVL 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 63/249 (25%), Positives = 91/249 (36%), Gaps = 67/249 (26%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
+ L + LG+G +G V G VA+K +K S ER
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-----HLTER--EALMS 75
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +LS L +H N+V+ G GP +TE+ G L FL++K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ +D L + A GM +L KN +H DL N+L+ + KI D
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR----ITKICD 188
Query: 954 LGLSKVKQQTLV-SGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK---WS 1007
GL++ + LP WMAPE S+ C + + WS
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPE----------------SIFNCVYTFESDVWS 232
Query: 1008 YDCYSLGIL 1016
Y GI
Sbjct: 233 Y-----GIF 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 19/201 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + LG G+YG V+ + + G A+KR + P +R R + E
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP--FRGPKDRARKL----AEVGSH 110
Query: 858 SSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ HP V + G L TE SL+Q + ++ + D
Sbjct: 111 EKVGQHPCCVRLEQAWEE--GGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
+ +LH + +VH D+K N+ + R CK+GD GL G +M
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 977 APELLSGKSHMVTEKVTLFSL 997
APELL G +FSL
Sbjct: 224 APELLQGSY---GTAADVFSL 241
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 36/235 (15%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYH-GKWRGSDVAIKRIKASCFAGKPSERERLIADFW 851
+ + LG G G++ + G + DVA+KRI CF ++RE
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADRE------- 67
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
LL S HPNV+ ++ +D E +L++++++KD + + +
Sbjct: 68 -VQLLRESDEHPNVIRYFCTEKD--RQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITL 123
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVSGGVR 970
G+ +LH NIVH DLK N+L++M + + I D GL K S R
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 971 ----GTLPWMAPELLSGKSHM-VTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
GT W+APE+LS T V D +S G +F+++
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTV----------------DIFSAGCVFYYV 222
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 60/252 (23%), Positives = 100/252 (39%), Gaps = 67/252 (26%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G + VA+K +K+ +E++
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-----TEKDL-- 118
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK------ 899
+D E ++ + H N+++ G +DGP L + E+ G+L+++LQ +
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLE 175
Query: 900 ---------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
+ + + + A A GMEYL K +H DL N+LV + V K
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMK 231
Query: 951 IGDLGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK-- 1005
I D GL+ + G LP WMAPE +L + +
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPE----------------ALFDRIYTHQSD 275
Query: 1006 -WSYDCYSLGIL 1016
WS+ G+L
Sbjct: 276 VWSF-----GVL 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAG 838
P +A+ + + +++G G + VY G VA+K+++
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFD 69
Query: 839 KPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ- 897
+ R AD KE LL L+HPNV+ +Y + D L V E G L + ++
Sbjct: 70 LMDAKAR--ADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKH 125
Query: 898 --KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
K+ R I R + +E++H + ++H D+K N+ + V K+GDLG
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLG 181
Query: 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSH 986
L + + + GT +M+PE + +
Sbjct: 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 58/195 (29%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GTYG VY G +AIK I P R +E L L H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI--------PERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI--IAMDAAFGMEYLH 923
V + G + +G + E + GSL L+ K + ++ I G++YLH
Sbjct: 82 VQYLGSFSE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPELLS 982
IVH D+K +N+L+N V KI D G SK + + GTL +MAPE++
Sbjct: 140 DNQIVHRDIKGDNVLINTYS---GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 983 GKSHMVTEKVTLFSL 997
+ ++SL
Sbjct: 197 KGPRGYGKAADIWSL 211
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 50/239 (20%), Positives = 91/239 (38%), Gaps = 35/239 (14%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIAD 849
G Q+ N LG G +V+ G+ + G AIK S +P + +
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQM---- 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRK 907
+E +L L+H N+V + I + + EF GSL L++ + +
Sbjct: 56 --REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
LI+ D GM +L IVH ++K N++ + + + V K+ D G ++ +
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 968 GVRGTLPWMAPELLSGKSHMV------TEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+ GT ++ P++ V D +S+G+ F+
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATV----------------DLWSIGVTFYHA 216
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 65/254 (25%), Positives = 91/254 (35%), Gaps = 72/254 (28%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
++LE + LGSG +G V + G VA+K +K ER
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----DSSER--EALMS 97
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +++ L H N+V+ G GP + + E+ G L +L+ K
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 900 -----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+ L A A GME+L K+ VH DL N+LV V
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HGKV 210
Query: 949 CKIGDLGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKVTLFSLKFCCFQLK 1005
KI D GL+ + + LP WMAPE SL + +K
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE----------------SLFEGIYTIK 254
Query: 1006 ---WSYDCYSLGIL 1016
WSY GIL
Sbjct: 255 SDVWSY-----GIL 263
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 70/226 (30%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
++ + +G G +G VY G R G+ VA+KR G E F E LS
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG---IEE-----FETEIETLS 90
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---RKRLIIAMDA 915
HP++VS G + + + ++M NG+LK+ L D +RL I + A
Sbjct: 91 FCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
A G+ YLH + I+H D+K N+L++ + V KI D G+SK QT +S V+GT
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
L ++ PE +TEK S D YS G++ F
Sbjct: 205 LGYIDPEYFI--KGRLTEK----S------------DVYSFGVVLF 232
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 50/229 (21%), Positives = 91/229 (39%), Gaps = 35/229 (15%)
Query: 791 ARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIA 848
A G+++ + E+ ++GSG +GSV+ R G AIKR K + + +
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP--LAGSVDEQNAL- 58
Query: 849 DFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---ID 904
+E + L H +VV ++ + D + E+ GSL + + R
Sbjct: 59 ---REVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFK 113
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---------------DPQRPVC 949
+ + + G+ Y+H ++VH D+K N+ ++ + +
Sbjct: 114 EAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG-KSHMVTEKVTLFSL 997
KIGDLG V G ++A E+L +H K +F+L
Sbjct: 174 KIGDLGHVTRISSPQV---EEGDSRFLANEVLQENYTH--LPKADIFAL 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 43/207 (20%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ++++G G++G K G IK I S ERE +E +L
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESR----REVAVL 77
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAA 916
+++ HPN+V + + +GSL V ++ G L + + K + L +
Sbjct: 78 ANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLVSGGVR 970
++++H + I+H D+K +N+ + ++GD G+++V + +
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDG----TVQLGDFGIARVLNSTVELARACI----- 186
Query: 971 GTLPWMAPELLSGKSHMVTEKVTLFSL 997
GT +++PE+ K + K +++L
Sbjct: 187 GTPYYLSPEICENKPY--NNKSDIWAL 211
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E + +G+G+YG + + G + K + +E++ L+ E LL
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLV----SEVNLL 59
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMD 914
L HPN+V +Y + D + +L V E+ G L + K + + +D L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 915 AAFGMEYLHGKN-----IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QT 963
++ H ++ ++H DLK N+ ++ + K+GD GL+++ +T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFGLARILNHDTSFAKT 175
Query: 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSL 997
V GT +M+PE ++ S+ EK ++SL
Sbjct: 176 FV-----GTPYYMSPEQMNRMSY--NEKSDIWSL 202
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 28/200 (14%)
Query: 808 LGSGTYGSVYHGK-WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G +G VY G+ G+ VA+KR+K G E + F E ++S H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQ-----FQTEVEMISMAVHRNLL 90
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMDAAFGMEYLH 923
G + L V +M NGS+ L+++ +D KR IA+ +A G+ YLH
Sbjct: 91 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 924 GK---NIVHFDLKCENLLVNMR-DPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLPWMA 977
I+H D+K N+L++ + +GD GL+K+ + T V+ VRGT+ +A
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 978 PE-LLSGKSHMVTEKVTLFS 996
PE L +GKS +EK +F
Sbjct: 204 PEYLSTGKS---SEKTDVFG 220
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASC-FAGKPSERERLIADFWKEALLLSSLHHPNVV 866
+G G +G VY G + VA+K++ A + +++ F +E +++ H N+V
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ-----FDQEIKVMAKCQHENLV 93
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFL--QKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
G DG D L V +M NGSL L + R IA AA G+ +LH
Sbjct: 94 ELLGFSSDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 925 KNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGTLPWMAPE 979
+ +H D+K N+L+ KI D GL++ QT+++ + GT +MAPE
Sbjct: 152 NHHIHRDIKSANILLDEAFT-A-----KISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 980 LLSGKSHMVTEKVTLFS 996
L G+ +T K ++S
Sbjct: 206 ALRGE---ITPKSDIYS 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 50/239 (20%), Positives = 91/239 (38%), Gaps = 35/239 (14%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIAD 849
G Q+ N LG G +V+ G+ + G AIK S +P + +
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQM---- 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRK 907
+E +L L+H N+V + I + + EF GSL L++ + +
Sbjct: 56 --REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
LI+ D GM +L IVH ++K N++ + + + V K+ D G ++ +
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 968 GVRGTLPWMAPELLSGKSHMV------TEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+ GT ++ P++ V D +S+G+ F+
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATV----------------DLWSIGVTFYHA 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 35/232 (15%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKE 853
I N +++LG G + V + G A+KRI + +RE +E
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQ----RE 76
Query: 854 ALLLSSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---RKR 908
A + +HPN++ + G + F G+L +++ + +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-- 966
L + + G+E +H K H DLK N+L+ + DLG +
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQPVLMDLGSMNQACIHVEGSR 192
Query: 967 --------GGVRGTLPWMAPELLSGKSHM-VTEKVTLFSL-----KFCCFQL 1004
R T+ + APEL S +SH + E+ ++SL +
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 48/241 (19%)
Query: 806 RELGSGTYGSVYH-GKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+ LG G+ G+V G ++G VA+KR+ + E LL S HPN
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALME--------IKLLTESDDHPN 70
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------IAMDAAFG 918
V+ +Y D L E N +L+ ++ K+ + + K + A G
Sbjct: 71 VIRYYCSETT--DRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC---------KIGDLGLSKVKQQTLVSGGV 969
+ +LH I+H DLK +N+LV+ I D GL K S
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 970 R-----GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024
GT W APELL +++ T++ +L S D +S+G +F+++ L
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKR-----------RLTRSIDIFSMGCVFYYI---L 233
Query: 1025 C 1025
Sbjct: 234 S 234
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 31/203 (15%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G++G V+ K G A+K++ RL +E + + L P
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKV-------------RLEVFRVEELVACAGLSSPR 111
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V YG VR+GP + E + GSL Q + K+ + + L A G+EYLH
Sbjct: 112 IVPLYGAVREGP--WVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG------VRGTLPWMAP 978
+ I+H D+K +N+L+ + D G + Q + + GT MAP
Sbjct: 169 RRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 979 ELLSGKSHMVTEKVTLFSLKFCC 1001
E++ GK KV ++S CC
Sbjct: 226 EVVMGKPC--DAKVDIWSS--CC 244
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 63/193 (32%), Positives = 95/193 (49%), Gaps = 18/193 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
+K+DD E++ ELG+G G V+ K G +A K I KP+ R ++I +E
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQII----REL 82
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + P +V FYG DG ++ E M GSL Q L KK I + +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIA 139
Query: 915 AAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+ YL K I+H D+K N+LVN R K+ D G+S ++ + V GT
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV-GTR 194
Query: 974 PWMAPELLSGKSH 986
+M+PE L G +
Sbjct: 195 SYMSPERLQGTHY 207
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-28
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG+G +G V + G VAIK+ + P RER E ++ L+HP
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWC----LEIQIMKKLNHP 72
Query: 864 NVVSFYGIVRDGPDGSLAT----VTEFMVNGSLKQFLQKKDRT--IDRRKRLIIAMDAAF 917
NVVS + + E+ G L+++L + + + + D +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH I+H DLK EN+++ + KI DLG +K Q + GTL ++A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
PELL K + T V D +S G L F
Sbjct: 192 PELLEQKKY--TVTV----------------DYWSFGTLAFEC 216
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 48/238 (20%), Positives = 85/238 (35%), Gaps = 40/238 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL--- 856
+D +R L G + + + A+K+ + S K + ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 857 ------LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
++ + + ++ GI+ + + + E+M N S+ +F + I
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 911 IAMDAAF-------GMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
Y+H KNI H D+K N+L+ D V K+ D G S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRV-KLSDFGESEYMVD 204
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+ G RGT +M PE S +S KV D +SLGI + +
Sbjct: 205 KKIK-GSRGTYEFMPPEFFSNESSYNGAKV----------------DIWSLGICLYVM 245
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 31/238 (13%)
Query: 795 QTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIA 848
Q++ L + + LGSG G V R VAI+ I FA +
Sbjct: 126 QSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL 185
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR 908
+ E +L L+HP ++ D D + V E M G L + R + +
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFF-DAEDYYI--VLELMEGGELFDKVVGNKRLKEATCK 242
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
L ++YLH I+H DLK EN+L++ ++ + KI D G SK+ +T +
Sbjct: 243 LYF-YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRT 300
Query: 969 VRGTLPWMAPELLSGKSHMV-TEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
+ GT ++APE+L V DC+SLG++ F L
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAV----------------DCWSLGVILFIC---LS 339
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 47/232 (20%), Positives = 82/232 (35%), Gaps = 30/232 (12%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 58
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 115
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 116 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
GT+ +M PE + S + + D +SLG + +++
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS-------DVWSLGCILYYM 213
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 60/246 (24%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+++ ++ + LGSG + V+ K R G A+K IK K +
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK------KSPAFRD--SS 52
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-- 907
E +L + H N+V+ I V + + G L F DR ++R
Sbjct: 53 LENEIAVLKKIKHENIVTLEDIYES--TTHYYLVMQLVSGGEL--F----DRILERGVYT 104
Query: 908 -RLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ DA+ ++YLH IVH DLK ENLL + + I D GLSK+
Sbjct: 105 EK-----DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKM 158
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFF 1019
+Q ++S GT ++APE+L+ K + ++ V DC+S+G++ +
Sbjct: 159 EQNGIMSTAC-GTPGYVAPEVLAQKPY--SKAV----------------DCWSIGVITYI 199
Query: 1020 LQFILC 1025
L LC
Sbjct: 200 L---LC 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 19/189 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
+K DDLE + ELG G YG V G +A+KRI+A+ E++RL+ D
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDL---D 57
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKRLII 911
+ + ++ P V+FYG + +G + E M + SL +F + K +TI I
Sbjct: 58 ISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 912 AMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
A+ +E+LH K +++H D+K N+L+N K+ D G+S +
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 971 GTLPWMAPE 979
G P+MAPE
Sbjct: 171 GCKPYMAPE 179
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 64/230 (27%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ LGSG G V R VAIK I FA + + E +L L+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------ 917
++ D D + V E M G L F D+ + KRL A
Sbjct: 76 CIIKIKNFF-DAEDYYI--VLELMEGGEL--F----DK-VVGNKRLKEA-TCKLYFYQML 124
Query: 918 -GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++YLH I+H DLK EN+L++ ++ + KI D G SK+ +T + + GT ++
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 977 APELLSGKSHMV-TEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
APE+L V DC+SLG++ F L
Sbjct: 184 APEVLVSVGTAGYNRAV----------------DCWSLGVILFIC---LS 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 47/232 (20%), Positives = 82/232 (35%), Gaps = 30/232 (12%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 77
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 78 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 135 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
GT+ +M PE + S + + D +SLG + +++
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS-------DVWSLGCILYYM 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 56/246 (22%), Positives = 105/246 (42%), Gaps = 46/246 (18%)
Query: 793 GLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
G++T K +E+ ELGSG + V + + G + A K IK + S R
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVC 58
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ +E +L + HPN+++ + + + + + E + G L F D +
Sbjct: 59 REEIEREVSILRQVLHPNIITLHDVYEN--RTDVVLILELVSGGEL--F----DFLAQKE 110
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ +A G+ YLH K I HFDLK EN+++ ++ P K+ D GL+
Sbjct: 111 S--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFF 1019
+ + + GT ++APE+++ + + + D +S+G++ +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEP--LGLEA----------------DMWSIGVITYI 210
Query: 1020 LQFILC 1025
L L
Sbjct: 211 L---LS 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 49/229 (21%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
+D E R LG G +G+VY + + S +A+K + KA RE I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI------ 62
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
S L HPN++ YG D + + E+ G++ + LQK + ++R I
Sbjct: 63 ---QSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGV 969
A + Y H K ++H D+K ENLL+ KI D G S ++ L
Sbjct: 118 LAN-ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSRRTDLC---- 168
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
GTL ++ PE++ G+ H EKV D +SLG+L +
Sbjct: 169 -GTLDYLPPEMIEGRMH--DEKV----------------DLWSLGVLCY 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 46/246 (18%)
Query: 793 GLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
G++ K +E+ ELGSG + V + + G + A K IK + S R
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVS 58
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ +E +L + H NV++ + + + + + E + G L F D +
Sbjct: 59 REEIEREVSILRQVLHHNVITLHDVYEN--RTDVVLILELVSGGEL--F----DFLAQKE 110
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ +A G+ YLH K I HFDLK EN+++ ++ P K+ D GL+
Sbjct: 111 S--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFF 1019
+ + + GT ++APE+++ + + + D +S+G++ +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEP--LGLEA----------------DMWSIGVITYI 210
Query: 1020 LQFILC 1025
L L
Sbjct: 211 L---LS 213
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-26
Identities = 46/232 (19%), Positives = 81/232 (34%), Gaps = 30/232 (12%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 105
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 162
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 163 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
G + +M PE + S + + D +SLG + +++
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS-------DVWSLGCILYYM 260
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 37/248 (14%), Positives = 75/248 (30%), Gaps = 49/248 (19%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIA 848
+ + + LG G + VY + +K K + E I
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK------PANPWEFYIG 114
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK----DRTID 904
+ L + FY V E G+L + ++ +
Sbjct: 115 T--QLMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-------KIGDLGLS 957
+ + AM + +E +H I+H D+K +N ++ ++ + DLG S
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 958 ---KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG 1014
K+ + + T + E+LS K ++ D + +
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW--NYQI----------------DYFGVA 272
Query: 1015 ILFFFLQF 1022
+ + F
Sbjct: 273 ATVYCMLF 280
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 20/191 (10%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+DL+++ E+G G YGSV K G +A+KRI+++ E+++L+ D
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQLLMDL--- 71
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL----KQFLQKKDRTIDRRKRL 909
+++ S P +V FYG + +G E M + S K D I
Sbjct: 72 DVVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128
Query: 910 IIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
I + + +L I+H D+K N+L++ + K+ D G+S ++
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLCDFGISGQLVDSIAKTR 184
Query: 969 VRGTLPWMAPE 979
G P+MAPE
Sbjct: 185 DAGCRPYMAPE 195
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 48/229 (20%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
N+ E V ELG G +G VY K G+ A K I ++ E + D+ E +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--------ETKSEEELEDYIVEIEI 69
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L++ HP +V G DG L + EF G++ + + DR + + ++
Sbjct: 70 LATCDHPYIVKLLGAYYH--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 127
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+ +LH K I+H DLK N+L+ + ++ D G+S K+ + +
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEG----DIRLADFGVSAKNLKTLQKRDSFI----- 178
Query: 971 GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDC----YSLGI 1015
GT WMAPE++ C YD +SLGI
Sbjct: 179 GTPYWMAPEVVM-----------------CETMKDTPYDYKADIWSLGI 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 45/187 (24%), Positives = 82/187 (43%), Gaps = 16/187 (8%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ +DLE + E+GSGT G V+ + G +A+K+++ S G E +R++ D
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDL--- 74
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
++L S P +V +G + + E M ++ ++ I R + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ YL K ++H D+K N+L++ +R K+ D G+S G
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDFGISGRLVDDKAKDRSAGC 187
Query: 973 LPWMAPE 979
+MAPE
Sbjct: 188 AAYMAPE 194
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 49/229 (21%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
DD + R LG G +G+VY + + + +A+K + K+ RE I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI------ 67
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
S L HPN++ Y D + + EF G L + LQK R ++R +
Sbjct: 68 ---QSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGV 969
A + Y H + ++H D+K ENLL+ + KI D G S ++++T+
Sbjct: 123 LAD-ALHYCHERKVIHRDIKPENLLMGYKG----ELKIADFGWSVHAPSLRRRTMC---- 173
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
GTL ++ PE++ GK+H EKV D + G+L +
Sbjct: 174 -GTLDYLPPEMIEGKTH--DEKV----------------DLWCAGVLCY 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+ +++++ ELGSG + V + + G A K IK R D
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS--RRGVSRED 60
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-- 907
+E +L + HPNV++ + + + + + E + G L F D ++
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYEN--KTDVILILELVAGGEL--F----DFLAEKESLT 112
Query: 908 -RLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+A G+ YLH I HFDLK EN+++ R+ +P KI D GL+
Sbjct: 113 EE-----EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSH 986
+ GT ++APE+++ +
Sbjct: 168 IDFGNEFKNIFGTPEFVAPEIVNYEPL 194
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 67/232 (28%), Positives = 96/232 (41%), Gaps = 57/232 (24%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELG G VY K +G+ A+K +K + E +L L HP
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK----------KTVDKKIVRTEIGVLLRLSHP 108
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF--- 917
N++ I ++ V E + G L F DR +++ R DAA
Sbjct: 109 NIIKLKEIFET--PTEISLVLELVTGGEL--F----DRIVEKGYYSER-----DAADAVK 155
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ YLH IVH DLK ENLL P P+ KI D GLSK+ + ++ V GT
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLMKTVCGTP 214
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
+ APE+L G ++ +V D +S+GI+ + L LC
Sbjct: 215 GYCAPEILRGCAY--GPEV----------------DMWSVGIITYIL---LC 245
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 57/233 (24%), Positives = 89/233 (38%), Gaps = 47/233 (20%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G G + V R G A+K + + F P D +EA + L HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKREASICHMLKHP 86
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA---MDAAFGM- 919
++V DG L V EFM L I +R A+ M
Sbjct: 87 HIVELLETYSS--DGMLYMVFEFMDGADL--C----FE-IVKRADAGFVYSEAVASHYMR 137
Query: 920 ------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGT 972
Y H NI+H D+K +L+ ++ PV K+G G++ + + LV+GG GT
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLVAGGRVGT 196
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
+MAPE++ + + + V D + G++ F L L
Sbjct: 197 PHFMAPEVVKREPY--GKPV----------------DVWGCGVILFIL---LS 228
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 51/232 (21%), Positives = 86/232 (37%), Gaps = 53/232 (22%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELG G + V + G + A K I R +EA + L HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIIN------TKKLSARDFQKLEREARICRKLQHP 65
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF--- 917
N+V + +++ + V + + G L F + + R DA+
Sbjct: 66 NIVRLHDSIQE--ESFHYLVFDLVTGGEL--F----EDIVAREFYSEA-----DASHCIQ 112
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ Y H IVH +LK ENLL+ + V K+ D GL+ + G GT
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTP 171
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
+++PE+L + ++ V D ++ G++ + L L
Sbjct: 172 GYLSPEVLKKDPY--SKPV----------------DIWACGVILYIL---LV 202
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 52/249 (20%), Positives = 89/249 (35%), Gaps = 58/249 (23%)
Query: 794 LQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLI 847
+ TI E ELG G + V G + A I R
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN------TKKLSARDH 54
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+EA + L HPN+V + + + +G + + + G L F + + R
Sbjct: 55 QKLEREARICRLLKHPNIVRLHDSISE--EGHHYLIFDLVTGGEL--F----EDIVAREY 106
Query: 908 ---RLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
DA+ + + H +VH +LK ENLL+ + V K+ D GL+
Sbjct: 107 YSEA-----DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLA 160
Query: 958 K-VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
V+ + G GT +++PE+L + + V D ++ G++
Sbjct: 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPY--GKPV----------------DLWACGVI 202
Query: 1017 FFFLQFILC 1025
+ L L
Sbjct: 203 LYIL---LV 208
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 785 AEAEAIARGLQTIKND---DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGK 839
+ ++ G+Q +K D ++ ++G G++G V+ G VAIK I +
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-----E 58
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
+E E I D +E +LS P V +YG L + E++ GS L +
Sbjct: 59 EAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLL--E 112
Query: 900 DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-- 957
+D + I + G++YLH + +H D+K N+L++ K+ D G++
Sbjct: 113 PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE----HGEVKLADFGVAGQ 168
Query: 958 ----KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSL 997
++K+ T V GT WMAPE++ ++ K ++SL
Sbjct: 169 LTDTQIKRNTFV-----GTPFWMAPEVIKQSAY--DSKADIWSL 205
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 54/259 (20%), Positives = 100/259 (38%), Gaps = 53/259 (20%)
Query: 782 PTIAEAEAIARGLQTI--KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKA 833
++ + + RG + + + + ELG G + V + G + A K I
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 834 SCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK 893
+ + + +EA + L HPN+V + +++ + V + + G L
Sbjct: 65 KKLSARDFQ------KLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGEL- 115
Query: 894 QFLQKKDRTIDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
F + I R+ A DA+ + Y H IVH +LK ENLL+ +
Sbjct: 116 -F----ED-IVAREFYSEA-DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168
Query: 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKW 1006
V K+ D GL+ + G GT +++PE+L + ++ V
Sbjct: 169 AV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY--SKPV-------------- 211
Query: 1007 SYDCYSLGILFFFLQFILC 1025
D ++ G++ + L L
Sbjct: 212 --DIWACGVILYIL---LV 225
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 61/270 (22%), Positives = 101/270 (37%), Gaps = 34/270 (12%)
Query: 729 AEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAE 788
AE + + + + E V+ G+I TV + +
Sbjct: 84 AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRG--KGTVSSNYDNYVFDIWK 141
Query: 789 AIARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSE 842
IK+D + + ELG+G +G V+ R G++ A K + S+
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESD 197
Query: 843 RERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+E KE +S L HP +V+ + D D + + EFM G L F ++
Sbjct: 198 KE----TVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGEL--F----EKV 245
Query: 903 IDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
D ++ +A G+ ++H N VH DLK EN++ + K+ D G
Sbjct: 246 ADEHNKMS-EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFG 302
Query: 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985
L+ GT + APE+ GK
Sbjct: 303 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 29/194 (14%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELGSG + V + + G + A K IK + R + +E +L + HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSS--RRGVSREEIEREVNILREIRHP 68
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF--- 917
N+++ + I + + + E + G L F D ++ +A
Sbjct: 69 NIITLHDIFEN--KTDVVLILELVSGGEL--F----DFLAEKESLTED-----EATQFLK 115
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGT 972
G+ YLH K I HFDLK EN+++ ++ P K+ D G++ ++ GT
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GT 174
Query: 973 LPWMAPELLSGKSH 986
++APE+++ +
Sbjct: 175 PEFVAPEIVNYEPL 188
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 23/186 (12%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++RE+G G++G+VY VAIK++ ++GK S + D KE
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEK--WQDIIKEVRF 107
Query: 857 LSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L L HPN + + G +R+ + V E+ GS L+ + + + + A
Sbjct: 108 LQKLRHPNTIQYRGCYLREH---TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS--KVKQQTLVSGGVRGTL 973
G+ YLH N++H D+K N+L++ + K+GD G + + V GT
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPANSFV-----GTP 214
Query: 974 PWMAPE 979
WMAPE
Sbjct: 215 YWMAPE 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++G G G+VY G +VAI+++ + ++ LI E L+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELII---NEILV 70
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ +PN+V++ G + L V E++ GSL + + +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+E+LH ++H D+K +N+L+ M K+ D G + K+ T+V
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMV----- 177
Query: 971 GTLPWMAPELLSGKSHMVTEKVTLFSL 997
GT WMAPE+++ K++ KV ++SL
Sbjct: 178 GTPYWMAPEVVTRKAY--GPKVDIWSL 202
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 70/241 (29%), Positives = 99/241 (41%), Gaps = 52/241 (21%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
K L E+ ++LGSG YG V + + + AIK I+ K S +
Sbjct: 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR------KTSVSTSSNSKLL 84
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---- 907
+E +L L HPN++ Y D + V E G L F D I R K
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFED--KRNYYLVMECYKGGEL--F----DEIIHRMKFNEV 136
Query: 908 ---RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
+I + + + YLH NIVH DLK ENLL+ ++ + KI D GLS V +
Sbjct: 137 DAAVIIKQVLSG--VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQK 193
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024
GT ++APE+L K EK D +S+G++ F L L
Sbjct: 194 KMKERLGTAYYIAPEVLRKK---YDEKC----------------DVWSIGVILFIL---L 231
Query: 1025 C 1025
Sbjct: 232 A 232
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 31/197 (15%)
Query: 808 LGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G GTYG VY K + D A+K+I+ G R E LL L HP
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACR-------EIALLRELKHP 78
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL--QKKDRTIDRRKRLIIAMDAAF---- 917
NV+S + D + + ++ L + + + + +L M +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQTLVSGGVR 970
G+ YLH ++H DLK N+LV P+R KI D+G ++ +K + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 971 GTLPWM-APELLSGKSH 986
T W APELL G H
Sbjct: 198 -TF-WYRAPELLLGARH 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 35/241 (14%)
Query: 769 DYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDD----LEEVRELGSGTYGSVYHG--KWR 822
D T + + A + D L+ ++G G+ G V K
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
G VA+K + + +R L+ E +++ H NVV Y G + L
Sbjct: 70 GRQVAVKMMDL-----RKQQRRELLF---NEVVIMRDYQHFNVVEMYKSYLVGEE--LWV 119
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
+ EF+ G+L + ++ + + + YLH + ++H D+K +++L+ +
Sbjct: 120 LMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177
Query: 943 DPQRPVCKIGDLGLS------KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFS 996
K+ D G K+++LV GT WMAPE++S + +V ++S
Sbjct: 178 G----RVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSLY--ATEVDIWS 226
Query: 997 L 997
L
Sbjct: 227 L 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 73/246 (29%), Positives = 104/246 (42%), Gaps = 51/246 (20%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIK-----ASCFAGKPSERERL 846
K + E R+LGSG YG V K + S+ AIK IK ++ E+
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ + E LL SL HPN++ + + D VTEF G L F ++ I R
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFED--KKYFYLVTEFYEGGEL--F----EQ-IINR 140
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ DAA G+ YLH NIVH D+K EN+L+ ++ + KI D GLS
Sbjct: 141 HKFD-ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSF 198
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFF 1019
+ GT ++APE+L K EK D +S G++ +
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKKKY---NEKC----------------DVWSCGVIMYI 239
Query: 1020 LQFILC 1025
L LC
Sbjct: 240 L---LC 242
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 63/241 (26%), Positives = 92/241 (38%), Gaps = 51/241 (21%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
+ R LG G++G V K + G + A+K I K
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLL 74
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---- 907
+E LL L HPN++ Y D G V E G L F D I R++
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGEL--F----DEIISRKRFSEV 126
Query: 908 ---RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
R+I + + + Y+H IVH DLK ENLL+ + + +I D GLS + +
Sbjct: 127 DAARIIRQVLSG--ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASK 183
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024
GT ++APE+L G EK D +S G++ + L L
Sbjct: 184 KMKDKIGTAYYIAPEVLHGT---YDEKC----------------DVWSTGVILYIL---L 221
Query: 1025 C 1025
Sbjct: 222 S 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 46/231 (19%), Positives = 79/231 (34%), Gaps = 45/231 (19%)
Query: 800 DDLEEVRELGSG--TYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
E + +G G +V K G V ++RI + ++ E
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE------ACSNEMVTFLQGELH 78
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM-- 913
+ +HPN+V + + L VT FM GS K + +D L IA
Sbjct: 79 VSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYIL 134
Query: 914 -DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVS 966
++Y+H VH +K ++L+++ + L + +Q+ +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISV----DGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 967 GGVR--GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGI 1015
LPW++PE+L K D YS+GI
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKS----------------DIYSVGI 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 42/223 (18%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++ VY + G +VAIK I K + + K +R+ E + L H
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--KAGMVQRVQ----NEVKIHCQLKH 70
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEY 921
P+++ Y D + V E NG + ++L+ + + R + GM Y
Sbjct: 71 PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT-GMLY 127
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMA 977
LH I+H DL NLL+ KI D GL+ + GT +++
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNM----NIKIADFGLATQLKM---PHEKHYTLCGTPNYIS 180
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
PE+ + +H + D +SLG +F+ L
Sbjct: 181 PEIATRSAH--GLES----------------DVWSLGCMFYTL 205
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 60/250 (24%), Positives = 101/250 (40%), Gaps = 53/250 (21%)
Query: 779 KIEPTIAEAEAIARGLQTIKNDDLEEVRE----LGSGTYGSVYHG--KWRGSDVAIKRIK 832
++ + + + EEV + LG G+YGSVY K G VAIK++
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63
Query: 833 ASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGS 891
E + + KE ++ P+VV +YG ++ L V E+ GS
Sbjct: 64 V----------ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT---DLWIVMEYCGAGS 110
Query: 892 LKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ ++ +++T+ + I G+EYLH +H D+K N+L+N K+
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG----HAKL 166
Query: 952 GDLGLS------KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK 1005
D G++ K+ T++ GT WMAPE++ +
Sbjct: 167 ADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIGY--NCVA------------- 206
Query: 1006 WSYDCYSLGI 1015
D +SLGI
Sbjct: 207 ---DIWSLGI 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 69/229 (30%), Positives = 96/229 (41%), Gaps = 48/229 (20%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V K R + A+K I K S + + + +E LL L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN------KASAKNKDTSTILREVELLKKLDHP 81
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
N++ + I+ D S V E G L F D I +RKR DAA +
Sbjct: 82 NIMKLFEILED--SSSFYIVGELYTGGEL--F----DE-IIKRKRFS-EHDAARIIKQVF 131
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
Y+H NIVH DLK EN+L+ ++ + KI D GLS QQ GT ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
APE+L G EK D +S G++ + L L
Sbjct: 191 APEVLRGTY---DEKC----------------DVWSAGVILYIL---LS 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 54/241 (22%), Positives = 90/241 (37%), Gaps = 54/241 (22%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
D+ + +G G++G V + A K+I + + F
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVD----RFK 54
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E ++ SL HPN++ Y D + + V E G L F +R + ++
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFED--NTDIYLVMELCTGGEL--F----ER-VVHKRVFR- 104
Query: 912 AMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
DAA M Y H N+ H DLK EN L P P+ K+ D GL+ +
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAARFKPGK 163
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024
+ GT +++P++L G + D +S G++ + L L
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLY---GPEC----------------DEWSAGVMMYVL---L 201
Query: 1025 C 1025
C
Sbjct: 202 C 202
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 32/204 (15%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+K + + ELGSG +G V+ + G K I P ++
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY----T 94
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
E +++ LHHP +++ + D + + EF+ G L F DR ++
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGEL--F----DRIAAEDYKM 146
Query: 910 IIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+ G++++H +IVH D+K EN++ + KI D GL+
Sbjct: 147 S-EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS--VKIIDFGLATKLNP 203
Query: 963 TLVSGGVRGTLPWMAPELLSGKSH 986
+ T + APE++ +
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREPV 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 62/243 (25%), Positives = 98/243 (40%), Gaps = 53/243 (21%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
++++ R+LGSG +G V+ + R G + IK I K + +
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN------KDRSQVP-MEQIE 68
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +L SL HPN++ + + D ++ V E G L +R + + R
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFED--YHNMYIVMETCEGGEL--L----ERIVSAQARGKA 120
Query: 912 A--MDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
A M Y H +++VH DLK EN+L P P+ KI D GL+++ +
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKS 179
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF 1022
S GT +MAPE+ VT K D +S G++ +FL
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRD---VTFKC----------------DIWSAGVVMYFL-- 218
Query: 1023 ILC 1025
L
Sbjct: 219 -LT 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-22
Identities = 51/266 (19%), Positives = 81/266 (30%), Gaps = 72/266 (27%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G G+YG V + AIK + + + E L+ LHHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE---RIKTEVRLMKKLHHP 88
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM---------- 913
N+ Y + D + + V E G L L + + +
Sbjct: 89 NIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 914 ----------------------DAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDP 944
+ + YLH + I H D+K EN L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 945 QRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSHMVTEKVTLFSLKF 999
+ K+ D GLSK + GT ++APE+L+ + K
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC------- 257
Query: 1000 CCFQLKWSYDCYSLGILFFFLQFILC 1025
D +S G+L L L
Sbjct: 258 ---------DAWSAGVLLHLL---LM 271
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 40/205 (19%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+I DD E +GSG V + VAIKRI + + + + KE
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-----EKCQTS--MDELLKE 63
Query: 854 ALLLSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL--- 909
+S HHPN+VS+Y V L V + + GS+ ++ + + +
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVV---KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 910 ----IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-------- 957
I + G+EYLH +H D+K N+L+ +I D G+S
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG----SVQIADFGVSAFLATGGD 176
Query: 958 ---KVKQQTLVSGGVRGTLPWMAPE 979
++T V GT WMAPE
Sbjct: 177 ITRNKVRKTFV-----GTPCWMAPE 196
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 45/209 (21%), Positives = 80/209 (38%), Gaps = 30/209 (14%)
Query: 791 ARGLQTIKNDDLEEV-----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSER 843
L ++ +ELG G + V + G + A K +K K
Sbjct: 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK------KRRRG 68
Query: 844 ERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+ A+ E +L P V++ + + + + + E+ G + F
Sbjct: 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEIILILEYAAGGEI--F----SLC 120
Query: 903 IDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
+ ++ D G+ YLH NIVH DLK +N+L++ P + KI D G
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI-KIVDFG 179
Query: 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGK 984
+S+ + GT ++APE+L+
Sbjct: 180 MSRKIGHACELREIMGTPEYLAPEILNYD 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 35/191 (18%), Positives = 67/191 (35%), Gaps = 31/191 (16%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+LG G +G V+ K +K K +++ KE +L+ H
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQV----LVKKEISILNIARHR 61
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------ 917
N++ + L + EF+ + F +R L +
Sbjct: 62 NILHLHESFES--MEELVMIFEFISGLDI--F----ERINTSAFELN-EREIVSYVHQVC 112
Query: 918 -GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPW 975
+++LH NI HFD++ EN++ + + KI + G + ++K +
Sbjct: 113 EALQFLHSHNIGHFDIRPENII--YQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEY 169
Query: 976 MAPELLSGKSH 986
APE+
Sbjct: 170 YAPEVHQHDVV 180
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 44/224 (19%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
R LG G + + A K + K+ KP +RE++ E + SL H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMS----MEISIHRSLAH 74
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+VV F+G D + + V E SL + +++ + R + G +YL
Sbjct: 75 QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYL 131
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMA 977
H ++H DLK NL +N KIGD GL+ + G R GT ++A
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATK----VEYDGERKKVLCGTPNYIA 183
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG-ILFFFL 1020
PE+LS K H + +V D +S+G I++ L
Sbjct: 184 PEVLSKKGH--SFEV----------------DVWSIGCIMYTLL 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 69/229 (30%), Positives = 96/229 (41%), Gaps = 48/229 (20%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V K R + A+K I K S + + + +E LL L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN------KASAKNKDTSTILREVELLKKLDHP 81
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
N++ + I+ D S V E G L F D I +RKR DAA +
Sbjct: 82 NIMKLFEILED--SSSFYIVGELYTGGEL--F----DE-IIKRKRFS-EHDAARIIKQVF 131
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
Y+H NIVH DLK EN+L+ ++ + KI D GLS QQ GT ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
APE+L G EK D +S G++ + L L
Sbjct: 191 APEVLRGT---YDEKC----------------DVWSAGVILYIL---LS 217
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-22
Identities = 54/293 (18%), Positives = 90/293 (30%), Gaps = 101/293 (34%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E ++ +G G +G V+ K + + AIKRI+ + RE++ +E L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKV----MREVKAL 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR------------ 905
+ L HP +V ++ + P + + +
Sbjct: 59 AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118
Query: 906 RKRLIIAMDAAFG--------MEY------------------------------------ 921
+ + M+
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 922 -LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---------- 970
LH K ++H DLK N+ M D V K+GD GL Q V
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 971 ---GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
GT +M+PE + G ++ + KV D +SLG++ F L
Sbjct: 235 GQVGTKLYMSPEQIHGNNY--SHKV----------------DIFSLGLILFEL 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 44/224 (19%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
R LG G + + A K + K+ KP +RE++ E + SL H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMS----MEISIHRSLAH 100
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+VV F+G D + + V E SL + +++ + R + G +YL
Sbjct: 101 QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYL 157
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMA 977
H ++H DLK NL +N KIGD GL+ + G R GT ++A
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATK----VEYDGERKKVLCGTPNYIA 209
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG-ILFFFL 1020
PE+LS K H + +V D +S+G I++ L
Sbjct: 210 PEVLSKKGH--SFEV----------------DVWSIGCIMYTLL 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 53/231 (22%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E V +G+GTYG VY G G AIK + E E + +E +L
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TGDEEEEIK----QEINMLKKY 77
Query: 861 -HHPNVVSFYG----IVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG G D L V EF GS+ ++ K T+ I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGG 968
G+ +LH ++H D+K +N+L+ K+ D G+S ++ T +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDC----YSLGI 1015
GT WMAPE+++ C +YD +SLGI
Sbjct: 191 --GTPYWMAPEVIA-----------------CDENPDATYDFKSDLWSLGI 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 52/229 (22%), Positives = 84/229 (36%), Gaps = 52/229 (22%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G G V R G A+K + S + +E + P++
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQE--------VDHHWQASGGPHI 84
Query: 866 VSFYGIVRDGPDGSLAT--VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
V + + G + E M G L F R +R + +AA M
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGEL--F----SRIQERGDQAFTEREAAEIMRDIG 138
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++LH NI H D+K ENLL ++ + K+ D G +K Q + T ++
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNALQTPC-YTPYYV 196
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
APE+L + + + D +SLG++ + L LC
Sbjct: 197 APEVLGPEKY--DKSC----------------DMWSLGVIMYIL---LC 224
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 51/231 (22%), Positives = 82/231 (35%), Gaps = 36/231 (15%)
Query: 772 NDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEV----RELGSGTYGSVYHG--KWRGSD 825
+ + P + GLQ KN +++ + LG G G V K
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 826 VAIKRIKASCFAGKPSERERLIADFWKE-ALLLSSLHHPNVVSFYGIVRDGPDGSLAT-- 882
A+K ++ +E L + P++V + + G
Sbjct: 90 FALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM-------EYLHGKNIVHFDLKCE 935
V E + G L F R DR + +A+ M +YLH NI H D+K E
Sbjct: 137 VMECLDGGEL--F----SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190
Query: 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
NLL + P + K+ D G +K T ++APE+L + +
Sbjct: 191 NLLYTSKRPNAIL-KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 50/238 (21%), Positives = 84/238 (35%), Gaps = 68/238 (28%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
++G G+Y + + A+K I S E +LL HP
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---EE--------IEILLRYGQHP 76
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAFGM- 919
N+++ + D + VTE M G L D+ + ++ R +A+ +
Sbjct: 77 NIITLKDVYDD--GKYVYVVTELMKGGEL--L----DKILRQKFFSER-----EASAVLF 123
Query: 920 ------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLVSG 967
EYLH + +VH DLK N+L +I D G +K + T
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-- 181
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
T ++APE+L + + D +SLG+L + + L
Sbjct: 182 ---YTANFVAPEVLERQGY--DAAC----------------DIWSLGVLLYTM---LT 215
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 62/309 (20%), Positives = 117/309 (37%), Gaps = 56/309 (18%)
Query: 728 GAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEA 787
+ +K ++ S + + A+ E + + + D + P +
Sbjct: 20 YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVD----IPAPPAPFDH 75
Query: 788 EAIARGLQTIKND-DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE 844
+ + + + + LG G +G V+ + G +A K IK ++E
Sbjct: 76 RIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKE 131
Query: 845 RLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
+ E +++ L H N++ Y + V E++ G L F DR ID
Sbjct: 132 ----EVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVDGGEL--F----DRIID 179
Query: 905 RRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
L +D G+ ++H I+H DLK EN+L RD ++ KI D GL+
Sbjct: 180 ESYNLT-ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ--IKIIDFGLA 236
Query: 958 K-VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGIL 1016
+ K + + GT ++APE+++ V+ D +S+G++
Sbjct: 237 RRYKPREKLKVNF-GTPEFLAPEVVNYDF--VSFPT----------------DMWSVGVI 277
Query: 1017 FFFLQFILC 1025
+ L L
Sbjct: 278 AYML---LS 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 2e-21
Identities = 28/246 (11%), Positives = 59/246 (23%), Gaps = 58/246 (23%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
L G V+ + D A+K F + + + L
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALK-----VFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 864 NVVSFYG------------------IVRDGPDGSLATVTEFMV-----NGSLKQFLQKKD 900
+ + P V +++ + L+ D
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 901 RTIDRRK------RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
R I+ L K +VH +NL + P + +GD+
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRL-MLGDV 238
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLG 1014
+ + + E L+ + T + + + LG
Sbjct: 239 SALWKVGTRGPASS--VPVTYAPREFLNASTATFTHAL----------------NAWQLG 280
Query: 1015 ILFFFL 1020
+ + +
Sbjct: 281 LSIYRV 286
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 57/192 (29%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK---EALLLSS 859
V+ LG G YG V R VA+K + + +R + E +
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV----------DMKRAVDCPENIKKEICINKM 61
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L+H NVV FYG R+G E+ G L ++ + +R ++A
Sbjct: 62 LNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GT 972
G+ YLHG I H D+K ENLL+ D + + KI D GL+ V + + GT
Sbjct: 117 --GVVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGT 170
Query: 973 LPWMAPELLSGK 984
LP++APELL +
Sbjct: 171 LPYVAPELLKRR 182
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 55/326 (16%), Positives = 99/326 (30%), Gaps = 53/326 (16%)
Query: 720 SVKRAALEGAEEVKAKVEESDDSVKPDTTTKE--APANEAELVNIHGEIEMDYDNDTVKT 777
S E +A+ E + + + + E ND
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 778 LKIEPTIAEAEAIARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRI 831
+ + +G G V R G + A+K +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 832 KASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLATVTEFMVNG 890
+ + P + E + +E +L + HP++++ + V + M G
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--SSFMFLVFDLMRKG 185
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRD 943
L F D + + L + + +LH NIVH DLK EN+L+ D
Sbjct: 186 EL--F----DY-LTEKVALS-EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---D 234
Query: 944 PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQ 1003
+ ++ D G S + + GT ++APE+L
Sbjct: 235 DNMQI-RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG------------ 281
Query: 1004 LKWSY----DCYSLGILFFFLQFILC 1025
Y D ++ G++ F L L
Sbjct: 282 ----YGKEVDLWACGVILFTL---LA 300
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 50/238 (21%), Positives = 79/238 (33%), Gaps = 54/238 (22%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSL-H 861
LG G V + + A+K I + E + L KE +L +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF- 917
HPN++ + V + M G L F D ++ + +
Sbjct: 83 HPNIIQLKDTYET--NTFFFLVFDLMKKGEL--F----DYLTEKVTLSEK-----ETRKI 129
Query: 918 ------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
+ LH NIVH DLK EN+L+ D + K+ D G S V G
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILL---DDDMNI-KLTDFGFSCQLDPGEKLREVCG 185
Query: 972 TLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSY----DCYSLGILFFFLQFILC 1025
T ++APE++ + Y D +S G++ + L L
Sbjct: 186 TPSYLAPEIIECSMNDNHPG----------------YGKEVDMWSTGVIMYTL---LA 224
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 55/255 (21%), Positives = 92/255 (36%), Gaps = 77/255 (30%)
Query: 797 IKNDDLEEV-------RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLI 847
+K+ + + LG G++ K A+K I +R+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-----------KRME 49
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
A+ KE L HPN+V + + D V E + G L F +R ++
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGEL--F----ERIKKKK 101
Query: 907 K---RLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
+A++ M ++H +VH DLK ENLL + + KI D G
Sbjct: 102 HFSET-----EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIIDFGF 155
Query: 957 SKVKQ------QTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDC 1010
+++K +T TL + APELL+ + E D
Sbjct: 156 ARLKPPDNQPLKTPC-----FTLHYAAPELLNQNGY--DESC----------------DL 192
Query: 1011 YSLGILFFFLQFILC 1025
+SLG++ + + L
Sbjct: 193 WSLGVILYTM---LS 204
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 57/192 (29%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK---EALLLSS 859
V+ LG G YG V R VA+K + + +R + E +
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV----------DMKRAVDCPENIKKEICINKM 61
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L+H NVV FYG R+G E+ G L ++ + +R ++A
Sbjct: 62 LNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GT 972
G+ YLHG I H D+K ENLL+ D + + KI D GL+ V + + GT
Sbjct: 117 --GVVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGT 170
Query: 973 LPWMAPELLSGK 984
LP++APELL +
Sbjct: 171 LPYVAPELLKRR 182
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 51/240 (21%), Positives = 90/240 (37%), Gaps = 43/240 (17%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ L R L G + VY + G + A+KR+ + + + +I +E
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAII----QE 75
Query: 854 ALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMV-----NGSLKQFLQKKDRT--IDR 905
+ L HPN+V F G + S EF++ G L +FL+K + +
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 906 RKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
L I ++++H + I+H DLK ENLL++ + K+ D G +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCDFGSATTISHY 191
Query: 964 LVSGG-------------VRGTLPWMAPELLSGKSHM-VTEKVTLFSL-----KFCCFQL 1004
T + PE++ S+ + EK +++L C Q
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 36/194 (18%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWK-EALLLSS 859
+ V+++GSG +G K VA+K I ER I + + E + S
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYI----------ERGAAIDENVQREIINHRS 72
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L HPN+V F ++ LA + E+ G L + + R + R + +++
Sbjct: 73 LRHPNIVRFKEVILTPTH--LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--- 127
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ-----TLVSGGVR 970
G+ Y H I H DLK EN L++ P KI D G SK + V
Sbjct: 128 --GVSYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV----- 178
Query: 971 GTLPWMAPELLSGK 984
GT ++APE+L +
Sbjct: 179 GTPAYIAPEVLLRQ 192
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 60/225 (26%), Positives = 88/225 (39%), Gaps = 43/225 (19%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI------------------KASCFAGKPSERER 845
E+G G+YG V + A+K + G +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 846 LIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID- 904
I ++E +L L HPNVV ++ D + L V E + G + + K + D
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 905 -RRK-RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--K 960
R + +I G+EYLH + I+H D+K NLLV KI D G+S
Sbjct: 139 ARFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNEFKG 189
Query: 961 QQTLVSGGVRGTLPWMAPELLSGKSHMVTEK--------VTLFSL 997
L+S V GT +MAPE LS + + K VTL+
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 32/198 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA-GKPSERERLIADFWKEALL 856
+ E++ ++G G+YG V+ + R G VAIK+ S R E +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-------EIRM 55
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-RLIIAMDA 915
L L HPN+V+ + R L V E+ + ++ L + R + + I
Sbjct: 56 LKQLKHPNLVNLLEVFRR--KRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTL 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQT-LVSGGV 969
+ + H N +H D+K EN+L+ V K+ D G V+
Sbjct: 113 Q-AVNFCHKHNCIHRDVKPENILITKHS----VIKLCDFGFARLLTGPSDYYDDEVA--- 164
Query: 970 RGTLPWM-APELLSGKSH 986
T W +PELL G +
Sbjct: 165 --TR-WYRSPELLVGDTQ 179
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 44/187 (23%), Positives = 79/187 (42%), Gaps = 20/187 (10%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LGSG +G V+ + +V +K IK + + E +LS + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGS-LKQFLQKKDRTID---RRK-RLIIAMDAAFG 918
N++ I + G V E +G L F+ + R + R +++
Sbjct: 90 NIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-----A 142
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+ YL K+I+H D+K EN+++ + K+ D G + +++ L GT+ + A
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYCA 197
Query: 978 PELLSGK 984
PE+L G
Sbjct: 198 PEVLMGN 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 3e-19
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 25/194 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA-GKPSERERLIADFWKEALLL 857
+ + ++G GTYG VY + G A+K+I+ G PS R E +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-------EISIL 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
L H N+V Y ++ L V E + + LK+ L + ++ K ++ +
Sbjct: 55 KELKHSNIVKLYDVIHT--KKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ Y H + ++H DLK +NLL+N + KI D GL++ + V T
Sbjct: 112 --GIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYTHEIV--T 163
Query: 973 LPWMAPELLSGKSH 986
L + AP++L G
Sbjct: 164 LWYRAPDVLMGSKK 177
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 25/186 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ +G G + V + G +VAIK I + P+ ++L +E ++ L+HP
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF----REVRIMKILNHP 74
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
N+V + ++ L + E+ G + +L R + R K R I++ +
Sbjct: 75 NIVKLFEVIETEKTLYL--IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AV 127
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAP 978
+Y H K IVH DLK ENLL+ D + KI D G S + + G P+ AP
Sbjct: 128 QYCHQKRIVHRDLKAENLLL---DADMNI-KIADFGFSNEFTVGGKLDAFC-GAPPYAAP 182
Query: 979 ELLSGK 984
EL GK
Sbjct: 183 ELFQGK 188
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
V +LG G +VY + VAIK I K +R F +E S L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKR----FEREVHNSSQLSH 70
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
N+VS + + L V E+ + G +L ++++ + + G+++
Sbjct: 71 QNIVSMIDVDEEDDCYYL--VMEY-IEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKH 126
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTLPWMAPE 979
H IVH D+K +N+L+ D + + KI D G++K +T + + V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILI---DSNKTL-KIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 980 LLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
G+ E D YS+GI+ +
Sbjct: 183 QAKGE--ATDECT----------------DIYSIGIVLY 203
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 36/197 (18%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE--RLIADFWKEALLLS 858
E + +G G+YG V + + G VAIK+ S + + + IA +E LL
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES------DDDKMVKKIA--MREIKLLK 79
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDAA 916
L H N+V+ + + V EF+ + ++ L+ +D + ++ + +
Sbjct: 80 QLRHENLVNLLEVCKK--KKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIIN- 135
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQT-LVSGGVR 970
G+ + H NI+H D+K EN+LV+ V K+ D G + + V+
Sbjct: 136 -GIGFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFARTLAAPGEVYDDEVA---- 186
Query: 971 GTLPWM-APELLSGKSH 986
T W APELL G
Sbjct: 187 -TR-WYRAPELLVGDVK 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 44/206 (21%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-------RLIADF 850
D + +LG GTYG VY VAIKRI+ E E R
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAIR----- 82
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
E LL L H N++ ++ + L + E+ LK++ +D+ +
Sbjct: 83 --EVSLLKELQHRNIIELKSVIHH--NHRLHLIFEYA-ENDLKKY-------MDKNPDVS 130
Query: 911 IAMDAAF------GMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGDLGLSKVKQ-- 961
+ + +F G+ + H + +H DLK +NLL+++ D + PV KIGD GL++
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 962 -QTLVSGGVRGTLPWMAPELLSGKSH 986
+ + TL + PE+L G H
Sbjct: 191 IRQFTHEII--TLWYRPPEILLGSRH 214
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 26/195 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA-GKPSERERLIADFWKEALL 856
E++ ++G GTYG+V+ K R VA+KR++ G PS R E L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICL 54
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMD 914
L L H N+V + ++ D L V EF + LK++ + +D K + +
Sbjct: 55 LKELKHKNIVRLHDVLHS--DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRG 971
G+ + H +N++H DLK +NLL+N + K+ + GL++ + + V
Sbjct: 112 K--GLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVV-- 163
Query: 972 TLPWMAPELLSGKSH 986
TL + P++L G
Sbjct: 164 TLWYRPPDVLFGAKL 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 51/219 (23%), Positives = 81/219 (36%), Gaps = 36/219 (16%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G G VY + R VA+K + + + P R R +EA L
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSET-LSSDPVFRTR----MQREARTAGRLQE 93
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P+VV + DG L +NG L L+++ + + + I ++
Sbjct: 94 PHVVPIHDFGEI--DGQLYVDMRL-INGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDA 149
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTLPWMAPE 979
H H D+K EN+LV+ D + D G++ + G GTL +MAPE
Sbjct: 150 AHAAGATHRDVKPENILVSADD----FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 980 LLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
S T + D Y+L + +
Sbjct: 206 RFSE--SHATYRA----------------DIYALTCVLY 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 51/237 (21%), Positives = 84/237 (35%), Gaps = 55/237 (23%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864
LG G + V + A+K I+ R R+ ++E +L H N
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRV----FREVEMLYQCQGHRN 72
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR-----RKRLIIAMDAAFGM 919
V+ + + V E M GS+ R + ++ D A +
Sbjct: 73 VLELIEFFEE--EDRFYLVFEKMRGGSI--L----SHIHKRRHFNELEASVVVQDVASAL 124
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--------G 971
++LH K I H DLK EN+L + PV KI D L + + G
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 972 TLPWMAPELLSGKSHMVT---EKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025
+ +MAPE++ S + ++ D +SLG++ + L L
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRC----------------DLWSLGVILYIL---LS 221
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 25/194 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA-GKPSERERLIADFWKEALLL 857
+ +++ ++G GTYG VY K G VA+KRI+ G PS R E LL
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EISLL 73
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
LHHPN+VS ++ + L V EFM LK+ L + + K + +
Sbjct: 74 KELHHPNIVSLIDVIHS--ERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ + H I+H DLK +NLL+N K+ D GL++ ++ V T
Sbjct: 131 --GVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLARAFGIPVRSYTHEVV--T 182
Query: 973 LPWMAPELLSGKSH 986
L + AP++L G
Sbjct: 183 LWYRAPDVLMGSKK 196
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 23/189 (12%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G+YG V A+K +K P+ + KE LL L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF---LQKKDRTIDRRK--RLIIAMDAAFG 918
NV+ ++ + + V E+ V G + +K+ +I G
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----G 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GTLPW 975
+EYLH + IVH D+K NLL+ + KI LG+++ R G+ +
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLL---TTGGTL-KISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 976 MAPELLSGK 984
PE+ +G
Sbjct: 178 QPPEIANGL 186
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 28/198 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+++ +LG+GTY +VY G + G VA+K +K G PS R E L+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EISLM 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N+V Y ++ + L V EFM + LK+++ + + L + + F
Sbjct: 58 KELKHENIVRLYDVIHT--ENKLTLVFEFM-DNDLKKYM-DSRTVGNTPRGLELNLVKYF 113
Query: 918 ------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGG 968
G+ + H I+H DLK +NLL+N +R K+GD GL++ T S
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 969 VRGTLPWMAPELLSGKSH 986
V TL + AP++L G
Sbjct: 170 V--TLWYRAPDVLMGSRT 185
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 2e-18
Identities = 31/248 (12%), Positives = 74/248 (29%), Gaps = 46/248 (18%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSE----RERLIADFWKEAL---- 855
LG + + G + + + E L +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 856 ------------LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
L+ ++ RD S + M +L+ F +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS 197
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+++ RL + + + LH +VH L+ ++++ D + V +
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGFEHL 253
Query: 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILF 1017
+VS + + PEL + ++ + + + F D ++LG++
Sbjct: 254 VRDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSF-------DAWALGLVI 303
Query: 1018 FFLQFILC 1025
+++ C
Sbjct: 304 YWI---WC 308
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 25/191 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ++ +LG GTY +VY GK + + VA+K I+ G P R E LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLL 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
L H N+V+ + I+ + SL V E++ + LKQ+L I+ K + +
Sbjct: 55 KDLKHANIVTLHDIIHT--EKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL-- 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ Y H + ++H DLK +NLL+N +R K+ D GL++ K +T + V T
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYDNEVV--T 163
Query: 973 LPWMAPELLSG 983
L + P++L G
Sbjct: 164 LWYRPPDILLG 174
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G V+ + DVA+K ++A A PS R F +EA ++L+H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLR----FRREAQNAAALNH 71
Query: 863 PNVVSFYGIVRD-GPDGSLA-TVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
P +V+ Y P G L V E+ V+G +L+ + + + ++ + + DA +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRGTLPW 975
+ H I+H D+K N+++ V K+ D G+++ + S V GT +
Sbjct: 130 NFSHQNGIIHRDVKPANIMI---SATNAV-KVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
++PE G V + D YSLG + +
Sbjct: 186 LSPEQARG--DSVDARS----------------DVYSLGCVLY 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 55/264 (20%), Positives = 101/264 (38%), Gaps = 51/264 (19%)
Query: 742 SVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDD 801
S +P TT+ + + G +++ D D K + T +G +
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPG------QGPDRPQEVS 55
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-RLIADFWKEALLLS 858
+ + +G+G++G VY K G VAIK++ + + R E ++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNR-------ELQIMR 102
Query: 859 SLHHPNVVS----FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L H N+V FY + L V +++ ++ + R +
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRV-------ARHYSRAKQTLP 154
Query: 915 AAF----------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQ 962
+ + Y+H I H D+K +NLL++ P V K+ D G +K V+ +
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQLVRGE 211
Query: 963 TLVSGGVRGTLPWMAPELLSGKSH 986
VS + + APEL+ G +
Sbjct: 212 PNVSYIC--SRYYRAPELIFGATD 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 53/242 (21%), Positives = 93/242 (38%), Gaps = 49/242 (20%)
Query: 768 MDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVR-----ELGSGTYGSVYHGKWR 822
N + +K+ P + I K + E+ +G+G++G V+ K
Sbjct: 3 FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62
Query: 823 GSD-VAIKRIKASCFAGKPSERE-RLIADFWKEALLLSSLHHPNVVS----FYGIVRDGP 876
SD VAIK++ + + R E ++ + HPNVV FY
Sbjct: 63 ESDEVAIKKVL------QDKRFKNR-------ELQIMRIVKHPNVVDLKAFFYSNGDKKD 109
Query: 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF----------GMEYLHGKN 926
+ L V E++ ++ + +L M + Y+H
Sbjct: 110 EVFLNLVLEYV-PETVYRA-------SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGK 984
I H D+K +NLL++ P V K+ D G +K + + VS + + APEL+ G
Sbjct: 162 ICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGA 216
Query: 985 SH 986
++
Sbjct: 217 TN 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 44/221 (19%), Positives = 79/221 (35%), Gaps = 45/221 (20%)
Query: 805 VRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+ G G +Y R G V +K + +G + E L+ +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAM----AMAERQFLAEVV 137
Query: 862 HPNVVSFYGIVRDGPDGSLAT---VTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HP++V + V V E+ V G SLK+ + + + + ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKG---QKLPVAEAIAYLLEILP 193
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH +V+ DLK EN+++ ++ K+ DLG G + GT + A
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML---TEEQL--KLIDLGAVSRINSF---GYLYGTPGFQA 245
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
PE++ + T D Y++G
Sbjct: 246 PEIVRTGPTVAT-------------------DIYTVGRTLA 267
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 40/191 (20%), Positives = 68/191 (35%), Gaps = 26/191 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIK-----RIKASCFAGKPSERERLIADFWKEALLLS 858
LG G +G+V+ G VAIK R+ +A W + +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW---KVGA 93
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGS-LKQFLQKKDR---TIDRRK-RLIIAM 913
HP V+ V E + L ++ +K R ++A
Sbjct: 94 GGGHPGVIRLLDWFET--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA- 150
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+++ H + +VH D+K EN+L+ D +R K+ D G + + GT
Sbjct: 151 ----AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202
Query: 974 PWMAPELLSGK 984
+ PE +S
Sbjct: 203 VYSPPEWISRH 213
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 57/200 (28%), Positives = 84/200 (42%), Gaps = 39/200 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIK----ASCFAGKPSERERLIADFWKE 853
E++ LG G + +VY + + VAIK+IK + G R E
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-------E 62
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
LL L HPN++ G +++ V +FM L+ ++ D L +
Sbjct: 63 IKLLQELSHPNIIGLLDAF--GHKSNISLVFDFM-ETDLEVIIK------DNSLVLTPSH 113
Query: 914 DAAF------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTL 964
A+ G+EYLH I+H DLK NLL++ + V K+ D GL+K +
Sbjct: 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAY 169
Query: 965 VSGGVRGTLPWM-APELLSG 983
V T W APELL G
Sbjct: 170 THQVV--TR-WYRAPELLFG 186
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG GT+G V G+ + G VA+K + ++ +E L HP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK----REIQNLKLFRHP 71
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
+++ Y ++ D V E++ G L ++ K R + RR + I++ +
Sbjct: 72 HIIKLYQVISTPTD--FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AV 124
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
+Y H +VH DLK EN+L+ D KI D GLS + G G+ +
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLSNMMSD----GEFLRTSCGSPNY 176
Query: 976 MAPELLSGK 984
APE++SG+
Sbjct: 177 AAPEVISGR 185
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 51/211 (24%), Positives = 80/211 (37%), Gaps = 52/211 (24%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-------RLIADF 850
E++ ++G GT+G V+ + R G VA+K++ +E+E R
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALR----- 65
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKKDRTID 904
E +L L H NVV+ I R GS+ V +F + L L
Sbjct: 66 --EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT 122
Query: 905 RR--KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
KR++ + G+ Y+H I+H D+K N+L+ + V K+ D GL+
Sbjct: 123 LSEIKRVMQMLLN--GLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLA----- 171
Query: 963 TLVSGGVRGTLPWM----------APELLSG 983
S PELL G
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 44/185 (23%), Positives = 69/185 (37%), Gaps = 36/185 (19%)
Query: 790 IARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSER 843
+ GLQ KN +++ + LG G G V + A+K ++
Sbjct: 4 VKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------- 54
Query: 844 ERLIADFWKE-ALLLSSLHHPNVVSFYGIVRDGPDGSLAT--VTEFMVNGSLKQFLQKKD 900
+E L + P++V + + G V E + G L F
Sbjct: 55 ----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL--F----S 104
Query: 901 RTIDRRKRLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
R DR + +A+ M +YLH NI H D+K ENLL + P + K+ D
Sbjct: 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTD 163
Query: 954 LGLSK 958
G +K
Sbjct: 164 FGFAK 168
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 41/204 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
+D + + LG G++ +V + + AIK + K RER +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV------ 83
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA- 912
+S L HP V Y +D D L + NG L ++++K + R A
Sbjct: 84 ---MSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKV--------KQQ 962
+ +A EYLHGK I+H DLK EN+L+ +M +I D G +KV +
Sbjct: 139 IVSAL--EYLHGKGIIHRDLKPENILLNEDMH------IQITDFGTAKVLSPESKQARAN 190
Query: 963 TLVSGGVRGTLPWMAPELLSGKSH 986
+ V GT +++PELL+ KS
Sbjct: 191 SFV-----GTAQYVSPELLTEKSA 209
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 41/205 (20%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERE-------RLIAD 849
E V E+G G YG V+ K G VA+KR++ + E R +A
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV------QTGEEGMPLSTIREVA- 63
Query: 850 FWKEALL--LSSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDR--- 901
+L L + HPNVV + + R + L V E + + L +L K
Sbjct: 64 -----VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGV 117
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961
+ K ++ + G+++LH +VH DLK +N+LV K+ D GL+++
Sbjct: 118 PTETIKDMMFQLLR--GLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYS 171
Query: 962 --QTLVSGGVRGTLPWMAPELLSGK 984
L S V TL + APE+L
Sbjct: 172 FQMALTSVVV--TLWYRAPEVLLQS 194
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWK 852
T + D + ++ LG+G++G V K + S A+K + K + E +
Sbjct: 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLN---- 90
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E +L +++ P +V +D + +L V E++ G + L++ R + R A
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGV 969
EYLH ++++ DLK ENLL++ Q+ ++ D G +K + TL
Sbjct: 149 -QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFAKRVKGRTWTLC---- 199
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
GT +APE++ K + + D ++LG+L +
Sbjct: 200 -GTPEALAPEIILSKGY------------------NKAVDWWALGVLIY 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 57/206 (27%), Positives = 85/206 (41%), Gaps = 43/206 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERE----------RLI 847
E V E+G G YG+VY + S VA+K ++ P+ R +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR------VPNGGGGGGGLPISTVREV 62
Query: 848 ADFWKEALL--LSSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDR- 901
A LL L + HPNVV + R + + V E + + L+ +L K
Sbjct: 63 A------LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPP 115
Query: 902 --TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ K L+ G+++LH IVH DLK EN+LV K+ D GL+++
Sbjct: 116 GLPAETIKDLMRQFLR--GLDFLHANCIVHRDLKPENILVT----SGGTVKLADFGLARI 169
Query: 960 KQ--QTLVSGGVRGTLPWMAPELLSG 983
L V TL + APE+L
Sbjct: 170 YSYQMALTPVVV--TLWYRAPEVLLQ 193
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 47/222 (21%), Positives = 83/222 (37%), Gaps = 51/222 (22%)
Query: 800 DDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD + VR+LG G Y V+ V +K +K P +++++ +E +L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIK----REIKIL 84
Query: 858 SSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+L PN+++ IV+D + A V E + N KQ Q + D
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----------LTDYDIR 133
Query: 917 F-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
F ++Y H I+H D+K N++++ + ++ D GL++
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMID---HEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 970 RGTLPWMAPELLSGKSH----------------MVTEKVTLF 995
+ + PELL M+ K F
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-16
Identities = 54/189 (28%), Positives = 81/189 (42%), Gaps = 31/189 (16%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V VA+K I ++ + +E L L HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-----KKSDMHMRVEREISYLKLLRHP 69
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
+++ Y ++ D + V E+ G L ++ +K R + RR + II +
Sbjct: 70 HIIKLYDVITTPTD--IVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AI 121
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
EY H IVH DLK ENLL+ D V KI D GLS + G G+ +
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNV-KIADFGLSNIMTD----GNFLKTSCGSPNY 173
Query: 976 MAPELLSGK 984
APE+++GK
Sbjct: 174 AAPEVINGK 182
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 40/189 (21%), Positives = 67/189 (35%), Gaps = 24/189 (12%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
LGSG +GSVY G VAIK + K + E +LL +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEVVLLKKVSS 105
Query: 863 --PNVVSFYGIVRDGPDGSLATVTEFMVN-GSLKQFLQKKDR---TIDRRK-RLIIAMDA 915
V+ S + E L F+ ++ + R ++
Sbjct: 106 GFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--- 160
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
+ + H ++H D+K EN+L+ D R K+ D G + + T+ + GT +
Sbjct: 161 --AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRVY 214
Query: 976 MAPELLSGK 984
PE +
Sbjct: 215 SPPEWIRYH 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 30/248 (12%), Positives = 68/248 (27%), Gaps = 46/248 (18%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPS----ERERLIADFWKEA- 854
L LG + + G + + + + E L +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 855 ------------LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFM--VNGSLKQFLQ--- 897
+ P + D D + + + +L+ F +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 898 ---KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+++ RL + + + LH +VH L+ ++++ D + V +
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGF 255
Query: 955 GLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
+ VS G A +L H +T D ++
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHH-PTLMTFAF------------DTWT 302
Query: 1013 LGILFFFL 1020
LG+ +++
Sbjct: 303 LGLAIYWI 310
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 40/194 (20%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIK-----RIKASCFAGKPSERERLIADFWKEALLLS 858
LG GT+G V GK G VA+K +I++ GK RE L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQN---------LK 71
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMD 914
HP+++ Y ++ D + V E++ G L ++ K R + RR + I++
Sbjct: 72 LFRHPHIIKLYQVISTPSD--IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-- 127
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G++Y H +VH DLK EN+L+ D KI D GLS + G
Sbjct: 128 ---GVDYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLSNMMSD----GEFLRTSC 176
Query: 971 GTLPWMAPELLSGK 984
G+ + APE++SG+
Sbjct: 177 GSPNYAAPEVISGR 190
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 46/227 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSERERLIADFWKEALL 856
D + +R LG+G++G V+ + R + A+K + K K + E E L+
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTND----ERLM 59
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS + HP ++ +G +D + + +++ G L L+K R + + A +
Sbjct: 60 LSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVC 116
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGVRGTL 973
+EYLH K+I++ DLK EN+L++ + KI D G +K TL GT
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYTLC-----GTP 167
Query: 974 PWMAPELLSGKSH--MVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
++APE++S K + + D +S GIL +
Sbjct: 168 DYIAPEVVSTKPYNKSI--------------------DWWSFGILIY 194
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 6e-14
Identities = 35/164 (21%), Positives = 56/164 (34%), Gaps = 7/164 (4%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
D L+ + LG G +G V G D + K E +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 860 L-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
+ HH NVV+ G P G L + EF G+L +L+ K R + + A
Sbjct: 82 IGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSK-----RNEFVPYKTKGARF 135
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+ + DLK + + + LS V+++
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 52/207 (25%), Positives = 79/207 (38%), Gaps = 47/207 (22%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKP-SERE-RLIADFWKEALLLS 858
+ R G GT+G+V GK + G VAIK++ RE +++ L+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQIMQ-------DLA 74
Query: 859 SLHHPNVVSFYGIV-----RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
LHHPN+V RD D L V E++ +L + R +A
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRC-------CRNYYRRQVAP 126
Query: 914 DAAF----------GMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--V 959
+ LH N+ H D+K N+LVN K+ D G +K
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN---EADGTLKLCDFGSAKKLS 183
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSH 986
+ V+ + + APEL+ G H
Sbjct: 184 PSEPNVAYIC--SRYYRAPELIFGNQH 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 51/230 (22%), Positives = 94/230 (40%), Gaps = 47/230 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSE---RERLIADFWKE 853
D E +R +G G++G V + + A+K + K C +E I
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI------ 68
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ L HP +V+ + +D + + V + ++ G L+ LQ+ + +L I
Sbjct: 69 ---MQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC- 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ ++YL + I+H D+K +N+L+ D V I D ++ + + + GT
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILL---DEHGHV-HITDFNIAAMLPRETQITTMAGTK 178
Query: 974 PWMAPELLSGK-----SHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
P+MAPE+ S + S V D +SLG+ +
Sbjct: 179 PYMAPEMFSSRKGAGYSFAV--------------------DWWSLGVTAY 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 53/274 (19%), Positives = 101/274 (36%), Gaps = 54/274 (19%)
Query: 766 IEMDYDNDTVKTLKIEPTIAE----AEAIARGLQT--IKNDDLEEVRELGSGTYGSVYHG 819
+ + L + +A+ AE I L+ ++ DD E ++ +G G + V
Sbjct: 21 LLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVV 80
Query: 820 KWRGSD--VAIKRIKASCFAGKPSERERL-IADFWKEALLLSSLHHPNVVSFYGIVRDGP 876
K + + A+K + K +R ++ F +E +L + + + +D
Sbjct: 81 KMKQTGQVYAMKIMN------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-- 132
Query: 877 DGSLATVTEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935
+ L V E+ V G L L K I R +A + ++ +H VH D+K +
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLGYVHRDIKPD 191
Query: 936 NLLVNMRDPQRPVCKIGDLGLSK-------VKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988
N+L++ ++ D G V+ V GT +++PE+L
Sbjct: 192 NILLDRCGH----IRLADFGSCLKLRADGTVRSLVAV-----GTPDYLSPEILQAVGGGP 242
Query: 989 TEKVTLFSLKFCCFQLKWSY----DCYSLGILFF 1018
SY D ++LG+ +
Sbjct: 243 GTG---------------SYGPECDWWALGVFAY 261
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 26/201 (12%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIAD--- 849
Q + + + R LG G +G V + R + A K+++ ++R+
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE----------KKRIKKRKGE 228
Query: 850 --FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI--DR 905
E +L ++ VVS +L V M G LK + + +
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEA 286
Query: 906 RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965
R A + G+E LH + IV+ DLK EN+L+ +I DLGL+ +
Sbjct: 287 RAVFYAA-EICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISDLGLAVHVPEGQT 341
Query: 966 SGGVRGTLPWMAPELLSGKSH 986
G GT+ +MAPE++ + +
Sbjct: 342 IKGRVGTVGYMAPEVVKNERY 362
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 45/202 (22%), Positives = 72/202 (35%), Gaps = 34/202 (16%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSER-ERLIADFWKEAL--- 855
R + SG+YG+V + G VAIKR+ + G+ K L
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSF--LCKRVLREI 80
Query: 856 -LLSSLHHPNVVSFYGIVRDGPDGSLAT---VTEFMVNGSLKQFLQKKDRTI-DRRKRLI 910
LL+ HHPN++ I + ++ VTE M L Q + + I + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 911 IAMDAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTL 964
+ + G+ LH +VH DL N+L+ I D L++
Sbjct: 140 M-----YHILLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADA 188
Query: 965 VSGGVRGTLPWMAPELLSGKSH 986
+ APEL+
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKG 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-12
Identities = 49/241 (20%), Positives = 91/241 (37%), Gaps = 22/241 (9%)
Query: 753 PANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGT 812
+E T + +K D + LG G+
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGS 353
Query: 813 YGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870
+G V + +G+D A+K +K + E + + K L L P + +
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVE--KRVLALPG-KPPFLTQLHS 409
Query: 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930
+ L V E++ G L +Q+ R + A + A G+ +L K I++
Sbjct: 410 CFQ--TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYR 466
Query: 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKS 985
DLK +N+++ D + + KI D G+ K + GV GT ++APE+++ +
Sbjct: 467 DLKLDNVML---DSEGHI-KIADFGMCKEN----IWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 986 H 986
+
Sbjct: 519 Y 519
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 47/226 (20%), Positives = 98/226 (43%), Gaps = 20/226 (8%)
Query: 769 DYDNDTVKTLK-IEPTIAEAEAIARGLQT--IKNDDLEEVRELGSGTYGSVYHGKWRGSD 825
+ +N ++ K I + A+ ++ + +D E ++ +G G +G V K + +D
Sbjct: 40 ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD 99
Query: 826 --VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883
A+K + K +E F +E +L + + + + +D D +L V
Sbjct: 100 KVFAMKILNKWEML-KRAETAC----FREERDVLVNGDSKWITTLHYAFQD--DNNLYLV 152
Query: 884 TEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
++ V G L L K + + R +A + ++ +H + VH D+K +N+L+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQLHYVHRDIKPDNILM--- 208
Query: 943 DPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGKSH 986
D + ++ D G ++ T+ S GT +++PE+L
Sbjct: 209 DMNGHI-RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 46/198 (23%), Positives = 84/198 (42%), Gaps = 29/198 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERL-IADFWKE 853
+K +D E V+ +G G +G V + + + A+K + K +R A FW+E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS------KFEMIKRSDSAFFWEE 119
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+++ + P VV + +D D L V E+M G L + D + +
Sbjct: 120 RDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 177
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-------VKQQTLVS 966
A + +H +H D+K +N+L++ + K+ D G V+ T V
Sbjct: 178 VLAL--DAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKMNKEGMVRCDTAV- 230
Query: 967 GGVRGTLPWMAPELLSGK 984
GT +++PE+L +
Sbjct: 231 ----GTPDYISPEVLKSQ 244
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 790 IARGLQTIKNDDLEEVRELGSGTYGSVY---HGKWRGSDV--AIKRIKASCFAGKPSERE 844
+ RG + I+ + E +R LG G YG V+ + A+K +K + +
Sbjct: 7 VNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA 66
Query: 845 RLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
A E +L + HP +V + G L + E++ G L L+++ ++
Sbjct: 67 HTKA----ERNILEEVKHPFIVDLIYAFQT--GGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
+A + + + +LH K I++ DLK EN+++ + Q V K+ D GL K
Sbjct: 121 DTACFYLA-EISMALGHLHQKGIIYRDLKPENIML---NHQGHV-KLTDFGLCKES---- 171
Query: 965 VSGGVR-----GTLPWMAPELLSGKSH 986
+ G GT+ +MAPE+L H
Sbjct: 172 IHDGTVTHTFCGTIEYMAPEILMRSGH 198
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 38/205 (18%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+++ LG G G V VAIK+I P + + +E ++
Sbjct: 14 MDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIV---L-TDPQSVKHAL----REIKIIRR 64
Query: 860 LHHPNVVSFYGIVRDGPDGSLAT------------VTEFMVNGSLKQFLQKKDRTIDRRK 907
L H N+V + I+ V E+M L L++ + +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHAR 123
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLV 965
+ + G++Y+H N++H DLK NL +N D KIGD GL+++
Sbjct: 124 LFMYQL--LRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGLARIMDPHYS 176
Query: 966 SGGVR----GTLPWMAPELLSGKSH 986
G T + +P LL ++
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNN 201
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 46/192 (23%), Positives = 79/192 (41%), Gaps = 20/192 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSER----ERLIADFWKE 853
+D R +G G +G VY + + A+K + K E ER++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---- 244
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L+S+ P +V L+ + + M G L L + + R A
Sbjct: 245 --LVSTGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA- 299
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ G+E++H + +V+ DLK N+L++ + +I DLGL+ + V GT
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKKPHASV-GTH 354
Query: 974 PWMAPELLSGKS 985
+MAPE+L
Sbjct: 355 GYMAPEVLQKGV 366
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-12
Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 24/250 (9%)
Query: 745 PDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEE 804
P+ + A + + + + D + ++A+ + ++ E
Sbjct: 93 PEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 152
Query: 805 VRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ LG GT+G V K + + A+K +K K E + E +L + H
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLT----ENRVLQNSRH 207
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P + + + L V E+ G L L ++ + R R A + ++YL
Sbjct: 208 PFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYL 264
Query: 923 HG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWM 976
H KN+V+ DLK ENL++ D + KI D GL K + G GT ++
Sbjct: 265 HSEKNVVYRDLKLENLML---DKDGHI-KITDFGLCKEG----IKDGATMKTFCGTPEYL 316
Query: 977 APELLSGKSH 986
APE+L +
Sbjct: 317 APEVLEDNDY 326
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + ++ LG GT+G V + + + A+K ++ K E + E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVT----ESRVL 59
Query: 858 SSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ HP + +F L V E+ G L L ++ + R R A
Sbjct: 60 QNTRHPFLTALKYAFQ------THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA- 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--- 970
+ +EYLH +++V+ D+K ENL++ D + KI D GL K +S G
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLML---DKDGHI-KITDFGLCKEG----ISDGATMKT 164
Query: 971 --GTLPWMAPELLSGKSH 986
GT ++APE+L +
Sbjct: 165 FCGTPEYLAPEVLEDNDY 182
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 45/187 (24%), Positives = 84/187 (44%), Gaps = 28/187 (14%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ +GSG G V + +VAIK++ +P + + ++E +L+ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKL------SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 863 PNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
N++ + P SL V E M + +L Q + + + +R L+ M
Sbjct: 84 KNIIGLLNVFT--PQKSLEEFQDVYIVMELM-DANLCQVI-QMELDHERMSYLLYQM--L 137
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V C KI D GL++ + + T
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 975 WMAPELL 981
+ APE++
Sbjct: 192 YRAPEVI 198
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 46/247 (18%), Positives = 99/247 (40%), Gaps = 38/247 (15%)
Query: 755 NEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYG 814
+ +I + + ++ E + ++ D + +R +G G+Y
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 815 SVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERLIADFWKEALLLSSLHHPNVV-- 866
V + + +D A++ + K + + E+ + + +HP +V
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV--------FEQASNHPFLVGL 118
Query: 867 --SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
F + L V E++ G L +Q++ + + R A + + + YLH
Sbjct: 119 HSCFQ------TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 171
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPE 979
+ I++ DLK +N+L+ D + + K+ D G+ K + G GT ++APE
Sbjct: 172 RGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEG----LRPGDTTSTFCGTPNYIAPE 223
Query: 980 LLSGKSH 986
+L G+ +
Sbjct: 224 ILRGEDY 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 21/200 (10%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWK 852
Q + D + R LG G +G V+ + + + A K++ + + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-KGYQGAMV---- 234
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK----QFLQKKDRTIDRRKR 908
E +L+ +H +VS L V M G ++ + + R
Sbjct: 235 EKKILAKVHSRFIVSLAYAFET--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVS 966
A G+E+LH +NI++ DLK EN+L++ +I DLGL+ QT
Sbjct: 293 FYTA-QIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVRISDLGLAVELKAGQTKTK 347
Query: 967 GGVRGTLPWMAPELLSGKSH 986
G GT +MAPELL G+ +
Sbjct: 348 GYA-GTPGFMAPELLLGEEY 366
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 52/205 (25%), Positives = 81/205 (39%), Gaps = 40/205 (19%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ LG G YG V H G VAIK+I+ F KP R + +E +L
Sbjct: 14 QLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEP--F-DKPLFALRTL----REIKILKH 65
Query: 860 LHHPNVVSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H N+++ + I R PD + E M L + + + + D + I
Sbjct: 66 FKHENIITIFNIQR--PDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQT- 121
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLS-KVKQQTLVSGGVRG 971
++ LHG N++H DLK NLL+N C K+ D GL+ + + + G
Sbjct: 122 -LRAVKVLHGSNVIHRDLKPSNLLINSN------CDLKVCDFGLARIIDESAADNSEPTG 174
Query: 972 TLPWM----------APELLSGKSH 986
M APE++ +
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAK 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 34/226 (15%), Positives = 69/226 (30%), Gaps = 59/226 (26%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG+G++G V G A+K++ + +E ++ L
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKV--------LQDPRYKN----RELDIMKVL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR-------------- 906
H N++ D + L +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 907 -------KRLIIAMDAAF-----------------GMEYLHGKNIVHFDLKCENLLVNMR 942
+++ + + + ++H I H D+K +NLLVN
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-- 175
Query: 943 DPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGKSH 986
+ K+ D G +K + + V+ + + APEL+ G +
Sbjct: 176 -SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATE 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 47/207 (22%), Positives = 75/207 (36%), Gaps = 37/207 (17%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE----RLIADFWKEALL 856
E +G+G+YG V + VAIK+I + E R++ +E +
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI------LRVFEDLIDCKRIL----REIAI 105
Query: 857 LSSLHHPNVVSFYGIVR---DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L+ L+H +VV IV L V E + K+ + + + ++
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL-- 162
Query: 914 DAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSG 967
+ G++Y+H I+H DLK N LVN C K+ D GL++
Sbjct: 163 ---YNLLVGVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGN 213
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKVTL 994
P L H K L
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQL 240
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 54/192 (28%), Positives = 85/192 (44%), Gaps = 29/192 (15%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ +GSG YG+V G+ VAIK++ +P + E ++E LL + H
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKL------YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 863 PNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
NV+ + PD +L V FM L + ++ + DR + L+ M
Sbjct: 84 ENVIGLLDVFT--PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQM--L 138
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+ Y+H I+H DLK NL VN C KI D GL++ + +G V T
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEM-TGYV-VTRW 190
Query: 975 WMAPELLSGKSH 986
+ APE++
Sbjct: 191 YRAPEVILNWMR 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSER---ERLIADF 850
+K +D + LG G++G V+ +++ ++ AIK + K E E+ +
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV--- 70
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + HP + + + +L V E++ G L +Q + R
Sbjct: 71 -----LSLAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY 123
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
A + G+++LH K IV+ DLK +N+L+ D + KI D G+ K + G +
Sbjct: 124 AA-EIILGLQFLHSKGIVYRDLKLDNILL---DKDGHI-KIADFGMCKEN----MLGDAK 174
Query: 971 -----GTLPWMAPELLSGKSH 986
GT ++APE+L G+ +
Sbjct: 175 TNTFCGTPDYIAPEILLGQKY 195
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 35/245 (14%), Positives = 65/245 (26%), Gaps = 60/245 (24%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + L+ ++G G +G V+ + VAIK I ++ + E ++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 857 LSSLH---------HPNVVSFYG--IVRDGPDGSLAT----------------------- 882
L + V+ L
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 883 ---VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLL 938
V EF G + ++ K ++ K I + H DL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKS--ILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 939 VNMRDPQRPVCK----------------IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982
+ ++ I D LS+++ G V M +L +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE----RDGIVVFCDVSMDEDLFT 250
Query: 983 GKSHM 987
G
Sbjct: 251 GDGDY 255
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 20/142 (14%), Positives = 37/142 (26%), Gaps = 20/142 (14%)
Query: 805 VRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ G W+ D VA+ + + L LS
Sbjct: 36 LIFHGGVPPLQF----WQALDTALDRQVALTFVDPQ-GVLPDDVLQE----TLSRTLRLS 86
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
+ P V +V V E++ GSL++ D + + A
Sbjct: 87 RIDKPGVARVLDVVHT--RAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAA 141
Query: 919 MEYLHGKNIVHFDLKCENLLVN 940
+ H + + V+
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVS 163
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 43/187 (22%), Positives = 84/187 (44%), Gaps = 24/187 (12%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + +VAIK++ +P + + ++E +L+ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRPFQNQTHAKRAYRELVLMKCV 118
Query: 861 HHPNVVSFYGIVRDGPDGS----LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+H N++S + + V E M + +L Q + + + +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QMELDHERMSYLLYQMLC- 175
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V C KI D GL++ + + T
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 975 WMAPELL 981
+ APE++
Sbjct: 229 YRAPEVI 235
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 50/234 (21%), Positives = 91/234 (38%), Gaps = 56/234 (23%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSER---ERLIADFWKE 853
D + LG G++G V + +G+D A+K + K E E+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV------ 73
Query: 854 ALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
L P + F L V E++ G L +Q+ R +
Sbjct: 74 --LALPGKPPFLTQLHSCFQ------TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
A + A G+ +L K I++ DLK +N+++ D + + KI D G+ K + GV
Sbjct: 126 YAA-EIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHI-KIADFGMCKEN----IWDGV 176
Query: 970 R-----GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
GT ++APE+++ + + + V D ++ G+L +
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPY--GKSV----------------DWWAFGVLLY 212
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 44/196 (22%), Positives = 82/196 (41%), Gaps = 22/196 (11%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V++LG G YG V + G VA+K+I F ++ +R +E ++L+
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKI-FDAF-QNSTDAQRTF----REIMILTE 64
Query: 860 LH-HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L H N+V+ ++R D + V ++M L ++ ++ ++ +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIK--V 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++YLH ++H D+K N+L+N C K+ D GLS+
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 977 APELLSGKSHMVTEKV 992
E ++T+ V
Sbjct: 176 NTENFDDDQPILTDYV 191
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 29/194 (14%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ + +GSG YGSV G VA+K++ +P + ++E LL +
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHM 85
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H NV+ + P SL VT M L ++ + T D + LI +
Sbjct: 86 KHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI- 141
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGT 972
G++Y+H +I+H DLK NL VN C KI D GL++ + +G V T
Sbjct: 142 -LRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLARHTADEM-TGYV-AT 192
Query: 973 LPWMAPELLSGKSH 986
+ APE++ H
Sbjct: 193 RWYRAPEIMLNWMH 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 6e-11
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 783 TIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFA 837
IA + G + E ++ LG G++G V+ G A+K +K +
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 838 GKPSER---ERLIADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNG 890
+ R ER I L ++HP +V +F +G L + +F+ G
Sbjct: 67 VRDRVRTKMERDI---------LVEVNHPFIVKLHYAFQ------TEGKLYLILDFLRGG 111
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
L L K+ + + +A + A +++LH I++ DLK EN+L+ D + + K
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILL---DEEGHI-K 166
Query: 951 IGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSH 986
+ D GLSK + + GT+ +MAPE+++ + H
Sbjct: 167 LTDFGLSKES----IDHEKKAYSFCGTVEYMAPEVVNRRGH 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 30/194 (15%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+GSG YGSV K G VAIK++ +P + E ++E LLL +
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL------SRPFQSEIFAKRAYRELLLLKHM 80
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H NV+ + P SL V FM L++ + + ++ + L+ M
Sbjct: 81 QHENVIGLLDVFT--PASSLRNFYDFYLVMPFM-QTDLQKIM-GLKFSEEKIQYLVYQM- 135
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGT 972
G++Y+H +VH DLK NL VN C KI D GL++ + +G V T
Sbjct: 136 -LKGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGYV-VT 186
Query: 973 LPWMAPELLSGKSH 986
+ APE++ H
Sbjct: 187 RWYRAPEVILSWMH 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 38/221 (17%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFA 837
E + + D+ E +R LG G++G V + + + A+K + K
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ 63
Query: 838 GKPSER---ERLIADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNG 890
E E+ I L + +HP + F L V EF+ G
Sbjct: 64 DDDVECTMTEKRI--------LSLARNHPFLTQLFCCFQ------TPDRLFFVMEFVNGG 109
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
L +QK R + R R A + + +LH K I++ DLK +N+L+ D + K
Sbjct: 110 DLMFHIQKSRRFDEARARFYAA-EIISALMFLHDKGIIYRDLKLDNVLL---DHEGHC-K 164
Query: 951 IGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSH 986
+ D G+ K + GV GT ++APE+L +
Sbjct: 165 LADFGMCKEG----ICNGVTTATFCGTPDYIAPEILQEMLY 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 56/274 (20%), Positives = 109/274 (39%), Gaps = 42/274 (15%)
Query: 756 EAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGS 815
E D + + L ++ + A + + ++ E ++ LG+G YG
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHA-EKVGIENFELLKVLGTGAYGK 69
Query: 816 VY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE-ALLLSSLHHPNVVSFY 869
V+ G G A+K +K + K E E +L P +V+ +
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT----ERQVLEHIRQSPFLVTLH 125
Query: 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929
+ + L + +++ G L L +++R + ++ + + +E+LH I++
Sbjct: 126 YAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLGIIY 182
Query: 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGK 984
D+K EN+L+ D V + D GLSK + + R GT+ +MAP+++ G
Sbjct: 183 RDIKLENILL---DSNGHV-VLTDFGLSK---EFVADETERAYDFCGTIEYMAPDIVRGG 235
Query: 985 SHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018
+ V D +SLG+L +
Sbjct: 236 DSGHDKAV----------------DWWSLGVLMY 253
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 45/209 (21%), Positives = 90/209 (43%), Gaps = 38/209 (18%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERL 846
+ + D + +R +G G+Y V + + +D A+K + K + + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 847 IADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+ + +HP +V F + L V E++ G L +Q++ +
Sbjct: 62 V--------FEQASNHPFLVGLHSCFQ------TESRLFFVIEYVNGGDLMFHMQRQRKL 107
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+ R A + + + YLH + I++ DLK +N+L+ D + + K+ D G+ K
Sbjct: 108 PEEHARFYSA-EISLALNYLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEG-- 160
Query: 963 TLVSGGVR-----GTLPWMAPELLSGKSH 986
+ G GT ++APE+L G+ +
Sbjct: 161 --LRPGDTTSTFCGTPNYIAPEILRGEDY 187
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 47/195 (24%), Positives = 78/195 (40%), Gaps = 27/195 (13%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G G YG V + VAIK+I F + +R + +E +L
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FE-HQTYCQRTL----REIKILLRF 82
Query: 861 HHPNVVSFYGIVRDGPDGSLAT---VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
H N++ I+R + V + M L + L+ + + D + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI--LR 139
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVR----G 971
G++Y+H N++H DLK NLL+N C KI D GL++V G
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 972 TLPWMAPELLSGKSH 986
T + APE++
Sbjct: 194 TRWYRAPEIMLNSKG 208
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 43/204 (21%), Positives = 78/204 (38%), Gaps = 34/204 (16%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+G G+YG VY + K +VAIK++ F + +R++ +E +L+ L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMF-EDLIDCKRIL----REITILNRL 82
Query: 861 HHPNVVSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ Y ++ PD L V E + LK+ + + + I+
Sbjct: 83 KSDYIIRLYDLII--PDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL---- 135
Query: 916 AF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLS-KVKQQTLVSGG 968
+ G ++H I+H DLK N L+N +D C K+ D GL+ + + +
Sbjct: 136 -YNLLLGENFIHESGIIHRDLKPANCLLN-QD-----CSVKVCDFGLARTINSEKDTNIV 188
Query: 969 VRGTLPWMAPELLSGKSHMVTEKV 992
+T V
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHV 212
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 7e-10
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 38/205 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERLIADF 850
K D ++ +G G++G V + + +V A+K + K + K + ER +
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV--- 91
Query: 851 WKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
LL ++ HP +V SF L V +++ G L LQ++ ++ R
Sbjct: 92 -----LLKNVKHPFLVGLHFSFQ------TADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
R A + A + YLH NIV+ DLK EN+L+ D Q + + D GL K +
Sbjct: 141 ARFYAA-EIASALGYLHSLNIVYRDLKPENILL---DSQGHI-VLTDFGLCKEN----IE 191
Query: 967 GGVR-----GTLPWMAPELLSGKSH 986
GT ++APE+L + +
Sbjct: 192 HNSTTSTFCGTPEYLAPEVLHKQPY 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 32/169 (18%), Positives = 62/169 (36%), Gaps = 23/169 (13%)
Query: 806 RELGSGTYGSVYHG-KWRGSDVAIKRIKASCFAGKPSERERLI-----------ADFWKE 853
+G G +G +Y V +PS+ L + ++
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKV--EPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV----NGSLKQFLQKKDRTIDRRKRL 909
+ L + V ++G G FM+ L++ + + R+ L
Sbjct: 99 WIRTRKLKYLGVPKYWGS---GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+++ +EY+H VH D+K NLL+N ++P + + D GL+
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ--VYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 19/158 (12%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R++GSG++G +Y G G +VAIK ++ +L E+ + +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLH----IESKIYKMMQG 63
Query: 863 -PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+ + +G V E + G SL+ R + L++A +E
Sbjct: 64 GVGIPTIRWCGAEG--DYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
Y+H KN +H D+K +N L+ + V I D GL+K
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAK 156
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 4e-07
Identities = 91/679 (13%), Positives = 180/679 (26%), Gaps = 238/679 (35%)
Query: 132 NHYVDGDDRESERRYVDALNNMNDGNDFRK---LQH-PDSP--VISS--IDDI------- 176
+H++D + E + +Y D L+ D F + D P ++S ID I
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 177 ---------------HMAERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRY 221
M ++F + + Y L P +Q +++ Y
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEV-------LRINYKF--LMSPIKTEQRQPSMMTRMY 112
Query: 222 NEMEGPWSPAYYSPRHYGHHDPPRP---------LPEFPSSPSSARFRMP-FGEERVPEE 271
E Y + + ++ R L E + + + G+ V +
Sbjct: 113 IEQR---DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD 169
Query: 272 YARQHVNHHPTYEPQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLT 331
Y+ Q + + W+ N + ++ + E +
Sbjct: 170 VCLS-------YKVQCKMDFKIFWLNLKNCNSPET-----------------VLEMLQKL 205
Query: 332 YHRNQLHLDQPNIGNGLPQVPLSCAECRQNRENLVLNAEAKLPGMYPK-----DNDSRSV 386
+ Q+ + + + + L + L+ + Y N V
Sbjct: 206 LY--QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK------PYENCLLVLLN----V 253
Query: 387 YNESHCHERGWVLQHQLNPRIEEARTHMSGAGRL---NDHYLVDGPGMNIPPGHGNLVDG 443
N N + L + D
Sbjct: 254 QNA-------KAWNA-FNLS---CKI-------LLTTRFKQVTDFLSAATT--------- 286
Query: 444 HHVSPNHAHHRTGPEMGNELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP---- 499
H+S +H P+ L L + P T P
Sbjct: 287 THISLDHHSMTLTPDEVKSLL----LKY---LDCRPQDL--------PREVLTTNPRRLS 331
Query: 500 -----VSHGHATAQNLWRNVQNPIHVTPLEASGPVINGSITPAYLRGAVEGNPRIAV--- 551
+ G AT N W++V T +E+S +N + PA R + R++V
Sbjct: 332 IIAESIRDGLATWDN-WKHVNCDKLTTIIESS---LN-VLEPAEYRKMFD---RLSVFPP 383
Query: 552 GVDSPNS-----WIDPSQRVP----------------GFKGTATPPEYYYSQTQKMN--- 587
P W D + + T + P Y K+
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443
Query: 588 ------------PQSYNQQNQLPDPV----------H--------QSDSFSALVQD---- 613
P++++ + +P + H + F + D
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 614 --KLVSSTTDCNLGLRVNNVSEAVRT-----DENCNLGQE----------KAANHVVKVE 656
K+ +T N + N + ++ +N + K +++ +
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
Query: 657 ETDVKRSCLEQNMIPEKPI 675
TD+ R L M ++ I
Sbjct: 564 YTDLLRIAL---MAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 8e-07
Identities = 90/639 (14%), Positives = 175/639 (27%), Gaps = 218/639 (34%)
Query: 449 NHAHHRTGPEMGNELFH--DPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYPVSHGHAT 506
+H HH E G + D ++ E+ V + D
Sbjct: 1 HHHHHHMDFETGEHQYQYKD----ILSVF-----EDAFVDNFDCKDVQDMP--------- 42
Query: 507 AQNLWRNVQNPIHVTPLEASGPVINGSITPAYLRGAVEGNPRIAV-----GVDSPN-SWI 560
+++ + + + S ++G++ L + V V N ++
Sbjct: 43 -----KSILSKEEIDHIIMSKDAVSGTL---RLFWTLLSKQEEMVQKFVEEVLRINYKFL 94
Query: 561 -DPSQRVPGFKGTATPPEYYYSQTQKM--NPQSYNQQN-QLPDPVHQSDSFSALVQDKLV 616
P + + + Y Q ++ + Q + + N P + ++ L
Sbjct: 95 MSPIKTEQ--RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK-------LRQAL- 144
Query: 617 SSTTDCNLGLRVNN---------------VSEAVRTDENCNLGQEKAANHV--VKVEETD 659
L LR + + + Q K + + ++ +
Sbjct: 145 -------LELRPAKNVLIDGVLGSGKTWVALDVCLSYKV----QCKMDFKIFWLNLKNCN 193
Query: 660 VKRSCLE--QNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHN-----LS 712
+ LE Q ++ + I + S NI+ S + E +LL L
Sbjct: 194 SPETVLEMLQKLLYQ--IDPNWTSRSDHSSNIKLRIH---SIQAELRRLLKSKPYENCLL 248
Query: 713 ILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDN 772
+L V+ A A + K+ TT+ + I +D
Sbjct: 249 VLLN----VQNAKAWNAFNLSCKIL---------LTTRFKQVTDFLSAATTTHISLD--- 292
Query: 773 DTVKTLKIEPTIAEAEAI-ARGLQTIKNDDL-EEVRELGSGTYGSVYHGKWRGSDVAIKR 830
TL T E +++ + L + DL EV + +
Sbjct: 293 HHSMTL----TPDEVKSLLLKYL-DCRPQDLPREVL---------------TTNPRRLSI 332
Query: 831 IKASCFAGKPSERERLI-ADFWK-------EALLLSSLHH--PNVV-SFY---GIVRDG- 875
I S R+ L D WK ++ SSL+ P + +
Sbjct: 333 IAESI-------RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 876 --PDGSLATV--------TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
P L+ + +VN K L +K K I +
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-----PKESTI---------SIPS- 430
Query: 926 NIVHFDLKCENL--------LVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
++ +LK + +V+ + + DL
Sbjct: 431 --IYLELKVKLENEYALHRSIVDHYNIPKTFDS-DDLI---------------------- 465
Query: 978 PELLSGKS------HMV----TEKVTLFSLKFCCFQLKW 1006
P L H+ E++TLF + F ++
Sbjct: 466 PPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF--LDFRF 502
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 9e-07
Identities = 56/341 (16%), Positives = 107/341 (31%), Gaps = 96/341 (28%)
Query: 19 DDVPRVKFLCSF-LG-RILPRPQDGKL-RYVGGETR----IVSLPRDVTYEELMSRMREL 71
+V K +F L +IL + ++ ++ T + +T +E+ L
Sbjct: 251 LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK----SL 306
Query: 72 YEGAVVLKYQQ-PDEDLDA---LVSVV--NDDDVINMMEEYEKLGSGDGFTR-LRIFLFS 124
+ + Q P E L +S++ + D + + ++ + D T + L
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC-DKLTTIIESSLNV 365
Query: 125 HSDQDGSNHYVD--------------------GDDRESERRYVDALNNMNDGNDFRKL-- 162
+ + + V+ L+ L
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK-------YSLVE 418
Query: 163 QHPDSPVISSIDDIHMAERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRYN 222
+ P IS I I++ + + + +Y LH+ V H N P + +
Sbjct: 419 KQPKESTIS-IPSIYLELK----------VKLENEYALHRSIVDHYNI-----PKTFDSD 462
Query: 223 EMEGPWSPAY-YSPRHYGHH----DPPRPLPEFPSSPSSARF-----RMPFGEERVP--- 269
++ P+ Y YS H GHH + P + F RF R
Sbjct: 463 DLIPPYLDQYFYS--HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI 520
Query: 270 -------EEYARQHV-NHHPTYEPQ--------PQFSENLI 294
+ Y + ++ ++ P YE P+ ENLI
Sbjct: 521 LNTLQQLKFY-KPYICDNDPKYERLVNAILDFLPKIEENLI 560
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 1e-04
Identities = 70/518 (13%), Positives = 144/518 (27%), Gaps = 149/518 (28%)
Query: 509 NLWRNVQ--NPIHVTPLEASGPVINGSITPAYLRGAV-EGNPRIAVGVD----SPNSWI- 560
L+ + Q +V+ L+ P + LR A+ E P V +D S +W+
Sbjct: 118 RLYNDNQVFAKYNVSRLQ---PYLK-------LRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 561 ------DPSQRVPGFK------GTATPPEYYYSQTQKMNPQSYNQQNQLPD-----PVHQ 603
Q FK PE QK+ Q D +
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 604 SDSFSAL------------------VQDK------------LVSSTTDCNLGLRVNNVSE 633
+ L VQ+ L+ TT R V++
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL--TT------RFKQVTD 279
Query: 634 AVRTDENCNLGQEKAANHVVKVEETDVKRSCLEQNMIPEK-P--IGSTSLLAMEVSGNIE 690
+ ++ + + + E + L + P+ P + +T+ + +
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYL--DCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 691 KPG-------EKSPSDR-------------PEDSKLLAHNLSILPELIASVK--RAALEG 728
+ G + D+ P + + + LS+ P S L
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP---SAHIPTILLSL 394
Query: 729 --AEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAE 786
+ +K+ V + + + ++ P ++I I ++ + +I +
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKE--STISIPS-IYLELKVKLENEYALHRSIVD 451
Query: 787 AEAIARGLQTIKNDDLEEVRELGSGTY-----GSVYHGKWRGSDVAIKRIKASCFAGKPS 841
I + +DDL Y G +H +K + +
Sbjct: 452 HYNIPKTFD---SDDLIPPYLDQ---YFYSHIG--HH------------LKNIEHPERMT 491
Query: 842 ERERLIADF-WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD 900
+ DF + E + + L T+ + K ++ D
Sbjct: 492 LFRMVFLDFRFLEQKIRHD----------STAWNASGSILNTLQQLKF---YKPYICDND 538
Query: 901 RTIDRRKRLIIAMDAAFGMEYLHGK--NIVHFDLKCEN 936
+R I+ + K +++ L E+
Sbjct: 539 PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 36/158 (22%), Positives = 68/158 (43%), Gaps = 19/158 (12%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH- 861
R++GSG++G +Y G +VAIK ++ +L+ E+ + L
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------TKHPQLL----YESKIYRILQG 61
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+ + +G V + + G SL+ R + + L++A +E
Sbjct: 62 GTGIPNVRWFGVEG--DYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
++H K+ +H D+K +N L+ + V I D GL+K
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAK 154
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 39/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH- 861
VR+LG G + +V+ K + VA+K ++ + +E E + +A
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 862 -HPNVVSFYG--IVRDGPDGS-LATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAA 916
+++ + GP+G + V E + +L ++K + R I I+
Sbjct: 84 GANHILKLLDHFNHK-GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQ--RPVCKIGDLGLS 957
G++Y+H + I+H D+K EN+L+ + D KI DLG +
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 38/165 (23%), Positives = 62/165 (37%), Gaps = 18/165 (10%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERE-----RL----IADFWKEA 854
+++GSG +G +Y + A +K P E R+ W E
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAM 913
L L P G+ V E + G L Q + ++ T + L + +
Sbjct: 103 KQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDL-QKISGQNGTFKKSTVLQLGI 158
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+EY+H VH D+K NLL+ ++P + + D GLS
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ--VYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 42/160 (26%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH- 862
+++G G +G + GK + VAIK S +L E L
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQL----HLEYRFYKQLGSG 64
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+ Y G A V E + G SL+ DRT + L+IA+ MEY
Sbjct: 65 DGIPQVYYFGPCG--KYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIG---DLGLSK 958
+H KN+++ D+K EN L + P ++ D L+K
Sbjct: 121 VHSKNLIYRDVKPENFL--IGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 23/161 (14%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G++G ++ G VAIK S+ +L ++ LL
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGI 68
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMV----NGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
PNV F G +G +V SL+ L R + + A
Sbjct: 69 PNVYYF------GQEGLHN----VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLSK 958
++ +H K++V+ D+K +N L+ + + + + D G+ K
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 27/181 (14%), Positives = 50/181 (27%), Gaps = 47/181 (25%)
Query: 806 RELGSGTYGSVYHG----------KWRGSDVAIK--RIKASCFAGKPSERERLIADFWKE 853
G +Y + ++K F + + +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 854 ALLLSSLHHPNVVSFYG----------IVRD--GPDGSLATVTEFMVNG----SLKQFLQ 897
L S + + G +V G SL + V+ S + LQ
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR--SLQSA--LDVSPKHVLSERSVLQ 163
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
R +D +E+LH VH ++ EN+ V+ D + + G +
Sbjct: 164 VACRLLDA-------------LEFLHENEYVHGNVTAENIFVDPEDQSQ--VTLAGYGFA 208
Query: 958 K 958
Sbjct: 209 F 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 34/150 (22%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+R+LG G + +V+ VA+K +K++ + + E + +++ S +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL----KSVRNSDPND 97
Query: 863 PN---VVSFYGIVR-DGPDGS-LATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAA 916
PN VV + G +G+ + V E + L +++ K + + I
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQ 945
G++YLH K I+H D+K EN+L+++ +
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQY 186
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 33/182 (18%), Positives = 70/182 (38%), Gaps = 23/182 (12%)
Query: 794 LQTIKNDDL----EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLI 847
+ +D + E ++ +G G++G V + VA+K ++ + +
Sbjct: 87 YVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAA 141
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVR--DGPD--GSLATVTEFMVNGSLKQFLQK-KDRT 902
+E +L L + + ++ + + E + + +L + ++K K +
Sbjct: 142 ----EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG 196
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
A ++ LH I+H DLK EN+L+ R K+ D G S + Q
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK--QQGRSGIKVIDFGSSCYEHQ 254
Query: 963 TL 964
+
Sbjct: 255 RV 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1033 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-15 | |
| d1ip9a_ | 85 | d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker' | 8e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + + + +GSG++G+VY GKW G DVA+K + + + + F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN------VTAPTPQQLQAFKNEVGV 57
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L H N++ F G LA VT++ SL L + + K + IA A
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK---QQTLVSGGVRGTL 973
GM+YLH K+I+H DLK N+ ++ + KIGD GL+ VK + + G++
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 974 PWMAPELLSGKSH-MVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
WMAPE++ + + + D Y+ GI+ + L
Sbjct: 171 LWMAPEVIRMQDKNPYSFQS----------------DVYAFGIVLYEL 202
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 1e-42
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEA 854
+K+DD E++ ELG+G G V+ + S +A K I + + +E
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-------HLEIKPAIRNQIIREL 55
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + P +V FYG DG ++ E M GSL Q L+K R I + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIA 112
Query: 915 AAFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMANSFV-GTR 167
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+M+PE L G + + + D +S+G+ +
Sbjct: 168 SYMSPERLQGTHY--SVQS----------------DIWSMGLSLVEM 196
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ +L+ ++ +G G +G V G +RG+ VA+K IK + F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----------NDATAQAFLAEASV 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDA 915
++ L H N+V G++ + G L VTE+M GSL +L+ + R+ + L ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
MEYL G N VH DL N+LV+ + V K+ D GL+K T +G + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
APE L K + K ++S +++
Sbjct: 167 TAPEALREKKF--STKSDVWSFGILLWEI 193
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-41
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWR DVAIK IK + +F +EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---------EFIEEAK 51
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ +L H +V YG+ + +TE+M NG L +L++ ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
MEYL K +H DL N LVN + V K+ D GLS+ + S G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
W PE+L + K +++ +++
Sbjct: 166 RWSPPEVLMYSKF--SSKSDIWAFGVLMWEI 194
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 4e-40
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++RE+G G++G+VY + VAIK++ S + D KE L L
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKL 72
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN + + G + + V E+ + + K + + + + A G+
Sbjct: 73 RHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLA 129
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
YLH N++H D+K N+L++ + K+GD G + + GT WMAPE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPA---NSFVGTPYWMAPEV 182
Query: 981 LSGKSHM-VTEKVTLFSLKFCCFQL 1004
+ KV ++SL C +L
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E + +G+G+YG + + G + K + S E E LL
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD------YGSMTEAEKQMLVSEVNLL 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMD 914
L HPN+V +Y + D + +L V E+ G L + K + +D L +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 915 AAFGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGG 968
++ H G ++H DLK N+ ++ + K+GD GL++ + T +
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFAKA 173
Query: 969 VRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYS 1012
GT +M+PE ++ S+ EK ++SL ++L ++
Sbjct: 174 FVGTPYYMSPEQMNRMSY--NEKSDIWSLGCLLYELCALMPPFT 215
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ E+G G++ +VY G +VA ++ SER+R F +EA +L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQR----FKEEAEMLKG 64
Query: 860 LHHPNVVSFYGIVRDGPDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L HPN+V FY G + VTE M +G+LK +L++ + +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILK 123
Query: 918 GMEYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+++LH I+H DLKC+N+ + KIGDLGL+ +K+ + + V GT +
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEF 179
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
MAPE+ K E V +++ C ++
Sbjct: 180 MAPEMYEEK---YDESVDVYAFGMCMLEM 205
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 20/211 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E + ELG G +G VY + + + A K I ++ E + D+ E +L
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--------TKSEEELEDYMVEIDIL 63
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+S HPN+V + +L + EF G++ + + +R + + ++
Sbjct: 64 ASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWM 976
+ YLH I+H DLK N+L K+ D G+S +T+ GT WM
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177
Query: 977 APELLSG---KSHMVTEKVTLFSLKFCCFQL 1004
APE++ K K ++SL ++
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEM 208
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ + + DF +EA
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---------DFIEEAE 52
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HP +V YG+ + + V EFM +G L +L+ + L + +D
Sbjct: 53 VMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
GM YL ++H DL N LV + V K+ D G+++ Q S G + +
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
W +PE+ S + + K D +S G+L + +
Sbjct: 167 KWASPEVFSFSRY--SSKS----------------DVWSFGVLMWEV 195
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-39
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E R LG G +G+VY + + S +A+K + + E+ + +E +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQ 60
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S L HPN++ YG D + + E+ G++ + LQK + D ++ + A
Sbjct: 61 SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 117
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ Y H K ++H D+K ENLL+ KI D G S + + GTL ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQL 1004
PE++ G+ H EKV L+SL C++
Sbjct: 173 PEMIEGRMH--DEKVDLWSLGVLCYEF 197
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-39
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V LG+G +G V+ G + + VA+K +K + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEAN 60
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMD 914
L+ L H +V Y +V P + +TE+M NGSL FL+ + K L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM ++ +N +H DL+ N+LV+ CKI D GL+++ + G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ W APE ++ + T K ++S ++
Sbjct: 174 IKWTAPEAINYGTF--TIKSDVWSFGILLTEI 203
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 23/217 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I DL + +LG G++G V G+W VA+K +K + + DF
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----SQPEAMDDFI 59
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E + SL H N++ YG+V P + VTE GSL L+K
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
A+ A GM YL K +H DL NLL+ RD + KIGD GL + ++
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQE 172
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ W APE L ++ + + +++
Sbjct: 173 HRKVPFAWCAPESLKTRTF--SHASDTWMFGVTLWEM 207
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + +
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKAN 55
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI ++ +T+ M G L ++++ I +
Sbjct: 56 KEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEY 168
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ G + + WMA E + + + T + ++S ++L
Sbjct: 169 HAEGGKVPIKWMALESILHRIY--THQSDVWSYGVTVWEL 206
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 142 bits (359), Expect = 2e-37
Identities = 47/228 (20%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
Q D + + ELGSG +G V+ + G K I P ++ +
Sbjct: 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVK----N 75
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E +++ LHHP +++ + D + + EF+ G L + +D + + +
Sbjct: 76 EISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
A G++++H +IVH D+K EN++ + KI D GL+ + T
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+ APE++ + + D +++G+L + L
Sbjct: 192 AEFAAPEIVDREPV------------------GFYTDMWAIGVLGYVL 221
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 59/217 (27%), Positives = 89/217 (41%), Gaps = 25/217 (11%)
Query: 797 IKNDDLEEV-RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFW 851
+K D+L ELG G +GSV G +R DVAIK +K + +
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-------QGTEKADTEEMM 57
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EA ++ L +P +V G+ + L V E G L +FL K I +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
+ GM+YL KN VH DL N+L+ R KI D GLSK
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARS 170
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ L W APE ++ + + + ++S ++
Sbjct: 171 AGKWPLKWYAPECINFRKF--SSRSDVWSYGVTMWEA 205
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 8e-37
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + V+ LG G YG V R ++ VA+K + + KE +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-------MKRAVDCPENIKKEICIN 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L+H NVV FYG R E+ G L + + D +
Sbjct: 58 KMLNHENVVKFYGHRR--EGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMA 114
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVRGTLP 974
G+ YLHG I H D+K ENLL++ RD KI D GL+ V + + + GTLP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERD----NLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
++APELL + E V ++S +
Sbjct: 171 YVAPELLKRR-EFHAEPVDVWSCGIVLTAM 199
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 42/236 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ +G G +G V+ GKWRG +VA+K ER E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS------SREERSWF---REAEIYQTVM 53
Query: 860 LHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N++ F +G L V+++ +GSL +L + T++ + +A+ A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK--LALSTAS 111
Query: 918 GMEYLH--------GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQTL 964
G+ +LH I H DLK +N+LV C I DLGL S +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDSATDTIDI 167
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
GT +MAPE+L +M + + D Y++G++F+ +
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRA------------DIYAMGLVFWEI 211
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (349), Expect = 3e-36
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 16/207 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + ELG+G +G V+ R G++ A K + P E ++ KE +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM------TPHESDK--ETVRKEIQTM 77
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S L HP +V+ + D D + + EFM G L + + + + + +
Sbjct: 78 SVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+ ++H N VH DLK EN++ + K+ D GL+ GT + A
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQL 1004
PE+ GK ++S+ + L
Sbjct: 194 PEVAEGKPV--GYYTDMWSVGVLSYIL 218
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 9e-36
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K + + F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFL 56
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGV 969
A + + YL K VH D+ N+LV+ D K+GD GLS+ +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ + WMAPE ++ + ++ C +++
Sbjct: 170 KLPIKWMAPESINFRRFT--SASDVWMFGVCMWEI 202
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 1e-35
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E + +F KEA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEA 64
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAM 913
++ + HPN+V G+ + +TEFM G+L +L++ +R + L +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ--QTLVSGGVRG 971
+ MEYL KN +H DL N LV + K+ D GLS++ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 972 TLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ W APE L+ + K +++ +++
Sbjct: 179 PIKWTAPESLAYNKF--SIKSDVWAFGVLLWEI 209
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K + + F +EA
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------AFLQEAQ 64
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF-LQKKDRTIDRRKRLIIAMD 914
++ L H +V Y +V + P + VTE+M GSL F + + + + + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM Y+ N VH DL+ N+LV + VCK+ D GL+++ + G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 973 LPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+ W APE T K D +S GIL L
Sbjct: 178 IKWTAPEAALYGRF--TIKS----------------DVWSFGILLTEL 207
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 62/241 (25%), Positives = 93/241 (38%), Gaps = 48/241 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
++LE + LGSG +G V + G VA+K +K SERE
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK---ADSSEREA---- 86
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR------- 901
E +++ L H N+V+ G G + + E+ G L +L+ K
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 902 ---------------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
+ L A A GME+L K+ VH DL N+LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HG 200
Query: 947 PVCKIGDLGLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQ 1003
V KI D GL++ +V G R + WMAPE L + T K ++S ++
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWE 258
Query: 1004 L 1004
+
Sbjct: 259 I 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 3e-35
Identities = 49/225 (21%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++G G G+VY G +VAI+++ + ++E +I E L+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELII----NEILV 70
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ +PN+V++ L V E++ GSL + + + + +
Sbjct: 71 MRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--VCRECL 126
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPW 975
+E+LH ++H D+K +N+L+ M K+ D G + + + GT W
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
MAPE+++ K++ KV D +SLGI+ +
Sbjct: 183 MAPEVVTRKAY--GPKV----------------DIWSLGIMAIEM 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 5e-35
Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 28/238 (11%)
Query: 780 IEP-TIAE-AEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIK 832
I+P T + EA+ + I ++ + +G+G +G V G + VAIK +K
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 833 ASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL 892
E+ DF EA ++ HPNV+ G+V + +TEFM NGSL
Sbjct: 64 -------SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSL 114
Query: 893 KQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
FL++ D + + + A GM+YL N VH DL N+LVN VCK+
Sbjct: 115 DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVS 170
Query: 953 DLGLSKV------KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
D GLS+ + G + + W APE + + ++S +++
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT--SASDVWSYGIVMWEV 226
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 8e-35
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 48/238 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWK 852
+++E VR++G G +G V+ + G VA+K +K + ADF +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-------EEASADMQADFQR 65
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR----------- 901
EA L++ +PN+V G+ G + + E+M G L +FL+
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 902 ------------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
+ ++L IA A GM YL + VH DL N LV + V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVV 179
Query: 950 KIGDLGLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
KI D GLS+ G + WM PE + + T + +++ +++
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEI 235
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (334), Expect = 9e-35
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 31/224 (13%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
D + LG+G + V + + VAIK I GK E +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-------GSMENEIAV 60
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + HPN+V+ I G L + + + G L + +K R +
Sbjct: 61 LHKIKHPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVL 117
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++YLH IVH DLK ENLL D + I D GLSK++ V GT ++
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
APE+L+ K + ++ V DC+S+G++ + L
Sbjct: 177 APEVLAQKPY--SKAV----------------DCWSIGVIAYIL 202
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-34
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
LE+ +ELGSG +G+V G ++ VA+K +K + L + EA ++
Sbjct: 10 LED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILK------NEANDPALKDELLAEANVM 62
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L +P +V GI S V E G L ++LQ+ R + + + + +
Sbjct: 63 QQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSM 118
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTL 973
GM+YL N VH DL N+L+ + KI D GLSK + + +
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
W APE ++ + K ++S ++
Sbjct: 175 KWYAPECINYYKF--SSKSDVWSFGVLMWEA 203
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 37/233 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ L + LG+G +G V G VA+K +K S +ERE
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREA---- 72
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E +LS L +H N+V+ G G +TE+ G L FL++K
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ +D L + A GM +L KN +H DL N+L+ +C
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDF 189
Query: 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
G K +V G R + WMAPE + + T + ++S ++L
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWEL 240
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-34
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
+ + +D + + LG G++ +V + + AIK ++ + +E + +
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTR 57
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E ++S L HP V Y +D D L + NG L ++++K + R A
Sbjct: 58 ERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGV 969
+ +EYLHGK I+H DLK EN+L+N + +I D G +KV + + +
Sbjct: 116 -EIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
GT +++PELL+ KS + L++L +QL
Sbjct: 171 VGTAQYVSPELLTEKSA--CKSSDLWALGCIIYQL 203
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 131 bits (330), Expect = 2e-34
Identities = 50/225 (22%), Positives = 82/225 (36%), Gaps = 23/225 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALL 856
++ E LG G V + + A+K I + E + L KE +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 857 LSSLH-HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L + HPN++ + V + M G L +L +K T+ ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRAL 119
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
+ LH NIVH DLK EN+L++ K+ D G S V GT +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+APE++ + D +S G++ + L
Sbjct: 176 LAPEIIECSMNDNHPGYGKEV------------DMWSTGVIMYTL 208
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 24/209 (11%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+G G +G VYHG +D A+K + ++ F E +++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-------RITDIGEVSQFLTEGIIMKDF 85
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPNV+S GI +GS V +M +G L+ F++ + + + + A GM+
Sbjct: 86 SHPNVLSLLGICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-----QQTLVSGGVRGTLPW 975
+L K VH DL N +++ ++ K+ D GL++ G + + W
Sbjct: 145 FLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 976 MAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
MA E L + T K ++S ++L
Sbjct: 201 MALESLQTQKF--TTKSDVWSFGVLLWEL 227
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D + ELGSG + V + + G A K IK K S R D +E +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT--KSSRRGVSREDIEREVSI 66
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + HPNV++ + + + + + E + G L FL +K+ + +
Sbjct: 67 LKEIQHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ-IL 123
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+ YLH I HFDLK EN+++ R+ +P KI D GL+ + GT ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQL 1004
APE+++ + + ++S+ + L
Sbjct: 184 APEIVNYEPL--GLEADMWSIGVITYIL 209
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-34
Identities = 40/223 (17%), Positives = 79/223 (35%), Gaps = 33/223 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ +LG G +G V+ S K +K K +++ KE +L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVL----VKKEISIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ H N++ + L + EF+ + + + ++ R+ +
Sbjct: 56 NIARHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+++LH NI HFD++ EN++ R KI + G ++ + + + A
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
PE+ + D +SLG L + L
Sbjct: 172 PEVHQHDVV--STAT----------------DMWSLGTLVYVL 196
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 41/234 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
I + + +G+G +G VY G + S VAIK +K E+ DF
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-------AGYTEKQRVDF 56
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
EA ++ H N++ G++ + +TE+M NG+L +FL++KD + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVS 966
+ A GM+YL N VH DL N+LVN VCK+ D GLS+V + T +
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
G + + W APE +S + + D +S GI+ + +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFT------------------SASDVWSFGIVMWEV 206
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWK 852
+ +D++ +G G +G V + + D AIKR+K + DF
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-------EYASKDDHRDFAG 59
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------- 900
E +L L HHPN+++ G G L E+ +G+L FL+K
Sbjct: 60 ELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117
Query: 901 ----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
T+ ++ L A D A GM+YL K +H DL N+LV + V KI D GL
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGL 173
Query: 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
S+ ++ + R + WMA E L+ + T ++S +++
Sbjct: 174 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEI 219
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 24/223 (10%)
Query: 793 GLQTIKN---DDLEEVRE-LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
GLQ KN DD + + LG G G V + A+K ++ + RE
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVE 56
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDG--PDGSLATVTEFMVNGSLKQFLQKK-DRTI 903
+ + P++V + + L V E + G L +Q + D+
Sbjct: 57 L--------HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
R+ I ++YLH NI H D+K ENLL + P + K+ D G +K
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSH 167
Query: 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKW 1006
T ++APE+L + + + ++SL + L
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKY--DKSCDMWSLGVIMYILLC 208
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (312), Expect = 4e-32
Identities = 39/210 (18%), Positives = 86/210 (40%), Gaps = 12/210 (5%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D E LG G V+ + DVA+K ++A + F +EA
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-----ARDPSFYLRFRREAQN 60
Query: 857 LSSLHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++L+HP +V+ Y V E++ +L+ + + + ++ + + D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD 119
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A + + H I+H D+K N++++ + + + ++ + V GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+++PE G S + ++SL +++
Sbjct: 180 YLSPEQARGDSV--DARSDVYSLGCVLYEV 207
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-32
Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + LG G++G V+ +++ AIK +K + E + ++ +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD-VVLMDDDVECTMV---EKRVLS 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ HP + + + +L V E++ G L +Q + D + A +
Sbjct: 58 LAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIIL 114
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWM 976
G+++LH K IV+ DLK +N+L++ KI D G+ K + GT ++
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGH----IKIADFGMCKENMLGDAKTNTFCGTPDYI 170
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
APE+L G+ + V D +S G+L + +
Sbjct: 171 APEILLGQKY--NHSV----------------DWWSFGVLLYEM 196
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (315), Expect = 1e-31
Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 29/223 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D R +G G +G VY + G A+K + K + E L + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLV 61
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S+ P +V L+ + + M G L L + + R A
Sbjct: 62 STGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IIL 118
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+E++H + +V+ DLK N+L++ + +I DLGL+ + GT +MA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK-PHASVGTHGYMA 173
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
PE+L D +SLG + F L
Sbjct: 174 PEVLQKGVA-YDSSA----------------DWFSLGCMLFKL 199
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-31
Identities = 54/227 (23%), Positives = 87/227 (38%), Gaps = 34/227 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ + + RELG G++G VY G +G VAIK + + R +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-------EAASMRERIE 69
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-------- 901
F EA ++ + +VV G+V + E M G LK +L+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 902 -TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV- 959
K + +A + A GM YL+ VH DL N +V + KIGD G+++
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 183
Query: 960 --KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
G + WM+PE L T ++S +++
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEI 228
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 37/233 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G D VA+K +K E+ +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-------SDATEKDL 62
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------- 899
+D E ++ + H N+++ G DG L + E+ G+L+++LQ +
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + A A GMEYL K +H DL N+LV + + +
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK-IADF 179
Query: 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
G + R + WMAPE L + + T + ++S +++
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEI 230
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L+ + LG G +G V G D VA+K +K + + A
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK------EGATHSEHRAL 63
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-------- 901
+ +L+ HH NVV+ G P G L + EF G+L +L+ K
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 902 -------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+ + + A GME+L + +H DL N+L++ ++ V KI D
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDF 178
Query: 955 GLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
GL++ + G R L WMAPE + + + T + ++S +++
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEI 229
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ E V E+G G YG V+ + G VA+KR++ + E + +E
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVA 59
Query: 856 LLSSL---HHPNVVSFYGIVRDGP---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
+L L HPNVV + + + L V E + + + +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
+ G+++LH +VH DLK +N+LV K+ D GL+++ + V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFGLARIYSFQMALTSV 175
Query: 970 RGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
TL + APE+L S+ V L+S+ ++
Sbjct: 176 VVTLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEM 208
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (292), Expect = 4e-29
Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + +R LG+G++G V+ + R G A+K +K R + + E L+L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLML 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S + HP ++ +G +D + + +++ G L L+K R + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 115
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+EYLH K+I++ DLK EN+L++ + KI D G +K + + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQL 1004
PE++S K + + + +S +++
Sbjct: 170 PEVVSTKPY--NKSIDWWSFGILIYEM 194
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-29
Identities = 42/226 (18%), Positives = 71/226 (31%), Gaps = 29/226 (12%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ LGSG +GSVY G VAIK ++ + E +L
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVL 60
Query: 857 LSSLH--HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L + V+ S + E + +
Sbjct: 61 LKKVSSGFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
+ + H ++H D+K EN+L+ D R K+ D G + + T+ + GT
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYT-DFDGTRV 174
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+ PE + + S +SLGIL + +
Sbjct: 175 YSPPEWIRYHRYHGR-----------------SAAVWSLGILLYDM 203
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
++ ++V ++G GTYG VY + + G VA+K+I+ +E E + + +E LL
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L+HPN+V ++ + L V EF+ K I
Sbjct: 56 KELNHPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW-M 976
G+ + H ++H DLK +NLL+N K+ D GL++ + + W
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
APE+L G + T + D +SLG +F +
Sbjct: 170 APEILLGCKYYST-----------------AVDIWSLGCIFAEM 196
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (287), Expect = 2e-28
Identities = 45/214 (21%), Positives = 85/214 (39%), Gaps = 22/214 (10%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
++ DD + VR+LG G Y V+ V +K +K P ++++
Sbjct: 29 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKK----IK 77
Query: 852 KEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +L PN+++ IV+D + A V E + N KQ Q +
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
+ ++Y H I+H D+K N+++ D + ++ D GL++
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYHPGQEYNVRV 190
Query: 971 GTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ + PELL + ++SL +
Sbjct: 191 ASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASM 223
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 9e-28
Identities = 47/226 (20%), Positives = 77/226 (34%), Gaps = 38/226 (16%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G G YG V VAIK+I P E + +E +L
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-------PFEHQTYCQRTLREIKILLRF 63
Query: 861 HHPNVVSFYGIVRDG--PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
H N++ I+R + ++ L + L K + + G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLP 974
++Y+H N++H DLK NLL+N KI D GL++V T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
+ APE++ D +S+G + +
Sbjct: 178 YRAPEIMLNSKGYTKSI-----------------DIWSVGCILAEM 206
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 25/218 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
E++ ++G GT+G V+ + R G VA+K++ +E+E +E +L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 63
Query: 858 SSLHHPNVVSFYGIVRDGP------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
L H NVV+ I R GS+ V +F + + + ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----- 966
M G+ Y+H I+H D+K N+L+ + V K+ D GL++ S
Sbjct: 124 QM-LLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
TL + PELL G+ + L+ ++
Sbjct: 179 TNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEM 215
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (276), Expect = 9e-27
Identities = 45/207 (21%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + ++ LG+G++G V K + G+ A+K + + + + I E +L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+++ P +V +D + L V E++ G + L++ R A
Sbjct: 96 QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVL 152
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
EYLH ++++ DLK ENLL++ + ++ D G +K + + + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKRVKGRTWT--LCGTPEALA 206
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQL 1004
PE++ K + + V ++L +++
Sbjct: 207 PEIILSKGY--NKAVDWWALGVLIYEM 231
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 1e-26
Identities = 42/210 (20%), Positives = 76/210 (36%), Gaps = 25/210 (11%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R++GSG++G +Y G G +VAIK + E+ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLEC----------VKTKHPQLHIESKIYKMMQG 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+ G +G + ++ SL+ R + L++A +EY+
Sbjct: 62 GVGIPTIRWC--GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--------VKQQTLVSGGVRGTLP 974
H KN +H D+K +N L+ + V I D GL+K + + GT
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ + G + + L SL +
Sbjct: 179 YASINTHLGIEQ--SRRDDLESLGYVLMYF 206
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (269), Expect = 3e-26
Identities = 40/211 (18%), Positives = 79/211 (37%), Gaps = 25/211 (11%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G++G ++ G VAIK + S+ +L ++ LL
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLRDEYRTYKLLAGCTGI 63
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PNV F G +G + ++ SL+ L R + + A ++ +
Sbjct: 64 PNVYYF------GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVS--------GGVRGTL 973
H K++V+ D+K +N L+ + + + D G+ K + + + GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 974 PWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+M+ G+ + + L +L
Sbjct: 178 RYMSINTHLGREQ--SRRDDLEALGHVFMYF 206
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 4e-26
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ LG G + +VY + + ++ VAIK+IK + ++ + +E LL L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQEL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN++ +++ V +FM + + M G+E
Sbjct: 58 SHPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLE 114
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-GTLPWMAPE 979
YLH I+H DLK NLL++ + V K+ D GL+K + + T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 980 LLSGKSHMVTEKVTLFSLKFCCFQL 1004
LL G M V ++++ +L
Sbjct: 171 LLFGA-RMYGVGVDMWAVGCILAEL 194
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-26
Identities = 42/221 (19%), Positives = 83/221 (37%), Gaps = 24/221 (10%)
Query: 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+G + + + +G+G++G VY K G VAIK++ ++
Sbjct: 12 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRF---- 59
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGS----LATVTEFMVNGSLKQFLQ--KKDRTI 903
+E ++ L H N+V + L V +++ + + +T+
Sbjct: 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
+ + Y+H I H D+K +N + DP V K+ D G +K +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN---LLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ + + APEL+ G T + ++S +L
Sbjct: 177 EPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAEL 216
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-26
Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + ++ LG GT+G V + + G A+K ++ K +A E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVL 59
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ HP + + + L V E+ G L L ++ + R R A +
Sbjct: 60 QNTRHPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVS 116
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWM 976
+EYLH +++V+ D+K ENL+++ + KI D GL K GT ++
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFL 1020
APE+L + V D + LG++ + +
Sbjct: 173 APEVLEDNDY--GRAV----------------DWWGLGVVMYEM 198
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 106 bits (266), Expect = 5e-26
Identities = 43/206 (20%), Positives = 82/206 (39%), Gaps = 14/206 (6%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ + ++G GTYG VY + G A+K+I+ E E + + +E +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L H N+V Y ++ L ++ LK+ L + ++ + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+ Y H + ++H DLK +NLL+N KI D GL++ + W
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 979 ELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ S + + ++S+ ++
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEM 194
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-25
Identities = 45/207 (21%), Positives = 85/207 (41%), Gaps = 15/207 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
E++ ++G GTYG+V+ K R VA+KR++ + E + + +E LL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N+V + ++ +L V EF K F + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLK 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+ + H +N++H DLK +NLL+N K+ + GL++ + W
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 978 PELLSGKSHMVTEKVTLFSLKFCCFQL 1004
P + + + + + ++S +L
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAEL 195
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 5e-24
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 800 DDLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ E ++ LG+G YG V+ G G A+K +K + K E E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTER 79
Query: 855 LLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L + P +V+ + + + L + +++ G L L +++R + ++ +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG- 136
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRG 971
+ +E+LH I++ D+K EN+L++ + D GLSK V +T + G
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGH----VVLTDFGLSKEFVADETERAYDFCG 192
Query: 972 TLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
T+ +MAP+++ G + V +SL ++L
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 225
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-23
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+++ +GSG YG+V G+ VAIK++ +P + E ++E LL +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHM 74
Query: 861 HHPNVVSFYGIVRDGPDGSLAT----VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H NV+ + T V FM G+ L K ++ + + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQML 131
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+ Y+H I+H DLK NL VN + KI D GL++ + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQL 1004
APE++ T+ V ++S+ ++
Sbjct: 186 APEVILNWMRY-TQTVDIWSVGCIMAEM 212
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 2e-22
Identities = 42/208 (20%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V +VAIK++ +P + + ++E +L+ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 73
Query: 861 HHPNVVSFYGIVRDGP----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+H N++S + + V E M + + +D + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQML 129
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+++LH I+H DLK N++V KI D GL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 977 APELLSGKSHMVTEKVTLFSLKFCCFQL 1004
APE++ G + E V ++S+ ++
Sbjct: 186 APEVILGMGY--KENVDIWSVGCIMGEM 211
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 6e-20
Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + + +GSG YGSV G VA+K++ +P + ++E LL
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLL 71
Query: 858 SSLHHPNVVSFYGIVRDG---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+ H NV+ + + + + ++ L ++ + T D + LI +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI- 130
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G++Y+H +I+H DLK NL VN KI D GL++ + T
Sbjct: 131 -LRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKILDFGLARHTDDEMTG--YVATRW 183
Query: 975 WMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
+ APE++ H + V ++S+ +L
Sbjct: 184 YRAPEIMLNWMHY-NQTVDIWSVGCIMAEL 212
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.0 bits (214), Expect = 1e-18
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 9/217 (4%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
+ K+ VR+LG G + +V+ K + VA+K ++ + +E E +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 853 EA--LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+A S+ +++ + V F V G L KK +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 911 --IAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
I+ G++Y+H + I+H D+K EN+L+ + D + +I L
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQL 1004
T + +PE+L G ++S F+L
Sbjct: 188 NSIQTREYRSPEVLLGAPW--GCGADIWSTACLIFEL 222
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.7 bits (175), Expect = 8e-15
Identities = 26/164 (15%), Positives = 45/164 (27%), Gaps = 30/164 (18%)
Query: 806 RELGSGTYGSVYHGK-WRGSDVAIKRIKAS----------CFAGKPSERERLIADFWKEA 854
+ +G G +V++ + + +K K G I E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L L V Y + A + E + L + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPDEV--------LDM 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+ + + IVH DL N+LV+ I D S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSV 150
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 85 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.3 bits (123), Expect = 8e-09
Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 5/69 (7%)
Query: 42 KLRYVGGETRIVSLPRDVTYEELMSRMRELYE-GAVVLKYQQPDEDLDALVSVVNDDDVI 100
K Y + + L D TY+EL S++ + L+ + D + D V
Sbjct: 16 KFYY-KDDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTKLFDGSG---EEIKTDSQVS 71
Query: 101 NMMEEYEKL 109
N+++ K+
Sbjct: 72 NIIQAKLKI 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1033 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 98.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.71 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.71 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 97.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.16 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 97.15 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 97.05 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.42 | |
| d1oeyj_ | 105 | Neutrophil cytosol factor 4 (p40phox component of | 89.53 | |
| d1pqsa_ | 77 | Cell division control protein 24, CDC24, C-termina | 88.59 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.16 Aligned_cols=205 Identities=23% Similarity=0.335 Sum_probs=177.5
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 3588813999964248379999998--59625999830333489924689999999999999971699980038899981
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 797 I~~~dYeiLkkLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e 874 (1033)
+..++|++++.||+|+||.||+|++ +++.||||++++.....+ .....+.+|+.+++.++||||+++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf 844742898898317684999999989998999999815654497-----999999999999986799988778764035
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEEC
Q ss_conf 89995599984214770899997327765899999999999999999994994215799996798058999990999844
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDF 954 (1033)
...+++||||+++|+|.+++.+... +++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~iv~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~----~~g~vkl~DF 149 (337)
T d1o6la_ 77 --HDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDF 149 (337)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCC
T ss_pred --CCCCCCCEECCCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEEEEC
T ss_conf --6421110003579860555532567-75999999999996521134315962246477784765----8998888205
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88411345-533477678886446410258876653023210000210357743440899999999990699998988
Q 001678 955 GLSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 955 GLAk~~~~-~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
|+|+.... .......+||+.|+|||++.+.. |+.++||||+||++|+|++|++||...+
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~------------------y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDND------------------YGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC------------------BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCCCCCCCCCCCCEECHHHHHHHHCCCCC------------------CCHHHCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 65200356786205510088996666504898------------------8833310223067889987899999969
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.58 Aligned_cols=202 Identities=30% Similarity=0.447 Sum_probs=175.0
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 335888139999642483799999985--962599983033348992468999999999999997169998003889998
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 796 ~I~~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~ 873 (1033)
++..++|+++++||+|+||+||+|++. ++.||+|+++.... .. ....+.+|+.+++.++||||++++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PA----IRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC---TT----HHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC---HH----HHHHHHHHHHHHHHCCCCCCCCEEEEEE
T ss_conf 7875688897897127780999999989996999999875409---78----9999999999998679999994999999
Q ss_pred CCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEEECCCCCCCEEEEE
Q ss_conf 189995599984214770899997327765899999999999999999994-9942157999967980589999909998
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 874 e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHs-kGIIHRDIKPsNILLd~~~~~~g~VKLi 952 (1033)
+ .+.+++||||+++|+|.+++.+.+. +++..+..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+
T Consensus 75 ~--~~~~~iVmEy~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----~~~~vkl~ 147 (322)
T d1s9ja_ 75 S--DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLC 147 (322)
T ss_dssp C--SSEEEEEEECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEEEC
T ss_pred E--CCEEEEEEECCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEC----CCCCEEEE
T ss_conf 8--9999999976799868998742499-999999999999999999999859997144577994687----89989995
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 448841134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|||+|+..... .....+||+.|+|||++.+.. |+.++||||+||++|+|++|+.||...
T Consensus 148 DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~------------------y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 148 DFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH------------------YSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCCCCHHHHHH-TC---CCSSCCCCHHHHHCSC------------------CCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ECCCCCCCCCC-CCCCCCCCCCCCCCHHHCCCC------------------CCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 48776256788-621113771411946875899------------------894888998999999999888998998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=324.72 Aligned_cols=201 Identities=26% Similarity=0.369 Sum_probs=175.4
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 88139999642483799999985--9625999830333489924689999999999999971699980038899981899
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e~ 877 (1033)
++|++++.||+|+||.||+|+++ ++.||||++.... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 95 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--D 95 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--T
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--C
T ss_conf 57589889840768199999988999899999984524--------3169999999999986799799929999998--9
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCCC
Q ss_conf 95599984214770899997327765899999999999999999994994215799996798058999990999844884
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLA 957 (1033)
+.+++||||+++|+|.+++.+....+++..+..|+.||+.||.|||+++||||||||+|||++.+ .++.+||+|||+|
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vkL~DFG~a 173 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLT 173 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCC--CCCEEEEEECCHH
T ss_conf 99999998579988999997623789999999999999999999975697600015467364168--8986999545210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 1134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 k~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
+............||+.|||||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~~~------------------~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 174 AHLDPKQSVKVTTGTAEFAAPEVAEGKP------------------VGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp EECCTTSCEEEECSCTTTCCHHHHHTCC------------------BCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCCCCCCCEECCCCCCCCHHHHCCCC------------------CCHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 4425654320006862421889975899------------------872676554659999998598998997
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=323.14 Aligned_cols=202 Identities=23% Similarity=0.321 Sum_probs=175.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 88813999964248379999998--5962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|++++.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++++++||||++++++|.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-- 97 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--------LDKYTVKNEISIMNQLHHPKLINLHDAFED-- 97 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--------HHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH--------HHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 4035998999317782999999989997999999887264--------679999999999986799798919999998--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+++||||+++|+|.+++......+++..++.|+.||+.||.|||+++||||||||+|||++.. ..+.+||+|||+
T Consensus 98 ~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~--~~~~vkL~DFGl 175 (352)
T d1koba_ 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGL 175 (352)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTT
T ss_pred CCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCC--CCCEEEEEECCC
T ss_conf 999999998289980888898638998999999999999999999997792651314455311346--788489952563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 41134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ak~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+............||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREP------------------VGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCC------------------BCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CEECCCCCCEEECCCCCCCCCHHHHCCCC------------------CCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf 03437887201004764534899974799------------------897633389899999999688998997
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.12 Aligned_cols=202 Identities=30% Similarity=0.366 Sum_probs=173.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|++++.||+|+||+||+|+++ ++.||||++...... ...+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-- 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRRE-- 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEE--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-------HHHHHHHHHHHHHHHCCCCCEEEEEEEECC--
T ss_conf 74608998972174809999999999979999998456641-------279999999999985799888469654046--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+++||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----~~~~~KL~DFG~ 149 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGL 149 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEECCCHH
T ss_conf 743679886458980899975379-999999999999999999999975983575468997887----899879832314
Q ss_pred CCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 4113455---33477678886446410258876653023210000210357743440899999999990699998988
Q 001678 957 SKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 957 Ak~~~~~---~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
|+..... ......+||+.|+|||++.+.. .++.++||||+||++|+|++|+.||+..+
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-----------------~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-----------------FHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSS-----------------BCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred HEEECCCCCCCCCCCEEECCCCCCHHHHCCCC-----------------CCCCCEEEEHHHHHHHHHHHCCCCCCCCC
T ss_conf 22404688653111325574742872861899-----------------99971016173799999982997888898
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.13 Aligned_cols=198 Identities=23% Similarity=0.344 Sum_probs=172.3
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|+++++||+|+||+||+|.++ ++.||||++....... .+.+.+|+.+++.++||||+++++++.+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 88 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLV-- 88 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHH--------HHHHHHHHHHHHHCCCCCEEEEEEEEEE--
T ss_conf 105388789812858299999998999899999984301727--------9999999999986799988058577988--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+++||||+++|+|.+++.+. .+++..++.++.||+.||.|||+++||||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~vkl~DFG~ 162 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEEEECCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEECCCHH
T ss_conf 99989999703798089886415--999999999999999999999987972267768886887----899686425156
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 4113455-3347767888644641025887665302321000021035774344089999999999069999898
Q 001678 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ak~~~~~-~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+..... ......+||+.|+|||++.+.. ++.++||||+||++|+|++|..||.-.
T Consensus 163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------------------~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA------------------YGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHSSSC------------------BCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HEEECCCCCCCCCCCCCCCCCCHHHHCCCC------------------CCCHHCEEHHHHHHHHHHHCCCCCCCC
T ss_conf 413213666444444477736826644799------------------880120313729999980488998997
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.63 Aligned_cols=203 Identities=26% Similarity=0.394 Sum_probs=175.0
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 5888139999642483799999985--96259998303334899246899999999999999716999800388999818
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~ 875 (1033)
..++|++++.||+|+||+||+|+++ ++.||+|++....... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~- 77 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----AGVEHQLRREVEIQSHLRHPNILRLYGYFHD- 77 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCC-----HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-
T ss_conf 1537699889851778589999998999499999981688567-----6899999999999985688888859999998-
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECC
Q ss_conf 99955999842147708999973277658999999999999999999949942157999967980589999909998448
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFG 955 (1033)
.+.+++||||+++|+|.+++.+.. .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 78 -~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~~kl~DFG 151 (263)
T d2j4za1 78 -ATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFG 151 (263)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCCC
T ss_pred -CCEEEEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEEC----CCCCEEECCCC
T ss_conf -999899985047985898875048-999999999999999999999988946522023441466----89987115556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 8411345533477678886446410258876653023210000210357743440899999999990699998988
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 956 LAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
+|+...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+
T Consensus 152 ~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~------------------~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 152 WSVHAPSSR-RTTLCGTLDYLPPEMIEGRM------------------HDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp SCSCCCCCC-CEETTEEGGGCCHHHHTTCC------------------CCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EEEECCCCC-CCCCCCCCCCCCHHHHCCCC------------------CCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 335448885-23557887634999975899------------------8931440467599999832999988899
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.19 Aligned_cols=209 Identities=31% Similarity=0.503 Sum_probs=176.2
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 23335888139999642483799999985962599983033348992468999999999999997169998003889998
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1033)
Q Consensus 794 ~~~I~~~dYeiLkkLGkGsFGtVYkAk~kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~ 873 (1033)
.|++..++|++.+.||+|+||+||+|++++ .||||+++...... ...+.|.+|+.++++++||||+++++++.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP------QQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT------THHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CCCCCCCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 713154518998898307885899999999-89999997346998------99999999999998479987864567971
Q ss_pred CCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEE
Q ss_conf 18999559998421477089999732776589999999999999999999499421579999679805899999099984
Q 001678 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 874 e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiD 953 (1033)
. ..+++||||+++|+|.+++......+++..++.|+.||+.||.|||+++||||||||+|||++ .++.+||+|
T Consensus 75 ~---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~----~~~~~Kl~D 147 (276)
T d1uwha_ 75 A---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGD 147 (276)
T ss_dssp S---SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTSSEEECC
T ss_pred C---CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEEC----CCCCEEECC
T ss_conf 5---589999965899888999852357899999999999999998887509995161478997981----899788750
Q ss_pred CCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 4884113455---3347767888644641025887665302321000021035774344089999999999069999898
Q 001678 954 LGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 954 FGLAk~~~~~---~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
||+|+..... .......||+.|||||++.+.... .++.++|||||||++|+|+||+.||.-.
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~---------------~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN---------------PYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSC---------------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCC---------------CCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 0221333556776312566557431799999505689---------------9995315163599999999788998998
Q ss_pred C
Q ss_conf 8
Q 001678 1031 S 1031 (1033)
Q Consensus 1031 s 1031 (1033)
+
T Consensus 213 ~ 213 (276)
T d1uwha_ 213 N 213 (276)
T ss_dssp C
T ss_pred C
T ss_conf 9
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.99 Aligned_cols=203 Identities=29% Similarity=0.391 Sum_probs=174.8
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 5888139999642483799999985--96259998303334899246899999999999999716999800388999818
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~ 875 (1033)
..++|++++.||+|+||+||+|+++ ++.||||++...... .......+.+|+.++++++||||+++++++.+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~- 79 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD- 79 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-
T ss_pred CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-
T ss_conf 998778988985087909999999899979999998657755-----77789999999999987688886179999998-
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECC
Q ss_conf 99955999842147708999973277658999999999999999999949942157999967980589999909998448
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFG 955 (1033)
.+.+|+||||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+||||||||+|||++ .++.+||+|||
T Consensus 80 -~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~----~~~~vkl~DFG 153 (288)
T d1uu3a_ 80 -DEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFG 153 (288)
T ss_dssp -SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCT
T ss_pred -CCEEEEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCC----CCCEEEECCCC
T ss_conf -998899997048987777653159-999999999999999999762165088476774123668----88538860321
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 84113455---3347767888644641025887665302321000021035774344089999999999069999898
Q 001678 956 LSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 956 LAk~~~~~---~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
+|+..... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------------------~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS------------------ACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCC------------------CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCEEECCCC------------------CCCCCCEEHHHHHHHHHHHCCCCCCCC
T ss_conf 024225677643335556775525844002689------------------896662304569999980388998995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=322.98 Aligned_cols=203 Identities=28% Similarity=0.366 Sum_probs=176.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.+.|++++.||+|+||+||+|+++ ++.||||++....... ....+.+|+.+++.++||||+++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------KEGSMENEIAVLHKIKHPNIVALDDIYES-- 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-------HHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 666699889940658399999999999899999981577312-------89999999999986799899919899998--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+++|+||||||+|||+...+ .++.+||+|||+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~ 156 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGL 156 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC--
T ss_pred CCEEEEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCC-CCCEEEEECCCE
T ss_conf 998889885268984888653036-788789999999999998752413055687046300110468-882499831543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 41134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ak~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+...........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.-.
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~------------------~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKP------------------YSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp ----------------CTTSCHHHHTTCC------------------CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEECCCCCEEEEEEECCCCCCCHHHCCCC------------------CCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 58725897044003284225918873799------------------980787345159999998597999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=319.39 Aligned_cols=207 Identities=25% Similarity=0.298 Sum_probs=171.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 5888139999642483799999985--96259998303334899246899999999999999716999800388999818
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~ 875 (1033)
..++|++++.||+|+||.||+|+++ ++.||||++......... ..........++.+++.++||||++++++|.+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~--~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~- 78 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 78 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE-
T ss_conf 777685101884288909999999999979999998458754266--79999999999999850899858899999998-
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECC
Q ss_conf 99955999842147708999973277658999999999999999999949942157999967980589999909998448
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFG 955 (1033)
.+.+|+||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+++||||||||+|||++ ..+.+||+|||
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~----~~g~iKl~DFG 152 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLG 152 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSSCEEECCCT
T ss_pred -CCEEEEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEEC----CCCCEEEEEEC
T ss_conf -998899999148983899987325-532789999999999999999977962204442216785----88967982201
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 8411345533477678886446410258876653023210000210357743440899999999990699998988
Q 001678 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 956 LAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
+|+...... ....+||+.|+|||++.... .++.++|||||||++|+|+||+.||...+
T Consensus 153 la~~~~~~~-~~~~~GT~~y~APE~~~~~~-----------------~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 153 LACDFSKKK-PHASVGTHGYMAPEVLQKGV-----------------AYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp TCEECSSSC-CCSCCSCGGGCCHHHHSTTC-----------------CCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred EEEECCCCC-CCCCCCCCCCCHHHHHHCCC-----------------CCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 023337886-43311345542168760389-----------------99844104677899999985999888899
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.95 Aligned_cols=209 Identities=26% Similarity=0.353 Sum_probs=179.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|++++.||+|+||+||+|+++ ++.||||++........... ...+.+.+|+.++++++||||++++++|.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG--VSREDIEREVSILKEIQHPNVITLHEVYEN-- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS--BCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 5677982798117895999999999998999999875663213406--899999999999986799899938899997--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+++||||+++|+|.+++.+.. .+++..++.++.|++.||.|||+.+|+||||||+|||++.++.....+||+|||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCCCCHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf 998999998677864310010356-4215578999999999987666254221133301279825898666469643344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 41134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ak~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+............||+.|+|||++.+.. ++.++||||+||++|+|++|+.||...
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~------------------~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEP------------------LGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCC------------------BCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHCCCC------------------CCCCCCCHHHHHHHHHHHCCCCCCCCC
T ss_conf 21057776312247777430999981899------------------997665221409999997088998899
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.60 Aligned_cols=206 Identities=26% Similarity=0.389 Sum_probs=174.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.+.|++++.||+|+||.||+|+++ +..||+|++...... ..+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~-- 80 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--------ELEDYMVEIDILASCDHPNIVKLLDAFYY-- 80 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--------GGGGTHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHH--------HHHHHHHHHHHHHHCCCCCCCEEEEEEEE--
T ss_conf 03759847993077819999999999939999998728999--------99999999999986799998849889800--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+++||||+++|+|.+++.+....+++..+..|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~----~~~~~Kl~DFG~ 156 (288)
T d2jfla1 81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGV 156 (288)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEEC----CCCCEEEEECHH
T ss_conf 9958999962799818899986289999999999999999999999988988714070031487----899989971612
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 4113455-33477678886446410258876653023210000210357743440899999999990699998988
Q 001678 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 957 Ak~~~~~-~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
|+..... ......+||+.|+|||++........ .++.++|||||||++|+|++|+.||.-.+
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~-------------~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR-------------PYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTS-------------STTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCC-------------CCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 3035778641001025626479999832025788-------------88806657878999999820889999989
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=317.78 Aligned_cols=201 Identities=28% Similarity=0.431 Sum_probs=174.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|++++.||+|+||+||+|+++ ++.||||+++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 75 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-- 75 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE--
T ss_conf 54708888972076808999999899979999998457754-----88999999999999986369675330356852--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+++||||+.+|+|..++..... +++..+..++.||+.||.|||+++||||||||+|||++ .++.+||+|||+
T Consensus 76 ~~~~~ivmE~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~----~~g~vkL~DFG~ 150 (316)
T d1fota_ 76 AQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGF 150 (316)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCSS
T ss_pred CCEEEEEEEECCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEEC----CCCCEEEECCCC
T ss_conf 8800567650378632234322221-11007999999998765541247677055681050386----899889831752
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 411345533477678886446410258876653023210000210357743440899999999990699998988
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 957 Ak~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
|+...... ...+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.-.+
T Consensus 151 a~~~~~~~--~~~~Gt~~Y~APE~l~~~~------------------y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 151 AKYVPDVT--YTLCGTPDYIAPEVVSTKP------------------YNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp CEECSSCB--CCCCSCTTTCCHHHHTTCC------------------BCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CEEECCCC--CCCCCCCCCCCHHHHCCCC------------------CCCHHHCCCCCHHHHHHHHCCCCCCCCC
T ss_conf 16712456--4345763435999983899------------------9804304653336899975989999969
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.80 Aligned_cols=205 Identities=25% Similarity=0.424 Sum_probs=175.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|++++.||+|+||.||+|+++ ++.||+|++...... +...+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC------HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 33379967983088919999999999979999998746579------799999999999999778999824899999178
Q ss_pred CCCEEEEEEECCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEEECCCCCCCE
Q ss_conf 9955999842147708999973---2776589999999999999999999499-----4215799996798058999990
Q 001678 877 DGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKN-----IVHFDLKCENLLVNMRDPQRPV 948 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk---~~k~lse~~il~IA~QIlkALeYLHskG-----IIHRDIKPsNILLd~~~~~~g~ 948 (1033)
.+.+++||||+++|+|.+++.+ ....+++..++.++.|++.||.|||+.+ ||||||||+|||++ .++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~----~~~~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQN 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----TTSC
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCC----CCCC
T ss_conf 998999995689993899998515457899999999999999999999997167788788586765425747----8885
Q ss_pred EEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 9998448841134553-347767888644641025887665302321000021035774344089999999999069999
Q 001678 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 949 VKLiDFGLAk~~~~~~-~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PF 1027 (1033)
+||+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~------------------~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS------------------YNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCC------------------CCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCC------------------CCHHHHHHHHCHHHHHHHHCCCCC
T ss_conf 79800100032245777556677882327999983999------------------993898875278999980188998
Q ss_pred CCCC
Q ss_conf 8988
Q 001678 1028 DFFS 1031 (1033)
Q Consensus 1028 d~~s 1031 (1033)
...+
T Consensus 215 ~~~~ 218 (269)
T d2java1 215 TAFS 218 (269)
T ss_dssp CCSS
T ss_pred CCCC
T ss_conf 9989
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=314.48 Aligned_cols=201 Identities=26% Similarity=0.403 Sum_probs=170.5
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 88139999642483799999985--9625999830333489924689999999999999971699980038899981899
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e~ 877 (1033)
..|+.+++||+|+||.||+|++. ++.||||++...... .....+.+.+|+.++++++||||+++++++.+ .
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~ 87 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--E 87 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC-----HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--C
T ss_conf 8567627970188809999999899939999998444435-----88999999999999997789998238999998--9
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCCC
Q ss_conf 95599984214770899997327765899999999999999999994994215799996798058999990999844884
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLA 957 (1033)
+.+++|||||.+|+|..++... ..+++..++.|+.||+.||.|||+++||||||||+|||++ .++.+||+|||+|
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 162 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTC
T ss_pred CEEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEEC----CCCCEEEEECCCC
T ss_conf 9889999806999457899737-9999999999999999999999868976667884217987----9997898443653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 1134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 958 k~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
+..... ....||+.|+|||++.+.... .|+.++|||||||++|+|++|..||.-.
T Consensus 163 ~~~~~~---~~~~GT~~Y~APE~~~~~~~~---------------~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 163 SIMAPA---NSFVGTPYWMAPEVILAMDEG---------------QYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHTTTTSC---------------CBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCCCCC---CCCCCCCCCCCHHHHHCCCCC---------------CCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 346778---731347663688998346788---------------8672145455899999998788999997
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=317.56 Aligned_cols=200 Identities=24% Similarity=0.367 Sum_probs=174.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|++++.||+|+||.||+|+++ ++.||||++...... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-- 112 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-- 112 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC--
T ss_conf 23708988961176808999999899989999998267745-----88999999999999997487727403444432--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
...+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++||||||||+|||++ .++.+||+|||+
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGF 187 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTT
T ss_pred CCCCCCCCCCCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCC----CCCCEEEEECEE
T ss_conf 222232222334662266675158-989999999999999989999859986176799993607----789788610103
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 41134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ak~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+..... .....||+.|||||++.+.. ++.++|||||||++|+|+||+.||...
T Consensus 188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~~------------------~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 188 AKRVKGR--TWTLCGTPEALAPEIILSKG------------------YNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CEECSSC--BCCCEECGGGCCHHHHTTCC------------------BCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEECCCC--CCCCCCCCCCCCHHHHCCCC------------------CCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 3322566--64336763567889971799------------------885331145007899997588998995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=309.54 Aligned_cols=202 Identities=28% Similarity=0.451 Sum_probs=167.7
Q ss_pred CCCC-EEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 8881-39999642483799999985--96259998303334899246899999999999999716999800388999818
Q 001678 799 NDDL-EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 799 ~~dY-eiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~ 875 (1033)
..+| ++.++||+|+||+||+|.++ +..||+|++...... ....+.|.+|+.++++++||||+++++++.+.
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 887788516970082849999999999959999998512279------89999999999999857999850699998403
Q ss_pred --CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEECCCCCCCEEEE
Q ss_conf --999559998421477089999732776589999999999999999999499--4215799996798058999990999
Q 001678 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 876 --e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskG--IIHRDIKPsNILLd~~~~~~g~VKL 951 (1033)
....+++||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~---~~~~~Kl 156 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKI 156 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---TTSCEEE
T ss_pred CCCCCEEEEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEEC---CCCCEEE
T ss_conf 345888999995789894899975135-546999999999999999999978997996876743511667---9998898
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8448841134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 952 iDFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
+|||+|+..... .....+||+.|+|||++.++ ++.++|||||||++|+|++|+.||.-.
T Consensus 157 ~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~~-------------------~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 157 GDLGLATLKRAS-FAKAVIGTPEFMAPEMYEEK-------------------YDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CCTTGGGGCCTT-SBEESCSSCCCCCGGGGGTC-------------------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EECCCCEECCCC-CCCCCCCCCCCCCHHHHCCC-------------------CCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf 005765423687-66775538130089884789-------------------998671100799999998788999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.59 Aligned_cols=207 Identities=29% Similarity=0.396 Sum_probs=172.3
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECCC-------CEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCC
Q ss_conf 333588813999964248379999998596-------259998303334899246899999999999999716-999800
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGS-------DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1033)
Q Consensus 795 ~~I~~~dYeiLkkLGkGsFGtVYkAk~kGt-------kVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL-~HPNIV 866 (1033)
|.+..++|++.+.||+|+||+||+|++.+. .||+|.+..... ......+.+|+.++.++ +|||||
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCC-------HHHHHHHHHHHHHHHHHCCCCCEE
T ss_conf 6577899397019830788199999985788554204999999663358-------789999999999999715899686
Q ss_pred EEEEEEECCCCCCEEEEEEECCCCCHHHHHHHCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 3889998189995599984214770899997327----------------------765899999999999999999994
Q 001678 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------RTIDRRKRLIIAMDAAFGMEYLHG 924 (1033)
Q Consensus 867 kLlGvf~e~e~g~l~LVmEYiegGSL~dlLkk~~----------------------k~lse~~il~IA~QIlkALeYLHs 924 (1033)
++++++.+ .+.+++||||+++|+|.++|+... ..+++..++.|+.||+.||.|||+
T Consensus 105 ~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~ 182 (325)
T d1rjba_ 105 NLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 182 (325)
T ss_dssp CEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEE--CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 87788862--9958999972799959999986257775102210000122200125778999999999999999999973
Q ss_pred CCCCCCCCCCCCEEEECCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHH
Q ss_conf 9942157999967980589999909998448841134553---3477678886446410258876653023210000210
Q 001678 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCC 1001 (1033)
Q Consensus 925 kGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L 1001 (1033)
++||||||||+|||++ .++.+||+|||+|+...... ......||+.|||||++.+..
T Consensus 183 ~~IiHRDlKp~Nill~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---------------- 242 (325)
T d1rjba_ 183 KSCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI---------------- 242 (325)
T ss_dssp TTEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC----------------
T ss_pred CCEEECCCCHHCCCCC----CCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCC----------------
T ss_conf 9905052703214434----59828985142222045778615623435787657838872799----------------
Q ss_pred CCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf 357743440899999999990-6999989889
Q 001678 1002 FQLKWSYDCYSLGILFFFLQF-ILCFIDFFSI 1032 (1033)
Q Consensus 1002 ~eittkvDIWSLGVILYeLLT-Gk~PFd~~si 1032 (1033)
++.++|||||||++|+|++ |..||.-.+.
T Consensus 243 --~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 243 --YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp --CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred --CCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf --996330300039999998389999999898
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-45 Score=312.73 Aligned_cols=206 Identities=31% Similarity=0.480 Sum_probs=172.1
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEEC--CC---CEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 3335888139999642483799999985--96---259998303334899246899999999999999716999800388
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 795 ~~I~~~dYeiLkkLGkGsFGtVYkAk~k--Gt---kVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLl 869 (1033)
..+..++|++.+.||+|+||+||+|+++ ++ .||||.+.... .....+.|.+|+.++++++|||||+++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 93 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLE 93 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCCCEE
T ss_conf 2208004278569802788299999995799788999999978445-------989999999999999857998886189
Q ss_pred EEEECCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEE
Q ss_conf 99981899955999842147708999973277658999999999999999999949942157999967980589999909
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 870 Gvf~e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~V 949 (1033)
|++.+ .+.+++||||+++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+
T Consensus 94 g~~~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~----~~~~~ 167 (299)
T d1jpaa_ 94 GVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVC 167 (299)
T ss_dssp EEECS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCE
T ss_pred EEEEE--CCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCE
T ss_conf 99962--8877999972279853002104567999999999999999988988527983576150448988----99919
Q ss_pred EEEECCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-
Q ss_conf 9984488411345533------477678886446410258876653023210000210357743440899999999990-
Q 001678 950 KIGDLGLSKVKQQTLV------SGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF- 1022 (1033)
Q Consensus 950 KLiDFGLAk~~~~~~~------s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT- 1022 (1033)
||+|||+|+....... .....||+.|+|||++.+.. ++.++|||||||++|+|+|
T Consensus 168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------------------~~~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK------------------FTSASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp EECCC-----------------------CGGGSCHHHHHSCC------------------CCHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCC------------------CCCCCCCCCCHHHHHHHHHC
T ss_conf 988844315756777765365025666883003878883699------------------78612144535789999867
Q ss_pred CCCCCCCCC
Q ss_conf 699998988
Q 001678 1023 ILCFIDFFS 1031 (1033)
Q Consensus 1023 Gk~PFd~~s 1031 (1033)
|+.||.-.+
T Consensus 230 g~~Pf~~~~ 238 (299)
T d1jpaa_ 230 GERPYWDMT 238 (299)
T ss_dssp SCCTTTTCC
T ss_pred CCCCCCCCC
T ss_conf 999999999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=312.06 Aligned_cols=200 Identities=24% Similarity=0.277 Sum_probs=169.2
Q ss_pred CCCCEEEE-EECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHH-CCCCCCCEEEEEEEC
Q ss_conf 88813999-964248379999998--59625999830333489924689999999999999971-699980038899981
Q 001678 799 NDDLEEVR-ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRD 874 (1033)
Q Consensus 799 ~~dYeiLk-kLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkk-L~HPNIVkLlGvf~e 874 (1033)
.++|+++. .||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.+ ++||||++++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------------HHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 148798107965454869999998899989999998974-------------7799999999986699997829899950
Q ss_pred --CCCCCEEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEE
Q ss_conf --89995599984214770899997327-765899999999999999999994994215799996798058999990999
Q 001678 875 --GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1033)
Q Consensus 875 --~e~g~l~LVmEYiegGSL~dlLkk~~-k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKL 951 (1033)
..+..+|+|||||++|+|.+++.+.+ ..+++..++.|+.||+.||.|||+.+|+||||||+|||++... ..+.+||
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~Kl 155 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKL 155 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEEE
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf 346897899999778998499999862787757999999999999999999976986444100220113555-5663113
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8448841134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 952 iDFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
+|||+|+...........+||+.|+|||++.+.. ++.++|||||||++|+|+||++||...
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK------------------YDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG------------------GSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCC------------------CCHHHHHHHHCHHHHHHHHCCCCCCCC
T ss_conf 5455123336888643226775637927774898------------------888888876451677886588998898
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=312.96 Aligned_cols=201 Identities=29% Similarity=0.494 Sum_probs=172.4
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 35888139999642483799999985-96259998303334899246899999999999999716999800388999818
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 797 I~~~dYeiLkkLGkGsFGtVYkAk~k-GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~ 875 (1033)
++.++|++++.||+|+||+||+|++. ++.||||+++..... .+.|.+|+.++++++||||++++|+|..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLE- 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCCCCCCCEECC-
T ss_conf 896995888898208882999999889999999998788676---------8999999999996689975653524315-
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECC
Q ss_conf 99955999842147708999973277658999999999999999999949942157999967980589999909998448
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFG 955 (1033)
.+.+++||||+++|+|.+++......+++..++.|+.|++.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 72 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~----~~~~~Kl~DFG 146 (263)
T d1sm2a_ 72 -QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG 146 (263)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC----GGGCEEECSCC
T ss_pred -CCCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEEC----CCCCEEECCCC
T ss_conf -9933799983699918997520134788999999999999987765316431044315326666----88776865532
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-CCCCCCCC
Q ss_conf 841134553--3477678886446410258876653023210000210357743440899999999990-69999898
Q 001678 956 LSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 956 LAk~~~~~~--~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT-Gk~PFd~~ 1030 (1033)
+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|+| +.+||...
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------------------~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR------------------YSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp ------------------CTTSCCHHHHTTCC------------------CCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred HHEECCCCCCEEECCEECCCCCCCHHHHCCCC------------------CCCHHHHCCHHHHHHHHHHCCCCCCCCC
T ss_conf 10023688733504300176667857860799------------------9840332105999999987898887789
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=309.93 Aligned_cols=202 Identities=19% Similarity=0.217 Sum_probs=174.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|++++.||+|+||+||+|.++ ++.||+|+++... . . ...+.+|+.+++.++||||++++++|.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~-~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~-- 72 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----T-D---QVLVKKEISILNIARHRNILHLHESFES-- 72 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----H-H---HHHHHHHHHHHHHSCCTTBCCEEEEEEE--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----C-C---HHHHHHHHHHHHHCCCCCCCEEEEEEEE--
T ss_conf 010588789831778399999998999699999975786-----6-5---9999999999985799798909899988--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+|+|||||.+|+|.+++.+.+..+++..++.|+.||+.||.|||+++|+||||||+|||++.+ ....+||+|||+
T Consensus 73 ~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~DFG~ 150 (321)
T d1tkia_ 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQ 150 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC--CCEEEEECCCCH
T ss_conf 998899995389980889987538999999999999999999999987699751355444344378--851899764411
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 411345533477678886446410258876653023210000210357743440899999999990699998988
Q 001678 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 957 Ak~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
++............+++.|+|||++.+.. ++.++||||+||++|+|++|+.||...+
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~------------------~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDV------------------VSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCE------------------ECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred HHCCCCCCCCCCCCCCCCCCCCHHCCCCC------------------CCCHHHCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 10034677532122332223402104877------------------7840113027999999982899999989
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=313.18 Aligned_cols=203 Identities=29% Similarity=0.528 Sum_probs=171.7
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 23335888139999642483799999985--9625999830333489924689999999999999971699980038899
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 794 ~~~I~~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGv 871 (1033)
.|++..++|++.++||+|+||+||+|.++ ++.||||+++..... .+.|.+|+.++++++||||++++++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCH---------HHHHHHHHHHHHHCCCCCEECCCCC
T ss_conf 5174579939865982088808999999999969999997776103---------9999999999986799988267752
Q ss_pred EECCCCCCEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 9818999559998421477089999732-776589999999999999999999499421579999679805899999099
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 872 f~e~e~g~l~LVmEYiegGSL~dlLkk~-~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VK 950 (1033)
|.+ .+.+++||||+++|+|.+++.+. ...+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+|
T Consensus 82 ~~~--~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~----~~~~~K 155 (287)
T d1opja_ 82 CTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVK 155 (287)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEE
T ss_pred EEE--CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEE
T ss_conf 745--78547876314676067775303554157999999999999978889878930576045768998----999289
Q ss_pred EEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCC-C
Q ss_conf 98448841134553--34776788864464102588766530232100002103577434408999999999906999-9
Q 001678 951 IGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCF-I 1027 (1033)
Q Consensus 951 LiDFGLAk~~~~~~--~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~P-F 1027 (1033)
|+|||+|+...... ......|++.|+|||++.+.. ++.++|||||||++|+|+++..| |
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------------------~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK------------------FSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC------------------CSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCC------------------CCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 8324454653788722103556654666927872799------------------9810430217899999986799887
Q ss_pred CC
Q ss_conf 89
Q 001678 1028 DF 1029 (1033)
Q Consensus 1028 d~ 1029 (1033)
..
T Consensus 218 ~~ 219 (287)
T d1opja_ 218 PG 219 (287)
T ss_dssp TT
T ss_pred CC
T ss_conf 74
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=307.97 Aligned_cols=202 Identities=25% Similarity=0.384 Sum_probs=170.3
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHH-HHCCCCCCCEEEEEEECCC
Q ss_conf 8813999964248379999998--596259998303334899246899999999999999-7169998003889998189
Q 001678 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~IL-kkL~HPNIVkLlGvf~e~e 876 (1033)
++|++++.||+|+||+||+|++ +++.||||+++......+ .....+..|..++ +.++||||+++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~-----~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-- 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-----DDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-- 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCH-----HHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--
T ss_conf 971886589408782899999999998999999805553384-----8999999999999984799968789889704--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+|+||||+++|+|.+++..... +++..+..++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||+
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~----~~~~~kl~DFG~ 149 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGM 149 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred CCCEEEEEEECCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEEC----CCCCEECCCCCH
T ss_conf 9831677750379808998640478-99999999999999999999868934034765404444----899630155530
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 4113455-33477678886446410258876653023210000210357743440899999999990699998988
Q 001678 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 957 Ak~~~~~-~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
++..... .......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||...+
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQK------------------YNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCC------------------BCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHCCCCCCCCCCCCCCCCCCCHHHHCCCC------------------CCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 232356653345457877768999982799------------------8832320112278989873889999989
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-44 Score=305.35 Aligned_cols=214 Identities=23% Similarity=0.233 Sum_probs=181.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCH-HHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEC
Q ss_conf 88813999964248379999998--59625999830333489924-68999999999999997169-9980038899981
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPS-ERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~-erer~ik~FlkEi~ILkkL~-HPNIVkLlGvf~e 874 (1033)
.++|++++.||+|+||+||+|++ +++.||||++.......... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEEC
Q ss_conf 89995599984214770899997327765899999999999999999994994215799996798058999990999844
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDF 954 (1033)
.+.+|+||||+++|+|.++++..+ .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+||
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~~kl~DF 154 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 154 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred --CCCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEEECCC
T ss_conf --760599997689866899998659-999999999999999999999875994323462548986----8998387124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88411345533477678886446410258876653023210000210357743440899999999990699998988
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 955 GLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
|+++............||+.|+|||++.+....... .++.++||||+||++|+|++|..||...+
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~------------~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP------------GYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSC------------CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCC------------CCCCHHEECCCCHHHHHHCCCCCCCCCCC
T ss_conf 031672688721345246788898886053445678------------89923318565602310322888988999
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=307.70 Aligned_cols=204 Identities=30% Similarity=0.428 Sum_probs=170.6
Q ss_pred CCCCCCCEEEE-EECCCCCEEEEEEEEC----CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 33588813999-9642483799999985----962599983033348992468999999999999997169998003889
Q 001678 796 TIKNDDLEEVR-ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 796 ~I~~~dYeiLk-kLGkGsFGtVYkAk~k----GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlG 870 (1033)
.+..++|.+.+ +||+|+||.||+|.++ +..||||+++... .....+.|.+|+.++++++|||||++++
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 654447188784873060809999999608976899999988203-------9789999999999998679988806865
Q ss_pred EEECCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 99818999559998421477089999732776589999999999999999999499421579999679805899999099
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 vf~e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VK 950 (1033)
++.+ +.+++||||+++|+|.+++......+++..++.|+.|++.||.|||+++|+||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----~~~~~K 149 (285)
T d1u59a_ 77 VCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAK 149 (285)
T ss_dssp EEES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEE
T ss_pred EECC---CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEC----CCCCEE
T ss_conf 6036---807999980789968997521256999999999999999987899868810576764660454----688542
Q ss_pred EEECCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-CCC
Q ss_conf 98448841134553----3477678886446410258876653023210000210357743440899999999990-699
Q 001678 951 IGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILC 1025 (1033)
Q Consensus 951 LiDFGLAk~~~~~~----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT-Gk~ 1025 (1033)
|+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|+|+| |+.
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK------------------FSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE------------------ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ECCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC------------------CCCCCHHHCCHHHHHHHHHCCCC
T ss_conf 033134211554343211356211374335868872799------------------99541232201789999938999
Q ss_pred CCCCCC
Q ss_conf 998988
Q 001678 1026 FIDFFS 1031 (1033)
Q Consensus 1026 PFd~~s 1031 (1033)
||.-.+
T Consensus 212 Pf~~~~ 217 (285)
T d1u59a_ 212 PYKKMK 217 (285)
T ss_dssp TTTTCC
T ss_pred CCCCCC
T ss_conf 999979
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=309.31 Aligned_cols=204 Identities=29% Similarity=0.491 Sum_probs=170.7
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 023335888139999642483799999985-9625999830333489924689999999999999971699980038899
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 793 ~~~~I~~~dYeiLkkLGkGsFGtVYkAk~k-GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGv 871 (1033)
..+++..++|++++.||+|+||.||+|.++ ++.||||+++..... .+.|.+|+.++++++|||||+++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 7700388993886798107982899999999999999998647688---------8999999999986799988578731
Q ss_pred EECCCCCCEEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 98189995599984214770899997327-76589999999999999999999499421579999679805899999099
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 872 f~e~e~g~l~LVmEYiegGSL~dlLkk~~-k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VK 950 (1033)
+.+ +.+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+|
T Consensus 77 ~~~---~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~----~~~~~K 149 (272)
T d1qpca_ 77 VTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCK 149 (272)
T ss_dssp ECS---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEE
T ss_pred ECC---CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEE----CCCCEE
T ss_conf 045---9769999957898288887514789887889999999999999999748954675642251562----024404
Q ss_pred EEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCC-CCCC
Q ss_conf 98448841134553--34776788864464102588766530232100002103577434408999999999906-9999
Q 001678 951 IGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFI-LCFI 1027 (1033)
Q Consensus 951 LiDFGLAk~~~~~~--~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTG-k~PF 1027 (1033)
|+|||+|+...... ......|++.|+|||++.+.. ++.++|||||||++|+|+|+ .+||
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~------------------~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT------------------FTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE------------------ECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCC------------------CCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 2341014773588644203567744445828983799------------------9824564525799999996898888
Q ss_pred CCC
Q ss_conf 898
Q 001678 1028 DFF 1030 (1033)
Q Consensus 1028 d~~ 1030 (1033)
...
T Consensus 212 ~~~ 214 (272)
T d1qpca_ 212 PGM 214 (272)
T ss_dssp TTC
T ss_pred CCC
T ss_conf 888
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=304.92 Aligned_cols=205 Identities=27% Similarity=0.464 Sum_probs=171.6
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEEC--CC----CEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEE
Q ss_conf 3335888139999642483799999985--96----25999830333489924689999999999999971699980038
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (1033)
Q Consensus 795 ~~I~~~dYeiLkkLGkGsFGtVYkAk~k--Gt----kVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkL 868 (1033)
..++..+|++++.||+|+||+||+|.+. ++ +||+|+++.... ....+.|.+|+.++++++||||+++
T Consensus 4 ~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l 76 (317)
T d1xkka_ 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-------PKANKEILDEAYVMASVDNPHVCRL 76 (317)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCEEEE
T ss_conf 438889997831982089929999999589988989999999651349-------7999999999999986799888158
Q ss_pred EEEEECCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCE
Q ss_conf 89998189995599984214770899997327765899999999999999999994994215799996798058999990
Q 001678 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1033)
Q Consensus 869 lGvf~e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~ 948 (1033)
+++|.+ +..++++||+.+++|.+++......+++..++.|+.||+.||.|||+++||||||||+|||++ .++.
T Consensus 77 ~g~~~~---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~----~~~~ 149 (317)
T d1xkka_ 77 LGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQH 149 (317)
T ss_dssp EEEEES---SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTE
T ss_pred EEEEEC---CCEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEEC----CCCC
T ss_conf 999961---983699984268740101113345799999999999999999999876950476212031167----9987
Q ss_pred EEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-CC
Q ss_conf 9998448841134553---3477678886446410258876653023210000210357743440899999999990-69
Q 001678 949 CKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-IL 1024 (1033)
Q Consensus 949 VKLiDFGLAk~~~~~~---~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT-Gk 1024 (1033)
+||+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|+|+| |.
T Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~------------------~~~~sDvwS~Gvil~el~t~g~ 211 (317)
T d1xkka_ 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI------------------YTHQSDVWSYGVTVWELMTFGS 211 (317)
T ss_dssp EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC------------------CCHHHHHHHHHHHHHHHHTTSC
T ss_pred EEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCC------------------CCHHHHHHHHHHHHHHHHHCCC
T ss_conf 5860255222335444532236510586446708874699------------------9835654407999999997799
Q ss_pred CCCCCCC
Q ss_conf 9998988
Q 001678 1025 CFIDFFS 1031 (1033)
Q Consensus 1025 ~PFd~~s 1031 (1033)
+||+..+
T Consensus 212 ~p~~~~~ 218 (317)
T d1xkka_ 212 KPYDGIP 218 (317)
T ss_dssp CTTTTSC
T ss_pred CCCCCCC
T ss_conf 9999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=302.27 Aligned_cols=201 Identities=31% Similarity=0.511 Sum_probs=169.5
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECC------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 3358881399996424837999999859------6259998303334899246899999999999999716999800388
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 796 ~I~~~dYeiLkkLGkGsFGtVYkAk~kG------tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLl 869 (1033)
++..++|++.+.||+|+||.||+|+++. ..||||++..... ......|.+|+.++++++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-------EKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 57889968615981177909999999689987879999999884459-------68999999999999856898783236
Q ss_pred EEEECCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEE
Q ss_conf 99981899955999842147708999973277658999999999999999999949942157999967980589999909
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 870 Gvf~e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~V 949 (1033)
|++.+ ...+++||||+.+++|.+++......+++..++.++.|++.||.|||+.+|+||||||+||||+ .++.+
T Consensus 76 g~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~----~~~~~ 149 (283)
T d1mqba_ 76 GVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVC 149 (283)
T ss_dssp EEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCE
T ss_pred EEEEC--CCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC----CCCEE
T ss_conf 77833--8803899972135740222102345420899999999999854121212342576564427888----99849
Q ss_pred EEEECCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 998448841134553----3477678886446410258876653023210000210357743440899999999990699
Q 001678 950 KIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 950 KLiDFGLAk~~~~~~----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~ 1025 (1033)
||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|+++..
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~------------------~~~~sDI~S~Gvil~el~t~~~ 211 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK------------------FTSASDVWSFGIVMWEVMTYGE 211 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCC------------------CCHHHHHHHHHHHHHHHHTTSC
T ss_pred EECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCC------------------CCCCCCCCCCHHHHHHHHHCCC
T ss_conf 9845510300357876526742677773434888870499------------------9973556344898999996798
Q ss_pred CC
Q ss_conf 99
Q 001678 1026 FI 1027 (1033)
Q Consensus 1026 PF 1027 (1033)
||
T Consensus 212 ~~ 213 (283)
T d1mqba_ 212 RP 213 (283)
T ss_dssp CT
T ss_pred CC
T ss_conf 86
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=306.10 Aligned_cols=201 Identities=26% Similarity=0.328 Sum_probs=166.5
Q ss_pred EEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCCE
Q ss_conf 3999964248379999998--59625999830333489924689999999999999971699980038899981899955
Q 001678 803 EEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1033)
Q Consensus 803 eiLkkLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e~g~l 880 (1033)
+.++.||+|+||+||+|++ +++.||||+++...... ........+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCC
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---HHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCE
T ss_conf 95638512728299999999999699999984202124---567999999999999986799998689854225--8740
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCCCCCC
Q ss_conf 99984214770899997327765899999999999999999994994215799996798058999990999844884113
Q 001678 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 881 ~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLAk~~ 960 (1033)
++||||+.++++..++ .....+++..+..++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||+|+..
T Consensus 76 ~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGGSTT
T ss_pred EEHHHHHCCHHHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEEC----CCCCCCCCCCCCCCCC
T ss_conf 2204553450776554-1266778999999999999999886316355035776258853----7784114657610005
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 4553-347767888644641025887665302321000021035774344089999999999069999898
Q 001678 961 QQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 961 ~~~~-~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
.... .....+||+.|+|||++.+.. .++.++||||+||++|+|++|.+||...
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------------~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGAR-----------------MYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCS-----------------CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCCCCCCEECCHHHCCHHHHCCCC-----------------CCCHHHHHHHCCHHHHHHHHCCCCCCCC
T ss_conf 78755433020473336399972677-----------------8880564363042899998596999999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-44 Score=300.82 Aligned_cols=201 Identities=28% Similarity=0.403 Sum_probs=169.1
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 88139999642483799999985--9625999830333489924689999999999999971699980038899981899
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e~ 877 (1033)
++|++++.||+|+||+||+|++. ++.||||+++..... +.....+.+|+.++++++||||++++++|.+ .
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~ 73 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHT--E 73 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--C
T ss_conf 9977651772376809999999999979999998022257------5899999999999986799838874453322--4
Q ss_pred CCEEEEEEECCCCCHHHHH-HHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 9559998421477089999-732776589999999999999999999499421579999679805899999099984488
Q 001678 878 GSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 878 g~l~LVmEYiegGSL~dlL-kk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
+.+++||||+.+ ++.+++ ......+++..+..++.|++.||.|||+.+||||||||+|||++ .++.+||+|||+
T Consensus 74 ~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~----~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 74 NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGL 148 (298)
T ss_dssp TEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTH
T ss_pred CCEEEEEEECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEEC----CCCCCEECCCCC
T ss_conf 320378862377-445554420256888899999999999999986528899213571140113----467621035786
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 4113455-3347767888644641025887665302321000021035774344089999999999069999898
Q 001678 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 957 Ak~~~~~-~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+..... .......||+.|+|||++.... .++.++|+||+||++|+|++|+.||+..
T Consensus 149 a~~~~~~~~~~~~~~gt~~y~apE~~~~~~-----------------~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCK-----------------YYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp HHHHCCCSBCTTCCBCCCTTCCHHHHTTCS-----------------SCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CEECCCCCCCCEEECCCCEEEEHHHHCCCC-----------------CCCCCCCCCCCCHHHHHHHHCCCCCCCC
T ss_conf 134368864100103652154112213665-----------------7774221033331342796687998988
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=302.97 Aligned_cols=201 Identities=32% Similarity=0.525 Sum_probs=173.3
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 5888139999642483799999985-962599983033348992468999999999999997169998003889998189
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~k-GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
+.++|+++++||+|+||+||+|+++ +..||||+++..... ...|++|+.++++++||||++++|+|.+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-- 70 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTK-- 70 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEEEEE--
T ss_conf 96997996898207883999999889989999998747577---------8999999999996689860158899850--
Q ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCC
Q ss_conf 99559998421477089999732776589999999999999999999499421579999679805899999099984488
Q 001678 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1033)
Q Consensus 877 ~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGL 956 (1033)
.+.+++||||+.+|+|.+++......+++..+++|+.|+++||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~----~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGL 146 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC----TTCCEEECCCSS
T ss_pred CCCEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEC----CCCCEEECCCHH
T ss_conf 7816999970489938886410246776899999999999999987546843466541358876----998479886144
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf 41134553--3477678886446410258876653023210000210357743440899999999990-699998988
Q 001678 957 SKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFFS 1031 (1033)
Q Consensus 957 Ak~~~~~~--~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT-Gk~PFd~~s 1031 (1033)
++...... ......||+.|+|||++.+.. ++.++|||||||++|+|+| |+.||.-.+
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------------------~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK------------------FSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC------------------CCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred HEECCCCCCEEECCCCCCCCCCCCHHHCCCC------------------CCCCEEECCCCHHHHHHHHCCCCCCCCCC
T ss_conf 2023578722524657887757807863799------------------88521033643246739755999988999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-43 Score=299.04 Aligned_cols=205 Identities=22% Similarity=0.310 Sum_probs=173.3
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|++++.||+|+||.||+|++. ++.||||+++..... .......|.+|+.+++.++||||+++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC
T ss_conf 62069868996089929999999999989999998556646-----9899999999999998569998873114354326
Q ss_pred C--CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEEC
Q ss_conf 9--95599984214770899997327765899999999999999999994994215799996798058999990999844
Q 001678 877 D--GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 877 ~--g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDF 954 (1033)
. ..+|+||||+++++|.+++...+ .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.++|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~----~~~~~~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTSCEEECCC
T ss_pred CCCCEEEEEEECCCCCEEHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----CCCCCEEEHH
T ss_conf 88766999997788987101120358-999999999999999999999857952763467556657----5432010034
Q ss_pred CCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8841134553----347767888644641025887665302321000021035774344089999999999069999898
Q 001678 955 GLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 955 GLAk~~~~~~----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|.+....... .....+||+.|+|||++.+.. ++.++|||||||++|+|+||+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------------------~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS------------------VDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCC------------------CCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCC------------------CCCCEECCCCHHHHHHHHHCCCCCCCC
T ss_conf 44322123544333346425762436999983999------------------996632026528999997697998996
Q ss_pred C
Q ss_conf 8
Q 001678 1031 S 1031 (1033)
Q Consensus 1031 s 1031 (1033)
+
T Consensus 218 ~ 218 (277)
T d1o6ya_ 218 S 218 (277)
T ss_dssp S
T ss_pred C
T ss_conf 9
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=301.61 Aligned_cols=199 Identities=27% Similarity=0.394 Sum_probs=163.8
Q ss_pred CCEEE-EEECCCCCEEEEEEEEC----CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 81399-99642483799999985----96259998303334899246899999999999999716999800388999818
Q 001678 801 DLEEV-RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1033)
Q Consensus 801 dYeiL-kkLGkGsFGtVYkAk~k----GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~ 875 (1033)
.+.+. ++||+|+||+||+|.++ ++.||||+++..... ....+.|.+|+.++++++||||++++++|..
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~- 79 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------PALKDELLAEANVMQQLDNPYIVRMIGICEA- 79 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-
T ss_pred HCEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-
T ss_conf 370018783458782999999816973859999998801089------8999999999999986799898527777505-
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECC
Q ss_conf 99955999842147708999973277658999999999999999999949942157999967980589999909998448
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFG 955 (1033)
+.+++||||+++|+|.+++.+.. .+++..++.|+.||+.||.|||+++||||||||+|||++ .++.+||+|||
T Consensus 80 --~~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~----~~~~~kl~DFG 152 (277)
T d1xbba_ 80 --ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFG 152 (277)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEECCCT
T ss_pred --CCEEEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCC----CCCCCCCCCHH
T ss_conf --97799997478896899975225-789999999999999997668747955677761131023----56751234134
Q ss_pred CCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-CCCCCCCC
Q ss_conf 841134553----3477678886446410258876653023210000210357743440899999999990-69999898
Q 001678 956 LSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFF 1030 (1033)
Q Consensus 956 LAk~~~~~~----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT-Gk~PFd~~ 1030 (1033)
+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.-.
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~------------------~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK------------------FSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE------------------EEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred HHHHCCCCCCCCCCCCCCCCCCEECCCHHHCCCC------------------CCCHHHHCCCHHHHHHHHHCCCCCCCCC
T ss_conf 5331343234432244567784203916653799------------------9843443034031328965899999998
Q ss_pred C
Q ss_conf 8
Q 001678 1031 S 1031 (1033)
Q Consensus 1031 s 1031 (1033)
+
T Consensus 215 ~ 215 (277)
T d1xbba_ 215 K 215 (277)
T ss_dssp C
T ss_pred C
T ss_conf 9
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=299.82 Aligned_cols=205 Identities=25% Similarity=0.452 Sum_probs=172.1
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECC-----CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 33358881399996424837999999859-----6259998303334899246899999999999999716999800388
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1033)
Q Consensus 795 ~~I~~~dYeiLkkLGkGsFGtVYkAk~kG-----tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLl 869 (1033)
+++..++|++.+.||+|+||.||+|++.. ..||||.++... .......|.+|+.++++++||||++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 9768899698779930788299999993699644999999936566-------879999999999999868999985698
Q ss_pred EEEECCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEE
Q ss_conf 99981899955999842147708999973277658999999999999999999949942157999967980589999909
Q 001678 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 870 Gvf~e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~V 949 (1033)
+++.+ +.+++||||+.+|+|.+++......+++..++.++.||+.||.|||+.++|||||||+|||++ .++.+
T Consensus 75 ~~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~----~~~~~ 147 (273)
T d1mp8a_ 75 GVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCV 147 (273)
T ss_dssp EEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEE
T ss_pred EEEEC---CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEEC----CCCCE
T ss_conf 89953---747999984069807765422478999999999999998775230226744141026553206----78967
Q ss_pred EEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-CCCC
Q ss_conf 998448841134553--3477678886446410258876653023210000210357743440899999999990-6999
Q 001678 950 KIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCF 1026 (1033)
Q Consensus 950 KLiDFGLAk~~~~~~--~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT-Gk~P 1026 (1033)
||+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |.+|
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~------------------~~~~~DiwSlGvil~e~lt~g~~P 209 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR------------------FTSASDVWMFGVCMWEILMHGVKP 209 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCC------------------CSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred EECCCHHHEECCCCCCEECCCEECCCCCCHHHHHCCCC------------------CCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 87650342133677623305400583103266751699------------------887452444247899998269999
Q ss_pred CCCCC
Q ss_conf 98988
Q 001678 1027 IDFFS 1031 (1033)
Q Consensus 1027 Fd~~s 1031 (1033)
|...+
T Consensus 210 ~~~~~ 214 (273)
T d1mp8a_ 210 FQGVK 214 (273)
T ss_dssp TTTCC
T ss_pred CCCCC
T ss_conf 88899
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=295.91 Aligned_cols=205 Identities=25% Similarity=0.329 Sum_probs=168.9
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC---CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCEEEEE
Q ss_conf 5888139999642483799999985---96259998303334899246899999999999999716---99980038899
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGI 871 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~k---GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL---~HPNIVkLlGv 871 (1033)
..++|+++++||+|+||+||+|++. ++.||||+++.......... .+.+|+.+++.| +||||++++++
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~------~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL------STIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBC------THHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHH------HHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 758979888992155869999999888998999999802324516799------99999999998742589880236632
Q ss_pred EECC---CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCE
Q ss_conf 9818---9995599984214770899997327765899999999999999999994994215799996798058999990
Q 001678 872 VRDG---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1033)
Q Consensus 872 f~e~---e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~ 948 (1033)
|... ....++++|||+.++.+..........+++..++.++.|++.||+|||+++||||||||+|||++ ..+.
T Consensus 79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~----~~~~ 154 (305)
T d1blxa_ 79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQ 154 (305)
T ss_dssp EEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCC
T ss_pred ECCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEC----CCCC
T ss_conf 214666667469999974058714444430378999899999999999999999758898357986278985----8997
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 99984488411345533477678886446410258876653023210000210357743440899999999990699998
Q 001678 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 949 VKLiDFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd 1028 (1033)
+||+|||+++............||+.|+|||++.+.. ++.++||||+||++|+|++|++||.
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~------------------y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 155 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS------------------YATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC------------------CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCC------------------CCHHEHHHCHHHHHHHHHHCCCCCC
T ss_conf 5421000101100234577765485114831001798------------------8811100032899999987879989
Q ss_pred CC
Q ss_conf 98
Q 001678 1029 FF 1030 (1033)
Q Consensus 1029 ~~ 1030 (1033)
..
T Consensus 217 ~~ 218 (305)
T d1blxa_ 217 GS 218 (305)
T ss_dssp CS
T ss_pred CC
T ss_conf 98
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-43 Score=297.08 Aligned_cols=206 Identities=28% Similarity=0.454 Sum_probs=171.8
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECC-------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCE
Q ss_conf 33358881399996424837999999859-------62599983033348992468999999999999997169998003
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (1033)
Q Consensus 795 ~~I~~~dYeiLkkLGkGsFGtVYkAk~kG-------tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVk 867 (1033)
.++..++|++++.||+|+||+||+|++++ +.||||+++... .......|.+|+.++++++||||++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 138988938867982078839999998887657788299999988210-------8579999999999999668997655
Q ss_pred EEEEEECCCCCCEEEEEEECCCCCHHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 889998189995599984214770899997327-----------------------765899999999999999999994
Q 001678 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------------------RTIDRRKRLIIAMDAAFGMEYLHG 924 (1033)
Q Consensus 868 LlGvf~e~e~g~l~LVmEYiegGSL~dlLkk~~-----------------------k~lse~~il~IA~QIlkALeYLHs 924 (1033)
+++++.. .+.++++|||+.+|+|.+++.... ..+++..++.|+.|++.||.|||+
T Consensus 81 ~~~~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 81 LLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp EEEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEECC--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC
T ss_conf 2466605--98038999815899299999852755421000011100121034678898999999999999998554135
Q ss_pred CCCCCCCCCCCCEEEECCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHH
Q ss_conf 9942157999967980589999909998448841134553---3477678886446410258876653023210000210
Q 001678 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCC 1001 (1033)
Q Consensus 925 kGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L 1001 (1033)
.++|||||||+|||++ .++.+||+|||+|+...... ......|++.|+|||++.+..
T Consensus 159 ~~ivHrDlKp~NILld----~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------- 218 (301)
T d1lufa_ 159 RKFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR---------------- 218 (301)
T ss_dssp TTCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC----------------
T ss_pred CCEEEEEECCCCEEEC----CCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCC----------------
T ss_conf 7868548840116898----99928983314421136776411157777676767989972688----------------
Q ss_pred CCCCCCCCHHHHHHHHHHHHCCC-CCCCCCC
Q ss_conf 35774344089999999999069-9998988
Q 001678 1002 FQLKWSYDCYSLGILFFFLQFIL-CFIDFFS 1031 (1033)
Q Consensus 1002 ~eittkvDIWSLGVILYeLLTGk-~PFd~~s 1031 (1033)
++.++|||||||++|+|+++. +||...+
T Consensus 219 --~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 219 --YTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp --CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred --CCHHHHHCCCHHHHHHHHCCCCCCCCCCC
T ss_conf --98056302523629999806899999989
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=292.38 Aligned_cols=199 Identities=22% Similarity=0.247 Sum_probs=163.7
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC--
Q ss_conf 88139999642483799999985--96259998303334899246899999999999999716999800388999818--
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG-- 875 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~-- 875 (1033)
.+|+.+++||+|+||+||+|++. ++.||||++..... .+.+|+.++++++|+||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH------------HHHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 776751698217683999999999997999999881606------------89999999986689898738789974476
Q ss_pred --CCCCEEEEEEECCCCCHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCC-CEEE
Q ss_conf --9995599984214770899997--3277658999999999999999999949942157999967980589999-9099
Q 001678 876 --PDGSLATVTEFMVNGSLKQFLQ--KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR-PVCK 950 (1033)
Q Consensus 876 --e~g~l~LVmEYiegGSL~dlLk--k~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~-g~VK 950 (1033)
...++++||||+.++.+..+.. .....+++..+..|+.||+.||+|||+++|+||||||+|||++ .+ ..+|
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~----~~~~~~k 163 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD----PDTAVLK 163 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTTCCEE
T ss_pred CCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE----CCCCCEE
T ss_conf 577318999984168860788886310368999999999999999999999866876457886037873----5897116
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 98448841134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 951 LiDFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+|||+++............|+..|+|||++.+.. .++.++||||+||++|+|++|++||...
T Consensus 164 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------------~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT-----------------DYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp ECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCS-----------------SCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred EECCCCHHHCCCCCCCCCCCCCCCCCCHHHHHCCC-----------------CCCCCEEECCCCEEEEEHHHCCCCCCCC
T ss_conf 73366054404776532002555556827764046-----------------8882100024652778550287998987
Q ss_pred C
Q ss_conf 8
Q 001678 1031 S 1031 (1033)
Q Consensus 1031 s 1031 (1033)
+
T Consensus 227 ~ 227 (350)
T d1q5ka_ 227 S 227 (350)
T ss_dssp S
T ss_pred C
T ss_conf 9
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=297.87 Aligned_cols=203 Identities=31% Similarity=0.509 Sum_probs=169.6
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEECC-CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 0233358881399996424837999999859-625999830333489924689999999999999971699980038899
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1033)
Q Consensus 793 ~~~~I~~~dYeiLkkLGkGsFGtVYkAk~kG-tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGv 871 (1033)
+.|.++.++|++.+.||+|+||.||+|++++ +.||||+++..... .+.|.+|+.++++++|+|||+++++
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 5607477997984699307980999999999999999998804488---------8999999999986666788689999
Q ss_pred EECCCCCCEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 9818999559998421477089999732-776589999999999999999999499421579999679805899999099
Q 001678 872 VRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 872 f~e~e~g~l~LVmEYiegGSL~dlLkk~-~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VK 950 (1033)
|.+ +.+++||||+++|+|..++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+|
T Consensus 81 ~~~---~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~----~~~~~k 153 (285)
T d1fmka3 81 VSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCK 153 (285)
T ss_dssp ECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEE
T ss_pred EEC---CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEEC----CCCCEE
T ss_conf 823---9759999944799435420000355305999999999999999987541143353123079998----999299
Q ss_pred EEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCC-C
Q ss_conf 98448841134553--34776788864464102588766530232100002103577434408999999999906999-9
Q 001678 951 IGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCF-I 1027 (1033)
Q Consensus 951 LiDFGLAk~~~~~~--~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~P-F 1027 (1033)
|+|||+|+...... ......||+.|+|||++.... ++.++|||||||++|+|+++..| |
T Consensus 154 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 154 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR------------------FTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp ECCCCTTC--------------CCGGGSCHHHHHHCC------------------CCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ECCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCC------------------CCCHHHHHCCHHHHHHHHHCCCCCC
T ss_conf 8442555425688733524545566545808983799------------------8917741323589999986899999
Q ss_pred CC
Q ss_conf 89
Q 001678 1028 DF 1029 (1033)
Q Consensus 1028 d~ 1029 (1033)
..
T Consensus 216 ~~ 217 (285)
T d1fmka3 216 PG 217 (285)
T ss_dssp TT
T ss_pred CC
T ss_conf 88
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=298.55 Aligned_cols=202 Identities=32% Similarity=0.525 Sum_probs=174.0
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 33358881399996424837999999859625999830333489924689999999999999971699980038899981
Q 001678 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1033)
Q Consensus 795 ~~I~~~dYeiLkkLGkGsFGtVYkAk~kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e 874 (1033)
|.+..++|++++.||+|+||.||+|+++++.||||+++.... .+.|.+|+.++++++||||++++|+|.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHHH----------HHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 955789948857982079808999999990999999885777----------9999999999986789898549878872
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEE
Q ss_conf 89995599984214770899997327-76589999999999999999999499421579999679805899999099984
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 875 ~e~g~l~LVmEYiegGSL~dlLkk~~-k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiD 953 (1033)
. .+.+++||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||+.+++||||||+|||++ .++.+||+|
T Consensus 72 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----~~~~~kl~d 146 (262)
T d1byga_ 72 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECC
T ss_pred C-CCCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEEC----CCCCEEECC
T ss_conf 3-89289999636999899998745788889999999999998523211337655366656760146----899776324
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf 488411345533477678886446410258876653023210000210357743440899999999990-699998988
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILCFIDFFS 1031 (1033)
Q Consensus 954 FGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT-Gk~PFd~~s 1031 (1033)
||+++...... ....++..|+|||++.+.. ++.++|||||||++|+|+| |++||...+
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~~~~------------------~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALREKK------------------FSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp CCC--------------CCTTTSCHHHHHHCC------------------CCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred CCCCEECCCCC--CCCCCCCCCCCHHHHHCCC------------------CCHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 56003447877--6556664677817872798------------------88588777579999999978999999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=295.41 Aligned_cols=208 Identities=27% Similarity=0.418 Sum_probs=167.8
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEECC-------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCC
Q ss_conf 233358881399996424837999999859-------6259998303334899246899999999999999716-99980
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1033)
Q Consensus 794 ~~~I~~~dYeiLkkLGkGsFGtVYkAk~kG-------tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL-~HPNI 865 (1033)
.+.+..++|++.++||+|+||.||+|.+.+ +.||||+++.... ....+.+.+|..++.++ +|+||
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~~e~~~l~~~~~h~~i 79 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNV 79 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-------HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCC-------CHHHHHHHHHHHHHHHHCCCCEE
T ss_conf 52616799798449841678399999986777555783999999860017-------17899999999998861499849
Q ss_pred CEEEEEEECCCCCCEEEEEEECCCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 03889998189995599984214770899997327---------------765899999999999999999994994215
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1033)
Q Consensus 866 VkLlGvf~e~e~g~l~LVmEYiegGSL~dlLkk~~---------------k~lse~~il~IA~QIlkALeYLHskGIIHR 930 (1033)
+.+++++... ...+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++||||
T Consensus 80 v~~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr 158 (299)
T d1ywna1 80 VNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158 (299)
T ss_dssp CCEEEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEECCC-CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 9741154047-975799998458992999998536666653222023321468999999999999999998873797178
Q ss_pred CCCCCCEEEECCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCC
Q ss_conf 7999967980589999909998448841134553---3477678886446410258876653023210000210357743
Q 001678 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWS 1007 (1033)
Q Consensus 931 DIKPsNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittk 1007 (1033)
||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+.. ++.+
T Consensus 159 DlKp~NILl~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~------------------~~~~ 216 (299)
T d1ywna1 159 DLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV------------------YTIQ 216 (299)
T ss_dssp CCCGGGEEEC----GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC------------------CCHH
T ss_pred CCCCCCEEEC----CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCC------------------CCCC
T ss_conf 6773106577----99828984575200113566522247516672102036864688------------------9966
Q ss_pred CCHHHHHHHHHHHHCC-CCCCCCCC
Q ss_conf 4408999999999906-99998988
Q 001678 1008 YDCYSLGILFFFLQFI-LCFIDFFS 1031 (1033)
Q Consensus 1008 vDIWSLGVILYeLLTG-k~PFd~~s 1031 (1033)
+|||||||++|+|+++ .+||....
T Consensus 217 sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 217 SDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCEEEHHHHHHHHHHCCCCCCCCCC
T ss_conf 3221367899999868899998999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=296.90 Aligned_cols=206 Identities=29% Similarity=0.445 Sum_probs=172.5
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECC-----CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 3358881399996424837999999859-----62599983033348992468999999999999997169998003889
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 796 ~I~~~dYeiLkkLGkGsFGtVYkAk~kG-----tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlG 870 (1033)
.+..++|++++.||+|+||.||+|++.. ..||||+++...... ....+.|.+|+.++++++||||++++|
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----PEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCC-----HHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 886489199789803888399999998899907999999998355579-----899999999999998689999878987
Q ss_pred EEECCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 99818999559998421477089999732776589999999999999999999499421579999679805899999099
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 vf~e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VK 950 (1033)
++.+ ..+++||||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 79 ~~~~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~----~~~~vk 151 (273)
T d1u46a_ 79 VVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVK 151 (273)
T ss_dssp EECS---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEEE---CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCC----CCCCEE
T ss_conf 7740---100114654238612544421268999999999999999999875217875205668881565----565433
Q ss_pred EEECCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHC-CCC
Q ss_conf 98448841134553----3477678886446410258876653023210000210357743440899999999990-699
Q 001678 951 IGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQF-ILC 1025 (1033)
Q Consensus 951 LiDFGLAk~~~~~~----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLT-Gk~ 1025 (1033)
|+|||+++...... ......|+..|+|||++.+.. ++.++|||||||++|+|+| |+.
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------------------~~~~~Di~S~Gvil~emlt~G~~ 213 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT------------------FSHASDTWMFGVTLWEMFTYGQE 213 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE------------------EEHHHHHHHHHHHHHHHHTTSCC
T ss_pred ECCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCC------------------CCCCHHHHHHHHHHHHHHHCCCC
T ss_conf 256115553035887526547632573107999983799------------------99421566148999999968999
Q ss_pred CCCCCC
Q ss_conf 998988
Q 001678 1026 FIDFFS 1031 (1033)
Q Consensus 1026 PFd~~s 1031 (1033)
||.-.+
T Consensus 214 Pf~~~~ 219 (273)
T d1u46a_ 214 PWIGLN 219 (273)
T ss_dssp TTTTCC
T ss_pred CCCCCC
T ss_conf 999969
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=297.45 Aligned_cols=205 Identities=21% Similarity=0.242 Sum_probs=168.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169--9980038899981
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFYGIVRD 874 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~--HPNIVkLlGvf~e 874 (1033)
.++|++.+.||+|+||.||+|++. ++.||||++............ ...++.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~--~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP--NGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT--TCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 88379967984087839999999999979999998568844334556--7999999999999743589881279999830
Q ss_pred CCCCCEEEEEEECCC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEE
Q ss_conf 899955999842147-7089999732776589999999999999999999499421579999679805899999099984
Q 001678 875 GPDGSLATVTEFMVN-GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 875 ~e~g~l~LVmEYieg-GSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiD 953 (1033)
.+.+++||||+.+ +++.+++.+.. .+++..++.++.||+.||.|||+.+|+||||||+|||++. ..+.+||+|
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~---~~~~vkl~D 154 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL---NRGELKLID 154 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEECC
T ss_pred --CCEEEEEEEECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC---CCCEEEECC
T ss_conf --9968999983368622899986158-9999999999999999999998779755667611147744---788489775
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 4884113455334776788864464102588766530232100002103577434408999999999906999989
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 954 FGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~ 1029 (1033)
||+|+...... .....||+.|+|||++.+.. .++.++||||+||++|+|++|+.||..
T Consensus 155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~-----------------~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR-----------------YHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CTTCEECCSSC-BCCCCSCGGGSCHHHHHHSC-----------------BCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCCCEECCCCC-CCCCCCCCCCCCHHHHCCCC-----------------CCCCCCCCCCCEEEEHHHHHCCCCCCC
T ss_conf 46535324445-56656587747999984899-----------------788653325540345367568899887
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=293.03 Aligned_cols=204 Identities=30% Similarity=0.436 Sum_probs=170.6
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECC--C--CEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCCEEEE
Q ss_conf 3358881399996424837999999859--6--259998303334899246899999999999999716-9998003889
Q 001678 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG--S--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYG 870 (1033)
Q Consensus 796 ~I~~~dYeiLkkLGkGsFGtVYkAk~kG--t--kVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL-~HPNIVkLlG 870 (1033)
.++.++|++.++||+|+||.||+|.+++ . .||||+++..... ...+.|.+|+.++.++ +||||+++++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-------DDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred CCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCH-------HHHHHHHHHHHHHHHCCCCCCEEEEEE
T ss_conf 6687996887798207882899999989996999999997823385-------799999999999986228998836788
Q ss_pred EEECCCCCCEEEEEEECCCCCHHHHHHHC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99818999559998421477089999732---------------776589999999999999999999499421579999
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (1033)
Q Consensus 871 vf~e~e~g~l~LVmEYiegGSL~dlLkk~---------------~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPs 935 (1033)
++.+ .+.+++||||+++|+|.++|.+. ...+++..+..++.||+.||.|||+.+++||||||+
T Consensus 79 ~~~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~ 156 (309)
T d1fvra_ 79 ACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156 (309)
T ss_dssp EEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEC--CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 8841--87369999802898699998640355555123101234578999999999999999987663089545550520
Q ss_pred CEEEECCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHH
Q ss_conf 67980589999909998448841134553347767888644641025887665302321000021035774344089999
Q 001678 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGI 1015 (1033)
Q Consensus 936 NILLd~~~~~~g~VKLiDFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGV 1015 (1033)
|||++ .++.+||+|||+|+............||..|+|||.+.+.. ++.++|||||||
T Consensus 157 NIL~~----~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~------------------~~~~sDvwSfGv 214 (309)
T d1fvra_ 157 NILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV------------------YTTNSDVWSYGV 214 (309)
T ss_dssp GEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE------------------ECHHHHHHHHHH
T ss_pred EEEEC----CCCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCC------------------CCCCCEEEHHHH
T ss_conf 48986----88763874344322444223455301377555538752699------------------996221531388
Q ss_pred HHHHHHCCC-CCCCCC
Q ss_conf 999999069-999898
Q 001678 1016 LFFFLQFIL-CFIDFF 1030 (1033)
Q Consensus 1016 ILYeLLTGk-~PFd~~ 1030 (1033)
++|+|++|. +||...
T Consensus 215 il~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 215 LLWEIVSLGGTPYCGM 230 (309)
T ss_dssp HHHHHHTTSCCTTTTC
T ss_pred HHHHHHHCCCCCCCCC
T ss_conf 9999983689999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-42 Score=289.44 Aligned_cols=201 Identities=24% Similarity=0.347 Sum_probs=168.9
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 88139999642483799999985-96259998303334899246899999999999999716999800388999818999
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~k-GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e~g 878 (1033)
++|+++++||+|+||+||+|+++ ++.||||+++...... ...+.+.+|+.++++++||||+++++++.. .+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHT--KK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SS
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCH------HHHHHHHHHHHHHHHCCCCCEEEEEEECCC--CC
T ss_conf 9963431872277818999996899999999981232685------899999999999986799868766012046--77
Q ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCCCC
Q ss_conf 55999842147708999973277658999999999999999999949942157999967980589999909998448841
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1033)
Q Consensus 879 ~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLAk 958 (1033)
.++++||++.++.+..+. .....+++..+..|+.||+.||+|||+.+||||||||+|||++ .++.+||+|||+|.
T Consensus 74 ~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~----~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred CEEEEEEEEHHHHHHHHH-HHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEEC----CCCCEEECCCCCCE
T ss_conf 315899740045678998-6047751445689999999999986057488267877505686----89978732366430
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 134553-347767888644641025887665302321000021035774344089999999999069999898
Q 001678 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 959 ~~~~~~-~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
...... ......|++.|+|||++.+.. .++.++|+||+||++|+|++|+.||...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-----------------~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSK-----------------KYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTTCC-----------------SCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ECCCCCCCCCEECCCCHHHHHHHHHCCC-----------------CCCCCEEEHHCCCHHHHHHHCCCCCCCC
T ss_conf 1146765410102431101378871788-----------------8884100211175899997797998988
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=286.98 Aligned_cols=202 Identities=22% Similarity=0.269 Sum_probs=166.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 88813999964248379999998--5962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
..+|+++++||+|+||+||+|.+ +++.||||++.... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-------CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 898599789940648099999999999499999980310-------9589999999999999768989885888995056
Q ss_pred C--CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEEC
Q ss_conf 9--95599984214770899997327765899999999999999999994994215799996798058999990999844
Q 001678 877 D--GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 877 ~--g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDF 954 (1033)
. ...+++++|+.+|+|.+++... .+++..++.++.|++.||+|||+++||||||||+|||++ ..+.+||+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~----~~~~~kl~Df 153 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICDF 153 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCC
T ss_pred CCCCCEEEEEEEECCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEEECCC
T ss_conf 4554149999962598656644058--999999999999999999999978986777876437887----9997787545
Q ss_pred CCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8841134553----347767888644641025887665302321000021035774344089999999999069999898
Q 001678 955 GLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 955 GLAk~~~~~~----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+|+...... .....+|++.|+|||++.... .++.++|+||+||++|+|++|+.||...
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------------~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK-----------------GYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC-----------------SCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCC-----------------CCCCHHHHHCCCCEEHHHHHCCCCCCCC
T ss_conf 70565047776410101102652000387860478-----------------8874101004670133776697997888
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=291.44 Aligned_cols=203 Identities=28% Similarity=0.429 Sum_probs=164.0
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC--
Q ss_conf 881399996424837999999859625999830333489924689999999999999971699980038899981899--
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD-- 877 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e~-- 877 (1033)
.+|.+.+.||+|+||.||+|+++++.||||+++... . . ...+..|+..+.+++||||+++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~------~-~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------E-R--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG------H-H--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC------H-H--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf 689998898207881999999999899999987200------4-6--799999999996279986832688998379860
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEEECCCCCCCEE
Q ss_conf 95599984214770899997327765899999999999999999994--------9942157999967980589999909
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG--------KNIVHFDLKCENLLVNMRDPQRPVC 949 (1033)
Q Consensus 878 g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHs--------kGIIHRDIKPsNILLd~~~~~~g~V 949 (1033)
..+++||||+++|+|.+++++. .+++..++.++.|++.||.|||. ++||||||||+|||++ .++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~----~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC----TTSCE
T ss_pred EEEEEEEECCCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEEC----CCCCE
T ss_conf 4899999646698989998658--99989999999999999999887665204689866153173135786----88776
Q ss_pred EEEECCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 998448841134553-----347767888644641025887665302321000021035774344089999999999069
Q 001678 950 KIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFIL 1024 (1033)
Q Consensus 950 KLiDFGLAk~~~~~~-----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk 1024 (1033)
||+|||+++...... ......||+.|+|||++.+...... ..++.++|||||||++|+|+||.
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------------~~~~~k~Di~S~Gvvl~el~tg~ 215 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH------------FESFKRADIYAMGLVFWEIARRC 215 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTC------------HHHHHHHHHHHHHHHHHHHHHTB
T ss_pred EEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCC------------CCCCCCHHHHHHHHHHHHHHHCC
T ss_conf 887638662346777620013552503547678221056545467------------77675012201599999996289
Q ss_pred CCCCC
Q ss_conf 99989
Q 001678 1025 CFIDF 1029 (1033)
Q Consensus 1025 ~PFd~ 1029 (1033)
.||..
T Consensus 216 ~~~~~ 220 (303)
T d1vjya_ 216 SIGGI 220 (303)
T ss_dssp CBTTB
T ss_pred CCCCC
T ss_conf 98876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=289.81 Aligned_cols=207 Identities=28% Similarity=0.443 Sum_probs=172.8
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEECC---------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCC
Q ss_conf 233358881399996424837999999859---------6259998303334899246899999999999999716-999
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHP 863 (1033)
Q Consensus 794 ~~~I~~~dYeiLkkLGkGsFGtVYkAk~kG---------tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL-~HP 863 (1033)
.+.+..++|++.+.||+|+||.||+|+..+ ..||||+++... .......+.+|...+.++ +||
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred CCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHHCCCC
T ss_conf 672258996970098516782899999857875556675499999988112-------8688999999999999813999
Q ss_pred CCCEEEEEEECCCCCCEEEEEEECCCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 8003889998189995599984214770899997327---------------7658999999999999999999949942
Q 001678 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIV 928 (1033)
Q Consensus 864 NIVkLlGvf~e~e~g~l~LVmEYiegGSL~dlLkk~~---------------k~lse~~il~IA~QIlkALeYLHskGII 928 (1033)
||++++++|.+ ++.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+||
T Consensus 80 nIv~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~iv 157 (299)
T d1fgka_ 80 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 157 (299)
T ss_dssp TBCCEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEECCCCCCC--CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 69734652201--8868999973699909999986067764322233457434679999999999999999876637978
Q ss_pred CCCCCCCCEEEECCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCC
Q ss_conf 157999967980589999909998448841134553---34776788864464102588766530232100002103577
Q 001678 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK 1005 (1033)
Q Consensus 929 HRDIKPsNILLd~~~~~~g~VKLiDFGLAk~~~~~~---~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eit 1005 (1033)
||||||+|||++ .++.+||+|||+++...... ......|++.|+|||++.+.. ++
T Consensus 158 HrDiKp~NiLl~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~------------------y~ 215 (299)
T d1fgka_ 158 HRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI------------------YT 215 (299)
T ss_dssp CSCCSGGGEEEC----TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC------------------CC
T ss_pred EEEECCCCEEEC----CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCC------------------CC
T ss_conf 630221022454----78976762211101135555543146678884663266751798------------------88
Q ss_pred CCCCHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf 43440899999999990-699998988
Q 001678 1006 WSYDCYSLGILFFFLQF-ILCFIDFFS 1031 (1033)
Q Consensus 1006 tkvDIWSLGVILYeLLT-Gk~PFd~~s 1031 (1033)
.++|||||||++|+|++ |.+||...+
T Consensus 216 ~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 216 HQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 255547758888874017989899999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-42 Score=287.50 Aligned_cols=207 Identities=28% Similarity=0.401 Sum_probs=172.4
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEEC-------CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCC
Q ss_conf 23335888139999642483799999985-------96259998303334899246899999999999999716-99980
Q 001678 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1033)
Q Consensus 794 ~~~I~~~dYeiLkkLGkGsFGtVYkAk~k-------GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL-~HPNI 865 (1033)
.|.+..++|++.+.||+|+||.||+|++. ++.||||+++.... ......|.+|+.+++++ +||||
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCCE
T ss_conf 26377899698549820688299999980664477886999999874248-------77999999999998762699988
Q ss_pred CEEEEEEECCCCCCEEEEEEECCCCCHHHHHHHCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 03889998189995599984214770899997327-----------------7658999999999999999999949942
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------------RTIDRRKRLIIAMDAAFGMEYLHGKNIV 928 (1033)
Q Consensus 866 VkLlGvf~e~e~g~l~LVmEYiegGSL~dlLkk~~-----------------k~lse~~il~IA~QIlkALeYLHskGII 928 (1033)
+++++++.+ ...+++||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||+.++|
T Consensus 90 v~~~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~iv 167 (311)
T d1t46a_ 90 VNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (311)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEEEEE--CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 789989831--997899997379987999998535665444445332223345889999999999999999988757926
Q ss_pred CCCCCCCCEEEECCCCCCCEEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCC
Q ss_conf 15799996798058999990999844884113455---334776788864464102588766530232100002103577
Q 001678 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLK 1005 (1033)
Q Consensus 929 HRDIKPsNILLd~~~~~~g~VKLiDFGLAk~~~~~---~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eit 1005 (1033)
||||||+|||++ ..+.+||+|||+++..... .......||+.|+|||++.+. .++
T Consensus 168 HrDLKp~NIl~~----~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------~~~ 225 (311)
T d1t46a_ 168 HRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC------------------VYT 225 (311)
T ss_dssp CSCCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC------------------CCC
T ss_pred ECCCCCCCCCCC----CCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCC------------------CCC
T ss_conf 662410210000----2575210234010233678861586201359687677886179------------------999
Q ss_pred CCCCHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf 43440899999999990-699998988
Q 001678 1006 WSYDCYSLGILFFFLQF-ILCFIDFFS 1031 (1033)
Q Consensus 1006 tkvDIWSLGVILYeLLT-Gk~PFd~~s 1031 (1033)
.++|||||||++|+|+| |.+||...+
T Consensus 226 ~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 226 FESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 740010258999999858998877899
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=287.89 Aligned_cols=200 Identities=24% Similarity=0.336 Sum_probs=169.3
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|+++++||+|+||+||+|.++ ++.||||+++.... .....+.+.+|+.+|+.++||||++++++|....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 7718998898017781999999999998999999852225------9699999999999998668987547999863576
Q ss_pred ----CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEE
Q ss_conf ----9955999842147708999973277658999999999999999999949942157999967980589999909998
Q 001678 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 877 ----~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLi 952 (1033)
...+++||||+ +.+|..+++.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~----~~~~~kl~ 163 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKIL 163 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred CCCCCCEEEEEEECC-CCCHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCC----CCCCCCCC
T ss_conf 555541599998405-52189998740--226999999999999999998737876456685111121----00122113
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 448841134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|||+|+...... ....||+.|+|||++.+.. .++.++||||+||++|+|++|++||...
T Consensus 164 Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~-----------------~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 164 DFGLARQADSEM--TGYVVTRWYRAPEVILNWM-----------------RYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CCTTCEECCSSC--CSSCSCGGGCCTHHHHTTT-----------------CCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCEECCCCCC--CCCCCCCCCCCHHHHCCCC-----------------CCCCCCHHHCCHHHHHHHHHCCCCCCCC
T ss_conf 431022068763--1024553335889981787-----------------8996501030038999999786998889
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.6e-42 Score=289.01 Aligned_cols=198 Identities=24% Similarity=0.317 Sum_probs=168.9
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEC
Q ss_conf 5888139999642483799999985--962599983033348992468999999999999997169-9980038899981
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~-HPNIVkLlGvf~e 874 (1033)
..++|+++++||+|+||+||+|++. ++.||||+++... .+++.+|+.+|+.+. ||||++++++|..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 9867189789831748199999988999799999988899-----------99999999999851579987679999981
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEEC
Q ss_conf 89995599984214770899997327765899999999999999999994994215799996798058999990999844
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1033)
Q Consensus 875 ~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDF 954 (1033)
.....+++||||+.+++|..+. +.+++..+..++.||+.||.|||+++|+||||||+|||++. .+..+||+||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~---~~~~vkl~DF 174 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHRKLRLIDW 174 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEEECCG
T ss_pred CCCCCEEEEEEECCCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEECCC
T ss_conf 6877126888631798589974----68999999999999999998876433443456441237748---9983664156
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8841134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 955 GLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|+|+............+|..|+|||++.+.. .++.++|+||+||++|+|++|+.||...
T Consensus 175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----------------~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-----------------MYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp GGCEECCTTCCCCSCCSCGGGCCHHHHTTCC-----------------CCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCCC-----------------CCCCCCCHHHHHHHHHHHCCCCCCCCCC
T ss_conf 5426646887444322486424761026888-----------------8884523233545558760488999887
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=288.61 Aligned_cols=208 Identities=27% Similarity=0.416 Sum_probs=172.5
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEEC-------CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 023335888139999642483799999985-------9625999830333489924689999999999999971699980
Q 001678 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865 (1033)
Q Consensus 793 ~~~~I~~~dYeiLkkLGkGsFGtVYkAk~k-------GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNI 865 (1033)
+.|.+..++|++.+.||+|+||+||+|.++ ++.||||+++... .......|.+|+.++++++||||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCE
T ss_conf 10042689918835982078818999998786447789689999987012-------86899999999999997699988
Q ss_pred CEEEEEEECCCCCCEEEEEEECCCCCHHHHHHHCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 03889998189995599984214770899997327---------765899999999999999999994994215799996
Q 001678 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (1033)
Q Consensus 866 VkLlGvf~e~e~g~l~LVmEYiegGSL~dlLkk~~---------k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsN 936 (1033)
+++++++.. ....++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|
T Consensus 86 v~~~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 86 VRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred EEEEEEEEC--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCC
T ss_conf 412547842--881067776048998899987503321134446887999999999999999998764796543286775
Q ss_pred EEEECCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHH
Q ss_conf 7980589999909998448841134553---3477678886446410258876653023210000210357743440899
Q 001678 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSL 1013 (1033)
Q Consensus 937 ILLd~~~~~~g~VKLiDFGLAk~~~~~~---~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSL 1013 (1033)
||++ .++.+||+|||+|+...... ......|++.|+|||.+.+.. ++.++|+|||
T Consensus 164 iLld----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~------------------~~~~~Dv~S~ 221 (308)
T d1p4oa_ 164 CMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV------------------FTTYSDVWSF 221 (308)
T ss_dssp EEEC----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC------------------CCHHHHHHHH
T ss_pred EEEC----CCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCC------------------CCCCCCCCCH
T ss_conf 4035----99649994245420235776303134023163237888873699------------------8833344437
Q ss_pred HHHHHHHHCC-CCCCCCCC
Q ss_conf 9999999906-99998988
Q 001678 1014 GILFFFLQFI-LCFIDFFS 1031 (1033)
Q Consensus 1014 GVILYeLLTG-k~PFd~~s 1031 (1033)
|+++|+|+|+ .+||...+
T Consensus 222 G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 222 GVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp HHHHHHHHHTSCCTTTTSC
T ss_pred HHHHHHHHHCCCCCCCCCC
T ss_conf 8999999968999999989
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=283.97 Aligned_cols=197 Identities=25% Similarity=0.437 Sum_probs=164.1
Q ss_pred EEEEEECCCCCEEEEEEEECC-----CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 399996424837999999859-----625999830333489924689999999999999971699980038899981899
Q 001678 803 EEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 803 eiLkkLGkGsFGtVYkAk~kG-----tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e~ 877 (1033)
.+.++||+|+||+||+|.+.. ..||||+++... .....++|++|+.++++++||||++++|++... +
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~ 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-E 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-T
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-C
T ss_conf 26669813688099999997799879999999988436-------978999999999999867899986786789806-9
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCCC
Q ss_conf 95599984214770899997327765899999999999999999994994215799996798058999990999844884
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLA 957 (1033)
+.+++||||+++|+|.+++........+..++.++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSSGGG
T ss_pred CCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEEC----CCCCEEEECCCCH
T ss_conf 943899987406741442101345404899999999988765200336762577668757677----9998899106523
Q ss_pred CCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 1134553-----34776788864464102588766530232100002103577434408999999999906999989
Q 001678 958 KVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDF 1029 (1033)
Q Consensus 958 k~~~~~~-----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~ 1029 (1033)
+...... ......||..|+|||++... .++.++||||||+++|+|+++..||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ------------------KFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC------------------CCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred HHCCCCCCCCCEECCCCCCCCCCCCHHHHHCC------------------CCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 22556655531002565556455676887437------------------999745746619999999978999988
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=283.34 Aligned_cols=203 Identities=24% Similarity=0.315 Sum_probs=166.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 888139999642483799999985--962599983033348992468999999999999997169998003889998189
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e 876 (1033)
.++|+++++||+|+||+||+|+++ ++.||||++........ ...++.+|+.++++++|+||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHH------HHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 2798899997227482999999989997999999842224637------8999999999999835999660676540246
Q ss_pred ------CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf ------99559998421477089999732776589999999999999999999499421579999679805899999099
Q 001678 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 877 ------~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VK 950 (1033)
.+.+++||||+.++.+. .+......+++..++.|+.|++.||.|||+.+|+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----~~~~~k 157 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLK 157 (318)
T ss_dssp --------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEE
T ss_pred CCCCCCCCEEEEEEECCCCCCCC-HHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEEC----CCCCEE
T ss_conf 54444576389998535787410-1222034433089999999999999885229988567672220366----899687
Q ss_pred EEECCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 98448841134553-----3477678886446410258876653023210000210357743440899999999990699
Q 001678 951 IGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 951 LiDFGLAk~~~~~~-----~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~ 1025 (1033)
|+|||+++...... .....+||+.|+|||++.+.. .++.++||||+||++|+|++|++
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-----------------~~~~k~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-----------------DYGPPIDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS-----------------SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCC-----------------CCCCHHHCCCCCCEEEEHHHCCC
T ss_conf 6313500223554443211356602497874289970799-----------------98917870067864661744879
Q ss_pred CCCC
Q ss_conf 9989
Q 001678 1026 FIDF 1029 (1033)
Q Consensus 1026 PFd~ 1029 (1033)
||+-
T Consensus 221 pf~~ 224 (318)
T d3blha1 221 IMQG 224 (318)
T ss_dssp SCCC
T ss_pred CCCC
T ss_conf 9899
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-41 Score=281.58 Aligned_cols=201 Identities=21% Similarity=0.273 Sum_probs=164.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE-EECC
Q ss_conf 888139999642483799999985--9625999830333489924689999999999999971699980038899-9818
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI-VRDG 875 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGv-f~e~ 875 (1033)
.++|++.+.||+|+||.||+|++. ++.||||++...... ..+..|+.+++.++|++++..+.. +.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~- 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE- 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----------HHHHHHHHHHHHCCCCCCCCEEEEEEEC-
T ss_conf 88899968985078809999999889989999997210058----------8899999999970389960179999951-
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECC
Q ss_conf 99955999842147708999973277658999999999999999999949942157999967980589999909998448
Q 001678 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1033)
Q Consensus 876 e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFG 955 (1033)
....++||||+ +++|.+.+......+++..++.++.|++.||+|||+++||||||||+|||++..+ .+..+||+|||
T Consensus 75 -~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~-~~~~vkl~DFG 151 (299)
T d1ckia_ 75 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 151 (299)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCS
T ss_pred -CCEEEEEEEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCC-CCCEEEEECCC
T ss_conf -98778999873-8713332443068876899999999999999999979944266787660643357-77615650467
Q ss_pred CCCCCCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 841134553--------347767888644641025887665302321000021035774344089999999999069999
Q 001678 956 LSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 956 LAk~~~~~~--------~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PF 1027 (1033)
+|+...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwSlG~~l~el~tg~~P~ 213 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE------------------QSRRDDLESLGYVLMYFNLGSLPW 213 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC------------------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCC------------------CCCHHHEEECCHHHHHHHHCCCCC
T ss_conf 51342554455410001357767873532999991899------------------898321886177899998498766
Q ss_pred CCCC
Q ss_conf 8988
Q 001678 1028 DFFS 1031 (1033)
Q Consensus 1028 d~~s 1031 (1033)
...+
T Consensus 214 ~~~~ 217 (299)
T d1ckia_ 214 QGLK 217 (299)
T ss_dssp CCCC
T ss_pred CCCC
T ss_conf 5530
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.1e-41 Score=279.90 Aligned_cols=203 Identities=18% Similarity=0.224 Sum_probs=169.8
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEC
Q ss_conf 5888139999642483799999985--9625999830333489924689999999999999971699-980038899981
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYGIVRD 874 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~H-PNIVkLlGvf~e 874 (1033)
..++|+++++||+|+||+||+|++. ++.||||++...... ..+.+|+.+++.+.| ++|+.+++++.+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----------HHHHHHHHHHHHHCCCCCCCEEEEEEEC
T ss_conf 898069979984178829999999889979999997502582----------9999999999996489998779999601
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC-CCCCEEEEEE
Q ss_conf 899955999842147708999973277658999999999999999999949942157999967980589-9999099984
Q 001678 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGD 953 (1033)
Q Consensus 875 ~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~-~~~g~VKLiD 953 (1033)
....++||||+ +++|.+++......++...++.++.|++.||.|||+++||||||||+|||++... ...+.+||+|
T Consensus 73 --~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 73 --GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred --CCCCEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECC
T ss_conf --88117999964-888799997520311068999999999999999997796626677131523475434479568723
Q ss_pred CCCCCCCCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 48841134553--------3477678886446410258876653023210000210357743440899999999990699
Q 001678 954 LGLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILC 1025 (1033)
Q Consensus 954 FGLAk~~~~~~--------~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~ 1025 (1033)
||+|+...... ......||+.|+|||++.+.. ++.++|+|||||++|+|++|+.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~------------------~~~~~DiwSlG~~l~elltg~~ 211 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE------------------QSRRDDLEALGHVFMYFLRGSL 211 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC------------------CCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCC------------------CCHHHHHHHHHHHHHHHHHCCC
T ss_conf 6605771467665411102467627751026798964888------------------8869998983199999986987
Q ss_pred CCCCCC
Q ss_conf 998988
Q 001678 1026 FIDFFS 1031 (1033)
Q Consensus 1026 PFd~~s 1031 (1033)
||....
T Consensus 212 Pf~~~~ 217 (293)
T d1csna_ 212 PWQGLK 217 (293)
T ss_dssp TTSSCC
T ss_pred CCCCCC
T ss_conf 678853
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=286.72 Aligned_cols=208 Identities=23% Similarity=0.347 Sum_probs=171.8
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE-----CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCCCEEEE
Q ss_conf 3588813999964248379999998-----59625999830333489924689999999999999971699-98003889
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYG 870 (1033)
Q Consensus 797 I~~~dYeiLkkLGkGsFGtVYkAk~-----kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~H-PNIVkLlG 870 (1033)
+..++|++++.||+|+||+||+|+. +++.||||+++......+... ...+.+|+.++++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~----~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT----TEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESS----GGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHH----HHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 451025999898328783999999876588794899999836772101689----9999999999986467983999620
Q ss_pred EEECCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 99818999559998421477089999732776589999999999999999999499421579999679805899999099
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 vf~e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VK 950 (1033)
++.+ ...++++|||+.+|+|.+++..... +.+.....++.|++.||.|||+.+|+||||||+|||++ .++.+|
T Consensus 97 ~~~~--~~~~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~vk 169 (322)
T d1vzoa_ 97 AFQT--ETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVV 169 (322)
T ss_dssp EEEE--TTEEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEE
T ss_pred EECC--CCCEEEEEECCCCCHHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEEC----CCCCEE
T ss_conf 0024--8730012312341179999873045-43788888899999999885149989654773201246----999888
Q ss_pred EEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 9844884113455--33477678886446410258876653023210000210357743440899999999990699998
Q 001678 951 IGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFID 1028 (1033)
Q Consensus 951 LiDFGLAk~~~~~--~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd 1028 (1033)
|+|||+++..... .......|++.|+|||.+.+.... ++.++||||+||+||+|++|+.||.
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~----------------~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG----------------HDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC-------------------CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EEECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCC----------------CCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 741320222034444322122233333106876057768----------------8713251777799999976899988
Q ss_pred CCC
Q ss_conf 988
Q 001678 1029 FFS 1031 (1033)
Q Consensus 1029 ~~s 1031 (1033)
..+
T Consensus 234 ~~~ 236 (322)
T d1vzoa_ 234 VDG 236 (322)
T ss_dssp CTT
T ss_pred CCC
T ss_conf 887
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-41 Score=279.71 Aligned_cols=200 Identities=23% Similarity=0.292 Sum_probs=169.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC-
Q ss_conf 888139999642483799999985--96259998303334899246899999999999999716999800388999818-
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~- 875 (1033)
.++|+++++||+|+||+||+|.++ ++.||||++...... .....++.+|+.+++.++||||++++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 37759988962175859999999999989999998823369------799999999999998648987648998970256
Q ss_pred ---CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEE
Q ss_conf ---99955999842147708999973277658999999999999999999949942157999967980589999909998
Q 001678 876 ---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1033)
Q Consensus 876 ---e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLi 952 (1033)
....+|+||||+.+ ++.+.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++ .++.+|++
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~----~~~~~kl~ 161 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 161 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEEC
T ss_pred CCCCCCEEEEEEECCCH-HHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----CCCCEEEE
T ss_conf 43457626999841446-7787650---3899999999999999999886522112456776321136----54431320
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 448841134553347767888644641025887665302321000021035774344089999999999069999898
Q 001678 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFF 1030 (1033)
Q Consensus 953 DFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~ 1030 (1033)
|||+++............+|+.|+|||++.+.. ++.++||||+||++|+|++|++||...
T Consensus 162 df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~------------------~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG------------------YKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp CCCC---------------CCTTCCHHHHTTCC------------------CCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCC------------------CCCCCCCCCCCCHHHHHHHCCCCCCCC
T ss_conf 102321146665533221465555813314777------------------787743335662578986598998889
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=281.68 Aligned_cols=202 Identities=22% Similarity=0.309 Sum_probs=167.9
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC-
Q ss_conf 88813999964248379999998--596259998303334899246899999999999999716999800388999818-
Q 001678 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1033)
Q Consensus 799 ~~dYeiLkkLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~- 875 (1033)
.++|+++++||+|+||+||+|++ +++.||||++..... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9871888898317883999999999997999999882002------8689999999999998668987425999996346
Q ss_pred --CCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEE
Q ss_conf --999559998421477089999732776589999999999999999999499421579999679805899999099984
Q 001678 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1033)
Q Consensus 876 --e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiD 953 (1033)
+....+++|+|+.+|+|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|++|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~----~~~~~kl~d 164 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILD 164 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECC
T ss_pred CCCCCCEEEEEEEECCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----CCCCCCCCC
T ss_conf 45668649999962588623200224--530999999999999999999738876516677633455----432200132
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 488411345533477678886446410258876653023210000210357743440899999999990699998988
Q 001678 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFIDFFS 1031 (1033)
Q Consensus 954 FGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PFd~~s 1031 (1033)
||++....... ....|++.|+|||++.+.. .++.++|+||+||++|+|++|++||...+
T Consensus 165 fg~a~~~~~~~--~~~~g~~~y~apE~~~~~~-----------------~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 165 FGLARHTDDEM--TGYVATRWYRAPEIMLNWM-----------------HYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp C----CCTGGG--SSSCHHHHTSCHHHHTTCS-----------------CCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCHHCCCCCCC--CCCCCCCCCCCCHHHCCCC-----------------CCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 10001257544--4434543555835533775-----------------67855124320589999976889978898
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=276.21 Aligned_cols=198 Identities=27% Similarity=0.358 Sum_probs=167.7
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 88139999642483799999985--9625999830333489924689999999999999971699980038899981899
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIVkLlGvf~e~e~ 877 (1033)
++|+++++||+|+||+||+|++. ++.||||+++...... .....+.+|+.+++.++|+||+++++++.+ .
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 73 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLHDVLHS--D 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST------THHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCH------HHHHHHHHHHHHHHHCCCCCEEEECCCCCC--C
T ss_conf 99786269712868199999999999699999980321786------899999999999985675788821354444--4
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEEEEECCCC
Q ss_conf 95599984214770899997327765899999999999999999994994215799996798058999990999844884
Q 001678 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1033)
Q Consensus 878 g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLA 957 (1033)
..++++++++.+++|..++... +.+++..+..++.|++.||+|||+++|+||||||+|||++ ..+.+||+|||.|
T Consensus 74 ~~~~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~----~~~~~kl~DFG~a 148 (292)
T d1unla_ 74 KKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp SEEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred CCEEEEEEECCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCC----CCCCEEEEECCHH
T ss_conf 3115886302332221121235-6540367899999999998774339986001467612113----3782665204601
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 1134553-347767888644641025887665302321000021035774344089999999999069999
Q 001678 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFFFLQFILCFI 1027 (1033)
Q Consensus 958 k~~~~~~-~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILYeLLTGk~PF 1027 (1033)
+...... ......++..|+|||++.... .++.++|+||+||++|+|++|+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----------------~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAK-----------------LYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCS-----------------CCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred HCCCCCCCCCEEECCCCCHHHHHHHCCCC-----------------CCCCHHHCCCCCHHHHHHHHCCCCC
T ss_conf 10468875100103443101466750698-----------------8880444026541889985189999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-35 Score=243.94 Aligned_cols=205 Identities=23% Similarity=0.242 Sum_probs=157.8
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----------CC
Q ss_conf 3588813999964248379999998--5962599983033348992468999999999999997169-----------99
Q 001678 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----------HP 863 (1033)
Q Consensus 797 I~~~dYeiLkkLGkGsFGtVYkAk~--kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~-----------HP 863 (1033)
+.+.+|+++++||+|+||+||+|++ +++.||||+++... .....+.+|+.+++.++ |+
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---------CCHHHHHHHHHHHHHHCCHHHHHHHHCCCC
T ss_conf 44785799899750778189999999999799999983431---------336899999999998401455555422767
Q ss_pred CCCEEEEEEECCCCCCEEEEEEECCCCCHHHH--HHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEEE
Q ss_conf 80038899981899955999842147708999--97327765899999999999999999994-9942157999967980
Q 001678 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF--LQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVN 940 (1033)
Q Consensus 864 NIVkLlGvf~e~e~g~l~LVmEYiegGSL~dl--Lkk~~k~lse~~il~IA~QIlkALeYLHs-kGIIHRDIKPsNILLd 940 (1033)
||+++++++........+++++++..+..... .......+.+..+..++.|++.||.|||+ .+|+||||||+|||++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred CEEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEE
T ss_conf 64789987631256520234320003542000001223467868999999999999988876405864656770570563
Q ss_pred CCCC--CCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCHHHCCCCCCCCHHHHHHHHH
Q ss_conf 5899--99909998448841134553347767888644641025887665302321000021035774344089999999
Q 001678 941 MRDP--QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKVTLFSLKFCCFQLKWSYDCYSLGILFF 1018 (1033)
Q Consensus 941 ~~~~--~~g~VKLiDFGLAk~~~~~~~s~~~~GT~~YmAPEvl~gk~~~~t~ksDIwSLGi~L~eittkvDIWSLGVILY 1018 (1033)
.++. ....+||+|||.+...... .....||+.|+|||++.+.. ++.++|+||+||+++
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~------------------~~~~~DiwSlG~il~ 220 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP------------------WGCGADIWSTACLIF 220 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC------------------CCTHHHHHHHHHHHH
T ss_pred CCCCCCCCCEEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHCCCCC------------------CCCCCCCCCHHHHHH
T ss_conf 0576564430567531442123445--42236652105713214667------------------776432012378999
Q ss_pred HHHCCCCCCCCC
Q ss_conf 999069999898
Q 001678 1019 FLQFILCFIDFF 1030 (1033)
Q Consensus 1019 eLLTGk~PFd~~ 1030 (1033)
+|++|+.||...
T Consensus 221 el~~g~~pF~~~ 232 (362)
T d1q8ya_ 221 ELITGDFLFEPD 232 (362)
T ss_dssp HHHHSSCCC---
T ss_pred HHHHCCCCCCCC
T ss_conf 998788998987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.8e-21 Score=154.45 Aligned_cols=142 Identities=18% Similarity=0.047 Sum_probs=107.1
Q ss_pred CEEEEEECCCCCEEEEEEEE-CCCCEEEEEEECCCCCCC----------CHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 13999964248379999998-596259998303334899----------2468999999999999997169998003889
Q 001678 802 LEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGK----------PSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1033)
Q Consensus 802 YeiLkkLGkGsFGtVYkAk~-kGtkVAIKvik~s~l~~k----------~~erer~ik~FlkEi~ILkkL~HPNIVkLlG 870 (1033)
+.+.++||+|+||+||+|.+ +++.||||+++......+ ..........+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCCCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 99818999559998421477089999732776589999999999999999999499421579999679805899999099
Q 001678 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1033)
Q Consensus 871 vf~e~e~g~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlkALeYLHskGIIHRDIKPsNILLd~~~~~~g~VK 950 (1033)
... .+++|||+.+..+.. ++......++.|++.+|.|||+.+|+||||||+|||++ .. .++
T Consensus 82 ~~~------~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~-~~~ 142 (191)
T d1zara2 82 WEG------NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EE-GIW 142 (191)
T ss_dssp EET------TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TT-EEE
T ss_pred ECC------CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEE----CC-CEE
T ss_conf 628------889999504565420--------01578999999999999998268889836890361142----89-899
Q ss_pred EEECCCCCCCCC
Q ss_conf 984488411345
Q 001678 951 IGDLGLSKVKQQ 962 (1033)
Q Consensus 951 LiDFGLAk~~~~ 962 (1033)
|+|||+|.....
T Consensus 143 liDFG~a~~~~~ 154 (191)
T d1zara2 143 IIDFPQSVEVGE 154 (191)
T ss_dssp ECCCTTCEETTS
T ss_pred EEECCCCCCCCC
T ss_conf 987788430899
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=2.4e-06 Score=56.00 Aligned_cols=141 Identities=17% Similarity=0.084 Sum_probs=86.3
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCCC
Q ss_conf 88139999642483799999985962599983033348992468999999999999997169-99800388999818999
Q 001678 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (1033)
Q Consensus 800 ~dYeiLkkLGkGsFGtVYkAk~kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~-HPNIVkLlGvf~e~e~g 878 (1033)
..|+..+..+.++.+.||+....+..+.+|+......... ..+.+|..++..+. +--+.+++.++.. .+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~--------~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT--------YDVEREKDMMLWLEGKLPVPKVLHFERH--DG 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST--------TCHHHHHHHHHHHTTTSCCCCEEEEEEE--TT
T ss_pred HCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCCH--------HHHHHHHHHHHHHHCCCCCCCEEEEEEC--CC
T ss_conf 3527997678998771899990898699998488765325--------5699999999987606998728999750--89
Q ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHH-----------------------------------------
Q ss_conf 559998421477089999732776589999999999999-----------------------------------------
Q 001678 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF----------------------------------------- 917 (1033)
Q Consensus 879 ~l~LVmEYiegGSL~dlLkk~~k~lse~~il~IA~QIlk----------------------------------------- 917 (1033)
..++||++++|.++.+...... ... .++.++..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~~---~~~---~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDEQ---SPE---KIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTCS---CHH---HHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred CEEEEEEECCCCCCCCCCCCCC---CHH---HHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 6499998604334354334402---699---9999899999998556842143576446565557789987765555430
Q ss_pred ------------HHHHHHHC------CCCCCCCCCCCEEEECCCCCCCEEEEEECCCCCCC
Q ss_conf ------------99999949------94215799996798058999990999844884113
Q 001678 918 ------------GMEYLHGK------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 918 ------------ALeYLHsk------GIIHRDIKPsNILLd~~~~~~g~VKLiDFGLAk~~ 960 (1033)
.+..+... .++|+|+.+.|||++ ++..+-|+||+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK----DGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE----TTEEEEECCCTTCEEE
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEEC----CCCEEEEEECHHCCCC
T ss_conf 33232005799999999844986781789860047642364----9965999602314418
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.28 E-value=2.1e-06 Score=56.43 Aligned_cols=77 Identities=19% Similarity=0.217 Sum_probs=60.9
Q ss_pred CCCCCCCCCCEEEEEEECCCEEECCCCCCCEEEECCCEEEEECCCCCCHHHHHHHHHHHHCC-CEEEEEECCCCCCCCEE
Q ss_conf 98888999990799951198220289999704426931589756899958999999988099-36998628999988265
Q 001678 13 STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEG-AVVLKYQQPDEDLDALV 91 (1033)
Q Consensus 13 ~~~~~~~~~~~vk~mcsygG~i~pr~~d~~l~Y~gG~tri~~v~r~~~~~~l~~kl~~~~~~-~~~~kyqlp~edld~Li 91 (1033)
+..++..+..++|.-+.|+ +|++++.|+.+++|.+|+.++.+.+.. .+.|||+ .|| +-+|
T Consensus 2 ~~~s~~~~~~~ikVKv~~~----------------~D~~~~~l~~~it~~dL~~kI~~rf~~~~~~lkY~--Ded-gd~v 62 (85)
T d1ip9a_ 2 AMGSSTSGLKTTKIKFYYK----------------DDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK--LFD-GSGE 62 (85)
T ss_dssp CCSCCCCCCCCEEEEECBT----------------TCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEEC--CSS-SCCS
T ss_pred CCCCCCCCCCCEEEEEEEC----------------CCEEEEEECCCCCHHHHHHHHHHHHCCCCEEEEEE--CCC-CCEE
T ss_conf 8887889998799999989----------------92999993799889999999999858783689999--689-9978
Q ss_pred EECCHHHHHHHHHHHHH
Q ss_conf 20470669999999977
Q 001678 92 SVVNDDDVINMMEEYEK 108 (1033)
Q Consensus 92 sv~~deDl~~m~~eydr 108 (1033)
+++||+||..+|++..+
T Consensus 63 ~i~sD~Dl~~ai~~~~k 79 (85)
T d1ip9a_ 63 EIKTDSQVSNIIQAKLK 79 (85)
T ss_dssp CCCSHHHHHHHHHTTCC
T ss_pred EEECHHHHHHHHHHCCC
T ss_conf 98378999999972282
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.71 E-value=0.00026 Score=42.83 Aligned_cols=138 Identities=17% Similarity=0.139 Sum_probs=77.8
Q ss_pred EEECCCC-CEEEEEEEECC-CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCCEEEEEEECCCCCCEE
Q ss_conf 9964248-37999999859-6259998303334899246899999999999999716999--800388999818999559
Q 001678 806 RELGSGT-YGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVRDGPDGSLA 881 (1033)
Q Consensus 806 kkLGkGs-FGtVYkAk~kG-tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HP--NIVkLlGvf~e~e~g~l~ 881 (1033)
..+..|. .+.||+...++ ..+++|........ .+..|...++.+... -+.+++.+..+ .+..+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----------~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~ 82 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----------ELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDW 82 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----------CHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEE
T ss_pred EECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH-----------HHHHHHHHHHHHHHCCCCCCCEEEECCC--CCCEE
T ss_conf 8767865477589999389878999958966776-----------8999999999998659998861322245--66159
Q ss_pred EEEEECCCCCHHH--------------HHHH-C-----CCC--CCHHHHHHHH--------------------HHHHHHH
Q ss_conf 9984214770899--------------9973-2-----776--5899999999--------------------9999999
Q 001678 882 TVTEFMVNGSLKQ--------------FLQK-K-----DRT--IDRRKRLIIA--------------------MDAAFGM 919 (1033)
Q Consensus 882 LVmEYiegGSL~d--------------lLkk-~-----~k~--lse~~il~IA--------------------~QIlkAL 919 (1033)
+||++++|.++.+ .+.+ + ... ........-. ......+
T Consensus 83 ~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 83 LLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp EEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred EEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 99874413554322126899999999999987368854488755412468899999987541101134011213799999
Q ss_pred HHHHHC-------CCCCCCCCCCCEEEECCCCCCCEEEEEECCCCCCC
Q ss_conf 999949-------94215799996798058999990999844884113
Q 001678 920 EYLHGK-------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 920 eYLHsk-------GIIHRDIKPsNILLd~~~~~~g~VKLiDFGLAk~~ 960 (1033)
..+... .++|+|+.+.|||++ .+..+-|+||+.+...
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~----~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVE----NGRFSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEE----TTEEEEECCCTTCEEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEE----CCCEEEEEECHHCCCC
T ss_conf 9998718765795678678887635773----7965899985332658
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.71 E-value=0.00032 Score=42.21 Aligned_cols=83 Identities=19% Similarity=0.118 Sum_probs=46.6
Q ss_pred EEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCC-CCCHHHHHHHHHHHHHHHHHHHCC---CCCCCEEEEEEECCCC
Q ss_conf 9999642483799999985--962599983033348-992468999999999999997169---9980038899981899
Q 001678 804 EVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA-GKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDGPD 877 (1033)
Q Consensus 804 iLkkLGkGsFGtVYkAk~k--GtkVAIKvik~s~l~-~k~~erer~ik~FlkEi~ILkkL~---HPNIVkLlGvf~e~e~ 877 (1033)
..+.||.|....||+.... +..+++|........ .+... ....+...|...++.+. ...+.+++.+ + .
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~--~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d--~ 103 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP--LTIDRARIESSALIRQGEHVPHLVPRVFYS--D--T 103 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC--CCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--T
T ss_pred EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCC--CCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--C--C
T ss_conf 699807985276899995799848999617713034677788--877899999999998650579885528998--5--9
Q ss_pred CCEEEEEEECCCCCH
Q ss_conf 955999842147708
Q 001678 878 GSLATVTEFMVNGSL 892 (1033)
Q Consensus 878 g~l~LVmEYiegGSL 892 (1033)
...++|||++.+..+
T Consensus 104 ~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMAVTVMEDLSHLKI 118 (392)
T ss_dssp TTTEEEECCCTTSEE
T ss_pred CCCEEEEECCCCCCC
T ss_conf 887798713577653
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.25 E-value=0.0017 Score=37.40 Aligned_cols=70 Identities=26% Similarity=0.493 Sum_probs=60.1
Q ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCCEEEEEECCCCCCCCEEEECCHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 69315897568999589999999880993699862899998826520470669999999977169999870899990
Q 001678 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (1033)
Q Consensus 47 gG~tri~~v~r~~~~~~l~~kl~~~~~~~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~rlr~flf 123 (1033)
-||-||+.++|.++|.+|..|+.+.+|..+.+-|- + -..+|.++|.+||+.-++..||- +.-+ .||+.|.
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n--~El~IPl~~Q~DLDkAvellDrs-~~~k--sLrilL~ 79 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--N--NELSILLKNQDDLDKAIDILDRS-SSMK--SLRILLL 79 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--C--SSCEEECCSHHHHHHHHHHHHHC-SSCC--SEEEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCEEEEEEE--C--CEEEEECCCHHHHHHHHHHHCCC-CCCC--EEEEEEE
T ss_conf 37068995278842999999999985983646775--6--71788525677789999987169-6633--0699973
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.16 E-value=0.0024 Score=36.47 Aligned_cols=78 Identities=14% Similarity=0.279 Sum_probs=46.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECC---------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC-CCE
Q ss_conf 58881399996424837999999859---------62599983033348992468999999999999997169998-003
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVS 867 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~kG---------tkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPN-IVk 867 (1033)
..+++++ +.|+.|-.-.+|++.... ..|.+++.-.. . .. ....+|..+++.+.-.+ ..+
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~--~~-----idr~~E~~i~~~ls~~gl~Pk 109 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E--TE-----SHLVAESVIFTLLSERHLGPK 109 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C--CH-----HHHHHHHHHHHHHHHTTSSSC
T ss_pred CCCCEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC---C--HH-----HHHHHHHHHHHHHHHCCCCCE
T ss_conf 9301699-99178533434899968877544578981799965996---1--16-----589999999999975799980
Q ss_pred EEEEEECCCCCCEEEEEEECCCCCH
Q ss_conf 8899981899955999842147708
Q 001678 868 FYGIVRDGPDGSLATVTEFMVNGSL 892 (1033)
Q Consensus 868 LlGvf~e~e~g~l~LVmEYiegGSL 892 (1033)
+++++.. .+|+||+++..|
T Consensus 110 ll~~~~~------g~I~efi~g~~l 128 (395)
T d1nw1a_ 110 LYGIFSG------GRLEEYIPSRPL 128 (395)
T ss_dssp EEEEETT------EEEECCCCEEEC
T ss_pred EEEECCC------CEEEEEECCCCC
T ss_conf 8998189------569997345548
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.15 E-value=0.002 Score=37.00 Aligned_cols=71 Identities=25% Similarity=0.443 Sum_probs=60.5
Q ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCCEEEEEECCCCCCCCEEEECCHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 693158975689995899999998809936998628999988265204706699999999771699998708999900
Q 001678 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFS 124 (1033)
Q Consensus 47 gG~tri~~v~r~~~~~~l~~kl~~~~~~~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~rlr~flf~ 124 (1033)
-||-||+.++|.++|.+|..|+.+.+|..+.+-|- + -.-+|.++|.+||+.-++..||- +.-+ .||+.|.-
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n--~EL~IPl~~Q~DLDkAvellDrs-~~~k--sLrilL~~ 80 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--N--NELVIPLTTQDDLDKAVELLDRS-IHMK--SLKILLVI 80 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--E--TTEEEECCCHHHHHHHHHHHHHC-SSCC--SEEEEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCEEEEEEE--C--CEEEEECCCHHHHHHHHHHHCCC-CCCC--CEEEEEEE
T ss_conf 37068995278843899999999985984668885--6--76888625677789999987169-6634--26899995
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.05 E-value=0.0036 Score=35.39 Aligned_cols=69 Identities=19% Similarity=0.307 Sum_probs=50.7
Q ss_pred CCCEEE--EECCCCCCHHHHHHHHHHHHCC-CEEEEEECCCCCCCCEEEECCHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 693158--9756899958999999988099-3699862899998826520470669999999977169999870899990
Q 001678 47 GGETRI--VSLPRDVTYEELMSRMRELYEG-AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (1033)
Q Consensus 47 gG~tri--~~v~r~~~~~~l~~kl~~~~~~-~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~~~~~~~rlr~flf 123 (1033)
||||+- |+.+++.+|.+|..++...++- .+.|||. .+| +-.|.++||+||+.-++-.-+ ....+|++++
T Consensus 12 ~~dt~RF~ls~~~~~~~~~L~~~i~~rf~l~~~~lkY~--Ddd-~e~v~l~~d~dl~E~~~~a~~-----~~~~irl~v~ 83 (85)
T d2bkfa1 12 KNEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--DEE-NEEVSINSQGEYEEALKMAVK-----QGNQLQMQVH 83 (85)
T ss_dssp TTEEEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE--CTT-SCEEEECSHHHHHHHHHHHHH-----TTTEEEEEEE
T ss_pred CCCEEEEEECCCCCCCHHHHHHHHHHHCCCCCCEEEEE--CCC-CCEEEEECHHHHHHHHHHHHC-----CCCEEEEEEE
T ss_conf 78458999648877769999999998669664138987--599-998998068889999999866-----8988999996
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.80 E-value=0.0065 Score=33.70 Aligned_cols=148 Identities=11% Similarity=0.020 Sum_probs=74.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCCCEE-EEE
Q ss_conf 5888139999642483799999985962599983033348992468999999999999997169-----9980038-899
Q 001678 798 KNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----HPNVVSF-YGI 871 (1033)
Q Consensus 798 ~~~dYeiLkkLGkGsFGtVYkAk~kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~-----HPNIVkL-lGv 871 (1033)
....+.-++.|..|.-.+.|+.+.++.++++|++..... .+ .+..|..++..|. -|..+.. -|.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~-~~---------~l~~~~~~l~~L~~~g~pvp~pi~~~~g~ 85 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE-KN---------DLPFFLGLMQHLAAKGLSCPLPLPRKDGE 85 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC----CC---------HHHHHHHHHHHHHHTTCCCCCBCCBTTCC
T ss_pred CCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCC-HH---------HHHHHHHHHHHHHHCCCCCCCCCEECCCC
T ss_conf 999856852378885267389997897289998078999-88---------99999999875430255545564104897
Q ss_pred EECCCCCCEEEEEEECCCCCH--------------HHHHHHCC--------CCC------------------CHHHHHHH
Q ss_conf 981899955999842147708--------------99997327--------765------------------89999999
Q 001678 872 VRDGPDGSLATVTEFMVNGSL--------------KQFLQKKD--------RTI------------------DRRKRLII 911 (1033)
Q Consensus 872 f~e~e~g~l~LVmEYiegGSL--------------~dlLkk~~--------k~l------------------se~~il~I 911 (1033)
....-.+....++.++.+... ...++... ... ........
T Consensus 86 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (316)
T d2ppqa1 86 LLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREE 165 (316)
T ss_dssp SCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHH
T ss_pred CCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHH
T ss_conf 62134125502453114655333204678888899876454443202453101110120024567777653114127999
Q ss_pred HHHHHHHHHHHHH----CCCCCCCCCCCCEEEECCCCCCCEEEEEECCCCCC
Q ss_conf 9999999999994----99421579999679805899999099984488411
Q 001678 912 AMDAAFGMEYLHG----KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1033)
Q Consensus 912 A~QIlkALeYLHs----kGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLAk~ 959 (1033)
+..+...+..... .++||+|+.+.||+++ .+...-|+||+.|..
T Consensus 166 l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~----~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 166 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL----GDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE----TTEEEEECCCTTCEE
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCC----CCCCEEEECCCCCCC
T ss_conf 999987642048554545033378636564020----454126742221236
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.42 E-value=0.0086 Score=32.89 Aligned_cols=133 Identities=14% Similarity=0.051 Sum_probs=66.5
Q ss_pred CCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCC--EEE-----EEEECCCCCCEEE
Q ss_conf 48379999998-596259998303334899246899999999999999716999800--388-----9998189995599
Q 001678 811 GTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV--SFY-----GIVRDGPDGSLAT 882 (1033)
Q Consensus 811 GsFGtVYkAk~-kGtkVAIKvik~s~l~~k~~erer~ik~FlkEi~ILkkL~HPNIV--kLl-----Gvf~e~e~g~l~L 882 (1033)
+--..||++.. +|..+++|+.+..... .+.+..|...+..|....|. ... ..+.. .+..+.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~--~~~~~~ 101 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFA 101 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEE
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEE--EEEEEE
T ss_conf 6120269998389997999984787788---------99999999999999855998787520689805665--347999
Q ss_pred EEEECCCCCHH-----H---------HHHH----C----CCCCCHH----------------------HHHHHHHHHHHH
Q ss_conf 98421477089-----9---------9973----2----7765899----------------------999999999999
Q 001678 883 VTEFMVNGSLK-----Q---------FLQK----K----DRTIDRR----------------------KRLIIAMDAAFG 918 (1033)
Q Consensus 883 VmEYiegGSL~-----d---------lLkk----~----~k~lse~----------------------~il~IA~QIlkA 918 (1033)
+++++.|..+. . .++. . ....+.. .....+..+...
T Consensus 102 l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 181 (325)
T d1zyla1 102 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 181 (325)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 98652776889999999999899999988630357865567789788766568999874769988989999999999999
Q ss_pred HHHHH----HCCCCCCCCCCCCEEEECCCCCCCEEEEEECCCCCCC
Q ss_conf 99999----4994215799996798058999990999844884113
Q 001678 919 MEYLH----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1033)
Q Consensus 919 LeYLH----skGIIHRDIKPsNILLd~~~~~~g~VKLiDFGLAk~~ 960 (1033)
+.-+- ..++||+|+.+.|||++ .+ ..++||+-|...
T Consensus 182 l~~~~~~~~p~~liHgDlh~~NvL~~----~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 182 VTAHWREDFTVLRLHGDCHAGNILWR----DG--PMFVDLDDARNG 221 (325)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES----SS--EEECCCTTCCEE
T ss_pred HHHHCCCCCCCEEECCCCCCCCEEEE----CC--CEEEECHHCCCC
T ss_conf 99845456871202478880428783----89--358865201468
|
| >d1oeyj_ d.15.2.2 (J:) Neutrophil cytosol factor 4 (p40phox component of NADPH oxidase) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Neutrophil cytosol factor 4 (p40phox component of NADPH oxidase) species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.53 E-value=0.44 Score=21.79 Aligned_cols=56 Identities=21% Similarity=0.463 Sum_probs=48.5
Q ss_pred CCCEEEEECCCCC----CHHHHHHHHHHHHCC-CEEEEEECCCCCCCCEEEECCHHHHHHHHHH
Q ss_conf 6931589756899----958999999988099-3699862899998826520470669999999
Q 001678 47 GGETRIVSLPRDV----TYEELMSRMRELYEG-AVVLKYQQPDEDLDALVSVVNDDDVINMMEE 105 (1033)
Q Consensus 47 gG~tri~~v~r~~----~~~~l~~kl~~~~~~-~~~~kyqlp~edld~Lisv~~deDl~~m~~e 105 (1033)
|+.+|=|+|.-+. +|.+|...+...++. +++|-|.=+..| ||-+.+|||+.-|+.|
T Consensus 15 ~~~~rDI~veedl~~~P~ykdLl~lmr~~f~~~dIaLNYrD~eGD---LIRllddeDv~LMv~~ 75 (105)
T d1oeyj_ 15 ISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAEGD---LVRLLSDEDVALMVRQ 75 (105)
T ss_dssp EEEEEEEEECSCTTCCCCHHHHHHHHHHHHCCSSEEEEEECTTSC---EEECCSHHHHHHHHHH
T ss_pred CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCEEEEEEECCCCC---EEEECCHHHHHHHHHH
T ss_conf 640312787200133945999999999773500067630468898---8998361258999987
|
| >d1pqsa_ d.15.2.2 (A:) Cell division control protein 24, CDC24, C-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Cell division control protein 24, CDC24, C-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=88.59 E-value=0.42 Score=21.91 Aligned_cols=57 Identities=19% Similarity=0.281 Sum_probs=44.3
Q ss_pred EEEECCCCCCHHHHHHHHHH-H--HCC-----CEEEEEECCCCCCCCEEEECCHHHHHHHHHHHHHHC
Q ss_conf 58975689995899999998-8--099-----369986289999882652047066999999997716
Q 001678 51 RIVSLPRDVTYEELMSRMRE-L--YEG-----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLG 110 (1033)
Q Consensus 51 ri~~v~r~~~~~~l~~kl~~-~--~~~-----~~~~kyqlp~edld~Lisv~~deDl~~m~~eydr~~ 110 (1033)
=.|.|+.+|+|.+|..|+.+ + |+. ...|||| .|| .-.|++.+|||..--++++....
T Consensus 4 fTLvV~~~i~f~~L~~kI~~Kia~~~~~~~~~~~rlrY~--DeD-GD~V~i~sddd~~~a~~~~~e~~ 68 (77)
T d1pqsa_ 4 FTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ--DED-GDFVVLGSDEDWNVAKEMLAENN 68 (77)
T ss_dssp EEEECTTCCCSHHHHHHHHHHTTTTTSSCSCSTTCCEEE--ETT-TEEEECCSTTHHHHHHHHHHHHC
T ss_pred EEEEEECCCCHHHHHHHHHHHHHHCCCCCCCCCCEEEEE--CCC-CCEEEEECCCHHHHHHHHHHHCC
T ss_conf 999997676789999999999974367787752047887--489-99999845326999999998604
|